data_2lsn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lsn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.626 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 55.7 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.313 0.578 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.484 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 78.2 mm-40 -55.51 -36.85 67.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.253 -0.904 . . . . 0.0 109.138 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.459 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -178.81 -167.71 36.88 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.447 ' CG1' ' CZ ' ' A' ' 11' ' ' TYR . 85.5 t -132.95 144.47 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.133 . . . . 0.0 109.154 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 34' ' ' HIS . 6.8 m-85 -118.21 121.38 40.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 109.925 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 52.7 m-85 -107.81 126.73 52.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 108.85 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.517 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 3.7 p -115.06 150.31 36.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 110.071 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 59.7 t0 -142.22 154.52 44.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.473 -0.767 . . . . 0.0 109.086 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -138.11 138.34 9.49 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.444 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 83.9 p -143.09 160.94 39.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -1.127 . . . . 0.0 109.437 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -146.26 150.44 35.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.668 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.5 HD12 ' CB ' ' A' ' 161' ' ' SER . 62.1 mt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.43 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -99.86 122.02 42.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.338 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -129.58 154.85 46.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.67 163.69 26.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.486 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 42.2 mtm -122.61 140.84 52.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -1.143 . . . . 0.0 109.531 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.446 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -126.19 123.75 4.91 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' ' 47' ' ' TRP . 26.3 mm -112.97 138.31 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -1.174 . . . . 0.0 109.516 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.453 ' CG1' HG21 ' A' ' 43' ' ' VAL . 41.0 t -122.59 135.47 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 109.378 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.688 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 72.5 m-70 -108.02 135.98 48.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 109.547 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.466 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -129.2 170.84 13.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.411 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.452 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 14.2 t -133.99 165.01 26.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.541 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' LYS . 49.6 m-85 -104.43 11.47 34.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.529 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.559 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 1.7 mtmt -51.46 179.46 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.034 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.4 Cg_endo -66.39 -5.15 12.04 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.183 1.922 . . . . 0.0 111.568 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -135.49 106.21 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 0.0 109.128 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.76 123.75 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 109.468 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -158.11 148.55 20.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.602 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.453 HG21 ' CG1' ' A' ' 33' ' ' VAL . 7.6 p -77.87 122.27 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.466 ' CD1' ' C ' ' A' ' 35' ' ' ALA . 6.3 mp -65.01 -39.95 94.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.135 -0.978 . . . . 0.0 109.351 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -173.15 162.47 4.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.364 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.461 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 89.7 mt-30 -112.83 154.72 25.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.393 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -135.26 132.55 37.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 t -122.94 128.1 49.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 109.396 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.43 91.55 40.99 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.543 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.64 133.18 23.41 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.698 2.266 . . . . 0.0 111.747 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 31.1 mt -99.73 147.14 25.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.65 -62.18 0.8 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -108.41 57.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -1.157 . . . . 0.0 109.531 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 80.6 m80 -129.47 177.99 6.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.2 t -124.17 169.08 12.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 109.455 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.38 -41.09 79.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.417 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -61.61 -40.61 95.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 97.0 mtp -70.83 -32.43 69.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.883 . . . . 0.0 109.507 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.64 -33.44 74.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.522 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.85 -47.97 56.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.595 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 13.7 tt -69.42 -38.01 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 109.549 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.509 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -65.8 -31.75 72.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.471 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.517 ' CB ' ' HB ' ' A' ' 12' ' ' THR . . . -65.98 -38.63 89.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.892 . . . . 0.0 109.554 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.527 ' CG2' HG23 ' A' ' 82' ' ' THR . 61.6 t -69.57 -38.11 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.667 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.432 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 71.8 tt0 -69.77 -38.04 76.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 109.123 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.584 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 26.3 t80 -55.75 -66.57 0.4 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.344 -0.847 . . . . 0.0 109.527 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 71' ' ' ALA . . . -59.94 -31.86 70.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.535 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.451 ' O ' HD13 ' A' ' 130' ' ' ILE . 41.3 t -50.65 -56.86 9.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.509 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -64.86 -42.93 94.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.482 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.584 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 63.1 mttm -64.55 -31.5 72.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.468 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 67' ' ' ALA . . . -66.24 -65.44 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.454 HD21 ' CB ' ' A' ' 126' ' ' MET . 0.9 OUTLIER -54.98 -38.71 68.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.307 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 72' ' ' LEU . 25.6 tttt -44.44 -47.25 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.044 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 8.7 mt -52.29 143.06 27.28 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 108.842 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.1 Cg_endo -65.48 -5.96 12.59 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.459 2.106 . . . . 0.0 111.631 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.484 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -129.26 170.1 20.38 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.463 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 49.8 Cg_endo -69.97 140.0 40.84 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.587 2.192 . . . . 0.0 111.801 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.574 HG11 ' CD1' ' A' ' 10' ' ' PHE . 39.5 t -127.59 162.6 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.626 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 7.2 mt -110.96 130.78 55.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 72.0 t -114.05 126.42 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.895 . . . . 0.0 109.527 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.454 HG12 ' HB2' ' A' ' 133' ' ' GLN . 13.8 mt -115.36 142.3 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.299 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.527 HG23 ' CG2' ' A' ' 64' ' ' VAL . 1.1 p -130.47 161.27 31.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 135' ' ' GLU . 55.0 p-10 -87.51 5.16 40.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.517 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.516 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 2.1 m -123.3 123.99 41.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 109.552 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.594 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 66.6 t80 -72.69 -41.62 65.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.349 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 90' ' ' SER . 67.7 t80 -54.01 -58.8 5.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 88' ' ' ALA . 12.7 p -58.31 -46.81 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.365 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.479 ' CA ' HG21 ' A' ' 132' ' ' ILE . . . -56.95 -63.6 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.205 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -57.24 -17.86 13.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.101 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.545 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 8.4 t -66.4 -65.53 0.67 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.299 -0.875 . . . . 0.0 109.258 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.515 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . . . -66.47 -10.56 45.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.489 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -88.32 -42.03 12.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.775 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 96' ' ' PRO . 8.3 ttpp -126.42 -49.24 1.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.167 -0.958 . . . . 0.0 109.775 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.57 ' HB3' ' CE2' ' A' ' 98' ' ' TRP . 73.2 mm-40 -53.53 -41.02 65.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.672 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.538 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -50.69 -63.98 1.57 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 49.8 Cg_endo -70.17 -36.6 9.44 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.708 2.272 . . . . 0.0 111.921 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -67.44 -42.41 83.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.57 ' CE2' ' HB3' ' A' ' 94' ' ' GLU . 18.9 m0 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.519 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.529 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 62.8 m80 60.88 37.68 18.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.42 -38.1 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.463 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 m -57.9 -45.47 86.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.464 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.42 -44.3 95.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.466 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.595 ' CZ2' ' CD1' ' A' ' 61' ' ' ILE . 69.8 m95 -69.4 -34.0 73.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.338 -0.852 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -58.01 -44.42 87.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.414 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.432 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 44.3 m -62.75 -43.42 98.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.362 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.449 HG22 ' SG ' ' A' ' 68' ' ' CYS . 71.9 mt -68.9 -34.21 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.421 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.411 ' HA ' HD12 ' A' ' 95' ' ' LEU . . . -61.87 -33.9 75.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -0.906 . . . . 0.0 109.42 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -64.76 -33.3 75.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.369 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.479 ' SG ' ' CD1' ' A' ' 130' ' ' ILE . 49.2 t -80.83 -52.12 7.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.883 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 128' ' ' PRO . 19.5 tp -62.54 -27.01 68.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.432 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.6 m -68.83 -26.61 65.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.483 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.454 ' CB ' HD21 ' A' ' 72' ' ' LEU . 64.1 mtt -71.25 -32.43 68.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 109.459 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.39 132.86 0.21 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 0.0 109.479 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.46 ' HA ' ' CD1' ' A' ' 124' ' ' LEU . 48.6 Cg_endo -69.78 -2.23 9.83 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.701 2.267 . . . . 0.0 111.719 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 96.8 m-20 -45.95 -26.88 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.439 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.479 ' CD1' ' SG ' ' A' ' 123' ' ' CYS . 64.9 mt -68.13 110.6 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.43 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.1 m -94.03 141.17 28.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.479 HG21 ' CA ' ' A' ' 88' ' ' ALA . 67.2 mt -118.84 137.33 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 109.521 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.454 ' HB2' HG12 ' A' ' 81' ' ' ILE . 86.2 mt-30 -134.84 157.38 46.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.594 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 12.8 t-80 -112.81 126.46 55.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 82' ' ' THR . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.0 m -55.38 -45.01 76.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.525 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -48.76 -49.83 36.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -60.04 -36.63 90.97 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -60.74 -38.07 83.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -1.151 . . . . 0.0 109.571 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.99 -46.69 77.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.564 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 74.8 mt -64.88 -38.92 92.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.63 -35.74 75.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.512 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -60.7 -42.97 98.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.517 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 41.7 mttt -65.92 -40.61 91.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 46' ' ' GLN . 77.2 mt -64.16 -41.47 97.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.541 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.67 96.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 109.584 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 29.0 m -65.53 -37.45 86.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 93.2 mt-30 -65.56 -31.91 73.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.518 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' A' ' 163' ' ' VAL . . . -63.58 -33.57 87.61 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.5 ' CB ' HD12 ' A' ' 17' ' ' ILE . 86.0 p -68.07 -34.36 76.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -1.135 . . . . 0.0 109.508 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -72.08 -22.1 61.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.416 HG21 ' HA2' ' A' ' 160' ' ' GLY . 48.9 t -70.03 -25.92 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.482 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 0.0 109.471 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CE2' HD12 ' A' ' 79' ' ' LEU . 27.4 m-85 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.39 0.614 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.532 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 76.2 mm-40 -71.6 -36.7 70.9 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.38 -0.825 . . . . 0.0 108.941 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.33 -166.36 35.01 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' CG2' ' OH ' ' A' ' 37' ' ' TYR . 85.5 t -140.61 140.68 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -1.111 . . . . 0.0 109.097 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.679 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 24.7 m-85 -117.89 150.78 38.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.995 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.577 ' CE1' HG13 ' A' ' 81' ' ' ILE . 78.3 m-85 -121.87 130.39 53.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 109.093 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.449 ' HA ' HD12 ' A' ' 32' ' ' ILE . 17.2 p -115.66 151.6 34.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.764 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 57.9 t0 -140.62 152.46 45.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 109.347 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -138.43 128.36 4.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 m -133.23 148.62 52.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -1.155 . . . . 0.0 109.349 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -136.58 146.88 46.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.618 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.509 HD13 ' CB ' ' A' ' 161' ' ' SER . 65.1 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 16.5 m120 -104.67 144.08 32.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.428 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -142.97 147.94 36.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.96 157.86 26.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.457 ' HE1' ' HB ' ' A' ' 49' ' ' ILE . 63.2 mtm -128.23 147.99 50.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 0.0 109.584 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.7 122.39 2.35 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 12' ' ' THR . 22.7 mm -110.2 133.68 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -1.186 . . . . 0.0 109.62 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG23 ' CB ' ' A' ' 153' ' ' ALA . 44.6 t -124.33 132.1 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.381 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.679 ' CE1' ' CE1' ' A' ' 10' ' ' PHE . 9.0 t60 -108.21 142.18 38.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.693 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.23 158.99 38.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.441 ' HB ' HD22 ' A' ' 44' ' ' LEU . 11.9 t -122.4 162.64 21.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.526 ' OH ' ' CG2' ' A' ' 9' ' ' VAL . 27.1 m-85 -106.8 5.01 28.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.546 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 1.8 mtpt -51.39 178.79 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 108.959 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.0 Cg_endo -65.91 -5.04 11.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.171 1.914 . . . . 0.0 111.615 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -127.78 106.2 8.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.863 . . . . 0.0 108.946 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -73.96 123.76 24.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.913 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -168.21 133.85 1.86 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.379 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -52.39 118.76 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.528 ' CD1' ' CD2' ' A' ' 34' ' ' HIS . 46.9 mt -64.13 -45.27 89.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 79.0 m-20 -160.17 154.43 23.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -118.13 144.03 46.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.2 -0.937 . . . . 0.0 109.305 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -129.52 142.02 50.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.0 t -132.83 128.0 35.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.349 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.457 ' HB ' ' HE1' ' A' ' 30' ' ' MET . 2.8 mp -125.91 89.29 52.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.421 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 48.2 Cg_endo -69.25 129.05 17.43 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.692 2.261 . . . . 0.0 111.83 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 164' ' ' VAL . 37.0 mt -103.16 147.97 26.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.479 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -120.81 -35.7 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.488 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 41.0 p-10 -119.68 44.16 2.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -1.135 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.518 ' HA ' ' CE ' ' A' ' 58' ' ' MET . 76.1 m80 -129.11 -175.89 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.429 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.0 t -126.5 170.31 12.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.93 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -56.59 -39.08 72.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.385 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 60' ' ' GLU . 77.4 mt-30 -64.08 -67.15 0.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.515 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.518 ' CE ' ' HA ' ' A' ' 54' ' ' HIS . 44.2 mtm -44.94 -28.05 0.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 0.0 109.21 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.39 -37.13 63.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 57' ' ' GLN . 98.9 mt-10 -66.92 -41.93 86.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.542 HD12 ' CD2' ' A' ' 117' ' ' TRP . 20.7 tt -70.5 -38.53 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 109.196 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.487 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -64.49 -39.31 93.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.338 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 12' ' ' THR . . . -52.32 -46.82 66.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.461 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.436 ' CG2' HG13 ' A' ' 87' ' ' VAL . 87.4 t -70.76 -49.24 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.339 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.4 tt0 -53.62 -43.4 68.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.273 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.594 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 10.9 t80 -55.84 -65.34 0.61 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.293 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' HB3' HG13 ' A' ' 80' ' ' VAL . . . -61.33 -15.91 40.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 48.5 t -68.62 -61.14 1.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.298 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -57.67 -48.67 78.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.944 . . . . 0.0 109.354 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.594 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 67.9 mttm -60.65 -42.12 96.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.389 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.526 ' CB ' HG12 ' A' ' 78' ' ' VAL . . . -54.16 -72.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.409 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.521 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 10.0 tt -48.91 -42.56 37.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.949 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 72' ' ' LEU . 80.7 tttt -44.13 -41.93 5.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.94 . . . . 0.0 109.149 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 32.0 mt -54.03 143.88 40.68 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.4 -0.812 . . . . 0.0 108.875 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.5 Cg_endo -65.4 -2.18 5.68 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.58 2.186 . . . . 0.0 112.26 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.532 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -139.44 169.22 24.64 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.458 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 49.2 Cg_endo -69.8 117.06 4.86 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.57 2.18 . . . . 0.0 111.877 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' A' ' 10' ' ' PHE . 5.8 p -110.31 153.6 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.239 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.578 HD12 ' CE2' ' A' ' 6' ' ' TYR . 15.1 mt -96.79 153.07 18.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.588 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 131' ' ' THR . 45.0 t -125.74 128.62 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.577 HG13 ' CE1' ' A' ' 11' ' ' TYR . 22.5 mm -107.99 139.49 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.2 -0.937 . . . . 0.0 109.431 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.9 p -131.07 161.59 31.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.494 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 86.4 m-20 -96.17 2.75 53.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.903 . . . . 0.0 109.531 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.409 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 48.9 m -126.06 130.34 50.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -0.977 . . . . 0.0 109.477 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.588 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 64.9 t80 -74.78 -39.79 61.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.411 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.74 -52.5 63.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.651 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' SER . 50.6 t -61.14 -54.23 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 109.508 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -50.77 -55.85 14.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.159 -0.963 . . . . 0.0 109.397 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.421 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 82.3 tt0 -56.56 -35.59 68.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.615 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 49.0 m -52.58 -51.37 60.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 109.506 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.508 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -88.18 -1.19 57.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.693 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -84.18 -72.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -0.994 . . . . 0.0 109.506 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 21.0 tptp -126.57 -26.6 3.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 109.785 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 46.6 mm-40 -65.17 -29.89 70.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.677 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.507 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -53.69 -59.09 10.45 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 109.668 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 47.0 Cg_endo -67.7 -32.99 29.1 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.679 2.253 . . . . 0.0 111.657 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -67.49 -39.97 85.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.221 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.5 m0 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 109.269 179.773 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 68.7 mttm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.457 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 46.7 m80 64.62 33.21 10.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.428 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 82.5 mt -60.94 -46.47 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -59.52 -46.37 89.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 109.409 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.419 ' HE2' ' SD ' ' A' ' 58' ' ' MET . 45.5 mttp -55.73 -46.44 77.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.863 . . . . 0.0 109.404 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.615 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 53.5 m95 -61.37 -37.66 84.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.882 . . . . 0.0 109.396 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 23.9 mttt -56.82 -43.04 80.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.2 m -57.14 -45.86 83.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.336 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.452 HG12 ' HG3' ' A' ' 65' ' ' GLU . 68.0 mt -67.39 -36.77 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.838 . . . . 0.0 109.496 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.86 76.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.56 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.38 -43.76 98.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.459 ' SG ' HD13 ' A' ' 130' ' ' ILE . 42.5 t -68.08 -44.14 76.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.51 ' CD1' ' HA ' ' A' ' 128' ' ' PRO . 20.8 tp -71.09 -30.49 66.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.249 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.2 t -62.39 -31.84 72.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.488 ' HB2' ' CD1' ' A' ' 72' ' ' LEU . 92.0 mtp -65.34 -31.05 71.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.461 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.37 135.65 0.21 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.582 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.51 ' HA ' ' CD1' ' A' ' 124' ' ' LEU . 48.9 Cg_endo -69.91 -1.81 9.22 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 122.614 2.209 . . . . 0.0 111.501 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 95.1 m-20 -44.02 -44.85 7.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.521 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 45.0 mt -55.27 123.4 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 80' ' ' VAL . 25.4 m -113.87 140.84 48.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.28 -0.887 . . . . 0.0 109.086 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.508 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -125.23 137.22 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.098 -1.001 . . . . 0.0 109.631 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.442 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 95.2 mt-30 -127.4 165.78 19.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.249 -0.907 . . . . 0.0 109.395 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 12.5 t-80 -111.57 138.25 48.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.487 ' CD ' ' CG2' ' A' ' 81' ' ' ILE . 71.0 mt-10 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.439 ' CD2' ' OH ' ' A' ' 11' ' ' TYR . 59.3 m170 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.405 ' HA ' ' OD1' ' A' ' 150' ' ' ASN . 60.3 p -60.72 -39.46 88.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.48 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -48.89 -51.03 32.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.848 . . . . 0.0 109.38 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.49 -40.84 62.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' HA ' ' A' ' 147' ' ' THR . 23.1 m120 -56.52 -45.58 81.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -1.101 . . . . 0.0 109.337 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.0 -55.47 30.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.329 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.9 -45.97 82.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.349 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.425 ' CB ' HG23 ' A' ' 33' ' ' VAL . . . -58.67 -41.82 87.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.436 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.462 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 87.7 m-20 -54.08 -44.86 71.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 22.7 mttp -59.87 -42.04 92.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.309 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 64.8 mt -67.07 -37.04 83.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.501 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.83 88.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.861 . . . . 0.0 109.408 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 46.1 m -61.76 -39.87 93.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.362 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 95.0 mt-30 -63.32 -33.3 75.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.439 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.435 ' HA2' HG21 ' A' ' 163' ' ' VAL . . . -55.46 -40.04 75.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.509 ' CB ' HD13 ' A' ' 17' ' ' ILE . 83.8 p -64.02 -35.36 80.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.122 . . . . 0.0 109.494 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -69.93 -22.65 63.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.435 HG21 ' HA2' ' A' ' 160' ' ' GLY . 38.9 t -65.18 -25.63 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 51' ' ' LEU . 18.4 m . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.538 ' CG ' HD11 ' A' ' 79' ' ' LEU . 94.3 m-85 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 24.5 tp10 -61.46 -35.03 76.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 109.381 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.461 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.59 -166.01 34.08 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 35' ' ' ALA . 5.7 p -134.85 143.89 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -1.136 . . . . 0.0 109.223 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.653 ' CZ ' ' CD2' ' A' ' 34' ' ' HIS . 32.3 m-85 -119.76 132.42 55.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.656 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.452 ' CE1' HD13 ' A' ' 81' ' ' ILE . 95.6 m-85 -112.14 125.09 53.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 109.052 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.51 ' HB ' ' CD1' ' A' ' 32' ' ' ILE . 28.3 p -115.99 146.11 42.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 109.812 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 30' ' ' MET . 66.5 t0 -144.93 137.97 26.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.438 -0.789 . . . . 0.0 109.341 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -139.61 126.14 3.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 t -143.48 154.06 43.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -1.162 . . . . 0.0 109.543 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -115.1 142.83 46.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.549 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.58 ' CD1' ' CB ' ' A' ' 161' ' ' SER . 70.1 mt . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 41.5 p30 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -99.46 109.42 21.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -106.11 143.4 34.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.9 155.55 26.56 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.504 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 58.2 mtm -127.32 159.82 33.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -1.166 . . . . 0.0 109.512 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -143.95 122.16 1.77 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 66' ' ' PHE . 26.9 mm -124.0 111.98 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.354 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.521 ' CG2' ' HG2' ' A' ' 46' ' ' GLN . 10.9 p -115.66 160.21 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.753 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.653 ' CD2' ' CZ ' ' A' ' 10' ' ' PHE . 7.4 t-160 -116.05 144.98 43.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.364 -0.835 . . . . 0.0 109.346 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.525 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -132.3 169.49 16.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -125.95 166.58 16.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 0.0 109.369 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 38' ' ' LYS . 60.5 m-85 -105.28 10.13 33.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.555 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.37 179.59 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 109.1 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 44.0 Cg_endo -66.58 -4.53 11.1 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.128 1.885 . . . . 0.0 111.693 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.438 ' OE2' ' NE2' ' A' ' 42' ' ' GLN . 80.4 tt0 -132.93 105.82 7.33 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.37 -0.831 . . . . 0.0 108.861 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 54.4 t80 -57.57 125.32 22.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.235 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 80.5 mt-30 -158.13 142.01 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.749 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.463 ' HB ' ' CG2' ' A' ' 33' ' ' VAL . 29.0 m -78.99 118.66 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -0.85 . . . . 0.0 109.391 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.488 HD11 ' ND1' ' A' ' 34' ' ' HIS . 24.4 mt -60.59 -46.2 91.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.171 -0.956 . . . . 0.0 109.317 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 33' ' ' VAL . 35.3 m120 -159.96 146.59 16.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.368 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.521 ' HG2' ' CG2' ' A' ' 33' ' ' VAL . 78.4 mt-30 -107.6 148.2 29.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.393 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.52 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 5.6 t-105 -132.07 140.83 48.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -0.953 . . . . 0.0 109.755 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.1 p -128.43 141.92 51.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.263 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.41 HD12 ' CE2' ' A' ' 66' ' ' PHE . 3.4 mt -135.11 94.68 15.75 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.609 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.495 ' CG ' HG12 ' A' ' 163' ' ' VAL . 51.1 Cg_endo -70.85 134.82 26.5 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.688 2.259 . . . . 0.0 111.718 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.427 ' O ' HG13 ' A' ' 164' ' ' VAL . 45.4 mt -104.35 140.14 38.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.47 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.503 ' HA2' ' CG2' ' A' ' 164' ' ' VAL . . . -86.92 -69.56 1.32 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -122.51 79.38 1.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -1.133 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -133.55 179.07 6.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.41 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.5 t -116.86 168.89 9.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 0.0 109.538 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -63.38 -29.69 70.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -68.3 -42.78 78.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.8 mtm -76.46 -26.93 55.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.457 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.04 -35.05 61.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.511 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 56' ' ' ALA . 98.7 mt-10 -73.71 -38.71 64.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.625 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 20.2 tt -71.03 -28.17 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 0.0 109.586 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.504 ' CB ' ' SD ' ' A' ' 30' ' ' MET . . . -74.81 -36.68 62.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.556 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.469 ' O ' HG21 ' A' ' 12' ' ' THR . . . -57.51 -39.19 75.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.14 -0.975 . . . . 0.0 109.677 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.467 ' CG2' ' CG1' ' A' ' 87' ' ' VAL . 77.9 t -75.45 -46.83 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 0.0 109.805 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.506 ' HG3' ' CG1' ' A' ' 120' ' ' ILE . 84.0 tt0 -60.28 -35.75 76.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.668 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.533 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 11.4 t80 -57.79 -68.67 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.675 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -61.67 -14.18 29.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.66 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 41.8 t -69.86 -60.34 2.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.454 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.439 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 65.4 tttm -61.28 -45.26 95.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.641 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 32.5 mttp -60.39 -34.11 73.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.577 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 67' ' ' ALA . . . -61.27 -58.92 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 109.443 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.527 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 2.9 tt -53.22 -46.36 69.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 72' ' ' LEU . 13.2 ttpt -42.88 -47.19 5.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 109.257 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.534 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 22.7 mm -48.9 141.93 9.84 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 108.794 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.7 Cg_endo -66.12 -4.9 11.16 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.514 2.143 . . . . 0.0 111.687 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.78 165.71 24.48 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 47.5 Cg_endo -68.87 131.44 22.52 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 122.545 2.164 . . . . 0.0 111.596 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.574 HG12 ' CD2' ' A' ' 10' ' ' PHE . 68.8 t -121.57 167.51 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.451 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.538 HD11 ' CG ' ' A' ' 6' ' ' TYR . 7.0 mp -115.82 130.49 56.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.538 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 ' CB ' ' A' ' 67' ' ' ALA . 96.9 t -104.36 134.94 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.387 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.452 HD13 ' CE1' ' A' ' 11' ' ' TYR . 40.7 mt -120.58 137.33 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.528 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.9 t -143.48 161.68 37.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.429 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 58.8 p30 -89.79 25.14 2.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.462 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.2 m -128.54 117.08 20.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.216 -0.928 . . . . 0.0 109.447 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.542 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 71.6 t80 -77.29 -44.98 27.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -58.44 -45.02 89.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.467 ' CG1' ' CG2' ' A' ' 64' ' ' VAL . 95.2 t -61.81 -49.66 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.462 ' HA ' HG23 ' A' ' 132' ' ' ILE . . . -57.33 -49.28 76.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.326 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -61.43 -36.62 80.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.638 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 47.7 t -53.16 -47.35 68.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.472 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 120' ' ' ILE . . . -92.48 -0.66 57.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 43.2 t-20 -87.17 -72.97 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.87 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 97.7 mttt -127.1 -23.95 3.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.551 ' HG2' ' CE2' ' A' ' 98' ' ' TRP . 42.6 tt0 -67.08 -27.48 67.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.961 -1.087 . . . . 0.0 109.755 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.528 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.5 OUTLIER -57.09 -57.86 21.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 109.59 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 43.8 Cg_endo -66.64 -24.72 47.78 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.452 2.101 . . . . 0.0 111.136 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -72.15 -36.72 69.4 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.551 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 38.6 m0 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.507 -0.745 . . . . 0.0 108.991 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 57.9 mttp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.294 0.569 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.537 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 55.4 m80 65.28 35.65 7.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.792 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 53.8 mt -67.36 -45.19 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.185 -0.947 . . . . 0.0 109.329 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 t -51.08 -47.62 61.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.22 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.66 -38.21 84.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.638 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 27.6 m95 -69.6 -40.28 76.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 109.351 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -55.06 -41.54 71.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.391 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.407 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 22.9 t -58.58 -45.77 88.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.506 ' CG1' ' HG3' ' A' ' 65' ' ' GLU . 79.4 mt -69.07 -36.22 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.378 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.81 93.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 126' ' ' MET . 83.1 tt0 -54.59 -40.61 69.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 109.409 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 1.3 m -76.6 -50.29 14.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.385 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.1 tt -57.78 -37.44 73.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.464 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.8 m -59.93 -33.07 71.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.507 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.451 ' HB2' HD13 ' A' ' 72' ' ' LEU . 88.4 mtp -64.85 -36.06 83.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.85 . . . . 0.0 109.463 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.35 143.85 0.24 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 129' ' ' ASP . 48.6 Cg_endo -69.5 -2.12 9.43 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.738 2.292 . . . . 0.0 111.734 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.479 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 92.8 m-20 -43.18 -38.25 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.358 -0.839 . . . . 0.0 109.4 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 54.9 mt -68.59 109.44 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.461 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 97.2 m -110.03 146.94 34.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.273 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.462 HG23 ' HA ' ' A' ' 88' ' ' ALA . 64.2 mt -120.62 145.7 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.421 ' HB2' HG12 ' A' ' 81' ' ' ILE . 88.8 mt-30 -124.99 155.2 40.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.401 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.542 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 32.3 t-80 -110.53 128.56 55.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.384 179.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.26 0.552 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 47.6 m -67.83 -35.47 78.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.53 -39.41 67.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -66.07 -37.86 93.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -65.09 -32.46 74.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -1.102 . . . . 0.0 109.361 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -66.76 -52.65 41.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.882 . . . . 0.0 109.514 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 59.1 mt -64.81 -46.78 80.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.56 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -54.48 -39.46 67.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.579 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -68.15 -36.99 80.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 66.3 mttm -56.43 -43.87 79.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.562 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.489 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 6.4 mp -72.11 -36.09 69.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.551 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.29 82.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.498 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 30.5 m -63.92 -41.57 97.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.56 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 94.5 mt-30 -66.17 -28.61 68.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.499 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.06 -39.67 97.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.58 ' CB ' ' CD1' ' A' ' 17' ' ' ILE . 25.0 m -60.79 -38.87 86.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.115 . . . . 0.0 109.516 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -66.99 -30.02 70.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.495 HG12 ' CG ' ' A' ' 50' ' ' PRO . 63.4 t -58.56 -38.0 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.575 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.503 ' CG2' ' HA2' ' A' ' 52' ' ' GLY . 12.3 p . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.604 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 99.0 m-85 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.463 ' HB2' HG22 ' A' ' 78' ' ' VAL . 70.0 mm-40 -68.57 -36.91 79.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.152 -0.967 . . . . 0.0 109.283 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.66 -174.13 44.61 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.437 HG21 ' CE2' ' A' ' 37' ' ' TYR . 90.4 t -137.98 136.34 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -1.106 . . . . 0.0 109.317 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.684 ' CE2' ' CG ' ' A' ' 34' ' ' HIS . 47.6 m-85 -118.88 137.76 53.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.742 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.558 ' CE2' HG13 ' A' ' 81' ' ' ILE . 23.2 m-85 -108.0 130.78 55.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.198 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.524 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 19.6 p -116.5 147.65 41.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 109.621 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CG ' ' OD1' ' A' ' 154' ' ' ASP . 23.3 t70 -148.56 153.51 38.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.6 126.23 3.38 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.6 m -128.68 153.51 47.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -1.148 . . . . 0.0 109.409 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.473 ' HB2' ' CA ' ' A' ' 56' ' ' ALA . . . -139.94 144.63 37.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.526 HD13 ' CB ' ' A' ' 161' ' ' SER . 38.0 mt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 89.2 m-20 -95.55 136.81 35.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.434 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 51' ' ' LEU . . . -145.71 149.47 34.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.504 ' HA2' ' CD1' ' A' ' 51' ' ' LEU . . . -157.78 164.44 33.16 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.498 ' CE ' ' HB ' ' A' ' 49' ' ' ILE . 66.2 mtm -123.19 163.51 20.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -1.156 . . . . 0.0 109.421 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.45 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -148.45 119.54 1.09 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 11' ' ' TYR . 24.8 mm -114.64 137.03 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -1.17 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.2 t -123.38 136.09 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.684 ' CG ' ' CE2' ' A' ' 10' ' ' PHE . 4.1 t60 -110.23 135.02 51.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.658 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.01 164.61 27.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.294 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.2 t -131.71 166.74 20.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 109.599 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.437 ' CE2' HG21 ' A' ' 9' ' ' VAL . 66.3 m-85 -100.64 11.63 39.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 109.406 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.555 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -51.29 179.65 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.328 -0.857 . . . . 0.0 109.05 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.6 Cg_endo -66.29 -5.0 11.56 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.122 1.881 . . . . 0.0 111.65 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -135.95 106.07 6.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.368 -0.832 . . . . 0.0 109.049 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 54.7 t80 -67.46 122.7 18.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.31 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 82.4 mt-30 -159.4 142.46 14.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 46.2 t -64.96 110.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.575 HD13 ' CD2' ' A' ' 34' ' ' HIS . 35.1 mt -57.14 -48.72 77.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 79.8 m-20 -159.76 153.74 23.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.426 ' HB3' HD11 ' A' ' 156' ' ' LEU . 91.0 mt-30 -109.48 146.47 34.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.45 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.4 t-105 -131.24 135.52 47.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 0.0 109.722 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.9 t -130.29 130.16 44.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 109.261 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.542 HD11 ' CD2' ' A' ' 66' ' ' PHE . 3.1 mp -131.65 98.69 17.71 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 109.741 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 51.3 Cg_endo -71.57 136.48 28.42 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.601 2.201 . . . . 0.0 111.676 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.554 ' HB3' ' CG ' ' A' ' 54' ' ' HIS . 3.3 mp -103.7 140.37 37.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 53' ' ' ASN . . . -103.34 113.38 4.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 52' ' ' GLY . 47.7 t30 75.63 36.64 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -1.157 . . . . 0.0 109.55 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.554 ' CG ' ' HB3' ' A' ' 51' ' ' LEU . 76.9 m80 -120.26 171.55 8.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.17 170.18 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.26 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.473 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . -56.98 -35.26 68.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.017 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 60' ' ' GLU . 89.7 mt-30 -70.14 -58.27 3.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 0.0 109.345 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.503 ' HE3' ' CD2' ' A' ' 54' ' ' HIS . 97.6 mtp -44.77 -30.72 1.01 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.304 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' A' ' 51' ' ' LEU . . . -77.62 -34.57 53.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.379 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 57' ' ' GLN . 97.0 mt-10 -63.33 -41.9 98.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 109.567 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.558 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 12.8 tt -71.56 -37.36 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.517 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -67.14 -31.66 72.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.308 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.524 ' CB ' ' HB ' ' A' ' 12' ' ' THR . . . -66.97 -38.6 86.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.488 ' CG2' HG23 ' A' ' 87' ' ' VAL . 85.3 t -69.91 -40.34 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -69.11 -39.81 78.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.56 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 19.2 t80 -58.77 -64.35 0.96 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.359 -0.838 . . . . 0.0 109.477 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.82 -32.88 69.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.421 ' O ' HD13 ' A' ' 130' ' ' ILE . 43.0 t -51.63 -52.64 46.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 67.8 mttm -64.5 -42.25 95.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.56 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 64.3 mttm -62.62 -37.81 87.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.562 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.71 -61.9 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 18.9 tp -55.21 -42.01 72.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.459 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 72' ' ' LEU . 64.9 tttt -45.17 -40.95 7.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.29 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 32.6 mm -59.1 143.07 85.01 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 108.899 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.3 Cg_endo -64.08 -5.87 10.22 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.53 2.153 . . . . 0.0 111.871 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.456 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -134.85 170.6 22.74 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 49.7 Cg_endo -69.27 135.6 32.06 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.392 2.061 . . . . 0.0 111.771 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.524 HG12 ' CD1' ' A' ' 10' ' ' PHE . 58.0 t -124.4 158.14 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.875 . . . . 0.0 109.374 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.604 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 14.2 mt -108.32 144.71 35.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.213 -0.929 . . . . 0.0 109.424 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 132' ' ' ILE . 13.6 m -123.48 143.92 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.558 HG13 ' CE2' ' A' ' 11' ' ' TYR . 26.1 mm -114.01 133.56 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.339 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 p -127.18 161.76 27.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.476 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -98.99 14.16 30.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 109.523 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 27.2 t -137.96 125.77 22.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.618 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 48.8 p90 -77.2 -36.63 54.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.456 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -53.79 -50.18 66.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.488 HG23 ' CG2' ' A' ' 64' ' ' VAL . 14.9 p -67.26 -44.72 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.907 . . . . 0.0 109.409 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.437 ' N ' ' CG1' ' A' ' 87' ' ' VAL . . . -54.89 -47.92 73.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 77.3 mm-40 -62.22 -40.27 95.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.594 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 64.4 m -50.79 -44.96 58.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 132' ' ' ILE . . . -94.51 -0.9 54.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.731 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 56.1 t30 -89.67 -72.93 0.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.581 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 65.0 tttm -127.05 -31.84 2.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 109.774 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 92.6 mt-10 -55.52 -34.23 64.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 0.0 109.743 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.497 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 0.8 OUTLIER -56.18 -62.13 5.33 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 109.581 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 44.5 Cg_endo -66.93 -32.71 34.97 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.836 2.357 . . . . 0.0 111.746 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -67.75 -38.24 83.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.164 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.9 m0 . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.288 -0.883 . . . . 0.0 109.259 179.779 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 73.6 mttt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.218 0.532 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 55.8 m80 63.42 27.68 15.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.619 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.8 mt -57.51 -41.46 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.312 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.5 m -50.3 -47.3 55.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.264 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -60.57 -45.16 94.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.321 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.594 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 22.8 m95 -65.7 -40.6 92.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.349 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -52.34 -49.82 63.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.333 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.2 m -55.67 -45.55 77.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.294 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.456 HG23 ' HB2' ' A' ' 91' ' ' ALA . 76.8 mt -67.95 -37.99 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 109.374 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -53.57 -42.38 67.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -54.6 -43.7 72.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 109.369 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 1.6 m -63.87 -49.16 73.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.425 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.5 tp -64.28 -33.05 74.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.3 m -61.8 -32.67 72.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.0 109.62 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.509 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 91.9 mmm -65.67 -28.94 69.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 163.37 146.87 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.559 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.5 Cg_endo -69.91 -1.87 9.33 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.672 2.248 . . . . 0.0 111.657 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 85.6 m-20 -43.42 -34.2 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -0.811 . . . . 0.0 109.503 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 45.9 mt -72.62 123.59 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.584 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.536 ' HB ' ' CD2' ' A' ' 79' ' ' LEU . 40.0 m -119.01 139.06 52.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 109.238 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.53 ' HA ' ' CG2' ' A' ' 80' ' ' VAL . 73.0 mt -119.76 137.33 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.664 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.512 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 94.8 mt-30 -120.62 155.63 33.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.365 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.618 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 19.9 t-80 -114.7 135.87 53.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.452 ' OE1' ' ND2' ' A' ' 150' ' ' ASN . 65.5 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.322 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.406 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 92.6 m-70 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 42.7 m -55.21 -48.81 73.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.5 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 152' ' ' LEU . 85.7 tt0 -49.04 -49.48 41.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.457 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -56.85 -39.08 87.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.452 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 87.7 m-20 -64.84 -35.8 82.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -1.123 . . . . 0.0 109.365 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.64 -47.11 86.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.413 ' CD1' ' O ' ' A' ' 148' ' ' GLU . 6.5 mp -65.25 -37.05 86.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.409 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.0 -41.66 90.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.915 . . . . 0.0 109.544 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.404 ' OD1' ' CG ' ' A' ' 13' ' ' ASP . 83.0 m-20 -57.6 -47.92 80.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.545 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -55.25 -48.01 74.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.515 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.45 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 62.7 mt -60.52 -38.76 85.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.568 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.05 -42.53 72.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 47.4 p -70.02 -30.94 68.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.569 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -62.66 -36.89 84.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -60.13 -37.82 93.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.526 ' CB ' HD13 ' A' ' 17' ' ' ILE . 14.5 m -59.95 -42.11 93.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.477 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.44 -25.33 68.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.72 -23.36 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.398 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 161' ' ' SER . 38.5 t . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.592 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 54.6 m-85 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.289 0.566 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.522 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 74.8 mm-40 -55.51 -38.27 68.97 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.217 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.458 ' O ' HG11 ' A' ' 78' ' ' VAL . . . -178.82 -175.52 45.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.436 HG22 ' CE2' ' A' ' 37' ' ' TYR . 74.7 t -133.53 137.61 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -1.081 . . . . 0.0 109.167 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.682 ' CZ ' ' CD2' ' A' ' 34' ' ' HIS . 57.0 m-85 -117.67 134.76 54.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.126 -0.984 . . . . 0.0 110.014 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.589 ' CE2' ' CD1' ' A' ' 81' ' ' ILE . 38.1 m-85 -107.49 129.12 54.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.034 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.444 ' CG2' HD13 ' A' ' 32' ' ' ILE . 12.8 p -118.48 147.65 43.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.862 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 65.5 t0 -138.31 146.46 42.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.481 -0.762 . . . . 0.0 109.143 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -135.17 136.92 8.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.4 p -143.47 161.88 37.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -1.139 . . . . 0.0 109.301 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -153.39 145.85 24.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.464 HD12 HG23 ' A' ' 17' ' ' ILE . 68.1 mt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.358 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.236 0.541 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 90.3 m-20 -105.31 135.96 45.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 51' ' ' LEU . . . -139.36 146.44 40.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.708 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 50' ' ' PRO . . . -137.18 159.06 24.59 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.423 ' HB2' ' HB ' ' A' ' 49' ' ' ILE . 66.6 mtm -131.89 151.21 51.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -1.148 . . . . 0.0 109.483 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -134.03 127.96 4.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.504 HG13 ' CD2' ' A' ' 66' ' ' PHE . 23.9 mm -115.6 135.72 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.489 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.0 t -126.25 135.01 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.682 ' CD2' ' CZ ' ' A' ' 10' ' ' PHE . 14.0 t-160 -111.4 127.54 55.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 109.538 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.52 171.65 8.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -129.9 165.86 21.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.436 ' CE2' HG22 ' A' ' 9' ' ' VAL . 55.3 m-85 -100.2 13.07 35.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 109.449 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.562 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.32 179.94 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 108.939 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.0 Cg_endo -66.41 -4.85 11.45 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.136 1.89 . . . . 0.0 111.707 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.443 ' CD ' ' NE2' ' A' ' 42' ' ' GLN . 83.7 tt0 -138.11 106.16 5.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -0.847 . . . . 0.0 109.041 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -54.44 121.5 8.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.462 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.443 ' NE2' ' CD ' ' A' ' 40' ' ' GLU . 91.1 mt-30 -152.74 156.6 39.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 43' ' ' VAL . 21.0 m -89.62 118.13 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' A' ' 34' ' ' HIS . 39.5 mt -58.49 -45.62 88.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.362 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 74.9 m-20 -162.71 168.45 21.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.425 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -121.7 145.07 48.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.436 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 2.9 t-105 -128.85 140.03 51.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -125.35 128.8 48.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 2.7 mp -127.17 86.94 57.65 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.622 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HB3' HG22 ' A' ' 163' ' ' VAL . 51.0 Cg_endo -70.65 130.53 18.39 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.746 2.297 . . . . 0.0 111.699 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 28' ' ' ALA . 43.9 mt -107.19 153.03 23.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 109.452 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -124.74 -40.95 0.4 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -108.0 32.07 5.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -1.113 . . . . 0.0 109.514 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 78.9 m80 -120.15 145.7 46.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.542 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.93 168.34 12.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.201 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -48.81 -38.95 23.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.135 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 60' ' ' GLU . 91.0 mt-30 -70.39 -58.26 3.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.459 ' O ' HG21 ' A' ' 61' ' ' ILE . 95.3 mtp -44.95 -30.48 1.02 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.352 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.67 -36.81 57.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' GLN . 98.8 mt-10 -65.49 -40.04 92.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.557 HD11 ' CZ2' ' A' ' 117' ' ' TRP . 20.5 tt -70.79 -34.57 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.509 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -69.41 -33.7 73.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.854 . . . . 0.0 109.45 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.17 91.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.524 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 96.3 t -70.79 -50.46 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.561 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' A' ' 120' ' ' ILE . 86.7 tt0 -59.17 -40.43 85.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.593 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.57 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 17.0 t80 -53.89 -70.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.908 . . . . 0.0 109.632 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.527 ' HB1' ' CG1' ' A' ' 80' ' ' VAL . . . -64.19 -10.96 26.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -0.906 . . . . 0.0 109.648 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 37.7 t -75.51 -56.34 4.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -63.25 -41.23 99.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.57 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 44.4 mttp -66.02 -34.68 78.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.94 -58.93 6.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.527 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 9.3 tt -55.4 -45.12 76.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 72' ' ' LEU . 58.2 tttm -43.27 -41.75 4.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 30.0 mm -56.52 143.15 68.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.304 -0.872 . . . . 0.0 108.736 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.1 Cg_endo -64.33 -5.01 8.93 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.729 2.286 . . . . 0.0 112.086 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.522 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -136.22 171.87 22.64 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 49.7 Cg_endo -70.1 132.33 22.57 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.44 2.094 . . . . 0.0 111.806 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.551 HG13 ' CD1' ' A' ' 10' ' ' PHE . 60.2 t -120.61 161.86 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.442 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.592 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 14.5 mt -107.83 137.73 45.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.527 ' CG1' ' HB1' ' A' ' 67' ' ' ALA . 45.6 t -116.62 130.22 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.589 ' CD1' ' CE2' ' A' ' 11' ' ' TYR . 35.4 mt -117.56 136.16 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.0 109.501 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.8 t -139.51 159.71 41.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -88.99 19.74 3.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.535 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.2 t -122.55 116.8 24.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 109.521 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.567 ' CG ' ' N ' ' A' ' 86' ' ' TYR . 38.9 p90 -77.27 -45.31 26.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.489 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.567 ' N ' ' CG ' ' A' ' 85' ' ' PHE . 69.9 t80 -55.7 -48.87 74.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' SER . 86.8 t -60.13 -49.42 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.318 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.501 ' CB ' HG23 ' A' ' 132' ' ' ILE . . . -53.24 -55.01 27.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.221 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 96.1 mt-10 -58.5 -28.39 65.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.325 -0.859 . . . . 0.0 109.391 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.627 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 23.9 m -59.88 -45.97 90.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.526 ' HB1' ' CD1' ' A' ' 132' ' ' ILE . . . -92.36 -0.74 57.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 109.774 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 82.3 m-20 -86.96 -68.19 0.76 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.004 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 67.8 mttm -122.19 -34.58 3.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 109.9 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.533 ' OE1' ' CZ2' ' A' ' 98' ' ' TRP . 83.4 mt-10 -62.41 -32.95 73.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 109.612 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.503 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -55.92 -59.65 11.0 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.416 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 46.1 Cg_endo -67.72 -32.53 29.97 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.707 2.272 . . . . 0.0 111.444 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -73.0 -37.31 67.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 108.954 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.533 ' CZ2' ' OE1' ' A' ' 94' ' ' GLU . 15.1 m0 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.369 -0.832 . . . . 0.0 109.17 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.405 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 58.4 m80 59.77 42.99 15.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.88 . . . . 0.0 109.438 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.45 HG22 ' HE3' ' A' ' 118' ' ' LYS . 91.9 mt -65.04 -42.68 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.466 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -61.87 -39.84 93.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -60.66 -44.77 96.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.627 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 52.7 m95 -65.03 -38.53 91.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.427 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.45 ' HE3' HG22 ' A' ' 114' ' ' ILE . 52.0 mttt -58.69 -37.54 76.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.8 m -62.85 -43.48 98.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.372 -0.83 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.449 HD11 ' HB2' ' A' ' 65' ' ' GLU . 73.0 mt -69.86 -35.69 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.49 ' HB3' ' CD1' ' A' ' 95' ' ' LEU . . . -64.76 -34.37 78.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -53.03 -37.24 61.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.436 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.459 ' HB3' HD12 ' A' ' 130' ' ' ILE . 12.4 m -83.63 -45.37 13.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.49 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.458 ' CD2' ' HB ' ' A' ' 130' ' ' ILE . 53.1 mt -61.57 -31.44 71.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.437 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 121' ' ' ALA . 31.0 m -56.41 -36.55 69.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.441 ' HB2' HD11 ' A' ' 72' ' ' LEU . 88.7 mtp -63.92 -36.8 85.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 171.24 157.32 0.22 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.5 Cg_endo -72.15 3.7 3.83 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.739 2.292 . . . . 0.0 112.061 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 85.7 m-20 -42.36 -35.71 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.212 -0.93 . . . . 0.0 109.623 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 62.8 mt -75.17 116.26 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 109.402 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.454 ' HB ' HD21 ' A' ' 79' ' ' LEU . 31.3 m -110.88 142.55 42.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.368 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.526 ' CD1' ' HB1' ' A' ' 91' ' ' ALA . 62.0 mt -120.74 137.13 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.66 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB2' HG12 ' A' ' 81' ' ' ILE . 88.5 mt-30 -118.65 165.2 14.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -0.888 . . . . 0.0 109.36 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.526 ' CD2' ' HB3' ' A' ' 85' ' ' PHE . 29.4 t-80 -120.56 133.64 55.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.513 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.451 ' OE2' HG21 ' A' ' 81' ' ' ILE . 93.6 mt-10 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.426 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.1 m -55.29 -45.59 76.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -51.67 -43.38 62.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.04 -39.04 89.01 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -1.139 . . . . 0.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -57.93 -51.72 68.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.417 HD11 ' N ' ' A' ' 152' ' ' LEU . 7.0 mp -65.46 -44.73 86.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 109.526 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.2 87.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.577 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.453 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 58.4 t0 -61.81 -38.04 86.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 24.1 mttm -62.96 -40.58 98.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.568 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 61.7 mt -72.09 -37.22 69.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.537 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.22 -44.51 75.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.47 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 31.1 m -61.03 -41.84 97.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.54 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 94.4 mt-30 -67.29 -26.66 66.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.485 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.478 ' O ' ' CG2' ' A' ' 163' ' ' VAL . . . -66.28 -26.73 72.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.6 p -76.06 -25.37 55.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -1.157 . . . . 0.0 109.457 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -81.36 -25.59 36.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.489 HG21 ' N ' ' A' ' 164' ' ' VAL . 5.1 m -62.76 -24.92 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.489 ' N ' HG21 ' A' ' 163' ' ' VAL . 41.3 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.586 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 50.1 m-85 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.512 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 31.8 tp10 -59.47 -37.1 77.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.268 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 9' ' ' VAL . . . -178.69 -169.45 39.39 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.569 HG22 ' CZ ' ' A' ' 37' ' ' TYR . 70.2 t -142.55 140.65 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -1.135 . . . . 0.0 109.253 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.686 ' CE1' ' CD2' ' A' ' 34' ' ' HIS . 31.3 m-85 -121.05 142.88 49.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.82 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.506 ' CE1' HG13 ' A' ' 81' ' ' ILE . 49.7 m-85 -114.58 130.16 56.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 108.952 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.517 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 29.2 p -112.69 150.17 31.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.075 -1.015 . . . . 0.0 109.956 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 66.6 t0 -145.2 145.99 31.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.056 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -139.98 137.36 8.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 87.3 p -143.53 162.72 35.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -1.127 . . . . 0.0 109.17 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.501 ' CB ' ' HB1' ' A' ' 28' ' ' ALA . . . -146.25 148.82 32.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.001 . . . . 0.0 109.757 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 161' ' ' SER . 60.6 mt . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -99.41 125.66 45.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.443 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 15' ' ' SER . . . -135.65 158.41 44.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.423 ' HA2' HD11 ' A' ' 51' ' ' LEU . . . -140.33 159.53 26.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.503 ' HE2' ' CD1' ' A' ' 49' ' ' ILE . 49.7 mtm -118.93 154.08 33.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -1.179 . . . . 0.0 109.399 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.45 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -139.68 120.04 1.77 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 11' ' ' TYR . 20.9 mm -111.13 133.08 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -1.154 . . . . 0.0 109.437 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' PHE . 42.7 t -118.64 137.89 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.686 ' CD2' ' CE1' ' A' ' 10' ' ' PHE . 23.6 t-160 -112.86 130.15 56.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.52 166.94 20.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.324 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.455 ' HB ' HD11 ' A' ' 44' ' ' LEU . 9.9 t -127.75 154.25 45.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.569 ' CZ ' HG22 ' A' ' 9' ' ' VAL . 11.8 m-30 -95.22 5.28 52.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.518 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.565 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.3 179.56 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.059 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.7 Cg_endo -66.39 -4.43 10.67 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.219 1.946 . . . . 0.0 111.825 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -130.38 105.93 8.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 108.745 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -71.22 130.3 41.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 109.554 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -167.99 151.83 6.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 43' ' ' VAL . 2.6 p -76.96 125.59 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.878 . . . . 0.0 109.406 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.636 ' CD2' ' CE1' ' A' ' 34' ' ' HIS . 7.5 mp -72.23 -36.67 69.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.902 . . . . 0.0 109.387 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -173.05 158.46 3.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.457 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.503 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 91.8 mt-30 -113.49 138.64 49.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.279 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.434 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 1.0 OUTLIER -121.25 135.42 55.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.657 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.7 t -128.71 129.95 46.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.196 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.503 ' CD1' ' HE2' ' A' ' 30' ' ' MET . 4.1 mt -134.45 93.17 19.23 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 109.691 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.406 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 50.5 Cg_endo -70.9 140.28 38.05 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.693 2.262 . . . . 0.0 111.658 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 54' ' ' HIS . 5.3 mp -109.0 154.84 21.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.531 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.04 -34.86 0.66 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.547 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 42.7 p-10 -118.47 36.67 4.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.161 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.547 ' CE1' ' OD1' ' A' ' 53' ' ' ASN . 77.7 m80 -126.47 169.75 12.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.441 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.402 HG21 ' CG ' ' A' ' 58' ' ' MET . 10.0 t -111.43 -176.27 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.459 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -67.52 -39.06 85.09 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.544 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -67.38 -45.23 76.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.557 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.461 ' O ' HG21 ' A' ' 61' ' ' ILE . 96.0 mtp -65.15 -36.46 84.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.616 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.82 88.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 56' ' ' ALA . 96.1 mt-10 -67.12 -48.4 68.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.6 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.579 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 13.1 tt -66.21 -36.15 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.452 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.508 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -64.9 -28.64 69.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.517 ' CB ' ' HB ' ' A' ' 12' ' ' THR . . . -68.16 -40.94 82.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.573 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 61.4 t -70.34 -38.24 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.593 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.529 ' HG2' ' CD1' ' A' ' 120' ' ' ILE . 97.3 mt-10 -66.4 -37.46 85.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.071 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.637 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 24.1 t80 -63.26 -67.1 0.45 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.451 -0.781 . . . . 0.0 109.761 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 68' ' ' CYS . . . -58.2 -45.3 87.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 109.867 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 42.5 t -42.47 -62.57 0.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 109.738 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 42.7 mttp -54.83 -50.46 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.637 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 64.2 mttm -55.23 -36.84 66.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.597 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 68' ' ' CYS . . . -58.03 -61.31 2.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.443 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.442 ' HB2' HD11 ' A' ' 130' ' ' ILE . 22.8 tp -51.53 -45.52 63.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 36.6 mmtt -43.82 -47.19 8.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.325 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 27.5 mm -48.39 142.73 7.97 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 108.923 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.6 Cg_endo -65.82 -3.91 9.01 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.553 2.169 . . . . 0.0 111.808 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -137.07 168.81 24.2 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 48.5 Cg_endo -69.44 130.53 19.9 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.53 2.154 . . . . 0.0 111.723 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.573 HG11 ' CD1' ' A' ' 10' ' ' PHE . 50.4 t -120.0 158.66 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.512 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.586 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 23.2 mt -101.74 143.85 31.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.9 t -119.48 130.4 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 133' ' ' GLN . 24.4 mm -111.08 142.0 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 p -131.95 157.99 42.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.487 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.448 ' OD2' ' OD1' ' A' ' 13' ' ' ASP . 60.5 m-20 -82.17 -20.02 38.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.479 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.498 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 46.9 t -110.62 131.64 54.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.57 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 46.4 p90 -76.11 -35.03 59.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -57.06 -52.58 64.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.418 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.498 ' CG1' ' HB3' ' A' ' 84' ' ' SER . 9.7 p -62.03 -47.31 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.341 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.466 ' N ' HG12 ' A' ' 87' ' ' VAL . . . -55.76 -53.66 53.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 85' ' ' PHE . 76.0 mm-40 -60.01 -35.14 74.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.357 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.554 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 33.6 m -51.7 -48.04 63.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.461 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.435 ' HB3' HD12 ' A' ' 120' ' ' ILE . . . -91.37 -0.99 57.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.633 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -85.61 -72.83 0.47 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.001 . . . . 0.0 109.744 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 21.4 mttt -126.72 -28.52 2.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.091 -1.005 . . . . 0.0 109.917 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.562 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 91.9 mt-10 -60.56 -31.98 71.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.033 . . . . 0.0 109.866 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.51 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -58.14 -59.88 11.91 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.503 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.8 Cg_endo -66.94 -33.23 33.48 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.664 2.242 . . . . 0.0 111.606 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -70.26 -35.43 73.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -0.887 . . . . 0.0 109.043 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.562 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 10.8 m0 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.374 -0.829 . . . . 0.0 109.192 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 23.8 mttm . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.303 0.573 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.538 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 50.4 m80 64.61 41.14 5.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.519 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -72.46 -42.84 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.305 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.7 m -62.12 -40.23 95.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.273 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.466 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 67.8 mttm -62.8 -44.27 96.61 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.387 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.579 ' CZ2' ' CD1' ' A' ' 61' ' ' ILE . 24.0 m95 -78.7 -31.69 46.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.295 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -57.88 -41.09 81.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.976 . . . . 0.0 109.343 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.3 m -60.81 -48.1 83.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.333 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.529 ' CD1' ' HG2' ' A' ' 65' ' ' GLU . 76.7 mt -70.36 -35.32 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.435 ' O ' ' OG ' ' A' ' 125' ' ' SER . . . -63.77 -34.68 78.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.369 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 126' ' ' MET . 82.5 tt0 -62.44 -36.42 82.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 19.9 m -79.97 -48.97 12.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.412 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.07 -35.93 74.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.848 . . . . 0.0 109.391 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 121' ' ' ALA . 43.4 m -63.33 -32.93 74.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.422 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.452 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 89.8 mtp -66.88 -34.41 77.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.873 . . . . 0.0 109.476 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.81 135.64 0.36 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.404 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.0 Cg_endo -69.6 -2.49 10.15 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.694 2.263 . . . . 0.0 111.57 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 88.4 m-20 -43.46 -36.88 2.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 109.344 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.442 HD11 ' HB2' ' A' ' 72' ' ' LEU . 50.0 mt -66.94 116.52 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.524 ' HB ' ' CD2' ' A' ' 79' ' ' LEU . 29.3 m -106.91 144.49 33.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 109.371 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.436 HG23 ' CA ' ' A' ' 88' ' ' ALA . 72.7 mt -125.23 137.46 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 109.496 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.517 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 95.1 mt-30 -135.35 159.3 42.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.57 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 22.4 t-80 -101.6 132.67 47.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.576 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.496 ' HB2' ' CG2' ' A' ' 81' ' ' ILE . 43.6 tp10 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 37.3 m80 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.7 m -49.15 -52.67 24.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.02 -49.51 63.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.398 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.32 -38.77 57.75 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -59.37 -42.36 91.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.183 . . . . 0.0 109.397 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.94 79.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.6 mt -59.97 -46.66 88.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 0.0 109.452 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . . . -59.65 -38.91 82.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.462 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 91.6 m-20 -57.28 -42.64 82.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.419 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 31.5 mttp -62.34 -40.65 97.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 109.449 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.503 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 6.5 mt -64.04 -43.52 95.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.443 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.41 -46.25 89.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 43.4 m -58.42 -41.92 86.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 96.3 mt-30 -63.07 -33.91 76.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -57.6 -41.74 93.76 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.424 ' HB2' HD13 ' A' ' 17' ' ' ILE . 70.5 p -65.19 -31.52 72.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -1.159 . . . . 0.0 109.45 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -68.67 -28.19 66.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 109.509 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.8 t -67.07 -22.18 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.954 . . . . 0.0 109.509 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.471 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.572 ' CE2' HD12 ' A' ' 79' ' ' LEU . 29.6 m-85 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.454 0.645 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -73.48 -34.16 65.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.868 . . . . 0.0 109.098 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -179.15 -166.84 35.7 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 10' ' ' PHE . 77.5 t -133.51 140.87 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.276 -1.132 . . . . 0.0 109.055 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.632 ' CE2' ' ND1' ' A' ' 34' ' ' HIS . 5.4 m-85 -113.24 147.33 37.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.844 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.562 ' CE1' HG13 ' A' ' 81' ' ' ILE . 96.9 m-85 -116.87 130.22 56.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 108.935 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 33.5 p -119.39 149.8 41.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.993 . . . . 0.0 109.933 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.02 163.07 37.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.437 -0.789 . . . . 0.0 109.203 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.436 ' CA ' ' OE2' ' A' ' 60' ' ' GLU . . . -139.53 118.73 1.55 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 157' ' ' ALA . 39.2 m -123.2 143.95 49.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -1.16 . . . . 0.0 109.468 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 27' ' ' ASN . . . -142.99 155.6 44.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.1 mt . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 109.401 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.257 0.551 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 80.7 m-20 -91.53 144.35 25.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.394 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -140.52 154.67 46.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' A' ' 51' ' ' LEU . . . -156.77 150.23 21.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.497 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 69.2 mtm -113.99 168.82 9.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -1.105 . . . . 0.0 109.432 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -152.96 115.45 0.68 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.529 ' CD1' ' CD1' ' A' ' 49' ' ' ILE . 5.4 mp -125.87 118.9 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.132 . . . . 0.0 109.253 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.488 ' CG2' ' HG2' ' A' ' 46' ' ' GLN . 10.3 p -118.63 151.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.72 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.632 ' ND1' ' CE2' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -104.11 136.95 42.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 109.253 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.55 158.4 34.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.624 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.447 ' HB ' HD12 ' A' ' 44' ' ' LEU . 14.4 t -125.58 164.42 20.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 109.384 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' LYS . 86.5 m-85 -116.68 8.38 13.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.184 -0.947 . . . . 0.0 109.619 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.563 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.65 -179.42 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 108.946 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.8 Cg_endo -65.95 -5.12 11.39 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.08 1.853 . . . . 0.0 111.749 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -125.84 106.02 9.37 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -73.74 122.89 23.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.196 -0.94 . . . . 0.0 109.531 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -168.0 117.78 0.79 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.88 . . . . 0.0 109.203 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.512 ' CG1' HD11 ' A' ' 152' ' ' LEU . 1.4 m -47.94 123.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -0.93 . . . . 0.0 109.399 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 5.8 mp -65.68 -38.31 88.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.661 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 46' ' ' GLN . 57.2 t-20 -175.27 155.02 1.82 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 109.88 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 89.8 mt-30 -112.37 150.55 30.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.809 . . . . 0.0 108.892 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.1 t-105 -128.78 131.16 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.989 . . . . 0.0 109.664 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -122.39 133.36 54.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.412 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.529 ' CD1' ' CD1' ' A' ' 32' ' ' ILE . 3.6 mp -134.1 88.42 31.43 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.88 139.22 39.28 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.728 2.286 . . . . 0.0 111.728 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.549 ' CD1' ' N ' ' A' ' 51' ' ' LEU . 3.0 mp -106.04 147.88 28.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.21 -67.58 1.08 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -104.89 60.87 0.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -1.145 . . . . 0.0 109.502 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.456 ' HB2' ' CB ' ' A' ' 51' ' ' LEU . 78.0 m80 -133.16 173.06 11.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.9 t -117.11 173.16 6.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 109.474 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -55.91 -45.54 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.849 . . . . 0.0 109.261 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 60' ' ' GLU . 85.6 mt-30 -58.36 -63.82 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.416 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.439 ' HE2' ' CD2' ' A' ' 54' ' ' HIS . 97.9 mtp -43.55 -29.2 0.45 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.485 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.44 -29.17 30.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.372 -0.83 . . . . 0.0 109.611 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 57' ' ' GLN . 62.7 mm-40 -71.08 -34.81 71.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.605 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 13.4 tt -82.1 -34.65 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 109.609 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.497 ' CB ' ' SD ' ' A' ' 30' ' ' MET . . . -69.61 -26.09 64.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.401 ' N ' ' SD ' ' A' ' 30' ' ' MET . . . -67.09 -36.45 82.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.414 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.524 ' CG2' HG21 ' A' ' 87' ' ' VAL . 84.9 t -75.57 -36.67 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.428 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 77.6 tt0 -70.4 -37.17 74.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.122 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.508 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 26.1 t80 -60.86 -66.33 0.55 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.398 -0.814 . . . . 0.0 109.508 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 32' ' ' ILE . . . -54.66 -31.15 57.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.456 ' O ' HD13 ' A' ' 130' ' ' ILE . 33.3 t -55.2 -57.63 10.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 31.9 tttt -63.7 -38.88 92.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.508 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 17.6 mmtt -59.84 -32.89 71.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.907 . . . . 0.0 109.47 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' LEU . . . -71.22 -59.8 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.291 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.444 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 25.8 tp -45.18 -47.27 12.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.278 -0.889 . . . . 0.0 109.296 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 57.4 mttm -44.13 -48.79 9.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.195 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 4.8 mt -54.65 141.91 54.34 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.056 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.5 Cg_endo -66.07 -7.33 16.75 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.525 2.15 . . . . 0.0 111.483 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.94 161.19 21.88 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 48.0 Cg_endo -69.05 146.67 65.34 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.437 2.091 . . . . 0.0 111.747 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.569 HG12 ' CE1' ' A' ' 10' ' ' PHE . 25.4 t -134.78 159.36 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.335 -0.853 . . . . 0.0 109.562 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.572 HD12 ' CE2' ' A' ' 6' ' ' TYR . 7.1 mp -109.02 132.41 54.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.542 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.5 t -103.18 133.15 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.203 -0.936 . . . . 0.0 109.433 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.562 HG13 ' CE1' ' A' ' 11' ' ' TYR . 21.2 mm -106.13 132.52 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.366 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -133.42 161.71 33.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.529 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -92.7 6.99 45.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.516 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.522 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 41.3 t -130.28 123.76 30.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.918 . . . . 0.0 109.603 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.618 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 40.3 p90 -77.05 -43.0 36.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.535 ' N ' ' CG ' ' A' ' 85' ' ' PHE . 69.9 t80 -47.16 -50.25 20.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.88 . . . . 0.0 109.447 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.524 HG21 ' CG2' ' A' ' 64' ' ' VAL . 7.2 p -66.71 -47.76 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.343 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.476 ' N ' HG12 ' A' ' 87' ' ' VAL . . . -54.04 -46.96 72.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.26 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 98.2 mt-10 -65.22 -35.47 81.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.331 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.575 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 68.3 m -52.74 -44.48 66.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.472 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.517 ' O ' ' CD1' ' A' ' 124' ' ' LEU . . . -96.43 -0.89 48.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 51.7 t30 -92.56 -72.74 0.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.031 . . . . 0.0 109.751 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 48.2 mttm -126.64 -27.67 3.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 87.3 mt-10 -61.23 -31.46 71.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.871 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.495 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -56.05 -60.2 9.56 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.681 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 45.6 Cg_endo -67.4 -34.55 26.3 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.727 2.285 . . . . 0.0 111.702 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -68.59 -36.45 78.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.227 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.426 ' CH2' ' OE1' ' A' ' 94' ' ' GLU . 13.8 m0 . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 83.7 mttt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.223 0.535 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 54.0 m80 65.52 26.51 11.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -0.819 . . . . 0.0 109.637 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.45 ' CG2' ' HE3' ' A' ' 118' ' ' LYS . 66.6 mt -64.29 -42.47 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.274 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -53.84 -46.23 71.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.161 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -58.51 -42.07 86.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.854 . . . . 0.0 109.251 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.605 ' CZ2' ' CD1' ' A' ' 61' ' ' ILE . 16.3 m95 -67.67 -34.14 76.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.45 ' HE3' ' CG2' ' A' ' 114' ' ' ILE . 62.3 mttt -60.12 -36.37 77.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.332 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.428 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 25.3 m -66.28 -44.4 83.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.338 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.466 HD12 ' HB3' ' A' ' 91' ' ' ALA . 74.4 mt -66.64 -38.73 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.426 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.21 -35.88 80.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.387 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 126' ' ' MET . 82.9 tt0 -54.12 -39.84 66.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.872 . . . . 0.0 109.398 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.9 m -77.39 -46.5 22.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 0.0 109.4 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 59.9 mt -61.42 -36.83 81.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.417 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.5 m -60.53 -34.13 73.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.402 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 89.3 mtp -64.17 -30.77 71.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.915 . . . . 0.0 109.511 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 176.27 136.32 0.19 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.532 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.58 -0.09 7.06 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.74 2.293 . . . . 0.0 111.805 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.479 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 93.6 m-20 -50.2 -21.57 1.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 68' ' ' CYS . 68.0 mt -81.15 114.52 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.64 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 55.6 m -112.17 135.28 53.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.498 ' CD1' ' HB2' ' A' ' 91' ' ' ALA . 75.6 mt -116.57 138.75 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.105 -0.997 . . . . 0.0 109.682 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.51 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 94.7 mt-30 -124.68 159.45 30.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.618 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 19.8 t-80 -119.54 142.18 48.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.499 ' HG3' ' CG2' ' A' ' 81' ' ' ILE . 92.9 mt-10 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.451 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.259 0.552 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.8 m -67.18 -42.98 83.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.506 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.449 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 97.9 mt-10 -60.06 -36.66 77.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.51 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -69.3 -24.85 75.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -75.52 -33.88 60.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -1.118 . . . . 0.0 109.471 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -74.74 -41.45 60.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.512 HD11 ' CG1' ' A' ' 43' ' ' VAL . 68.9 mt -64.87 -38.2 90.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 0.0 109.55 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.13 -39.58 75.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -65.84 -39.38 90.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.125 -0.984 . . . . 0.0 109.464 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 66.8 mttm -64.85 -35.41 81.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.55 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 39.9 mt -68.19 -40.26 82.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 109.58 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.439 ' HB3' ' OG ' ' A' ' 15' ' ' SER . . . -64.98 -43.42 92.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.52 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 38.4 m -58.38 -44.06 88.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.519 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -61.94 -37.08 83.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.534 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.0 -48.2 84.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 164' ' ' VAL . 85.8 p -64.84 -33.45 76.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -1.148 . . . . 0.0 109.59 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -63.44 -38.41 91.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 68.7 t -57.06 -38.17 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 161' ' ' SER . 41.2 t . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.517 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.628 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 49.5 p90 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.468 ' HG2' HG22 ' A' ' 74' ' ' ILE . 2.6 pp20? -89.54 -27.08 20.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.589 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.463 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -161.4 -174.61 31.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.576 HG21 ' CZ ' ' A' ' 11' ' ' TYR . 14.6 p -130.43 143.7 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -1.141 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CE2' ' CE1' ' A' ' 34' ' ' HIS . 26.5 m-85 -119.44 123.6 44.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.932 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.576 ' CZ ' HG21 ' A' ' 9' ' ' VAL . 87.7 m-85 -105.81 130.83 53.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 15.8 p -119.93 150.75 39.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.508 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 57.3 t0 -142.64 151.47 41.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -133.64 119.19 2.24 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.6 m -127.85 152.22 48.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -1.172 . . . . 0.0 109.5 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 27' ' ' ASN . . . -137.62 156.05 48.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 109.453 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.928 . . . . 0.0 109.504 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 70.3 m-20 -86.63 145.19 26.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -140.29 150.22 43.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.93 165.24 30.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.496 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 56.0 mtm -132.7 152.79 51.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -1.109 . . . . 0.0 109.291 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.37 125.22 2.97 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.513 HG13 ' CD2' ' A' ' 66' ' ' PHE . 19.1 mm -111.08 142.51 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -1.154 . . . . 0.0 109.301 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.3 t -136.64 123.52 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.159 -0.963 . . . . 0.0 109.756 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.576 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 23.6 t60 -101.01 138.27 38.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.141 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.25 163.18 33.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 109.836 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.0 t -123.16 164.96 17.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.415 -0.803 . . . . 0.0 109.172 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.572 ' CD1' ' OH ' ' A' ' 6' ' ' TYR . 83.8 m-85 -103.49 9.47 37.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.094 -1.004 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 2.0 mtmt -51.21 -179.25 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.8 Cg_endo -65.13 -5.78 11.7 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.039 1.826 . . . . 0.0 111.649 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -127.28 105.74 8.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.339 -0.85 . . . . 0.0 108.741 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -74.01 126.81 31.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.43 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -167.33 148.3 5.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 109.589 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.444 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 10.6 m -71.47 121.96 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.365 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.549 HD13 ' CD2' ' A' ' 34' ' ' HIS . 41.0 mt -65.06 -43.95 90.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.327 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 76.8 m-20 -159.17 147.79 18.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.377 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.517 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 90.6 mt-30 -106.85 144.26 33.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.402 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.81 138.53 45.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 0.0 109.714 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.5 p -130.85 144.87 51.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.353 -0.842 . . . . 0.0 109.273 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.449 ' HB ' ' HE1' ' A' ' 30' ' ' MET . 4.7 mp -138.35 97.28 9.55 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.554 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.81 137.43 32.38 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.641 2.227 . . . . 0.0 111.711 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 39.4 mt -103.67 141.02 36.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.63 -66.54 0.94 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -115.58 61.12 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.154 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 74.7 m80 -130.26 -176.66 4.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.409 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.449 HG21 ' HG3' ' A' ' 58' ' ' MET . 15.3 t -126.96 168.01 15.1 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.898 . . . . 0.0 109.542 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.69 -36.59 62.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.512 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -60.9 -41.06 95.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.449 ' HG3' HG21 ' A' ' 55' ' ' THR . 65.6 mtt -65.62 -32.95 74.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.455 ' O ' ' HB1' ' A' ' 63' ' ' ALA . . . -66.91 -34.05 76.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.596 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.78 -41.69 68.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.885 . . . . 0.0 109.582 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.497 HG23 ' N ' ' A' ' 62' ' ' ALA . 17.9 tt -73.71 -34.77 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.633 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.497 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -75.82 -30.13 58.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 59' ' ' ALA . . . -65.27 -39.71 92.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 87' ' ' VAL . 89.7 t -73.26 -40.4 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.636 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.446 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 83.7 tt0 -68.72 -40.06 80.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 109.231 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.63 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 31.3 t80 -52.37 -64.15 0.91 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 109.634 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.425 ' HB2' ' CG1' ' A' ' 80' ' ' VAL . . . -62.75 -27.63 69.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.675 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.449 ' O ' HD13 ' A' ' 130' ' ' ILE . 48.8 t -58.1 -58.05 10.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.543 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.442 ' HG2' ' SG ' ' A' ' 123' ' ' CYS . 40.3 mttt -61.11 -46.42 90.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.571 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.63 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 65.2 mttm -63.95 -33.99 76.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.35 -60.25 3.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.512 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 126' ' ' MET . 18.8 tp -57.66 -36.01 71.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -51.81 -43.46 63.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -0.918 . . . . 0.0 109.369 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 35.5 mm -48.36 143.04 7.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.898 . . . . 0.0 108.886 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.6 Cg_endo -64.36 -6.06 11.04 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.541 2.161 . . . . 0.0 111.724 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.23 171.73 23.53 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 48.3 Cg_endo -69.04 134.49 29.63 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.449 2.099 . . . . 0.0 111.676 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.565 HG12 ' CE2' ' A' ' 10' ' ' PHE . 32.1 t -127.41 167.67 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 109.26 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.628 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 3.9 mt -125.87 127.58 46.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.291 -0.881 . . . . 0.0 109.78 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 10' ' ' PHE . 34.7 t -101.44 133.01 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 109.235 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.451 HG12 ' HB2' ' A' ' 133' ' ' GLN . 23.5 mt -117.04 134.13 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.5 t -142.81 159.96 41.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.248 -0.907 . . . . 0.0 109.503 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 50.6 p-10 -83.9 -4.65 58.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.516 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.51 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 63.5 m -77.95 97.23 5.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.386 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.574 ' HA ' ' CD2' ' A' ' 134' ' ' HIS . 97.6 m-85 -64.16 -49.57 71.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 109.381 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -63.23 -52.25 62.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.65 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.52 HG12 ' CG2' ' A' ' 64' ' ' VAL . 38.8 t -55.88 -59.9 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.923 . . . . 0.0 109.591 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.544 ' CB ' ' CD2' ' A' ' 134' ' ' HIS . . . -43.57 -57.62 3.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.436 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 98.0 mt-10 -53.98 -40.74 67.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.463 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.567 ' CB ' ' CZ3' ' A' ' 117' ' ' TRP . 50.0 m -47.26 -52.13 16.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.492 ' HB1' ' CD1' ' A' ' 132' ' ' ILE . . . -89.7 -0.98 57.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.673 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 44.5 t-20 -82.14 -72.67 0.43 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.652 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 96.3 mttt -126.5 -22.7 3.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.075 -1.016 . . . . 0.0 110.062 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 96.3 mt-10 -67.13 -25.6 66.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.039 . . . . 0.0 109.66 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.513 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -54.57 -58.77 12.62 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.598 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 45.9 Cg_endo -67.16 -32.31 34.16 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.554 2.169 . . . . 0.0 111.464 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -66.01 -40.21 90.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 108.982 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 39.8 m0 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.475 -0.766 . . . . 0.0 109.192 179.688 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.557 ' HE3' ' CE1' ' A' ' 113' ' ' HIS . 51.9 tttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.557 ' CE1' ' HE3' ' A' ' 112' ' ' LYS . 59.4 m80 62.35 27.81 16.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.399 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.486 HG22 HD12 ' A' ' 114' ' ' ILE . 77.1 mt -60.96 -41.21 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 109.436 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.9 m -55.47 -46.55 76.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.4 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -60.37 -47.06 87.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.502 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.567 ' CZ3' ' CB ' ' A' ' 90' ' ' SER . 88.1 m95 -68.03 -33.61 74.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -56.21 -44.28 79.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.481 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.446 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 36.2 m -58.2 -43.4 87.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.444 HG12 ' HG3' ' A' ' 65' ' ' GLU . 78.0 mt -66.38 -40.13 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.978 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.46 ' HB1' ' CD1' ' A' ' 95' ' ' LEU . . . -62.98 -35.27 79.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.44 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -56.65 -35.48 68.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.442 ' SG ' ' HG2' ' A' ' 69' ' ' LYS . 77.7 m -80.02 -49.2 12.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.422 HD22 HD11 ' A' ' 130' ' ' ILE . 51.9 mt -57.98 -37.0 73.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 25.5 m -58.77 -33.42 70.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.33 -0.856 . . . . 0.0 109.501 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.463 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 90.0 mtp -63.9 -37.67 88.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 177.3 143.44 0.26 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.1 Cg_endo -69.65 -1.35 8.23 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.722 2.281 . . . . 0.0 111.749 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.452 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 88.3 m-20 -43.4 -35.22 1.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.441 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 68' ' ' CYS . 67.5 mt -69.74 121.47 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.421 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.518 ' HB ' ' CD2' ' A' ' 79' ' ' LEU . 23.8 m -119.06 143.48 47.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.369 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.492 ' CD1' ' HB1' ' A' ' 91' ' ' ALA . 70.6 mt -122.78 130.72 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.451 ' HB2' HG12 ' A' ' 81' ' ' ILE . 89.9 mt-30 -125.01 153.54 42.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.392 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.574 ' CD2' ' HA ' ' A' ' 85' ' ' PHE . 37.3 m170 -89.74 133.33 34.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.605 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.799 . . . . 0.0 109.519 -179.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 68.2 m80 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 95.2 m -58.56 -42.86 88.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -52.36 -45.25 65.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.595 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.41 -36.96 91.25 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -65.1 -33.84 76.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -1.169 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -64.98 -52.29 57.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.475 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 6.9 mp -65.45 -46.73 78.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.592 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . . . -57.9 -40.53 80.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.533 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -63.17 -34.93 78.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 69.5 mttt -63.03 -43.5 98.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.511 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.517 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 6.4 mp -71.82 -37.18 70.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.55 -43.09 91.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 109.56 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 36.6 m -63.79 -41.37 97.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.605 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 163' ' ' VAL . 94.2 mt-30 -61.74 -35.73 78.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.575 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.57 -51.45 58.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 164' ' ' VAL . 25.0 m -64.56 -37.19 86.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -1.182 . . . . 0.0 109.672 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -64.1 -33.96 76.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 159' ' ' GLN . 45.8 t -65.86 -15.05 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 161' ' ' SER . 47.3 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.469 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.63 ' CE2' ' CD2' ' A' ' 79' ' ' LEU . 17.8 m-85 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.424 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 77.1 mm-40 -69.58 -33.94 73.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 108.931 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.27 -168.75 38.77 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.51 ' CG1' ' HB2' ' A' ' 35' ' ' ALA . 7.8 p -123.0 145.19 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.241 -1.153 . . . . 0.0 109.115 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.687 ' CE2' ' CD2' ' A' ' 34' ' ' HIS . 9.4 m-85 -122.48 137.42 54.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 109.859 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -118.24 126.75 52.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.317 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.461 ' CG2' HD13 ' A' ' 32' ' ' ILE . 27.5 p -117.75 144.22 45.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 43.8 t0 -143.2 149.92 38.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.407 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -129.69 123.18 4.01 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m -129.36 147.75 51.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -1.102 . . . . 0.0 109.313 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.473 ' CA ' ' O ' ' A' ' 27' ' ' ASN . . . -137.81 151.8 48.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -0.96 . . . . 0.0 109.628 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 20.4 mt . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.855 . . . . 0.0 109.262 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.473 ' O ' ' CA ' ' A' ' 16' ' ' ALA . 85.5 m-20 -83.31 137.22 34.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -137.81 151.25 47.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.417 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' A' ' 51' ' ' LEU . . . -154.3 162.6 30.7 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.511 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 74.0 mtm -127.41 168.52 14.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -1.121 . . . . 0.0 109.479 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -152.96 113.76 0.59 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' TRP . 10.9 mm -119.44 114.09 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.166 . . . . 0.0 109.338 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.53 ' CG2' ' HG2' ' A' ' 46' ' ' GLN . 7.5 p -118.52 148.01 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.2 -0.938 . . . . 0.0 109.691 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.687 ' CD2' ' CE2' ' A' ' 10' ' ' PHE . 7.4 m170 -101.62 145.01 29.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 109.118 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.51 ' HB2' ' CG1' ' A' ' 9' ' ' VAL . . . -136.9 166.81 22.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.109 -0.995 . . . . 0.0 109.677 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.472 ' HB ' HD11 ' A' ' 44' ' ' LEU . 9.9 t -123.24 165.41 16.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.352 -0.842 . . . . 0.0 109.458 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' LYS . 55.2 m-85 -105.94 10.84 32.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.539 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 3.1 mtpt -51.18 178.76 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.839 . . . . 0.0 109.103 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.5 Cg_endo -65.09 -6.19 12.47 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.187 1.925 . . . . 0.0 111.663 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -131.23 106.28 8.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 108.982 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 48.9 t80 -58.54 127.62 33.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 81.2 mt-30 -159.45 141.92 13.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.51 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.417 ' HB ' ' CG2' ' A' ' 33' ' ' VAL . 25.0 m -78.93 122.38 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 34' ' ' HIS . 7.4 mp -67.09 -42.96 83.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 29.8 m120 -160.41 149.95 17.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.53 ' HG2' ' CG2' ' A' ' 33' ' ' VAL . 90.2 mt-30 -110.22 150.93 27.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.199 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.7 t-105 -133.31 137.16 45.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.005 . . . . 0.0 109.8 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.1 t -125.74 132.56 52.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.213 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.572 HD12 ' CD1' ' A' ' 66' ' ' PHE . 6.1 mt -135.53 89.8 21.49 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.951 . . . . 0.0 109.702 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.3 Cg_endo -71.05 144.57 47.54 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 122.63 2.22 . . . . 0.0 111.596 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 51' ' ' LEU . 3.7 mp -110.93 147.86 33.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.588 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.74 -75.59 1.26 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -98.56 61.74 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.127 . . . . 0.0 109.448 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.493 ' CB ' HD21 ' A' ' 51' ' ' LEU . 76.6 m80 -131.62 -177.56 4.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.938 . . . . 0.0 109.529 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 57' ' ' GLN . 15.3 t -128.22 166.84 17.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 0.0 109.5 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -48.13 -44.73 32.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.94 . . . . 0.0 109.331 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 60' ' ' GLU . 86.2 mt-30 -55.2 -58.17 8.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.303 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.446 ' SD ' ' HA ' ' A' ' 54' ' ' HIS . 62.1 mtt -44.81 -34.62 2.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.266 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.4 -31.51 60.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.319 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 57' ' ' GLN . 96.5 mt-10 -72.66 -38.35 67.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.327 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.46 ' HA ' ' CG2' ' A' ' 87' ' ' VAL . 7.3 tt -81.53 -38.47 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.511 ' CB ' ' SD ' ' A' ' 30' ' ' MET . . . -66.06 -36.48 83.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.352 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.91 -48.18 76.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.367 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.471 HG21 ' CG1' ' A' ' 87' ' ' VAL . 78.4 t -64.04 -48.98 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.8 tt0 -58.24 -43.94 88.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.572 ' CD1' HD12 ' A' ' 49' ' ' ILE . 13.0 t80 -54.63 -68.12 0.21 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.37 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.458 ' HB3' HG13 ' A' ' 80' ' ' VAL . . . -56.48 -19.21 14.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.204 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.464 ' SG ' ' CG2' ' A' ' 120' ' ' ILE . 19.3 t -66.46 -64.94 0.75 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.269 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -58.66 -46.38 87.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -58.36 -30.08 66.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.907 . . . . 0.0 109.263 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.564 ' CB ' ' CG1' ' A' ' 78' ' ' VAL . . . -67.35 -63.87 0.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.562 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 22.8 tp -50.18 -44.06 52.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.173 -0.954 . . . . 0.0 109.334 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 72' ' ' LEU . 26.4 tttt -43.27 -48.71 6.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.1 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 10.6 mt -48.4 143.19 7.58 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.369 -0.832 . . . . 0.0 108.879 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 45.5 Cg_endo -66.36 -2.25 6.85 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.625 2.217 . . . . 0.0 112.124 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.424 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -139.98 167.9 25.24 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.45 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 47.7 Cg_endo -68.94 116.74 4.62 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.446 2.097 . . . . 0.0 111.578 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.593 ' CG2' ' CD1' ' A' ' 10' ' ' PHE . 6.5 p -109.25 148.53 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.349 -0.845 . . . . 0.0 109.403 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.63 ' CD2' ' CE2' ' A' ' 6' ' ' TYR . 7.4 mp -96.31 138.87 33.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 67' ' ' ALA . 29.9 t -115.78 135.13 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.371 -0.831 . . . . 0.0 109.149 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.525 ' CG2' ' HG3' ' A' ' 135' ' ' GLU . 15.0 mt -122.44 136.85 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.602 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 t -139.1 160.33 40.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.341 -0.849 . . . . 0.0 109.316 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -81.59 -13.07 58.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.924 . . . . 0.0 109.564 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.46 ' OG ' ' HB3' ' A' ' 60' ' ' GLU . 29.5 m -93.15 115.62 28.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.571 ' HB2' ' CG ' ' A' ' 134' ' ' HIS . 46.4 t80 -81.4 -38.58 26.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.365 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -55.42 -46.71 76.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.54 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 88' ' ' ALA . 14.1 p -70.18 -46.49 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 109.499 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.474 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -56.57 -48.32 77.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.267 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -60.55 -37.34 80.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.537 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 50.2 m -52.47 -55.11 24.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.472 ' HB3' HD11 ' A' ' 124' ' ' LEU . . . -83.73 -0.89 52.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.903 . . . . 0.0 109.628 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 38.6 t-20 -83.15 -72.76 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.951 . . . . 0.0 109.729 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 87.0 mttt -126.71 -25.36 3.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 97.9 mt-10 -69.57 -24.47 63.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.131 -0.98 . . . . 0.0 109.731 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.529 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -54.58 -57.34 19.32 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.644 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 46.1 Cg_endo -67.47 -34.36 26.52 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.507 2.138 . . . . 0.0 111.663 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -65.82 -38.68 89.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.118 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 43.0 m0 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.34 179.821 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.1 mttp . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 48.0 m80 61.53 34.44 17.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.489 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.7 mt -54.19 -45.39 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.423 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.6 m -50.82 -48.35 59.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.543 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.1 -35.94 76.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.48 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.537 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 20.1 m95 -70.45 -38.13 74.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 109.516 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -58.83 -39.4 81.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.426 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.6 m -62.51 -43.06 99.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.464 ' CG2' ' SG ' ' A' ' 68' ' ' CYS . 83.6 mt -71.72 -36.09 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.29 -34.95 79.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -56.06 -38.47 70.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 61.3 m -81.18 -49.37 10.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.877 . . . . 0.0 109.467 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' A' ' 91' ' ' ALA . 54.7 mt -60.52 -31.9 70.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.432 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.4 t -62.38 -33.0 73.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 94.9 mmm -64.73 -38.05 89.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.16 146.48 0.56 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.284 -0.885 . . . . 0.0 109.447 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 129' ' ' ASP . 50.1 Cg_endo -70.79 0.66 6.07 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.739 2.292 . . . . 0.0 111.899 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 88.8 m-20 -44.09 -50.53 8.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.398 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 58.3 mt -55.25 113.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.777 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.471 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 54.9 m -110.54 144.18 39.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 108.986 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 64.4 mt -124.29 141.45 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 109.83 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.438 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.4 mt-30 -128.58 159.56 35.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.389 -0.819 . . . . 0.0 109.184 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.571 ' CG ' ' HB2' ' A' ' 85' ' ' PHE . 32.2 t-80 -119.52 140.29 50.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 109.665 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.525 ' HG3' ' CG2' ' A' ' 81' ' ' ILE . 94.9 mt-10 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.334 -0.854 . . . . 0.0 109.218 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 57.2 m80 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.5 p -68.79 -41.51 78.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.94 -38.48 64.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.48 -37.62 94.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -64.44 -42.93 95.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.289 -1.124 . . . . 0.0 109.431 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.5 64.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.867 . . . . 0.0 109.461 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.465 ' O ' HD11 ' A' ' 156' ' ' LEU . 64.5 mt -60.38 -48.84 80.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.823 . . . . 0.0 109.485 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . . . -52.76 -40.3 63.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.566 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.422 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 54.3 t0 -60.06 -49.32 78.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -52.89 -37.96 61.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.533 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.521 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 7.1 mp -69.37 -41.53 76.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 30' ' ' MET . . . -69.55 -44.99 69.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.562 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 33.6 m -58.81 -42.18 88.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.539 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -61.94 -39.47 92.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.501 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -62.0 -45.75 95.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.435 ' HA ' HG13 ' A' ' 164' ' ' VAL . 85.2 p -69.53 -25.75 64.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -1.184 . . . . 0.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -67.68 -36.34 80.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.504 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.3 t -72.91 -19.08 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.435 HG13 ' HA ' ' A' ' 161' ' ' SER . 14.8 p . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.524 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.581 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 18.4 p90 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.442 0.639 . . . . 0.0 109.898 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -79.59 -45.14 19.71 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.422 -0.799 . . . . 0.0 108.996 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.45 ' O ' ' CG2' ' A' ' 78' ' ' VAL . . . -161.21 178.52 37.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 10' ' ' PHE . 67.9 t -129.73 146.27 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -1.14 . . . . 0.0 109.501 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.594 ' CE1' ' ND1' ' A' ' 34' ' ' HIS . 6.5 m-85 -118.4 155.39 30.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -118.03 123.17 45.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.332 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.509 ' CG2' HD13 ' A' ' 32' ' ' ILE . 24.2 p -117.06 145.78 43.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.551 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 56.7 t0 -143.99 152.98 41.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -137.33 117.08 1.46 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 29' ' ' GLY . 47.0 t -133.49 155.18 50.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.319 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . . . -137.95 158.68 43.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.595 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 65.0 mt . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.453 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 42.5 p-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 19.9 m120 -94.36 125.94 39.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 0.0 109.367 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 51' ' ' LEU . . . -103.5 156.07 18.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.534 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -147.22 148.38 19.94 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.42 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 63.6 mtm -124.02 165.11 18.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -1.2 . . . . 0.0 109.573 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 32' ' ' ILE . . . -149.87 116.86 0.81 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.518 ' O ' ' CB ' ' A' ' 47' ' ' TRP . 15.1 mm -120.26 115.27 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -1.161 . . . . 0.0 109.486 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.452 ' CG2' ' HB ' ' A' ' 43' ' ' VAL . 12.3 p -118.76 148.39 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.498 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.594 ' ND1' ' CE1' ' A' ' 10' ' ' PHE . 9.4 t60 -101.16 137.23 39.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.556 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.485 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -122.23 158.16 30.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.494 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 12.0 t -125.11 162.23 25.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.877 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.57 ' CE2' ' OH ' ' A' ' 6' ' ' TYR . 58.5 m-85 -108.64 11.47 26.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.968 . . . . 0.0 109.618 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.539 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 5.3 mttt -51.21 178.74 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.0 Cg_endo -64.43 -6.05 11.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.185 1.924 . . . . 0.0 111.704 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.442 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 70.0 mm-40 -129.53 105.36 8.03 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.254 -0.904 . . . . 0.0 108.759 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -64.54 125.31 24.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.574 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -168.18 129.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.464 HG11 HD21 ' A' ' 152' ' ' LEU . 22.6 m -58.7 126.04 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.457 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.543 ' CD2' ' CD2' ' A' ' 34' ' ' HIS . 6.1 mp -67.33 -42.79 83.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.448 ' O ' HG21 ' A' ' 33' ' ' VAL . 77.9 m-20 -160.61 154.41 22.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.617 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.523 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 90.9 mt-30 -113.1 148.22 35.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 109.131 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CB ' ' O ' ' A' ' 32' ' ' ILE . 11.6 t-105 -127.34 138.88 53.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.105 -0.997 . . . . 0.0 109.843 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.5 m -126.96 136.73 52.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.118 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.417 HD12 ' HE1' ' A' ' 30' ' ' MET . 3.8 mt -144.03 92.05 6.38 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.733 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.1 Cg_endo -70.76 148.32 58.32 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.66 2.24 . . . . 0.0 111.557 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 51' ' ' LEU . 5.7 mp -119.65 145.5 46.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.95 -48.36 0.17 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -90.42 9.95 27.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -1.133 . . . . 0.0 109.393 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.446 ' HB3' ' SD ' ' A' ' 58' ' ' MET . 56.7 m80 -117.75 -176.08 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 0.0 109.522 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.8 t -124.49 166.36 16.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.493 ' CB ' ' HB3' ' A' ' 16' ' ' ALA . . . -46.21 -45.51 16.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 0.0 109.346 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 60' ' ' GLU . 84.6 mt-30 -54.38 -59.34 4.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 109.428 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.446 ' SD ' ' HB3' ' A' ' 54' ' ' HIS . 61.2 mtt -44.08 -33.98 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.444 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.416 ' HB2' ' CG ' ' A' ' 30' ' ' MET . . . -71.85 -31.45 66.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.27 -0.893 . . . . 0.0 109.389 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 57' ' ' GLN . 96.8 mt-10 -70.88 -33.61 70.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.446 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 7.1 tt -86.92 -30.84 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 109.341 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.42 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -74.95 -29.71 61.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.417 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 12' ' ' THR . . . -64.98 -39.07 92.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.478 ' CG2' HG21 ' A' ' 82' ' ' THR . 71.8 t -71.95 -45.6 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.489 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.3 tt0 -64.3 -37.01 85.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.6 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 13.7 t80 -56.07 -69.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB3' ' CG1' ' A' ' 80' ' ' VAL . . . -60.4 -15.82 29.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.903 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.438 ' O ' HD12 ' A' ' 130' ' ' ILE . 44.8 t -67.66 -63.92 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HG2' ' SG ' ' A' ' 123' ' ' CYS . 23.6 mttm -58.64 -44.54 90.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.6 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 66.5 mttm -63.51 -38.54 91.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.576 ' CB ' ' CG1' ' A' ' 78' ' ' VAL . . . -54.83 -61.62 2.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.534 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 9.1 tt -51.55 -45.33 62.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 72' ' ' LEU . 65.0 tttm -43.64 -42.41 5.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.175 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 48.4 mm -48.93 143.21 8.68 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.331 -0.856 . . . . 0.0 108.806 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.8 Cg_endo -63.7 -4.71 7.52 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.669 2.246 . . . . 0.0 112.311 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.06 171.8 24.81 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.489 ' HG2' ' HA ' ' A' ' 6' ' ' TYR . 43.9 Cg_endo -67.22 118.61 5.7 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.495 2.13 . . . . 0.0 111.684 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.578 HG22 ' CD1' ' A' ' 10' ' ' PHE . 9.0 p -114.67 151.43 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.394 -0.816 . . . . 0.0 109.266 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.581 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 12.2 mt -96.82 154.73 17.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.83 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 131' ' ' THR . 38.9 t -125.87 133.07 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.536 -0.727 . . . . 0.0 109.049 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.441 HG12 ' HB2' ' A' ' 133' ' ' GLN . 26.2 mt -120.04 133.8 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.61 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.478 HG21 ' CG2' ' A' ' 64' ' ' VAL . 7.1 t -136.5 161.72 35.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.511 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 13' ' ' ASP . 58.3 p30 -89.33 15.04 9.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.479 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 26.7 t -123.93 114.73 20.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.918 . . . . 0.0 109.487 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.573 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 61.3 t80 -77.16 -43.15 34.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.573 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -49.0 -48.26 43.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 88' ' ' ALA . 8.9 p -68.03 -45.36 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.593 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.504 ' N ' HG12 ' A' ' 87' ' ' VAL . . . -53.4 -49.69 66.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.925 . . . . 0.0 109.544 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 80.5 tt0 -60.55 -34.39 74.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.303 -0.873 . . . . 0.0 109.516 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.633 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 50.5 m -56.42 -55.87 28.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.728 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.522 ' HB1' ' CD1' ' A' ' 132' ' ' ILE . . . -82.02 -0.75 45.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 109.702 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 47.0 t-20 -84.66 -73.23 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 109.812 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 62.6 tttt -127.37 -30.98 2.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.092 -1.005 . . . . 0.0 109.924 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.582 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 58.9 mm-40 -56.75 -37.69 71.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.108 -0.995 . . . . 0.0 109.922 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -51.38 -61.56 3.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 109.628 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 45.5 Cg_endo -67.76 -27.19 38.12 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.571 2.18 . . . . 0.0 111.449 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -73.47 -34.99 65.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 108.983 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.582 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 15.8 m0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.847 . . . . 0.0 109.19 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 21.4 mttp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.262 0.553 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 28.1 m80 68.75 31.76 4.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 109.553 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 75.8 mt -61.73 -41.36 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.296 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.9 m -53.27 -50.18 65.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 109.257 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -60.38 -38.4 83.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.334 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.633 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 25.3 m95 -72.35 -36.76 68.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -55.65 -44.97 77.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.325 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.2 m -60.41 -45.78 92.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.319 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.416 HG23 ' HB2' ' A' ' 91' ' ' ALA . 73.5 mt -69.34 -32.83 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.496 ' N ' HD23 ' A' ' 95' ' ' LEU . . . -60.91 -38.07 84.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.931 . . . . 0.0 109.4 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 126' ' ' MET . 96.2 mt-10 -61.7 -40.51 95.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.332 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.487 ' HB3' ' CD1' ' A' ' 130' ' ' ILE . 56.6 m -64.85 -51.02 64.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.492 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 3.4 tm? -65.02 -37.05 86.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.0 109.231 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.2 t -56.1 -36.11 67.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.446 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 65.4 mtt -64.25 -32.88 74.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.293 -0.88 . . . . 0.0 109.369 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 167.78 153.3 0.12 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.3 Cg_endo -71.39 0.36 6.94 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.621 2.214 . . . . 0.0 111.702 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 92.1 m-20 -43.07 -48.21 6.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.372 -0.83 . . . . 0.0 109.543 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 74.3 mt -65.38 122.12 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 80' ' ' VAL . 32.6 m -116.98 149.58 40.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.193 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.522 ' CD1' ' HB1' ' A' ' 91' ' ' ALA . 55.4 mt -127.01 132.69 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.134 -0.979 . . . . 0.0 109.712 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB2' HG12 ' A' ' 81' ' ' ILE . 86.4 mt-30 -118.09 159.39 23.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.17 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.573 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 28.2 t-80 -120.28 133.56 55.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.991 . . . . 0.0 109.683 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.419 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 62.5 m170 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.5 m -64.93 -41.71 95.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.23 -41.33 75.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.07 -36.16 87.22 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -66.56 -38.13 86.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -1.159 . . . . 0.0 109.395 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.16 -53.07 62.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.462 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.464 HD21 HG11 ' A' ' 43' ' ' VAL . 6.8 mp -67.39 -46.41 73.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.348 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.28 -38.26 73.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.448 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 81.5 m-20 -63.11 -43.63 97.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.526 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.88 -41.61 78.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.535 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.523 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 6.8 mt -64.43 -41.21 96.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.935 . . . . 0.0 109.399 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.54 96.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 37.2 m -55.78 -45.81 78.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.32 -36.18 81.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -0.906 . . . . 0.0 109.482 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -53.31 -59.2 9.89 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.459 ' OG ' HD11 ' A' ' 17' ' ' ILE . 92.1 p -63.49 -33.63 75.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -1.135 . . . . 0.0 109.503 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -63.66 -37.37 87.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 71.5 t -57.41 -37.01 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.494 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 0.0 109.483 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.531 ' CD2' HD21 ' A' ' 79' ' ' LEU . 36.6 m-85 . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 45.4 tp10 -66.75 -32.64 74.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.95 . . . . 0.0 109.043 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.0 -177.24 47.43 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.1 t -129.13 139.01 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -1.154 . . . . 0.0 109.232 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.668 ' CD2' ' CD2' ' A' ' 34' ' ' HIS . 6.9 m-85 -117.5 143.87 45.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.866 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CE2' ' CD1' ' A' ' 81' ' ' ILE . 92.7 m-85 -117.38 121.76 41.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.143 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.8 p -111.83 150.28 30.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.074 -1.016 . . . . 0.0 109.632 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.4 ' OD2' ' OD1' ' A' ' 154' ' ' ASP . 45.5 t0 -152.51 146.8 25.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.88 136.39 10.95 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 29' ' ' GLY . 17.9 t -138.69 142.69 38.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 109.612 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -135.01 150.13 50.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.291 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 27' ' ' ASN . 69.3 mt . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.672 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 38.7 p-10 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 17' ' ' ILE . 23.5 m120 -85.8 139.09 31.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.164 -0.96 . . . . 0.0 109.555 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -125.32 151.36 46.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.933 . . . . 0.0 109.492 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -154.99 157.79 27.87 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.473 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 54.9 mtm -127.29 165.85 18.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.129 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 156' ' ' LEU . . . -156.82 124.68 1.47 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 32' ' ' ILE . 4.8 mp -116.89 142.36 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -1.163 . . . . 0.0 109.382 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.508 HG23 ' CA ' ' A' ' 153' ' ' ALA . 38.2 t -127.06 134.26 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 109.551 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.668 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 27.1 m170 -106.87 138.65 42.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.615 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.42 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -140.4 164.62 29.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 0.0 109.527 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.463 ' HB ' HD12 ' A' ' 44' ' ' LEU . 13.2 t -133.64 164.96 26.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.0 109.447 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.418 ' O ' ' O ' ' A' ' 38' ' ' LYS . 44.5 m-85 -103.32 11.09 37.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 109.575 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.552 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.26 179.73 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.185 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 44.8 Cg_endo -66.88 -5.64 13.87 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.203 1.935 . . . . 0.0 111.425 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.49 ' OE2' ' NE2' ' A' ' 42' ' ' GLN . 82.6 tt0 -132.74 105.49 7.2 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.377 -0.827 . . . . 0.0 108.947 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.451 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 43.1 t80 -64.28 122.01 15.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.49 ' NE2' ' OE2' ' A' ' 40' ' ' GLU . 66.5 mt-30 -159.0 136.38 9.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.124 -0.985 . . . . 0.0 109.753 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 37.5 t -62.5 125.99 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.893 . . . . 0.0 109.32 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 HD12 ' HB ' ' A' ' 36' ' ' THR . 7.4 mp -68.63 -38.69 80.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 109.336 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -175.62 155.04 1.68 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 109.343 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.511 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 94.0 mt-30 -110.01 138.4 46.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.456 ' HB3' HD11 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -122.75 125.95 46.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.676 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.2 m -121.14 138.91 53.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 109.271 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.47 ' HB ' ' HE3' ' A' ' 30' ' ' MET . 2.4 mp -133.67 96.22 16.87 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.94 129.84 18.09 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.667 2.245 . . . . 0.0 111.741 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 43.1 mt -108.39 145.36 34.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.331 -0.856 . . . . 0.0 109.384 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.33 -28.85 1.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.531 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 46.4 p-10 -121.94 34.67 5.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -1.213 . . . . 0.0 109.507 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.531 ' CE1' ' OD1' ' A' ' 53' ' ' ASN . 77.4 m80 -124.4 175.68 6.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 109.362 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.426 HG22 ' HE1' ' A' ' 58' ' ' MET . 14.4 t -123.03 169.44 11.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.63 -38.93 72.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.419 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.0 -54.45 44.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.458 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.455 ' O ' HG21 ' A' ' 61' ' ' ILE . 67.9 mtm -66.64 -30.32 70.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.551 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.7 86.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.459 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -64.28 -49.1 73.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.509 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.581 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 13.0 tt -64.59 -39.62 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.504 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -59.41 -31.41 69.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.535 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.45 97.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.481 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.518 ' CG2' HG23 ' A' ' 82' ' ' THR . 87.9 t -71.0 -38.67 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.47 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 86.4 tt0 -68.8 -39.05 80.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.106 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.526 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 22.3 t80 -61.17 -64.37 0.97 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.364 -0.835 . . . . 0.0 109.491 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 71' ' ' ALA . . . -58.26 -31.44 67.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.429 ' O ' HD11 ' A' ' 130' ' ' ILE . 24.3 t -53.43 -54.7 33.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.607 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -62.03 -45.48 93.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.526 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 68.9 mttm -67.36 -29.75 69.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.951 . . . . 0.0 109.308 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.521 ' HB1' ' CG1' ' A' ' 78' ' ' VAL . . . -62.24 -64.48 0.92 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 27.8 tp -55.57 -43.29 75.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.883 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' LEU . 16.2 tttt -43.22 -43.14 4.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.254 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 26.4 mm -48.2 143.45 6.94 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 108.855 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.8 Cg_endo -65.87 -3.16 7.72 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.512 2.141 . . . . 0.0 111.896 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -142.07 170.82 24.8 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 48.2 Cg_endo -69.2 122.82 9.66 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.366 2.044 . . . . 0.0 111.74 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.571 HG23 ' CD1' ' A' ' 10' ' ' PHE . 7.1 p -116.24 150.18 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.451 -0.781 . . . . 0.0 109.288 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.531 HD21 ' CD2' ' A' ' 6' ' ' TYR . 6.7 mp -97.8 130.7 44.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.909 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 132' ' ' ILE . 47.6 t -106.46 131.09 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.36 -0.837 . . . . 0.0 109.122 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.549 ' CD1' ' CE2' ' A' ' 11' ' ' TYR . 4.4 mt -115.15 144.29 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.159 -0.963 . . . . 0.0 109.666 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.518 HG23 ' CG2' ' A' ' 64' ' ' VAL . 0.8 OUTLIER -134.3 161.66 34.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 109.37 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -90.91 3.66 53.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.525 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.46 ' O ' HG13 ' A' ' 87' ' ' VAL . 20.2 t -122.93 125.55 45.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.539 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 65.8 t80 -75.1 -40.6 59.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.433 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -50.5 -56.76 10.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.472 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 64' ' ' VAL . 8.8 p -58.75 -47.69 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.364 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.462 ' O ' ' OD1' ' A' ' 92' ' ' ASN . . . -58.25 -57.21 13.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 0.0 109.204 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.485 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 85.3 tt0 -51.13 -30.81 17.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.615 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 37.1 m -60.32 -59.65 5.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.433 -0.792 . . . . 0.0 109.67 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.24 -0.83 26.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 109.794 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.485 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 9.8 m120 -83.56 -72.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 0.0 109.796 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 80.5 mttt -126.56 -27.86 3.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.787 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.5 mt-10 -66.0 -24.33 66.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.616 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.517 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -58.51 -58.66 17.44 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.563 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.5 Cg_endo -66.91 -35.1 27.76 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.596 2.197 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -64.59 -42.01 95.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.897 . . . . 0.0 109.116 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.4 m0 . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.312 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.9 mttm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.402 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 43.4 m80 60.4 37.64 19.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.198 -0.939 . . . . 0.0 109.482 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.43 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 82.1 mt -63.84 -44.81 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.321 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 t -60.01 -41.99 93.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -59.22 -40.61 86.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.615 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 17.4 m95 -68.02 -37.96 82.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 31.2 mttt -57.41 -41.31 80.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.925 . . . . 0.0 109.371 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.47 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 19.9 m -61.62 -46.13 91.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.309 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 75.7 mt -71.21 -34.68 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.35 92.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.03 -40.28 88.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 109.503 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 89.5 m -66.22 -49.21 68.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.425 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.425 ' CD1' ' HA ' ' A' ' 128' ' ' PRO . 23.7 tp -63.82 -31.71 72.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.2 m -61.48 -31.7 71.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.499 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.457 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 92.6 mtp -68.56 -31.7 71.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 170.47 147.78 0.14 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.44 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 129' ' ' ASP . 50.5 Cg_endo -70.96 -0.95 8.71 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.688 2.259 . . . . 0.0 111.637 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.479 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 94.1 m-20 -43.05 -45.39 5.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.367 -0.833 . . . . 0.0 109.659 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 46.4 mt -61.77 117.39 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.743 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 132' ' ' ILE . 97.4 m -109.81 144.9 37.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.186 -0.946 . . . . 0.0 109.069 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.479 ' N ' HG22 ' A' ' 131' ' ' THR . 32.5 mm -119.69 136.68 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 109.745 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.46 ' NE2' HD23 ' A' ' 79' ' ' LEU . 87.4 mt-30 -125.43 158.22 34.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.427 -0.795 . . . . 0.0 109.19 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 20.3 t-80 -117.26 133.25 56.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.641 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.524 ' HG2' ' CG2' ' A' ' 81' ' ' ILE . 71.2 mm-40 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.425 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 57.5 m -55.56 -47.46 76.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.372 -0.83 . . . . 0.0 109.452 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.19 -52.18 28.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.409 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.18 -39.52 58.3 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -55.15 -48.8 73.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -1.108 . . . . 0.0 109.37 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.74 37.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.309 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.43 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 6.8 mp -58.84 -47.97 82.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.508 ' CA ' HG23 ' A' ' 33' ' ' VAL . . . -55.42 -42.56 74.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 109.418 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.4 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 63.7 m-20 -55.69 -44.09 77.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.876 . . . . 0.0 109.394 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -57.75 -42.14 83.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.928 . . . . 0.0 109.412 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 7.0 mp -64.98 -40.15 94.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.78 -51.67 46.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.358 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 42.0 m -59.83 -41.41 91.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.68 -38.41 91.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -62.54 -50.38 64.95 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.0 p -64.94 -34.24 77.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -1.183 . . . . 0.0 109.434 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -64.03 -37.68 88.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.431 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 73.0 t -52.93 -39.67 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 109.467 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.42 HG13 ' ND2' ' A' ' 27' ' ' ASN . 42.5 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.502 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.528 ' CB ' HD21 ' A' ' 79' ' ' LEU . 33.9 p90 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.293 0.568 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.444 ' OE1' HG22 ' A' ' 74' ' ' ILE . 21.3 tt0 -79.78 -42.76 23.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -159.88 176.52 36.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.1 t -124.96 141.1 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -1.18 . . . . 0.0 109.515 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.656 ' CD2' ' CD2' ' A' ' 34' ' ' HIS . 5.7 m-85 -117.33 151.7 36.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.622 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -123.87 135.97 54.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 p -121.7 150.1 42.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.596 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 153' ' ' ALA . 22.9 t70 -140.12 148.27 41.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.482 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.41 134.25 5.42 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 83.1 p -143.21 161.01 39.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -1.177 . . . . 0.0 109.457 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB3' ' ND2' ' A' ' 26' ' ' ASN . . . -137.9 150.51 47.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.566 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' ASN . 47.7 mt . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.515 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.503 ' ND2' ' HB3' ' A' ' 16' ' ' ALA . 48.1 p-10 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 17' ' ' ILE . 23.3 m120 -104.49 125.01 50.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.965 . . . . 0.0 109.393 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 15' ' ' SER . . . -132.16 158.51 41.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 109.768 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.32 165.2 26.77 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.412 ' HB2' ' HB ' ' A' ' 49' ' ' ILE . 69.7 mtm -126.28 156.54 40.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -1.168 . . . . 0.0 109.461 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.51 128.21 3.58 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.527 HG13 ' CD2' ' A' ' 66' ' ' PHE . 22.3 mm -113.16 134.41 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -1.132 . . . . 0.0 109.301 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.95 125.38 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.692 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.656 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 10.3 m170 -103.54 136.12 43.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.208 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.08 161.31 35.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.752 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.2 t -125.6 164.08 21.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 109.241 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.466 ' CE2' ' OH ' ' A' ' 6' ' ' TYR . 85.0 m-85 -107.91 13.95 25.79 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.104 -0.998 . . . . 0.0 109.534 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.561 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.27 -179.17 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.321 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.6 Cg_endo -65.42 -4.73 9.97 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.074 1.849 . . . . 0.0 111.849 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.421 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 71.8 mm-40 -134.1 106.09 7.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 108.785 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.507 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 66.9 t80 -57.81 123.89 17.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 109.534 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 84.4 mt-30 -159.62 152.25 21.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.85 . . . . 0.0 109.516 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.445 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 10.1 m -89.06 120.48 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.394 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 40.9 mt -58.28 -44.18 88.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.429 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 25.2 m-20 -168.76 157.4 8.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.433 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.426 ' HB3' HD23 ' A' ' 156' ' ' LEU . 92.4 mt-30 -116.2 149.6 38.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.444 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.443 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -132.16 137.96 47.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.625 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.9 p -123.61 144.8 49.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.286 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.533 HD11 ' CE1' ' A' ' 66' ' ' PHE . 3.3 mt -146.52 94.55 4.76 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.198 -0.939 . . . . 0.0 109.648 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.495 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 51.0 Cg_endo -70.81 132.26 21.3 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.654 2.236 . . . . 0.0 111.67 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.504 ' CD1' ' HB3' ' A' ' 59' ' ' ALA . 43.8 mt -115.0 142.89 46.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.566 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.03 -42.86 0.21 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -90.97 8.85 33.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -1.114 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 77.3 m80 -107.05 150.25 26.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.915 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.65 170.04 10.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.884 . . . . 0.0 109.24 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.37 -30.09 17.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.319 -0.863 . . . . 0.0 109.123 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -79.5 -57.36 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.357 -0.84 . . . . 0.0 109.315 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.465 ' O ' HG23 ' A' ' 61' ' ' ILE . 93.4 mtp -47.78 -34.47 8.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 109.364 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.504 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . . . -78.72 -33.94 46.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.442 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.435 ' OE2' HG21 ' A' ' 87' ' ' VAL . 82.1 tt0 -64.45 -40.11 95.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.561 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 19.5 tt -77.34 -29.59 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.374 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' CB ' ' SD ' ' A' ' 30' ' ' MET . . . -68.77 -29.49 67.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.478 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.82 94.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.491 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 82' ' ' THR . 87.0 t -75.86 -48.29 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 98.1 mt-10 -51.87 -41.57 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.569 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 14.1 t80 -56.82 -67.86 0.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.647 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.446 ' HB3' HG13 ' A' ' 80' ' ' VAL . . . -63.67 -13.98 47.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.606 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 38.0 t -66.82 -66.04 0.6 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.521 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 73.9 tttt -60.01 -42.61 94.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.634 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.569 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 56.7 mttp -64.94 -35.62 81.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.513 ' HB2' ' CG1' ' A' ' 78' ' ' VAL . . . -58.3 -60.44 3.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.525 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 21.0 tp -56.71 -44.12 81.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 109.388 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 72' ' ' LEU . 55.6 tttp -43.59 -42.13 4.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.155 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 19.6 mm -48.39 142.76 7.95 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.86 . . . . 0.0 108.961 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.9 Cg_endo -65.49 -4.58 9.79 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.548 2.165 . . . . 0.0 111.937 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.02 167.28 25.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HG2' ' HA ' ' A' ' 6' ' ' TYR . 45.2 Cg_endo -67.88 116.4 4.27 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.565 2.176 . . . . 0.0 111.699 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.574 ' CG2' ' CD1' ' A' ' 10' ' ' PHE . 7.2 p -111.31 149.82 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.333 -0.854 . . . . 0.0 109.578 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.528 HD21 ' CB ' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -104.51 137.41 42.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 109.59 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 43.7 t -110.27 130.46 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.145 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 81' ' ' ILE . 15.8 mt -114.61 132.08 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.447 HG21 HG21 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -124.85 161.99 25.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 56.4 p30 -87.14 13.08 10.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.499 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 67.2 m -123.26 125.28 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.485 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.564 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 70.4 t80 -78.38 -41.89 31.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -58.54 -52.71 64.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 90' ' ' SER . 48.4 t -59.23 -51.8 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.448 ' HA ' HG23 ' A' ' 132' ' ' ILE . . . -49.68 -52.97 27.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.288 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -60.08 -33.75 72.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.17 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.629 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 34.1 m -52.72 -47.22 67.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.327 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -94.25 -0.75 54.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.612 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -86.93 -71.99 0.53 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.957 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 24.7 mttm -116.64 -35.53 4.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 109.831 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 91.4 mt-10 -59.84 -38.8 83.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.624 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -53.16 -60.18 7.4 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 47.4 Cg_endo -68.15 -32.37 27.49 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.71 2.273 . . . . 0.0 111.596 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -72.54 -40.6 66.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.28 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.434 ' CZ2' ' OE1' ' A' ' 94' ' ' GLU . 24.9 m0 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.358 -0.839 . . . . 0.0 109.371 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HD3' ' CE1' ' A' ' 113' ' ' HIS . 85.1 tttt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.571 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 33.8 m80 65.98 33.07 8.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.505 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.4 mt -62.33 -47.05 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.253 -0.904 . . . . 0.0 109.406 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.8 m -59.38 -43.57 92.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.432 ' HD3' HG21 ' A' ' 61' ' ' ILE . 35.7 mttp -58.49 -46.9 85.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.285 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.629 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 65.6 m95 -70.16 -30.08 67.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.406 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -60.25 -41.6 93.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.495 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -58.22 -40.7 82.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.515 ' CG1' ' HG2' ' A' ' 65' ' ' GLU . 77.8 mt -72.95 -32.84 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -64.91 -37.16 86.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -60.41 -34.27 73.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.476 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.446 ' HA ' ' HE3' ' A' ' 126' ' ' MET . 6.8 m -79.21 -50.21 11.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.508 ' CD2' ' HB ' ' A' ' 130' ' ' ILE . 57.6 mt -61.04 -34.86 75.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.476 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.8 t -59.27 -34.13 71.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.435 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.495 ' CE ' HD23 ' A' ' 72' ' ' LEU . 71.7 mtm -67.76 -34.53 77.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.423 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -173.99 128.51 0.47 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.475 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.5 Cg_endo -69.74 -1.8 9.07 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.68 2.253 . . . . 0.0 111.638 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 90.9 m-20 -43.83 -43.13 6.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.316 -0.865 . . . . 0.0 109.458 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 40.3 mt -53.99 118.55 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.335 -0.853 . . . . 0.0 109.671 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.451 ' HB ' HD22 ' A' ' 79' ' ' LEU . 9.0 m -119.28 129.65 55.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 108.984 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 52.9 mt -110.47 144.4 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.06 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.481 ' N ' HG22 ' A' ' 132' ' ' ILE . 76.4 mt-30 -132.58 154.32 50.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.343 -0.848 . . . . 0.0 109.163 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.564 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 15.8 t-80 -104.05 128.28 51.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.618 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 83' ' ' ASP . 85.1 tt0 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 109.295 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.424 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 70.0 p -64.12 -36.99 85.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.558 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -49.61 -45.81 48.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 109.552 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.07 -37.56 94.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -58.63 -41.5 86.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -1.142 . . . . 0.0 109.556 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.48 -51.7 66.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.55 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.463 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 52.5 mt -58.8 -45.7 89.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.527 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . . . -56.88 -42.51 79.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.525 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -59.23 -36.53 75.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -63.36 -42.26 98.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.628 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 152' ' ' LEU . 6.4 mp -74.17 -34.04 63.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.573 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.89 -40.86 97.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.425 ' O ' ' OG ' ' A' ' 161' ' ' SER . 50.0 p -69.07 -39.52 79.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.532 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -62.32 -33.56 74.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -64.51 -31.85 82.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.441 ' HB2' HD13 ' A' ' 17' ' ' ILE . 94.5 p -65.96 -34.67 78.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -1.16 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -68.23 -26.99 65.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.495 ' HB ' ' CB ' ' A' ' 50' ' ' PRO . 60.1 t -54.87 -40.4 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.88 . . . . 0.0 109.452 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.4 t . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.432 -179.943 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.575 ' CZ ' HD12 ' A' ' 79' ' ' LEU . 34.3 m-85 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.283 0.563 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -77.06 -31.91 56.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 108.872 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.6 -166.84 35.95 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 79' ' ' LEU . 72.7 t -136.33 143.01 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -1.162 . . . . 0.0 108.978 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.616 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 6.1 m-85 -114.16 146.41 40.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.971 . . . . 0.0 109.907 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.516 ' CE1' HD13 ' A' ' 81' ' ' ILE . 66.9 m-85 -118.41 118.35 31.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.264 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 9.8 p -106.45 155.64 19.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 59.1 t0 -149.58 145.64 26.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.565 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -146.9 118.95 1.08 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 66.8 m -132.0 150.89 52.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -1.158 . . . . 0.0 109.588 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HA ' ' CB ' ' A' ' 28' ' ' ALA . . . -114.78 135.19 54.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.507 ' CD1' ' CB ' ' A' ' 161' ' ' SER . 58.3 mt . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.31 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -98.74 97.56 8.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.328 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 16' ' ' ALA . . . -110.85 155.91 21.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.7 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.44 154.71 25.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.507 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 33.2 mtm -115.39 156.76 24.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -1.113 . . . . 0.0 109.417 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.89 124.23 1.73 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 32' ' ' ILE . 5.4 mp -116.94 134.58 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -1.095 . . . . 0.0 109.102 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG13 ' CG2' ' A' ' 43' ' ' VAL . 50.0 t -127.09 131.39 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.77 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.616 ' CE1' ' CE1' ' A' ' 10' ' ' PHE . 3.5 t60 -102.15 131.0 48.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.196 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.34 159.37 37.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.759 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.448 ' HB ' HD12 ' A' ' 44' ' ' LEU . 7.7 t -117.46 161.45 19.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.863 . . . . 0.0 109.126 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.453 ' OH ' HG23 ' A' ' 9' ' ' VAL . 91.9 m-85 -104.66 8.75 35.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.134 -0.979 . . . . 0.0 109.634 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.557 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.8 -178.94 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.322 -0.861 . . . . 0.0 108.766 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.2 Cg_endo -66.5 -3.13 8.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.122 1.881 . . . . 0.0 111.945 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -132.36 105.78 7.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 108.706 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.5 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 63.3 t80 -66.57 125.5 25.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 109.329 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.5 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 73.0 mt-30 -160.62 152.72 20.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 0.0 109.391 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.489 ' CG2' HG13 ' A' ' 33' ' ' VAL . 13.5 p -82.85 124.33 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.434 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.565 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 6.4 mp -74.06 -42.33 60.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 80.5 m-20 -159.05 149.46 19.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -117.09 148.01 41.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -0.949 . . . . 0.0 109.398 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.456 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -130.92 131.38 44.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.188 -0.945 . . . . 0.0 109.587 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.2 p -123.79 141.95 51.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.451 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.429 HG22 HD23 ' A' ' 51' ' ' LEU . 3.7 mp -149.52 95.67 3.73 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.27 128.16 16.06 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.683 2.256 . . . . 0.0 111.759 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 44.4 mt -111.74 142.9 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 0.0 109.534 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.12 -42.88 0.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -91.96 9.32 33.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 109.522 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 79.4 m80 -110.47 147.31 34.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 0.0 109.467 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.437 HG23 ' HG3' ' A' ' 58' ' ' MET . 9.5 t -90.89 -178.54 5.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.29 -46.6 82.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 60' ' ' GLU . 87.8 mt-30 -63.11 -61.12 2.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.359 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.46 ' O ' HG21 ' A' ' 61' ' ' ILE . 94.2 mtp -44.01 -32.91 1.27 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.426 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -76.19 -30.36 58.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 0.0 109.526 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 57' ' ' GLN . 95.4 mt-10 -70.34 -38.93 74.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.597 ' CD1' ' CE2' ' A' ' 117' ' ' TRP . 18.0 tt -72.49 -34.57 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.507 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -70.21 -32.5 70.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.409 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.456 ' HB2' ' HB ' ' A' ' 12' ' ' THR . . . -65.03 -40.15 94.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.509 HG22 ' CG2' ' A' ' 82' ' ' THR . 70.2 t -72.32 -39.7 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 109.49 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.23 -39.74 86.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.192 -0.942 . . . . 0.0 109.019 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.463 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 30.8 t80 -57.7 -63.59 1.19 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.369 -0.832 . . . . 0.0 109.528 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 68' ' ' CYS . . . -64.12 -39.55 94.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.601 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.465 ' O ' HD12 ' A' ' 130' ' ' ILE . 37.2 t -43.06 -62.43 1.04 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.444 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 67.6 mttm -59.27 -46.09 89.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -0.929 . . . . 0.0 109.426 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 66' ' ' PHE . 30.9 mmtt -56.15 -38.18 70.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.389 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.59 ' CB ' ' CG1' ' A' ' 78' ' ' VAL . . . -59.94 -64.95 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.473 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 1.0 OUTLIER -48.56 -47.12 39.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 109.461 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 72' ' ' LEU . 49.9 mttm -43.25 -42.46 4.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.33 -0.857 . . . . 0.0 109.097 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 30.1 mm -49.39 143.65 9.68 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.397 -0.814 . . . . 0.0 109.001 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.1 Cg_endo -65.11 -4.35 8.89 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.51 2.14 . . . . 0.0 111.895 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.61 172.31 24.97 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.481 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.1 Cg_endo -69.02 120.63 7.51 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 122.408 2.072 . . . . 0.0 111.677 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.59 ' CG1' ' CB ' ' A' ' 71' ' ' ALA . 7.2 p -114.89 153.76 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 109.141 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.575 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 6.6 mp -97.1 139.98 32.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.025 -1.047 . . . . 0.0 109.931 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 58.1 t -118.0 121.98 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.418 -0.801 . . . . 0.0 109.004 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.516 HD13 ' CE1' ' A' ' 11' ' ' TYR . 3.7 mt -107.29 142.44 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.117 -0.99 . . . . 0.0 109.62 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.509 ' CG2' HG22 ' A' ' 64' ' ' VAL . 0.7 OUTLIER -128.18 161.7 28.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.415 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -87.74 7.11 31.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 109.507 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -123.95 129.42 50.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.526 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.454 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 68.0 t80 -77.8 -39.3 44.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -63.35 -48.15 79.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.496 HG13 ' CG2' ' A' ' 64' ' ' VAL . 59.5 t -58.96 -53.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 0.0 109.369 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.411 ' CB ' HG22 ' A' ' 132' ' ' ILE . . . -48.35 -55.0 11.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.933 . . . . 0.0 109.314 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 85' ' ' PHE . 77.1 mm-40 -56.35 -35.1 67.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.575 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 38.6 m -53.39 -46.63 69.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.473 ' CB ' ' CD1' ' A' ' 132' ' ' ILE . . . -92.5 -0.88 57.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.87 . . . . 0.0 109.674 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -89.03 -72.86 0.53 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.067 -1.021 . . . . 0.0 109.761 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 23.2 mttm -126.86 -29.55 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.904 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 88.4 mt-10 -59.58 -28.34 67.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.494 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -58.77 -60.88 8.99 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.124 -0.985 . . . . 0.0 109.552 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.1 Cg_endo -66.41 -31.44 42.68 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.724 2.283 . . . . 0.0 111.411 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -68.89 -38.46 79.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.236 -0.915 . . . . 0.0 108.883 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 35.3 m0 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.19 179.653 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.505 ' HE3' ' NE2' ' A' ' 113' ' ' HIS . 33.8 tttp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.278 0.561 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.505 ' NE2' ' HE3' ' A' ' 112' ' ' LYS . 70.6 m-70 65.25 36.79 6.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.653 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 114' ' ' ILE . 86.1 mt -53.93 -43.89 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.242 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.9 m -49.68 -45.89 49.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.267 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HD2' ' HB3' ' A' ' 113' ' ' HIS . 64.1 mttm -58.6 -48.09 82.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.307 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.597 ' CE2' ' CD1' ' A' ' 61' ' ' ILE . 60.9 m95 -65.65 -38.14 88.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.839 . . . . 0.0 109.385 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -56.87 -46.64 81.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.479 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.4 p -57.67 -39.54 77.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 109.423 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 73.9 mt -66.75 -37.24 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.861 . . . . 0.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' O ' ' OG ' ' A' ' 125' ' ' SER . . . -65.32 -32.66 74.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 126' ' ' MET . 83.9 tt0 -54.18 -38.15 65.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.329 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.406 ' HB3' HD11 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -80.87 -49.25 11.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.419 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 22.7 tp -63.08 -31.86 73.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 121' ' ' ALA . 50.8 m -66.12 -33.24 75.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.475 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 65.1 mtt -65.99 -34.5 78.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.2 OUTLIER -176.47 140.82 0.52 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.501 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.0 Cg_endo -70.51 -0.8 8.08 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.655 2.236 . . . . 0.0 111.717 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 84.8 m-20 -43.8 -47.98 8.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.473 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 58.5 mt -58.45 114.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.46 ' HB ' ' HA ' ' A' ' 79' ' ' LEU . 91.0 m -104.81 147.05 28.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.277 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.473 ' CD1' ' CB ' ' A' ' 91' ' ' ALA . 54.3 mt -122.82 142.68 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.615 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -135.71 164.96 26.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.268 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 18.0 t-80 -113.57 138.55 50.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.558 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 82' ' ' THR . 96.9 mt-10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.463 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.208 0.528 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.2 m -63.23 -40.85 98.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.548 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.25 -36.9 76.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.593 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -67.25 -30.27 75.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -72.45 -33.26 66.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -1.169 . . . . 0.0 109.524 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.12 -51.51 37.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.543 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 56.3 mt -59.19 -47.27 85.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . . . -56.84 -38.75 73.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 109.564 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.27 -32.26 73.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.647 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 159' ' ' GLN . 24.7 mttm -67.84 -41.88 82.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.63 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.479 ' CD1' ' O ' ' A' ' 152' ' ' LEU . 6.3 mp -73.14 -31.59 64.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.94 . . . . 0.0 109.585 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.61 -62.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.589 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 35.5 m -59.25 -43.3 92.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.473 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 63.1 tp60 -61.32 -33.61 73.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.629 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.52 -31.16 73.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.507 ' CB ' ' CD1' ' A' ' 17' ' ' ILE . 19.0 m -66.71 -29.33 69.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -1.142 . . . . 0.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -75.37 -21.52 58.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.76 -43.95 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' A' ' 161' ' ' SER . 4.6 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.518 ' CD2' HD12 ' A' ' 79' ' ' LEU . 99.7 m-85 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.27 0.557 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.512 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 31.7 tp10 -64.2 -37.89 89.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.362 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -178.48 -175.34 45.5 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.2 t -134.47 142.86 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -1.121 . . . . 0.0 109.354 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.659 ' CD2' ' CD2' ' A' ' 34' ' ' HIS . 7.3 m-85 -123.06 140.36 53.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.634 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.491 ' CE2' HD12 ' A' ' 81' ' ' ILE . 42.9 m-85 -113.32 132.56 55.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.308 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.5 ' CG2' HD11 ' A' ' 32' ' ' ILE . 24.6 p -120.17 142.57 48.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.831 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.456 ' OD2' ' OD1' ' A' ' 154' ' ' ASP . 52.4 t0 -137.0 155.91 49.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.405 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -142.42 127.29 3.16 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 40.2 m -124.21 157.74 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -1.133 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' CB ' ' CB ' ' A' ' 56' ' ' ALA . . . -145.35 144.49 30.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 109.625 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' A' ' 161' ' ' SER . 47.7 mt . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 0.0 109.402 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 71.1 m-20 -92.14 113.37 25.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.943 . . . . 0.0 109.337 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -112.14 145.68 39.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.775 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.62 165.46 23.3 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.512 ' CE ' HG23 ' A' ' 49' ' ' ILE . 67.9 mtm -133.46 150.94 51.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -1.184 . . . . 0.0 109.684 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.46 120.24 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.5 HD11 ' CG2' ' A' ' 12' ' ' THR . 23.4 mm -110.36 140.62 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -1.159 . . . . 0.0 109.547 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.515 ' CG2' ' HB3' ' A' ' 153' ' ' ALA . 42.4 t -124.82 130.41 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.353 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.659 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 25.4 m170 -105.67 138.2 42.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 109.655 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.7 168.62 18.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.2 t -138.16 165.13 27.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.175 -0.953 . . . . 0.0 109.713 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 38' ' ' LYS . 68.8 m-85 -106.63 10.21 31.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.09 -179.96 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.039 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.6 Cg_endo -66.39 -4.57 10.93 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.159 1.906 . . . . 0.0 111.64 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -132.12 105.92 7.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.35 -0.844 . . . . 0.0 108.811 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.46 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 58.6 t80 -63.53 117.72 7.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 109.408 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.46 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 85.7 mt-30 -157.98 144.79 17.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.684 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 6.3 m -72.78 124.73 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 68.3 mt -59.72 -39.14 83.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.94 . . . . 0.0 109.483 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 20.3 t-20 -179.57 157.02 0.74 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -108.39 139.33 43.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.873 . . . . 0.0 109.515 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.403 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 0.5 OUTLIER -118.86 139.93 50.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.264 -0.897 . . . . 0.0 109.483 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 t -130.81 125.45 33.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.449 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.512 HG23 ' CE ' ' A' ' 30' ' ' MET . 2.2 mp -130.82 95.74 25.04 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.527 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 50.1 Cg_endo -69.93 134.98 28.92 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.785 2.323 . . . . 0.0 111.813 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.461 HD11 ' HB1' ' A' ' 59' ' ' ALA . 38.8 mt -113.21 152.01 30.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.57 -48.37 0.13 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -89.16 7.49 34.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -1.177 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 74.4 m80 -111.18 142.08 43.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.439 HG23 ' HG3' ' A' ' 58' ' ' MET . 9.6 t -87.43 -176.27 5.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.51 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . . . -60.45 -44.7 95.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -62.06 -48.58 79.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.463 ' O ' HG22 ' A' ' 61' ' ' ILE . 96.3 mtp -61.63 -30.12 70.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.497 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.461 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -71.02 -28.74 64.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.427 ' HB3' HG22 ' A' ' 87' ' ' VAL . 98.1 mt-10 -73.69 -45.2 53.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.516 HG21 ' N ' ' A' ' 62' ' ' ALA . 16.1 tt -63.12 -32.03 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.875 . . . . 0.0 109.465 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.516 ' N ' HG21 ' A' ' 61' ' ' ILE . . . -74.2 -34.52 63.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.329 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.24 -42.82 77.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.534 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 32.7 t -71.32 -45.5 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.51 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.505 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 97.8 mt-10 -55.76 -35.57 66.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.907 . . . . 0.0 109.56 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.502 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 8.8 t80 -62.11 -69.04 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.607 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 -13.95 51.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.492 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.452 ' O ' HD13 ' A' ' 130' ' ' ILE . 41.4 t -66.08 -60.41 2.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.179 -0.951 . . . . 0.0 109.432 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -65.13 -40.12 93.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.463 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HE3' ' CE2' ' A' ' 66' ' ' PHE . 63.2 mttm -64.26 -34.96 79.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.416 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.41 ' O ' HG12 ' A' ' 74' ' ' ILE . . . -63.71 -65.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' LYS . 24.9 tp -51.23 -44.33 61.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.953 . . . . 0.0 109.589 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' LEU . 83.5 tttt -43.55 -47.35 7.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.284 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.552 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 9.5 mm -48.51 142.72 8.24 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.14 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.2 Cg_endo -65.88 -5.02 11.09 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.49 2.127 . . . . 0.0 111.556 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.74 168.22 23.67 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 47.7 Cg_endo -68.85 137.35 37.96 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.583 2.188 . . . . 0.0 111.585 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.562 HG11 ' CD1' ' A' ' 10' ' ' PHE . 21.7 t -123.82 159.1 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.46 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.518 HD12 ' CD2' ' A' ' 6' ' ' TYR . 6.5 mp -105.92 123.8 48.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.863 . . . . 0.0 109.59 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 40.2 t -103.6 121.62 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.453 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.491 HD12 ' CE2' ' A' ' 11' ' ' TYR . 13.8 mt -106.85 139.05 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.311 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.86 161.74 29.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.406 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -93.43 -2.5 54.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.501 ' CB ' HG22 ' A' ' 87' ' ' VAL . 71.1 m -108.5 120.75 43.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.565 ' HA ' ' CD2' ' A' ' 134' ' ' HIS . 61.2 t80 -71.31 -28.64 64.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.345 -0.847 . . . . 0.0 109.541 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -78.98 -46.33 18.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.316 -0.865 . . . . 0.0 109.745 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.501 HG22 ' CB ' ' A' ' 84' ' ' SER . 30.9 t -57.68 -60.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 109.437 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . . . -53.19 -51.75 61.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 0.0 109.408 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -52.31 -38.27 58.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.511 ' HB3' ' CH2' ' A' ' 117' ' ' TRP . 19.2 t -56.91 -48.2 78.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.43 ' HB3' HD12 ' A' ' 132' ' ' ILE . . . -81.92 -0.91 45.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 109.765 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -92.68 -73.77 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.003 -1.06 . . . . 0.0 110.072 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 32.5 mmtp -127.52 -27.13 2.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.0 . . . . 0.0 110.239 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 53.8 mt-10 -62.75 -20.54 65.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 110.176 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.515 ' HB3' ' CD ' ' A' ' 96' ' ' PRO . 25.4 tp -64.86 -58.33 13.32 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.965 -1.084 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.515 ' CD ' ' HB3' ' A' ' 95' ' ' LEU . 44.2 Cg_endo -66.14 -36.12 30.45 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.545 2.163 . . . . 0.0 111.442 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -65.79 -34.61 78.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 108.935 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 23.1 m0 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.4 -0.812 . . . . 0.0 109.123 179.65 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.9 mttt . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 61.71 34.83 17.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.057 -1.027 . . . . 0.0 109.149 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 114' ' ' ILE . 45.6 mm -48.86 -41.64 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 109.08 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.8 t -47.39 -44.01 23.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 108.784 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.452 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 40.3 mttm -63.38 -46.08 88.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 108.952 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.511 ' CH2' ' HB3' ' A' ' 90' ' ' SER . 47.9 m95 -62.17 -42.39 99.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -0.867 . . . . 0.0 109.216 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -51.66 -48.15 63.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.255 -0.903 . . . . 0.0 109.34 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.2 m -49.54 -39.8 35.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.24 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.505 ' CG1' ' HG2' ' A' ' 65' ' ' GLU . 61.9 mt -73.27 -33.32 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.268 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . . . -64.96 -36.82 85.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -54.25 -40.3 67.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.407 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.442 ' HB3' HD12 ' A' ' 130' ' ' ILE . 72.1 m -76.92 -50.61 12.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.41 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.49 -35.98 75.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.357 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.2 t -58.96 -35.14 72.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.476 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.454 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 65.9 mtt -65.35 -34.78 79.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 172.37 152.72 0.22 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 0.0 109.557 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.7 Cg_endo -71.76 3.2 3.97 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.813 2.342 . . . . 0.0 112.059 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 81.2 m-20 -42.36 -30.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 109.581 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 68' ' ' CYS . 38.1 mt -82.76 111.64 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.514 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.455 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 32.9 m -97.72 151.16 20.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.391 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.537 ' CG2' ' CB ' ' A' ' 88' ' ' ALA . 63.7 mt -125.27 129.07 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.634 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.464 ' OE1' HD11 ' A' ' 81' ' ' ILE . 87.2 mt-30 -119.17 157.31 28.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.38 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.565 ' CD2' ' HA ' ' A' ' 85' ' ' PHE . 27.3 m170 -112.03 133.57 54.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.665 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.441 ' CD ' ' ND2' ' A' ' 150' ' ' ASN . 49.7 tp10 . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.873 . . . . 0.0 109.289 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.2 m -51.95 -48.49 64.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.439 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -47.59 -51.37 21.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -52.39 -40.4 53.68 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.441 ' ND2' ' CD ' ' A' ' 135' ' ' GLU . 87.9 m-20 -64.96 -39.26 93.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -1.141 . . . . 0.0 109.465 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.79 -48.54 72.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.447 ' O ' HD13 ' A' ' 156' ' ' LEU . 6.6 mp -64.17 -41.13 97.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.441 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.515 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -64.9 -36.97 86.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.456 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 76.4 m-20 -61.18 -42.74 99.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -60.8 -45.45 94.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.527 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 152' ' ' LEU . 1.0 OUTLIER -63.89 -38.19 90.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.23 93.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 109.465 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 56.2 m -64.7 -41.65 95.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.5 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.49 -33.14 72.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.89 . . . . 0.0 109.624 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.23 96.38 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 164' ' ' VAL . 95.6 p -56.73 -28.68 61.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -1.171 . . . . 0.0 109.631 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -72.72 -25.11 61.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 109.524 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 50' ' ' PRO . 77.1 t -64.17 -42.55 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.899 . . . . 0.0 109.411 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 161' ' ' SER . 41.0 t . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.413 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 7.9 p90 . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.493 ' OE2' ' CD ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -88.5 -31.41 18.74 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.289 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.465 ' O ' HG21 ' A' ' 78' ' ' VAL . . . -177.24 -177.08 45.87 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 79' ' ' LEU . 59.4 t -124.8 142.63 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -1.133 . . . . 0.0 109.25 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.676 ' CD2' ' CD2' ' A' ' 34' ' ' HIS . 5.4 m-85 -114.3 146.58 40.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.861 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.578 ' CE2' HG13 ' A' ' 81' ' ' ILE . 67.8 m-85 -119.64 129.1 54.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.394 -0.817 . . . . 0.0 109.104 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.451 HG22 HD13 ' A' ' 32' ' ' ILE . 16.0 p -118.02 147.46 43.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.64 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 58.8 t0 -144.34 150.65 38.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.548 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -134.96 120.99 2.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.7 m -133.13 150.68 52.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -1.137 . . . . 0.0 109.625 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -119.75 154.46 34.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.479 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 161' ' ' SER . 66.6 mt . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.162 -0.961 . . . . 0.0 109.629 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 7.8 m120 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' ILE . 23.7 m120 -99.53 113.7 26.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.413 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -93.17 150.35 20.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.9 143.03 9.81 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 63.4 mtm -115.39 162.86 16.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -1.152 . . . . 0.0 109.359 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' A' ' 156' ' ' LEU . . . -151.27 130.22 3.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' A' ' 47' ' ' TRP . 23.4 mm -114.76 140.65 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -1.116 . . . . 0.0 109.382 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 153' ' ' ALA . 40.6 t -127.88 130.2 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.676 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 19.6 m170 -105.67 137.57 43.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.144 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.1 168.63 19.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.709 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -137.01 164.32 28.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.379 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 38' ' ' LYS . 59.4 m-85 -102.48 14.78 31.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.494 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.559 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -51.17 179.8 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 108.942 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.3 Cg_endo -66.1 -6.21 14.05 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.137 1.891 . . . . 0.0 111.447 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.469 ' CD ' ' NE2' ' A' ' 42' ' ' GLN . 79.7 tt0 -135.16 106.55 6.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.427 -0.795 . . . . 0.0 109.066 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -58.38 122.96 14.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.258 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.469 ' NE2' ' CD ' ' A' ' 40' ' ' GLU . 45.1 mt-30 -154.14 148.17 25.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.683 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 8.6 p -82.96 123.78 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 54.4 mt -64.27 -34.18 77.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 21.7 t-20 178.69 155.3 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.512 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.448 ' HB3' HD23 ' A' ' 156' ' ' LEU . 94.2 mt-30 -109.32 142.39 40.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.322 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.455 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -126.52 136.4 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.591 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.1 t -127.29 132.49 50.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.361 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.577 HD13 ' CD2' ' A' ' 66' ' ' PHE . 3.3 mt -132.77 91.73 28.72 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.74 136.22 29.89 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.713 2.275 . . . . 0.0 111.728 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 44.0 mt -101.48 143.98 30.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.41 -68.41 1.13 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -109.87 64.09 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.19 . . . . 0.0 109.537 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 81.0 m80 -132.1 171.95 12.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.439 HG23 ' HG3' ' A' ' 58' ' ' MET . 11.7 t -121.0 174.22 6.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.83 -45.26 78.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' GLU . 90.1 mt-30 -60.35 -64.03 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.447 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.439 ' HG3' HG23 ' A' ' 55' ' ' THR . 97.1 mtp -44.35 -35.3 2.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 109.371 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.43 ' HB3' HD11 ' A' ' 51' ' ' LEU . . . -80.39 -25.9 38.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 57' ' ' GLN . 78.0 tt0 -64.48 -40.56 95.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.404 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.592 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 12.1 tt -84.1 -29.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.73 -25.84 65.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.465 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.38 81.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.512 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 96.7 t -79.29 -38.97 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.569 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -66.8 -39.37 87.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.078 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.577 ' CD2' HD13 ' A' ' 49' ' ' ILE . 27.6 t80 -59.72 -64.54 0.91 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.447 -0.783 . . . . 0.0 109.608 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.94 -32.2 70.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.839 . . . . 0.0 109.751 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.494 ' SG ' ' CG2' ' A' ' 120' ' ' ILE . 50.8 t -54.82 -54.18 45.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -62.87 -45.67 91.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.581 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.526 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 62.9 mttm -63.38 -38.0 89.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 109.669 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 74' ' ' ILE . . . -56.75 -63.05 1.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.57 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.534 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 25.2 tp -53.48 -45.74 69.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.489 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 72' ' ' LEU . 20.8 tttp -43.06 -43.21 4.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.371 -0.831 . . . . 0.0 109.23 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 8.0 mt -48.25 142.44 7.92 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 108.877 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.8 Cg_endo -66.11 -4.3 10.06 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.447 2.098 . . . . 0.0 111.696 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.414 ' HA3' ' CD ' ' A' ' 7' ' ' GLU . . . -140.77 166.96 25.76 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.493 ' CD ' ' OE2' ' A' ' 7' ' ' GLU . 46.7 Cg_endo -67.64 127.17 15.88 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.418 2.079 . . . . 0.0 111.591 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.586 HG22 ' CD1' ' A' ' 10' ' ' PHE . 7.3 p -123.47 151.41 28.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.165 -0.959 . . . . 0.0 109.495 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.521 ' CD2' ' HB ' ' A' ' 131' ' ' THR . 15.5 mt -93.15 146.78 23.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 131' ' ' THR . 65.1 t -118.09 135.84 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 109.396 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.578 HG13 ' CE2' ' A' ' 11' ' ' TYR . 26.1 mm -114.75 132.67 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.427 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -129.77 161.62 30.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.953 . . . . 0.0 109.481 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 58.7 p30 -94.57 11.38 31.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.363 -0.835 . . . . 0.0 109.435 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.453 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.3 t -131.92 119.21 20.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.498 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.528 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 68.9 t80 -75.96 -34.3 59.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.339 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -57.95 -53.62 56.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 88' ' ' ALA . 13.7 p -61.06 -46.67 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.338 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.499 ' N ' HG12 ' A' ' 87' ' ' VAL . . . -53.5 -51.72 61.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.204 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 84.4 tt0 -55.93 -36.5 67.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.623 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 67.8 m -54.87 -49.51 71.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.451 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 124' ' ' LEU . . . -85.95 -1.0 56.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.719 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.453 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 81.3 m-20 -87.1 -73.32 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.072 -1.017 . . . . 0.0 109.722 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 67.6 mttm -127.08 -30.76 2.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -0.87 . . . . 0.0 109.835 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.479 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 69.4 mt-10 -58.09 -28.21 64.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.727 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.487 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -59.64 -61.23 8.29 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.0 109.458 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -66.3 -30.87 44.77 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.691 2.261 . . . . 0.0 111.572 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -67.55 -39.51 84.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.013 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.479 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 27.9 m0 . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.173 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 12.8 mmtp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 49.0 m80 65.61 34.56 7.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.517 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.421 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 35.8 mm -68.09 -42.73 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.414 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 23.2 m -55.96 -40.76 73.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 109.346 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -65.37 -39.21 92.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.623 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 22.6 m95 -71.64 -39.15 70.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.317 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 55.3 mtmt -57.38 -42.16 81.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 109.383 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.3 m -58.41 -42.42 87.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.494 ' CG2' ' SG ' ' A' ' 68' ' ' CYS . 83.4 mt -76.36 -34.06 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.44 ' CA ' HD11 ' A' ' 95' ' ' LEU . . . -63.62 -40.05 95.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.941 . . . . 0.0 109.432 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -57.46 -42.53 82.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.438 ' HB3' HD13 ' A' ' 130' ' ' ILE . 35.4 m -67.53 -49.68 62.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.583 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 56.0 mt -62.71 -30.56 71.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.913 . . . . 0.0 109.571 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 121' ' ' ALA . 39.0 m -56.04 -36.37 67.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.498 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.404 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 65.3 mtt -64.15 -34.85 79.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.985 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 126' ' ' MET . 1.3 mttp 170.76 156.53 0.21 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.626 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 129' ' ' ASP . 53.4 Cg_endo -71.82 2.65 4.51 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.823 2.349 . . . . 0.0 111.897 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 91.3 m-20 -41.73 -43.97 3.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.875 . . . . 0.0 109.685 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 50.3 mt -68.35 115.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.51 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.521 ' HB ' ' CD2' ' A' ' 79' ' ' LEU . 24.5 m -107.52 142.95 36.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 0.0 109.095 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.45 ' HB ' ' OD1' ' A' ' 92' ' ' ASN . 61.8 mt -124.96 137.99 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 109.781 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.49 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 94.8 mt-30 -133.03 161.19 35.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.354 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.528 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 20.0 t-80 -105.07 135.68 45.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 109.412 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.525 ' CG ' HG21 ' A' ' 81' ' ' ILE . 99.4 mt-10 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 62.9 m80 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.326 0.584 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 51.9 m -56.86 -49.17 76.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 109.444 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.03 -48.3 64.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.433 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.6 -37.35 82.52 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -60.08 -40.06 88.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -1.119 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.06 -52.84 62.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.489 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.9 mt -57.31 -48.64 78.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.491 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.49 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -54.43 -40.44 68.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.453 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 88.8 m-20 -59.25 -40.29 85.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -60.58 -42.64 97.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.538 ' CD1' ' N ' ' A' ' 156' ' ' LEU . 6.6 mp -66.28 -39.86 89.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.527 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.72 -53.2 58.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.0 m -59.12 -42.83 91.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -63.11 -40.05 96.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.73 -51.29 58.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.524 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 30.3 m -61.92 -33.39 74.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -1.133 . . . . 0.0 109.465 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -62.99 -35.86 81.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.892 . . . . 0.0 109.46 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.4 t -64.96 -16.76 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 -179.956 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.598 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 64.8 m-85 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.527 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 76.6 mm-40 -63.0 -38.66 92.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.171 -0.956 . . . . 0.0 108.942 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.48 -170.71 41.64 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.554 HG23 ' CZ ' ' A' ' 37' ' ' TYR . 73.8 t -133.26 139.1 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -1.082 . . . . 0.0 109.007 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.635 ' CD2' ' ND1' ' A' ' 34' ' ' HIS . 5.1 m-85 -113.8 138.6 50.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.905 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.546 ' CE1' HD11 ' A' ' 81' ' ' ILE . 75.2 m-85 -114.05 117.2 30.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.146 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.459 ' CG2' HG22 ' A' ' 32' ' ' ILE . 10.4 p -114.55 157.16 23.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.786 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 49.9 t0 -155.77 156.01 34.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.279 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.495 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -131.25 141.96 13.29 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.9 t -141.62 138.6 32.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.543 ' CB ' ' CB ' ' A' ' 56' ' ' ALA . . . -118.97 143.62 46.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.521 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.438 HD13 ' OG ' ' A' ' 161' ' ' SER . 63.9 mt . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.378 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.526 ' HB3' ' CG2' ' A' ' 164' ' ' VAL . 21.8 m120 -91.68 114.97 27.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.485 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 51' ' ' LEU . . . -99.26 143.08 29.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.93 151.44 20.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.517 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 72.4 mtm -128.68 160.45 32.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -1.145 . . . . 0.0 109.518 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -153.34 115.67 0.69 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 47' ' ' TRP . 4.3 mp -123.54 120.53 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -1.175 . . . . 0.0 109.431 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.549 ' CG2' ' CG1' ' A' ' 43' ' ' VAL . 11.6 p -120.82 148.0 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.635 ' ND1' ' CD2' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -109.24 145.52 35.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.03 173.11 11.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -133.22 157.03 46.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 109.664 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.554 ' CZ ' HG23 ' A' ' 9' ' ' VAL . 16.7 m-30 -103.48 12.79 34.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.51 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.569 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -50.82 -179.62 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 108.941 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.5 Cg_endo -65.11 -7.43 15.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.038 1.825 . . . . 0.0 111.288 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -128.11 106.25 8.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.429 -0.795 . . . . 0.0 108.965 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -61.82 127.37 31.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.149 -0.97 . . . . 0.0 109.237 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -161.42 154.24 20.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.925 . . . . 0.0 109.562 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.549 ' CG1' ' CG2' ' A' ' 33' ' ' VAL . 41.9 t -91.05 122.54 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 109.24 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 45.5 mt -62.46 -40.21 95.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 109.346 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.46 ' O ' HG23 ' A' ' 33' ' ' VAL . 64.2 t30 178.45 154.49 0.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.878 . . . . 0.0 109.684 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.529 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 56.2 mt-30 -107.58 143.06 36.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.054 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.2 t-105 -118.52 131.85 56.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 109.599 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.2 m -121.88 145.34 48.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.476 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 9.9 mt -149.56 96.88 3.57 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.554 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.0 Cg_endo -70.02 128.4 15.74 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.684 2.256 . . . . 0.0 111.661 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 28' ' ' ALA . 49.0 mt -114.36 148.67 37.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 109.49 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.65 -46.89 0.2 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -87.47 11.11 15.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 78.2 m80 -112.61 147.21 37.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.414 HG21 ' HG3' ' A' ' 58' ' ' MET . 0.1 OUTLIER -89.58 168.47 12.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.9 . . . . 0.0 109.111 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.543 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . . . -49.38 -38.76 29.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.1 -1.0 . . . . 0.0 109.056 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' MET . 89.2 mt-30 -70.09 -58.77 3.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.332 -0.855 . . . . 0.0 109.311 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.46 ' O ' HG22 ' A' ' 61' ' ' ILE . 93.3 mtp -45.43 -30.59 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.158 -0.964 . . . . 0.0 109.199 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.28 -37.35 60.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.416 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.447 ' HB3' ' OG ' ' A' ' 84' ' ' SER . 96.3 mt-10 -62.74 -44.9 95.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.358 -0.839 . . . . 0.0 109.562 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.63 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 8.2 tt -67.29 -35.09 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.517 ' CB ' ' SD ' ' A' ' 30' ' ' MET . . . -65.89 -29.69 70.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.192 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 12' ' ' THR . . . -70.01 -44.79 68.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.44 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.516 HG22 ' CG1' ' A' ' 87' ' ' VAL . 68.6 t -63.13 -47.3 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.335 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.452 ' HG3' HG12 ' A' ' 120' ' ' ILE . 84.6 tt0 -64.83 -38.3 90.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 109.417 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.529 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 16.3 t80 -53.66 -68.82 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.395 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.23 -15.94 58.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.369 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.459 ' O ' HD13 ' A' ' 130' ' ' ILE . 39.8 t -70.79 -58.03 4.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.435 ' NZ ' ' OE2' ' A' ' 65' ' ' GLU . 25.5 mttt -59.76 -48.69 80.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.486 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.529 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 37.5 mttm -60.87 -38.48 85.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.227 -0.92 . . . . 0.0 109.505 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.566 ' CB ' ' CG1' ' A' ' 78' ' ' VAL . . . -55.74 -69.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 71' ' ' ALA . 6.3 tp -44.89 -48.51 11.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 109.434 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 20.2 mttm -43.81 -44.36 6.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.281 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.551 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 9.7 mt -48.81 143.11 8.51 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.043 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.6 Cg_endo -66.29 -2.68 7.48 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.601 2.2 . . . . 0.0 111.921 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.527 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -141.64 166.4 26.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.47 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.3 Cg_endo -69.34 122.75 9.54 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 122.552 2.168 . . . . 0.0 111.714 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.572 HG22 ' CE1' ' A' ' 10' ' ' PHE . 2.8 p -112.77 156.44 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.598 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 19.3 mt -101.58 140.26 36.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.759 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 52.0 t -120.92 130.33 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.137 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.546 HD11 ' CE1' ' A' ' 11' ' ' TYR . 8.0 mt -118.71 136.23 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.742 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.8 t -140.97 143.26 34.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.237 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -66.69 -25.34 66.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.905 . . . . 0.0 109.57 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.58 ' CB ' ' CG1' ' A' ' 87' ' ' VAL . 3.6 m -64.69 110.93 2.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 109.286 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.659 ' CD2' ' CE1' ' A' ' 134' ' ' HIS . 49.2 t80 -78.05 -41.45 35.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.688 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -71.15 -35.98 71.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 0.0 109.908 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.58 ' CG1' ' CB ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -67.36 -47.16 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.135 -0.978 . . . . 0.0 109.497 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.579 ' CB ' ' NE2' ' A' ' 134' ' ' HIS . . . -54.32 -51.4 64.8 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.229 -0.919 . . . . 0.0 108.964 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.447 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 72.6 tt0 -55.26 -33.39 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.332 -0.855 . . . . 0.0 108.967 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.637 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 16.6 m -57.3 -49.11 77.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.844 . . . . 0.0 109.352 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.482 ' CB ' ' CD1' ' A' ' 132' ' ' ILE . . . -85.71 -0.72 55.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.749 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.472 ' OD1' ' HB ' ' A' ' 132' ' ' ILE . 85.7 m-20 -88.48 -73.48 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 109.947 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 63.0 mttt -127.42 -30.07 2.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.017 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 37.5 mm-40 -57.04 -31.54 65.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.078 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.486 ' CD1' ' O ' ' A' ' 90' ' ' SER . 0.5 OUTLIER -58.32 -60.8 9.05 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 0.0 109.503 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -66.8 -26.33 45.12 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.642 2.228 . . . . 0.0 111.581 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -73.82 -36.83 65.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 108.977 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.1 m0 . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.35 -0.844 . . . . 0.0 109.239 179.663 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HD3' ' CE1' ' A' ' 113' ' ' HIS . 80.8 tttt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.276 0.56 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.546 ' CE1' ' HD3' ' A' ' 112' ' ' LYS . 39.5 m80 65.31 28.55 11.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.569 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.451 HD13 HG21 ' A' ' 114' ' ' ILE . 80.0 mt -62.88 -45.48 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.167 -0.958 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -55.67 -46.08 77.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.53 -45.48 91.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.637 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 54.3 m95 -66.42 -36.55 83.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.439 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -56.4 -46.17 80.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.484 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.6 m -59.96 -44.11 94.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.407 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.452 HG12 ' HG3' ' A' ' 65' ' ' GLU . 87.8 mt -68.79 -39.58 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.453 ' O ' ' OG ' ' A' ' 125' ' ' SER . . . -62.87 -36.24 82.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.472 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -56.2 -37.92 70.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 6.0 m -79.43 -51.34 9.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.387 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.4 tp -58.56 -34.59 71.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.417 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 121' ' ' ALA . 50.0 m -60.47 -31.88 70.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.549 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.78 -33.38 75.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.447 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.45 145.95 0.29 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 109.511 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.6 Cg_endo -72.35 2.72 4.76 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.741 2.294 . . . . 0.0 111.774 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 79.5 m-20 -42.87 -46.16 5.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.504 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 68' ' ' CYS . 52.8 mt -61.92 121.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.342 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.52 ' HB ' ' CD2' ' A' ' 79' ' ' LEU . 24.4 m -110.85 146.77 35.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.372 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.482 ' CD1' ' CB ' ' A' ' 91' ' ' ALA . 54.1 mt -125.12 128.13 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.467 ' HB2' HG12 ' A' ' 81' ' ' ILE . 79.9 mt-30 -127.24 154.9 44.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.659 ' CE1' ' CD2' ' A' ' 85' ' ' PHE . 34.1 m170 -90.67 141.01 29.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.791 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.463 ' HG2' ' OD1' ' A' ' 150' ' ' ASN . 98.3 mt-10 . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 109.286 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.5 ' NE2' ' OH ' ' A' ' 37' ' ' TYR . 71.9 m80 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.1 m -51.35 -45.92 62.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.315 -0.866 . . . . 0.0 109.563 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -52.22 -49.81 63.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 109.506 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.43 -36.1 75.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.463 ' OD1' ' HG2' ' A' ' 135' ' ' GLU . 77.1 m-20 -60.42 -41.13 93.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -1.15 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.24 -48.48 79.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.402 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 26.0 tp -65.28 -42.26 93.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.32 -40.73 98.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 0.0 109.509 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.451 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 56.2 t0 -58.26 -43.17 87.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 0.0 109.559 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 78.6 tttt -62.19 -38.13 87.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.51 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 46' ' ' GLN . 78.8 mt -64.29 -38.2 90.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.568 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.22 83.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.923 . . . . 0.0 109.463 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 36.3 m -61.59 -41.46 97.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.472 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 95.2 mt-30 -62.4 -35.96 80.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -62.54 -55.94 24.38 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.438 ' OG ' HD13 ' A' ' 17' ' ' ILE . 88.1 p -67.48 -28.69 68.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -1.146 . . . . 0.0 109.516 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -63.85 -36.14 82.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.551 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 39.1 t -64.95 -11.79 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.514 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.526 ' CG2' ' HB3' ' A' ' 27' ' ' ASN . 22.3 m . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.455 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.549 ' OH ' ' CG ' ' A' ' 37' ' ' TYR . 24.0 p90 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.274 0.559 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.489 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -94.72 -33.86 12.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 108.924 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.469 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -165.74 175.42 41.4 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.511 HG22 ' CE1' ' A' ' 37' ' ' TYR . 91.8 t -124.95 138.02 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.196 -1.179 . . . . 0.0 109.357 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE2' ' CG ' ' A' ' 34' ' ' HIS . 5.3 m-85 -111.38 139.55 46.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.558 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 82.2 m-85 -113.93 127.34 55.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.908 . . . . 0.0 109.39 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 16.3 p -118.49 152.6 35.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.574 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 53.7 t0 -151.36 152.87 33.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -135.08 118.0 1.84 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.8 m -122.18 150.28 42.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -1.149 . . . . 0.0 109.536 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.44 145.89 48.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.441 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.493 ' CD1' ' OG ' ' A' ' 161' ' ' SER . 74.5 mt . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 109.461 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.281 0.562 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -92.9 115.55 28.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.477 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.19 148.29 24.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 109.463 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.83 153.18 24.05 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.514 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 70.9 mtm -119.95 161.5 20.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.449 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -154.42 117.48 0.79 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' TRP . 4.8 mp -125.74 120.29 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -1.138 . . . . 0.0 109.256 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.509 ' CG2' ' CG1' ' A' ' 43' ' ' VAL . 9.6 p -119.59 145.89 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.735 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.688 ' CG ' ' CE2' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -105.72 136.17 45.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.147 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.38 167.37 20.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.642 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.6 t -124.56 159.85 29.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.369 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.549 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 17.7 m-85 -106.71 16.9 23.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.71 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.568 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -51.28 -178.7 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.852 . . . . 0.0 108.711 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.5 Cg_endo -65.02 -6.37 12.73 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.964 1.776 . . . . 0.0 111.566 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -131.64 106.09 7.94 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.44 126.02 25.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.469 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -155.21 149.14 25.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -0.91 . . . . 0.0 109.534 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.509 ' CG1' ' CG2' ' A' ' 33' ' ' VAL . 51.4 t -91.49 121.06 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 109.523 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 53.1 mt -63.93 -38.89 92.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.453 ' O ' HG22 ' A' ' 33' ' ' VAL . 39.9 t30 -179.99 156.29 0.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.579 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.51 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 93.5 mt-30 -110.46 147.82 33.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.426 -0.796 . . . . 0.0 109.025 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -126.07 132.89 51.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.124 -0.985 . . . . 0.0 109.716 -179.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.7 t -126.22 132.11 51.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.242 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.469 ' HB ' ' CE ' ' A' ' 30' ' ' MET . 3.0 mt -135.51 111.64 10.69 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.722 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.484 ' HB3' ' CG2' ' A' ' 163' ' ' VAL . 50.2 Cg_endo -70.87 134.92 26.65 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.729 2.286 . . . . 0.0 111.665 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.495 HD13 ' CB ' ' A' ' 59' ' ' ALA . 49.9 mt -104.51 138.28 41.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.907 . . . . 0.0 109.617 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' O ' ' ND1' ' A' ' 54' ' ' HIS . . . -113.81 127.63 7.91 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 18.4 m120 64.44 38.55 7.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -1.181 . . . . 0.0 109.469 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 52' ' ' GLY . 75.9 m80 -124.74 165.46 17.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.492 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.455 HG22 ' CG ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -110.56 171.42 7.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 109.179 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.406 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -53.95 -39.72 66.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.094 -1.004 . . . . 0.0 109.231 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 60' ' ' GLU . 92.4 mt-30 -67.35 -53.66 27.48 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.871 . . . . 0.0 109.263 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.466 ' O ' HG23 ' A' ' 61' ' ' ILE . 69.7 mmm -44.73 -34.61 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.33 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.495 ' CB ' HD13 ' A' ' 51' ' ' LEU . . . -76.83 -32.49 57.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.399 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' GLN . 97.7 mt-10 -62.85 -40.61 97.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.58 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.566 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 17.7 tt -74.73 -35.12 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.549 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.514 ' CB ' ' SD ' ' A' ' 30' ' ' MET . . . -71.02 -30.15 66.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.56 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' HB2' ' HB ' ' A' ' 12' ' ' THR . . . -59.93 -39.29 84.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.555 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.432 HG22 HG11 ' A' ' 87' ' ' VAL . 44.3 t -77.14 -43.99 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 98.1 mt-10 -55.78 -36.83 67.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.548 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.562 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 10.8 t80 -59.87 -68.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.645 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.77 -13.58 16.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 109.602 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.427 ' O ' HD11 ' A' ' 130' ' ' ILE . 40.2 t -66.3 -60.77 2.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.485 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -65.65 -40.99 93.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.562 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 54.3 mttm -65.86 -27.42 68.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.566 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.14 -57.13 5.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.437 HD12 ' OD2' ' A' ' 129' ' ' ASP . 24.7 tp -61.52 -39.25 90.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -47.07 -37.47 9.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 33.9 mm -61.66 142.8 94.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 108.958 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.5 Cg_endo -64.6 -5.94 11.19 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.575 2.183 . . . . 0.0 111.731 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.29 166.79 24.03 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 47.5 Cg_endo -68.65 140.97 48.57 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.547 2.165 . . . . 0.0 111.679 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.563 HG12 ' CE1' ' A' ' 10' ' ' PHE . 21.8 t -126.32 159.31 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.537 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.548 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 1.9 mp -113.32 124.52 52.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.834 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 62.4 t -104.9 133.13 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.441 HG12 ' HB2' ' A' ' 133' ' ' GLN . 31.9 mt -119.97 135.71 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.935 . . . . 0.0 109.479 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.66 161.79 30.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 109.258 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 53.9 p-10 -90.02 10.86 22.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.945 . . . . 0.0 109.548 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.4 t -112.04 126.02 54.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.576 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 70.8 t80 -80.64 -40.23 25.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.408 ' O ' ' HB2' ' A' ' 90' ' ' SER . 96.0 m-85 -61.02 -49.56 76.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 90' ' ' SER . 48.4 t -61.7 -52.12 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.403 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HA ' HG22 ' A' ' 132' ' ' ILE . . . -52.88 -61.04 2.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.895 . . . . 0.0 109.341 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 81.5 tt0 -57.82 -18.98 25.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.191 -0.943 . . . . 0.0 109.277 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.522 ' HA ' ' CG ' ' A' ' 94' ' ' GLU . 8.4 t -66.73 -65.09 0.72 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.557 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.506 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -69.82 -7.5 40.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.553 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 85.1 m-20 -86.58 -46.33 10.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.678 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.427 ' C ' ' HD2' ' A' ' 96' ' ' PRO . 62.6 mttp -126.46 -47.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 109.732 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.582 ' HB3' ' CE2' ' A' ' 98' ' ' TRP . 81.7 mt-10 -51.46 -44.22 62.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.694 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.521 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 0.3 OUTLIER -50.68 -63.45 1.87 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.912 . . . . 0.0 109.54 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.521 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 48.0 Cg_endo -68.69 -42.05 5.24 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.749 2.299 . . . . 0.0 112.035 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.31 -40.05 96.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.582 ' CE2' ' HB3' ' A' ' 94' ' ' GLU . 39.9 m0 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.59 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 34.2 mttt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.291 0.567 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 64.0 m80 60.23 27.05 16.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.444 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 80.5 mt -62.5 -38.33 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.361 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.9 t -56.27 -45.85 79.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.278 -0.889 . . . . 0.0 109.315 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 61.8 mttp -60.06 -54.06 50.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.566 ' CZ2' HD12 ' A' ' 61' ' ' ILE . 91.9 m95 -65.21 -33.15 75.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 109.387 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -54.01 -45.95 71.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.378 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.9 m -53.29 -44.13 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.306 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.526 ' CG1' ' HG2' ' A' ' 65' ' ' GLU . 83.7 mt -72.01 -32.79 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.364 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.415 ' CA ' HD13 ' A' ' 95' ' ' LEU . . . -61.23 -38.91 88.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.89 . . . . 0.0 109.358 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.91 -39.01 83.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.506 ' SG ' ' CD1' ' A' ' 130' ' ' ILE . 23.0 t -68.58 -44.09 75.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.431 HD11 ' HG ' ' A' ' 95' ' ' LEU . 55.1 mt -68.15 -34.15 75.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.5 t -59.64 -33.75 71.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.427 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 92.0 mtp -67.91 -33.96 75.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.6 OUTLIER 177.35 136.58 0.22 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.512 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.9 Cg_endo -71.56 2.45 4.55 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.728 2.285 . . . . 0.0 112.078 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 31.6 p-10 -43.71 -39.04 3.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.662 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.506 ' CD1' ' SG ' ' A' ' 123' ' ' CYS . 52.6 mt -59.3 115.57 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.741 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.0 m -111.6 134.05 53.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.025 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -116.44 135.9 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.081 -1.012 . . . . 0.0 109.887 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.8 mt-30 -126.0 154.22 43.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.359 -0.838 . . . . 0.0 109.3 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.576 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 17.4 t-80 -108.34 127.0 53.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 179.968 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.332 0.587 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.3 p -69.05 -40.24 78.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.478 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.07 -37.41 64.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -65.13 -34.54 89.98 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -65.73 -38.12 88.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -1.185 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.91 -48.8 67.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.551 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 mt -65.7 -44.32 86.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . . . -60.92 -37.7 83.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.421 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 57.4 t0 -62.59 -41.24 98.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 69.0 mttm -63.4 -36.02 82.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.51 ' CD1' ' HB3' ' A' ' 46' ' ' GLN . 71.4 mt -69.31 -37.23 77.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.49 -43.94 68.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 31.7 m -60.14 -42.2 94.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 95.1 mt-30 -65.23 -33.31 75.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 109.541 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.449 ' O ' ' CG2' ' A' ' 163' ' ' VAL . . . -61.84 -46.61 93.8 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.493 ' OG ' ' CD1' ' A' ' 17' ' ' ILE . 91.2 p -72.9 -26.19 61.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -68.36 -35.99 78.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 50' ' ' PRO . 18.1 m -70.87 -14.23 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.573 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 41.0 t . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.508 -179.968 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.6 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 43.9 m-85 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.326 0.584 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -76.48 -36.3 57.91 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.256 -0.903 . . . . 0.0 109.19 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.47 -166.46 35.26 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' CG1' ' HB2' ' A' ' 35' ' ' ALA . 7.2 p -125.29 140.72 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -1.072 . . . . 0.0 108.996 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.674 ' CE2' ' CG ' ' A' ' 34' ' ' HIS . 6.6 m-85 -117.69 135.89 53.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 109.85 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.509 ' CE1' HD13 ' A' ' 81' ' ' ILE . 95.0 m-85 -114.08 118.72 34.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.517 ' CG2' ' HB3' ' A' ' 67' ' ' ALA . 19.0 p -115.79 151.61 34.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 0.0 109.728 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 53.1 t0 -147.51 156.15 42.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.351 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -163.21 117.11 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 68.7 m -138.85 147.98 43.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -1.163 . . . . 0.0 109.74 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -107.81 140.52 40.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.465 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.527 HD12 ' CB ' ' A' ' 161' ' ' SER . 68.6 mt . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.905 . . . . 0.0 109.524 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 96.0 m-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -93.65 129.2 40.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 108.987 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.643 ' CB ' ' CE1' ' A' ' 54' ' ' HIS . . . -119.46 164.47 15.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -0.99 . . . . 0.0 110.158 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.82 146.77 18.75 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.519 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 61.7 mtm -120.0 145.75 46.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.479 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.81 118.61 1.78 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 47' ' ' TRP . 4.6 mp -120.86 116.87 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -1.153 . . . . 0.0 109.255 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' HB ' ' A' ' 43' ' ' VAL . 7.2 p -124.45 144.47 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.101 -1.0 . . . . 0.0 109.731 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.674 ' CG ' ' CE2' ' A' ' 10' ' ' PHE . 1.4 m-70 -101.59 141.72 34.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.852 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.462 ' HB2' ' CG1' ' A' ' 9' ' ' VAL . . . -129.81 165.81 21.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.44 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 t -126.16 165.25 19.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 38' ' ' LYS . 82.8 m-85 -107.92 10.16 28.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.556 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.18 179.72 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.007 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.2 Cg_endo -65.45 -5.38 11.31 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.183 1.922 . . . . 0.0 111.658 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -129.25 106.02 8.54 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -64.83 129.93 41.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -167.66 154.12 7.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.479 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.482 ' HB ' ' CG2' ' A' ' 33' ' ' VAL . 32.6 m -89.37 120.59 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.887 . . . . 0.0 109.461 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 55.3 mt -57.78 -38.8 76.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.342 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.462 ' O ' HG22 ' A' ' 33' ' ' VAL . 60.9 t30 -169.6 155.43 6.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.918 . . . . 0.0 109.594 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.526 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 91.9 mt-30 -112.59 137.8 50.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.831 . . . . 0.0 109.103 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.52 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -118.01 133.38 55.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.142 -0.974 . . . . 0.0 109.659 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 t -119.85 140.17 51.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 109.31 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.588 ' CD1' ' CE1' ' A' ' 66' ' ' PHE . 1.7 mt -145.5 92.32 5.57 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 109.693 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.452 ' O ' HD23 ' A' ' 51' ' ' LEU . 49.8 Cg_endo -70.39 147.5 58.98 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.682 2.254 . . . . 0.0 111.598 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 50' ' ' PRO . 43.1 mt -123.88 129.44 51.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.698 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.461 ' HA2' HG13 ' A' ' 164' ' ' VAL . . . -92.78 -73.57 1.24 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -102.22 87.98 3.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.165 . . . . 0.0 109.154 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.643 ' CE1' ' CB ' ' A' ' 28' ' ' ALA . 6.7 p-80 -132.29 -163.82 1.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.976 . . . . 0.0 109.949 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.488 HG21 ' CE ' ' A' ' 58' ' ' MET . 0.2 OUTLIER -128.93 144.8 51.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.039 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -44.69 -33.91 2.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.084 -1.01 . . . . 0.0 109.13 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -77.79 -47.78 18.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.491 ' HA ' ' CG2' ' A' ' 61' ' ' ILE . 24.2 ttm -48.79 -35.07 13.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.987 . . . . 0.0 109.23 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.518 ' HB3' ' CD2' ' A' ' 54' ' ' HIS . . . -74.18 -45.86 45.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.382 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.91 -34.83 77.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.577 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.603 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 18.7 tt -77.32 -37.28 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.557 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.519 ' CB ' ' SD ' ' A' ' 30' ' ' MET . . . -65.9 -29.78 70.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.15 92.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.524 ' CG2' HG23 ' A' ' 82' ' ' THR . 46.5 t -77.82 -49.97 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.524 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.2 tt0 -53.09 -39.79 63.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.632 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.588 ' CE1' ' CD1' ' A' ' 49' ' ' ILE . 13.0 t80 -57.76 -69.11 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 109.57 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.517 ' HB3' ' CG2' ' A' ' 12' ' ' THR . . . -62.34 -15.95 51.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 109.462 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.515 ' SG ' ' CG2' ' A' ' 120' ' ' ILE . 39.4 t -66.09 -63.07 1.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -60.99 -44.35 97.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.541 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 48.7 mttm -62.85 -36.52 83.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.506 ' CB ' ' CG1' ' A' ' 78' ' ' VAL . . . -59.28 -64.18 1.04 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.366 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 20.0 tp -51.98 -46.73 64.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.922 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 72' ' ' LEU . 19.4 tttm -42.58 -41.1 2.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.0 109.276 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.549 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 34.8 mm -52.29 143.44 25.98 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.823 . . . . 0.0 108.802 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.549 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.1 Cg_endo -65.09 -2.47 5.73 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.632 2.221 . . . . 0.0 112.203 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.13 170.65 25.29 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 47.7 Cg_endo -69.46 119.86 6.77 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.445 2.097 . . . . 0.0 111.693 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.567 HG23 ' CD1' ' A' ' 10' ' ' PHE . 7.7 p -114.01 146.56 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.399 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.6 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 15.9 mt -93.05 143.28 26.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.737 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.495 ' CG1' ' HB2' ' A' ' 67' ' ' ALA . 49.6 t -124.13 126.33 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 109.183 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.536 HD12 HG21 ' A' ' 81' ' ' ILE . 33.6 mt -113.49 136.22 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.784 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.524 HG23 ' CG2' ' A' ' 64' ' ' VAL . 10.3 t -142.31 159.27 42.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.351 -0.843 . . . . 0.0 109.276 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.449 ' HB3' ' OE1' ' A' ' 135' ' ' GLU . 51.0 p-10 -92.69 20.22 6.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.152 -0.967 . . . . 0.0 109.466 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.483 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 41.9 m -105.57 104.48 14.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 109.347 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.567 ' CE2' ' OE2' ' A' ' 89' ' ' GLU . 74.8 t80 -69.37 -50.19 48.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 109.583 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -60.81 -40.57 93.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.521 HG11 ' CG2' ' A' ' 64' ' ' VAL . 92.5 t -62.84 -39.57 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.378 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.61 -60.66 3.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.567 ' OE2' ' CE2' ' A' ' 85' ' ' PHE . 94.0 mt-10 -50.93 -35.35 32.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.618 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 70.6 m -55.91 -47.24 77.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.451 ' HB1' ' CD1' ' A' ' 132' ' ' ILE . . . -88.6 -0.92 57.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.907 . . . . 0.0 109.805 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.449 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 84.2 m-20 -90.61 -73.61 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.122 -0.986 . . . . 0.0 109.953 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HA ' ' HG2' ' A' ' 96' ' ' PRO . 96.8 mttt -127.13 -31.66 2.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 109.842 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 57.0 mt-10 -52.18 -40.49 61.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.911 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.522 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 6.4 tp -62.93 -58.3 17.16 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.063 -1.023 . . . . 0.0 109.537 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -65.89 -26.02 52.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.521 2.147 . . . . 0.0 111.261 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 93' ' ' LYS . 60.3 t80 -75.56 -35.74 60.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.345 -0.847 . . . . 0.0 108.72 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.9 m0 . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.291 -0.881 . . . . 0.0 108.979 179.407 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 20.6 mttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.277 0.561 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.568 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 48.1 m80 66.29 30.4 9.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.341 -0.849 . . . . 0.0 109.679 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.56 -50.35 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.133 -0.98 . . . . 0.0 109.308 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m -60.08 -44.18 94.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.233 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -59.19 -50.17 75.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.308 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.618 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 53.0 m95 -69.27 -35.77 76.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.907 . . . . 0.0 109.325 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -56.88 -45.93 82.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.341 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.9 m -55.43 -45.36 76.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.375 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.515 ' CG2' ' SG ' ' A' ' 68' ' ' CYS . 69.0 mt -66.82 -36.62 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.409 -0.807 . . . . 0.0 109.411 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.507 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -57.42 -43.4 83.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.461 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.21 -45.84 75.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.506 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 93.4 m -66.52 -46.56 75.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.23 -32.51 73.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.365 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.4 m -61.65 -35.17 77.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.417 ' C ' ' HG2' ' A' ' 127' ' ' LYS . 66.1 mtt -64.6 -34.38 78.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HG2' ' C ' ' A' ' 126' ' ' MET . 0.2 OUTLIER 174.57 145.39 0.21 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.242 -0.911 . . . . 0.0 109.559 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.6 Cg_endo -72.17 2.33 5.07 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.698 2.265 . . . . 0.0 111.763 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 76.9 m-20 -42.39 -46.79 4.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.559 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 60.5 mt -56.6 122.14 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.527 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.523 ' CB ' HD21 ' A' ' 79' ' ' LEU . 24.6 m -112.2 141.55 45.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.154 -0.966 . . . . 0.0 109.337 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 70.8 mt -125.25 134.61 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.935 . . . . 0.0 109.669 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.451 ' HB2' HG12 ' A' ' 81' ' ' ILE . 91.4 mt-30 -124.94 157.89 34.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.476 ' NE2' ' HB2' ' A' ' 85' ' ' PHE . 46.4 t-80 -113.48 127.75 56.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.499 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.449 ' OE1' ' HB3' ' A' ' 83' ' ' ASP . 95.3 mt-10 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 65.8 m170 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.7 m -61.24 -47.01 88.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 109.52 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.15 -46.23 53.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -61.66 -36.82 93.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 154' ' ' ASP . 82.1 m-20 -63.55 -37.25 86.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -1.191 . . . . 0.0 109.418 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.89 -51.6 66.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 57.1 mt -66.32 -43.64 85.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.59 87.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.542 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.451 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 94.8 m-20 -66.35 -41.25 89.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.88 . . . . 0.0 109.534 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -59.45 -39.79 84.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.54 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 46' ' ' GLN . 70.8 mt -65.57 -37.43 86.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.91 93.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.926 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 50.6 m -61.76 -41.66 97.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.943 . . . . 0.0 109.667 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.46 ' O ' HG21 ' A' ' 163' ' ' VAL . 62.1 tt0 -63.34 -34.34 77.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.603 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.24 -42.37 88.21 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.527 ' CB ' HD12 ' A' ' 17' ' ' ILE . 17.3 m -61.47 -37.21 82.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -1.161 . . . . 0.0 109.581 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -69.53 -21.09 63.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 0.0 109.509 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 159' ' ' GLN . 39.3 t -66.0 -29.6 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.461 HG13 ' HA2' ' A' ' 52' ' ' GLY . 47.5 t . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.507 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.628 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 98.2 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.53 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 74.5 mm-40 -68.45 -37.01 79.82 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.079 -1.013 . . . . 0.0 109.04 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.35 -177.06 47.5 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.472 HG22 ' CZ ' ' A' ' 37' ' ' TYR . 95.1 t -133.29 132.23 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.346 -1.09 . . . . 0.0 108.943 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.578 ' CE1' HG22 ' A' ' 78' ' ' VAL . 6.9 m-85 -113.23 140.1 48.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 110.058 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE2' HD11 ' A' ' 81' ' ' ILE . 70.9 m-85 -112.15 133.71 54.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.364 -0.835 . . . . 0.0 109.095 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.529 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 7.1 p -121.05 152.51 38.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.645 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' A' ' 153' ' ' ALA . 21.6 t70 -152.86 152.6 31.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.347 -0.846 . . . . 0.0 109.388 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.17 128.67 5.68 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.515 ' OG ' ' CB ' ' A' ' 157' ' ' ALA . 50.6 m -122.17 148.88 44.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -1.146 . . . . 0.0 109.307 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 27' ' ' ASN . . . -133.82 145.03 49.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 78.3 mt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.325 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 96.7 m-20 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 95.1 m-20 -96.12 129.12 43.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.406 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -112.2 156.35 22.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.736 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.25 160.48 26.82 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.484 ' SD ' ' CD2' ' A' ' 51' ' ' LEU . 76.2 mtp -121.15 150.89 40.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -1.189 . . . . 0.0 109.678 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.53 117.76 0.84 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 11' ' ' TYR . 5.4 mp -121.73 139.89 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 109.638 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.446 HG23 ' HB1' ' A' ' 153' ' ' ALA . 21.3 t -114.73 139.64 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.323 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.559 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 40.5 m170 -107.24 139.95 40.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.615 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.59 166.51 24.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.596 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.4 t -139.9 164.45 29.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.654 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.472 ' CZ ' HG22 ' A' ' 9' ' ' VAL . 58.6 m-85 -97.69 14.17 27.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.645 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.555 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 2.2 mttt -50.88 178.57 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 108.776 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.5 Cg_endo -65.33 -6.46 13.4 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.179 1.92 . . . . 0.0 111.534 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG3' ' HG3' ' A' ' 42' ' ' GLN . 38.9 tp10 -137.75 106.43 5.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -0.846 . . . . 0.0 109.086 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -63.3 118.09 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.908 . . . . 0.0 109.297 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HG3' ' HG3' ' A' ' 40' ' ' GLU . 93.5 mt-30 -151.9 145.61 25.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.582 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.427 HG13 HG13 ' A' ' 33' ' ' VAL . 24.5 t -63.56 117.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.3 -0.875 . . . . 0.0 109.512 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.0 mt -63.51 -37.55 87.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -177.59 158.99 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -106.94 138.81 42.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.329 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -126.45 131.4 51.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.776 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.4 m -129.92 136.45 49.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.244 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.449 ' O ' ' HB2' ' A' ' 30' ' ' MET . 3.8 mt -134.95 112.12 11.28 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.53 138.06 34.57 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.744 2.296 . . . . 0.0 111.623 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' CD1' ' HA ' ' A' ' 59' ' ' ALA . 61.6 mt -111.18 139.58 46.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.51 ' O ' ' ND1' ' A' ' 54' ' ' HIS . . . -115.17 132.03 10.11 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 72.3 m-20 62.94 38.02 11.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.151 . . . . 0.0 109.502 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 52' ' ' GLY . 74.3 m80 -124.61 159.56 30.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.449 HG22 ' SD ' ' A' ' 58' ' ' MET . 0.1 OUTLIER -101.87 168.47 9.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 0.0 109.171 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.86 -33.57 66.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -0.981 . . . . 0.0 108.975 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.2 -50.89 24.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.319 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.454 ' O ' HG23 ' A' ' 61' ' ' ILE . 99.2 mtp -55.15 -28.84 55.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.503 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . . . -74.18 -40.42 62.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.493 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.432 ' OE1' ' OG ' ' A' ' 84' ' ' SER . 99.0 mt-10 -60.17 -42.83 95.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.612 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.614 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 14.9 tt -69.62 -32.11 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.497 ' N ' HG22 ' A' ' 61' ' ' ILE . . . -66.73 -27.7 67.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.327 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.529 ' CB ' ' HB ' ' A' ' 12' ' ' THR . . . -71.27 -38.07 71.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.483 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 89.8 t -69.44 -40.52 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.531 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 99.2 mt-10 -64.74 -41.95 95.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.016 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.571 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 27.8 t80 -59.73 -65.25 0.71 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.485 -0.759 . . . . 0.0 109.711 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.21 68.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 109.725 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 50.4 t -60.7 -53.49 56.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 109.485 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -59.12 -50.86 72.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.664 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.571 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 62.9 mttm -61.15 -36.31 79.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.862 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.52 ' CB ' ' CG1' ' A' ' 78' ' ' VAL . . . -57.0 -69.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.718 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.509 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 22.1 tp -46.83 -46.32 20.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.591 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 72' ' ' LEU . 14.4 tptt -44.19 -45.13 8.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.206 -0.934 . . . . 0.0 109.269 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 7.3 mt -48.36 142.87 7.79 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.023 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.8 Cg_endo -65.57 -4.77 10.25 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.573 2.182 . . . . 0.0 111.749 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.53 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -140.62 168.57 25.18 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.475 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.1 Cg_endo -68.4 122.11 9.11 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.411 2.074 . . . . 0.0 111.77 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.578 HG22 ' CE1' ' A' ' 10' ' ' PHE . 4.6 p -113.71 155.25 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.419 -0.801 . . . . 0.0 109.262 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.628 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 22.6 mt -99.8 149.04 23.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 109.833 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 76.0 t -130.35 135.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.38 -0.825 . . . . 0.0 109.066 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.575 HD11 ' CE2' ' A' ' 11' ' ' TYR . 20.4 mt -119.87 139.47 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.953 . . . . 0.0 109.649 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.45 HG23 HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -128.29 161.85 28.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.364 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 58.3 p30 -92.48 13.39 19.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.432 ' OG ' ' OE1' ' A' ' 60' ' ' GLU . 42.6 m -132.82 125.47 30.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.59 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 67.5 t80 -77.59 -42.02 36.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -49.9 -57.25 7.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.381 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.492 ' CG2' ' HA ' ' A' ' 61' ' ' ILE . 14.9 p -61.05 -46.61 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.291 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.462 ' N ' ' CG1' ' A' ' 87' ' ' VAL . . . -55.52 -55.5 31.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.902 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 79.6 tt0 -54.75 -31.56 58.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.944 . . . . 0.0 109.184 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.604 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 18.0 t -56.68 -56.27 23.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 132' ' ' ILE . . . -80.32 -0.83 38.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.729 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 89.8 m-20 -84.54 -73.35 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.094 -1.004 . . . . 0.0 110.038 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 74.5 mttt -127.34 -27.84 2.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.132 -0.98 . . . . 0.0 110.269 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 68.1 mm-40 -61.04 -30.87 70.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.095 -1.003 . . . . 0.0 109.89 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.526 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -61.41 -58.53 18.07 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.718 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 43.9 Cg_endo -66.02 -25.47 51.64 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.552 2.168 . . . . 0.0 111.694 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -71.46 -38.17 71.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.173 -0.954 . . . . 0.0 109.044 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 39.1 m0 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.257 179.704 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 18.9 mttp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.267 0.556 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.569 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 36.7 m80 67.48 31.07 6.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 78.5 mt -68.74 -39.0 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.366 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.6 m -62.07 -44.61 96.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.362 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.462 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 54.3 mttp -61.45 -41.36 97.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.614 ' CZ2' ' CD1' ' A' ' 61' ' ' ILE . 40.2 m95 -76.75 -30.69 56.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.37 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -59.27 -39.25 82.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.8 m -62.54 -44.86 95.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.531 ' CG1' ' HG2' ' A' ' 65' ' ' GLU . 78.0 mt -72.58 -30.25 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.442 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.461 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . . . -61.72 -41.62 97.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.416 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -59.04 -40.23 84.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 109.387 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 46.3 m -68.15 -47.11 68.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.2 tp -63.32 -32.4 73.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.34 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 m -61.59 -31.8 71.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.568 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.466 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 93.6 mmm -67.54 -34.17 76.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 170.67 147.6 0.14 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.0 Cg_endo -71.63 -0.04 7.69 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.73 2.286 . . . . 0.0 111.633 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 93.4 m-20 -42.49 -47.24 5.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.428 -0.795 . . . . 0.0 109.632 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 56.8 mt -58.89 119.14 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.524 ' HB ' ' CD2' ' A' ' 79' ' ' LEU . 24.8 m -112.42 140.44 47.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 91' ' ' ALA . 58.8 mt -122.54 137.46 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 109.696 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.435 ' HB2' HG12 ' A' ' 81' ' ' ILE . 84.6 mt-30 -122.73 163.07 20.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.218 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.59 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 14.8 t-80 -118.58 131.39 56.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 109.62 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.526 ' HG3' ' CG2' ' A' ' 81' ' ' ILE . 96.5 mt-10 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.403 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.417 ' CE1' HD12 ' A' ' 81' ' ' ILE . 13.1 m170 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.232 0.539 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 45.0 m -67.34 -45.27 76.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.0 109.679 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.99 -36.46 70.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.48 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 153' ' ' ALA . . . -70.41 -28.51 71.14 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -69.38 -36.0 76.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 109.592 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -72.89 -52.8 13.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.462 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 25.0 tp -61.64 -37.71 85.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.172 -0.955 . . . . 0.0 109.626 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.446 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -64.58 -35.76 82.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.664 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -67.68 -36.37 80.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.67 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.401 ' HE2' ' NE2' ' A' ' 159' ' ' GLN . 78.4 tttt -70.99 -36.11 72.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.775 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 66.4 mt -68.23 -34.77 76.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 109.658 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.515 ' CB ' ' OG ' ' A' ' 15' ' ' SER . . . -70.15 -39.73 75.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 44.7 m -66.06 -38.76 89.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.401 ' NE2' ' HE2' ' A' ' 155' ' ' LYS . 94.6 mt-30 -66.35 -34.0 76.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 0.0 109.558 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.22 91.57 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.7 m -63.87 -37.42 87.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -62.85 -40.76 98.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.602 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 95.4 t -53.79 -39.61 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 66.7 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.937 . . . . 0.0 109.546 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.82 69.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -1.166 . . . . 0.0 109.476 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.528 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 90.4 mtp -64.49 -33.62 76.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.27 -164.33 38.28 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -125.0 119.47 28.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.46 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.626 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 55.7 m-85 -116.24 158.22 23.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.467 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 78.2 mm-40 -55.51 -36.85 67.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.253 -0.904 . . . . 0.0 109.138 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.459 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -178.81 -167.71 36.88 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.447 ' CG1' ' CZ ' ' A' ' 11' ' ' TYR . 85.5 t -132.95 144.47 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.133 . . . . 0.0 109.154 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 34' ' ' HIS . 6.8 m-85 -118.21 121.38 40.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 109.925 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 52.7 m-85 -107.81 126.73 52.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 108.85 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.517 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 3.7 p -115.06 150.31 36.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 110.071 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 59.7 t0 -142.22 154.52 44.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.473 -0.767 . . . . 0.0 109.086 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -138.11 138.34 9.49 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.444 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 83.9 p -143.09 160.94 39.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -1.127 . . . . 0.0 109.437 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -146.26 150.44 35.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.668 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.5 HD12 ' CB ' ' A' ' 161' ' ' SER . 62.1 mt -126.54 137.98 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -108.08 139.26 42.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.476 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 1.0 OUTLIER -124.27 165.03 26.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.542 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.5 -30.85 18.22 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.706 2.271 . . . . 0.0 111.826 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.55 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -74.02 -64.14 0.78 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 49.6 Cg_endo -70.15 66.7 2.0 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.7 2.266 . . . . 0.0 111.817 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.5 m -56.03 -50.4 71.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.61 32.44 1.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 69.9 m -151.37 142.83 23.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.553 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 25' ' ' SER . 62.3 m-20 -136.82 152.34 50.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -99.86 122.02 42.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.338 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -129.58 154.85 46.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.67 163.69 26.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.486 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 42.2 mtm -122.61 140.84 52.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -1.143 . . . . 0.0 109.531 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -126.19 123.75 4.91 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' ' 47' ' ' TRP . 26.3 mm -112.97 138.31 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -1.174 . . . . 0.0 109.516 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.453 ' CG1' HG21 ' A' ' 43' ' ' VAL . 41.0 t -122.59 135.47 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 109.378 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.688 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 72.5 m-70 -108.02 135.98 48.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 109.547 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.466 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -129.2 170.84 13.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.411 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.452 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 14.2 t -133.99 165.01 26.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.541 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' LYS . 49.6 m-85 -104.43 11.47 34.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.529 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.559 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 1.7 mtmt -51.46 179.46 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.034 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.4 Cg_endo -66.39 -5.15 12.04 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.183 1.922 . . . . 0.0 111.568 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -135.49 106.21 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 0.0 109.128 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.76 123.75 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 109.468 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -158.11 148.55 20.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.602 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.453 HG21 ' CG1' ' A' ' 33' ' ' VAL . 7.6 p -77.87 122.27 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.466 ' CD1' ' C ' ' A' ' 35' ' ' ALA . 6.3 mp -65.01 -39.95 94.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.135 -0.978 . . . . 0.0 109.351 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -173.15 162.47 4.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.364 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.461 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 89.7 mt-30 -112.83 154.72 25.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.393 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -135.26 132.55 37.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 t -122.94 128.1 49.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 109.396 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.43 91.55 40.99 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.543 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.64 133.18 23.41 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.698 2.266 . . . . 0.0 111.747 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 31.1 mt -99.73 147.14 25.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.65 -62.18 0.8 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -108.41 57.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -1.157 . . . . 0.0 109.531 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 80.6 m80 -129.47 177.99 6.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.2 t -124.17 169.08 12.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 109.455 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.38 -41.09 79.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.417 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -61.61 -40.61 95.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 97.0 mtp -70.83 -32.43 69.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.883 . . . . 0.0 109.507 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.64 -33.44 74.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.522 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.85 -47.97 56.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.595 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 13.7 tt -69.42 -38.01 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 109.549 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.509 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -65.8 -31.75 72.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.471 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.517 ' CB ' ' HB ' ' A' ' 12' ' ' THR . . . -65.98 -38.63 89.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.892 . . . . 0.0 109.554 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.527 ' CG2' HG23 ' A' ' 82' ' ' THR . 61.6 t -69.57 -38.11 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.667 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.432 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 71.8 tt0 -69.77 -38.04 76.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 109.123 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.584 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 26.3 t80 -55.75 -66.57 0.4 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.344 -0.847 . . . . 0.0 109.527 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 71' ' ' ALA . . . -59.94 -31.86 70.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.535 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.451 ' O ' HD13 ' A' ' 130' ' ' ILE . 41.3 t -50.65 -56.86 9.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.509 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -64.86 -42.93 94.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.482 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.584 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 63.1 mttm -64.55 -31.5 72.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.468 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 67' ' ' ALA . . . -66.24 -65.44 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.454 HD21 ' CB ' ' A' ' 126' ' ' MET . 0.9 OUTLIER -54.98 -38.71 68.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.307 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 72' ' ' LEU . 25.6 tttt -44.44 -47.25 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.044 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 8.7 mt -52.29 143.06 27.28 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 108.842 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.1 Cg_endo -65.48 -5.96 12.59 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.459 2.106 . . . . 0.0 111.631 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.484 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -129.26 170.1 20.38 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.463 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 49.8 Cg_endo -69.97 140.0 40.84 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.587 2.192 . . . . 0.0 111.801 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.574 HG11 ' CD1' ' A' ' 10' ' ' PHE . 39.5 t -127.59 162.6 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.626 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 7.2 mt -110.96 130.78 55.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 72.0 t -114.05 126.42 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.895 . . . . 0.0 109.527 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.454 HG12 ' HB2' ' A' ' 133' ' ' GLN . 13.8 mt -115.36 142.3 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.299 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.527 HG23 ' CG2' ' A' ' 64' ' ' VAL . 1.1 p -130.47 161.27 31.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 135' ' ' GLU . 55.0 p-10 -87.51 5.16 40.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.517 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.516 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 2.1 m -123.3 123.99 41.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 109.552 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.594 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 66.6 t80 -72.69 -41.62 65.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.349 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 90' ' ' SER . 67.7 t80 -54.01 -58.8 5.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 88' ' ' ALA . 12.7 p -58.31 -46.81 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.365 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.479 ' CA ' HG21 ' A' ' 132' ' ' ILE . . . -56.95 -63.6 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.205 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -57.24 -17.86 13.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.101 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.545 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 8.4 t -66.4 -65.53 0.67 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.299 -0.875 . . . . 0.0 109.258 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.515 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . . . -66.47 -10.56 45.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.489 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -88.32 -42.03 12.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.775 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 96' ' ' PRO . 8.3 ttpp -126.42 -49.24 1.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.167 -0.958 . . . . 0.0 109.775 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.57 ' HB3' ' CE2' ' A' ' 98' ' ' TRP . 73.2 mm-40 -53.53 -41.02 65.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.672 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.538 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -50.69 -63.98 1.57 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 49.8 Cg_endo -70.17 -36.6 9.44 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.708 2.272 . . . . 0.0 111.921 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -67.44 -42.41 83.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.575 ' CE2' HD12 ' A' ' 111' ' ' LEU . 18.9 m0 -63.91 -42.25 97.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.519 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -54.31 -42.05 69.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 m -58.59 -37.08 75.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.894 . . . . 0.0 109.496 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -91.83 16.66 10.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.454 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 72.52 41.5 51.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 111' ' ' LEU . 8.6 m-85 66.63 33.88 6.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -1.154 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.32 133.16 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.506 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -75.28 -70.72 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 109' ' ' LYS . 81.1 m-20 -129.39 154.66 46.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -62.92 -26.0 68.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.444 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -67.74 -38.28 83.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.354 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 106' ' ' ASN . 19.1 mttt -139.83 140.49 24.65 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.853 . . . . 0.0 109.45 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.26 169.72 18.88 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.687 2.258 . . . . 0.0 111.744 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.575 HD12 ' CE2' ' A' ' 98' ' ' TRP . 36.4 tp -75.19 132.98 41.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -96.76 150.44 20.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.405 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.529 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 62.8 m80 60.88 37.68 18.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.429 HG12 ' HB3' ' A' ' 111' ' ' LEU . 84.1 mt -63.42 -38.1 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.463 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 m -57.9 -45.47 86.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.464 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.42 -44.3 95.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.466 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.595 ' CZ2' ' CD1' ' A' ' 61' ' ' ILE . 69.8 m95 -69.4 -34.0 73.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.338 -0.852 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -58.01 -44.42 87.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.414 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.432 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 44.3 m -62.75 -43.42 98.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.362 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.449 HG22 ' SG ' ' A' ' 68' ' ' CYS . 71.9 mt -68.9 -34.21 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.421 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.411 ' HA ' HD12 ' A' ' 95' ' ' LEU . . . -61.87 -33.9 75.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -0.906 . . . . 0.0 109.42 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -64.76 -33.3 75.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.369 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.479 ' SG ' ' CD1' ' A' ' 130' ' ' ILE . 49.2 t -80.83 -52.12 7.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.883 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 128' ' ' PRO . 19.5 tp -62.54 -27.01 68.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.432 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.6 m -68.83 -26.61 65.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.483 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.454 ' CB ' HD21 ' A' ' 72' ' ' LEU . 64.1 mtt -71.25 -32.43 68.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 109.459 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.39 132.86 0.21 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 0.0 109.479 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.46 ' HA ' ' CD1' ' A' ' 124' ' ' LEU . 48.6 Cg_endo -69.78 -2.23 9.83 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.701 2.267 . . . . 0.0 111.719 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 96.8 m-20 -45.95 -26.88 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.439 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.479 ' CD1' ' SG ' ' A' ' 123' ' ' CYS . 64.9 mt -68.13 110.6 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.43 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.1 m -94.03 141.17 28.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.479 HG21 ' CA ' ' A' ' 88' ' ' ALA . 67.2 mt -118.84 137.33 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 109.521 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.454 ' HB2' HG12 ' A' ' 81' ' ' ILE . 86.2 mt-30 -134.84 157.38 46.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.594 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 12.8 t-80 -112.81 126.46 55.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 82' ' ' THR . 96.3 mt-10 -62.33 151.91 35.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.443 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -96.15 38.16 1.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 92.51 -148.08 18.95 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 139' ' ' GLN . 84.3 t60 -114.48 127.39 55.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -1.139 . . . . 0.0 109.492 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 138' ' ' HIS . 32.8 tt0 44.36 64.52 7.15 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.384 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.414 ' C ' HG22 ' A' ' 141' ' ' THR . 50.6 Cg_endo -70.58 -30.44 18.47 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.755 2.303 . . . . 0.0 111.911 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.414 HG22 ' C ' ' A' ' 140' ' ' PRO . 23.1 p -129.81 164.96 22.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.604 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -49.44 -35.99 21.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.433 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.1 m -138.89 136.33 35.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.395 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 47.7 t -154.65 132.81 11.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 97.5 mt -77.49 -33.96 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.506 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -70.07 -33.51 72.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.0 m -55.38 -45.01 76.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.525 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -48.76 -49.83 36.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -60.04 -36.63 90.97 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -60.74 -38.07 83.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -1.151 . . . . 0.0 109.571 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.99 -46.69 77.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.564 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 74.8 mt -64.88 -38.92 92.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.63 -35.74 75.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.512 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -60.7 -42.97 98.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.517 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 41.7 mttt -65.92 -40.61 91.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 46' ' ' GLN . 77.2 mt -64.16 -41.47 97.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.541 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.67 96.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 109.584 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 29.0 m -65.53 -37.45 86.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 93.2 mt-30 -65.56 -31.91 73.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.518 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' A' ' 163' ' ' VAL . . . -63.58 -33.57 87.61 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.5 ' CB ' HD12 ' A' ' 17' ' ' ILE . 86.0 p -68.07 -34.36 76.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -1.135 . . . . 0.0 109.508 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -72.08 -22.1 61.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.416 HG21 ' HA2' ' A' ' 160' ' ' GLY . 48.9 t -70.03 -25.92 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.482 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 165' ' ' ASN . 46.9 t -129.22 157.13 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 0.0 109.471 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.463 ' N ' HG11 ' A' ' 164' ' ' VAL . 82.0 m-20 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.454 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 5' ' ' GLN . . . -59.36 -31.93 69.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.218 -1.166 . . . . 0.0 109.431 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.555 ' CE ' ' CZ ' ' A' ' 37' ' ' TYR . 81.6 mtp -62.77 -38.87 92.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 0.0 109.387 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.26 -21.14 11.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 94.3 mt-30 -50.77 -36.61 37.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -1.093 . . . . 0.0 109.44 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CE2' HD12 ' A' ' 79' ' ' LEU . 27.4 m-85 -90.74 166.84 12.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.532 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 76.2 mm-40 -71.6 -36.7 70.9 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.38 -0.825 . . . . 0.0 108.941 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.33 -166.36 35.01 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' CG2' ' OH ' ' A' ' 37' ' ' TYR . 85.5 t -140.61 140.68 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -1.111 . . . . 0.0 109.097 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.679 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 24.7 m-85 -117.89 150.78 38.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.995 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.577 ' CE1' HG13 ' A' ' 81' ' ' ILE . 78.3 m-85 -121.87 130.39 53.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 109.093 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.449 ' HA ' HD12 ' A' ' 32' ' ' ILE . 17.2 p -115.66 151.6 34.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.764 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 57.9 t0 -140.62 152.46 45.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 109.347 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -138.43 128.36 4.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 m -133.23 148.62 52.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -1.155 . . . . 0.0 109.349 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -136.58 146.88 46.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.618 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.509 HD13 ' CB ' ' A' ' 161' ' ' SER . 65.1 mt -123.51 140.04 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -105.67 137.32 43.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.51 ' HB3' ' CG ' ' A' ' 22' ' ' PRO . 5.3 t -119.34 154.35 53.95 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.381 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.468 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 48.2 Cg_endo -68.5 -24.69 35.94 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.576 2.184 . . . . 0.0 111.941 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.533 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -72.51 -63.3 1.2 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.274 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 50.5 Cg_endo -71.1 79.88 1.32 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.725 2.284 . . . . 0.0 111.757 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -57.17 -48.19 79.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.258 -0.901 . . . . 0.0 109.515 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -103.14 33.28 3.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 27.4 m -149.91 152.75 35.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.951 . . . . 0.0 109.615 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -149.59 169.93 19.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.851 . . . . 0.0 109.426 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.45 ' ND2' ' OD1' ' A' ' 165' ' ' ASN . 16.5 m120 -104.67 144.08 32.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.428 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -142.97 147.94 36.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.96 157.86 26.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.457 ' HE1' ' HB ' ' A' ' 49' ' ' ILE . 63.2 mtm -128.23 147.99 50.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 0.0 109.584 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.7 122.39 2.35 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 12' ' ' THR . 22.7 mm -110.2 133.68 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -1.186 . . . . 0.0 109.62 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG23 ' CB ' ' A' ' 153' ' ' ALA . 44.6 t -124.33 132.1 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.381 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.679 ' CE1' ' CE1' ' A' ' 10' ' ' PHE . 9.0 t60 -108.21 142.18 38.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.693 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.23 158.99 38.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.441 ' HB ' HD22 ' A' ' 44' ' ' LEU . 11.9 t -122.4 162.64 21.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.555 ' CZ ' ' CE ' ' A' ' 3' ' ' MET . 27.1 m-85 -106.8 5.01 28.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.546 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 1.8 mtpt -51.39 178.79 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 108.959 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.0 Cg_endo -65.91 -5.04 11.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.171 1.914 . . . . 0.0 111.615 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -127.78 106.2 8.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.863 . . . . 0.0 108.946 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.457 ' CE1' ' CG2' ' A' ' 145' ' ' ILE . 61.6 t80 -73.96 123.76 24.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.913 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -168.21 133.85 1.86 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.379 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -52.39 118.76 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.528 ' CD1' ' CD2' ' A' ' 34' ' ' HIS . 46.9 mt -64.13 -45.27 89.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 79.0 m-20 -160.17 154.43 23.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -118.13 144.03 46.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.2 -0.937 . . . . 0.0 109.305 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -129.52 142.02 50.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.0 t -132.83 128.0 35.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.349 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.457 ' HB ' ' HE1' ' A' ' 30' ' ' MET . 2.8 mp -125.91 89.29 52.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.421 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 48.2 Cg_endo -69.25 129.05 17.43 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.692 2.261 . . . . 0.0 111.83 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 164' ' ' VAL . 37.0 mt -103.16 147.97 26.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.479 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -120.81 -35.7 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.488 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 41.0 p-10 -119.68 44.16 2.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -1.135 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.518 ' HA ' ' CE ' ' A' ' 58' ' ' MET . 76.1 m80 -129.11 -175.89 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.429 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.0 t -126.5 170.31 12.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.93 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -56.59 -39.08 72.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.385 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 60' ' ' GLU . 77.4 mt-30 -64.08 -67.15 0.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.515 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.518 ' CE ' ' HA ' ' A' ' 54' ' ' HIS . 44.2 mtm -44.94 -28.05 0.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 0.0 109.21 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.39 -37.13 63.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 57' ' ' GLN . 98.9 mt-10 -66.92 -41.93 86.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.542 HD12 ' CD2' ' A' ' 117' ' ' TRP . 20.7 tt -70.5 -38.53 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 109.196 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.487 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -64.49 -39.31 93.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.338 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 12' ' ' THR . . . -52.32 -46.82 66.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.461 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.436 ' CG2' HG13 ' A' ' 87' ' ' VAL . 87.4 t -70.76 -49.24 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.339 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.4 tt0 -53.62 -43.4 68.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.273 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.594 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 10.9 t80 -55.84 -65.34 0.61 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.293 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.412 ' HB3' HG13 ' A' ' 80' ' ' VAL . . . -61.33 -15.91 40.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 48.5 t -68.62 -61.14 1.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.298 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -57.67 -48.67 78.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.944 . . . . 0.0 109.354 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.594 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 67.9 mttm -60.65 -42.12 96.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.389 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.526 ' CB ' HG12 ' A' ' 78' ' ' VAL . . . -54.16 -72.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.409 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.521 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 10.0 tt -48.91 -42.56 37.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.949 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 72' ' ' LEU . 80.7 tttt -44.13 -41.93 5.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.94 . . . . 0.0 109.149 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 32.0 mt -54.03 143.88 40.68 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.4 -0.812 . . . . 0.0 108.875 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.5 Cg_endo -65.4 -2.18 5.68 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.58 2.186 . . . . 0.0 112.26 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.532 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -139.44 169.22 24.64 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.458 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 49.2 Cg_endo -69.8 117.06 4.86 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.57 2.18 . . . . 0.0 111.877 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' A' ' 10' ' ' PHE . 5.8 p -110.31 153.6 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.239 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.578 HD12 ' CE2' ' A' ' 6' ' ' TYR . 15.1 mt -96.79 153.07 18.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.588 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 131' ' ' THR . 45.0 t -125.74 128.62 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.577 HG13 ' CE1' ' A' ' 11' ' ' TYR . 22.5 mm -107.99 139.49 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.2 -0.937 . . . . 0.0 109.431 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.9 p -131.07 161.59 31.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.494 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 86.4 m-20 -96.17 2.75 53.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.903 . . . . 0.0 109.531 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.409 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 48.9 m -126.06 130.34 50.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -0.977 . . . . 0.0 109.477 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.588 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 64.9 t80 -74.78 -39.79 61.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.411 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.74 -52.5 63.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.651 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' SER . 50.6 t -61.14 -54.23 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 109.508 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -50.77 -55.85 14.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.159 -0.963 . . . . 0.0 109.397 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 82.3 tt0 -56.56 -35.59 68.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.615 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 49.0 m -52.58 -51.37 60.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 109.506 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.508 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -88.18 -1.19 57.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.693 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -84.18 -72.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -0.994 . . . . 0.0 109.506 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 21.0 tptp -126.57 -26.6 3.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 109.785 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 46.6 mm-40 -65.17 -29.89 70.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.677 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.507 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -53.69 -59.09 10.45 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 109.668 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 47.0 Cg_endo -67.7 -32.99 29.1 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.679 2.253 . . . . 0.0 111.657 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -67.49 -39.97 85.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.221 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.428 ' CE2' HD13 ' A' ' 111' ' ' LEU . 28.5 m0 -63.36 -49.82 72.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 109.269 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -52.08 -38.75 58.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 0.0 109.434 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.5 m -59.65 -41.61 90.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.219 -0.926 . . . . 0.0 109.38 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.464 ' O ' ' CG2' ' A' ' 104' ' ' VAL . 78.5 m-20 -83.82 10.03 10.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.525 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 71.56 40.15 59.79 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.53 ' CE1' ' HE2' ' A' ' 118' ' ' LYS . 38.6 m-85 65.46 34.35 8.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -1.16 . . . . 0.0 109.35 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 101' ' ' ASN . 42.4 t -107.59 134.76 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.463 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 109' ' ' LYS . 59.4 t30 -84.62 129.26 34.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -54.01 -31.88 52.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.456 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -73.05 160.88 31.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -57.2 -34.45 68.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 8.4 mttt -69.59 140.45 89.61 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.87 163.3 38.88 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.746 2.298 . . . . 0.0 111.791 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.476 ' CD2' HG12 ' A' ' 114' ' ' ILE . 2.4 tp -81.07 128.72 34.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.475 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 68.7 mttm -99.72 154.31 18.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.502 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.457 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 46.7 m80 64.62 33.21 10.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.476 HG12 ' CD2' ' A' ' 111' ' ' LEU . 82.5 mt -60.94 -46.47 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -59.52 -46.37 89.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 109.409 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.419 ' HE2' ' SD ' ' A' ' 58' ' ' MET . 45.5 mttp -55.73 -46.44 77.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.863 . . . . 0.0 109.404 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.615 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 53.5 m95 -61.37 -37.66 84.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.882 . . . . 0.0 109.396 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.53 ' HE2' ' CE1' ' A' ' 103' ' ' PHE . 23.9 mttt -56.82 -43.04 80.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.2 m -57.14 -45.86 83.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.336 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.452 HG12 ' HG3' ' A' ' 65' ' ' GLU . 68.0 mt -67.39 -36.77 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.838 . . . . 0.0 109.496 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.86 76.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.56 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.38 -43.76 98.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.459 ' SG ' HD13 ' A' ' 130' ' ' ILE . 42.5 t -68.08 -44.14 76.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.51 ' CD1' ' HA ' ' A' ' 128' ' ' PRO . 20.8 tp -71.09 -30.49 66.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.249 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.2 t -62.39 -31.84 72.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.488 ' HB2' ' CD1' ' A' ' 72' ' ' LEU . 92.0 mtp -65.34 -31.05 71.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.461 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.37 135.65 0.21 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.582 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.51 ' HA ' ' CD1' ' A' ' 124' ' ' LEU . 48.9 Cg_endo -69.91 -1.81 9.22 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 122.614 2.209 . . . . 0.0 111.501 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 95.1 m-20 -44.02 -44.85 7.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.521 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 45.0 mt -55.27 123.4 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 80' ' ' VAL . 25.4 m -113.87 140.84 48.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.28 -0.887 . . . . 0.0 109.086 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.508 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -125.23 137.22 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.098 -1.001 . . . . 0.0 109.631 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.442 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 95.2 mt-30 -127.4 165.78 19.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.249 -0.907 . . . . 0.0 109.395 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 12.5 t-80 -111.57 138.25 48.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.487 ' CD ' ' CG2' ' A' ' 81' ' ' ILE . 71.0 mt-10 -137.64 139.49 40.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -98.8 134.45 41.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.49 -170.22 40.62 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.4 m80 47.65 32.77 2.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -1.144 . . . . 0.0 109.474 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -119.42 80.69 22.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.459 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.21 -27.55 24.19 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.711 2.274 . . . . 0.0 111.791 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.0 m -59.51 -39.05 82.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -108.36 117.24 33.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.185 -0.947 . . . . 0.0 109.528 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.8 m -121.49 140.49 52.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.452 ' O ' ' OG1' ' A' ' 147' ' ' THR . 59.1 p -153.99 168.72 25.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.457 ' CG2' ' CE1' ' A' ' 41' ' ' TYR . 82.4 mt -59.43 -34.74 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.439 ' CD2' ' OH ' ' A' ' 11' ' ' TYR . 59.3 m170 -67.99 -38.92 83.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.333 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 144' ' ' SER . 60.3 p -60.72 -39.46 88.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.48 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -48.89 -51.03 32.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.848 . . . . 0.0 109.38 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.49 -40.84 62.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' HA ' ' A' ' 147' ' ' THR . 23.1 m120 -56.52 -45.58 81.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -1.101 . . . . 0.0 109.337 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.0 -55.47 30.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.329 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.9 -45.97 82.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.349 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.425 ' CB ' HG23 ' A' ' 33' ' ' VAL . . . -58.67 -41.82 87.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.436 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.462 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 87.7 m-20 -54.08 -44.86 71.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 22.7 mttp -59.87 -42.04 92.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.309 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 64.8 mt -67.07 -37.04 83.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.501 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.83 88.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.861 . . . . 0.0 109.408 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 46.1 m -61.76 -39.87 93.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.362 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 95.0 mt-30 -63.32 -33.3 75.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.439 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.435 ' HA2' HG21 ' A' ' 163' ' ' VAL . . . -55.46 -40.04 75.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.509 ' CB ' HD13 ' A' ' 17' ' ' ILE . 83.8 p -64.02 -35.36 80.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.122 . . . . 0.0 109.494 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -69.93 -22.65 63.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.435 HG21 ' HA2' ' A' ' 160' ' ' GLY . 38.9 t -65.18 -25.63 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 51' ' ' LEU . 18.4 m -131.61 143.37 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.516 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.45 ' OD1' ' ND2' ' A' ' 27' ' ' ASN . 21.8 m120 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.54 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.59 -27.86 68.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -1.131 . . . . 0.0 109.518 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.545 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 98.4 mmm -66.82 -30.62 70.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.502 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 93.07 -14.75 64.51 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 92.7 mt-30 60.66 41.32 15.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.255 -1.144 . . . . 0.0 109.469 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 3' ' ' MET . 94.3 m-85 -55.69 173.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 24.5 tp10 -61.46 -35.03 76.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 109.381 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.461 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.59 -166.01 34.08 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 35' ' ' ALA . 5.7 p -134.85 143.89 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -1.136 . . . . 0.0 109.223 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.653 ' CZ ' ' CD2' ' A' ' 34' ' ' HIS . 32.3 m-85 -119.76 132.42 55.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.656 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.452 ' CE1' HD13 ' A' ' 81' ' ' ILE . 95.6 m-85 -112.14 125.09 53.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 109.052 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.51 ' HB ' ' CD1' ' A' ' 32' ' ' ILE . 28.3 p -115.99 146.11 42.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 109.812 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 30' ' ' MET . 66.5 t0 -144.93 137.97 26.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.438 -0.789 . . . . 0.0 109.341 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -139.61 126.14 3.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 t -143.48 154.06 43.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -1.162 . . . . 0.0 109.543 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -115.1 142.83 46.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.549 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.58 ' CD1' ' CB ' ' A' ' 161' ' ' SER . 70.1 mt -118.29 138.37 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -105.21 124.03 48.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -110.31 161.15 25.7 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.07 -33.99 14.38 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.771 2.314 . . . . 0.0 111.834 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.561 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -63.39 -64.82 2.54 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 109.483 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 49.0 Cg_endo -69.9 78.27 1.07 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.618 2.212 . . . . 0.0 111.749 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.0 m -55.04 -32.31 61.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.528 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 25' ' ' SER . 24.6 mttt -106.89 151.26 25.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.453 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 45.1 t 63.1 169.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 41.5 p30 -139.22 -177.82 5.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.361 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -99.46 109.42 21.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -106.11 143.4 34.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.9 155.55 26.56 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.504 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 58.2 mtm -127.32 159.82 33.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -1.166 . . . . 0.0 109.512 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -143.95 122.16 1.77 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 66' ' ' PHE . 26.9 mm -124.0 111.98 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.354 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.521 ' CG2' ' HG2' ' A' ' 46' ' ' GLN . 10.9 p -115.66 160.21 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.753 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.653 ' CD2' ' CZ ' ' A' ' 10' ' ' PHE . 7.4 t-160 -116.05 144.98 43.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.364 -0.835 . . . . 0.0 109.346 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.525 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -132.3 169.49 16.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -125.95 166.58 16.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 0.0 109.369 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 38' ' ' LYS . 60.5 m-85 -105.28 10.13 33.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.555 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.37 179.59 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 109.1 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 44.0 Cg_endo -66.58 -4.53 11.1 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.128 1.885 . . . . 0.0 111.693 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.438 ' OE2' ' NE2' ' A' ' 42' ' ' GLN . 80.4 tt0 -132.93 105.82 7.33 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.37 -0.831 . . . . 0.0 108.861 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 54.4 t80 -57.57 125.32 22.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.235 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 80.5 mt-30 -158.13 142.01 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.749 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.463 ' HB ' ' CG2' ' A' ' 33' ' ' VAL . 29.0 m -78.99 118.66 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -0.85 . . . . 0.0 109.391 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.488 HD11 ' ND1' ' A' ' 34' ' ' HIS . 24.4 mt -60.59 -46.2 91.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.171 -0.956 . . . . 0.0 109.317 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 33' ' ' VAL . 35.3 m120 -159.96 146.59 16.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.368 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.521 ' HG2' ' CG2' ' A' ' 33' ' ' VAL . 78.4 mt-30 -107.6 148.2 29.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.393 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.52 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 5.6 t-105 -132.07 140.83 48.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -0.953 . . . . 0.0 109.755 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.1 p -128.43 141.92 51.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.263 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.41 HD12 ' CE2' ' A' ' 66' ' ' PHE . 3.4 mt -135.11 94.68 15.75 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.609 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.495 ' CG ' HG12 ' A' ' 163' ' ' VAL . 51.1 Cg_endo -70.85 134.82 26.5 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.688 2.259 . . . . 0.0 111.718 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.427 ' O ' HG13 ' A' ' 164' ' ' VAL . 45.4 mt -104.35 140.14 38.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.47 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.503 ' HA2' ' CG2' ' A' ' 164' ' ' VAL . . . -86.92 -69.56 1.32 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -122.51 79.38 1.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -1.133 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -133.55 179.07 6.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.41 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.5 t -116.86 168.89 9.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 0.0 109.538 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -63.38 -29.69 70.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -68.3 -42.78 78.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 52.8 mtm -76.46 -26.93 55.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.457 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.04 -35.05 61.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.511 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 56' ' ' ALA . 98.7 mt-10 -73.71 -38.71 64.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.625 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 20.2 tt -71.03 -28.17 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 0.0 109.586 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.504 ' CB ' ' SD ' ' A' ' 30' ' ' MET . . . -74.81 -36.68 62.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.556 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.469 ' O ' HG21 ' A' ' 12' ' ' THR . . . -57.51 -39.19 75.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.14 -0.975 . . . . 0.0 109.677 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.467 ' CG2' ' CG1' ' A' ' 87' ' ' VAL . 77.9 t -75.45 -46.83 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 0.0 109.805 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.506 ' HG3' ' CG1' ' A' ' 120' ' ' ILE . 84.0 tt0 -60.28 -35.75 76.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.668 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.533 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 11.4 t80 -57.79 -68.67 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.675 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -61.67 -14.18 29.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.66 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 41.8 t -69.86 -60.34 2.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.454 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.439 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 65.4 tttm -61.28 -45.26 95.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.641 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 32.5 mttp -60.39 -34.11 73.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.577 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 67' ' ' ALA . . . -61.27 -58.92 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 109.443 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.527 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 2.9 tt -53.22 -46.36 69.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 72' ' ' LEU . 13.2 ttpt -42.88 -47.19 5.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 109.257 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.534 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 22.7 mm -48.9 141.93 9.84 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 108.794 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.7 Cg_endo -66.12 -4.9 11.16 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.514 2.143 . . . . 0.0 111.687 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.78 165.71 24.48 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 47.5 Cg_endo -68.87 131.44 22.52 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 122.545 2.164 . . . . 0.0 111.596 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.574 HG12 ' CD2' ' A' ' 10' ' ' PHE . 68.8 t -121.57 167.51 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.451 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.538 HD11 ' CG ' ' A' ' 6' ' ' TYR . 7.0 mp -115.82 130.49 56.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.538 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 ' CB ' ' A' ' 67' ' ' ALA . 96.9 t -104.36 134.94 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.387 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.452 HD13 ' CE1' ' A' ' 11' ' ' TYR . 40.7 mt -120.58 137.33 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.528 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.9 t -143.48 161.68 37.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.429 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 58.8 p30 -89.79 25.14 2.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.462 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.2 m -128.54 117.08 20.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.216 -0.928 . . . . 0.0 109.447 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.542 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 71.6 t80 -77.29 -44.98 27.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -58.44 -45.02 89.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.467 ' CG1' ' CG2' ' A' ' 64' ' ' VAL . 95.2 t -61.81 -49.66 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.462 ' HA ' HG23 ' A' ' 132' ' ' ILE . . . -57.33 -49.28 76.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.326 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -61.43 -36.62 80.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.638 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 47.7 t -53.16 -47.35 68.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.472 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 120' ' ' ILE . . . -92.48 -0.66 57.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 43.2 t-20 -87.17 -72.97 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.87 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 97.7 mttt -127.1 -23.95 3.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.551 ' HG2' ' CE2' ' A' ' 98' ' ' TRP . 42.6 tt0 -67.08 -27.48 67.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.961 -1.087 . . . . 0.0 109.755 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.528 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.5 OUTLIER -57.09 -57.86 21.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 109.59 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 43.8 Cg_endo -66.64 -24.72 47.78 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.452 2.101 . . . . 0.0 111.136 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -72.15 -36.72 69.4 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.551 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 38.6 m0 -65.41 -50.04 66.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.507 -0.745 . . . . 0.0 108.991 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.549 ' HG2' ' CE1' ' A' ' 103' ' ' PHE . 26.1 mttt -43.63 -43.24 5.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.473 -0.767 . . . . 0.0 109.365 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -53.25 -44.42 68.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.371 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -86.89 11.27 13.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.324 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 82.07 37.98 14.36 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.549 ' CE1' ' HG2' ' A' ' 99' ' ' LYS . 37.5 m-85 67.07 28.13 8.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -1.134 . . . . 0.0 109.464 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.444 ' HA ' ' HB2' ' A' ' 111' ' ' LEU . 47.9 t -119.2 124.86 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.498 ' HB2' ' CD1' ' A' ' 111' ' ' LEU . 47.2 t30 -53.51 -39.03 64.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.483 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -170.64 144.69 2.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -53.12 -24.2 9.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.355 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -70.21 -38.38 75.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.77 138.32 18.22 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.452 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.413 ' HA ' HG13 ' A' ' 104' ' ' VAL . 50.2 Cg_endo -69.94 159.74 52.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.749 2.3 . . . . 0.0 111.814 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.547 HD22 ' CD2' ' A' ' 98' ' ' TRP . 15.4 tp -81.84 133.43 35.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.428 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 57.9 mttp -98.67 149.27 22.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.215 -0.928 . . . . 0.0 109.568 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.537 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 55.4 m80 65.28 35.65 7.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.792 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.461 HG12 ' HB3' ' A' ' 111' ' ' LEU . 53.8 mt -67.36 -45.19 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.185 -0.947 . . . . 0.0 109.329 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 t -51.08 -47.62 61.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.22 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.66 -38.21 84.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.638 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 27.6 m95 -69.6 -40.28 76.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 109.351 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -55.06 -41.54 71.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.391 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.407 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 22.9 t -58.58 -45.77 88.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.506 ' CG1' ' HG3' ' A' ' 65' ' ' GLU . 79.4 mt -69.07 -36.22 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.378 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.81 93.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 126' ' ' MET . 83.1 tt0 -54.59 -40.61 69.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 109.409 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 1.3 m -76.6 -50.29 14.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.385 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.1 tt -57.78 -37.44 73.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.464 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.8 m -59.93 -33.07 71.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.507 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.451 ' HB2' HD13 ' A' ' 72' ' ' LEU . 88.4 mtp -64.85 -36.06 83.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.85 . . . . 0.0 109.463 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.35 143.85 0.24 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 129' ' ' ASP . 48.6 Cg_endo -69.5 -2.12 9.43 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.738 2.292 . . . . 0.0 111.734 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.479 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 92.8 m-20 -43.18 -38.25 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.358 -0.839 . . . . 0.0 109.4 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 54.9 mt -68.59 109.44 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.461 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 97.2 m -110.03 146.94 34.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.273 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.462 HG23 ' HA ' ' A' ' 88' ' ' ALA . 64.2 mt -120.62 145.7 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.421 ' HB2' HG12 ' A' ' 81' ' ' ILE . 88.8 mt-30 -124.99 155.2 40.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.401 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.542 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 32.3 t-80 -110.53 128.56 55.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -122.9 146.6 47.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 139' ' ' GLN . 93.0 mttt -109.32 125.02 51.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.507 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.15 -29.83 61.88 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -62.29 -37.61 86.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -1.141 . . . . 0.0 109.408 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 136' ' ' LYS . 0.9 OUTLIER -117.52 159.23 42.8 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.533 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.53 155.14 67.5 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.798 2.332 . . . . 0.0 111.852 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 143' ' ' THR . 29.6 p -78.57 166.98 21.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.416 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -51.09 -38.85 54.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.548 ' HB ' ' CD2' ' A' ' 146' ' ' HIS . 24.4 m -125.01 137.98 54.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.382 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 88.0 p -61.21 -23.63 65.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.499 ' CG2' HG21 ' A' ' 143' ' ' THR . 19.9 tt -63.11 -40.11 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.548 ' CD2' ' HB ' ' A' ' 143' ' ' THR . 88.2 m-70 -67.23 -27.09 66.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.92 . . . . 0.0 109.538 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 47.6 m -67.83 -35.47 78.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.53 -39.41 67.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -66.07 -37.86 93.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -65.09 -32.46 74.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -1.102 . . . . 0.0 109.361 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -66.76 -52.65 41.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.882 . . . . 0.0 109.514 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 59.1 mt -64.81 -46.78 80.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.56 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -54.48 -39.46 67.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.579 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -68.15 -36.99 80.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 66.3 mttm -56.43 -43.87 79.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.562 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.489 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 6.4 mp -72.11 -36.09 69.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.551 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.29 82.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.498 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 30.5 m -63.92 -41.57 97.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.56 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 94.5 mt-30 -66.17 -28.61 68.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.499 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.06 -39.67 97.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.58 ' CB ' ' CD1' ' A' ' 17' ' ' ILE . 25.0 m -60.79 -38.87 86.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.115 . . . . 0.0 109.516 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -66.99 -30.02 70.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.495 HG12 ' CG ' ' A' ' 50' ' ' PRO . 63.4 t -58.56 -38.0 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.575 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.503 ' CG2' ' HA2' ' A' ' 52' ' ' GLY . 12.3 p -111.81 138.35 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.447 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.97 -26.59 68.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -1.166 . . . . 0.0 109.397 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.55 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 92.3 mtp -64.15 -36.72 84.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.489 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 102.88 -15.52 55.36 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 6' ' ' TYR . 90.6 mt-30 63.04 47.38 4.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -1.143 . . . . 0.0 109.525 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.604 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 99.0 m-85 -52.11 -174.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 109.469 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.463 ' HB2' HG22 ' A' ' 78' ' ' VAL . 70.0 mm-40 -68.57 -36.91 79.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.152 -0.967 . . . . 0.0 109.283 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.66 -174.13 44.61 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.437 HG21 ' CE2' ' A' ' 37' ' ' TYR . 90.4 t -137.98 136.34 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -1.106 . . . . 0.0 109.317 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.684 ' CE2' ' CG ' ' A' ' 34' ' ' HIS . 47.6 m-85 -118.88 137.76 53.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.742 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.558 ' CE2' HG13 ' A' ' 81' ' ' ILE . 23.2 m-85 -108.0 130.78 55.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.198 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.524 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 19.6 p -116.5 147.65 41.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 109.621 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CG ' ' OD1' ' A' ' 154' ' ' ASP . 23.3 t70 -148.56 153.51 38.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.6 126.23 3.38 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.6 m -128.68 153.51 47.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -1.148 . . . . 0.0 109.409 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.473 ' HB2' ' CA ' ' A' ' 56' ' ' ALA . . . -139.94 144.63 37.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.526 HD13 ' CB ' ' A' ' 161' ' ' SER . 38.0 mt -117.76 147.86 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -100.55 164.97 11.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.555 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.53 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -125.65 176.63 2.34 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 109.094 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 47.6 Cg_endo -69.1 124.25 11.16 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.44 2.093 . . . . 0.0 111.413 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 2.5 m-20 61.49 57.76 3.2 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.913 . . . . 0.0 109.014 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 19' ' ' SER . 50.4 Cg_endo -70.71 63.43 2.34 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.869 2.379 . . . . 0.0 112.128 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.528 ' O ' ' CG ' ' A' ' 24' ' ' LYS . 35.2 m -56.72 -45.76 81.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 109.093 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 23' ' ' THR . 76.3 mttt -159.73 41.04 0.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.43 -0.794 . . . . 0.0 109.313 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 26' ' ' ASN . 20.0 m -137.19 140.76 41.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 109.476 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 25' ' ' SER . 77.2 m-20 -160.09 146.65 15.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 109.359 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 89.2 m-20 -95.55 136.81 35.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.434 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 51' ' ' LEU . . . -145.71 149.47 34.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.504 ' HA2' ' CD1' ' A' ' 51' ' ' LEU . . . -157.78 164.44 33.16 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.498 ' CE ' ' HB ' ' A' ' 49' ' ' ILE . 66.2 mtm -123.19 163.51 20.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -1.156 . . . . 0.0 109.421 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.45 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -148.45 119.54 1.09 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 11' ' ' TYR . 24.8 mm -114.64 137.03 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -1.17 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.2 t -123.38 136.09 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.684 ' CG ' ' CE2' ' A' ' 10' ' ' PHE . 4.1 t60 -110.23 135.02 51.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.658 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.01 164.61 27.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.294 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.2 t -131.71 166.74 20.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 109.599 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.504 ' OH ' ' CE ' ' A' ' 3' ' ' MET . 66.3 m-85 -100.64 11.63 39.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 109.406 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.555 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -51.29 179.65 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.328 -0.857 . . . . 0.0 109.05 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.6 Cg_endo -66.29 -5.0 11.56 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.122 1.881 . . . . 0.0 111.65 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -135.95 106.07 6.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.368 -0.832 . . . . 0.0 109.049 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.55 ' CD1' HD12 ' A' ' 145' ' ' ILE . 54.7 t80 -67.46 122.7 18.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.31 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 82.4 mt-30 -159.4 142.46 14.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 46.2 t -64.96 110.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.575 HD13 ' CD2' ' A' ' 34' ' ' HIS . 35.1 mt -57.14 -48.72 77.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 79.8 m-20 -159.76 153.74 23.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.426 ' HB3' HD11 ' A' ' 156' ' ' LEU . 91.0 mt-30 -109.48 146.47 34.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.45 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.4 t-105 -131.24 135.52 47.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 0.0 109.722 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.9 t -130.29 130.16 44.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 109.261 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.542 HD11 ' CD2' ' A' ' 66' ' ' PHE . 3.1 mp -131.65 98.69 17.71 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 109.741 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 51.3 Cg_endo -71.57 136.48 28.42 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.601 2.201 . . . . 0.0 111.676 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.554 ' HB3' ' CG ' ' A' ' 54' ' ' HIS . 3.3 mp -103.7 140.37 37.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 53' ' ' ASN . . . -103.34 113.38 4.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 52' ' ' GLY . 47.7 t30 75.63 36.64 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -1.157 . . . . 0.0 109.55 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.554 ' CG ' ' HB3' ' A' ' 51' ' ' LEU . 76.9 m80 -120.26 171.55 8.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.17 170.18 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.26 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.473 ' CA ' ' HB2' ' A' ' 16' ' ' ALA . . . -56.98 -35.26 68.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.017 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 60' ' ' GLU . 89.7 mt-30 -70.14 -58.27 3.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 0.0 109.345 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.503 ' HE3' ' CD2' ' A' ' 54' ' ' HIS . 97.6 mtp -44.77 -30.72 1.01 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.304 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' A' ' 51' ' ' LEU . . . -77.62 -34.57 53.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.379 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 57' ' ' GLN . 97.0 mt-10 -63.33 -41.9 98.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 109.567 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.558 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 12.8 tt -71.56 -37.36 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.517 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -67.14 -31.66 72.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.308 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.524 ' CB ' ' HB ' ' A' ' 12' ' ' THR . . . -66.97 -38.6 86.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.488 ' CG2' HG23 ' A' ' 87' ' ' VAL . 85.3 t -69.91 -40.34 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -69.11 -39.81 78.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.56 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 19.2 t80 -58.77 -64.35 0.96 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.359 -0.838 . . . . 0.0 109.477 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.82 -32.88 69.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.421 ' O ' HD13 ' A' ' 130' ' ' ILE . 43.0 t -51.63 -52.64 46.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 67.8 mttm -64.5 -42.25 95.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.56 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 64.3 mttm -62.62 -37.81 87.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.562 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.71 -61.9 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 18.9 tp -55.21 -42.01 72.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.459 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 72' ' ' LEU . 64.9 tttt -45.17 -40.95 7.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.29 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 32.6 mm -59.1 143.07 85.01 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 108.899 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.3 Cg_endo -64.08 -5.87 10.22 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.53 2.153 . . . . 0.0 111.871 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.456 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -134.85 170.6 22.74 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 49.7 Cg_endo -69.27 135.6 32.06 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.392 2.061 . . . . 0.0 111.771 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.524 HG12 ' CD1' ' A' ' 10' ' ' PHE . 58.0 t -124.4 158.14 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.875 . . . . 0.0 109.374 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.604 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 14.2 mt -108.32 144.71 35.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.213 -0.929 . . . . 0.0 109.424 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 132' ' ' ILE . 13.6 m -123.48 143.92 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.558 HG13 ' CE2' ' A' ' 11' ' ' TYR . 26.1 mm -114.01 133.56 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.339 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 p -127.18 161.76 27.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.476 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -98.99 14.16 30.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 109.523 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 27.2 t -137.96 125.77 22.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.618 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 48.8 p90 -77.2 -36.63 54.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.456 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -53.79 -50.18 66.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.488 HG23 ' CG2' ' A' ' 64' ' ' VAL . 14.9 p -67.26 -44.72 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.907 . . . . 0.0 109.409 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.437 ' N ' ' CG1' ' A' ' 87' ' ' VAL . . . -54.89 -47.92 73.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 77.3 mm-40 -62.22 -40.27 95.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.594 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 64.4 m -50.79 -44.96 58.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 132' ' ' ILE . . . -94.51 -0.9 54.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.731 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 56.1 t30 -89.67 -72.93 0.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.581 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 65.0 tttm -127.05 -31.84 2.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 109.774 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 92.6 mt-10 -55.52 -34.23 64.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 0.0 109.743 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.497 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 0.8 OUTLIER -56.18 -62.13 5.33 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 109.581 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 44.5 Cg_endo -66.93 -32.71 34.97 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.836 2.357 . . . . 0.0 111.746 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -67.75 -38.24 83.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.164 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -64.96 -48.95 72.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -0.883 . . . . 0.0 109.259 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -47.87 -42.26 26.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.397 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.4 m -59.21 -40.74 86.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.458 ' O ' ' CG2' ' A' ' 104' ' ' VAL . 73.3 m-20 -87.64 12.21 13.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.869 . . . . 0.0 109.394 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 70.59 38.23 68.17 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.497 ' HA ' ' CD1' ' A' ' 111' ' ' LEU . 91.1 m-85 61.34 46.56 7.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -1.166 . . . . 0.0 109.434 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 101' ' ' ASN . 55.1 t -112.3 132.54 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.492 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.426 ' HB2' HD21 ' A' ' 111' ' ' LEU . 49.2 t-20 -93.73 142.58 27.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.413 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -49.96 -36.25 27.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.523 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -68.76 151.9 46.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -50.21 -33.43 19.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.4 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.99 140.7 74.05 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.29 173.78 10.94 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.666 2.244 . . . . 0.0 111.764 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.497 ' CD1' ' HA ' ' A' ' 103' ' ' PHE . 76.7 mt -65.84 137.97 57.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 73.6 mttt -107.56 153.93 22.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.6 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 55.8 m80 63.42 27.68 15.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.619 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.8 mt -57.51 -41.46 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.312 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.5 m -50.3 -47.3 55.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.264 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -60.57 -45.16 94.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.321 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.594 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 22.8 m95 -65.7 -40.6 92.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.349 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -52.34 -49.82 63.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.333 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.2 m -55.67 -45.55 77.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.294 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.456 HG23 ' HB2' ' A' ' 91' ' ' ALA . 76.8 mt -67.95 -37.99 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 109.374 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -53.57 -42.38 67.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -54.6 -43.7 72.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 109.369 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 1.6 m -63.87 -49.16 73.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.425 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.5 tp -64.28 -33.05 74.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.3 m -61.8 -32.67 72.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.0 109.62 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.509 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 91.9 mmm -65.67 -28.94 69.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 163.37 146.87 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.559 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.5 Cg_endo -69.91 -1.87 9.33 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.672 2.248 . . . . 0.0 111.657 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 85.6 m-20 -43.42 -34.2 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -0.811 . . . . 0.0 109.503 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 45.9 mt -72.62 123.59 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.584 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.536 ' HB ' ' CD2' ' A' ' 79' ' ' LEU . 40.0 m -119.01 139.06 52.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 109.238 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.53 ' HA ' ' CG2' ' A' ' 80' ' ' VAL . 73.0 mt -119.76 137.33 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.664 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.512 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 94.8 mt-30 -120.62 155.63 33.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.365 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.618 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 19.9 t-80 -114.7 135.87 53.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.452 ' OE1' ' ND2' ' A' ' 150' ' ' ASN . 65.5 tt0 -104.73 139.51 39.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.322 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -73.76 96.98 2.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.504 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.51 -20.39 77.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -60.35 -43.74 96.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -1.129 . . . . 0.0 109.328 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.64 82.36 6.78 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.315 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.99 137.76 35.53 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.704 2.269 . . . . 0.0 111.947 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.7 p -123.26 153.01 40.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -0.861 . . . . 0.0 109.313 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -90.7 8.08 36.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.5 p -66.58 -17.16 64.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.361 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 25.2 t -109.1 138.03 46.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.505 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.55 HD12 ' CD1' ' A' ' 41' ' ' TYR . 19.9 tt -66.36 -20.8 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.406 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 92.6 m-70 -69.5 -32.54 71.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 42.7 m -55.21 -48.81 73.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.5 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 152' ' ' LEU . 85.7 tt0 -49.04 -49.48 41.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.457 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -56.85 -39.08 87.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.452 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 87.7 m-20 -64.84 -35.8 82.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -1.123 . . . . 0.0 109.365 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.64 -47.11 86.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.413 ' CD1' ' O ' ' A' ' 148' ' ' GLU . 6.5 mp -65.25 -37.05 86.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.409 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.0 -41.66 90.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.915 . . . . 0.0 109.544 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.404 ' OD1' ' CG ' ' A' ' 13' ' ' ASP . 83.0 m-20 -57.6 -47.92 80.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.545 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -55.25 -48.01 74.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.515 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.45 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 62.7 mt -60.52 -38.76 85.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.568 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.05 -42.53 72.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 47.4 p -70.02 -30.94 68.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.569 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -62.66 -36.89 84.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -60.13 -37.82 93.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.526 ' CB ' HD13 ' A' ' 17' ' ' ILE . 14.5 m -59.95 -42.11 93.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.477 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.44 -25.33 68.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.72 -23.36 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.398 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.505 HG11 ' N ' ' A' ' 165' ' ' ASN . 38.5 t -128.36 156.42 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.505 ' N ' HG11 ' A' ' 164' ' ' VAL . 79.5 m-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.402 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.61 147.37 37.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.419 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.5 mmm -62.95 -40.55 98.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.471 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.02 -160.74 27.49 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -138.44 110.93 7.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -1.117 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.592 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 54.6 m-85 -122.31 161.57 23.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.578 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.522 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 74.8 mm-40 -55.51 -38.27 68.97 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.217 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.458 ' O ' HG11 ' A' ' 78' ' ' VAL . . . -178.82 -175.52 45.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.436 HG22 ' CE2' ' A' ' 37' ' ' TYR . 74.7 t -133.53 137.61 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -1.081 . . . . 0.0 109.167 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.682 ' CZ ' ' CD2' ' A' ' 34' ' ' HIS . 57.0 m-85 -117.67 134.76 54.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.126 -0.984 . . . . 0.0 110.014 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.589 ' CE2' ' CD1' ' A' ' 81' ' ' ILE . 38.1 m-85 -107.49 129.12 54.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.034 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.444 ' CG2' HD13 ' A' ' 32' ' ' ILE . 12.8 p -118.48 147.65 43.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.862 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 65.5 t0 -138.31 146.46 42.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.481 -0.762 . . . . 0.0 109.143 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -135.17 136.92 8.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.4 p -143.47 161.88 37.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -1.139 . . . . 0.0 109.301 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -153.39 145.85 24.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.464 HD12 HG23 ' A' ' 17' ' ' ILE . 68.1 mt -116.59 138.86 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.358 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -112.04 125.73 54.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.486 ' OG ' ' HD2' ' A' ' 20' ' ' PRO . 2.3 t -121.39 157.09 57.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.186 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.486 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 43.8 Cg_endo -66.38 -18.11 54.64 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.642 2.228 . . . . 0.0 112.054 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.601 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 1.0 OUTLIER -84.86 -67.9 0.17 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 109.243 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 53.5 Cg_endo -73.04 51.79 2.1 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.441 2.094 . . . . 0.0 111.562 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.8 m -54.5 -41.89 70.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.547 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -99.95 27.61 5.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.531 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -125.4 -67.17 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 109.481 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 25' ' ' SER . 85.2 m-20 62.16 130.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.596 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 90.3 m-20 -105.31 135.96 45.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 51' ' ' LEU . . . -139.36 146.44 40.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.708 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 50' ' ' PRO . . . -137.18 159.06 24.59 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.423 ' HB2' ' HB ' ' A' ' 49' ' ' ILE . 66.6 mtm -131.89 151.21 51.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -1.148 . . . . 0.0 109.483 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -134.03 127.96 4.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.504 HG13 ' CD2' ' A' ' 66' ' ' PHE . 23.9 mm -115.6 135.72 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.489 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.0 t -126.25 135.01 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.682 ' CD2' ' CZ ' ' A' ' 10' ' ' PHE . 14.0 t-160 -111.4 127.54 55.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 109.538 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.52 171.65 8.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -129.9 165.86 21.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.436 ' CE2' HG22 ' A' ' 9' ' ' VAL . 55.3 m-85 -100.2 13.07 35.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 109.449 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.562 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.32 179.94 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 108.939 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.0 Cg_endo -66.41 -4.85 11.45 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.136 1.89 . . . . 0.0 111.707 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.443 ' CD ' ' NE2' ' A' ' 42' ' ' GLN . 83.7 tt0 -138.11 106.16 5.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -0.847 . . . . 0.0 109.041 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -54.44 121.5 8.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.462 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.443 ' NE2' ' CD ' ' A' ' 40' ' ' GLU . 91.1 mt-30 -152.74 156.6 39.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 43' ' ' VAL . 21.0 m -89.62 118.13 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' A' ' 34' ' ' HIS . 39.5 mt -58.49 -45.62 88.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.362 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 74.9 m-20 -162.71 168.45 21.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.425 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -121.7 145.07 48.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.436 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 2.9 t-105 -128.85 140.03 51.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -125.35 128.8 48.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 2.7 mp -127.17 86.94 57.65 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.622 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HB3' HG22 ' A' ' 163' ' ' VAL . 51.0 Cg_endo -70.65 130.53 18.39 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.746 2.297 . . . . 0.0 111.699 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 28' ' ' ALA . 43.9 mt -107.19 153.03 23.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 109.452 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -124.74 -40.95 0.4 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -108.0 32.07 5.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -1.113 . . . . 0.0 109.514 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 78.9 m80 -120.15 145.7 46.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.542 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.93 168.34 12.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.201 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -48.81 -38.95 23.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.135 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 60' ' ' GLU . 91.0 mt-30 -70.39 -58.26 3.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.459 ' O ' HG21 ' A' ' 61' ' ' ILE . 95.3 mtp -44.95 -30.48 1.02 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.352 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.67 -36.81 57.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' GLN . 98.8 mt-10 -65.49 -40.04 92.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.557 HD11 ' CZ2' ' A' ' 117' ' ' TRP . 20.5 tt -70.79 -34.57 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.509 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -69.41 -33.7 73.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.854 . . . . 0.0 109.45 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.17 91.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.524 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 96.3 t -70.79 -50.46 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.561 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' A' ' 120' ' ' ILE . 86.7 tt0 -59.17 -40.43 85.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.593 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.57 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 17.0 t80 -53.89 -70.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.908 . . . . 0.0 109.632 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.527 ' HB1' ' CG1' ' A' ' 80' ' ' VAL . . . -64.19 -10.96 26.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -0.906 . . . . 0.0 109.648 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 37.7 t -75.51 -56.34 4.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -63.25 -41.23 99.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.57 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 44.4 mttp -66.02 -34.68 78.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.94 -58.93 6.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.527 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 9.3 tt -55.4 -45.12 76.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 72' ' ' LEU . 58.2 tttm -43.27 -41.75 4.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 30.0 mm -56.52 143.15 68.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.304 -0.872 . . . . 0.0 108.736 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.1 Cg_endo -64.33 -5.01 8.93 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.729 2.286 . . . . 0.0 112.086 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.522 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -136.22 171.87 22.64 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 49.7 Cg_endo -70.1 132.33 22.57 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.44 2.094 . . . . 0.0 111.806 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.551 HG13 ' CD1' ' A' ' 10' ' ' PHE . 60.2 t -120.61 161.86 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.442 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.592 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 14.5 mt -107.83 137.73 45.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.527 ' CG1' ' HB1' ' A' ' 67' ' ' ALA . 45.6 t -116.62 130.22 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.589 ' CD1' ' CE2' ' A' ' 11' ' ' TYR . 35.4 mt -117.56 136.16 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.0 109.501 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.8 t -139.51 159.71 41.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -88.99 19.74 3.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.535 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.2 t -122.55 116.8 24.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 109.521 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.567 ' CG ' ' N ' ' A' ' 86' ' ' TYR . 38.9 p90 -77.27 -45.31 26.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.489 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.567 ' N ' ' CG ' ' A' ' 85' ' ' PHE . 69.9 t80 -55.7 -48.87 74.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' SER . 86.8 t -60.13 -49.42 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.318 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.501 ' CB ' HG23 ' A' ' 132' ' ' ILE . . . -53.24 -55.01 27.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.221 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 96.1 mt-10 -58.5 -28.39 65.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.325 -0.859 . . . . 0.0 109.391 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.627 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 23.9 m -59.88 -45.97 90.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.526 ' HB1' ' CD1' ' A' ' 132' ' ' ILE . . . -92.36 -0.74 57.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 109.774 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 82.3 m-20 -86.96 -68.19 0.76 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.004 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 67.8 mttm -122.19 -34.58 3.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 109.9 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.533 ' OE1' ' CZ2' ' A' ' 98' ' ' TRP . 83.4 mt-10 -62.41 -32.95 73.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 109.612 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.503 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -55.92 -59.65 11.0 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.416 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 46.1 Cg_endo -67.72 -32.53 29.97 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.707 2.272 . . . . 0.0 111.444 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -73.0 -37.31 67.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 108.954 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.533 ' CZ2' ' OE1' ' A' ' 94' ' ' GLU . 15.1 m0 -60.18 -52.98 63.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.369 -0.832 . . . . 0.0 109.17 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.496 ' HG3' ' CZ ' ' A' ' 103' ' ' PHE . 77.1 tttt -44.65 -42.58 7.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.333 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 82.4 p -73.57 -28.31 61.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 98' ' ' TRP . 54.4 t30 -87.19 9.73 19.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 104' ' ' VAL . . . 81.37 25.56 54.12 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.496 ' CZ ' ' HG3' ' A' ' 99' ' ' LYS . 61.2 m-85 60.38 34.35 20.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -1.16 . . . . 0.0 109.448 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 102' ' ' GLY . 60.9 t -123.87 127.99 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.443 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.443 ' HB2' HD12 ' A' ' 111' ' ' LEU . 40.7 t-20 -58.2 -40.9 82.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -175.69 156.36 1.86 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.454 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -60.44 -28.68 68.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.435 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 109' ' ' LYS . 23.2 mttm -67.01 -36.28 81.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 108' ' ' LYS . 5.4 mmtt -145.75 138.58 13.98 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.432 ' HA ' HG12 ' A' ' 104' ' ' VAL . 49.2 Cg_endo -69.74 165.34 31.26 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.673 2.249 . . . . 0.0 111.81 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.443 HD12 ' HB2' ' A' ' 105' ' ' ASN . 13.7 tp -84.45 133.36 34.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -94.93 151.05 19.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.423 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.405 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 58.4 m80 59.77 42.99 15.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.88 . . . . 0.0 109.438 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.45 HG22 ' HE3' ' A' ' 118' ' ' LYS . 91.9 mt -65.04 -42.68 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.466 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -61.87 -39.84 93.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -60.66 -44.77 96.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.627 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 52.7 m95 -65.03 -38.53 91.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.427 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.45 ' HE3' HG22 ' A' ' 114' ' ' ILE . 52.0 mttt -58.69 -37.54 76.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.8 m -62.85 -43.48 98.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.372 -0.83 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.449 HD11 ' HB2' ' A' ' 65' ' ' GLU . 73.0 mt -69.86 -35.69 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.49 ' HB3' ' CD1' ' A' ' 95' ' ' LEU . . . -64.76 -34.37 78.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -53.03 -37.24 61.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.436 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.459 ' HB3' HD12 ' A' ' 130' ' ' ILE . 12.4 m -83.63 -45.37 13.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.49 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.458 ' CD2' ' HB ' ' A' ' 130' ' ' ILE . 53.1 mt -61.57 -31.44 71.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.437 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 121' ' ' ALA . 31.0 m -56.41 -36.55 69.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.441 ' HB2' HD11 ' A' ' 72' ' ' LEU . 88.7 mtp -63.92 -36.8 85.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 171.24 157.32 0.22 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.5 Cg_endo -72.15 3.7 3.83 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.739 2.292 . . . . 0.0 112.061 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 85.7 m-20 -42.36 -35.71 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.212 -0.93 . . . . 0.0 109.623 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 62.8 mt -75.17 116.26 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 109.402 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.454 ' HB ' HD21 ' A' ' 79' ' ' LEU . 31.3 m -110.88 142.55 42.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.368 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.526 ' CD1' ' HB1' ' A' ' 91' ' ' ALA . 62.0 mt -120.74 137.13 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.66 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB2' HG12 ' A' ' 81' ' ' ILE . 88.5 mt-30 -118.65 165.2 14.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -0.888 . . . . 0.0 109.36 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.526 ' CD2' ' HB3' ' A' ' 85' ' ' PHE . 29.4 t-80 -120.56 133.64 55.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.513 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.451 ' OE2' HG21 ' A' ' 81' ' ' ILE . 93.6 mt-10 -102.13 159.5 15.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.426 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 140' ' ' PRO . 24.0 mttm -96.03 34.27 1.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.19 -175.66 51.42 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.474 ' O ' ' CD ' ' A' ' 140' ' ' PRO . 86.3 t60 -65.29 -36.75 85.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -1.126 . . . . 0.0 109.444 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -105.67 75.94 0.34 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.474 ' CD ' ' O ' ' A' ' 138' ' ' HIS . 49.2 Cg_endo -70.2 144.34 51.38 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.672 2.248 . . . . 0.0 111.805 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 49.1 m -57.08 -38.2 72.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.431 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -113.08 128.53 56.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.373 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.6 m -78.87 135.81 37.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.1 p -143.72 170.36 16.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.875 . . . . 0.0 109.461 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 145' ' ' ILE . 95.2 mt -63.85 -31.0 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.551 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -68.8 -26.2 65.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.411 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.439 HG21 ' HG3' ' A' ' 140' ' ' PRO . 58.1 m -55.29 -45.59 76.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -51.67 -43.38 62.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.04 -39.04 89.01 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.433 ' OD1' ' HA ' ' A' ' 138' ' ' HIS . 22.9 t-20 -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -1.139 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -57.93 -51.72 68.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.417 HD11 ' N ' ' A' ' 152' ' ' LEU . 7.0 mp -65.46 -44.73 86.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 109.526 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.2 87.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.577 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.453 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 58.4 t0 -61.81 -38.04 86.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 24.1 mttm -62.96 -40.58 98.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.568 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 61.7 mt -72.09 -37.22 69.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.537 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.22 -44.51 75.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.47 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 31.1 m -61.03 -41.84 97.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.54 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 94.4 mt-30 -67.29 -26.66 66.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.485 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.478 ' O ' ' CG2' ' A' ' 163' ' ' VAL . . . -66.28 -26.73 72.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.6 p -76.06 -25.37 55.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -1.157 . . . . 0.0 109.457 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -81.36 -25.59 36.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.489 HG21 ' N ' ' A' ' 164' ' ' VAL . 5.1 m -62.76 -24.92 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.489 ' N ' HG21 ' A' ' 163' ' ' VAL . 41.3 t -124.08 136.35 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.468 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.05 69.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -1.152 . . . . 0.0 109.502 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.479 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 93.1 mtp -62.83 -34.26 76.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.61 -167.2 38.53 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -122.86 121.81 37.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -1.115 . . . . 0.0 109.485 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.586 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 50.1 m-85 -120.9 162.5 19.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.37 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.512 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 31.8 tp10 -59.47 -37.1 77.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.268 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 9' ' ' VAL . . . -178.69 -169.45 39.39 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.569 HG22 ' CZ ' ' A' ' 37' ' ' TYR . 70.2 t -142.55 140.65 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -1.135 . . . . 0.0 109.253 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.686 ' CE1' ' CD2' ' A' ' 34' ' ' HIS . 31.3 m-85 -121.05 142.88 49.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.82 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.506 ' CE1' HG13 ' A' ' 81' ' ' ILE . 49.7 m-85 -114.58 130.16 56.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 108.952 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.517 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 29.2 p -112.69 150.17 31.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.075 -1.015 . . . . 0.0 109.956 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 66.6 t0 -145.2 145.99 31.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.056 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -139.98 137.36 8.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 87.3 p -143.53 162.72 35.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -1.127 . . . . 0.0 109.17 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.501 ' CB ' ' HB1' ' A' ' 28' ' ' ALA . . . -146.25 148.82 32.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.001 . . . . 0.0 109.757 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 161' ' ' SER . 60.6 mt -117.88 141.87 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -103.22 125.32 49.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.54 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.469 ' OG ' ' HD2' ' A' ' 22' ' ' PRO . 4.9 t -117.89 154.56 51.3 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.304 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.466 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 45.6 Cg_endo -67.73 -7.3 19.05 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.662 2.242 . . . . 0.0 111.975 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.598 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -100.11 -69.76 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.456 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 54.2 Cg_endo -72.9 53.7 2.44 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.369 2.046 . . . . 0.0 111.657 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.7 m -54.79 -42.3 71.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 109.586 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -96.45 30.98 2.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -134.37 -58.31 0.84 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 109.499 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 25' ' ' SER . 82.1 m-20 62.36 129.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -99.41 125.66 45.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.443 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 15' ' ' SER . . . -135.65 158.41 44.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' HA2' HD11 ' A' ' 51' ' ' LEU . . . -140.33 159.53 26.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.503 ' HE2' ' CD1' ' A' ' 49' ' ' ILE . 49.7 mtm -118.93 154.08 33.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -1.179 . . . . 0.0 109.399 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.45 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -139.68 120.04 1.77 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 11' ' ' TYR . 20.9 mm -111.13 133.08 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -1.154 . . . . 0.0 109.437 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' PHE . 42.7 t -118.64 137.89 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.686 ' CD2' ' CE1' ' A' ' 10' ' ' PHE . 23.6 t-160 -112.86 130.15 56.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.52 166.94 20.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.324 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.455 ' HB ' HD11 ' A' ' 44' ' ' LEU . 9.9 t -127.75 154.25 45.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.569 ' CZ ' HG22 ' A' ' 9' ' ' VAL . 11.8 m-30 -95.22 5.28 52.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.518 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.565 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.3 179.56 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.059 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.7 Cg_endo -66.39 -4.43 10.67 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.219 1.946 . . . . 0.0 111.825 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -130.38 105.93 8.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 108.745 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -71.22 130.3 41.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 109.554 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -167.99 151.83 6.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 43' ' ' VAL . 2.6 p -76.96 125.59 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.878 . . . . 0.0 109.406 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.636 ' CD2' ' CE1' ' A' ' 34' ' ' HIS . 7.5 mp -72.23 -36.67 69.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.902 . . . . 0.0 109.387 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -173.05 158.46 3.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.457 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.503 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 91.8 mt-30 -113.49 138.64 49.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.279 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.434 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 1.0 OUTLIER -121.25 135.42 55.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.657 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.7 t -128.71 129.95 46.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.196 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.503 ' CD1' ' HE2' ' A' ' 30' ' ' MET . 4.1 mt -134.45 93.17 19.23 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 109.691 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.406 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 50.5 Cg_endo -70.9 140.28 38.05 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.693 2.262 . . . . 0.0 111.658 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 54' ' ' HIS . 5.3 mp -109.0 154.84 21.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.531 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.04 -34.86 0.66 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.547 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 42.7 p-10 -118.47 36.67 4.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.161 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.547 ' CE1' ' OD1' ' A' ' 53' ' ' ASN . 77.7 m80 -126.47 169.75 12.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.441 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.402 HG21 ' CG ' ' A' ' 58' ' ' MET . 10.0 t -111.43 -176.27 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.459 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -67.52 -39.06 85.09 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.544 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -67.38 -45.23 76.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.557 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.461 ' O ' HG21 ' A' ' 61' ' ' ILE . 96.0 mtp -65.15 -36.46 84.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.616 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.82 88.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 56' ' ' ALA . 96.1 mt-10 -67.12 -48.4 68.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.6 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.579 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 13.1 tt -66.21 -36.15 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.452 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.508 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -64.9 -28.64 69.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.517 ' CB ' ' HB ' ' A' ' 12' ' ' THR . . . -68.16 -40.94 82.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.573 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 61.4 t -70.34 -38.24 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.593 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.529 ' HG2' ' CD1' ' A' ' 120' ' ' ILE . 97.3 mt-10 -66.4 -37.46 85.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.071 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.637 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 24.1 t80 -63.26 -67.1 0.45 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.451 -0.781 . . . . 0.0 109.761 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 68' ' ' CYS . . . -58.2 -45.3 87.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 109.867 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 42.5 t -42.47 -62.57 0.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 109.738 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 42.7 mttp -54.83 -50.46 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.637 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 64.2 mttm -55.23 -36.84 66.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.597 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 68' ' ' CYS . . . -58.03 -61.31 2.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.443 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.442 ' HB2' HD11 ' A' ' 130' ' ' ILE . 22.8 tp -51.53 -45.52 63.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 36.6 mmtt -43.82 -47.19 8.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.325 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 27.5 mm -48.39 142.73 7.97 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 108.923 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.6 Cg_endo -65.82 -3.91 9.01 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.553 2.169 . . . . 0.0 111.808 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -137.07 168.81 24.2 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 48.5 Cg_endo -69.44 130.53 19.9 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.53 2.154 . . . . 0.0 111.723 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.573 HG11 ' CD1' ' A' ' 10' ' ' PHE . 50.4 t -120.0 158.66 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.512 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.586 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 23.2 mt -101.74 143.85 31.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.9 t -119.48 130.4 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 133' ' ' GLN . 24.4 mm -111.08 142.0 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 p -131.95 157.99 42.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.487 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.448 ' OD2' ' OD1' ' A' ' 13' ' ' ASP . 60.5 m-20 -82.17 -20.02 38.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.479 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.498 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 46.9 t -110.62 131.64 54.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.57 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 46.4 p90 -76.11 -35.03 59.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -57.06 -52.58 64.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.418 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.498 ' CG1' ' HB3' ' A' ' 84' ' ' SER . 9.7 p -62.03 -47.31 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.341 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.466 ' N ' HG12 ' A' ' 87' ' ' VAL . . . -55.76 -53.66 53.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 85' ' ' PHE . 76.0 mm-40 -60.01 -35.14 74.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.357 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.554 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 33.6 m -51.7 -48.04 63.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.461 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.435 ' HB3' HD12 ' A' ' 120' ' ' ILE . . . -91.37 -0.99 57.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.633 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -85.61 -72.83 0.47 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.001 . . . . 0.0 109.744 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 21.4 mttt -126.72 -28.52 2.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.091 -1.005 . . . . 0.0 109.917 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.562 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 91.9 mt-10 -60.56 -31.98 71.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.033 . . . . 0.0 109.866 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.51 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -58.14 -59.88 11.91 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.503 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.8 Cg_endo -66.94 -33.23 33.48 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.664 2.242 . . . . 0.0 111.606 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.492 ' CE2' ' OD1' ' A' ' 101' ' ' ASN . 76.3 t80 -70.26 -35.43 73.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -0.887 . . . . 0.0 109.043 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.568 ' CE2' HD13 ' A' ' 111' ' ' LEU . 10.8 m0 -63.8 -50.78 67.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.374 -0.829 . . . . 0.0 109.192 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.551 ' HG2' ' CE1' ' A' ' 103' ' ' PHE . 4.5 mtpm? -47.97 -41.9 26.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 109.415 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 97' ' ' TYR . 62.3 p -62.37 -34.33 76.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.492 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 23.2 m120 -85.29 7.56 21.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 77.71 29.97 53.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.551 ' CE1' ' HG2' ' A' ' 99' ' ' LYS . 74.3 m-85 62.38 43.68 7.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 109.456 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 109' ' ' LYS . 13.1 p -118.18 135.7 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.875 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 109' ' ' LYS . 46.7 t30 -89.54 121.48 31.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.505 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -61.02 -32.5 72.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -59.28 -39.03 81.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -134.81 -73.26 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.588 ' CB ' ' CD ' ' A' ' 110' ' ' PRO . 0.2 OUTLIER 176.83 -66.32 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.448 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 109' ' ' LYS . 51.0 Cg_endo -70.99 122.2 8.57 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.723 2.282 . . . . 0.0 111.801 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.568 HD13 ' CE2' ' A' ' 98' ' ' TRP . 19.3 tp -61.16 -37.06 81.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.315 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 23.8 mttm 61.81 146.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.569 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.538 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 50.4 m80 64.61 41.14 5.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.519 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 111' ' ' LEU . 40.6 mm -72.46 -42.84 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.305 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.7 m -62.12 -40.23 95.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.273 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.466 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 67.8 mttm -62.8 -44.27 96.61 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.387 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.579 ' CZ2' ' CD1' ' A' ' 61' ' ' ILE . 24.0 m95 -78.7 -31.69 46.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.295 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -57.88 -41.09 81.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.976 . . . . 0.0 109.343 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.3 m -60.81 -48.1 83.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.333 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.529 ' CD1' ' HG2' ' A' ' 65' ' ' GLU . 76.7 mt -70.36 -35.32 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.435 ' O ' ' OG ' ' A' ' 125' ' ' SER . . . -63.77 -34.68 78.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.369 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 126' ' ' MET . 82.5 tt0 -62.44 -36.42 82.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 19.9 m -79.97 -48.97 12.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.412 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.07 -35.93 74.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.848 . . . . 0.0 109.391 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 121' ' ' ALA . 43.4 m -63.33 -32.93 74.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.422 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.452 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 89.8 mtp -66.88 -34.41 77.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.873 . . . . 0.0 109.476 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.81 135.64 0.36 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.404 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.0 Cg_endo -69.6 -2.49 10.15 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.694 2.263 . . . . 0.0 111.57 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 88.4 m-20 -43.46 -36.88 2.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 109.344 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.442 HD11 ' HB2' ' A' ' 72' ' ' LEU . 50.0 mt -66.94 116.52 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.524 ' HB ' ' CD2' ' A' ' 79' ' ' LEU . 29.3 m -106.91 144.49 33.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 109.371 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.436 HG23 ' CA ' ' A' ' 88' ' ' ALA . 72.7 mt -125.23 137.46 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 109.496 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.517 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 95.1 mt-30 -135.35 159.3 42.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.57 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 22.4 t-80 -101.6 132.67 47.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.576 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.496 ' HB2' ' CG2' ' A' ' 81' ' ' ILE . 43.6 tp10 -124.16 150.86 44.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.483 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 4.8 tttm 49.16 -149.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.446 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.15 -115.11 5.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -110.54 131.38 55.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -1.135 . . . . 0.0 109.511 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 47.93 70.65 1.95 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.566 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.414 ' HB2' ' OD1' ' A' ' 142' ' ' ASN . 50.3 Cg_endo -70.53 139.17 36.96 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.693 2.262 . . . . 0.0 111.744 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.518 ' CG2' ' OG1' ' A' ' 143' ' ' THR . 46.2 m -63.29 -36.83 84.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.506 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.414 ' OD1' ' HB2' ' A' ' 140' ' ' PRO . 72.2 m-20 57.0 43.11 25.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.518 ' OG1' ' CG2' ' A' ' 141' ' ' THR . 0.2 OUTLIER -144.15 14.1 1.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.486 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 89.7 p -116.62 154.14 31.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.431 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.9 pt -68.6 -16.26 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.513 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -65.9 -28.66 69.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.455 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.7 m -49.15 -52.67 24.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.02 -49.51 63.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.398 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.32 -38.77 57.75 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -59.37 -42.36 91.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.183 . . . . 0.0 109.397 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.94 79.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.6 mt -59.97 -46.66 88.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 0.0 109.452 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . . . -59.65 -38.91 82.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.462 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 91.6 m-20 -57.28 -42.64 82.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.419 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 31.5 mttp -62.34 -40.65 97.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 109.449 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.503 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 6.5 mt -64.04 -43.52 95.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.443 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.41 -46.25 89.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 43.4 m -58.42 -41.92 86.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 96.3 mt-30 -63.07 -33.91 76.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -57.6 -41.74 93.76 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.424 ' HB2' HD13 ' A' ' 17' ' ' ILE . 70.5 p -65.19 -31.52 72.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -1.159 . . . . 0.0 109.45 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -68.67 -28.19 66.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 109.509 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.8 t -67.07 -22.18 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.954 . . . . 0.0 109.509 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.45 134.79 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.471 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.477 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.27 77.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -1.152 . . . . 0.0 109.483 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.574 ' HE1' ' CE2' ' A' ' 37' ' ' TYR . 88.6 mmm -62.68 -37.21 85.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.499 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.03 -24.73 51.79 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -49.77 -47.16 51.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -1.093 . . . . 0.0 109.46 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.572 ' CE2' HD12 ' A' ' 79' ' ' LEU . 29.6 m-85 -96.36 167.83 10.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -73.48 -34.16 65.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.868 . . . . 0.0 109.098 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -179.15 -166.84 35.7 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 10' ' ' PHE . 77.5 t -133.51 140.87 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.276 -1.132 . . . . 0.0 109.055 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.632 ' CE2' ' ND1' ' A' ' 34' ' ' HIS . 5.4 m-85 -113.24 147.33 37.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.844 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.562 ' CE1' HG13 ' A' ' 81' ' ' ILE . 96.9 m-85 -116.87 130.22 56.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 108.935 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 33.5 p -119.39 149.8 41.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.993 . . . . 0.0 109.933 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.02 163.07 37.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.437 -0.789 . . . . 0.0 109.203 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.436 ' CA ' ' OE2' ' A' ' 60' ' ' GLU . . . -139.53 118.73 1.55 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 157' ' ' ALA . 39.2 m -123.2 143.95 49.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -1.16 . . . . 0.0 109.468 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 27' ' ' ASN . . . -142.99 155.6 44.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.1 mt -119.9 138.33 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 109.401 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -114.94 144.21 43.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.945 . . . . 0.0 109.574 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.454 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -125.37 170.39 9.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.312 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 19' ' ' SER . 47.6 Cg_endo -68.38 -35.69 17.64 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.683 2.255 . . . . 0.0 111.596 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -120.88 70.37 18.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.175 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.09 60.54 1.33 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.768 2.312 . . . . 0.0 111.812 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.9 p -60.16 -26.56 66.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.357 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 25' ' ' SER . 88.5 mttt -112.2 30.42 7.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.442 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 24' ' ' LYS . 0.5 OUTLIER 68.72 163.5 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.615 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -69.01 163.39 24.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.53 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 165' ' ' ASN . 80.7 m-20 -91.53 144.35 25.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.394 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -140.52 154.67 46.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' A' ' 51' ' ' LEU . . . -156.77 150.23 21.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.497 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 69.2 mtm -113.99 168.82 9.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -1.105 . . . . 0.0 109.432 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -152.96 115.45 0.68 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.529 ' CD1' ' CD1' ' A' ' 49' ' ' ILE . 5.4 mp -125.87 118.9 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.132 . . . . 0.0 109.253 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.488 ' CG2' ' HG2' ' A' ' 46' ' ' GLN . 10.3 p -118.63 151.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.72 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.632 ' ND1' ' CE2' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -104.11 136.95 42.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 109.253 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.55 158.4 34.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.624 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.447 ' HB ' HD12 ' A' ' 44' ' ' LEU . 14.4 t -125.58 164.42 20.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 109.384 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.574 ' CE2' ' HE1' ' A' ' 3' ' ' MET . 86.5 m-85 -116.68 8.38 13.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.184 -0.947 . . . . 0.0 109.619 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.563 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.65 -179.42 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 108.946 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.8 Cg_endo -65.95 -5.12 11.39 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.08 1.853 . . . . 0.0 111.749 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -125.84 106.02 9.37 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.639 ' CE1' ' CG1' ' A' ' 145' ' ' ILE . 78.9 t80 -73.74 122.89 23.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.196 -0.94 . . . . 0.0 109.531 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -168.0 117.78 0.79 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.88 . . . . 0.0 109.203 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.512 ' CG1' HD11 ' A' ' 152' ' ' LEU . 1.4 m -47.94 123.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -0.93 . . . . 0.0 109.399 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 5.8 mp -65.68 -38.31 88.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.661 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 46' ' ' GLN . 57.2 t-20 -175.27 155.02 1.82 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 109.88 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 89.8 mt-30 -112.37 150.55 30.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.809 . . . . 0.0 108.892 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.1 t-105 -128.78 131.16 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.989 . . . . 0.0 109.664 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -122.39 133.36 54.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.412 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.529 ' CD1' ' CD1' ' A' ' 32' ' ' ILE . 3.6 mp -134.1 88.42 31.43 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.88 139.22 39.28 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.728 2.286 . . . . 0.0 111.728 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.549 ' CD1' ' N ' ' A' ' 51' ' ' LEU . 3.0 mp -106.04 147.88 28.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.21 -67.58 1.08 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -104.89 60.87 0.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -1.145 . . . . 0.0 109.502 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.456 ' HB2' ' CB ' ' A' ' 51' ' ' LEU . 78.0 m80 -133.16 173.06 11.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.9 t -117.11 173.16 6.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 109.474 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -55.91 -45.54 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.849 . . . . 0.0 109.261 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 60' ' ' GLU . 85.6 mt-30 -58.36 -63.82 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.416 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.439 ' HE2' ' CD2' ' A' ' 54' ' ' HIS . 97.9 mtp -43.55 -29.2 0.45 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.485 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.44 -29.17 30.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.372 -0.83 . . . . 0.0 109.611 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 57' ' ' GLN . 62.7 mm-40 -71.08 -34.81 71.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.605 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 13.4 tt -82.1 -34.65 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 109.609 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.497 ' CB ' ' SD ' ' A' ' 30' ' ' MET . . . -69.61 -26.09 64.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.401 ' N ' ' SD ' ' A' ' 30' ' ' MET . . . -67.09 -36.45 82.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.414 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.524 ' CG2' HG21 ' A' ' 87' ' ' VAL . 84.9 t -75.57 -36.67 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 77.6 tt0 -70.4 -37.17 74.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.122 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.508 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 26.1 t80 -60.86 -66.33 0.55 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.398 -0.814 . . . . 0.0 109.508 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 32' ' ' ILE . . . -54.66 -31.15 57.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.456 ' O ' HD13 ' A' ' 130' ' ' ILE . 33.3 t -55.2 -57.63 10.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 31.9 tttt -63.7 -38.88 92.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.508 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 17.6 mmtt -59.84 -32.89 71.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.907 . . . . 0.0 109.47 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' LEU . . . -71.22 -59.8 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.291 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.444 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 25.8 tp -45.18 -47.27 12.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.278 -0.889 . . . . 0.0 109.296 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 57.4 mttm -44.13 -48.79 9.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.195 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 4.8 mt -54.65 141.91 54.34 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.056 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.5 Cg_endo -66.07 -7.33 16.75 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.525 2.15 . . . . 0.0 111.483 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.94 161.19 21.88 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 48.0 Cg_endo -69.05 146.67 65.34 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.437 2.091 . . . . 0.0 111.747 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.569 HG12 ' CE1' ' A' ' 10' ' ' PHE . 25.4 t -134.78 159.36 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.335 -0.853 . . . . 0.0 109.562 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.572 HD12 ' CE2' ' A' ' 6' ' ' TYR . 7.1 mp -109.02 132.41 54.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.542 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.5 t -103.18 133.15 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.203 -0.936 . . . . 0.0 109.433 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.562 HG13 ' CE1' ' A' ' 11' ' ' TYR . 21.2 mm -106.13 132.52 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.366 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -133.42 161.71 33.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.529 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -92.7 6.99 45.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.516 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.522 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 41.3 t -130.28 123.76 30.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.918 . . . . 0.0 109.603 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.618 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 40.3 p90 -77.05 -43.0 36.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.535 ' N ' ' CG ' ' A' ' 85' ' ' PHE . 69.9 t80 -47.16 -50.25 20.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.88 . . . . 0.0 109.447 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.524 HG21 ' CG2' ' A' ' 64' ' ' VAL . 7.2 p -66.71 -47.76 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.343 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.476 ' N ' HG12 ' A' ' 87' ' ' VAL . . . -54.04 -46.96 72.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.26 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 98.2 mt-10 -65.22 -35.47 81.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.331 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.575 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 68.3 m -52.74 -44.48 66.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.472 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.517 ' O ' ' CD1' ' A' ' 124' ' ' LEU . . . -96.43 -0.89 48.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 51.7 t30 -92.56 -72.74 0.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.031 . . . . 0.0 109.751 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 48.2 mttm -126.64 -27.67 3.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 87.3 mt-10 -61.23 -31.46 71.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.871 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.495 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.6 OUTLIER -56.05 -60.2 9.56 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.681 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 45.6 Cg_endo -67.4 -34.55 26.3 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.727 2.285 . . . . 0.0 111.702 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -68.59 -36.45 78.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.227 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.564 ' CD2' HD21 ' A' ' 111' ' ' LEU . 13.8 m0 -65.05 -47.45 77.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.55 ' HG2' ' CE1' ' A' ' 103' ' ' PHE . 87.6 mttt -43.03 -43.97 4.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.865 . . . . 0.0 109.436 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.5 p -63.49 -34.81 78.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.387 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 98' ' ' TRP . 19.9 m120 -84.58 7.84 18.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 82.77 30.49 32.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.55 ' CE1' ' HG2' ' A' ' 99' ' ' LYS . 56.4 m-85 64.29 27.3 13.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -1.182 . . . . 0.0 109.493 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 101' ' ' ASN . 9.9 p -125.52 125.63 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.471 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -59.59 -35.76 74.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.421 ' O ' ' O ' ' A' ' 109' ' ' LYS . 43.0 t-20 -173.39 150.05 1.8 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -57.71 -26.59 61.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.537 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -65.3 -36.07 82.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.423 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 106' ' ' ASN . 5.5 mttt -148.06 143.43 17.63 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 50.3 Cg_endo -70.29 151.5 66.07 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.646 2.23 . . . . 0.0 111.915 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.564 HD21 ' CD2' ' A' ' 98' ' ' TRP . 20.6 tp -57.06 -37.96 72.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.434 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 83.7 mttt 62.74 139.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.56 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 54.0 m80 65.52 26.51 11.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -0.819 . . . . 0.0 109.637 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.46 HG12 ' HB3' ' A' ' 111' ' ' LEU . 66.6 mt -64.29 -42.47 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.274 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -53.84 -46.23 71.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.161 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -58.51 -42.07 86.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.854 . . . . 0.0 109.251 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.605 ' CZ2' ' CD1' ' A' ' 61' ' ' ILE . 16.3 m95 -67.67 -34.14 76.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.45 ' HE3' ' CG2' ' A' ' 114' ' ' ILE . 62.3 mttt -60.12 -36.37 77.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.332 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.428 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 25.3 m -66.28 -44.4 83.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.338 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.466 HD12 ' HB3' ' A' ' 91' ' ' ALA . 74.4 mt -66.64 -38.73 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.426 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.21 -35.88 80.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.387 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 126' ' ' MET . 82.9 tt0 -54.12 -39.84 66.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.872 . . . . 0.0 109.398 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.9 m -77.39 -46.5 22.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 0.0 109.4 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 59.9 mt -61.42 -36.83 81.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.417 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.5 m -60.53 -34.13 73.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.402 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 89.3 mtp -64.17 -30.77 71.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.915 . . . . 0.0 109.511 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 176.27 136.32 0.19 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.532 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.58 -0.09 7.06 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.74 2.293 . . . . 0.0 111.805 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.479 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 93.6 m-20 -50.2 -21.57 1.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 68' ' ' CYS . 68.0 mt -81.15 114.52 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.64 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 55.6 m -112.17 135.28 53.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.498 ' CD1' ' HB2' ' A' ' 91' ' ' ALA . 75.6 mt -116.57 138.75 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.105 -0.997 . . . . 0.0 109.682 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.51 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 94.7 mt-30 -124.68 159.45 30.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.618 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 19.8 t-80 -119.54 142.18 48.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.499 ' HG3' ' CG2' ' A' ' 81' ' ' ILE . 92.9 mt-10 -106.0 145.06 31.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.451 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HB2' ' HG2' ' A' ' 139' ' ' GLN . 80.8 mttt -92.6 37.86 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.69 -107.84 1.31 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -95.93 102.16 13.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -1.169 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.42 ' HB2' ' HD2' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -149.34 158.21 38.49 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.414 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 139' ' ' GLN . 50.2 Cg_endo -70.25 126.46 13.01 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.742 2.295 . . . . 0.0 111.854 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.1 m -122.33 144.75 48.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -52.65 -34.53 51.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.435 ' OG1' HG23 ' A' ' 145' ' ' ILE . 28.0 p -126.55 150.95 48.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 109.493 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.1 p -91.97 2.34 56.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.649 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.639 ' CG1' ' CE1' ' A' ' 41' ' ' TYR . 20.7 tt -69.62 -33.04 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.554 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.433 ' N ' HG22 ' A' ' 145' ' ' ILE . 97.2 m-70 -69.71 -29.88 67.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.605 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.8 m -67.18 -42.98 83.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.506 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.449 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 97.9 mt-10 -60.06 -36.66 77.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.51 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -69.3 -24.85 75.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -75.52 -33.88 60.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -1.118 . . . . 0.0 109.471 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -74.74 -41.45 60.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.512 HD11 ' CG1' ' A' ' 43' ' ' VAL . 68.9 mt -64.87 -38.2 90.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 0.0 109.55 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.13 -39.58 75.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -65.84 -39.38 90.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.125 -0.984 . . . . 0.0 109.464 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 66.8 mttm -64.85 -35.41 81.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.55 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 39.9 mt -68.19 -40.26 82.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 109.58 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.439 ' HB3' ' OG ' ' A' ' 15' ' ' SER . . . -64.98 -43.42 92.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.52 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 38.4 m -58.38 -44.06 88.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.519 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -61.94 -37.08 83.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.534 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.0 -48.2 84.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 164' ' ' VAL . 85.8 p -64.84 -33.45 76.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -1.148 . . . . 0.0 109.59 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -63.44 -38.41 91.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 68.7 t -57.06 -38.17 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 161' ' ' SER . 41.2 t -105.37 134.69 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.517 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.509 ' HA ' ' ND2' ' A' ' 27' ' ' ASN . 84.4 m-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.453 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.19 146.23 44.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -1.16 . . . . 0.0 109.415 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.551 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 56.8 mtp -66.29 -28.12 68.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.37 -14.87 43.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 95.3 mt-30 -57.83 -44.49 86.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.177 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.628 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 49.5 p90 -91.75 154.41 18.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.481 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' HG2' HG22 ' A' ' 74' ' ' ILE . 2.6 pp20? -89.54 -27.08 20.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.589 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.463 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -161.4 -174.61 31.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.576 HG21 ' CZ ' ' A' ' 11' ' ' TYR . 14.6 p -130.43 143.7 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -1.141 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CE2' ' CE1' ' A' ' 34' ' ' HIS . 26.5 m-85 -119.44 123.6 44.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.932 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.576 ' CZ ' HG21 ' A' ' 9' ' ' VAL . 87.7 m-85 -105.81 130.83 53.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 15.8 p -119.93 150.75 39.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.508 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 57.3 t0 -142.64 151.47 41.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -133.64 119.19 2.24 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.6 m -127.85 152.22 48.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -1.172 . . . . 0.0 109.5 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 27' ' ' ASN . . . -137.62 156.05 48.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 109.453 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.9 mt -123.7 140.84 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.928 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -107.21 132.66 52.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.52 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.493 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -119.31 162.05 33.98 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.235 -0.916 . . . . 0.0 109.33 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.94 -45.81 1.36 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.724 2.282 . . . . 0.0 111.765 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.469 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -56.79 -60.48 9.28 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.501 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.493 ' CG ' ' HB2' ' A' ' 19' ' ' SER . 50.6 Cg_endo -71.26 66.66 2.7 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.626 2.217 . . . . 0.0 111.626 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 m -54.81 -50.07 69.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.388 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -97.64 29.08 3.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.388 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.511 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 75.8 m -146.29 146.94 30.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.938 . . . . 0.0 109.532 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 25' ' ' SER . 12.2 m120 -143.39 152.99 42.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 70.3 m-20 -86.63 145.19 26.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -140.29 150.22 43.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.93 165.24 30.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.496 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 56.0 mtm -132.7 152.79 51.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -1.109 . . . . 0.0 109.291 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.37 125.22 2.97 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.513 HG13 ' CD2' ' A' ' 66' ' ' PHE . 19.1 mm -111.08 142.51 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -1.154 . . . . 0.0 109.301 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.3 t -136.64 123.52 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.159 -0.963 . . . . 0.0 109.756 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.576 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 23.6 t60 -101.01 138.27 38.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.141 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.25 163.18 33.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 109.836 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.0 t -123.16 164.96 17.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.415 -0.803 . . . . 0.0 109.172 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.572 ' CD1' ' OH ' ' A' ' 6' ' ' TYR . 83.8 m-85 -103.49 9.47 37.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.094 -1.004 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 2.0 mtmt -51.21 -179.25 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.8 Cg_endo -65.13 -5.78 11.7 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.039 1.826 . . . . 0.0 111.649 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -127.28 105.74 8.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.339 -0.85 . . . . 0.0 108.741 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -74.01 126.81 31.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.43 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -167.33 148.3 5.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 109.589 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.444 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 10.6 m -71.47 121.96 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.365 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.549 HD13 ' CD2' ' A' ' 34' ' ' HIS . 41.0 mt -65.06 -43.95 90.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.327 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 76.8 m-20 -159.17 147.79 18.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.377 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.517 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 90.6 mt-30 -106.85 144.26 33.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.402 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.81 138.53 45.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 0.0 109.714 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.5 p -130.85 144.87 51.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.353 -0.842 . . . . 0.0 109.273 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.449 ' HB ' ' HE1' ' A' ' 30' ' ' MET . 4.7 mp -138.35 97.28 9.55 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.554 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.81 137.43 32.38 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.641 2.227 . . . . 0.0 111.711 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 39.4 mt -103.67 141.02 36.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.63 -66.54 0.94 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -115.58 61.12 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.154 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 74.7 m80 -130.26 -176.66 4.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.409 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.449 HG21 ' HG3' ' A' ' 58' ' ' MET . 15.3 t -126.96 168.01 15.1 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.898 . . . . 0.0 109.542 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.69 -36.59 62.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.512 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -60.9 -41.06 95.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.449 ' HG3' HG21 ' A' ' 55' ' ' THR . 65.6 mtt -65.62 -32.95 74.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.455 ' O ' ' HB1' ' A' ' 63' ' ' ALA . . . -66.91 -34.05 76.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.596 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.78 -41.69 68.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.885 . . . . 0.0 109.582 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.497 HG23 ' N ' ' A' ' 62' ' ' ALA . 17.9 tt -73.71 -34.77 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.633 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.497 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -75.82 -30.13 58.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 59' ' ' ALA . . . -65.27 -39.71 92.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 87' ' ' VAL . 89.7 t -73.26 -40.4 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.636 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.446 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 83.7 tt0 -68.72 -40.06 80.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 109.231 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.63 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 31.3 t80 -52.37 -64.15 0.91 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 109.634 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.425 ' HB2' ' CG1' ' A' ' 80' ' ' VAL . . . -62.75 -27.63 69.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.675 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.449 ' O ' HD13 ' A' ' 130' ' ' ILE . 48.8 t -58.1 -58.05 10.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.543 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.442 ' HG2' ' SG ' ' A' ' 123' ' ' CYS . 40.3 mttt -61.11 -46.42 90.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.571 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.63 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 65.2 mttm -63.95 -33.99 76.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.35 -60.25 3.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.512 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 126' ' ' MET . 18.8 tp -57.66 -36.01 71.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -51.81 -43.46 63.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -0.918 . . . . 0.0 109.369 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 35.5 mm -48.36 143.04 7.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.898 . . . . 0.0 108.886 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.6 Cg_endo -64.36 -6.06 11.04 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.541 2.161 . . . . 0.0 111.724 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.23 171.73 23.53 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 48.3 Cg_endo -69.04 134.49 29.63 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.449 2.099 . . . . 0.0 111.676 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.565 HG12 ' CE2' ' A' ' 10' ' ' PHE . 32.1 t -127.41 167.67 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 109.26 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.628 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 3.9 mt -125.87 127.58 46.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.291 -0.881 . . . . 0.0 109.78 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 10' ' ' PHE . 34.7 t -101.44 133.01 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 109.235 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.451 HG12 ' HB2' ' A' ' 133' ' ' GLN . 23.5 mt -117.04 134.13 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.5 t -142.81 159.96 41.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.248 -0.907 . . . . 0.0 109.503 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 50.6 p-10 -83.9 -4.65 58.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.516 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.51 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 63.5 m -77.95 97.23 5.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.386 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.574 ' HA ' ' CD2' ' A' ' 134' ' ' HIS . 97.6 m-85 -64.16 -49.57 71.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 109.381 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -63.23 -52.25 62.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.65 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.52 HG12 ' CG2' ' A' ' 64' ' ' VAL . 38.8 t -55.88 -59.9 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.923 . . . . 0.0 109.591 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.544 ' CB ' ' CD2' ' A' ' 134' ' ' HIS . . . -43.57 -57.62 3.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.436 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 98.0 mt-10 -53.98 -40.74 67.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.463 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.567 ' CB ' ' CZ3' ' A' ' 117' ' ' TRP . 50.0 m -47.26 -52.13 16.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.492 ' HB1' ' CD1' ' A' ' 132' ' ' ILE . . . -89.7 -0.98 57.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.673 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 44.5 t-20 -82.14 -72.67 0.43 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.652 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 96.3 mttt -126.5 -22.7 3.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.075 -1.016 . . . . 0.0 110.062 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 96.3 mt-10 -67.13 -25.6 66.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.039 . . . . 0.0 109.66 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.513 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -54.57 -58.77 12.62 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.598 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 45.9 Cg_endo -67.16 -32.31 34.16 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.554 2.169 . . . . 0.0 111.464 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -66.01 -40.21 90.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 108.982 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.565 ' CE2' HD11 ' A' ' 111' ' ' LEU . 39.8 m0 -62.74 -50.48 70.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -0.766 . . . . 0.0 109.192 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.633 ' CD ' ' CZ ' ' A' ' 103' ' ' PHE . 22.6 tptm -43.03 -42.9 4.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.336 -0.852 . . . . 0.0 109.364 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 m -60.13 -39.18 85.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.375 -0.828 . . . . 0.0 109.361 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 98' ' ' TRP . 21.7 m120 -87.48 11.43 14.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.449 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 76.04 38.6 34.87 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.633 ' CZ ' ' CD ' ' A' ' 99' ' ' LYS . 75.0 m-85 63.7 32.35 13.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -1.174 . . . . 0.0 109.418 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.409 ' HA ' ' HB2' ' A' ' 111' ' ' LEU . 45.2 t -128.64 123.13 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.491 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -59.6 -39.97 85.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.513 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 109' ' ' LYS . 41.7 t-20 -160.36 145.59 14.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -58.59 -23.22 58.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.315 -0.866 . . . . 0.0 109.425 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.27 -37.77 86.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.923 . . . . 0.0 109.391 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.451 ' O ' ' O ' ' A' ' 106' ' ' ASN . 0.3 OUTLIER -144.17 148.69 42.4 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.56 154.97 64.2 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.682 2.255 . . . . 0.0 111.777 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' A' ' 98' ' ' TRP . 33.2 tp -62.4 -31.32 71.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.373 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.557 ' HE3' ' CE1' ' A' ' 113' ' ' HIS . 51.9 tttp 67.11 140.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.475 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.557 ' CE1' ' HE3' ' A' ' 112' ' ' LYS . 59.4 m80 62.35 27.81 16.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.399 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.486 HG22 HD12 ' A' ' 114' ' ' ILE . 77.1 mt -60.96 -41.21 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 109.436 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.9 m -55.47 -46.55 76.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.4 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -60.37 -47.06 87.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.502 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.567 ' CZ3' ' CB ' ' A' ' 90' ' ' SER . 88.1 m95 -68.03 -33.61 74.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -56.21 -44.28 79.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.481 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.446 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 36.2 m -58.2 -43.4 87.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.444 HG12 ' HG3' ' A' ' 65' ' ' GLU . 78.0 mt -66.38 -40.13 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.978 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.46 ' HB1' ' CD1' ' A' ' 95' ' ' LEU . . . -62.98 -35.27 79.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.44 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -56.65 -35.48 68.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.442 ' SG ' ' HG2' ' A' ' 69' ' ' LYS . 77.7 m -80.02 -49.2 12.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.422 HD22 HD11 ' A' ' 130' ' ' ILE . 51.9 mt -57.98 -37.0 73.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 25.5 m -58.77 -33.42 70.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.33 -0.856 . . . . 0.0 109.501 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.463 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 90.0 mtp -63.9 -37.67 88.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 177.3 143.44 0.26 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.1 Cg_endo -69.65 -1.35 8.23 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.722 2.281 . . . . 0.0 111.749 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.452 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 88.3 m-20 -43.4 -35.22 1.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.441 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 68' ' ' CYS . 67.5 mt -69.74 121.47 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.421 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.518 ' HB ' ' CD2' ' A' ' 79' ' ' LEU . 23.8 m -119.06 143.48 47.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.369 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.492 ' CD1' ' HB1' ' A' ' 91' ' ' ALA . 70.6 mt -122.78 130.72 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.451 ' HB2' HG12 ' A' ' 81' ' ' ILE . 89.9 mt-30 -125.01 153.54 42.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.392 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.574 ' CD2' ' HA ' ' A' ' 85' ' ' PHE . 37.3 m170 -89.74 133.33 34.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.605 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.96 140.38 52.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.799 . . . . 0.0 109.519 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 137' ' ' GLY . 40.1 mttm -87.89 69.25 9.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 109.419 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -43.8 -88.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.517 ' O ' ' CB ' ' A' ' 139' ' ' GLN . 43.2 m80 -127.97 137.51 52.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.181 -1.188 . . . . 0.0 109.506 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.578 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.7 OUTLIER 164.29 -65.66 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 139' ' ' GLN . 48.2 Cg_endo -72.02 -59.84 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.587 2.191 . . . . 0.0 111.924 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.432 HG21 ' C ' ' A' ' 140' ' ' PRO . 48.8 p -136.63 173.98 11.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.344 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -64.2 -40.21 95.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.296 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.418 ' O ' ' OG1' ' A' ' 141' ' ' THR . 17.7 p -134.31 160.88 36.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 109.289 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.46 ' OG ' ' OG1' ' A' ' 147' ' ' THR . 56.6 p -146.01 162.3 38.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.566 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 145' ' ' ILE . 80.6 mt -56.29 -46.29 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.535 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -66.57 -24.74 66.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.471 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.46 ' OG1' ' OG ' ' A' ' 144' ' ' SER . 95.2 m -58.56 -42.86 88.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -52.36 -45.25 65.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.595 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.41 -36.96 91.25 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -65.1 -33.84 76.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -1.169 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -64.98 -52.29 57.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.475 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 6.9 mp -65.45 -46.73 78.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.592 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . . . -57.9 -40.53 80.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.533 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -63.17 -34.93 78.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 69.5 mttt -63.03 -43.5 98.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.511 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.517 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 6.4 mp -71.82 -37.18 70.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.55 -43.09 91.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 109.56 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 36.6 m -63.79 -41.37 97.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.605 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 163' ' ' VAL . 94.2 mt-30 -61.74 -35.73 78.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.575 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.57 -51.45 58.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 164' ' ' VAL . 25.0 m -64.56 -37.19 86.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -1.182 . . . . 0.0 109.672 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -64.1 -33.96 76.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 159' ' ' GLN . 45.8 t -65.86 -15.05 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 161' ' ' SER . 47.3 t -129.12 156.7 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.469 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 16.1 m120 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.57 157.6 6.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -1.19 . . . . 0.0 109.457 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.562 ' HE1' ' CE1' ' A' ' 37' ' ' TYR . 68.7 mtm -69.3 -41.4 76.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.36 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.577 ' HA3' ' CE2' ' A' ' 6' ' ' TYR . . . -120.51 24.82 7.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 95.1 mt-30 62.66 44.54 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -1.13 . . . . 0.0 109.752 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.63 ' CE2' ' CD2' ' A' ' 79' ' ' LEU . 17.8 m-85 -103.36 162.15 13.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.272 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.424 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 77.1 mm-40 -69.58 -33.94 73.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 108.931 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.27 -168.75 38.77 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.51 ' CG1' ' HB2' ' A' ' 35' ' ' ALA . 7.8 p -123.0 145.19 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.241 -1.153 . . . . 0.0 109.115 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.687 ' CE2' ' CD2' ' A' ' 34' ' ' HIS . 9.4 m-85 -122.48 137.42 54.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 109.859 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -118.24 126.75 52.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.317 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.461 ' CG2' HD13 ' A' ' 32' ' ' ILE . 27.5 p -117.75 144.22 45.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 43.8 t0 -143.2 149.92 38.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.407 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -129.69 123.18 4.01 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m -129.36 147.75 51.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -1.102 . . . . 0.0 109.313 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.473 ' CA ' ' O ' ' A' ' 27' ' ' ASN . . . -137.81 151.8 48.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -0.96 . . . . 0.0 109.628 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 20.4 mt -120.23 149.06 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.855 . . . . 0.0 109.262 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -108.61 146.66 33.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.11 -0.994 . . . . 0.0 109.666 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.545 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.7 OUTLIER -94.48 179.95 1.11 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 0.0 109.053 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 50.5 Cg_endo -71.27 -23.71 23.94 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.233 1.955 . . . . 0.0 111.614 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.405 ' N ' ' HD3' ' A' ' 22' ' ' PRO . 1.3 m-20 -131.83 62.74 65.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 109.078 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 19' ' ' SER . 55.4 Cg_endo -81.87 62.67 8.24 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.768 2.312 . . . . 0.0 112.004 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.511 ' O ' ' CG ' ' A' ' 24' ' ' LYS . 48.8 m -55.06 -44.32 74.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.202 -0.936 . . . . 0.0 109.151 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 23' ' ' THR . 35.9 mttp -159.9 38.33 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 109.384 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 39.8 t -149.55 135.5 18.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 109.577 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 25' ' ' SER . 97.1 m-20 -143.41 155.51 44.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.4 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.473 ' O ' ' CA ' ' A' ' 16' ' ' ALA . 85.5 m-20 -83.31 137.22 34.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -137.81 151.25 47.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.417 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' A' ' 51' ' ' LEU . . . -154.3 162.6 30.7 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.511 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 74.0 mtm -127.41 168.52 14.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -1.121 . . . . 0.0 109.479 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -152.96 113.76 0.59 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' TRP . 10.9 mm -119.44 114.09 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.166 . . . . 0.0 109.338 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.53 ' CG2' ' HG2' ' A' ' 46' ' ' GLN . 7.5 p -118.52 148.01 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.2 -0.938 . . . . 0.0 109.691 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.687 ' CD2' ' CE2' ' A' ' 10' ' ' PHE . 7.4 m170 -101.62 145.01 29.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 109.118 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.51 ' HB2' ' CG1' ' A' ' 9' ' ' VAL . . . -136.9 166.81 22.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.109 -0.995 . . . . 0.0 109.677 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.472 ' HB ' HD11 ' A' ' 44' ' ' LEU . 9.9 t -123.24 165.41 16.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.352 -0.842 . . . . 0.0 109.458 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.562 ' CE1' ' HE1' ' A' ' 3' ' ' MET . 55.2 m-85 -105.94 10.84 32.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.539 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 3.1 mtpt -51.18 178.76 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.839 . . . . 0.0 109.103 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.5 Cg_endo -65.09 -6.19 12.47 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.187 1.925 . . . . 0.0 111.663 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -131.23 106.28 8.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 108.982 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 48.9 t80 -58.54 127.62 33.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 81.2 mt-30 -159.45 141.92 13.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.51 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.417 ' HB ' ' CG2' ' A' ' 33' ' ' VAL . 25.0 m -78.93 122.38 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 34' ' ' HIS . 7.4 mp -67.09 -42.96 83.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 29.8 m120 -160.41 149.95 17.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.53 ' HG2' ' CG2' ' A' ' 33' ' ' VAL . 90.2 mt-30 -110.22 150.93 27.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.199 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.7 t-105 -133.31 137.16 45.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.005 . . . . 0.0 109.8 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.1 t -125.74 132.56 52.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.213 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.572 HD12 ' CD1' ' A' ' 66' ' ' PHE . 6.1 mt -135.53 89.8 21.49 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.951 . . . . 0.0 109.702 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.3 Cg_endo -71.05 144.57 47.54 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 122.63 2.22 . . . . 0.0 111.596 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 51' ' ' LEU . 3.7 mp -110.93 147.86 33.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.588 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.74 -75.59 1.26 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -98.56 61.74 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.127 . . . . 0.0 109.448 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.493 ' CB ' HD21 ' A' ' 51' ' ' LEU . 76.6 m80 -131.62 -177.56 4.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.938 . . . . 0.0 109.529 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 57' ' ' GLN . 15.3 t -128.22 166.84 17.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 0.0 109.5 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -48.13 -44.73 32.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.94 . . . . 0.0 109.331 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 60' ' ' GLU . 86.2 mt-30 -55.2 -58.17 8.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.303 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.446 ' SD ' ' HA ' ' A' ' 54' ' ' HIS . 62.1 mtt -44.81 -34.62 2.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.266 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.4 -31.51 60.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.319 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 57' ' ' GLN . 96.5 mt-10 -72.66 -38.35 67.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.327 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.46 ' HA ' ' CG2' ' A' ' 87' ' ' VAL . 7.3 tt -81.53 -38.47 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.511 ' CB ' ' SD ' ' A' ' 30' ' ' MET . . . -66.06 -36.48 83.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.352 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.91 -48.18 76.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.367 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.471 HG21 ' CG1' ' A' ' 87' ' ' VAL . 78.4 t -64.04 -48.98 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.8 tt0 -58.24 -43.94 88.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.572 ' CD1' HD12 ' A' ' 49' ' ' ILE . 13.0 t80 -54.63 -68.12 0.21 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.37 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' HB3' HG13 ' A' ' 80' ' ' VAL . . . -56.48 -19.21 14.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.204 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.464 ' SG ' ' CG2' ' A' ' 120' ' ' ILE . 19.3 t -66.46 -64.94 0.75 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.269 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -58.66 -46.38 87.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -58.36 -30.08 66.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.907 . . . . 0.0 109.263 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.564 ' CB ' ' CG1' ' A' ' 78' ' ' VAL . . . -67.35 -63.87 0.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.562 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 22.8 tp -50.18 -44.06 52.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.173 -0.954 . . . . 0.0 109.334 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 72' ' ' LEU . 26.4 tttt -43.27 -48.71 6.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.1 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 10.6 mt -48.4 143.19 7.58 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.369 -0.832 . . . . 0.0 108.879 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 45.5 Cg_endo -66.36 -2.25 6.85 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.625 2.217 . . . . 0.0 112.124 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -139.98 167.9 25.24 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.45 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 47.7 Cg_endo -68.94 116.74 4.62 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.446 2.097 . . . . 0.0 111.578 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.593 ' CG2' ' CD1' ' A' ' 10' ' ' PHE . 6.5 p -109.25 148.53 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.349 -0.845 . . . . 0.0 109.403 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.63 ' CD2' ' CE2' ' A' ' 6' ' ' TYR . 7.4 mp -96.31 138.87 33.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 67' ' ' ALA . 29.9 t -115.78 135.13 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.371 -0.831 . . . . 0.0 109.149 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.525 ' CG2' ' HG3' ' A' ' 135' ' ' GLU . 15.0 mt -122.44 136.85 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.602 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 t -139.1 160.33 40.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.341 -0.849 . . . . 0.0 109.316 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -81.59 -13.07 58.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.924 . . . . 0.0 109.564 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.46 ' OG ' ' HB3' ' A' ' 60' ' ' GLU . 29.5 m -93.15 115.62 28.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.571 ' HB2' ' CG ' ' A' ' 134' ' ' HIS . 46.4 t80 -81.4 -38.58 26.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.365 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -55.42 -46.71 76.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.54 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 88' ' ' ALA . 14.1 p -70.18 -46.49 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 109.499 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.474 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -56.57 -48.32 77.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.267 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -60.55 -37.34 80.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.537 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 50.2 m -52.47 -55.11 24.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.472 ' HB3' HD11 ' A' ' 124' ' ' LEU . . . -83.73 -0.89 52.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.903 . . . . 0.0 109.628 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 38.6 t-20 -83.15 -72.76 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.951 . . . . 0.0 109.729 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 87.0 mttt -126.71 -25.36 3.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 97.9 mt-10 -69.57 -24.47 63.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.131 -0.98 . . . . 0.0 109.731 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.529 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -54.58 -57.34 19.32 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.644 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 46.1 Cg_endo -67.47 -34.36 26.52 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.507 2.138 . . . . 0.0 111.663 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -65.82 -38.68 89.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.118 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.571 ' CE2' HD22 ' A' ' 111' ' ' LEU . 43.0 m0 -64.72 -49.75 69.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.34 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -47.93 -42.44 27.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -61.08 -38.57 86.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.897 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -87.85 11.6 15.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.49 41.71 50.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 111' ' ' LEU . 57.5 m-85 61.84 35.71 16.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.454 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.25 125.9 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 32.5 t30 -55.26 -42.47 73.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -177.07 -149.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.521 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -68.59 122.37 18.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.55 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.3 mttp 55.36 30.28 14.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.844 . . . . 0.0 109.533 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 105' ' ' ASN . 14.9 mttt -130.16 87.3 51.57 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.58 152.92 65.4 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.654 2.236 . . . . 0.0 111.804 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.571 HD22 ' CE2' ' A' ' 98' ' ' TRP . 96.4 mt -85.3 139.59 31.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -93.18 148.69 21.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.574 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 48.0 m80 61.53 34.44 17.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.489 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.423 HG12 ' HB2' ' A' ' 111' ' ' LEU . 69.7 mt -54.19 -45.39 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.423 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.6 m -50.82 -48.35 59.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.543 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.1 -35.94 76.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.48 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.537 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 20.1 m95 -70.45 -38.13 74.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 109.516 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -58.83 -39.4 81.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.426 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.6 m -62.51 -43.06 99.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.464 ' CG2' ' SG ' ' A' ' 68' ' ' CYS . 83.6 mt -71.72 -36.09 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.29 -34.95 79.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -56.06 -38.47 70.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 61.3 m -81.18 -49.37 10.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.877 . . . . 0.0 109.467 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' A' ' 91' ' ' ALA . 54.7 mt -60.52 -31.9 70.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.432 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.4 t -62.38 -33.0 73.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 94.9 mmm -64.73 -38.05 89.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.16 146.48 0.56 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.284 -0.885 . . . . 0.0 109.447 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 129' ' ' ASP . 50.1 Cg_endo -70.79 0.66 6.07 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.739 2.292 . . . . 0.0 111.899 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 88.8 m-20 -44.09 -50.53 8.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.398 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 58.3 mt -55.25 113.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.777 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.471 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 54.9 m -110.54 144.18 39.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 108.986 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 64.4 mt -124.29 141.45 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 109.83 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.438 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.4 mt-30 -128.58 159.56 35.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.389 -0.819 . . . . 0.0 109.184 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.571 ' CG ' ' HB2' ' A' ' 85' ' ' PHE . 32.2 t-80 -119.52 140.29 50.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 109.665 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.525 ' HG3' ' CG2' ' A' ' 81' ' ' ILE . 94.9 mt-10 -128.4 139.88 52.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.334 -0.854 . . . . 0.0 109.218 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 139' ' ' GLN . 72.1 mttt -104.46 121.81 44.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 0.0 109.482 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.0 -33.52 84.1 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -64.08 -43.77 94.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -1.186 . . . . 0.0 109.361 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 136' ' ' LYS . 15.8 tp60 -109.75 128.35 25.55 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.54 144.23 49.31 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.758 2.305 . . . . 0.0 111.776 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 143' ' ' THR . 21.1 p -73.7 171.85 12.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -56.04 -36.84 68.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 109.529 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.418 ' O ' ' OG1' ' A' ' 141' ' ' THR . 33.5 m -116.95 137.19 52.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.518 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 86.1 p -65.51 -23.75 66.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.161 -0.962 . . . . 0.0 109.435 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 41' ' ' TYR . 82.5 mt -52.49 -45.89 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.93 . . . . 0.0 109.514 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -65.84 -38.0 87.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.93 . . . . 0.0 109.429 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.5 p -68.79 -41.51 78.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 144' ' ' SER . 97.8 mt-10 -53.94 -38.48 64.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.48 -37.62 94.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -64.44 -42.93 95.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.289 -1.124 . . . . 0.0 109.431 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.5 64.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.867 . . . . 0.0 109.461 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.465 ' O ' HD11 ' A' ' 156' ' ' LEU . 64.5 mt -60.38 -48.84 80.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.823 . . . . 0.0 109.485 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . . . -52.76 -40.3 63.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.566 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.422 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 54.3 t0 -60.06 -49.32 78.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -52.89 -37.96 61.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.533 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.521 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 7.1 mp -69.37 -41.53 76.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 30' ' ' MET . . . -69.55 -44.99 69.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.562 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 33.6 m -58.81 -42.18 88.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.539 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -61.94 -39.47 92.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.501 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -62.0 -45.75 95.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.435 ' HA ' HG13 ' A' ' 164' ' ' VAL . 85.2 p -69.53 -25.75 64.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -1.184 . . . . 0.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -67.68 -36.34 80.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.504 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.3 t -72.91 -19.08 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.435 HG13 ' HA ' ' A' ' 161' ' ' SER . 14.8 p -113.93 134.37 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.524 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.454 ' HA ' ' ND2' ' A' ' 27' ' ' ASN . 44.2 t-20 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.64 70.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -1.139 . . . . 0.0 109.442 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.561 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 95.5 mmm -64.31 -38.65 91.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.83 -14.14 36.05 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -55.11 -26.29 37.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -1.17 . . . . 0.0 109.602 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.581 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 18.4 p90 -110.69 163.7 13.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 109.898 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -79.59 -45.14 19.71 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.422 -0.799 . . . . 0.0 108.996 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.45 ' O ' ' CG2' ' A' ' 78' ' ' VAL . . . -161.21 178.52 37.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 10' ' ' PHE . 67.9 t -129.73 146.27 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -1.14 . . . . 0.0 109.501 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.594 ' CE1' ' ND1' ' A' ' 34' ' ' HIS . 6.5 m-85 -118.4 155.39 30.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -118.03 123.17 45.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.332 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.509 ' CG2' HD13 ' A' ' 32' ' ' ILE . 24.2 p -117.06 145.78 43.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.551 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 56.7 t0 -143.99 152.98 41.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -137.33 117.08 1.46 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 29' ' ' GLY . 47.0 t -133.49 155.18 50.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.319 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HB3' ' CB ' ' A' ' 56' ' ' ALA . . . -137.95 158.68 43.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.595 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 65.0 mt -118.13 140.19 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -102.6 136.41 42.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.49 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -113.26 173.18 3.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 48.5 Cg_endo -68.9 -33.57 19.77 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.713 2.275 . . . . 0.0 111.709 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.26 71.04 33.96 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.316 -0.865 . . . . 0.0 109.345 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.34 54.3 1.0 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.71 2.273 . . . . 0.0 111.731 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.8 m -59.58 -31.64 69.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.873 . . . . 0.0 109.349 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 25' ' ' SER . 67.7 mttt -110.11 29.91 7.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.414 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 24' ' ' LYS . 1.0 OUTLIER 71.84 164.3 0.28 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.689 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 42.5 p-10 -64.18 163.6 12.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 109.487 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 19.9 m120 -94.36 125.94 39.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 0.0 109.367 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 51' ' ' LEU . . . -103.5 156.07 18.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.534 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -147.22 148.38 19.94 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.42 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 63.6 mtm -124.02 165.11 18.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -1.2 . . . . 0.0 109.573 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 32' ' ' ILE . . . -149.87 116.86 0.81 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.518 ' O ' ' CB ' ' A' ' 47' ' ' TRP . 15.1 mm -120.26 115.27 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -1.161 . . . . 0.0 109.486 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' CG2' ' HB ' ' A' ' 43' ' ' VAL . 12.3 p -118.76 148.39 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.498 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.594 ' ND1' ' CE1' ' A' ' 10' ' ' PHE . 9.4 t60 -101.16 137.23 39.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.556 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.485 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -122.23 158.16 30.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.494 ' HB ' ' CD1' ' A' ' 44' ' ' LEU . 12.0 t -125.11 162.23 25.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.877 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.57 ' CE2' ' OH ' ' A' ' 6' ' ' TYR . 58.5 m-85 -108.64 11.47 26.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.968 . . . . 0.0 109.618 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.539 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 5.3 mttt -51.21 178.74 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.0 Cg_endo -64.43 -6.05 11.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.185 1.924 . . . . 0.0 111.704 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.442 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 70.0 mm-40 -129.53 105.36 8.03 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.254 -0.904 . . . . 0.0 108.759 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -64.54 125.31 24.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.574 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -168.18 129.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.464 HG11 HD21 ' A' ' 152' ' ' LEU . 22.6 m -58.7 126.04 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.457 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.543 ' CD2' ' CD2' ' A' ' 34' ' ' HIS . 6.1 mp -67.33 -42.79 83.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.448 ' O ' HG21 ' A' ' 33' ' ' VAL . 77.9 m-20 -160.61 154.41 22.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.617 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.523 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 90.9 mt-30 -113.1 148.22 35.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 109.131 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CB ' ' O ' ' A' ' 32' ' ' ILE . 11.6 t-105 -127.34 138.88 53.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.105 -0.997 . . . . 0.0 109.843 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.5 m -126.96 136.73 52.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.118 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.417 HD12 ' HE1' ' A' ' 30' ' ' MET . 3.8 mt -144.03 92.05 6.38 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.733 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.1 Cg_endo -70.76 148.32 58.32 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.66 2.24 . . . . 0.0 111.557 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 51' ' ' LEU . 5.7 mp -119.65 145.5 46.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.95 -48.36 0.17 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -90.42 9.95 27.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -1.133 . . . . 0.0 109.393 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.446 ' HB3' ' SD ' ' A' ' 58' ' ' MET . 56.7 m80 -117.75 -176.08 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 0.0 109.522 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.8 t -124.49 166.36 16.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.493 ' CB ' ' HB3' ' A' ' 16' ' ' ALA . . . -46.21 -45.51 16.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 0.0 109.346 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 60' ' ' GLU . 84.6 mt-30 -54.38 -59.34 4.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 109.428 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.446 ' SD ' ' HB3' ' A' ' 54' ' ' HIS . 61.2 mtt -44.08 -33.98 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.444 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.416 ' HB2' ' CG ' ' A' ' 30' ' ' MET . . . -71.85 -31.45 66.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.27 -0.893 . . . . 0.0 109.389 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 57' ' ' GLN . 96.8 mt-10 -70.88 -33.61 70.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.446 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 7.1 tt -86.92 -30.84 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 109.341 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.42 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -74.95 -29.71 61.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.417 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 12' ' ' THR . . . -64.98 -39.07 92.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.478 ' CG2' HG21 ' A' ' 82' ' ' THR . 71.8 t -71.95 -45.6 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.489 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.3 tt0 -64.3 -37.01 85.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.6 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 13.7 t80 -56.07 -69.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB3' ' CG1' ' A' ' 80' ' ' VAL . . . -60.4 -15.82 29.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.903 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.438 ' O ' HD12 ' A' ' 130' ' ' ILE . 44.8 t -67.66 -63.92 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HG2' ' SG ' ' A' ' 123' ' ' CYS . 23.6 mttm -58.64 -44.54 90.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.6 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 66.5 mttm -63.51 -38.54 91.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.576 ' CB ' ' CG1' ' A' ' 78' ' ' VAL . . . -54.83 -61.62 2.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.534 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 9.1 tt -51.55 -45.33 62.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 72' ' ' LEU . 65.0 tttm -43.64 -42.41 5.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.175 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 48.4 mm -48.93 143.21 8.68 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.331 -0.856 . . . . 0.0 108.806 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.8 Cg_endo -63.7 -4.71 7.52 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.669 2.246 . . . . 0.0 112.311 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.06 171.8 24.81 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.489 ' HG2' ' HA ' ' A' ' 6' ' ' TYR . 43.9 Cg_endo -67.22 118.61 5.7 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.495 2.13 . . . . 0.0 111.684 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.578 HG22 ' CD1' ' A' ' 10' ' ' PHE . 9.0 p -114.67 151.43 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.394 -0.816 . . . . 0.0 109.266 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.581 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 12.2 mt -96.82 154.73 17.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.83 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 131' ' ' THR . 38.9 t -125.87 133.07 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.536 -0.727 . . . . 0.0 109.049 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.441 HG12 ' HB2' ' A' ' 133' ' ' GLN . 26.2 mt -120.04 133.8 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.61 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.478 HG21 ' CG2' ' A' ' 64' ' ' VAL . 7.1 t -136.5 161.72 35.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.511 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 13' ' ' ASP . 58.3 p30 -89.33 15.04 9.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.479 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 26.7 t -123.93 114.73 20.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.918 . . . . 0.0 109.487 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.573 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 61.3 t80 -77.16 -43.15 34.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.573 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -49.0 -48.26 43.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 88' ' ' ALA . 8.9 p -68.03 -45.36 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.593 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.504 ' N ' HG12 ' A' ' 87' ' ' VAL . . . -53.4 -49.69 66.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.925 . . . . 0.0 109.544 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 80.5 tt0 -60.55 -34.39 74.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.303 -0.873 . . . . 0.0 109.516 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.633 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 50.5 m -56.42 -55.87 28.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.728 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.522 ' HB1' ' CD1' ' A' ' 132' ' ' ILE . . . -82.02 -0.75 45.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 109.702 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 47.0 t-20 -84.66 -73.23 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 109.812 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 62.6 tttt -127.37 -30.98 2.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.092 -1.005 . . . . 0.0 109.924 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.582 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 58.9 mm-40 -56.75 -37.69 71.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.108 -0.995 . . . . 0.0 109.922 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -51.38 -61.56 3.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 109.628 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 45.5 Cg_endo -67.76 -27.19 38.12 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.571 2.18 . . . . 0.0 111.449 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.452 ' O ' ' OG ' ' A' ' 100' ' ' SER . 83.5 t80 -73.47 -34.99 65.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 108.983 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.582 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 15.8 m0 -66.96 -48.35 68.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.847 . . . . 0.0 109.19 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 98' ' ' TRP . 25.2 mttt -43.5 -40.59 3.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.427 -0.796 . . . . 0.0 109.363 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 97' ' ' TYR . 83.2 p -62.37 -39.83 94.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.311 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 98' ' ' TRP . 85.5 m-20 -85.79 10.58 13.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 109.379 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 80.04 38.16 19.9 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.517 ' O ' ' CB ' ' A' ' 111' ' ' LEU . 62.1 m-85 64.78 34.61 9.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -1.143 . . . . 0.0 109.393 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.514 ' CG1' ' HA ' ' A' ' 110' ' ' PRO . 50.5 t -122.25 123.07 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.497 ' HA ' ' NE1' ' A' ' 98' ' ' TRP . 32.2 t-20 -56.71 -49.27 75.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 109.364 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -148.59 160.59 42.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.422 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -65.1 -26.28 68.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -66.41 -43.51 85.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.31 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -139.15 146.54 49.64 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.367 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.514 ' HA ' ' CG1' ' A' ' 104' ' ' VAL . 49.8 Cg_endo -70.09 177.37 5.88 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.647 2.232 . . . . 0.0 111.805 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.575 HD21 ' CE3' ' A' ' 98' ' ' TRP . 19.2 tp -88.39 133.5 34.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.449 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 21.4 mttp -99.77 149.01 23.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 28.1 m80 68.75 31.76 4.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 109.553 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.416 HG23 ' HB3' ' A' ' 103' ' ' PHE . 75.8 mt -61.73 -41.36 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.296 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.9 m -53.27 -50.18 65.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 109.257 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -60.38 -38.4 83.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.334 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.633 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 25.3 m95 -72.35 -36.76 68.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -55.65 -44.97 77.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.325 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.2 m -60.41 -45.78 92.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.319 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.416 HG23 ' HB2' ' A' ' 91' ' ' ALA . 73.5 mt -69.34 -32.83 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.496 ' N ' HD23 ' A' ' 95' ' ' LEU . . . -60.91 -38.07 84.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.931 . . . . 0.0 109.4 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 126' ' ' MET . 96.2 mt-10 -61.7 -40.51 95.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.332 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.487 ' HB3' ' CD1' ' A' ' 130' ' ' ILE . 56.6 m -64.85 -51.02 64.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.492 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 3.4 tm? -65.02 -37.05 86.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.0 109.231 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.2 t -56.1 -36.11 67.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.446 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 65.4 mtt -64.25 -32.88 74.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.293 -0.88 . . . . 0.0 109.369 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 167.78 153.3 0.12 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.3 Cg_endo -71.39 0.36 6.94 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.621 2.214 . . . . 0.0 111.702 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 92.1 m-20 -43.07 -48.21 6.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.372 -0.83 . . . . 0.0 109.543 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 74.3 mt -65.38 122.12 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 80' ' ' VAL . 32.6 m -116.98 149.58 40.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.193 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.522 ' CD1' ' HB1' ' A' ' 91' ' ' ALA . 55.4 mt -127.01 132.69 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.134 -0.979 . . . . 0.0 109.712 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB2' HG12 ' A' ' 81' ' ' ILE . 86.4 mt-30 -118.09 159.39 23.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.17 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.573 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 28.2 t-80 -120.28 133.56 55.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.991 . . . . 0.0 109.683 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.427 ' HG3' HG23 ' A' ' 141' ' ' THR . 81.0 tt0 -94.19 145.61 24.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.419 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.492 ' CB ' ' HB2' ' A' ' 139' ' ' GLN . 59.3 mttp -90.41 29.32 1.29 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.499 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.41 -132.74 52.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -47.11 -46.43 22.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -1.172 . . . . 0.0 109.35 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 136' ' ' LYS . 3.7 mt-30 -46.38 141.95 4.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.94 148.84 64.77 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.705 2.27 . . . . 0.0 111.848 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.427 HG23 ' HG3' ' A' ' 135' ' ' GLU . 18.7 p -91.36 170.02 10.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.396 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -51.13 -35.82 37.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.421 HG23 ' HB ' ' A' ' 145' ' ' ILE . 33.4 m -125.63 134.01 52.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.549 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.9 p -63.6 -28.0 69.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.842 . . . . 0.0 109.47 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.421 ' HB ' HG23 ' A' ' 143' ' ' THR . 84.3 mt -61.08 -40.38 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.557 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -65.5 -29.41 70.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.155 -0.965 . . . . 0.0 109.529 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.5 m -64.93 -41.71 95.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.23 -41.33 75.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.07 -36.16 87.22 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -66.56 -38.13 86.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -1.159 . . . . 0.0 109.395 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.16 -53.07 62.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.462 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.464 HD21 HG11 ' A' ' 43' ' ' VAL . 6.8 mp -67.39 -46.41 73.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.348 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.28 -38.26 73.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.448 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 81.5 m-20 -63.11 -43.63 97.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.526 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.88 -41.61 78.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.535 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.523 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 6.8 mt -64.43 -41.21 96.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.935 . . . . 0.0 109.399 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.54 96.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 37.2 m -55.78 -45.81 78.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -62.32 -36.18 81.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -0.906 . . . . 0.0 109.482 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -53.31 -59.2 9.89 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.459 ' OG ' HD11 ' A' ' 17' ' ' ILE . 92.1 p -63.49 -33.63 75.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -1.135 . . . . 0.0 109.503 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -63.66 -37.37 87.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 71.5 t -57.41 -37.01 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.494 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 41.4 t -104.6 134.02 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 0.0 109.483 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.473 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.47 152.43 23.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -1.164 . . . . 0.0 109.545 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.563 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 29.3 mtm -63.92 -25.92 68.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -44.58 -30.56 2.2 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -50.62 -47.64 58.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.167 -1.196 . . . . 0.0 109.415 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.563 ' CE2' ' HA ' ' A' ' 3' ' ' MET . 36.6 m-85 -47.05 157.94 0.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 109.186 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 45.4 tp10 -66.75 -32.64 74.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.95 . . . . 0.0 109.043 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.0 -177.24 47.43 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.1 t -129.13 139.01 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -1.154 . . . . 0.0 109.232 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.668 ' CD2' ' CD2' ' A' ' 34' ' ' HIS . 6.9 m-85 -117.5 143.87 45.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.866 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CE2' ' CD1' ' A' ' 81' ' ' ILE . 92.7 m-85 -117.38 121.76 41.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.143 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.8 p -111.83 150.28 30.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.074 -1.016 . . . . 0.0 109.632 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.4 ' OD2' ' OD1' ' A' ' 154' ' ' ASP . 45.5 t0 -152.51 146.8 25.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.88 136.39 10.95 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 29' ' ' GLY . 17.9 t -138.69 142.69 38.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 109.612 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -135.01 150.13 50.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.291 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 27' ' ' ASN . 69.3 mt -116.58 136.6 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.672 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -118.24 152.48 35.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.286 -0.884 . . . . 0.0 109.071 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.496 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -118.84 173.7 3.23 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.443 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 45.2 Cg_endo -67.93 -41.07 8.25 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.56 2.174 . . . . 0.0 111.175 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -111.11 69.86 0.69 Allowed Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.88 58.73 0.55 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.873 2.382 . . . . 0.0 112.149 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.2 p -55.01 -21.29 11.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.176 -0.953 . . . . 0.0 108.838 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -126.99 -174.22 3.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 0.0 109.326 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.5 m -68.36 138.19 55.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 109.734 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 38.7 p-10 -51.74 168.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.184 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.503 ' OD1' ' ND2' ' A' ' 165' ' ' ASN . 23.5 m120 -85.8 139.09 31.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.164 -0.96 . . . . 0.0 109.555 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -125.32 151.36 46.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.933 . . . . 0.0 109.492 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -154.99 157.79 27.87 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.473 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 54.9 mtm -127.29 165.85 18.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.129 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 156' ' ' LEU . . . -156.82 124.68 1.47 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 32' ' ' ILE . 4.8 mp -116.89 142.36 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -1.163 . . . . 0.0 109.382 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.508 HG23 ' CA ' ' A' ' 153' ' ' ALA . 38.2 t -127.06 134.26 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 109.551 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.668 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 27.1 m170 -106.87 138.65 42.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.615 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.42 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -140.4 164.62 29.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 0.0 109.527 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.463 ' HB ' HD12 ' A' ' 44' ' ' LEU . 13.2 t -133.64 164.96 26.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.0 109.447 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.418 ' O ' ' O ' ' A' ' 38' ' ' LYS . 44.5 m-85 -103.32 11.09 37.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 109.575 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.552 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.26 179.73 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.185 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 44.8 Cg_endo -66.88 -5.64 13.87 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.203 1.935 . . . . 0.0 111.425 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' OE2' ' NE2' ' A' ' 42' ' ' GLN . 82.6 tt0 -132.74 105.49 7.2 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.377 -0.827 . . . . 0.0 108.947 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.451 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 43.1 t80 -64.28 122.01 15.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.49 ' NE2' ' OE2' ' A' ' 40' ' ' GLU . 66.5 mt-30 -159.0 136.38 9.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.124 -0.985 . . . . 0.0 109.753 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 37.5 t -62.5 125.99 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.893 . . . . 0.0 109.32 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 HD12 ' HB ' ' A' ' 36' ' ' THR . 7.4 mp -68.63 -38.69 80.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 109.336 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -175.62 155.04 1.68 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 109.343 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.511 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 94.0 mt-30 -110.01 138.4 46.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.456 ' HB3' HD11 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -122.75 125.95 46.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.676 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.2 m -121.14 138.91 53.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 109.271 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.47 ' HB ' ' HE3' ' A' ' 30' ' ' MET . 2.4 mp -133.67 96.22 16.87 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.94 129.84 18.09 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.667 2.245 . . . . 0.0 111.741 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 43.1 mt -108.39 145.36 34.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.331 -0.856 . . . . 0.0 109.384 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.33 -28.85 1.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.531 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 46.4 p-10 -121.94 34.67 5.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -1.213 . . . . 0.0 109.507 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.531 ' CE1' ' OD1' ' A' ' 53' ' ' ASN . 77.4 m80 -124.4 175.68 6.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 109.362 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.426 HG22 ' HE1' ' A' ' 58' ' ' MET . 14.4 t -123.03 169.44 11.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.63 -38.93 72.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.419 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.0 -54.45 44.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.458 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.455 ' O ' HG21 ' A' ' 61' ' ' ILE . 67.9 mtm -66.64 -30.32 70.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.551 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.7 86.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.459 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -64.28 -49.1 73.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.509 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.581 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 13.0 tt -64.59 -39.62 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.504 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -59.41 -31.41 69.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.535 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.45 97.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.481 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.518 ' CG2' HG23 ' A' ' 82' ' ' THR . 87.9 t -71.0 -38.67 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.47 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 86.4 tt0 -68.8 -39.05 80.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.106 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.526 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 22.3 t80 -61.17 -64.37 0.97 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.364 -0.835 . . . . 0.0 109.491 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 71' ' ' ALA . . . -58.26 -31.44 67.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.429 ' O ' HD11 ' A' ' 130' ' ' ILE . 24.3 t -53.43 -54.7 33.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.607 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -62.03 -45.48 93.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.526 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 68.9 mttm -67.36 -29.75 69.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.951 . . . . 0.0 109.308 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.521 ' HB1' ' CG1' ' A' ' 78' ' ' VAL . . . -62.24 -64.48 0.92 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 27.8 tp -55.57 -43.29 75.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.883 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' LEU . 16.2 tttt -43.22 -43.14 4.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.254 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 26.4 mm -48.2 143.45 6.94 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 108.855 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.8 Cg_endo -65.87 -3.16 7.72 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.512 2.141 . . . . 0.0 111.896 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -142.07 170.82 24.8 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 48.2 Cg_endo -69.2 122.82 9.66 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.366 2.044 . . . . 0.0 111.74 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.571 HG23 ' CD1' ' A' ' 10' ' ' PHE . 7.1 p -116.24 150.18 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.451 -0.781 . . . . 0.0 109.288 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.531 HD21 ' CD2' ' A' ' 6' ' ' TYR . 6.7 mp -97.8 130.7 44.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.909 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 132' ' ' ILE . 47.6 t -106.46 131.09 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.36 -0.837 . . . . 0.0 109.122 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.549 ' CD1' ' CE2' ' A' ' 11' ' ' TYR . 4.4 mt -115.15 144.29 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.159 -0.963 . . . . 0.0 109.666 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.518 HG23 ' CG2' ' A' ' 64' ' ' VAL . 0.8 OUTLIER -134.3 161.66 34.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 109.37 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -90.91 3.66 53.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.525 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.46 ' O ' HG13 ' A' ' 87' ' ' VAL . 20.2 t -122.93 125.55 45.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.539 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 65.8 t80 -75.1 -40.6 59.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.433 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -50.5 -56.76 10.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.472 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 64' ' ' VAL . 8.8 p -58.75 -47.69 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.364 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.462 ' O ' ' OD1' ' A' ' 92' ' ' ASN . . . -58.25 -57.21 13.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 0.0 109.204 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.485 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 85.3 tt0 -51.13 -30.81 17.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.615 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 37.1 m -60.32 -59.65 5.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.433 -0.792 . . . . 0.0 109.67 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.24 -0.83 26.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 109.794 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.485 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 9.8 m120 -83.56 -72.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 0.0 109.796 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 80.5 mttt -126.56 -27.86 3.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.787 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.5 mt-10 -66.0 -24.33 66.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.616 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.517 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -58.51 -58.66 17.44 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.563 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.5 Cg_endo -66.91 -35.1 27.76 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.596 2.197 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -64.59 -42.01 95.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.897 . . . . 0.0 109.116 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.458 ' CE2' HD12 ' A' ' 111' ' ' LEU . 26.4 m0 -60.74 -50.23 74.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.312 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 98' ' ' TRP . 49.9 tttp -43.0 -43.49 4.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.3 -0.875 . . . . 0.0 109.474 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.4 m -56.74 -42.6 79.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 109.372 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -86.24 12.56 9.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 109.409 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.81 41.44 49.59 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.442 ' HA ' ' HB3' ' A' ' 98' ' ' TRP . 70.7 m-85 61.23 33.38 19.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -1.131 . . . . 0.0 109.395 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.6 t -119.22 134.06 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 0.0 109.519 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.409 ' OD1' ' HB2' ' A' ' 107' ' ' LYS . 23.7 t-20 -63.3 139.66 58.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -51.85 -34.37 40.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HB2' ' OD1' ' A' ' 105' ' ' ASN . 63.1 mttp -72.22 158.72 35.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.441 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -55.53 -29.31 58.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.89 . . . . 0.0 109.407 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -60.27 139.37 91.72 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.586 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.98 157.04 61.26 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.706 2.27 . . . . 0.0 111.663 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.458 HD12 ' CE2' ' A' ' 98' ' ' TRP . 9.3 tp -80.44 130.14 34.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.95 . . . . 0.0 109.478 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -92.61 153.82 18.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.89 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.402 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 43.4 m80 60.4 37.64 19.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.198 -0.939 . . . . 0.0 109.482 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.457 HG12 ' HB3' ' A' ' 111' ' ' LEU . 82.1 mt -63.84 -44.81 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.321 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 t -60.01 -41.99 93.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -59.22 -40.61 86.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.615 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 17.4 m95 -68.02 -37.96 82.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 31.2 mttt -57.41 -41.31 80.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.925 . . . . 0.0 109.371 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.47 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 19.9 m -61.62 -46.13 91.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.309 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 75.7 mt -71.21 -34.68 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.35 92.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.03 -40.28 88.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 109.503 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 89.5 m -66.22 -49.21 68.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.425 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.425 ' CD1' ' HA ' ' A' ' 128' ' ' PRO . 23.7 tp -63.82 -31.71 72.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.2 m -61.48 -31.7 71.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.499 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.457 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 92.6 mtp -68.56 -31.7 71.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 170.47 147.78 0.14 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.44 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 129' ' ' ASP . 50.5 Cg_endo -70.96 -0.95 8.71 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.688 2.259 . . . . 0.0 111.637 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.479 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 94.1 m-20 -43.05 -45.39 5.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.367 -0.833 . . . . 0.0 109.659 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 46.4 mt -61.77 117.39 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.743 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 132' ' ' ILE . 97.4 m -109.81 144.9 37.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.186 -0.946 . . . . 0.0 109.069 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.479 ' N ' HG22 ' A' ' 131' ' ' THR . 32.5 mm -119.69 136.68 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 109.745 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.46 ' NE2' HD23 ' A' ' 79' ' ' LEU . 87.4 mt-30 -125.43 158.22 34.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.427 -0.795 . . . . 0.0 109.19 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 20.3 t-80 -117.26 133.25 56.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.641 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.524 ' HG2' ' CG2' ' A' ' 81' ' ' ILE . 71.2 mm-40 -124.34 150.47 45.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.425 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -96.55 138.48 34.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.18 -35.15 68.89 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -117.87 139.72 50.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -1.125 . . . . 0.0 109.446 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.503 ' CG ' ' HD2' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -121.04 167.76 12.42 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.376 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.503 ' HD2' ' CG ' ' A' ' 139' ' ' GLN . 50.5 Cg_endo -69.69 -173.78 0.77 Allowed 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.689 2.26 . . . . 0.0 111.863 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.0 m -49.72 -39.68 38.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.84 155.56 32.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.564 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.0 p -120.07 160.44 22.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.6 m -121.07 149.35 42.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.538 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 87.7 mt -54.22 -37.53 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.589 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -65.17 -30.6 71.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.261 -0.9 . . . . 0.0 109.416 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 57.5 m -55.56 -47.46 76.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.372 -0.83 . . . . 0.0 109.452 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.19 -52.18 28.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.409 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.18 -39.52 58.3 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -55.15 -48.8 73.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -1.108 . . . . 0.0 109.37 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.74 37.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.309 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.43 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 6.8 mp -58.84 -47.97 82.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.508 ' CA ' HG23 ' A' ' 33' ' ' VAL . . . -55.42 -42.56 74.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 109.418 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.4 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 63.7 m-20 -55.69 -44.09 77.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.876 . . . . 0.0 109.394 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -57.75 -42.14 83.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.928 . . . . 0.0 109.412 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 7.0 mp -64.98 -40.15 94.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.78 -51.67 46.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.358 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 42.0 m -59.83 -41.41 91.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.68 -38.41 91.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -62.54 -50.38 64.95 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.0 p -64.94 -34.24 77.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -1.183 . . . . 0.0 109.434 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -64.03 -37.68 88.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.431 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 73.0 t -52.93 -39.67 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 109.467 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.42 HG13 ' ND2' ' A' ' 27' ' ' ASN . 42.5 t -65.48 -30.98 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.502 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.503 ' ND2' ' OD1' ' A' ' 27' ' ' ASN . 89.6 m-20 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.51 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 5' ' ' GLN . . . -144.41 157.87 44.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -1.181 . . . . 0.0 109.523 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.571 ' HE1' ' CE1' ' A' ' 37' ' ' TYR . 77.4 mtp -65.76 -27.1 68.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.552 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.15 -17.59 17.61 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 96.3 mt-30 -53.17 -33.57 53.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -1.166 . . . . 0.0 109.573 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.568 ' CD2' ' O ' ' A' ' 3' ' ' MET . 33.9 p90 -103.37 156.53 17.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.206 -0.934 . . . . 0.0 109.655 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.444 ' OE1' HG22 ' A' ' 74' ' ' ILE . 21.3 tt0 -79.78 -42.76 23.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -159.88 176.52 36.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.1 t -124.96 141.1 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -1.18 . . . . 0.0 109.515 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.656 ' CD2' ' CD2' ' A' ' 34' ' ' HIS . 5.7 m-85 -117.33 151.7 36.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.622 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -123.87 135.97 54.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 p -121.7 150.1 42.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.596 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 153' ' ' ALA . 22.9 t70 -140.12 148.27 41.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.482 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.41 134.25 5.42 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 83.1 p -143.21 161.01 39.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -1.177 . . . . 0.0 109.457 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB3' ' ND2' ' A' ' 26' ' ' ASN . . . -137.9 150.51 47.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.566 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' ASN . 47.7 mt -126.79 131.98 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.515 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -107.28 144.45 34.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.294 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.531 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -109.63 176.3 1.61 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.317 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 45.7 Cg_endo -67.87 -35.51 20.83 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 122.471 2.114 . . . . 0.0 111.38 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.87 70.36 5.0 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.381 -0.825 . . . . 0.0 108.876 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 19' ' ' SER . 45.0 Cg_endo -67.04 57.28 0.55 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.833 2.355 . . . . 0.0 111.968 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.0 p -59.46 -16.81 26.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.838 . . . . 0.0 109.018 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -129.76 -163.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.304 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 26' ' ' ASN . 33.2 m -78.06 140.76 39.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.676 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.503 ' ND2' ' HB3' ' A' ' 16' ' ' ALA . 48.1 p-10 -47.3 172.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 109.303 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 17' ' ' ILE . 23.3 m120 -104.49 125.01 50.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.965 . . . . 0.0 109.393 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 15' ' ' SER . . . -132.16 158.51 41.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 109.768 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.32 165.2 26.77 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.412 ' HB2' ' HB ' ' A' ' 49' ' ' ILE . 69.7 mtm -126.28 156.54 40.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -1.168 . . . . 0.0 109.461 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.51 128.21 3.58 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.527 HG13 ' CD2' ' A' ' 66' ' ' PHE . 22.3 mm -113.16 134.41 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -1.132 . . . . 0.0 109.301 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.95 125.38 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.692 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.656 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 10.3 m170 -103.54 136.12 43.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.208 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.08 161.31 35.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.752 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.2 t -125.6 164.08 21.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 109.241 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.571 ' CE1' ' HE1' ' A' ' 3' ' ' MET . 85.0 m-85 -107.91 13.95 25.79 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.104 -0.998 . . . . 0.0 109.534 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.561 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.27 -179.17 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.321 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.6 Cg_endo -65.42 -4.73 9.97 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.074 1.849 . . . . 0.0 111.849 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.421 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 71.8 mm-40 -134.1 106.09 7.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 108.785 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 66.9 t80 -57.81 123.89 17.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 109.534 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 84.4 mt-30 -159.62 152.25 21.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.85 . . . . 0.0 109.516 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.445 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 10.1 m -89.06 120.48 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.394 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 40.9 mt -58.28 -44.18 88.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.429 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 25.2 m-20 -168.76 157.4 8.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.433 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.426 ' HB3' HD23 ' A' ' 156' ' ' LEU . 92.4 mt-30 -116.2 149.6 38.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.444 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.443 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -132.16 137.96 47.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.625 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.9 p -123.61 144.8 49.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.286 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.533 HD11 ' CE1' ' A' ' 66' ' ' PHE . 3.3 mt -146.52 94.55 4.76 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.198 -0.939 . . . . 0.0 109.648 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.495 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 51.0 Cg_endo -70.81 132.26 21.3 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.654 2.236 . . . . 0.0 111.67 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.504 ' CD1' ' HB3' ' A' ' 59' ' ' ALA . 43.8 mt -115.0 142.89 46.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.566 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.03 -42.86 0.21 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -90.97 8.85 33.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -1.114 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 77.3 m80 -107.05 150.25 26.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.915 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.65 170.04 10.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.884 . . . . 0.0 109.24 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.37 -30.09 17.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.319 -0.863 . . . . 0.0 109.123 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -79.5 -57.36 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.357 -0.84 . . . . 0.0 109.315 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.465 ' O ' HG23 ' A' ' 61' ' ' ILE . 93.4 mtp -47.78 -34.47 8.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 109.364 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.504 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . . . -78.72 -33.94 46.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.442 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' OE2' HG21 ' A' ' 87' ' ' VAL . 82.1 tt0 -64.45 -40.11 95.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.561 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 19.5 tt -77.34 -29.59 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.374 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' CB ' ' SD ' ' A' ' 30' ' ' MET . . . -68.77 -29.49 67.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.478 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.82 94.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.491 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 82' ' ' THR . 87.0 t -75.86 -48.29 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 98.1 mt-10 -51.87 -41.57 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.569 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 14.1 t80 -56.82 -67.86 0.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.647 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' HB3' HG13 ' A' ' 80' ' ' VAL . . . -63.67 -13.98 47.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.606 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 65' ' ' GLU . 38.0 t -66.82 -66.04 0.6 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.521 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 73.9 tttt -60.01 -42.61 94.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.634 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.569 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 56.7 mttp -64.94 -35.62 81.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.513 ' HB2' ' CG1' ' A' ' 78' ' ' VAL . . . -58.3 -60.44 3.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.525 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 21.0 tp -56.71 -44.12 81.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 109.388 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 72' ' ' LEU . 55.6 tttp -43.59 -42.13 4.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.155 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 19.6 mm -48.39 142.76 7.95 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.86 . . . . 0.0 108.961 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.9 Cg_endo -65.49 -4.58 9.79 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.548 2.165 . . . . 0.0 111.937 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.02 167.28 25.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HG2' ' HA ' ' A' ' 6' ' ' TYR . 45.2 Cg_endo -67.88 116.4 4.27 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.565 2.176 . . . . 0.0 111.699 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.574 ' CG2' ' CD1' ' A' ' 10' ' ' PHE . 7.2 p -111.31 149.82 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.333 -0.854 . . . . 0.0 109.578 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.528 HD21 ' CB ' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -104.51 137.41 42.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 109.59 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 43.7 t -110.27 130.46 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.145 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 81' ' ' ILE . 15.8 mt -114.61 132.08 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.447 HG21 HG21 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -124.85 161.99 25.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 56.4 p30 -87.14 13.08 10.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.499 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 67.2 m -123.26 125.28 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.485 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.564 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 70.4 t80 -78.38 -41.89 31.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -58.54 -52.71 64.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 90' ' ' SER . 48.4 t -59.23 -51.8 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.448 ' HA ' HG23 ' A' ' 132' ' ' ILE . . . -49.68 -52.97 27.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.288 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -60.08 -33.75 72.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.17 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.629 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 34.1 m -52.72 -47.22 67.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.327 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -94.25 -0.75 54.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.612 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -86.93 -71.99 0.53 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.957 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 24.7 mttm -116.64 -35.53 4.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 109.831 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 91.4 mt-10 -59.84 -38.8 83.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.624 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -53.16 -60.18 7.4 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 47.4 Cg_endo -68.15 -32.37 27.49 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.71 2.273 . . . . 0.0 111.596 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -72.54 -40.6 66.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.28 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.462 ' CE2' HD13 ' A' ' 111' ' ' LEU . 24.9 m0 -61.66 -44.23 97.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.358 -0.839 . . . . 0.0 109.371 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -50.65 -50.38 54.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.865 . . . . 0.0 109.446 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.6 m -65.98 -34.93 79.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.497 ' OD1' ' CG1' ' A' ' 104' ' ' VAL . 53.6 t-20 -66.17 -26.17 67.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.525 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.3 28.26 8.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.45 ' HB3' HG23 ' A' ' 114' ' ' ILE . 8.3 m-85 61.85 30.82 18.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -1.158 . . . . 0.0 109.486 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.497 ' CG1' ' OD1' ' A' ' 101' ' ' ASN . 11.8 p -118.56 133.93 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 109' ' ' LYS . 44.8 t30 -84.75 143.29 29.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.469 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -51.7 -33.26 33.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.525 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -75.65 162.39 28.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 109.567 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -55.85 -31.71 62.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 1.5 tptp -70.81 138.8 85.54 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.415 ' HD2' ' HG3' ' A' ' 109' ' ' LYS . 50.0 Cg_endo -70.34 169.97 18.37 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.637 2.224 . . . . 0.0 111.866 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.462 HD13 ' CE2' ' A' ' 98' ' ' TRP . 5.3 tp -73.44 134.89 44.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 109.431 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HD3' ' CE1' ' A' ' 113' ' ' HIS . 85.1 tttt -96.13 149.55 21.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.571 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 33.8 m80 65.98 33.07 8.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.505 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.45 HG23 ' HB3' ' A' ' 103' ' ' PHE . 82.4 mt -62.33 -47.05 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.253 -0.904 . . . . 0.0 109.406 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.8 m -59.38 -43.57 92.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.432 ' HD3' HG21 ' A' ' 61' ' ' ILE . 35.7 mttp -58.49 -46.9 85.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.285 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.629 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 65.6 m95 -70.16 -30.08 67.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.406 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -60.25 -41.6 93.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.495 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -58.22 -40.7 82.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.515 ' CG1' ' HG2' ' A' ' 65' ' ' GLU . 77.8 mt -72.95 -32.84 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -64.91 -37.16 86.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -60.41 -34.27 73.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.476 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.446 ' HA ' ' HE3' ' A' ' 126' ' ' MET . 6.8 m -79.21 -50.21 11.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.508 ' CD2' ' HB ' ' A' ' 130' ' ' ILE . 57.6 mt -61.04 -34.86 75.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.476 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.8 t -59.27 -34.13 71.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.435 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.495 ' CE ' HD23 ' A' ' 72' ' ' LEU . 71.7 mtm -67.76 -34.53 77.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.423 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -173.99 128.51 0.47 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.475 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.5 Cg_endo -69.74 -1.8 9.07 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.68 2.253 . . . . 0.0 111.638 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 90.9 m-20 -43.83 -43.13 6.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.316 -0.865 . . . . 0.0 109.458 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 40.3 mt -53.99 118.55 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.335 -0.853 . . . . 0.0 109.671 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.451 ' HB ' HD22 ' A' ' 79' ' ' LEU . 9.0 m -119.28 129.65 55.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 108.984 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 52.9 mt -110.47 144.4 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.06 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.481 ' N ' HG22 ' A' ' 132' ' ' ILE . 76.4 mt-30 -132.58 154.32 50.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.343 -0.848 . . . . 0.0 109.163 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.564 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 15.8 t-80 -104.05 128.28 51.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.618 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 83' ' ' ASP . 85.1 tt0 -122.11 142.87 49.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 109.295 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -108.18 131.68 54.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.643 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -115.34 4.03 21.89 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -60.09 -33.97 72.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -1.165 . . . . 0.0 109.479 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -92.69 111.46 51.12 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.99 -23.98 29.12 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.714 2.276 . . . . 0.0 111.79 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.0 p -82.28 171.98 13.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.473 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.2 m120 60.5 49.54 6.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.518 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.8 m -70.96 141.55 51.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.863 . . . . 0.0 109.467 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 147' ' ' THR . 94.8 p -133.71 171.29 14.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 87.4 mt -55.17 -41.97 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -65.7 -38.71 90.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 144' ' ' SER . 70.0 p -64.12 -36.99 85.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.558 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -49.61 -45.81 48.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 109.552 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.07 -37.56 94.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -58.63 -41.5 86.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -1.142 . . . . 0.0 109.556 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.48 -51.7 66.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.55 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.463 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 52.5 mt -58.8 -45.7 89.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.527 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . . . -56.88 -42.51 79.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.525 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -59.23 -36.53 75.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -63.36 -42.26 98.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.628 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 152' ' ' LEU . 6.4 mp -74.17 -34.04 63.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.573 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.89 -40.86 97.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.425 ' O ' ' OG ' ' A' ' 161' ' ' SER . 50.0 p -69.07 -39.52 79.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.532 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -62.32 -33.56 74.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -64.51 -31.85 82.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.441 ' HB2' HD13 ' A' ' 17' ' ' ILE . 94.5 p -65.96 -34.67 78.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -1.16 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 165' ' ' ASN . 95.8 m-85 -68.23 -26.99 65.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.495 ' HB ' ' CB ' ' A' ' 50' ' ' PRO . 60.1 t -54.87 -40.4 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.88 . . . . 0.0 109.452 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.31 -39.92 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.432 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 162' ' ' TYR . 83.3 m-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.441 ' N ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 5' ' ' GLN . . . -64.64 140.39 58.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.278 -1.131 . . . . 0.0 109.395 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.582 ' HE2' ' CZ ' ' A' ' 37' ' ' TYR . 90.8 mmm -65.7 -29.96 70.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.571 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.79 -28.1 56.72 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 20.0 mt-30 -50.53 -40.12 50.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -1.161 . . . . 0.0 109.532 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.575 ' CZ ' HD12 ' A' ' 79' ' ' LEU . 34.3 m-85 -103.91 165.94 10.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.561 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -77.06 -31.91 56.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 108.872 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.6 -166.84 35.95 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 79' ' ' LEU . 72.7 t -136.33 143.01 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -1.162 . . . . 0.0 108.978 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.616 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 6.1 m-85 -114.16 146.41 40.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.971 . . . . 0.0 109.907 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.516 ' CE1' HD13 ' A' ' 81' ' ' ILE . 66.9 m-85 -118.41 118.35 31.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.264 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 9.8 p -106.45 155.64 19.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 59.1 t0 -149.58 145.64 26.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.565 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -146.9 118.95 1.08 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 66.8 m -132.0 150.89 52.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -1.158 . . . . 0.0 109.588 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HA ' ' CB ' ' A' ' 28' ' ' ALA . . . -114.78 135.19 54.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.507 ' CD1' ' CB ' ' A' ' 161' ' ' SER . 58.3 mt -110.82 142.54 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.31 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.515 ' CE ' ' HG3' ' A' ' 22' ' ' PRO . 78.8 tttt -92.49 139.61 30.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.581 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.545 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -99.26 179.27 1.08 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.111 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 50.8 Cg_endo -71.64 -23.24 23.21 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.381 2.054 . . . . 0.0 111.708 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' N ' ' HD3' ' A' ' 22' ' ' PRO . 2.8 p30 -128.93 61.35 56.0 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.303 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.515 ' HG3' ' CE ' ' A' ' 18' ' ' LYS . 55.2 Cg_endo -81.71 68.82 7.92 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.762 2.308 . . . . 0.0 111.915 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 79.6 m -54.72 -31.56 58.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.168 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 23' ' ' THR . 48.1 tttm 178.42 33.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.296 -0.877 . . . . 0.0 109.475 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -152.92 138.41 17.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.558 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -118.11 165.54 13.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.333 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -98.74 97.56 8.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.328 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 16' ' ' ALA . . . -110.85 155.91 21.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.7 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.44 154.71 25.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.507 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 33.2 mtm -115.39 156.76 24.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -1.113 . . . . 0.0 109.417 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.89 124.23 1.73 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 32' ' ' ILE . 5.4 mp -116.94 134.58 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -1.095 . . . . 0.0 109.102 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG13 ' CG2' ' A' ' 43' ' ' VAL . 50.0 t -127.09 131.39 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.77 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.616 ' CE1' ' CE1' ' A' ' 10' ' ' PHE . 3.5 t60 -102.15 131.0 48.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.196 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.34 159.37 37.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.759 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.448 ' HB ' HD12 ' A' ' 44' ' ' LEU . 7.7 t -117.46 161.45 19.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.863 . . . . 0.0 109.126 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.582 ' CZ ' ' HE2' ' A' ' 3' ' ' MET . 91.9 m-85 -104.66 8.75 35.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.134 -0.979 . . . . 0.0 109.634 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.557 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.8 -178.94 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.322 -0.861 . . . . 0.0 108.766 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.2 Cg_endo -66.5 -3.13 8.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.122 1.881 . . . . 0.0 111.945 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -132.36 105.78 7.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 108.706 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.589 ' CD1' ' CD1' ' A' ' 145' ' ' ILE . 63.3 t80 -66.57 125.5 25.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 109.329 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.5 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 73.0 mt-30 -160.62 152.72 20.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 0.0 109.391 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.489 ' CG2' HG13 ' A' ' 33' ' ' VAL . 13.5 p -82.85 124.33 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.434 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.565 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 6.4 mp -74.06 -42.33 60.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 80.5 m-20 -159.05 149.46 19.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -117.09 148.01 41.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -0.949 . . . . 0.0 109.398 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.456 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -130.92 131.38 44.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.188 -0.945 . . . . 0.0 109.587 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.2 p -123.79 141.95 51.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.451 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.429 HG22 HD23 ' A' ' 51' ' ' LEU . 3.7 mp -149.52 95.67 3.73 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.27 128.16 16.06 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.683 2.256 . . . . 0.0 111.759 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 44.4 mt -111.74 142.9 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 0.0 109.534 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.12 -42.88 0.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -91.96 9.32 33.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 109.522 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 79.4 m80 -110.47 147.31 34.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 0.0 109.467 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.437 HG23 ' HG3' ' A' ' 58' ' ' MET . 9.5 t -90.89 -178.54 5.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.29 -46.6 82.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 60' ' ' GLU . 87.8 mt-30 -63.11 -61.12 2.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.359 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.46 ' O ' HG21 ' A' ' 61' ' ' ILE . 94.2 mtp -44.01 -32.91 1.27 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.426 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -76.19 -30.36 58.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 0.0 109.526 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 57' ' ' GLN . 95.4 mt-10 -70.34 -38.93 74.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.597 ' CD1' ' CE2' ' A' ' 117' ' ' TRP . 18.0 tt -72.49 -34.57 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.507 ' N ' HG23 ' A' ' 61' ' ' ILE . . . -70.21 -32.5 70.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.409 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.456 ' HB2' ' HB ' ' A' ' 12' ' ' THR . . . -65.03 -40.15 94.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.509 HG22 ' CG2' ' A' ' 82' ' ' THR . 70.2 t -72.32 -39.7 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 109.49 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.23 -39.74 86.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.192 -0.942 . . . . 0.0 109.019 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.463 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 30.8 t80 -57.7 -63.59 1.19 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.369 -0.832 . . . . 0.0 109.528 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 68' ' ' CYS . . . -64.12 -39.55 94.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.601 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.465 ' O ' HD12 ' A' ' 130' ' ' ILE . 37.2 t -43.06 -62.43 1.04 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.444 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 67.6 mttm -59.27 -46.09 89.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -0.929 . . . . 0.0 109.426 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 66' ' ' PHE . 30.9 mmtt -56.15 -38.18 70.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.389 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.59 ' CB ' ' CG1' ' A' ' 78' ' ' VAL . . . -59.94 -64.95 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.473 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 1.0 OUTLIER -48.56 -47.12 39.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 109.461 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 72' ' ' LEU . 49.9 mttm -43.25 -42.46 4.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.33 -0.857 . . . . 0.0 109.097 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 30.1 mm -49.39 143.65 9.68 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.397 -0.814 . . . . 0.0 109.001 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.1 Cg_endo -65.11 -4.35 8.89 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.51 2.14 . . . . 0.0 111.895 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.61 172.31 24.97 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.481 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.1 Cg_endo -69.02 120.63 7.51 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 122.408 2.072 . . . . 0.0 111.677 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.59 ' CG1' ' CB ' ' A' ' 71' ' ' ALA . 7.2 p -114.89 153.76 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 109.141 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.575 HD12 ' CZ ' ' A' ' 6' ' ' TYR . 6.6 mp -97.1 139.98 32.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.025 -1.047 . . . . 0.0 109.931 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 58.1 t -118.0 121.98 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.418 -0.801 . . . . 0.0 109.004 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.516 HD13 ' CE1' ' A' ' 11' ' ' TYR . 3.7 mt -107.29 142.44 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.117 -0.99 . . . . 0.0 109.62 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.509 ' CG2' HG22 ' A' ' 64' ' ' VAL . 0.7 OUTLIER -128.18 161.7 28.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.415 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -87.74 7.11 31.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 109.507 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -123.95 129.42 50.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.526 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.454 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 68.0 t80 -77.8 -39.3 44.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -63.35 -48.15 79.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.496 HG13 ' CG2' ' A' ' 64' ' ' VAL . 59.5 t -58.96 -53.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 0.0 109.369 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.411 ' CB ' HG22 ' A' ' 132' ' ' ILE . . . -48.35 -55.0 11.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.933 . . . . 0.0 109.314 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 85' ' ' PHE . 77.1 mm-40 -56.35 -35.1 67.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.575 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 38.6 m -53.39 -46.63 69.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.473 ' CB ' ' CD1' ' A' ' 132' ' ' ILE . . . -92.5 -0.88 57.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.87 . . . . 0.0 109.674 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -89.03 -72.86 0.53 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.067 -1.021 . . . . 0.0 109.761 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 23.2 mttm -126.86 -29.55 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.904 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 88.4 mt-10 -59.58 -28.34 67.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.494 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -58.77 -60.88 8.99 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.124 -0.985 . . . . 0.0 109.552 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.1 Cg_endo -66.41 -31.44 42.68 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.724 2.283 . . . . 0.0 111.411 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -68.89 -38.46 79.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.236 -0.915 . . . . 0.0 108.883 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.553 ' CD2' HD11 ' A' ' 111' ' ' LEU . 35.3 m0 -61.96 -52.91 62.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.19 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 98' ' ' TRP . 46.6 tttt -43.54 -41.66 4.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.365 -0.835 . . . . 0.0 109.496 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.2 m -58.95 -42.21 89.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.915 . . . . 0.0 109.415 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.408 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 76.5 m-20 -84.48 7.35 20.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.142 -0.974 . . . . 0.0 109.524 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 82.55 32.42 27.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 111' ' ' LEU . 89.5 m-85 63.31 34.05 13.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -1.129 . . . . 0.0 109.473 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.462 ' CG1' ' O ' ' A' ' 104' ' ' VAL . 7.4 p -121.67 121.4 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 109.555 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.501 ' CA ' HD22 ' A' ' 111' ' ' LEU . 53.3 t30 -53.7 -46.97 70.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.482 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.437 ' O ' HG21 ' A' ' 104' ' ' VAL . 81.9 m-20 -147.73 175.16 11.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.522 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -57.85 -31.68 66.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.515 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.411 ' C ' ' HG2' ' A' ' 109' ' ' LYS . 44.7 mttt -118.69 13.54 13.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.515 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 1.9 mmtt -133.02 89.28 34.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.85 . . . . 0.0 109.439 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.44 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 49.8 Cg_endo -70.34 152.22 66.17 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.777 2.318 . . . . 0.0 111.784 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.553 HD11 ' CD2' ' A' ' 98' ' ' TRP . 91.6 mt -74.27 146.79 42.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.374 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.505 ' HE3' ' NE2' ' A' ' 113' ' ' HIS . 33.8 tttp -104.9 139.72 39.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.636 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.505 ' NE2' ' HE3' ' A' ' 112' ' ' LYS . 70.6 m-70 65.25 36.79 6.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.653 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.451 HG21 ' HB3' ' A' ' 103' ' ' PHE . 86.1 mt -53.93 -43.89 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.242 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.9 m -49.68 -45.89 49.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.267 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HD2' ' HB3' ' A' ' 113' ' ' HIS . 64.1 mttm -58.6 -48.09 82.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.307 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.597 ' CE2' ' CD1' ' A' ' 61' ' ' ILE . 60.9 m95 -65.65 -38.14 88.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.839 . . . . 0.0 109.385 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -56.87 -46.64 81.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.479 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.4 p -57.67 -39.54 77.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 109.423 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 73.9 mt -66.75 -37.24 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.861 . . . . 0.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' O ' ' OG ' ' A' ' 125' ' ' SER . . . -65.32 -32.66 74.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 126' ' ' MET . 83.9 tt0 -54.18 -38.15 65.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.329 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.406 ' HB3' HD11 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -80.87 -49.25 11.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.419 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 22.7 tp -63.08 -31.86 73.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 121' ' ' ALA . 50.8 m -66.12 -33.24 75.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.475 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 65.1 mtt -65.99 -34.5 78.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.2 OUTLIER -176.47 140.82 0.52 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.501 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.0 Cg_endo -70.51 -0.8 8.08 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.655 2.236 . . . . 0.0 111.717 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 84.8 m-20 -43.8 -47.98 8.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.473 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 58.5 mt -58.45 114.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.46 ' HB ' ' HA ' ' A' ' 79' ' ' LEU . 91.0 m -104.81 147.05 28.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.277 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.473 ' CD1' ' CB ' ' A' ' 91' ' ' ALA . 54.3 mt -122.82 142.68 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.615 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -135.71 164.96 26.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.268 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 18.0 t-80 -113.57 138.55 50.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.558 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 82' ' ' THR . 96.9 mt-10 -88.04 154.84 20.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.463 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.456 ' HB2' ' NE2' ' A' ' 139' ' ' GLN . 21.1 mttp -96.86 34.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.2 -122.63 30.53 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -109.66 145.66 36.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -1.184 . . . . 0.0 109.469 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.456 ' NE2' ' HB2' ' A' ' 136' ' ' LYS . 1.4 mt-30 -118.24 162.05 31.89 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.461 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 139' ' ' GLN . 50.6 Cg_endo -70.48 -16.94 34.58 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.627 2.218 . . . . 0.0 111.647 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.6 m -129.13 128.94 44.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 109.413 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -92.97 9.59 34.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.498 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 46.4 m -59.1 -38.23 79.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.415 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 62.6 m -57.22 138.93 54.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.141 -0.974 . . . . 0.0 109.439 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.589 ' CD1' ' CD1' ' A' ' 41' ' ' TYR . 18.9 tt -71.18 -27.71 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -67.33 -33.7 75.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.2 m -63.23 -40.85 98.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.548 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.25 -36.9 76.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.593 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -67.25 -30.27 75.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -72.45 -33.26 66.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -1.169 . . . . 0.0 109.524 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.12 -51.51 37.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.543 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 56.3 mt -59.19 -47.27 85.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . . . -56.84 -38.75 73.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 109.564 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.27 -32.26 73.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.647 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 159' ' ' GLN . 24.7 mttm -67.84 -41.88 82.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.63 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.479 ' CD1' ' O ' ' A' ' 152' ' ' LEU . 6.3 mp -73.14 -31.59 64.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.94 . . . . 0.0 109.585 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.61 -62.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.589 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 35.5 m -59.25 -43.3 92.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.473 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 63.1 tp60 -61.32 -33.61 73.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.629 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.52 -31.16 73.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.507 ' CB ' ' CD1' ' A' ' 17' ' ' ILE . 19.0 m -66.71 -29.33 69.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -1.142 . . . . 0.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.451 ' O ' ' OD1' ' A' ' 165' ' ' ASN . 28.1 m-85 -75.37 -21.52 58.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.434 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.76 -43.95 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 165' ' ' ASN . 4.6 p -64.05 -32.09 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.492 ' N ' HG13 ' A' ' 164' ' ' VAL . 79.7 m-20 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.504 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.34 -22.54 66.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -1.118 . . . . 0.0 109.465 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.523 ' CE ' ' OH ' ' A' ' 37' ' ' TYR . 96.2 mmm -66.51 -30.76 71.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 90.07 -16.7 56.5 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 92.7 mt-30 61.76 36.65 16.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -1.141 . . . . 0.0 109.526 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.518 ' CD2' HD12 ' A' ' 79' ' ' LEU . 99.7 m-85 -57.04 177.87 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.523 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.512 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 31.7 tp10 -64.2 -37.89 89.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.362 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -178.48 -175.34 45.5 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.2 t -134.47 142.86 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -1.121 . . . . 0.0 109.354 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.659 ' CD2' ' CD2' ' A' ' 34' ' ' HIS . 7.3 m-85 -123.06 140.36 53.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.634 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.491 ' CE2' HD12 ' A' ' 81' ' ' ILE . 42.9 m-85 -113.32 132.56 55.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.308 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.5 ' CG2' HD11 ' A' ' 32' ' ' ILE . 24.6 p -120.17 142.57 48.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.831 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.456 ' OD2' ' OD1' ' A' ' 154' ' ' ASP . 52.4 t0 -137.0 155.91 49.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.405 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -142.42 127.29 3.16 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 40.2 m -124.21 157.74 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -1.133 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' CB ' ' CB ' ' A' ' 56' ' ' ALA . . . -145.35 144.49 30.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 109.625 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' A' ' 161' ' ' SER . 47.7 mt -122.14 135.32 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 0.0 109.402 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -103.26 133.94 47.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.468 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -117.66 161.86 31.77 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.926 . . . . 0.0 109.538 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.28 -24.39 27.35 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.684 2.256 . . . . 0.0 111.826 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -79.87 -66.58 0.26 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 49.2 Cg_endo -70.13 65.16 2.02 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.554 2.17 . . . . 0.0 111.786 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.4 m -56.03 -45.14 79.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 109.419 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -94.86 28.73 2.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 109.457 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 30.6 t -154.52 144.68 21.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.935 . . . . 0.0 109.485 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 25' ' ' SER . 58.4 m-20 -137.9 154.76 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.44 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 71.1 m-20 -92.14 113.37 25.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.943 . . . . 0.0 109.337 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -112.14 145.68 39.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.775 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.62 165.46 23.3 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.512 ' CE ' HG23 ' A' ' 49' ' ' ILE . 67.9 mtm -133.46 150.94 51.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -1.184 . . . . 0.0 109.684 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.46 120.24 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.5 HD11 ' CG2' ' A' ' 12' ' ' THR . 23.4 mm -110.36 140.62 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -1.159 . . . . 0.0 109.547 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.515 ' CG2' ' HB3' ' A' ' 153' ' ' ALA . 42.4 t -124.82 130.41 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.353 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.659 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 25.4 m170 -105.67 138.2 42.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 109.655 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.7 168.62 18.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.2 t -138.16 165.13 27.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.175 -0.953 . . . . 0.0 109.713 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.523 ' OH ' ' CE ' ' A' ' 3' ' ' MET . 68.8 m-85 -106.63 10.21 31.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.09 -179.96 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.039 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.6 Cg_endo -66.39 -4.57 10.93 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.159 1.906 . . . . 0.0 111.64 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -132.12 105.92 7.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.35 -0.844 . . . . 0.0 108.811 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.46 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 58.6 t80 -63.53 117.72 7.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 109.408 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.46 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 85.7 mt-30 -157.98 144.79 17.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.684 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 6.3 m -72.78 124.73 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 68.3 mt -59.72 -39.14 83.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.94 . . . . 0.0 109.483 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 20.3 t-20 -179.57 157.02 0.74 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -108.39 139.33 43.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.873 . . . . 0.0 109.515 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.403 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 0.5 OUTLIER -118.86 139.93 50.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.264 -0.897 . . . . 0.0 109.483 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 t -130.81 125.45 33.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.449 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.512 HG23 ' CE ' ' A' ' 30' ' ' MET . 2.2 mp -130.82 95.74 25.04 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.527 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 50.1 Cg_endo -69.93 134.98 28.92 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.785 2.323 . . . . 0.0 111.813 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.461 HD11 ' HB1' ' A' ' 59' ' ' ALA . 38.8 mt -113.21 152.01 30.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.57 -48.37 0.13 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -89.16 7.49 34.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -1.177 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 74.4 m80 -111.18 142.08 43.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.439 HG23 ' HG3' ' A' ' 58' ' ' MET . 9.6 t -87.43 -176.27 5.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.51 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . . . -60.45 -44.7 95.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -62.06 -48.58 79.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.463 ' O ' HG22 ' A' ' 61' ' ' ILE . 96.3 mtp -61.63 -30.12 70.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.497 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.461 ' HB1' HD11 ' A' ' 51' ' ' LEU . . . -71.02 -28.74 64.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.427 ' HB3' HG22 ' A' ' 87' ' ' VAL . 98.1 mt-10 -73.69 -45.2 53.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.516 HG21 ' N ' ' A' ' 62' ' ' ALA . 16.1 tt -63.12 -32.03 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.875 . . . . 0.0 109.465 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.516 ' N ' HG21 ' A' ' 61' ' ' ILE . . . -74.2 -34.52 63.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.329 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.24 -42.82 77.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.534 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 32.7 t -71.32 -45.5 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.51 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.505 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 97.8 mt-10 -55.76 -35.57 66.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.907 . . . . 0.0 109.56 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.502 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 8.8 t80 -62.11 -69.04 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.607 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 -13.95 51.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.492 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.452 ' O ' HD13 ' A' ' 130' ' ' ILE . 41.4 t -66.08 -60.41 2.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.179 -0.951 . . . . 0.0 109.432 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -65.13 -40.12 93.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.463 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HE3' ' CE2' ' A' ' 66' ' ' PHE . 63.2 mttm -64.26 -34.96 79.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.416 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.41 ' O ' HG12 ' A' ' 74' ' ' ILE . . . -63.71 -65.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 73' ' ' LYS . 24.9 tp -51.23 -44.33 61.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.953 . . . . 0.0 109.589 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' LEU . 83.5 tttt -43.55 -47.35 7.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.284 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.552 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 9.5 mm -48.51 142.72 8.24 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.14 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.2 Cg_endo -65.88 -5.02 11.09 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.49 2.127 . . . . 0.0 111.556 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.74 168.22 23.67 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 47.7 Cg_endo -68.85 137.35 37.96 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.583 2.188 . . . . 0.0 111.585 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.562 HG11 ' CD1' ' A' ' 10' ' ' PHE . 21.7 t -123.82 159.1 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.46 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.518 HD12 ' CD2' ' A' ' 6' ' ' TYR . 6.5 mp -105.92 123.8 48.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.863 . . . . 0.0 109.59 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 40.2 t -103.6 121.62 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.453 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.491 HD12 ' CE2' ' A' ' 11' ' ' TYR . 13.8 mt -106.85 139.05 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.311 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.86 161.74 29.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.406 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -93.43 -2.5 54.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.501 ' CB ' HG22 ' A' ' 87' ' ' VAL . 71.1 m -108.5 120.75 43.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.565 ' HA ' ' CD2' ' A' ' 134' ' ' HIS . 61.2 t80 -71.31 -28.64 64.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.345 -0.847 . . . . 0.0 109.541 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -78.98 -46.33 18.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.316 -0.865 . . . . 0.0 109.745 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.501 HG22 ' CB ' ' A' ' 84' ' ' SER . 30.9 t -57.68 -60.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 109.437 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . . . -53.19 -51.75 61.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 0.0 109.408 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -52.31 -38.27 58.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.511 ' HB3' ' CH2' ' A' ' 117' ' ' TRP . 19.2 t -56.91 -48.2 78.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.43 ' HB3' HD12 ' A' ' 132' ' ' ILE . . . -81.92 -0.91 45.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 109.765 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -92.68 -73.77 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.003 -1.06 . . . . 0.0 110.072 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 32.5 mmtp -127.52 -27.13 2.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.0 . . . . 0.0 110.239 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 53.8 mt-10 -62.75 -20.54 65.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 110.176 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.515 ' HB3' ' CD ' ' A' ' 96' ' ' PRO . 25.4 tp -64.86 -58.33 13.32 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.965 -1.084 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.515 ' CD ' ' HB3' ' A' ' 95' ' ' LEU . 44.2 Cg_endo -66.14 -36.12 30.45 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.545 2.163 . . . . 0.0 111.442 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -65.79 -34.61 78.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 108.935 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.579 ' CE2' HD13 ' A' ' 111' ' ' LEU . 23.1 m0 -64.74 -50.41 67.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.4 -0.812 . . . . 0.0 109.123 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 98' ' ' TRP . 79.2 mttt -44.11 -31.31 0.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 109.609 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -29.06 62.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.194 -0.941 . . . . 0.0 109.587 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 98' ' ' TRP . 77.0 m-20 -99.31 23.11 9.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 109.606 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.568 ' O ' ' CG ' ' A' ' 103' ' ' PHE . . . 64.23 35.26 91.75 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.568 ' CG ' ' O ' ' A' ' 102' ' ' GLY . 9.4 p90 40.75 34.26 0.25 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -1.04 . . . . 0.0 109.903 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.536 ' N ' HD22 ' A' ' 111' ' ' LEU . 21.5 t -99.81 114.04 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.969 . . . . 0.0 109.631 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.476 ' CB ' ' HA ' ' A' ' 109' ' ' LYS . 53.7 p30 -51.32 173.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.421 -0.8 . . . . 0.0 109.71 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -129.73 -111.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.324 -0.86 . . . . 0.0 109.024 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -64.37 -30.09 71.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.759 -1.213 . . . . 0.0 108.849 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.514 ' CB ' ' HD3' ' A' ' 110' ' ' PRO . 42.4 mttt -109.2 -160.99 0.74 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 108.927 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -133.96 43.18 0.94 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 0.0 109.837 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 109' ' ' LYS . 50.5 Cg_endo -73.1 -18.63 23.68 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.409 2.072 . . . . 0.0 111.99 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.579 HD13 ' CE2' ' A' ' 98' ' ' TRP . 7.7 mp -91.84 21.21 5.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 0.0 109.469 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.504 ' CD ' ' HB2' ' A' ' 109' ' ' LYS . 45.9 mttt -89.24 157.37 18.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 108.847 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 61.71 34.83 17.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.057 -1.027 . . . . 0.0 109.149 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.514 ' CD1' ' O ' ' A' ' 111' ' ' LEU . 45.6 mm -48.86 -41.64 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 109.08 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.8 t -47.39 -44.01 23.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 108.784 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.452 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 40.3 mttm -63.38 -46.08 88.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 108.952 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.511 ' CH2' ' HB3' ' A' ' 90' ' ' SER . 47.9 m95 -62.17 -42.39 99.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -0.867 . . . . 0.0 109.216 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -51.66 -48.15 63.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.255 -0.903 . . . . 0.0 109.34 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.2 m -49.54 -39.8 35.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.24 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.505 ' CG1' ' HG2' ' A' ' 65' ' ' GLU . 61.9 mt -73.27 -33.32 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.268 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . . . -64.96 -36.82 85.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -54.25 -40.3 67.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.407 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.442 ' HB3' HD12 ' A' ' 130' ' ' ILE . 72.1 m -76.92 -50.61 12.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.41 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.49 -35.98 75.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.357 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.2 t -58.96 -35.14 72.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.476 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.454 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 65.9 mtt -65.35 -34.78 79.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 172.37 152.72 0.22 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 0.0 109.557 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.7 Cg_endo -71.76 3.2 3.97 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.813 2.342 . . . . 0.0 112.059 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 81.2 m-20 -42.36 -30.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 109.581 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 68' ' ' CYS . 38.1 mt -82.76 111.64 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.514 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.455 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 32.9 m -97.72 151.16 20.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.391 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.537 ' CG2' ' CB ' ' A' ' 88' ' ' ALA . 63.7 mt -125.27 129.07 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.634 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.464 ' OE1' HD11 ' A' ' 81' ' ' ILE . 87.2 mt-30 -119.17 157.31 28.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.38 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.565 ' CD2' ' HA ' ' A' ' 85' ' ' PHE . 27.3 m170 -112.03 133.57 54.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.665 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.441 ' CD ' ' ND2' ' A' ' 150' ' ' ASN . 49.7 tp10 -90.64 146.08 24.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.873 . . . . 0.0 109.289 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -90.05 32.02 0.94 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -0.943 . . . . 0.0 109.523 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.27 -47.44 55.84 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -54.95 -44.23 74.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -1.17 . . . . 0.0 109.445 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -124.23 84.75 55.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.533 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.26 54.28 1.35 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.649 2.233 . . . . 0.0 111.822 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.1 m -60.98 -37.18 81.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 109.331 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -139.36 -179.53 5.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 0.0 109.396 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 p -127.8 158.16 38.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.527 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 79.2 p -145.78 162.19 38.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.3 tt -55.54 -31.38 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.857 . . . . 0.0 109.554 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -66.33 -31.77 72.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.435 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.2 m -51.95 -48.49 64.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.439 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -47.59 -51.37 21.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -52.39 -40.4 53.68 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.441 ' ND2' ' CD ' ' A' ' 135' ' ' GLU . 87.9 m-20 -64.96 -39.26 93.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -1.141 . . . . 0.0 109.465 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.79 -48.54 72.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.447 ' O ' HD13 ' A' ' 156' ' ' LEU . 6.6 mp -64.17 -41.13 97.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.441 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.515 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -64.9 -36.97 86.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.456 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 76.4 m-20 -61.18 -42.74 99.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -60.8 -45.45 94.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.527 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 152' ' ' LEU . 1.0 OUTLIER -63.89 -38.19 90.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.23 93.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 109.465 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 56.2 m -64.7 -41.65 95.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.5 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.49 -33.14 72.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.89 . . . . 0.0 109.624 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.23 96.38 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 164' ' ' VAL . 95.6 p -56.73 -28.68 61.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -1.171 . . . . 0.0 109.631 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -72.72 -25.11 61.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 109.524 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 50' ' ' PRO . 77.1 t -64.17 -42.55 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.899 . . . . 0.0 109.411 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.506 HG11 ' N ' ' A' ' 165' ' ' ASN . 41.0 t -122.43 158.63 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.413 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.506 ' N ' HG11 ' A' ' 164' ' ' VAL . 47.9 t-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.471 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.27 -25.85 68.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -1.155 . . . . 0.0 109.504 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.581 ' O ' ' CD1' ' A' ' 6' ' ' TYR . 89.3 mtp -62.67 -35.86 81.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.147 -0.971 . . . . 0.0 109.498 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . -42.7 164.39 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 74.2 mt-30 66.36 39.84 3.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.121 . . . . 0.0 109.63 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 3' ' ' MET . 7.9 p90 -135.62 152.7 51.5 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.312 -0.868 . . . . 0.0 109.35 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.493 ' OE2' ' CD ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -88.5 -31.41 18.74 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.289 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.465 ' O ' HG21 ' A' ' 78' ' ' VAL . . . -177.24 -177.08 45.87 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 79' ' ' LEU . 59.4 t -124.8 142.63 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -1.133 . . . . 0.0 109.25 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.676 ' CD2' ' CD2' ' A' ' 34' ' ' HIS . 5.4 m-85 -114.3 146.58 40.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.861 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.578 ' CE2' HG13 ' A' ' 81' ' ' ILE . 67.8 m-85 -119.64 129.1 54.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.394 -0.817 . . . . 0.0 109.104 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.451 HG22 HD13 ' A' ' 32' ' ' ILE . 16.0 p -118.02 147.46 43.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.64 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 58.8 t0 -144.34 150.65 38.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.548 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -134.96 120.99 2.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.7 m -133.13 150.68 52.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -1.137 . . . . 0.0 109.625 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -119.75 154.46 34.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.479 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 161' ' ' SER . 66.6 mt -122.55 134.17 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.162 -0.961 . . . . 0.0 109.629 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.408 ' HG2' ' CG ' ' A' ' 26' ' ' ASN . 37.2 mttp -103.12 152.31 21.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -124.61 176.35 2.4 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.362 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 46.4 Cg_endo -68.78 128.62 17.22 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.497 2.131 . . . . 0.0 111.321 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 53.75 60.32 11.59 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 108.917 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 19' ' ' SER . 46.7 Cg_endo -67.75 69.5 0.79 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.938 2.425 . . . . 0.0 112.013 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 p -57.67 -16.94 12.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.858 . . . . 0.0 109.2 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -118.26 -174.97 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 m -70.37 151.64 44.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 7.8 m120 -60.43 -178.99 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.843 . . . . 0.0 109.431 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' ILE . 23.7 m120 -99.53 113.7 26.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.413 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -93.17 150.35 20.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.9 143.03 9.81 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 63.4 mtm -115.39 162.86 16.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -1.152 . . . . 0.0 109.359 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' A' ' 156' ' ' LEU . . . -151.27 130.22 3.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' A' ' 47' ' ' TRP . 23.4 mm -114.76 140.65 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -1.116 . . . . 0.0 109.382 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 153' ' ' ALA . 40.6 t -127.88 130.2 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.676 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 19.6 m170 -105.67 137.57 43.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.144 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.1 168.63 19.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.709 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -137.01 164.32 28.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.379 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.537 ' CE2' ' HE1' ' A' ' 3' ' ' MET . 59.4 m-85 -102.48 14.78 31.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.494 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.559 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -51.17 179.8 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 108.942 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.3 Cg_endo -66.1 -6.21 14.05 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.137 1.891 . . . . 0.0 111.447 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' CD ' ' NE2' ' A' ' 42' ' ' GLN . 79.7 tt0 -135.16 106.55 6.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.427 -0.795 . . . . 0.0 109.066 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -58.38 122.96 14.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.258 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.469 ' NE2' ' CD ' ' A' ' 40' ' ' GLU . 45.1 mt-30 -154.14 148.17 25.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.683 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 8.6 p -82.96 123.78 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 54.4 mt -64.27 -34.18 77.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 21.7 t-20 178.69 155.3 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.512 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.448 ' HB3' HD23 ' A' ' 156' ' ' LEU . 94.2 mt-30 -109.32 142.39 40.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.322 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.455 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -126.52 136.4 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.591 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.1 t -127.29 132.49 50.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.361 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.577 HD13 ' CD2' ' A' ' 66' ' ' PHE . 3.3 mt -132.77 91.73 28.72 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.74 136.22 29.89 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.713 2.275 . . . . 0.0 111.728 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 44.0 mt -101.48 143.98 30.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.41 -68.41 1.13 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -109.87 64.09 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.19 . . . . 0.0 109.537 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 81.0 m80 -132.1 171.95 12.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.439 HG23 ' HG3' ' A' ' 58' ' ' MET . 11.7 t -121.0 174.22 6.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.83 -45.26 78.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' GLU . 90.1 mt-30 -60.35 -64.03 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.447 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.439 ' HG3' HG23 ' A' ' 55' ' ' THR . 97.1 mtp -44.35 -35.3 2.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 109.371 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.43 ' HB3' HD11 ' A' ' 51' ' ' LEU . . . -80.39 -25.9 38.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 57' ' ' GLN . 78.0 tt0 -64.48 -40.56 95.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.404 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.592 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 12.1 tt -84.1 -29.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.73 -25.84 65.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.465 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.38 81.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.512 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 96.7 t -79.29 -38.97 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.569 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -66.8 -39.37 87.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.078 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.577 ' CD2' HD13 ' A' ' 49' ' ' ILE . 27.6 t80 -59.72 -64.54 0.91 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.447 -0.783 . . . . 0.0 109.608 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.94 -32.2 70.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.839 . . . . 0.0 109.751 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.494 ' SG ' ' CG2' ' A' ' 120' ' ' ILE . 50.8 t -54.82 -54.18 45.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -62.87 -45.67 91.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.581 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.526 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 62.9 mttm -63.38 -38.0 89.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 109.669 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 74' ' ' ILE . . . -56.75 -63.05 1.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.57 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.534 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 25.2 tp -53.48 -45.74 69.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.489 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 72' ' ' LEU . 20.8 tttp -43.06 -43.21 4.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.371 -0.831 . . . . 0.0 109.23 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 8.0 mt -48.25 142.44 7.92 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 108.877 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.8 Cg_endo -66.11 -4.3 10.06 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.447 2.098 . . . . 0.0 111.696 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.414 ' HA3' ' CD ' ' A' ' 7' ' ' GLU . . . -140.77 166.96 25.76 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.493 ' CD ' ' OE2' ' A' ' 7' ' ' GLU . 46.7 Cg_endo -67.64 127.17 15.88 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.418 2.079 . . . . 0.0 111.591 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.586 HG22 ' CD1' ' A' ' 10' ' ' PHE . 7.3 p -123.47 151.41 28.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.165 -0.959 . . . . 0.0 109.495 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.521 ' CD2' ' HB ' ' A' ' 131' ' ' THR . 15.5 mt -93.15 146.78 23.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 131' ' ' THR . 65.1 t -118.09 135.84 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 109.396 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.578 HG13 ' CE2' ' A' ' 11' ' ' TYR . 26.1 mm -114.75 132.67 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.427 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -129.77 161.62 30.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.953 . . . . 0.0 109.481 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 58.7 p30 -94.57 11.38 31.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.363 -0.835 . . . . 0.0 109.435 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.453 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.3 t -131.92 119.21 20.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.498 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.528 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 68.9 t80 -75.96 -34.3 59.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.339 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -57.95 -53.62 56.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 88' ' ' ALA . 13.7 p -61.06 -46.67 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.338 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.499 ' N ' HG12 ' A' ' 87' ' ' VAL . . . -53.5 -51.72 61.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.204 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 84.4 tt0 -55.93 -36.5 67.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.623 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 67.8 m -54.87 -49.51 71.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.451 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 124' ' ' LEU . . . -85.95 -1.0 56.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.719 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.453 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 81.3 m-20 -87.1 -73.32 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.072 -1.017 . . . . 0.0 109.722 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 67.6 mttm -127.08 -30.76 2.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -0.87 . . . . 0.0 109.835 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.479 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 69.4 mt-10 -58.09 -28.21 64.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.727 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.487 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -59.64 -61.23 8.29 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.0 109.458 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -66.3 -30.87 44.77 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.691 2.261 . . . . 0.0 111.572 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -67.55 -39.51 84.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.013 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.55 ' CD2' HD22 ' A' ' 111' ' ' LEU . 27.9 m0 -63.46 -51.38 65.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.173 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 98' ' ' TRP . 15.3 tttp -45.0 -41.98 7.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 m -57.91 -41.55 82.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -86.09 10.82 13.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.465 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 75.99 39.79 31.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 85.9 m-85 62.42 43.56 7.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -1.168 . . . . 0.0 109.48 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.81 135.11 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.551 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.458 ' HB2' HD13 ' A' ' 111' ' ' LEU . 41.0 t-20 -67.57 141.51 56.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.45 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -51.66 -35.29 41.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -77.54 164.24 25.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -55.61 -31.34 62.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 2.1 mptp? -61.43 141.82 94.25 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.516 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.11 154.69 66.11 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.732 2.288 . . . . 0.0 111.742 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.555 ' CD2' ' CD1' ' A' ' 114' ' ' ILE . 10.1 tp -81.92 134.2 35.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 12.8 mmtp -115.24 167.08 11.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.56 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 49.0 m80 65.61 34.56 7.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.517 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.555 ' CD1' ' CD2' ' A' ' 111' ' ' LEU . 35.8 mm -68.09 -42.73 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.414 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 23.2 m -55.96 -40.76 73.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 109.346 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -65.37 -39.21 92.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.623 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 22.6 m95 -71.64 -39.15 70.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.317 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 55.3 mtmt -57.38 -42.16 81.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 109.383 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.3 m -58.41 -42.42 87.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.494 ' CG2' ' SG ' ' A' ' 68' ' ' CYS . 83.4 mt -76.36 -34.06 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.44 ' CA ' HD11 ' A' ' 95' ' ' LEU . . . -63.62 -40.05 95.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.941 . . . . 0.0 109.432 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -57.46 -42.53 82.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.438 ' HB3' HD13 ' A' ' 130' ' ' ILE . 35.4 m -67.53 -49.68 62.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.583 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 56.0 mt -62.71 -30.56 71.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.913 . . . . 0.0 109.571 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 121' ' ' ALA . 39.0 m -56.04 -36.37 67.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.498 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.404 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 65.3 mtt -64.15 -34.85 79.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.985 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 126' ' ' MET . 1.3 mttp 170.76 156.53 0.21 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.626 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 129' ' ' ASP . 53.4 Cg_endo -71.82 2.65 4.51 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.823 2.349 . . . . 0.0 111.897 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 91.3 m-20 -41.73 -43.97 3.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.875 . . . . 0.0 109.685 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 50.3 mt -68.35 115.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.51 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.521 ' HB ' ' CD2' ' A' ' 79' ' ' LEU . 24.5 m -107.52 142.95 36.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 0.0 109.095 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.45 ' HB ' ' OD1' ' A' ' 92' ' ' ASN . 61.8 mt -124.96 137.99 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 109.781 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.49 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 94.8 mt-30 -133.03 161.19 35.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.354 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.528 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 20.0 t-80 -105.07 135.68 45.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 109.412 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.525 ' CG ' HG21 ' A' ' 81' ' ' ILE . 99.4 mt-10 -75.16 154.54 37.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.84 33.66 1.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.476 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.13 -164.17 40.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -118.93 132.87 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -1.131 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.427 ' HG2' ' HD2' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -143.3 138.46 15.59 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.168 -0.957 . . . . 0.0 109.526 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.427 ' HD2' ' HG2' ' A' ' 139' ' ' GLN . 49.6 Cg_endo -70.71 -24.51 25.25 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.733 2.288 . . . . 0.0 111.695 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.501 ' CG2' HG21 ' A' ' 143' ' ' THR . 40.6 m -64.53 -35.46 81.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.454 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.415 ' OD1' HG23 ' A' ' 147' ' ' THR . 72.2 m-20 56.63 49.33 14.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.501 HG21 ' CG2' ' A' ' 141' ' ' THR . 48.6 p -70.44 -20.26 62.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.483 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.9 p -117.62 152.02 36.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.462 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 12.9 tt -67.01 -28.69 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.515 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -65.41 -34.38 78.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.902 . . . . 0.0 109.467 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.415 HG23 ' OD1' ' A' ' 142' ' ' ASN . 51.9 m -56.86 -49.17 76.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 109.444 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.03 -48.3 64.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.433 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.6 -37.35 82.52 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -60.08 -40.06 88.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -1.119 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.06 -52.84 62.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.489 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.9 mt -57.31 -48.64 78.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.491 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.49 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -54.43 -40.44 68.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.453 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 88.8 m-20 -59.25 -40.29 85.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -60.58 -42.64 97.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.538 ' CD1' ' N ' ' A' ' 156' ' ' LEU . 6.6 mp -66.28 -39.86 89.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.527 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.72 -53.2 58.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.0 m -59.12 -42.83 91.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -63.11 -40.05 96.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.73 -51.29 58.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.524 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 30.3 m -61.92 -33.39 74.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -1.133 . . . . 0.0 109.465 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -62.99 -35.86 81.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.892 . . . . 0.0 109.46 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.4 t -64.96 -16.76 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 40.2 t -109.34 134.76 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.472 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.32 79.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.451 ' O ' ' OH ' ' A' ' 6' ' ' TYR . 59.4 mtm -62.72 -33.01 74.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.88 177.26 19.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -103.73 116.14 31.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -1.149 . . . . 0.0 109.511 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.598 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 64.8 m-85 -119.47 168.65 10.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.352 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 76.6 mm-40 -63.0 -38.66 92.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.171 -0.956 . . . . 0.0 108.942 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.48 -170.71 41.64 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.554 HG23 ' CZ ' ' A' ' 37' ' ' TYR . 73.8 t -133.26 139.1 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -1.082 . . . . 0.0 109.007 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.635 ' CD2' ' ND1' ' A' ' 34' ' ' HIS . 5.1 m-85 -113.8 138.6 50.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.905 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.546 ' CE1' HD11 ' A' ' 81' ' ' ILE . 75.2 m-85 -114.05 117.2 30.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.146 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.459 ' CG2' HG22 ' A' ' 32' ' ' ILE . 10.4 p -114.55 157.16 23.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.786 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 49.9 t0 -155.77 156.01 34.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.279 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.495 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -131.25 141.96 13.29 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.9 t -141.62 138.6 32.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.543 ' CB ' ' CB ' ' A' ' 56' ' ' ALA . . . -118.97 143.62 46.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.521 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.438 HD13 ' OG ' ' A' ' 161' ' ' SER . 63.9 mt -119.82 134.96 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.378 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -97.35 127.02 42.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.464 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 3.7 m -115.21 158.77 40.29 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.435 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.47 -28.33 21.99 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.747 2.298 . . . . 0.0 111.855 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.591 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -72.61 -66.44 0.6 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.528 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 50.0 Cg_endo -69.7 65.7 1.75 Allowed 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.671 2.247 . . . . 0.0 111.804 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 m -54.72 -43.14 72.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -97.88 33.43 2.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.44 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 22' ' ' PRO . 35.2 t -162.69 147.98 12.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -131.24 159.96 36.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.526 ' HB3' ' CG2' ' A' ' 164' ' ' VAL . 21.8 m120 -91.68 114.97 27.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.485 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 51' ' ' LEU . . . -99.26 143.08 29.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.93 151.44 20.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.517 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 72.4 mtm -128.68 160.45 32.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -1.145 . . . . 0.0 109.518 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -153.34 115.67 0.69 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 47' ' ' TRP . 4.3 mp -123.54 120.53 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -1.175 . . . . 0.0 109.431 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.549 ' CG2' ' CG1' ' A' ' 43' ' ' VAL . 11.6 p -120.82 148.0 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.635 ' ND1' ' CD2' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -109.24 145.52 35.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.03 173.11 11.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -133.22 157.03 46.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 109.664 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.554 ' CZ ' HG23 ' A' ' 9' ' ' VAL . 16.7 m-30 -103.48 12.79 34.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.51 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.569 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -50.82 -179.62 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 108.941 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.5 Cg_endo -65.11 -7.43 15.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.038 1.825 . . . . 0.0 111.288 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -128.11 106.25 8.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.429 -0.795 . . . . 0.0 108.965 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -61.82 127.37 31.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.149 -0.97 . . . . 0.0 109.237 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -161.42 154.24 20.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.925 . . . . 0.0 109.562 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.549 ' CG1' ' CG2' ' A' ' 33' ' ' VAL . 41.9 t -91.05 122.54 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 109.24 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 45.5 mt -62.46 -40.21 95.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 109.346 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.46 ' O ' HG23 ' A' ' 33' ' ' VAL . 64.2 t30 178.45 154.49 0.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.878 . . . . 0.0 109.684 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.529 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 56.2 mt-30 -107.58 143.06 36.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.054 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.2 t-105 -118.52 131.85 56.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 109.599 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.2 m -121.88 145.34 48.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.476 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 9.9 mt -149.56 96.88 3.57 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.554 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.0 Cg_endo -70.02 128.4 15.74 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.684 2.256 . . . . 0.0 111.661 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 28' ' ' ALA . 49.0 mt -114.36 148.67 37.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 109.49 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.65 -46.89 0.2 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -87.47 11.11 15.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 78.2 m80 -112.61 147.21 37.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.414 HG21 ' HG3' ' A' ' 58' ' ' MET . 0.1 OUTLIER -89.58 168.47 12.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.9 . . . . 0.0 109.111 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.543 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . . . -49.38 -38.76 29.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.1 -1.0 . . . . 0.0 109.056 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' MET . 89.2 mt-30 -70.09 -58.77 3.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.332 -0.855 . . . . 0.0 109.311 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.46 ' O ' HG22 ' A' ' 61' ' ' ILE . 93.3 mtp -45.43 -30.59 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.158 -0.964 . . . . 0.0 109.199 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.28 -37.35 60.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.416 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.447 ' HB3' ' OG ' ' A' ' 84' ' ' SER . 96.3 mt-10 -62.74 -44.9 95.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.358 -0.839 . . . . 0.0 109.562 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.63 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 8.2 tt -67.29 -35.09 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.517 ' CB ' ' SD ' ' A' ' 30' ' ' MET . . . -65.89 -29.69 70.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.192 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 12' ' ' THR . . . -70.01 -44.79 68.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.44 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.516 HG22 ' CG1' ' A' ' 87' ' ' VAL . 68.6 t -63.13 -47.3 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.335 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.452 ' HG3' HG12 ' A' ' 120' ' ' ILE . 84.6 tt0 -64.83 -38.3 90.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 109.417 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.529 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 16.3 t80 -53.66 -68.82 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.395 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.23 -15.94 58.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.369 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.459 ' O ' HD13 ' A' ' 130' ' ' ILE . 39.8 t -70.79 -58.03 4.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.435 ' NZ ' ' OE2' ' A' ' 65' ' ' GLU . 25.5 mttt -59.76 -48.69 80.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.486 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.529 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 37.5 mttm -60.87 -38.48 85.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.227 -0.92 . . . . 0.0 109.505 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.566 ' CB ' ' CG1' ' A' ' 78' ' ' VAL . . . -55.74 -69.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 71' ' ' ALA . 6.3 tp -44.89 -48.51 11.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 109.434 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 20.2 mttm -43.81 -44.36 6.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.281 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.551 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 9.7 mt -48.81 143.11 8.51 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.043 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.6 Cg_endo -66.29 -2.68 7.48 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.601 2.2 . . . . 0.0 111.921 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.527 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -141.64 166.4 26.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.47 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.3 Cg_endo -69.34 122.75 9.54 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 122.552 2.168 . . . . 0.0 111.714 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.572 HG22 ' CE1' ' A' ' 10' ' ' PHE . 2.8 p -112.77 156.44 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.598 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 19.3 mt -101.58 140.26 36.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.759 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 52.0 t -120.92 130.33 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.137 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.546 HD11 ' CE1' ' A' ' 11' ' ' TYR . 8.0 mt -118.71 136.23 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.742 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.8 t -140.97 143.26 34.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.237 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -66.69 -25.34 66.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.905 . . . . 0.0 109.57 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.58 ' CB ' ' CG1' ' A' ' 87' ' ' VAL . 3.6 m -64.69 110.93 2.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 109.286 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.659 ' CD2' ' CE1' ' A' ' 134' ' ' HIS . 49.2 t80 -78.05 -41.45 35.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.688 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -71.15 -35.98 71.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 0.0 109.908 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.58 ' CG1' ' CB ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -67.36 -47.16 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.135 -0.978 . . . . 0.0 109.497 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.579 ' CB ' ' NE2' ' A' ' 134' ' ' HIS . . . -54.32 -51.4 64.8 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.229 -0.919 . . . . 0.0 108.964 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.447 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 72.6 tt0 -55.26 -33.39 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.332 -0.855 . . . . 0.0 108.967 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.637 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 16.6 m -57.3 -49.11 77.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.844 . . . . 0.0 109.352 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.482 ' CB ' ' CD1' ' A' ' 132' ' ' ILE . . . -85.71 -0.72 55.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.749 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.472 ' OD1' ' HB ' ' A' ' 132' ' ' ILE . 85.7 m-20 -88.48 -73.48 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 109.947 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 63.0 mttt -127.42 -30.07 2.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.017 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 37.5 mm-40 -57.04 -31.54 65.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.078 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.486 ' CD1' ' O ' ' A' ' 90' ' ' SER . 0.5 OUTLIER -58.32 -60.8 9.05 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 0.0 109.503 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -66.8 -26.33 45.12 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.642 2.228 . . . . 0.0 111.581 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.507 ' CE2' ' OD1' ' A' ' 101' ' ' ASN . 77.7 t80 -73.82 -36.83 65.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 108.977 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.458 ' CE3' HD23 ' A' ' 111' ' ' LEU . 17.1 m0 -65.33 -50.35 65.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.35 -0.844 . . . . 0.0 109.239 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -51.03 -40.09 57.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.382 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 97' ' ' TYR . 82.7 p -63.46 -35.99 82.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.389 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.507 ' OD1' ' CE2' ' A' ' 97' ' ' TYR . 24.5 m120 -85.73 8.37 20.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 77.41 37.16 32.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 87.3 m-85 63.25 48.8 3.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -1.173 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 101' ' ' ASN . 46.7 t -110.14 134.89 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.54 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.512 ' HB2' ' CD1' ' A' ' 111' ' ' LEU . 48.8 t30 -98.89 136.3 39.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.464 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -57.47 -38.78 75.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.4 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -67.66 -46.46 72.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.396 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 105' ' ' ASN . 33.7 mttm -132.86 145.22 50.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.9 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.573 ' CB ' ' CD ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -44.71 -65.2 0.66 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 109.531 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 109' ' ' LYS . 49.3 Cg_endo -70.1 138.4 36.67 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.686 2.257 . . . . 0.0 111.873 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.512 ' CD1' ' HB2' ' A' ' 105' ' ' ASN . 11.3 tp -85.96 142.25 28.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.393 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HD3' ' CE1' ' A' ' 113' ' ' HIS . 80.8 tttt -101.23 151.88 21.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.591 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.546 ' CE1' ' HD3' ' A' ' 112' ' ' LYS . 39.5 m80 65.31 28.55 11.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.569 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.493 ' CG1' ' HB3' ' A' ' 111' ' ' LEU . 80.0 mt -62.88 -45.48 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.167 -0.958 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -55.67 -46.08 77.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.53 -45.48 91.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.637 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 54.3 m95 -66.42 -36.55 83.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.439 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -56.4 -46.17 80.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.484 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.6 m -59.96 -44.11 94.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.407 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.452 HG12 ' HG3' ' A' ' 65' ' ' GLU . 87.8 mt -68.79 -39.58 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.453 ' O ' ' OG ' ' A' ' 125' ' ' SER . . . -62.87 -36.24 82.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.472 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -56.2 -37.92 70.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 6.0 m -79.43 -51.34 9.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.387 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.4 tp -58.56 -34.59 71.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.417 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 121' ' ' ALA . 50.0 m -60.47 -31.88 70.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.549 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.78 -33.38 75.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.447 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.45 145.95 0.29 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 109.511 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.6 Cg_endo -72.35 2.72 4.76 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.741 2.294 . . . . 0.0 111.774 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 79.5 m-20 -42.87 -46.16 5.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.504 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 68' ' ' CYS . 52.8 mt -61.92 121.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.342 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.52 ' HB ' ' CD2' ' A' ' 79' ' ' LEU . 24.4 m -110.85 146.77 35.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.372 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.482 ' CD1' ' CB ' ' A' ' 91' ' ' ALA . 54.1 mt -125.12 128.13 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.467 ' HB2' HG12 ' A' ' 81' ' ' ILE . 79.9 mt-30 -127.24 154.9 44.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.659 ' CE1' ' CD2' ' A' ' 85' ' ' PHE . 34.1 m170 -90.67 141.01 29.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.791 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.463 ' HG2' ' OD1' ' A' ' 150' ' ' ASN . 98.3 mt-10 -75.71 147.03 39.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 109.286 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -101.55 37.85 1.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.559 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -46.26 -33.96 5.94 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -91.32 135.2 33.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 0.0 109.428 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.479 ' O ' ' CG2' ' A' ' 143' ' ' THR . 2.2 tp60 67.11 73.02 0.39 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.506 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.432 ' HA ' HG21 ' A' ' 143' ' ' THR . 50.0 Cg_endo -70.63 -16.94 33.92 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.704 2.27 . . . . 0.0 111.719 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 142' ' ' ASN . 58.6 m -76.3 139.89 41.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.496 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 141' ' ' THR . 64.8 m-20 60.74 44.51 11.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.448 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 139' ' ' GLN . 27.1 p -119.31 159.05 24.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.463 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.3 m -70.99 174.52 6.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.535 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 24.3 pt -70.2 -10.04 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.893 . . . . 0.0 109.476 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.5 ' NE2' ' OH ' ' A' ' 37' ' ' TYR . 71.9 m80 -65.31 -27.09 68.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.1 m -51.35 -45.92 62.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.315 -0.866 . . . . 0.0 109.563 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -52.22 -49.81 63.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 109.506 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.43 -36.1 75.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.463 ' OD1' ' HG2' ' A' ' 135' ' ' GLU . 77.1 m-20 -60.42 -41.13 93.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -1.15 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.24 -48.48 79.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.402 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 26.0 tp -65.28 -42.26 93.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.32 -40.73 98.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 0.0 109.509 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.451 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 56.2 t0 -58.26 -43.17 87.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 0.0 109.559 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 78.6 tttt -62.19 -38.13 87.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.51 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 46' ' ' GLN . 78.8 mt -64.29 -38.2 90.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.568 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.22 83.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.923 . . . . 0.0 109.463 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 36.3 m -61.59 -41.46 97.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.472 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 95.2 mt-30 -62.4 -35.96 80.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -62.54 -55.94 24.38 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.438 ' OG ' HD13 ' A' ' 17' ' ' ILE . 88.1 p -67.48 -28.69 68.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -1.146 . . . . 0.0 109.516 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -63.85 -36.14 82.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.551 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 39.1 t -64.95 -11.79 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.514 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.526 ' CG2' ' HB3' ' A' ' 27' ' ' ASN . 22.3 m -126.98 155.55 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.455 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 164' ' ' VAL . 17.0 m120 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.539 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.5 146.22 49.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -1.157 . . . . 0.0 109.55 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 77.9 mtm -63.92 -40.27 96.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 68.5 -172.21 35.67 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 75.0 mm-40 82.55 -24.91 0.16 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.724 -0.868 . . . . 0.0 110.259 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.549 ' OH ' ' CG ' ' A' ' 37' ' ' TYR . 24.0 p90 -129.22 166.74 18.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.902 -1.124 . . . . 0.0 109.565 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.489 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -94.72 -33.86 12.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 108.924 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.469 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -165.74 175.42 41.4 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.511 HG22 ' CE1' ' A' ' 37' ' ' TYR . 91.8 t -124.95 138.02 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.196 -1.179 . . . . 0.0 109.357 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE2' ' CG ' ' A' ' 34' ' ' HIS . 5.3 m-85 -111.38 139.55 46.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.558 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 82.2 m-85 -113.93 127.34 55.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.908 . . . . 0.0 109.39 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 16.3 p -118.49 152.6 35.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.574 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 53.7 t0 -151.36 152.87 33.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -135.08 118.0 1.84 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.8 m -122.18 150.28 42.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -1.149 . . . . 0.0 109.536 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.44 145.89 48.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.441 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.493 ' CD1' ' OG ' ' A' ' 161' ' ' SER . 74.5 mt -117.73 141.48 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 109.461 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 pttm -104.62 136.43 44.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.587 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.479 ' OG ' ' HD2' ' A' ' 20' ' ' PRO . 4.0 t -120.04 155.1 55.81 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.479 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 46.4 Cg_endo -67.67 -18.51 48.11 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.621 2.214 . . . . 0.0 112.009 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.582 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -82.38 -66.4 0.22 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.223 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 52.3 Cg_endo -71.91 68.4 3.11 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.592 2.195 . . . . 0.0 111.56 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.0 m -54.61 -43.64 72.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.374 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -98.41 36.06 1.68 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.312 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 22' ' ' PRO . 16.2 t -161.5 138.12 8.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.371 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -126.36 159.13 34.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.559 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -92.9 115.55 28.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.477 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.19 148.29 24.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 109.463 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.83 153.18 24.05 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.514 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 70.9 mtm -119.95 161.5 20.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.449 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -154.42 117.48 0.79 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' TRP . 4.8 mp -125.74 120.29 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -1.138 . . . . 0.0 109.256 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.509 ' CG2' ' CG1' ' A' ' 43' ' ' VAL . 9.6 p -119.59 145.89 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.735 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.688 ' CG ' ' CE2' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -105.72 136.17 45.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.147 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.38 167.37 20.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.642 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.6 t -124.56 159.85 29.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.369 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.549 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 17.7 m-85 -106.71 16.9 23.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.71 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.568 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -51.28 -178.7 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.852 . . . . 0.0 108.711 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.5 Cg_endo -65.02 -6.37 12.73 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.964 1.776 . . . . 0.0 111.566 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -131.64 106.09 7.94 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.574 ' CE1' HG22 ' A' ' 145' ' ' ILE . 60.5 t80 -57.44 126.02 25.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.469 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -155.21 149.14 25.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -0.91 . . . . 0.0 109.534 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.509 ' CG1' ' CG2' ' A' ' 33' ' ' VAL . 51.4 t -91.49 121.06 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 109.523 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 53.1 mt -63.93 -38.89 92.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.453 ' O ' HG22 ' A' ' 33' ' ' VAL . 39.9 t30 -179.99 156.29 0.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.579 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.51 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 93.5 mt-30 -110.46 147.82 33.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.426 -0.796 . . . . 0.0 109.025 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -126.07 132.89 51.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.124 -0.985 . . . . 0.0 109.716 -179.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.7 t -126.22 132.11 51.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.242 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.469 ' HB ' ' CE ' ' A' ' 30' ' ' MET . 3.0 mt -135.51 111.64 10.69 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.722 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.484 ' HB3' ' CG2' ' A' ' 163' ' ' VAL . 50.2 Cg_endo -70.87 134.92 26.65 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.729 2.286 . . . . 0.0 111.665 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.495 HD13 ' CB ' ' A' ' 59' ' ' ALA . 49.9 mt -104.51 138.28 41.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.907 . . . . 0.0 109.617 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' O ' ' ND1' ' A' ' 54' ' ' HIS . . . -113.81 127.63 7.91 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 18.4 m120 64.44 38.55 7.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -1.181 . . . . 0.0 109.469 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 52' ' ' GLY . 75.9 m80 -124.74 165.46 17.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.492 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.455 HG22 ' CG ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -110.56 171.42 7.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 109.179 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.406 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -53.95 -39.72 66.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.094 -1.004 . . . . 0.0 109.231 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 60' ' ' GLU . 92.4 mt-30 -67.35 -53.66 27.48 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.871 . . . . 0.0 109.263 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.466 ' O ' HG23 ' A' ' 61' ' ' ILE . 69.7 mmm -44.73 -34.61 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.33 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.495 ' CB ' HD13 ' A' ' 51' ' ' LEU . . . -76.83 -32.49 57.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.399 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' GLN . 97.7 mt-10 -62.85 -40.61 97.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.58 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.566 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 17.7 tt -74.73 -35.12 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.549 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.514 ' CB ' ' SD ' ' A' ' 30' ' ' MET . . . -71.02 -30.15 66.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.56 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' HB2' ' HB ' ' A' ' 12' ' ' THR . . . -59.93 -39.29 84.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.555 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.432 HG22 HG11 ' A' ' 87' ' ' VAL . 44.3 t -77.14 -43.99 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 98.1 mt-10 -55.78 -36.83 67.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.548 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.562 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 10.8 t80 -59.87 -68.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.645 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.77 -13.58 16.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 109.602 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.427 ' O ' HD11 ' A' ' 130' ' ' ILE . 40.2 t -66.3 -60.77 2.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.485 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -65.65 -40.99 93.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.562 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 54.3 mttm -65.86 -27.42 68.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.566 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.14 -57.13 5.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.437 HD12 ' OD2' ' A' ' 129' ' ' ASP . 24.7 tp -61.52 -39.25 90.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -47.07 -37.47 9.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 33.9 mm -61.66 142.8 94.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 108.958 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.5 Cg_endo -64.6 -5.94 11.19 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.575 2.183 . . . . 0.0 111.731 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.29 166.79 24.03 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 47.5 Cg_endo -68.65 140.97 48.57 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.547 2.165 . . . . 0.0 111.679 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.563 HG12 ' CE1' ' A' ' 10' ' ' PHE . 21.8 t -126.32 159.31 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.537 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.548 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 1.9 mp -113.32 124.52 52.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.834 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 62.4 t -104.9 133.13 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.441 HG12 ' HB2' ' A' ' 133' ' ' GLN . 31.9 mt -119.97 135.71 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.935 . . . . 0.0 109.479 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.66 161.79 30.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 109.258 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 53.9 p-10 -90.02 10.86 22.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.945 . . . . 0.0 109.548 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.4 t -112.04 126.02 54.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.576 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 70.8 t80 -80.64 -40.23 25.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.408 ' O ' ' HB2' ' A' ' 90' ' ' SER . 96.0 m-85 -61.02 -49.56 76.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 90' ' ' SER . 48.4 t -61.7 -52.12 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.403 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HA ' HG22 ' A' ' 132' ' ' ILE . . . -52.88 -61.04 2.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.895 . . . . 0.0 109.341 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 81.5 tt0 -57.82 -18.98 25.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.191 -0.943 . . . . 0.0 109.277 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.522 ' HA ' ' CG ' ' A' ' 94' ' ' GLU . 8.4 t -66.73 -65.09 0.72 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.557 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.506 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -69.82 -7.5 40.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.553 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 85.1 m-20 -86.58 -46.33 10.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.678 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' C ' ' HD2' ' A' ' 96' ' ' PRO . 62.6 mttp -126.46 -47.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 109.732 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.582 ' HB3' ' CE2' ' A' ' 98' ' ' TRP . 81.7 mt-10 -51.46 -44.22 62.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.694 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.521 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 0.3 OUTLIER -50.68 -63.45 1.87 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.912 . . . . 0.0 109.54 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.521 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 48.0 Cg_endo -68.69 -42.05 5.24 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.749 2.299 . . . . 0.0 112.035 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.31 -40.05 96.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.622 ' CE2' ' CD2' ' A' ' 111' ' ' LEU . 39.9 m0 -65.07 -43.71 91.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.59 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -50.18 -39.89 45.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.565 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.1 p -66.02 -29.95 70.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -90.31 8.57 32.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.511 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 69.68 33.24 71.23 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 111' ' ' LEU . 20.8 m-85 68.21 32.59 4.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -1.108 . . . . 0.0 109.457 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.24 127.26 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.406 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.503 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 18.7 t-20 -87.8 -73.64 0.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.538 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 105' ' ' ASN . 25.1 m120 -144.25 157.11 44.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.524 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -60.94 -32.52 72.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.94 -37.45 84.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.207 -0.933 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.86 127.24 3.96 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.429 ' HG2' ' HE2' ' A' ' 112' ' ' LYS . 50.4 Cg_endo -70.25 167.19 25.79 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.593 2.195 . . . . 0.0 111.739 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.622 ' CD2' ' CE2' ' A' ' 98' ' ' TRP . 21.0 mt -59.51 -39.03 82.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.452 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 111' ' ' LEU . 34.2 mttt 59.74 152.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 64.0 m80 60.23 27.05 16.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.444 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 80.5 mt -62.5 -38.33 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.361 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.9 t -56.27 -45.85 79.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.278 -0.889 . . . . 0.0 109.315 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 61.8 mttp -60.06 -54.06 50.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.566 ' CZ2' HD12 ' A' ' 61' ' ' ILE . 91.9 m95 -65.21 -33.15 75.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 109.387 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -54.01 -45.95 71.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.378 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.9 m -53.29 -44.13 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.306 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.526 ' CG1' ' HG2' ' A' ' 65' ' ' GLU . 83.7 mt -72.01 -32.79 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.364 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.415 ' CA ' HD13 ' A' ' 95' ' ' LEU . . . -61.23 -38.91 88.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.89 . . . . 0.0 109.358 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.91 -39.01 83.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.506 ' SG ' ' CD1' ' A' ' 130' ' ' ILE . 23.0 t -68.58 -44.09 75.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.431 HD11 ' HG ' ' A' ' 95' ' ' LEU . 55.1 mt -68.15 -34.15 75.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.5 t -59.64 -33.75 71.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.427 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 92.0 mtp -67.91 -33.96 75.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.6 OUTLIER 177.35 136.58 0.22 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.512 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.9 Cg_endo -71.56 2.45 4.55 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.728 2.285 . . . . 0.0 112.078 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 31.6 p-10 -43.71 -39.04 3.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.662 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.506 ' CD1' ' SG ' ' A' ' 123' ' ' CYS . 52.6 mt -59.3 115.57 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.741 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.0 m -111.6 134.05 53.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.025 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -116.44 135.9 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.081 -1.012 . . . . 0.0 109.887 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.8 mt-30 -126.0 154.22 43.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.359 -0.838 . . . . 0.0 109.3 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.576 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 17.4 t-80 -108.34 127.0 53.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.48 145.8 50.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 141' ' ' THR . 30.8 mttm -96.25 35.4 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.418 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.74 -154.27 41.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -56.28 -40.75 74.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -1.136 . . . . 0.0 109.511 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -64.94 125.83 89.9 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.46 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.508 ' HB3' ' CG2' ' A' ' 147' ' ' THR . 50.3 Cg_endo -70.43 136.74 31.94 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.641 2.227 . . . . 0.0 111.761 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.434 ' O ' ' OD1' ' A' ' 142' ' ' ASN . 45.3 m -57.15 -44.27 83.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.404 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 141' ' ' THR . 96.5 m-20 -139.3 -43.17 0.46 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.416 HG22 ' C ' ' A' ' 142' ' ' ASN . 17.3 p -130.17 159.87 35.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.466 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 82.5 p -70.15 -14.16 62.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.574 HG22 ' CE1' ' A' ' 41' ' ' TYR . 88.4 mt -61.93 -35.38 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.583 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -69.15 -36.85 77.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.509 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.508 ' CG2' ' HB3' ' A' ' 140' ' ' PRO . 58.3 p -69.05 -40.24 78.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.478 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 144' ' ' SER . 97.3 mt-10 -54.07 -37.41 64.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.54 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -65.13 -34.54 89.98 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -65.73 -38.12 88.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -1.185 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.91 -48.8 67.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.551 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 mt -65.7 -44.32 86.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . . . -60.92 -37.7 83.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.421 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 57.4 t0 -62.59 -41.24 98.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 69.0 mttm -63.4 -36.02 82.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.51 ' CD1' ' HB3' ' A' ' 46' ' ' GLN . 71.4 mt -69.31 -37.23 77.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.49 -43.94 68.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 31.7 m -60.14 -42.2 94.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 95.1 mt-30 -65.23 -33.31 75.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 109.541 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.449 ' O ' ' CG2' ' A' ' 163' ' ' VAL . . . -61.84 -46.61 93.8 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.493 ' OG ' ' CD1' ' A' ' 17' ' ' ILE . 91.2 p -72.9 -26.19 61.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -68.36 -35.99 78.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 50' ' ' PRO . 18.1 m -70.87 -14.23 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.573 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.34 134.69 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.508 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 51.3 t30 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.472 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.44 ' O ' ' HG3' ' A' ' 5' ' ' GLN . . . -63.78 -31.2 72.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -1.185 . . . . 0.0 109.475 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.631 ' CE ' ' CZ ' ' A' ' 37' ' ' TYR . 92.7 mmm -62.6 -32.95 74.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.513 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.94 -18.15 32.08 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 97.3 mt-30 -52.12 -33.24 38.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -1.138 . . . . 0.0 109.525 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.6 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 43.9 m-85 -100.76 176.09 5.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.611 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -76.48 -36.3 57.91 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.256 -0.903 . . . . 0.0 109.19 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.47 -166.46 35.26 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' CG1' ' HB2' ' A' ' 35' ' ' ALA . 7.2 p -125.29 140.72 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -1.072 . . . . 0.0 108.996 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.674 ' CE2' ' CG ' ' A' ' 34' ' ' HIS . 6.6 m-85 -117.69 135.89 53.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 109.85 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.509 ' CE1' HD13 ' A' ' 81' ' ' ILE . 95.0 m-85 -114.08 118.72 34.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.517 ' CG2' ' HB3' ' A' ' 67' ' ' ALA . 19.0 p -115.79 151.61 34.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 0.0 109.728 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 53.1 t0 -147.51 156.15 42.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.351 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -163.21 117.11 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 68.7 m -138.85 147.98 43.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -1.163 . . . . 0.0 109.74 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -107.81 140.52 40.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.465 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.527 HD12 ' CB ' ' A' ' 161' ' ' SER . 68.6 mt -107.58 137.52 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.905 . . . . 0.0 109.524 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 36.6 tttp -93.08 145.3 24.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.266 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.526 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -125.53 176.38 2.49 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.346 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 44.9 Cg_endo -68.27 -7.74 20.9 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.463 2.109 . . . . 0.0 111.284 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -134.81 70.63 70.89 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.455 -0.778 . . . . 0.0 109.091 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.78 7.22 0.6 Allowed 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.95 2.433 . . . . 0.0 112.773 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 m -57.61 -25.14 59.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.903 -1.123 . . . . 0.0 109.147 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 25' ' ' SER . 42.9 mttt -103.68 25.91 9.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.369 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 8.2 t 66.63 164.01 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 109.651 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 96.0 m-20 -77.31 149.56 35.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.464 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -93.65 129.2 40.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 108.987 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.643 ' CB ' ' CE1' ' A' ' 54' ' ' HIS . . . -119.46 164.47 15.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -0.99 . . . . 0.0 110.158 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.82 146.77 18.75 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.519 ' SD ' ' CB ' ' A' ' 62' ' ' ALA . 61.7 mtm -120.0 145.75 46.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.479 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.81 118.61 1.78 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 47' ' ' TRP . 4.6 mp -120.86 116.87 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -1.153 . . . . 0.0 109.255 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' HB ' ' A' ' 43' ' ' VAL . 7.2 p -124.45 144.47 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.101 -1.0 . . . . 0.0 109.731 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.674 ' CG ' ' CE2' ' A' ' 10' ' ' PHE . 1.4 m-70 -101.59 141.72 34.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.852 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.462 ' HB2' ' CG1' ' A' ' 9' ' ' VAL . . . -129.81 165.81 21.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.44 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 t -126.16 165.25 19.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.631 ' CZ ' ' CE ' ' A' ' 3' ' ' MET . 82.8 m-85 -107.92 10.16 28.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.556 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.18 179.72 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.007 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.2 Cg_endo -65.45 -5.38 11.31 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.183 1.922 . . . . 0.0 111.658 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -129.25 106.02 8.54 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -64.83 129.93 41.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -167.66 154.12 7.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.479 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.482 ' HB ' ' CG2' ' A' ' 33' ' ' VAL . 32.6 m -89.37 120.59 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.887 . . . . 0.0 109.461 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 55.3 mt -57.78 -38.8 76.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.342 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.462 ' O ' HG22 ' A' ' 33' ' ' VAL . 60.9 t30 -169.6 155.43 6.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.918 . . . . 0.0 109.594 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.526 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 91.9 mt-30 -112.59 137.8 50.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.831 . . . . 0.0 109.103 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.52 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -118.01 133.38 55.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.142 -0.974 . . . . 0.0 109.659 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 t -119.85 140.17 51.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 109.31 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.588 ' CD1' ' CE1' ' A' ' 66' ' ' PHE . 1.7 mt -145.5 92.32 5.57 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 109.693 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.452 ' O ' HD23 ' A' ' 51' ' ' LEU . 49.8 Cg_endo -70.39 147.5 58.98 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.682 2.254 . . . . 0.0 111.598 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 50' ' ' PRO . 43.1 mt -123.88 129.44 51.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.698 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.461 ' HA2' HG13 ' A' ' 164' ' ' VAL . . . -92.78 -73.57 1.24 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -102.22 87.98 3.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.165 . . . . 0.0 109.154 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.643 ' CE1' ' CB ' ' A' ' 28' ' ' ALA . 6.7 p-80 -132.29 -163.82 1.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.976 . . . . 0.0 109.949 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.488 HG21 ' CE ' ' A' ' 58' ' ' MET . 0.2 OUTLIER -128.93 144.8 51.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.039 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -44.69 -33.91 2.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.084 -1.01 . . . . 0.0 109.13 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -77.79 -47.78 18.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.491 ' HA ' ' CG2' ' A' ' 61' ' ' ILE . 24.2 ttm -48.79 -35.07 13.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.987 . . . . 0.0 109.23 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.518 ' HB3' ' CD2' ' A' ' 54' ' ' HIS . . . -74.18 -45.86 45.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.382 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.91 -34.83 77.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.577 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.603 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 18.7 tt -77.32 -37.28 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.557 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.519 ' CB ' ' SD ' ' A' ' 30' ' ' MET . . . -65.9 -29.78 70.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.15 92.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.524 ' CG2' HG23 ' A' ' 82' ' ' THR . 46.5 t -77.82 -49.97 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.524 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.2 tt0 -53.09 -39.79 63.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.632 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.588 ' CE1' ' CD1' ' A' ' 49' ' ' ILE . 13.0 t80 -57.76 -69.11 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 109.57 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.517 ' HB3' ' CG2' ' A' ' 12' ' ' THR . . . -62.34 -15.95 51.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 109.462 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.515 ' SG ' ' CG2' ' A' ' 120' ' ' ILE . 39.4 t -66.09 -63.07 1.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -60.99 -44.35 97.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.541 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 48.7 mttm -62.85 -36.52 83.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.506 ' CB ' ' CG1' ' A' ' 78' ' ' VAL . . . -59.28 -64.18 1.04 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.366 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 20.0 tp -51.98 -46.73 64.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.922 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 72' ' ' LEU . 19.4 tttm -42.58 -41.1 2.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.0 109.276 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.549 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 34.8 mm -52.29 143.44 25.98 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.823 . . . . 0.0 108.802 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.549 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.1 Cg_endo -65.09 -2.47 5.73 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.632 2.221 . . . . 0.0 112.203 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.13 170.65 25.29 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 47.7 Cg_endo -69.46 119.86 6.77 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.445 2.097 . . . . 0.0 111.693 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.567 HG23 ' CD1' ' A' ' 10' ' ' PHE . 7.7 p -114.01 146.56 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.399 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.6 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 15.9 mt -93.05 143.28 26.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.737 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.495 ' CG1' ' HB2' ' A' ' 67' ' ' ALA . 49.6 t -124.13 126.33 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 109.183 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.536 HD12 HG21 ' A' ' 81' ' ' ILE . 33.6 mt -113.49 136.22 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.784 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.524 HG23 ' CG2' ' A' ' 64' ' ' VAL . 10.3 t -142.31 159.27 42.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.351 -0.843 . . . . 0.0 109.276 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.449 ' HB3' ' OE1' ' A' ' 135' ' ' GLU . 51.0 p-10 -92.69 20.22 6.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.152 -0.967 . . . . 0.0 109.466 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.483 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 41.9 m -105.57 104.48 14.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 109.347 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.567 ' CE2' ' OE2' ' A' ' 89' ' ' GLU . 74.8 t80 -69.37 -50.19 48.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 109.583 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -60.81 -40.57 93.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.521 HG11 ' CG2' ' A' ' 64' ' ' VAL . 92.5 t -62.84 -39.57 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.378 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.61 -60.66 3.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.567 ' OE2' ' CE2' ' A' ' 85' ' ' PHE . 94.0 mt-10 -50.93 -35.35 32.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.618 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 70.6 m -55.91 -47.24 77.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.451 ' HB1' ' CD1' ' A' ' 132' ' ' ILE . . . -88.6 -0.92 57.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.907 . . . . 0.0 109.805 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.449 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 84.2 m-20 -90.61 -73.61 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.122 -0.986 . . . . 0.0 109.953 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HA ' ' HG2' ' A' ' 96' ' ' PRO . 96.8 mttt -127.13 -31.66 2.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 109.842 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 57.0 mt-10 -52.18 -40.49 61.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.911 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.522 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 6.4 tp -62.93 -58.3 17.16 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.063 -1.023 . . . . 0.0 109.537 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -65.89 -26.02 52.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.521 2.147 . . . . 0.0 111.261 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 93' ' ' LYS . 60.3 t80 -75.56 -35.74 60.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.345 -0.847 . . . . 0.0 108.72 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.433 ' O ' ' C ' ' A' ' 99' ' ' LYS . 15.9 m0 -63.05 -48.31 79.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.291 -0.881 . . . . 0.0 108.979 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 98' ' ' TRP . 4.6 mtmt -43.57 -44.03 5.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 109.418 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.4 m -64.2 -42.17 96.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.4 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -68.72 -14.14 62.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.332 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 84.53 34.11 17.44 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 40.4 m-85 67.22 37.97 3.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -1.148 . . . . 0.0 109.375 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 60.9 t -117.07 129.33 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.499 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 109' ' ' LYS . 40.0 t-20 -86.23 117.31 24.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.89 . . . . 0.0 109.446 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -58.57 -35.67 72.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.433 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -58.17 -37.19 74.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 109.463 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.476 ' O ' ' CG ' ' A' ' 109' ' ' LYS . 85.4 mttt -135.17 -82.57 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.418 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.591 ' CB ' ' CD ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -172.53 -67.44 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.168 -0.957 . . . . 0.0 109.529 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 109' ' ' LYS . 52.6 Cg_endo -71.85 141.35 36.96 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.598 2.199 . . . . 0.0 111.933 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.526 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 19.0 tp -93.65 133.98 36.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.239 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 20.6 mttt -97.61 149.14 22.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.667 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.568 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 48.1 m80 66.29 30.4 9.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.341 -0.849 . . . . 0.0 109.679 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.526 ' CG1' ' HB3' ' A' ' 111' ' ' LEU . 91.1 mt -64.56 -50.35 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.133 -0.98 . . . . 0.0 109.308 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m -60.08 -44.18 94.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.233 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -59.19 -50.17 75.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.308 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.618 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 53.0 m95 -69.27 -35.77 76.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.907 . . . . 0.0 109.325 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -56.88 -45.93 82.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.341 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.9 m -55.43 -45.36 76.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.375 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.515 ' CG2' ' SG ' ' A' ' 68' ' ' CYS . 69.0 mt -66.82 -36.62 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.409 -0.807 . . . . 0.0 109.411 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.507 ' CB ' HD21 ' A' ' 95' ' ' LEU . . . -57.42 -43.4 83.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.461 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.21 -45.84 75.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.506 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 93.4 m -66.52 -46.56 75.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.23 -32.51 73.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.365 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.4 m -61.65 -35.17 77.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.417 ' C ' ' HG2' ' A' ' 127' ' ' LYS . 66.1 mtt -64.6 -34.38 78.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HG2' ' C ' ' A' ' 126' ' ' MET . 0.2 OUTLIER 174.57 145.39 0.21 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.242 -0.911 . . . . 0.0 109.559 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.6 Cg_endo -72.17 2.33 5.07 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.698 2.265 . . . . 0.0 111.763 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 76.9 m-20 -42.39 -46.79 4.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.559 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 60.5 mt -56.6 122.14 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.527 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.523 ' CB ' HD21 ' A' ' 79' ' ' LEU . 24.6 m -112.2 141.55 45.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.154 -0.966 . . . . 0.0 109.337 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 70.8 mt -125.25 134.61 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.935 . . . . 0.0 109.669 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.451 ' HB2' HG12 ' A' ' 81' ' ' ILE . 91.4 mt-30 -124.94 157.89 34.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.476 ' NE2' ' HB2' ' A' ' 85' ' ' PHE . 46.4 t-80 -113.48 127.75 56.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.499 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.449 ' OE1' ' HB3' ' A' ' 83' ' ' ASP . 95.3 mt-10 -58.05 151.68 18.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 140' ' ' PRO . 65.6 mttm -93.65 33.71 1.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.41 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.95 -164.21 29.81 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -78.11 -27.34 48.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.289 -1.124 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -116.39 76.19 6.9 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.885 . . . . 0.0 109.419 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.474 ' CG ' ' OG1' ' A' ' 147' ' ' THR . 49.1 Cg_endo -69.93 153.9 67.65 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.722 2.282 . . . . 0.0 111.738 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 37.8 m -120.15 142.82 48.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 109.362 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.485 ' O ' ' CG2' ' A' ' 143' ' ' THR . 81.4 m-20 55.85 48.03 18.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 142' ' ' ASN . 0.1 OUTLIER 176.6 35.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.437 ' O ' ' HB ' ' A' ' 147' ' ' THR . 86.8 p -64.67 -23.65 67.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 83.4 mt -58.36 -55.29 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -65.4 -21.46 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.474 ' OG1' ' CG ' ' A' ' 140' ' ' PRO . 97.7 m -61.24 -47.01 88.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 109.52 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.15 -46.23 53.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -61.66 -36.82 93.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 154' ' ' ASP . 82.1 m-20 -63.55 -37.25 86.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -1.191 . . . . 0.0 109.418 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.89 -51.6 66.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 57.1 mt -66.32 -43.64 85.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.59 87.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.542 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.451 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 94.8 m-20 -66.35 -41.25 89.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.88 . . . . 0.0 109.534 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -59.45 -39.79 84.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.54 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 46' ' ' GLN . 70.8 mt -65.57 -37.43 86.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.91 93.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.926 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 50.6 m -61.76 -41.66 97.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.943 . . . . 0.0 109.667 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.46 ' O ' HG21 ' A' ' 163' ' ' VAL . 62.1 tt0 -63.34 -34.34 77.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.603 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.24 -42.37 88.21 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.527 ' CB ' HD12 ' A' ' 17' ' ' ILE . 17.3 m -61.47 -37.21 82.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -1.161 . . . . 0.0 109.581 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -69.53 -21.09 63.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 0.0 109.509 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 159' ' ' GLN . 39.3 t -66.0 -29.6 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.461 HG13 ' HA2' ' A' ' 52' ' ' GLY . 47.5 t -112.82 137.63 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.507 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.446 179.965 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.88 142.73 53.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -1.158 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.575 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 88.5 mtp -62.9 -37.17 85.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.487 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 106.86 -14.37 41.28 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 92.3 mt-30 62.99 44.85 5.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -1.101 . . . . 0.0 109.488 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.628 ' CD2' ' CD1' ' A' ' 79' ' ' LEU . 98.2 m-85 -50.4 -179.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.135 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.53 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 74.5 mm-40 -68.45 -37.01 79.82 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.079 -1.013 . . . . 0.0 109.04 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.35 -177.06 47.5 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.472 HG22 ' CZ ' ' A' ' 37' ' ' TYR . 95.1 t -133.29 132.23 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.346 -1.09 . . . . 0.0 108.943 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.578 ' CE1' HG22 ' A' ' 78' ' ' VAL . 6.9 m-85 -113.23 140.1 48.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 110.058 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE2' HD11 ' A' ' 81' ' ' ILE . 70.9 m-85 -112.15 133.71 54.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.364 -0.835 . . . . 0.0 109.095 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.529 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 7.1 p -121.05 152.51 38.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.645 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' A' ' 153' ' ' ALA . 21.6 t70 -152.86 152.6 31.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.347 -0.846 . . . . 0.0 109.388 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.17 128.67 5.68 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.515 ' OG ' ' CB ' ' A' ' 157' ' ' ALA . 50.6 m -122.17 148.88 44.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -1.146 . . . . 0.0 109.307 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 27' ' ' ASN . . . -133.82 145.03 49.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 78.3 mt -119.69 137.7 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.325 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.441 ' HG3' ' OD1' ' A' ' 26' ' ' ASN . 20.8 tttt -99.97 158.17 16.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.506 ' CB ' ' CD ' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -126.55 -177.71 0.63 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.459 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 19' ' ' SER . 55.3 Cg_endo -85.95 104.8 0.77 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.798 2.332 . . . . 0.0 111.668 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.596 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER 58.89 41.36 0.61 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.149 -0.969 . . . . 0.0 110.151 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 21' ' ' ASP . 54.6 Cg_endo -74.03 91.1 0.94 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.061 1.841 . . . . 0.0 111.229 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.1 m -52.44 -20.23 2.72 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.621 -0.832 . . . . 0.0 108.93 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 25' ' ' SER . 14.5 ttpt -93.57 140.41 29.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 0.0 108.699 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 26' ' ' ASN . 26.4 t -41.61 147.79 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.102 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 25' ' ' SER . 96.7 m-20 -47.51 174.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.446 -0.784 . . . . 0.0 109.279 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 95.1 m-20 -96.12 129.12 43.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.406 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -112.2 156.35 22.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.736 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.25 160.48 26.82 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.484 ' SD ' ' CD2' ' A' ' 51' ' ' LEU . 76.2 mtp -121.15 150.89 40.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -1.189 . . . . 0.0 109.678 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.53 117.76 0.84 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 11' ' ' TYR . 5.4 mp -121.73 139.89 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 109.638 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG23 ' HB1' ' A' ' 153' ' ' ALA . 21.3 t -114.73 139.64 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.323 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.559 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 40.5 m170 -107.24 139.95 40.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.615 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.59 166.51 24.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.596 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.4 t -139.9 164.45 29.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.654 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.472 ' CZ ' HG22 ' A' ' 9' ' ' VAL . 58.6 m-85 -97.69 14.17 27.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.645 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.555 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 2.2 mttt -50.88 178.57 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 108.776 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.5 Cg_endo -65.33 -6.46 13.4 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.179 1.92 . . . . 0.0 111.534 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG3' ' HG3' ' A' ' 42' ' ' GLN . 38.9 tp10 -137.75 106.43 5.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -0.846 . . . . 0.0 109.086 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.492 ' CE2' HG21 ' A' ' 145' ' ' ILE . 51.7 t80 -63.3 118.09 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.908 . . . . 0.0 109.297 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HG3' ' HG3' ' A' ' 40' ' ' GLU . 93.5 mt-30 -151.9 145.61 25.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.582 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.427 HG13 HG13 ' A' ' 33' ' ' VAL . 24.5 t -63.56 117.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.3 -0.875 . . . . 0.0 109.512 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.0 mt -63.51 -37.55 87.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -177.59 158.99 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -106.94 138.81 42.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.329 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -126.45 131.4 51.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.776 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.4 m -129.92 136.45 49.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.244 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.449 ' O ' ' HB2' ' A' ' 30' ' ' MET . 3.8 mt -134.95 112.12 11.28 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.53 138.06 34.57 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.744 2.296 . . . . 0.0 111.623 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' CD1' ' HA ' ' A' ' 59' ' ' ALA . 61.6 mt -111.18 139.58 46.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.51 ' O ' ' ND1' ' A' ' 54' ' ' HIS . . . -115.17 132.03 10.11 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 72.3 m-20 62.94 38.02 11.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.151 . . . . 0.0 109.502 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 52' ' ' GLY . 74.3 m80 -124.61 159.56 30.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.449 HG22 ' SD ' ' A' ' 58' ' ' MET . 0.1 OUTLIER -101.87 168.47 9.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 0.0 109.171 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.86 -33.57 66.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -0.981 . . . . 0.0 108.975 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.2 -50.89 24.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.319 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.454 ' O ' HG23 ' A' ' 61' ' ' ILE . 99.2 mtp -55.15 -28.84 55.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.503 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . . . -74.18 -40.42 62.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.493 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.432 ' OE1' ' OG ' ' A' ' 84' ' ' SER . 99.0 mt-10 -60.17 -42.83 95.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.612 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.614 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 14.9 tt -69.62 -32.11 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.497 ' N ' HG22 ' A' ' 61' ' ' ILE . . . -66.73 -27.7 67.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.327 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.529 ' CB ' ' HB ' ' A' ' 12' ' ' THR . . . -71.27 -38.07 71.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.483 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 68' ' ' CYS . 89.8 t -69.44 -40.52 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.531 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 99.2 mt-10 -64.74 -41.95 95.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.016 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.571 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 27.8 t80 -59.73 -65.25 0.71 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.485 -0.759 . . . . 0.0 109.711 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.21 68.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 109.725 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 50.4 t -60.7 -53.49 56.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 109.485 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -59.12 -50.86 72.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.664 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.571 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 62.9 mttm -61.15 -36.31 79.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.862 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.52 ' CB ' ' CG1' ' A' ' 78' ' ' VAL . . . -57.0 -69.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.718 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.509 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 22.1 tp -46.83 -46.32 20.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.591 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 72' ' ' LEU . 14.4 tptt -44.19 -45.13 8.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.206 -0.934 . . . . 0.0 109.269 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 7.3 mt -48.36 142.87 7.79 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.023 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.8 Cg_endo -65.57 -4.77 10.25 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.573 2.182 . . . . 0.0 111.749 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.53 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -140.62 168.57 25.18 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.475 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.1 Cg_endo -68.4 122.11 9.11 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.411 2.074 . . . . 0.0 111.77 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.578 HG22 ' CE1' ' A' ' 10' ' ' PHE . 4.6 p -113.71 155.25 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.419 -0.801 . . . . 0.0 109.262 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.628 ' CD1' ' CD2' ' A' ' 6' ' ' TYR . 22.6 mt -99.8 149.04 23.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 109.833 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 76.0 t -130.35 135.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.38 -0.825 . . . . 0.0 109.066 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.575 HD11 ' CE2' ' A' ' 11' ' ' TYR . 20.4 mt -119.87 139.47 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.953 . . . . 0.0 109.649 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.45 HG23 HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -128.29 161.85 28.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.364 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 58.3 p30 -92.48 13.39 19.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.432 ' OG ' ' OE1' ' A' ' 60' ' ' GLU . 42.6 m -132.82 125.47 30.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.59 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 67.5 t80 -77.59 -42.02 36.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -49.9 -57.25 7.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.381 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.492 ' CG2' ' HA ' ' A' ' 61' ' ' ILE . 14.9 p -61.05 -46.61 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.291 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.462 ' N ' ' CG1' ' A' ' 87' ' ' VAL . . . -55.52 -55.5 31.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.902 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 79.6 tt0 -54.75 -31.56 58.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.944 . . . . 0.0 109.184 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.604 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 18.0 t -56.68 -56.27 23.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 132' ' ' ILE . . . -80.32 -0.83 38.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.729 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 89.8 m-20 -84.54 -73.35 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.094 -1.004 . . . . 0.0 110.038 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 74.5 mttt -127.34 -27.84 2.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.132 -0.98 . . . . 0.0 110.269 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 68.1 mm-40 -61.04 -30.87 70.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.095 -1.003 . . . . 0.0 109.89 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.526 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -61.41 -58.53 18.07 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.718 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 43.9 Cg_endo -66.02 -25.47 51.64 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.552 2.168 . . . . 0.0 111.694 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -71.46 -38.17 71.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.173 -0.954 . . . . 0.0 109.044 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.564 ' CE3' HD21 ' A' ' 111' ' ' LEU . 39.1 m0 -67.01 -47.89 70.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.257 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -47.38 -42.67 22.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.856 . . . . 0.0 109.472 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.6 m -57.42 -39.2 75.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.373 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.446 ' O ' HG21 ' A' ' 104' ' ' VAL . 74.0 m-20 -90.28 10.45 24.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.436 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 72.65 40.92 52.31 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.467 ' CD1' HG22 ' A' ' 114' ' ' ILE . 97.9 m-85 60.69 33.08 20.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -1.123 . . . . 0.0 109.444 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 101' ' ' ASN . 41.9 t -112.57 133.99 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -77.44 148.2 35.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.939 . . . . 0.0 109.521 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -50.13 -32.26 15.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.365 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -77.02 158.26 30.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -56.22 -31.45 63.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.506 ' HD2' ' N ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -63.19 143.84 97.55 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.495 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.71 165.82 29.64 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.659 2.239 . . . . 0.0 111.811 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.564 HD21 ' CE3' ' A' ' 98' ' ' TRP . 10.4 tp -78.92 135.6 37.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.465 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 18.9 mttp -98.81 152.45 19.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.569 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 36.7 m80 67.48 31.07 6.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.467 HG22 ' CD1' ' A' ' 103' ' ' PHE . 78.5 mt -68.74 -39.0 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.366 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.6 m -62.07 -44.61 96.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.362 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.462 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 54.3 mttp -61.45 -41.36 97.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.614 ' CZ2' ' CD1' ' A' ' 61' ' ' ILE . 40.2 m95 -76.75 -30.69 56.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.37 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -59.27 -39.25 82.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.8 m -62.54 -44.86 95.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.531 ' CG1' ' HG2' ' A' ' 65' ' ' GLU . 78.0 mt -72.58 -30.25 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.442 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.461 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . . . -61.72 -41.62 97.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.416 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -59.04 -40.23 84.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 109.387 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 46.3 m -68.15 -47.11 68.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.2 tp -63.32 -32.4 73.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.34 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 m -61.59 -31.8 71.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.568 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.466 ' O ' ' HB3' ' A' ' 127' ' ' LYS . 93.6 mmm -67.54 -34.17 76.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 170.67 147.6 0.14 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.0 Cg_endo -71.63 -0.04 7.69 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.73 2.286 . . . . 0.0 111.633 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 93.4 m-20 -42.49 -47.24 5.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.428 -0.795 . . . . 0.0 109.632 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 72' ' ' LEU . 56.8 mt -58.89 119.14 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.524 ' HB ' ' CD2' ' A' ' 79' ' ' LEU . 24.8 m -112.42 140.44 47.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 91' ' ' ALA . 58.8 mt -122.54 137.46 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 109.696 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.435 ' HB2' HG12 ' A' ' 81' ' ' ILE . 84.6 mt-30 -122.73 163.07 20.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.218 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.59 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 14.8 t-80 -118.58 131.39 56.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 109.62 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.526 ' HG3' ' CG2' ' A' ' 81' ' ' ILE . 96.5 mt-10 -129.22 138.45 51.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.403 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.416 ' CE ' ' HB3' ' A' ' 138' ' ' HIS . 20.8 tttp -118.29 125.68 50.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.78 -41.54 96.01 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.416 ' HB3' ' CE ' ' A' ' 136' ' ' LYS . 84.9 t60 -58.36 -44.26 88.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.12 . . . . 0.0 109.569 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -85.89 151.8 55.49 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 109.502 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.53 143.01 50.52 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.752 2.301 . . . . 0.0 111.818 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.509 ' CG2' ' HB2' ' A' ' 146' ' ' HIS . 40.5 m -74.99 139.8 43.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -51.74 -40.23 59.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.535 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.3 p -126.77 152.06 47.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.166 -0.959 . . . . 0.0 109.517 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.4 m -69.85 -26.49 64.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.66 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.492 HG21 ' CE2' ' A' ' 41' ' ' TYR . 92.4 mt -60.9 -45.65 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 109.599 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.509 ' HB2' ' CG2' ' A' ' 141' ' ' THR . 13.1 m170 -68.77 -23.23 64.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.562 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.404 ' OG1' ' HB ' ' A' ' 141' ' ' THR . 45.0 m -67.34 -45.27 76.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.0 109.679 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.99 -36.46 70.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.48 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 153' ' ' ALA . . . -70.41 -28.51 71.14 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -69.38 -36.0 76.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 109.592 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -72.89 -52.8 13.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.462 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 25.0 tp -61.64 -37.71 85.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.172 -0.955 . . . . 0.0 109.626 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.446 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -64.58 -35.76 82.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.664 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -67.68 -36.37 80.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.67 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.401 ' HE2' ' NE2' ' A' ' 159' ' ' GLN . 78.4 tttt -70.99 -36.11 72.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.775 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 66.4 mt -68.23 -34.77 76.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 109.658 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.515 ' CB ' ' OG ' ' A' ' 15' ' ' SER . . . -70.15 -39.73 75.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 44.7 m -66.06 -38.76 89.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.401 ' NE2' ' HE2' ' A' ' 155' ' ' LYS . 94.6 mt-30 -66.35 -34.0 76.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 0.0 109.558 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.22 91.57 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.7 m -63.87 -37.42 87.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.418 ' O ' ' OD1' ' A' ' 165' ' ' ASN . 62.3 t80 -62.85 -40.76 98.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.602 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 95.4 t -53.79 -39.61 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 66.7 t -55.95 -44.62 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.937 . . . . 0.0 109.546 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 162' ' ' TYR . 93.0 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.417 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 1.125 ' CD2' HD11 ' A' ' 79' ' ' LEU . 55.7 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.313 0.578 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.472 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 78.2 mm-40 -55.51 -36.85 67.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.253 -0.904 . . . . 0.0 109.138 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.471 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.81 -167.71 36.88 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.481 HG11 ' CZ ' ' A' ' 11' ' ' TYR . 85.5 t -132.95 144.47 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.133 . . . . 0.0 109.154 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 34' ' ' HIS . 6.8 m-85 -118.21 121.38 40.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 109.925 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.799 ' CE1' HD12 ' A' ' 81' ' ' ILE . 52.7 m-85 -107.81 126.73 52.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 108.85 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 1.037 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 3.7 p -115.06 150.31 36.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 110.071 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.537 ' HB2' ' HB1' ' A' ' 153' ' ' ALA . 59.7 t0 -142.22 154.52 44.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.473 -0.767 . . . . 0.0 109.086 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -138.11 138.34 9.49 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.9 p -143.09 160.94 39.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -1.127 . . . . 0.0 109.437 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -146.26 150.44 35.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.668 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.763 HD12 ' HB2' ' A' ' 161' ' ' SER . 62.1 mt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.43 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -99.86 122.02 42.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.338 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -129.58 154.85 46.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.67 163.69 26.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.768 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 42.2 mtm -122.61 140.84 52.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -1.143 . . . . 0.0 109.531 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -126.19 123.75 4.91 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.601 HD12 HG22 ' A' ' 12' ' ' THR . 26.3 mm -112.97 138.31 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -1.174 . . . . 0.0 109.516 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 11' ' ' TYR . 41.0 t -122.59 135.47 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 109.378 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.688 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 72.5 m-70 -108.02 135.98 48.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 109.547 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.466 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -129.2 170.84 13.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.411 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.986 ' HB ' HD11 ' A' ' 44' ' ' LEU . 14.2 t -133.99 165.01 26.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.541 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.658 ' OH ' HD12 ' A' ' 79' ' ' LEU . 49.6 m-85 -104.43 11.47 34.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.529 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.58 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 1.7 mtmt -51.46 179.46 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.034 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.4 Cg_endo -66.39 -5.15 12.04 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.183 1.922 . . . . 0.0 111.568 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 40' ' ' GLU . 71.0 mm-40 -135.49 106.21 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 0.0 109.128 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.76 123.75 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 109.468 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -158.11 148.55 20.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.602 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.6 p -77.87 122.27 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.986 HD11 ' HB ' ' A' ' 36' ' ' THR . 6.3 mp -65.01 -39.95 94.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.135 -0.978 . . . . 0.0 109.351 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -173.15 162.47 4.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.364 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.654 ' HB3' HD11 ' A' ' 156' ' ' LEU . 89.7 mt-30 -112.83 154.72 25.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.393 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.489 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -135.26 132.55 37.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 t -122.94 128.1 49.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 109.396 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.468 HD11 ' CE2' ' A' ' 66' ' ' PHE . 2.9 mp -129.43 91.55 40.99 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.543 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HG3' HG11 ' A' ' 163' ' ' VAL . 50.2 Cg_endo -70.64 133.18 23.41 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.698 2.266 . . . . 0.0 111.747 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.508 ' HB3' ' CD2' ' A' ' 54' ' ' HIS . 31.1 mt -99.73 147.14 25.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.65 -62.18 0.8 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -108.41 57.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -1.157 . . . . 0.0 109.531 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.508 ' CD2' ' HB3' ' A' ' 51' ' ' LEU . 77.7 m-70 -129.47 177.99 6.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.614 HG23 ' H ' ' A' ' 58' ' ' MET . 13.2 t -124.17 169.08 12.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 109.455 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.466 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -57.38 -41.09 79.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.417 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -61.61 -40.61 95.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.614 ' H ' HG23 ' A' ' 55' ' ' THR . 97.0 mtp -70.83 -32.43 69.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.883 . . . . 0.0 109.507 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.64 -33.44 74.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.522 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.85 -47.97 56.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.73 ' HA ' HG21 ' A' ' 87' ' ' VAL . 13.7 tt -69.42 -38.01 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 109.549 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.768 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -65.8 -31.75 72.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.471 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.037 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -65.98 -38.63 89.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.892 . . . . 0.0 109.554 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.74 HG22 HG21 ' A' ' 82' ' ' THR . 61.6 t -69.57 -38.11 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.667 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.432 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 71.8 tt0 -69.77 -38.04 76.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 109.123 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.584 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 26.3 t80 -55.75 -66.57 0.4 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.344 -0.847 . . . . 0.0 109.527 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 71' ' ' ALA . . . -59.94 -31.86 70.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.535 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' A' ' 120' ' ' ILE . 41.3 t -50.65 -56.86 9.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.509 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -64.86 -42.93 94.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.482 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.584 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 63.1 mttm -64.55 -31.5 72.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.468 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 67' ' ' ALA . . . -66.24 -65.44 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.666 ' HB2' HD11 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -54.98 -38.71 68.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.307 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 72' ' ' LEU . 25.6 tttt -44.44 -47.25 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.044 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.058 HD12 HG21 ' A' ' 78' ' ' VAL . 8.7 mt -52.29 143.06 27.28 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 108.842 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.1 Cg_endo -65.48 -5.96 12.59 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.459 2.106 . . . . 0.0 111.631 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.472 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -129.26 170.1 20.38 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.444 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 49.8 Cg_endo -69.97 140.0 40.84 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.587 2.192 . . . . 0.0 111.801 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.058 HG21 HD12 ' A' ' 74' ' ' ILE . 39.5 t -127.59 162.6 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.125 HD11 ' CD2' ' A' ' 6' ' ' TYR . 7.2 mt -110.96 130.78 55.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 10' ' ' PHE . 72.0 t -114.05 126.42 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.895 . . . . 0.0 109.527 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.799 HD12 ' CE1' ' A' ' 11' ' ' TYR . 13.8 mt -115.36 142.3 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.299 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.74 HG21 HG22 ' A' ' 64' ' ' VAL . 1.1 p -130.47 161.27 31.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 135' ' ' GLU . 55.0 p-10 -87.51 5.16 40.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.517 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.542 ' CB ' HG12 ' A' ' 87' ' ' VAL . 2.1 m -123.3 123.99 41.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 109.552 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.7 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 66.6 t80 -72.69 -41.62 65.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.349 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.447 ' O ' ' HB2' ' A' ' 90' ' ' SER . 67.7 t80 -54.01 -58.8 5.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 61' ' ' ILE . 12.7 p -58.31 -46.81 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.365 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.596 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -56.95 -63.6 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.205 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -57.24 -17.86 13.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.101 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.545 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 8.4 t -66.4 -65.53 0.67 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.299 -0.875 . . . . 0.0 109.258 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.766 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -66.47 -10.56 45.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.489 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -88.32 -42.03 12.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.775 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 96' ' ' PRO . 8.3 ttpp -126.42 -49.24 1.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.167 -0.958 . . . . 0.0 109.775 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.572 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 73.2 mm-40 -53.53 -41.02 65.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.672 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.766 HD23 ' HA ' ' A' ' 91' ' ' ALA . 0.4 OUTLIER -50.69 -63.98 1.57 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 49.8 Cg_endo -70.17 -36.6 9.44 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.708 2.272 . . . . 0.0 111.921 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -67.44 -42.41 83.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.572 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 18.9 m0 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.519 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.529 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 62.8 m80 60.88 37.68 18.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.42 -38.1 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.463 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 m -57.9 -45.47 86.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.464 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.42 -44.3 95.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.466 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.695 ' CZ2' HD11 ' A' ' 61' ' ' ILE . 69.8 m95 -69.4 -34.0 73.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.338 -0.852 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -58.01 -44.42 87.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.414 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.432 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 44.3 m -62.75 -43.42 98.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.362 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.461 HG23 ' SG ' ' A' ' 68' ' ' CYS . 71.9 mt -68.9 -34.21 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.421 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -61.87 -33.9 75.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -0.906 . . . . 0.0 109.42 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -64.76 -33.3 75.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.369 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.692 ' SG ' HD11 ' A' ' 130' ' ' ILE . 49.2 t -80.83 -52.12 7.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.883 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 128' ' ' PRO . 19.5 tp -62.54 -27.01 68.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.432 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.6 m -68.83 -26.61 65.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.483 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.1 mtt -71.25 -32.43 68.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 109.459 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.39 132.86 0.21 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 0.0 109.479 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.489 ' HA ' HD11 ' A' ' 124' ' ' LEU . 48.6 Cg_endo -69.78 -2.23 9.83 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.701 2.267 . . . . 0.0 111.719 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 96.8 m-20 -45.95 -26.88 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.439 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.692 HD11 ' SG ' ' A' ' 123' ' ' CYS . 64.9 mt -68.13 110.6 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.1 m -94.03 141.17 28.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.704 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 67.2 mt -118.84 137.33 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 109.521 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.471 ' HB2' HG23 ' A' ' 81' ' ' ILE . 86.2 mt-30 -134.84 157.38 46.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.7 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 38.9 t60 -112.81 126.46 55.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 82' ' ' THR . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.0 m -55.38 -45.01 76.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.525 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -48.76 -49.83 36.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -60.04 -36.63 90.97 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -60.74 -38.07 83.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -1.151 . . . . 0.0 109.571 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.99 -46.69 77.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.564 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 74.8 mt -64.88 -38.92 92.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 13' ' ' ASP . . . -69.63 -35.74 75.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.512 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -60.7 -42.97 98.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.517 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 41.7 mttt -65.92 -40.61 91.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.654 HD11 ' HB3' ' A' ' 46' ' ' GLN . 77.2 mt -64.16 -41.47 97.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.541 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.67 96.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 109.584 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.791 HG22 ' HE2' ' A' ' 162' ' ' TYR . 29.0 m -65.53 -37.45 86.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.522 ' O ' HG23 ' A' ' 163' ' ' VAL . 93.2 mt-30 -65.56 -31.91 73.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.518 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.58 -33.57 87.61 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.763 ' HB2' HD12 ' A' ' 17' ' ' ILE . 86.0 p -68.07 -34.36 76.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -1.135 . . . . 0.0 109.508 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.791 ' HE2' HG22 ' A' ' 158' ' ' THR . 90.0 m-85 -72.08 -22.1 61.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 159' ' ' GLN . 48.9 t -70.03 -25.92 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.482 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 0.0 109.471 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 1.011 ' CD2' HD11 ' A' ' 79' ' ' LEU . 27.4 m-85 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.39 0.614 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.521 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 76.2 mm-40 -71.6 -36.7 70.9 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.38 -0.825 . . . . 0.0 108.941 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.33 -166.36 35.01 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.75 HG21 ' OH ' ' A' ' 37' ' ' TYR . 85.5 t -140.61 140.68 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -1.111 . . . . 0.0 109.097 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.679 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 24.7 m-85 -117.89 150.78 38.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.995 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.595 ' CE1' HG13 ' A' ' 81' ' ' ILE . 78.3 m-85 -121.87 130.39 53.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 109.093 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.899 HG22 HD12 ' A' ' 32' ' ' ILE . 17.2 p -115.66 151.6 34.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.764 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 57.9 t0 -140.62 152.46 45.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 109.347 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -138.43 128.36 4.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 m -133.23 148.62 52.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -1.155 . . . . 0.0 109.349 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.578 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -136.58 146.88 46.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.618 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.786 HD12 ' HB2' ' A' ' 161' ' ' SER . 65.1 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 16.5 m120 -104.67 144.08 32.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.428 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -142.97 147.94 36.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.96 157.86 26.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.725 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 63.2 mtm -128.23 147.99 50.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 0.0 109.584 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.7 122.39 2.35 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.899 HD12 HG22 ' A' ' 12' ' ' THR . 22.7 mm -110.2 133.68 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -1.186 . . . . 0.0 109.62 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 153' ' ' ALA . 44.6 t -124.33 132.1 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.381 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 1.03 ' CD2' HD12 ' A' ' 44' ' ' LEU . 9.0 t60 -108.21 142.18 38.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.693 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.23 158.99 38.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.514 ' HB ' HD21 ' A' ' 44' ' ' LEU . 11.9 t -122.4 162.64 21.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.75 ' OH ' HG21 ' A' ' 9' ' ' VAL . 27.1 m-85 -106.8 5.01 28.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 1.8 mtpt -51.39 178.79 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 108.959 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.0 Cg_endo -65.91 -5.04 11.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.171 1.914 . . . . 0.0 111.615 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -127.78 106.2 8.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.863 . . . . 0.0 108.946 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -73.96 123.76 24.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.913 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -168.21 133.85 1.86 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.379 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -52.39 118.76 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.03 HD12 ' CD2' ' A' ' 34' ' ' HIS . 46.9 mt -64.13 -45.27 89.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 79.0 m-20 -160.17 154.43 23.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.401 ' HB3' HD11 ' A' ' 156' ' ' LEU . 94.0 mt-30 -118.13 144.03 46.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.2 -0.937 . . . . 0.0 109.305 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -129.52 142.02 50.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.0 t -132.83 128.0 35.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.349 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 2.8 mp -125.91 89.29 52.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.64 ' HG3' HG11 ' A' ' 163' ' ' VAL . 48.2 Cg_endo -69.25 129.05 17.43 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.692 2.261 . . . . 0.0 111.83 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 37.0 mt -103.16 147.97 26.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.479 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -120.81 -35.7 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.488 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 41.0 p-10 -119.68 44.16 2.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -1.135 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.524 ' HA ' ' CE ' ' A' ' 58' ' ' MET . 76.1 m80 -129.11 -175.89 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.429 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 58' ' ' MET . 10.0 t -126.5 170.31 12.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.93 . . . . 0.0 109.479 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.578 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -56.59 -39.08 72.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.385 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 60' ' ' GLU . 77.4 mt-30 -64.08 -67.15 0.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.515 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.524 ' CE ' ' HA ' ' A' ' 54' ' ' HIS . 44.2 mtm -44.94 -28.05 0.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 0.0 109.21 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.39 -37.13 63.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.609 ' HB3' HG21 ' A' ' 87' ' ' VAL . 98.9 mt-10 -66.92 -41.93 86.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.654 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 20.7 tt -70.5 -38.53 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 109.196 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.725 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -64.49 -39.31 93.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.338 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -52.32 -46.82 66.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.461 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.728 HG21 HG12 ' A' ' 87' ' ' VAL . 87.4 t -70.76 -49.24 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.339 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HG3' HG12 ' A' ' 120' ' ' ILE . 87.4 tt0 -53.62 -43.4 68.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.273 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.594 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 10.9 t80 -55.84 -65.34 0.61 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.293 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -61.33 -15.91 40.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.497 ' SG ' HG23 ' A' ' 120' ' ' ILE . 48.5 t -68.62 -61.14 1.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.298 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.402 ' HB3' ' HE3' ' A' ' 69' ' ' LYS . 20.7 ttpp -57.67 -48.67 78.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.944 . . . . 0.0 109.354 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.594 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 67.9 mttm -60.65 -42.12 96.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.389 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.896 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -54.16 -72.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.409 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.819 ' HB2' HD11 ' A' ' 130' ' ' ILE . 10.0 tt -48.91 -42.56 37.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.949 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 72' ' ' LEU . 80.7 tttt -44.13 -41.93 5.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.94 . . . . 0.0 109.149 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.565 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 32.0 mt -54.03 143.88 40.68 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.4 -0.812 . . . . 0.0 108.875 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.565 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.5 Cg_endo -65.4 -2.18 5.68 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.58 2.186 . . . . 0.0 112.26 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.521 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -139.44 169.22 24.64 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.451 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 49.2 Cg_endo -69.8 117.06 4.86 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.57 2.18 . . . . 0.0 111.877 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.896 HG11 ' HA ' ' A' ' 71' ' ' ALA . 5.8 p -110.31 153.6 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.239 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.011 HD11 ' CD2' ' A' ' 6' ' ' TYR . 15.1 mt -96.79 153.07 18.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.588 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 131' ' ' THR . 45.0 t -125.74 128.62 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.639 HG21 ' CD ' ' A' ' 135' ' ' GLU . 22.5 mm -107.99 139.49 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.2 -0.937 . . . . 0.0 109.431 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.504 ' CG2' HG22 ' A' ' 64' ' ' VAL . 1.9 p -131.07 161.59 31.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.494 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 86.4 m-20 -96.17 2.75 53.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.903 . . . . 0.0 109.531 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.9 m -126.06 130.34 50.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -0.977 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.59 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 64.9 t80 -74.78 -39.79 61.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.411 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.74 -52.5 63.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.651 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.728 HG12 HG21 ' A' ' 64' ' ' VAL . 50.6 t -61.14 -54.23 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 109.508 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.521 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -50.77 -55.85 14.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.159 -0.963 . . . . 0.0 109.397 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 82.3 tt0 -56.56 -35.59 68.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.615 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 49.0 m -52.58 -51.37 60.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 109.506 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.707 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -88.18 -1.19 57.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.693 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 45.6 t-20 -84.18 -72.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -0.994 . . . . 0.0 109.506 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 21.0 tptp -126.57 -26.6 3.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 109.785 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 46.6 mm-40 -65.17 -29.89 70.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.677 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -53.69 -59.09 10.45 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 109.668 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 47.0 Cg_endo -67.7 -32.99 29.1 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.679 2.253 . . . . 0.0 111.657 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -67.49 -39.97 85.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.221 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.5 m0 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 109.269 179.773 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 68.7 mttm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.457 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 46.7 m80 64.62 33.21 10.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.43 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 82.5 mt -60.94 -46.47 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -59.52 -46.37 89.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 109.409 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.433 ' HE2' ' SD ' ' A' ' 58' ' ' MET . 45.5 mttp -55.73 -46.44 77.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.863 . . . . 0.0 109.404 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.654 ' CZ2' HD12 ' A' ' 61' ' ' ILE . 53.5 m95 -61.37 -37.66 84.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.882 . . . . 0.0 109.396 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 23.9 mttt -56.82 -43.04 80.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.2 m -57.14 -45.86 83.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.336 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.497 HG23 ' SG ' ' A' ' 68' ' ' CYS . 68.0 mt -67.39 -36.77 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.838 . . . . 0.0 109.496 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -59.18 -36.86 76.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.56 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.38 -43.76 98.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.606 ' SG ' HD11 ' A' ' 130' ' ' ILE . 42.5 t -68.08 -44.14 76.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.683 HD11 ' HA ' ' A' ' 128' ' ' PRO . 20.8 tp -71.09 -30.49 66.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.249 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.2 t -62.39 -31.84 72.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.583 ' HB2' HD11 ' A' ' 72' ' ' LEU . 92.0 mtp -65.34 -31.05 71.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.461 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.37 135.65 0.21 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.582 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.683 ' HA ' HD11 ' A' ' 124' ' ' LEU . 48.9 Cg_endo -69.91 -1.81 9.22 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 122.614 2.209 . . . . 0.0 111.501 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 95.1 m-20 -44.02 -44.85 7.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.819 HD11 ' HB2' ' A' ' 72' ' ' LEU . 45.0 mt -55.27 123.4 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.654 ' HB ' HD22 ' A' ' 79' ' ' LEU . 25.4 m -113.87 140.84 48.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.28 -0.887 . . . . 0.0 109.086 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.707 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -125.23 137.22 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.098 -1.001 . . . . 0.0 109.631 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.469 ' HB2' HD12 ' A' ' 81' ' ' ILE . 95.2 mt-30 -127.4 165.78 19.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.249 -0.907 . . . . 0.0 109.395 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.59 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 37.4 t60 -111.57 138.25 48.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.639 ' CD ' HG21 ' A' ' 81' ' ' ILE . 71.0 mt-10 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.415 ' HA ' ' OD1' ' A' ' 150' ' ' ASN . 60.3 p -60.72 -39.46 88.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.48 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -48.89 -51.03 32.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.848 . . . . 0.0 109.38 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.49 -40.84 62.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.415 ' OD1' ' HA ' ' A' ' 147' ' ' THR . 23.1 m120 -56.52 -45.58 81.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -1.101 . . . . 0.0 109.337 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.0 -55.47 30.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.329 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.9 -45.97 82.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.349 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.4 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -58.67 -41.82 87.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.436 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.47 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 87.7 m-20 -54.08 -44.86 71.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 22.7 mttp -59.87 -42.04 92.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.309 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.401 HD11 ' HB3' ' A' ' 46' ' ' GLN . 64.8 mt -67.07 -37.04 83.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.83 88.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.861 . . . . 0.0 109.408 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 46.1 m -61.76 -39.87 93.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.362 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 163' ' ' VAL . 95.0 mt-30 -63.32 -33.3 75.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.439 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 50' ' ' PRO . . . -55.46 -40.04 75.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.786 ' HB2' HD12 ' A' ' 17' ' ' ILE . 83.8 p -64.02 -35.36 80.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.122 . . . . 0.0 109.494 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -69.93 -22.65 63.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.64 HG11 ' HG3' ' A' ' 50' ' ' PRO . 38.9 t -65.18 -25.63 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.516 -179.978 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.728 ' CE2' HD21 ' A' ' 79' ' ' LEU . 94.3 m-85 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' HB3' HG22 ' A' ' 78' ' ' VAL . 24.5 tp10 -61.46 -35.03 76.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 109.381 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.59 -166.01 34.08 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.031 ' CG1' ' HB3' ' A' ' 35' ' ' ALA . 5.7 p -134.85 143.89 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -1.136 . . . . 0.0 109.223 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.73 ' CD2' HG11 ' A' ' 78' ' ' VAL . 32.3 m-85 -119.76 132.42 55.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.656 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.894 ' CE1' HD12 ' A' ' 81' ' ' ILE . 95.6 m-85 -112.14 125.09 53.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 109.052 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 1.036 HG22 HD12 ' A' ' 32' ' ' ILE . 28.3 p -115.99 146.11 42.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 109.812 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 30' ' ' MET . 66.5 t0 -144.93 137.97 26.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.438 -0.789 . . . . 0.0 109.341 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -139.61 126.14 3.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 t -143.48 154.06 43.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -1.162 . . . . 0.0 109.543 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -115.1 142.83 46.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.549 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.001 HD12 ' CB ' ' A' ' 161' ' ' SER . 70.1 mt . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 41.5 p30 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.402 ' HB2' ' HB ' ' A' ' 17' ' ' ILE . 88.9 m-20 -99.46 109.42 21.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.485 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -106.11 143.4 34.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.9 155.55 26.56 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.854 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 58.2 mtm -127.32 159.82 33.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -1.166 . . . . 0.0 109.512 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.693 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -143.95 122.16 1.77 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.036 HD12 HG22 ' A' ' 12' ' ' THR . 26.9 mm -124.0 111.98 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.354 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.54 ' CG2' ' HG2' ' A' ' 46' ' ' GLN . 10.9 p -115.66 160.21 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.753 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.881 ' CD2' HD12 ' A' ' 44' ' ' LEU . 20.7 t60 -116.05 144.98 43.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.364 -0.835 . . . . 0.0 109.346 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.031 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -132.3 169.49 16.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -125.95 166.58 16.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 0.0 109.369 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 38' ' ' LYS . 60.5 m-85 -105.28 10.13 33.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.573 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.37 179.59 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 109.1 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 44.0 Cg_endo -66.58 -4.53 11.1 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.128 1.885 . . . . 0.0 111.693 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -132.93 105.82 7.33 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.37 -0.831 . . . . 0.0 108.861 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 54.4 t80 -57.57 125.32 22.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.235 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 25.0 mt-30 -158.13 142.01 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.749 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.717 HG11 HD12 ' A' ' 152' ' ' LEU . 29.0 m -78.99 118.66 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -0.85 . . . . 0.0 109.391 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.881 HD12 ' CD2' ' A' ' 34' ' ' HIS . 24.4 mt -60.59 -46.2 91.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.171 -0.956 . . . . 0.0 109.317 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 35.3 m120 -159.96 146.59 16.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.368 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.697 ' HB3' HD21 ' A' ' 156' ' ' LEU . 78.4 mt-30 -107.6 148.2 29.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.393 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.52 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 5.6 t-105 -132.07 140.83 48.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -0.953 . . . . 0.0 109.755 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.1 p -128.43 141.92 51.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.263 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 3.4 mt -135.11 94.68 15.75 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.609 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' CG ' HG11 ' A' ' 163' ' ' VAL . 51.1 Cg_endo -70.85 134.82 26.5 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.688 2.259 . . . . 0.0 111.718 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.67 ' O ' HG11 ' A' ' 164' ' ' VAL . 45.4 mt -104.35 140.14 38.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.47 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.769 ' HA2' HG21 ' A' ' 164' ' ' VAL . . . -86.92 -69.56 1.32 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -122.51 79.38 1.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -1.133 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -133.55 179.07 6.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.41 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.618 HG23 ' H ' ' A' ' 58' ' ' MET . 12.5 t -116.86 168.89 9.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 0.0 109.538 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.453 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -63.38 -29.69 70.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -68.3 -42.78 78.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.618 ' H ' HG23 ' A' ' 55' ' ' THR . 52.8 mtm -76.46 -26.93 55.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.457 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.04 -35.05 61.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.511 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 56' ' ' ALA . 98.7 mt-10 -73.71 -38.71 64.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.625 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 20.2 tt -71.03 -28.17 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 0.0 109.586 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.854 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -74.81 -36.68 62.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.556 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.576 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -57.51 -39.19 75.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.14 -0.975 . . . . 0.0 109.677 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.593 ' CG2' HG21 ' A' ' 82' ' ' THR . 77.9 t -75.45 -46.83 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 0.0 109.805 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.536 ' HB2' HD11 ' A' ' 120' ' ' ILE . 84.0 tt0 -60.28 -35.75 76.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.668 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.542 ' CD2' HG13 ' A' ' 32' ' ' ILE . 11.4 t80 -57.79 -68.67 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.675 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.444 ' HB3' HG13 ' A' ' 80' ' ' VAL . . . -61.67 -14.18 29.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.66 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.854 ' SG ' HG23 ' A' ' 120' ' ' ILE . 41.8 t -69.86 -60.34 2.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.454 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.448 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 65.4 tttm -61.28 -45.26 95.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.641 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 32.5 mttp -60.39 -34.11 73.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.577 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.27 -58.92 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 109.443 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.977 ' HB2' HD11 ' A' ' 130' ' ' ILE . 2.9 tt -53.22 -46.36 69.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 72' ' ' LEU . 13.2 ttpt -42.88 -47.19 5.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 109.257 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 22.7 mm -48.9 141.93 9.84 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 108.794 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.7 Cg_endo -66.12 -4.9 11.16 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.514 2.143 . . . . 0.0 111.687 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.412 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -134.78 165.71 24.48 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 47.5 Cg_endo -68.87 131.44 22.52 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 122.545 2.164 . . . . 0.0 111.596 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.73 HG11 ' CD2' ' A' ' 10' ' ' PHE . 68.8 t -121.57 167.51 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.451 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 6' ' ' TYR . 7.0 mp -115.82 130.49 56.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.538 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 96.9 t -104.36 134.94 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.387 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.894 HD12 ' CE1' ' A' ' 11' ' ' TYR . 40.7 mt -120.58 137.33 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.528 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.593 HG21 ' CG2' ' A' ' 64' ' ' VAL . 8.9 t -143.48 161.68 37.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.429 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 58.8 p30 -89.79 25.14 2.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.462 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.528 ' H ' HG23 ' A' ' 82' ' ' THR . 49.2 m -128.54 117.08 20.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.216 -0.928 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.719 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 71.6 t80 -77.29 -44.98 27.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -58.44 -45.02 89.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.592 HG12 HG21 ' A' ' 64' ' ' VAL . 95.2 t -61.81 -49.66 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -57.33 -49.28 76.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.326 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 82.4 tt0 -61.43 -36.62 80.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.638 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 47.7 t -53.16 -47.35 68.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.472 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.673 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -92.48 -0.66 57.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 43.2 t-20 -87.17 -72.97 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.87 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 97.7 mttt -127.1 -23.95 3.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.55 ' HG2' ' CE2' ' A' ' 98' ' ' TRP . 42.6 tt0 -67.08 -27.48 67.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.961 -1.087 . . . . 0.0 109.755 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -57.09 -57.86 21.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 109.59 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 43.8 Cg_endo -66.64 -24.72 47.78 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.452 2.101 . . . . 0.0 111.136 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -72.15 -36.72 69.4 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.55 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 38.6 m0 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.507 -0.745 . . . . 0.0 108.991 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 57.9 mttp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.294 0.569 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.537 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 78.0 m-70 65.28 35.65 7.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.792 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.492 HG22 ' HE2' ' A' ' 118' ' ' LYS . 53.8 mt -67.36 -45.19 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.185 -0.947 . . . . 0.0 109.329 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 t -51.08 -47.62 61.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.22 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.66 -38.21 84.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.638 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 27.6 m95 -69.6 -40.28 76.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 109.351 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.492 ' HE2' HG22 ' A' ' 114' ' ' ILE . 64.0 mttm -55.06 -41.54 71.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.391 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.415 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 22.9 t -58.58 -45.77 88.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.854 HG23 ' SG ' ' A' ' 68' ' ' CYS . 79.4 mt -69.07 -36.22 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.378 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.81 93.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 126' ' ' MET . 83.1 tt0 -54.59 -40.61 69.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 109.409 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 1.3 m -76.6 -50.29 14.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.385 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 124' ' ' LEU . 9.1 tt -57.78 -37.44 73.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.464 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.8 m -59.93 -33.07 71.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.507 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.597 ' HB2' HD11 ' A' ' 72' ' ' LEU . 88.4 mtp -64.85 -36.06 83.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.85 . . . . 0.0 109.463 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.35 143.85 0.24 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 129' ' ' ASP . 48.6 Cg_endo -69.5 -2.12 9.43 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.738 2.292 . . . . 0.0 111.734 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 92.8 m-20 -43.18 -38.25 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.358 -0.839 . . . . 0.0 109.4 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.977 HD11 ' HB2' ' A' ' 72' ' ' LEU . 54.9 mt -68.59 109.44 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.475 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 97.2 m -110.03 146.94 34.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.273 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.478 HG21 ' HA ' ' A' ' 88' ' ' ALA . 64.2 mt -120.62 145.7 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.431 ' HB2' HG12 ' A' ' 81' ' ' ILE . 88.8 mt-30 -124.99 155.2 40.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.401 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.719 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 83.8 t60 -110.53 128.56 55.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HG2' ' CG2' ' A' ' 81' ' ' ILE . 74.6 mm-40 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.26 0.552 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 47.6 m -67.83 -35.47 78.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.53 -39.41 67.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -66.07 -37.86 93.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -65.09 -32.46 74.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -1.102 . . . . 0.0 109.361 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -66.76 -52.65 41.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.882 . . . . 0.0 109.514 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.717 HD12 HG11 ' A' ' 43' ' ' VAL . 59.1 mt -64.81 -46.78 80.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.56 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -54.48 -39.46 67.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.579 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -68.15 -36.99 80.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 66.3 mttm -56.43 -43.87 79.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.562 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.4 mp -72.11 -36.09 69.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.551 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.29 82.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.498 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.403 HG22 ' HE2' ' A' ' 162' ' ' TYR . 30.5 m -63.92 -41.57 97.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.56 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 94.5 mt-30 -66.17 -28.61 68.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.499 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.06 -39.67 97.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . 1.001 ' CB ' HD12 ' A' ' 17' ' ' ILE . 25.0 m -60.79 -38.87 86.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.115 . . . . 0.0 109.516 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.403 ' HE2' HG22 ' A' ' 158' ' ' THR . 91.5 m-85 -66.99 -30.02 70.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.487 HG11 ' CG ' ' A' ' 50' ' ' PRO . 63.4 t -58.56 -38.0 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.575 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.769 HG21 ' HA2' ' A' ' 52' ' ' GLY . 12.3 p . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 1.056 ' CD2' HD11 ' A' ' 79' ' ' LEU . 99.0 m-85 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' A' ' 78' ' ' VAL . 70.0 mm-40 -68.57 -36.91 79.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.152 -0.967 . . . . 0.0 109.283 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.478 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.66 -174.13 44.61 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.589 HG22 ' HB2' ' A' ' 79' ' ' LEU . 90.4 t -137.98 136.34 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -1.106 . . . . 0.0 109.317 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.684 ' CE2' ' CG ' ' A' ' 34' ' ' HIS . 47.6 m-85 -118.88 137.76 53.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.742 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.58 ' CE2' HG13 ' A' ' 81' ' ' ILE . 23.2 m-85 -108.0 130.78 55.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.198 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.993 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 19.6 p -116.5 147.65 41.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 109.621 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CG ' ' OD1' ' A' ' 154' ' ' ASP . 23.3 t70 -148.56 153.51 38.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.6 126.23 3.38 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.6 m -128.68 153.51 47.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -1.148 . . . . 0.0 109.409 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . . . -139.94 144.63 37.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.868 HD12 ' HB3' ' A' ' 161' ' ' SER . 38.0 mt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.459 ' HB2' ' HB ' ' A' ' 17' ' ' ILE . 89.2 m-20 -95.55 136.81 35.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.434 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -145.71 149.47 34.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.759 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -157.78 164.44 33.16 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.893 ' HG3' HD11 ' A' ' 51' ' ' LEU . 66.2 mtm -123.19 163.51 20.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -1.156 . . . . 0.0 109.421 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -148.45 119.54 1.09 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.925 HD12 HG22 ' A' ' 12' ' ' THR . 24.8 mm -114.64 137.03 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -1.17 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.2 t -123.38 136.09 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.992 ' CD2' HD12 ' A' ' 44' ' ' LEU . 4.1 t60 -110.23 135.02 51.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.658 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.01 164.61 27.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.294 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.2 t -131.71 166.74 20.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 109.599 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.587 ' OH ' HG21 ' A' ' 9' ' ' VAL . 66.3 m-85 -100.64 11.63 39.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 109.406 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.571 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -51.29 179.65 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.328 -0.857 . . . . 0.0 109.05 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.571 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.6 Cg_endo -66.29 -5.0 11.56 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.122 1.881 . . . . 0.0 111.65 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -135.95 106.07 6.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.368 -0.832 . . . . 0.0 109.049 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 54.7 t80 -67.46 122.7 18.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.31 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 82.4 mt-30 -159.4 142.46 14.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.769 HG21 HD22 ' A' ' 152' ' ' LEU . 46.2 t -64.96 110.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.992 HD12 ' CD2' ' A' ' 34' ' ' HIS . 35.1 mt -57.14 -48.72 77.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 79.8 m-20 -159.76 153.74 23.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.483 ' HB3' HD11 ' A' ' 156' ' ' LEU . 91.0 mt-30 -109.48 146.47 34.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.485 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.4 t-105 -131.24 135.52 47.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 0.0 109.722 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.9 t -130.29 130.16 44.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 109.261 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.505 ' HB ' ' CE ' ' A' ' 30' ' ' MET . 3.1 mp -131.65 98.69 17.71 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 109.741 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 51.3 Cg_endo -71.57 136.48 28.42 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.601 2.201 . . . . 0.0 111.676 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.893 HD11 ' HG3' ' A' ' 30' ' ' MET . 3.3 mp -103.7 140.37 37.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 53' ' ' ASN . . . -103.34 113.38 4.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 52' ' ' GLY . 47.7 t30 75.63 36.64 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -1.157 . . . . 0.0 109.55 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 51' ' ' LEU . 76.9 m80 -120.26 171.55 8.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.585 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -111.17 170.18 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.26 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -56.98 -35.26 68.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.017 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 60' ' ' GLU . 89.7 mt-30 -70.14 -58.27 3.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 0.0 109.345 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.585 ' SD ' HG23 ' A' ' 55' ' ' THR . 97.6 mtp -44.77 -30.72 1.01 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.304 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 30' ' ' MET . . . -77.62 -34.57 53.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.379 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 57' ' ' GLN . 97.0 mt-10 -63.33 -41.9 98.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 109.567 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.72 ' HA ' HG21 ' A' ' 87' ' ' VAL . 12.8 tt -71.56 -37.36 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.769 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -67.14 -31.66 72.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.308 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.993 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -66.97 -38.6 86.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.426 HG22 HG21 ' A' ' 82' ' ' THR . 85.3 t -69.91 -40.34 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HB2' HD11 ' A' ' 120' ' ' ILE . 80.7 tt0 -69.11 -39.81 78.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.565 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 19.2 t80 -58.77 -64.35 0.96 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.359 -0.838 . . . . 0.0 109.477 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.82 -32.88 69.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 120' ' ' ILE . 43.0 t -51.63 -52.64 46.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 67.8 mttm -64.5 -42.25 95.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.565 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 64.3 mttm -62.62 -37.81 87.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.562 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.71 -61.9 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.919 ' HB2' HD11 ' A' ' 130' ' ' ILE . 18.9 tp -55.21 -42.01 72.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.459 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 72' ' ' LEU . 64.9 tttt -45.17 -40.95 7.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.29 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.633 HG13 HG21 ' A' ' 78' ' ' VAL . 32.6 mm -59.1 143.07 85.01 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 108.899 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.3 Cg_endo -64.08 -5.87 10.22 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.53 2.153 . . . . 0.0 111.871 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -134.85 170.6 22.74 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 49.7 Cg_endo -69.27 135.6 32.06 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.392 2.061 . . . . 0.0 111.771 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.633 HG21 HG13 ' A' ' 74' ' ' ILE . 58.0 t -124.4 158.14 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.875 . . . . 0.0 109.374 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.056 HD11 ' CD2' ' A' ' 6' ' ' TYR . 14.2 mt -108.32 144.71 35.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.213 -0.929 . . . . 0.0 109.424 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 132' ' ' ILE . 13.6 m -123.48 143.92 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.58 HG13 ' CE2' ' A' ' 11' ' ' TYR . 26.1 mm -114.01 133.56 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.339 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.426 HG21 HG22 ' A' ' 64' ' ' VAL . 1.2 p -127.18 161.76 27.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.476 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -98.99 14.16 30.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 109.523 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.582 ' HB3' HG12 ' A' ' 87' ' ' VAL . 27.2 t -137.96 125.77 22.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.67 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 48.8 p90 -77.2 -36.63 54.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.456 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -53.79 -50.18 66.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 61' ' ' ILE . 14.9 p -67.26 -44.72 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.907 . . . . 0.0 109.409 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.582 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -54.89 -47.92 73.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 77.3 mm-40 -62.22 -40.27 95.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.594 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 64.4 m -50.79 -44.96 58.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.675 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -94.51 -0.9 54.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.731 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 56.1 t30 -89.67 -72.93 0.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.581 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 65.0 tttm -127.05 -31.84 2.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 109.774 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 92.6 mt-10 -55.52 -34.23 64.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 0.0 109.743 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 91' ' ' ALA . 0.8 OUTLIER -56.18 -62.13 5.33 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 109.581 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 44.5 Cg_endo -66.93 -32.71 34.97 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.836 2.357 . . . . 0.0 111.746 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -67.75 -38.24 83.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.164 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.9 m0 . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.288 -0.883 . . . . 0.0 109.259 179.779 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 73.6 mttt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.218 0.532 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 55.8 m80 63.42 27.68 15.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.619 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.8 mt -57.51 -41.46 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.312 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.5 m -50.3 -47.3 55.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.264 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -60.57 -45.16 94.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.321 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.64 ' HH2' HG23 ' A' ' 87' ' ' VAL . 22.8 m95 -65.7 -40.6 92.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.349 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -52.34 -49.82 63.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.333 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.2 m -55.67 -45.55 77.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.294 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.548 HG23 ' SG ' ' A' ' 68' ' ' CYS . 76.8 mt -67.95 -37.99 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 109.374 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.458 ' HA ' HD13 ' A' ' 95' ' ' LEU . . . -53.57 -42.38 67.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 126' ' ' MET . 76.3 mm-40 -54.6 -43.7 72.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 109.369 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 1.6 m -63.87 -49.16 73.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.425 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.5 tp -64.28 -33.05 74.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.3 m -61.8 -32.67 72.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.0 109.62 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.509 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 91.9 mmm -65.67 -28.94 69.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 163.37 146.87 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.559 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.5 Cg_endo -69.91 -1.87 9.33 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.672 2.248 . . . . 0.0 111.657 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 85.6 m-20 -43.42 -34.2 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -0.811 . . . . 0.0 109.503 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.919 HD11 ' HB2' ' A' ' 72' ' ' LEU . 45.9 mt -72.62 123.59 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.584 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.606 ' HB ' HD22 ' A' ' 79' ' ' LEU . 40.0 m -119.01 139.06 52.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 109.238 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.675 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 73.0 mt -119.76 137.33 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.664 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.524 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 94.8 mt-30 -120.62 155.63 33.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.365 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.67 ' CD2' ' HB3' ' A' ' 85' ' ' PHE . 63.8 t60 -114.7 135.87 53.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.452 ' OE1' ' ND2' ' A' ' 150' ' ' ASN . 65.5 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.322 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.413 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 92.6 m-70 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 42.7 m -55.21 -48.81 73.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.5 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 152' ' ' LEU . 85.7 tt0 -49.04 -49.48 41.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -56.85 -39.08 87.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.452 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 87.7 m-20 -64.84 -35.8 82.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -1.123 . . . . 0.0 109.365 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.64 -47.11 86.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.769 HD22 HG21 ' A' ' 43' ' ' VAL . 6.5 mp -65.25 -37.05 86.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.409 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.0 -41.66 90.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.915 . . . . 0.0 109.544 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.404 ' OD1' ' CG ' ' A' ' 13' ' ' ASP . 83.0 m-20 -57.6 -47.92 80.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.545 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -55.25 -48.01 74.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.515 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.494 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 62.7 mt -60.52 -38.76 85.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.568 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.05 -42.53 72.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 47.4 p -70.02 -30.94 68.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.569 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 163' ' ' VAL . 60.3 tt0 -62.66 -36.89 84.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -60.13 -37.82 93.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.868 ' HB3' HD12 ' A' ' 17' ' ' ILE . 14.5 m -59.95 -42.11 93.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.477 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.44 -25.33 68.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 159' ' ' GLN . 40.9 t -68.72 -23.36 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.398 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 161' ' ' SER . 38.5 t . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 1.032 ' CD2' HD11 ' A' ' 79' ' ' LEU . 54.6 m-85 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.289 0.566 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.511 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 74.8 mm-40 -55.51 -38.27 68.97 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.217 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.478 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.82 -175.52 45.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.644 HG21 ' OH ' ' A' ' 37' ' ' TYR . 74.7 t -133.53 137.61 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -1.081 . . . . 0.0 109.167 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.682 ' CZ ' ' CD2' ' A' ' 34' ' ' HIS . 57.0 m-85 -117.67 134.76 54.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.126 -0.984 . . . . 0.0 110.014 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 1.026 ' CE2' HD12 ' A' ' 81' ' ' ILE . 38.1 m-85 -107.49 129.12 54.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.034 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.914 HG22 HD12 ' A' ' 32' ' ' ILE . 12.8 p -118.48 147.65 43.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.862 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 65.5 t0 -138.31 146.46 42.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.481 -0.762 . . . . 0.0 109.143 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -135.17 136.92 8.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.4 p -143.47 161.88 37.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -1.139 . . . . 0.0 109.301 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -153.39 145.85 24.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.1 mt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.358 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.236 0.541 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 90.3 m-20 -105.31 135.96 45.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -139.36 146.44 40.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.708 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 50' ' ' PRO . . . -137.18 159.06 24.59 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 66.6 mtm -131.89 151.21 51.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -1.148 . . . . 0.0 109.483 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.517 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -134.03 127.96 4.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.914 HD12 HG22 ' A' ' 12' ' ' THR . 23.9 mm -115.6 135.72 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.489 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.0 t -126.25 135.01 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 1.138 ' CE1' HD12 ' A' ' 44' ' ' LEU . 14.0 t-160 -111.4 127.54 55.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 109.538 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.52 171.65 8.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -129.9 165.86 21.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.644 ' OH ' HG21 ' A' ' 9' ' ' VAL . 55.3 m-85 -100.2 13.07 35.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 109.449 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.583 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.32 179.94 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 108.939 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.0 Cg_endo -66.41 -4.85 11.45 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.136 1.89 . . . . 0.0 111.707 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.443 ' CD ' ' NE2' ' A' ' 42' ' ' GLN . 83.7 tt0 -138.11 106.16 5.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -0.847 . . . . 0.0 109.041 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -54.44 121.5 8.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.462 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.443 ' NE2' ' CD ' ' A' ' 40' ' ' GLU . 91.1 mt-30 -152.74 156.6 39.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 43' ' ' VAL . 21.0 m -89.62 118.13 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.138 HD12 ' CE1' ' A' ' 34' ' ' HIS . 39.5 mt -58.49 -45.62 88.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.362 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 74.9 m-20 -162.71 168.45 21.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.425 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -121.7 145.07 48.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.469 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 2.9 t-105 -128.85 140.03 51.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -125.35 128.8 48.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.462 HD11 ' CE2' ' A' ' 66' ' ' PHE . 2.7 mp -127.17 86.94 57.65 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.622 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.616 ' HB3' HG21 ' A' ' 163' ' ' VAL . 51.0 Cg_endo -70.65 130.53 18.39 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.746 2.297 . . . . 0.0 111.699 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 28' ' ' ALA . 43.9 mt -107.19 153.03 23.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 109.452 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -124.74 -40.95 0.4 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -108.0 32.07 5.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -1.113 . . . . 0.0 109.514 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 78.9 m80 -120.15 145.7 46.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.542 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.497 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -89.93 168.34 12.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.201 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -48.81 -38.95 23.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.135 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 60' ' ' GLU . 91.0 mt-30 -70.39 -58.26 3.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.548 ' O ' HG22 ' A' ' 61' ' ' ILE . 95.3 mtp -44.95 -30.48 1.02 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.352 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.67 -36.81 57.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' GLN . 98.8 mt-10 -65.49 -40.04 92.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 58' ' ' MET . 20.5 tt -70.79 -34.57 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.46 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -69.41 -33.7 73.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.854 . . . . 0.0 109.45 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.545 ' HB1' ' OG1' ' A' ' 12' ' ' THR . . . -59.0 -43.17 91.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.524 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.667 HG21 HG12 ' A' ' 87' ' ' VAL . 96.3 t -70.79 -50.46 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.561 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.468 ' HG3' HG12 ' A' ' 120' ' ' ILE . 86.7 tt0 -59.17 -40.43 85.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.593 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.558 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 17.0 t80 -53.89 -70.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.908 . . . . 0.0 109.632 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.711 ' HB3' HG13 ' A' ' 80' ' ' VAL . . . -64.19 -10.96 26.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -0.906 . . . . 0.0 109.648 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.871 ' SG ' HG23 ' A' ' 120' ' ' ILE . 37.7 t -75.51 -56.34 4.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -63.25 -41.23 99.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 44.4 mttp -66.02 -34.68 78.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HB1' ' HB ' ' A' ' 78' ' ' VAL . . . -59.94 -58.93 6.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.965 ' HB2' HD11 ' A' ' 130' ' ' ILE . 9.3 tt -55.4 -45.12 76.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 72' ' ' LEU . 58.2 tttm -43.27 -41.75 4.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.592 HG13 HG21 ' A' ' 78' ' ' VAL . 30.0 mm -56.52 143.15 68.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.304 -0.872 . . . . 0.0 108.736 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.1 Cg_endo -64.33 -5.01 8.93 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.729 2.286 . . . . 0.0 112.086 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.511 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -136.22 171.87 22.64 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 49.7 Cg_endo -70.1 132.33 22.57 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.44 2.094 . . . . 0.0 111.806 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.592 HG21 HG13 ' A' ' 74' ' ' ILE . 60.2 t -120.61 161.86 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.442 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.032 HD11 ' CD2' ' A' ' 6' ' ' TYR . 14.5 mt -107.83 137.73 45.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.711 HG13 ' HB3' ' A' ' 67' ' ' ALA . 45.6 t -116.62 130.22 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.026 HD12 ' CE2' ' A' ' 11' ' ' TYR . 35.4 mt -117.56 136.16 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.0 109.501 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 84' ' ' SER . 12.8 t -139.51 159.71 41.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -88.99 19.74 3.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.535 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.533 ' H ' HG23 ' A' ' 82' ' ' THR . 34.2 t -122.55 116.8 24.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 109.521 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.614 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 38.9 p90 -77.27 -45.31 26.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.489 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.567 ' N ' ' CG ' ' A' ' 85' ' ' PHE . 69.9 t80 -55.7 -48.87 74.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.667 HG12 HG21 ' A' ' 64' ' ' VAL . 86.8 t -60.13 -49.42 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.318 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -53.24 -55.01 27.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.221 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 96.1 mt-10 -58.5 -28.39 65.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.325 -0.859 . . . . 0.0 109.391 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.627 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 23.9 m -59.88 -45.97 90.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.655 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -92.36 -0.74 57.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 109.774 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 82.3 m-20 -86.96 -68.19 0.76 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.004 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 67.8 mttm -122.19 -34.58 3.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 109.9 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.533 ' OE1' ' CZ2' ' A' ' 98' ' ' TRP . 83.4 mt-10 -62.41 -32.95 73.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 109.612 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 90' ' ' SER . 0.1 OUTLIER -55.92 -59.65 11.0 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.416 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 46.1 Cg_endo -67.72 -32.53 29.97 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.707 2.272 . . . . 0.0 111.444 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -73.0 -37.31 67.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 108.954 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.533 ' CZ2' ' OE1' ' A' ' 94' ' ' GLU . 15.1 m0 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.369 -0.832 . . . . 0.0 109.17 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.405 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 58.4 m80 59.77 42.99 15.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.88 . . . . 0.0 109.438 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.56 HG22 ' HE3' ' A' ' 118' ' ' LYS . 91.9 mt -65.04 -42.68 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.466 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -61.87 -39.84 93.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -60.66 -44.77 96.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.627 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 52.7 m95 -65.03 -38.53 91.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.427 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.56 ' HE3' HG22 ' A' ' 114' ' ' ILE . 52.0 mttt -58.69 -37.54 76.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.8 m -62.85 -43.48 98.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.372 -0.83 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.871 HG23 ' SG ' ' A' ' 68' ' ' CYS . 73.0 mt -69.86 -35.69 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -64.76 -34.37 78.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -53.03 -37.24 61.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.436 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.491 ' CA ' HD13 ' A' ' 72' ' ' LEU . 12.4 m -83.63 -45.37 13.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.49 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.466 ' CD2' ' HB ' ' A' ' 130' ' ' ILE . 53.1 mt -61.57 -31.44 71.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.437 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.0 m -56.41 -36.55 69.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.468 ' HB2' HD11 ' A' ' 72' ' ' LEU . 88.7 mtp -63.92 -36.8 85.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 171.24 157.32 0.22 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.5 Cg_endo -72.15 3.7 3.83 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.739 2.292 . . . . 0.0 112.061 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 128' ' ' PRO . 85.7 m-20 -42.36 -35.71 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.212 -0.93 . . . . 0.0 109.623 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.965 HD11 ' HB2' ' A' ' 72' ' ' LEU . 62.8 mt -75.17 116.26 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 109.402 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.574 ' HB ' HD22 ' A' ' 79' ' ' LEU . 31.3 m -110.88 142.55 42.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.368 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.655 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 62.0 mt -120.74 137.13 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.66 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB2' HG12 ' A' ' 81' ' ' ILE . 88.5 mt-30 -118.65 165.2 14.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -0.888 . . . . 0.0 109.36 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.614 ' CE1' ' HB3' ' A' ' 85' ' ' PHE . 74.9 t60 -120.56 133.64 55.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.513 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HG3' HG22 ' A' ' 81' ' ' ILE . 93.6 mt-10 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.426 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.1 m -55.29 -45.59 76.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -51.67 -43.38 62.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.04 -39.04 89.01 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -1.139 . . . . 0.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -57.93 -51.72 68.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 152' ' ' LEU . 7.0 mp -65.46 -44.73 86.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 109.526 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.2 87.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.577 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.46 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 58.4 t0 -61.81 -38.04 86.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 24.1 mttm -62.96 -40.58 98.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.568 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 61.7 mt -72.09 -37.22 69.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.537 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.22 -44.51 75.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.47 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.588 HG22 ' HE2' ' A' ' 162' ' ' TYR . 31.1 m -61.03 -41.84 97.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.54 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.574 ' O ' HG13 ' A' ' 163' ' ' VAL . 94.4 mt-30 -67.29 -26.66 66.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.485 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.962 ' O ' HG22 ' A' ' 163' ' ' VAL . . . -66.28 -26.73 72.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.6 p -76.06 -25.37 55.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -1.157 . . . . 0.0 109.457 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.588 ' HE2' HG22 ' A' ' 158' ' ' THR . 93.4 m-85 -81.36 -25.59 36.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.055 HG23 HG23 ' A' ' 164' ' ' VAL . 5.1 m -62.76 -24.92 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 1.055 HG23 HG23 ' A' ' 163' ' ' VAL . 41.3 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 1.027 ' CD2' HD11 ' A' ' 79' ' ' LEU . 50.1 m-85 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.558 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.8 tp10 -59.47 -37.1 77.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.268 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.484 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.69 -169.45 39.39 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.829 HG21 ' CZ ' ' A' ' 37' ' ' TYR . 70.2 t -142.55 140.65 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -1.135 . . . . 0.0 109.253 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.686 ' CE1' ' CD2' ' A' ' 34' ' ' HIS . 31.3 m-85 -121.05 142.88 49.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.82 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CE1' HG13 ' A' ' 81' ' ' ILE . 49.7 m-85 -114.58 130.16 56.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 108.952 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.997 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 29.2 p -112.69 150.17 31.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.075 -1.015 . . . . 0.0 109.956 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 66.6 t0 -145.2 145.99 31.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.056 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -139.98 137.36 8.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.687 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 87.3 p -143.53 162.72 35.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -1.127 . . . . 0.0 109.17 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . . . -146.25 148.82 32.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.001 . . . . 0.0 109.757 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.418 HD12 ' HB2' ' A' ' 161' ' ' SER . 60.6 mt . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -99.41 125.66 45.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.443 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 15' ' ' SER . . . -135.65 158.41 44.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 50' ' ' PRO . . . -140.33 159.53 26.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.84 ' HE3' HD12 ' A' ' 49' ' ' ILE . 49.7 mtm -118.93 154.08 33.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -1.179 . . . . 0.0 109.399 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -139.68 120.04 1.77 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.928 HD12 HG22 ' A' ' 12' ' ' THR . 20.9 mm -111.13 133.08 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -1.154 . . . . 0.0 109.437 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' PHE . 42.7 t -118.64 137.89 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 1.137 ' CE1' HD22 ' A' ' 44' ' ' LEU . 23.6 t-160 -112.86 130.15 56.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.52 166.94 20.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.324 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.594 ' HB ' HD11 ' A' ' 44' ' ' LEU . 9.9 t -127.75 154.25 45.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.829 ' CZ ' HG21 ' A' ' 9' ' ' VAL . 11.8 m-30 -95.22 5.28 52.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.518 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.585 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.3 179.56 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.059 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.7 Cg_endo -66.39 -4.43 10.67 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.219 1.946 . . . . 0.0 111.825 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -130.38 105.93 8.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 108.745 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -71.22 130.3 41.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 109.554 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -167.99 151.83 6.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.429 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.6 p -76.96 125.59 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.878 . . . . 0.0 109.406 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.137 HD22 ' CE1' ' A' ' 34' ' ' HIS . 7.5 mp -72.23 -36.67 69.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.902 . . . . 0.0 109.387 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -173.05 158.46 3.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.457 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.856 ' HB3' HD21 ' A' ' 156' ' ' LEU . 91.8 mt-30 -113.49 138.64 49.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.279 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.465 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -121.25 135.42 55.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.657 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.7 t -128.71 129.95 46.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.196 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.84 HD12 ' HE3' ' A' ' 30' ' ' MET . 4.1 mt -134.45 93.17 19.23 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 109.691 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 50.5 Cg_endo -70.9 140.28 38.05 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.693 2.262 . . . . 0.0 111.658 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.772 HD11 ' HG3' ' A' ' 30' ' ' MET . 5.3 mp -109.0 154.84 21.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.531 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.04 -34.86 0.66 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.525 ' OD1' ' CD2' ' A' ' 54' ' ' HIS . 42.7 p-10 -118.47 36.67 4.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.161 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.556 ' CG ' HD23 ' A' ' 51' ' ' LEU . 92.8 m-70 -126.47 169.75 12.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.441 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.618 HG23 ' H ' ' A' ' 58' ' ' MET . 10.0 t -111.43 -176.27 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.459 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.645 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -67.52 -39.06 85.09 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.544 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -67.38 -45.23 76.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.557 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.618 ' H ' HG23 ' A' ' 55' ' ' THR . 96.0 mtp -65.15 -36.46 84.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.616 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.82 88.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 56' ' ' ALA . 96.1 mt-10 -67.12 -48.4 68.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.6 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.744 ' HA ' HG21 ' A' ' 87' ' ' VAL . 13.1 tt -66.21 -36.15 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.452 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.572 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -64.9 -28.64 69.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.997 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -68.16 -40.94 82.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.573 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.519 HG22 ' CG2' ' A' ' 82' ' ' THR . 61.4 t -70.34 -38.24 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.593 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.594 ' HG2' HD11 ' A' ' 120' ' ' ILE . 97.3 mt-10 -66.4 -37.46 85.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.071 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.637 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 24.1 t80 -63.26 -67.1 0.45 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.451 -0.781 . . . . 0.0 109.761 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 68' ' ' CYS . . . -58.2 -45.3 87.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 109.867 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.779 ' SG ' HG23 ' A' ' 120' ' ' ILE . 42.5 t -42.47 -62.57 0.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 109.738 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 42.7 mttp -54.83 -50.46 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.637 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 64.2 mttm -55.23 -36.84 66.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.597 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.03 -61.31 2.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.443 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.777 ' HB2' HD11 ' A' ' 130' ' ' ILE . 22.8 tp -51.53 -45.52 63.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 36.6 mmtt -43.82 -47.19 8.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.325 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.556 HG13 HG21 ' A' ' 78' ' ' VAL . 27.5 mm -48.39 142.73 7.97 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 108.923 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.6 Cg_endo -65.82 -3.91 9.01 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.553 2.169 . . . . 0.0 111.808 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.427 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -137.07 168.81 24.2 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 48.5 Cg_endo -69.44 130.53 19.9 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.53 2.154 . . . . 0.0 111.723 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.59 HG11 ' CE1' ' A' ' 10' ' ' PHE . 50.4 t -120.0 158.66 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.512 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.027 HD11 ' CD2' ' A' ' 6' ' ' TYR . 23.2 mt -101.74 143.85 31.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.9 t -119.48 130.4 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.527 HG13 ' CE1' ' A' ' 11' ' ' TYR . 24.4 mm -111.08 142.0 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.519 ' CG2' HG22 ' A' ' 64' ' ' VAL . 1.4 p -131.95 157.99 42.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.487 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.448 ' OD2' ' OD1' ' A' ' 13' ' ' ASP . 60.5 m-20 -82.17 -20.02 38.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.479 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.626 ' HB3' HG12 ' A' ' 87' ' ' VAL . 46.9 t -110.62 131.64 54.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.576 ' HB3' ' CG ' ' A' ' 134' ' ' HIS . 46.4 p90 -76.11 -35.03 59.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -57.06 -52.58 64.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.418 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.744 HG21 ' HA ' ' A' ' 61' ' ' ILE . 9.7 p -62.03 -47.31 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.341 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.771 ' HB1' HG22 ' A' ' 132' ' ' ILE . . . -55.76 -53.66 53.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 85' ' ' PHE . 76.0 mm-40 -60.01 -35.14 74.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.357 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.554 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 33.6 m -51.7 -48.04 63.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.461 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.874 ' HB1' HG21 ' A' ' 120' ' ' ILE . . . -91.37 -0.99 57.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.633 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 44.3 t-20 -85.61 -72.83 0.47 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.001 . . . . 0.0 109.744 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 21.4 mttt -126.72 -28.52 2.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.091 -1.005 . . . . 0.0 109.917 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.576 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 91.9 mt-10 -60.56 -31.98 71.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.033 . . . . 0.0 109.866 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -58.14 -59.88 11.91 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.503 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.8 Cg_endo -66.94 -33.23 33.48 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.664 2.242 . . . . 0.0 111.606 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -70.26 -35.43 73.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -0.887 . . . . 0.0 109.043 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.576 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 10.8 m0 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.374 -0.829 . . . . 0.0 109.192 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 23.8 mttm . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.303 0.573 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.538 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 50.4 m80 64.61 41.14 5.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.519 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -72.46 -42.84 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.305 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.7 m -62.12 -40.23 95.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.273 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 67.8 mttm -62.8 -44.27 96.61 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.387 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.714 ' HB3' HD21 ' A' ' 95' ' ' LEU . 24.0 m95 -78.7 -31.69 46.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.295 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -57.88 -41.09 81.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.976 . . . . 0.0 109.343 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.3 m -60.81 -48.1 83.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.333 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.874 HG21 ' HB1' ' A' ' 91' ' ' ALA . 76.7 mt -70.36 -35.32 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.435 ' O ' ' OG ' ' A' ' 125' ' ' SER . . . -63.77 -34.68 78.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.369 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 126' ' ' MET . 82.5 tt0 -62.44 -36.42 82.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 19.9 m -79.97 -48.97 12.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.412 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.07 -35.93 74.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.848 . . . . 0.0 109.391 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 121' ' ' ALA . 43.4 m -63.33 -32.93 74.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.422 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 89.8 mtp -66.88 -34.41 77.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.873 . . . . 0.0 109.476 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.81 135.64 0.36 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.404 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.0 Cg_endo -69.6 -2.49 10.15 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.694 2.263 . . . . 0.0 111.57 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 128' ' ' PRO . 88.4 m-20 -43.46 -36.88 2.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 109.344 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.777 HD11 ' HB2' ' A' ' 72' ' ' LEU . 50.0 mt -66.94 116.52 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.573 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.3 m -106.91 144.49 33.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 109.371 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.771 HG22 ' HB1' ' A' ' 88' ' ' ALA . 72.7 mt -125.23 137.46 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 109.496 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.527 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 95.1 mt-30 -135.35 159.3 42.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.576 ' CG ' ' HB3' ' A' ' 85' ' ' PHE . 72.0 t60 -101.6 132.67 47.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.576 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.52 ' HB2' ' CG2' ' A' ' 81' ' ' ILE . 43.6 tp10 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 37.3 m80 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.7 m -49.15 -52.67 24.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.02 -49.51 63.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.398 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.32 -38.77 57.75 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -59.37 -42.36 91.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.183 . . . . 0.0 109.397 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.94 79.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.6 mt -59.97 -46.66 88.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 0.0 109.452 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.663 ' HA ' HD12 ' A' ' 156' ' ' LEU . . . -59.65 -38.91 82.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.469 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 91.6 m-20 -57.28 -42.64 82.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.419 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 31.5 mttp -62.34 -40.65 97.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 109.449 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.856 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.5 mt -64.04 -43.52 95.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.443 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.41 -46.25 89.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 43.4 m -58.42 -41.92 86.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 96.3 mt-30 -63.07 -33.91 76.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -57.6 -41.74 93.76 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.418 ' HB2' HD12 ' A' ' 17' ' ' ILE . 70.5 p -65.19 -31.52 72.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -1.159 . . . . 0.0 109.45 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -68.67 -28.19 66.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 109.509 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.8 t -67.07 -22.18 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.954 . . . . 0.0 109.509 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.471 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.511 ' CE2' HD21 ' A' ' 79' ' ' LEU . 29.6 m-85 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.454 0.645 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -73.48 -34.16 65.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.868 . . . . 0.0 109.098 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.566 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -179.15 -166.84 35.7 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.626 HG22 ' HB2' ' A' ' 79' ' ' LEU . 77.5 t -133.51 140.87 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.276 -1.132 . . . . 0.0 109.055 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.632 ' CE2' ' ND1' ' A' ' 34' ' ' HIS . 5.4 m-85 -113.24 147.33 37.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.844 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE1' HG13 ' A' ' 81' ' ' ILE . 96.9 m-85 -116.87 130.22 56.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 108.935 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.786 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 33.5 p -119.39 149.8 41.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.993 . . . . 0.0 109.933 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.02 163.07 37.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.437 -0.789 . . . . 0.0 109.203 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.436 ' CA ' ' OE2' ' A' ' 60' ' ' GLU . . . -139.53 118.73 1.55 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.2 m -123.2 143.95 49.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -1.16 . . . . 0.0 109.468 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 27' ' ' ASN . . . -142.99 155.6 44.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.1 mt . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 109.401 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.257 0.551 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.643 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 80.7 m-20 -91.53 144.35 25.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.394 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -140.52 154.67 46.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -156.77 150.23 21.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.757 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 69.2 mtm -113.99 168.82 9.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -1.105 . . . . 0.0 109.432 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -152.96 115.45 0.68 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.604 HD13 ' CD1' ' A' ' 49' ' ' ILE . 5.4 mp -125.87 118.9 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.132 . . . . 0.0 109.253 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 45' ' ' ASN . 10.3 p -118.63 151.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.72 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.632 ' ND1' ' CE2' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -104.11 136.95 42.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 109.253 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.55 158.4 34.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.624 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.893 ' HB ' HD11 ' A' ' 44' ' ' LEU . 14.4 t -125.58 164.42 20.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 109.384 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.548 ' HE2' HG23 ' A' ' 9' ' ' VAL . 86.5 m-85 -116.68 8.38 13.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.184 -0.947 . . . . 0.0 109.619 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.587 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.65 -179.42 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 108.946 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.8 Cg_endo -65.95 -5.12 11.39 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.08 1.853 . . . . 0.0 111.749 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -125.84 106.02 9.37 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -73.74 122.89 23.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.196 -0.94 . . . . 0.0 109.531 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -168.0 117.78 0.79 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.88 . . . . 0.0 109.203 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.627 HG11 HD13 ' A' ' 152' ' ' LEU . 1.4 m -47.94 123.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -0.93 . . . . 0.0 109.399 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.893 HD11 ' HB ' ' A' ' 36' ' ' THR . 5.8 mp -65.68 -38.31 88.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.661 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.576 ' O ' HG23 ' A' ' 33' ' ' VAL . 57.2 t-20 -175.27 155.02 1.82 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 109.88 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 89.8 mt-30 -112.37 150.55 30.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.809 . . . . 0.0 108.892 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.1 t-105 -128.78 131.16 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.989 . . . . 0.0 109.664 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -122.39 133.36 54.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.412 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.604 ' CD1' HD13 ' A' ' 32' ' ' ILE . 3.6 mp -134.1 88.42 31.43 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.88 139.22 39.28 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.728 2.286 . . . . 0.0 111.728 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.832 ' N ' HD12 ' A' ' 51' ' ' LEU . 3.0 mp -106.04 147.88 28.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.402 ' HA2' HG11 ' A' ' 164' ' ' VAL . . . -93.21 -67.58 1.08 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -104.89 60.87 0.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -1.145 . . . . 0.0 109.502 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.557 ' CD2' ' HB3' ' A' ' 51' ' ' LEU . 71.9 m-70 -133.16 173.06 11.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 58' ' ' MET . 8.9 t -117.11 173.16 6.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 109.474 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -55.91 -45.54 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.849 . . . . 0.0 109.261 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 60' ' ' GLU . 85.6 mt-30 -58.36 -63.82 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.416 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.471 ' H ' HG23 ' A' ' 55' ' ' THR . 97.9 mtp -43.55 -29.2 0.45 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.485 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.44 -29.17 30.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.372 -0.83 . . . . 0.0 109.611 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 57' ' ' GLN . 62.7 mm-40 -71.08 -34.81 71.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.704 HD11 ' CZ2' ' A' ' 117' ' ' TRP . 13.4 tt -82.1 -34.65 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 109.609 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.757 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -69.61 -26.09 64.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.786 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -67.09 -36.45 82.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.414 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.725 HG22 HG21 ' A' ' 82' ' ' THR . 84.9 t -75.57 -36.67 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.428 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 77.6 tt0 -70.4 -37.17 74.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.122 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.525 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 26.1 t80 -60.86 -66.33 0.55 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.398 -0.814 . . . . 0.0 109.508 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.66 -31.15 57.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.551 ' SG ' HD13 ' A' ' 130' ' ' ILE . 33.3 t -55.2 -57.63 10.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 31.9 tttt -63.7 -38.88 92.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 17.6 mmtt -59.84 -32.89 71.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.907 . . . . 0.0 109.47 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' LEU . . . -71.22 -59.8 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.291 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 130' ' ' ILE . 25.8 tp -45.18 -47.27 12.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.278 -0.889 . . . . 0.0 109.296 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 57.4 mttm -44.13 -48.79 9.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.195 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.068 HD12 HG21 ' A' ' 78' ' ' VAL . 4.8 mt -54.65 141.91 54.34 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.056 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.5 Cg_endo -66.07 -7.33 16.75 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.525 2.15 . . . . 0.0 111.483 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.94 161.19 21.88 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.0 Cg_endo -69.05 146.67 65.34 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.437 2.091 . . . . 0.0 111.747 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.068 HG21 HD12 ' A' ' 74' ' ' ILE . 25.4 t -134.78 159.36 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.335 -0.853 . . . . 0.0 109.562 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.632 HD12 ' C ' ' A' ' 78' ' ' VAL . 7.1 mp -109.02 132.41 54.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.542 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.5 t -103.18 133.15 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.203 -0.936 . . . . 0.0 109.433 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.813 HG21 ' OE2' ' A' ' 135' ' ' GLU . 21.2 mm -106.13 132.52 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.366 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.725 HG21 HG22 ' A' ' 64' ' ' VAL . 1.1 p -133.42 161.71 33.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.529 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -92.7 6.99 45.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.516 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.511 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 41.3 t -130.28 123.76 30.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.918 . . . . 0.0 109.603 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.723 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 40.3 p90 -77.05 -43.0 36.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.535 ' N ' ' CG ' ' A' ' 85' ' ' PHE . 69.9 t80 -47.16 -50.25 20.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.88 . . . . 0.0 109.447 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.726 HG23 ' HH2' ' A' ' 117' ' ' TRP . 7.2 p -66.71 -47.76 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.343 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.596 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -54.04 -46.96 72.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.26 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 98.2 mt-10 -65.22 -35.47 81.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.331 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.577 ' HB2' ' CH2' ' A' ' 117' ' ' TRP . 68.3 m -52.74 -44.48 66.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.472 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.747 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -96.43 -0.89 48.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 51.7 t30 -92.56 -72.74 0.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.031 . . . . 0.0 109.751 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 48.2 mttm -126.64 -27.67 3.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.49 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 87.3 mt-10 -61.23 -31.46 71.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.871 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 91' ' ' ALA . 0.6 OUTLIER -56.05 -60.2 9.56 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.681 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 45.6 Cg_endo -67.4 -34.55 26.3 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.727 2.285 . . . . 0.0 111.702 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -68.59 -36.45 78.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.227 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.43 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 13.8 m0 . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 83.7 mttt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.223 0.535 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 54.0 m80 65.52 26.51 11.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -0.819 . . . . 0.0 109.637 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.783 HG22 ' HE3' ' A' ' 118' ' ' LYS . 66.6 mt -64.29 -42.47 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.274 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -53.84 -46.23 71.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.161 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -58.51 -42.07 86.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.854 . . . . 0.0 109.251 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.726 ' HH2' HG23 ' A' ' 87' ' ' VAL . 16.3 m95 -67.67 -34.14 76.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.783 ' HE3' HG22 ' A' ' 114' ' ' ILE . 62.3 mttt -60.12 -36.37 77.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.332 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.428 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 25.3 m -66.28 -44.4 83.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.338 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.747 HG21 ' CB ' ' A' ' 91' ' ' ALA . 74.4 mt -66.64 -38.73 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.426 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.447 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -62.21 -35.88 80.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.387 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 126' ' ' MET . 82.9 tt0 -54.12 -39.84 66.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.872 . . . . 0.0 109.398 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.9 m -77.39 -46.5 22.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 0.0 109.4 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 59.9 mt -61.42 -36.83 81.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.417 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.5 m -60.53 -34.13 73.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.402 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.442 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 89.3 mtp -64.17 -30.77 71.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.915 . . . . 0.0 109.511 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 176.27 136.32 0.19 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.532 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.58 -0.09 7.06 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.74 2.293 . . . . 0.0 111.805 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 93.6 m-20 -50.2 -21.57 1.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 72' ' ' LEU . 68.0 mt -81.15 114.52 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.64 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 55.6 m -112.17 135.28 53.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.601 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 75.6 mt -116.57 138.75 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.105 -0.997 . . . . 0.0 109.682 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.587 ' NE2' HD23 ' A' ' 79' ' ' LEU . 94.7 mt-30 -124.68 159.45 30.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.723 ' CD2' ' HB3' ' A' ' 85' ' ' PHE . 60.7 t60 -119.54 142.18 48.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.813 ' OE2' HG21 ' A' ' 81' ' ' ILE . 92.9 mt-10 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.451 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.259 0.552 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.8 m -67.18 -42.98 83.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.506 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.459 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 97.9 mt-10 -60.06 -36.66 77.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.51 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -69.3 -24.85 75.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -75.52 -33.88 60.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -1.118 . . . . 0.0 109.471 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -74.74 -41.45 60.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.627 HD13 HG11 ' A' ' 43' ' ' VAL . 68.9 mt -64.87 -38.2 90.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 0.0 109.55 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.13 -39.58 75.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -65.84 -39.38 90.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.125 -0.984 . . . . 0.0 109.464 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 66.8 mttm -64.85 -35.41 81.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.55 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 39.9 mt -68.19 -40.26 82.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 109.58 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.42 92.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.52 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 38.4 m -58.38 -44.06 88.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.519 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -61.94 -37.08 83.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.534 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.0 -48.2 84.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 164' ' ' VAL . 85.8 p -64.84 -33.45 76.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -1.148 . . . . 0.0 109.59 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -63.44 -38.41 91.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 68.7 t -57.06 -38.17 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 51' ' ' LEU . 41.2 t . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.517 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.856 ' CD2' HD11 ' A' ' 79' ' ' LEU . 49.5 p90 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.744 ' HG3' HG22 ' A' ' 78' ' ' VAL . 2.6 pp20? -89.54 -27.08 20.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.589 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.4 -174.61 31.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.501 HG13 ' CE2' ' A' ' 11' ' ' TYR . 14.6 p -130.43 143.7 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -1.141 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.669 ' CD2' HG11 ' A' ' 78' ' ' VAL . 26.5 m-85 -119.44 123.6 44.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.932 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.643 ' CE1' HD12 ' A' ' 81' ' ' ILE . 87.7 m-85 -105.81 130.83 53.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.816 HG22 HD12 ' A' ' 32' ' ' ILE . 15.8 p -119.93 150.75 39.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.508 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 57.3 t0 -142.64 151.47 41.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -133.64 119.19 2.24 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.6 m -127.85 152.22 48.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -1.172 . . . . 0.0 109.5 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 27' ' ' ASN . . . -137.62 156.05 48.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 109.453 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.928 . . . . 0.0 109.504 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 70.3 m-20 -86.63 145.19 26.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.632 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -140.29 150.22 43.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.93 165.24 30.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.844 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 56.0 mtm -132.7 152.79 51.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -1.109 . . . . 0.0 109.291 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.37 125.22 2.97 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.816 HD12 HG22 ' A' ' 12' ' ' THR . 19.1 mm -111.08 142.51 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -1.154 . . . . 0.0 109.301 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.3 t -136.64 123.52 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.159 -0.963 . . . . 0.0 109.756 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 1.012 ' CD2' HD12 ' A' ' 44' ' ' LEU . 23.6 t60 -101.01 138.27 38.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.141 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.25 163.18 33.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 109.836 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.0 t -123.16 164.96 17.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.415 -0.803 . . . . 0.0 109.172 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 38' ' ' LYS . 83.8 m-85 -103.49 9.47 37.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.094 -1.004 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.578 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 2.0 mtmt -51.21 -179.25 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.8 Cg_endo -65.13 -5.78 11.7 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.039 1.826 . . . . 0.0 111.649 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -127.28 105.74 8.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.339 -0.85 . . . . 0.0 108.741 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -74.01 126.81 31.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.43 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -167.33 148.3 5.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 109.589 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.6 m -71.47 121.96 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.365 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.012 HD12 ' CD2' ' A' ' 34' ' ' HIS . 41.0 mt -65.06 -43.95 90.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.327 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 76.8 m-20 -159.17 147.79 18.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.377 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.924 ' HB3' HD21 ' A' ' 156' ' ' LEU . 90.6 mt-30 -106.85 144.26 33.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.402 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.81 138.53 45.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 0.0 109.714 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.413 ' C ' HD12 ' A' ' 49' ' ' ILE . 96.5 p -130.85 144.87 51.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.353 -0.842 . . . . 0.0 109.273 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 4.7 mp -138.35 97.28 9.55 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.554 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.81 137.43 32.38 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.641 2.227 . . . . 0.0 111.711 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' A' ' 28' ' ' ALA . 39.4 mt -103.67 141.02 36.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.63 -66.54 0.94 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -115.58 61.12 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.154 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 74.7 m80 -130.26 -176.66 4.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.409 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.514 HG22 ' HG3' ' A' ' 58' ' ' MET . 15.3 t -126.96 168.01 15.1 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.898 . . . . 0.0 109.542 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.69 -36.59 62.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.512 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -60.9 -41.06 95.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 55' ' ' THR . 65.6 mtt -65.62 -32.95 74.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' HG2' ' A' ' 30' ' ' MET . . . -66.91 -34.05 76.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.596 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.78 -41.69 68.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.885 . . . . 0.0 109.582 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 58' ' ' MET . 17.9 tt -73.71 -34.77 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.633 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.844 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -75.82 -30.13 58.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.592 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -65.27 -39.71 92.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.822 HG21 HG12 ' A' ' 87' ' ' VAL . 89.7 t -73.26 -40.4 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.636 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.469 ' HG3' HG12 ' A' ' 120' ' ' ILE . 83.7 tt0 -68.72 -40.06 80.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 109.231 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.63 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 31.3 t80 -52.37 -64.15 0.91 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 109.634 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.623 ' HB3' HG11 ' A' ' 80' ' ' VAL . . . -62.75 -27.63 69.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.675 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.638 ' SG ' HG23 ' A' ' 120' ' ' ILE . 48.8 t -58.1 -58.05 10.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.543 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.454 ' HG2' ' SG ' ' A' ' 123' ' ' CYS . 40.3 mttt -61.11 -46.42 90.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.571 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.63 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 65.2 mttm -63.95 -33.99 76.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.35 -60.25 3.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.512 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.584 ' HB2' HD11 ' A' ' 130' ' ' ILE . 18.8 tp -57.66 -36.01 71.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -51.81 -43.46 63.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -0.918 . . . . 0.0 109.369 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.704 HG13 HG21 ' A' ' 78' ' ' VAL . 35.5 mm -48.36 143.04 7.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.898 . . . . 0.0 108.886 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.6 Cg_endo -64.36 -6.06 11.04 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.541 2.161 . . . . 0.0 111.724 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.449 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -139.23 171.73 23.53 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.04 134.49 29.63 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.449 2.099 . . . . 0.0 111.676 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.744 HG22 ' HG3' ' A' ' 7' ' ' GLU . 32.1 t -127.41 167.67 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 109.26 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.856 HD11 ' CD2' ' A' ' 6' ' ' TYR . 3.9 mt -125.87 127.58 46.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.291 -0.881 . . . . 0.0 109.78 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.623 HG11 ' HB3' ' A' ' 67' ' ' ALA . 34.7 t -101.44 133.01 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 109.235 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.643 HD12 ' CE1' ' A' ' 11' ' ' TYR . 23.5 mt -117.04 134.13 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.5 t -142.81 159.96 41.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.248 -0.907 . . . . 0.0 109.503 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 50.6 p-10 -83.9 -4.65 58.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.516 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.518 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 63.5 m -77.95 97.23 5.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.386 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.584 ' HA ' ' CD2' ' A' ' 134' ' ' HIS . 97.6 m-85 -64.16 -49.57 71.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 109.381 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -63.23 -52.25 62.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.65 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.822 HG12 HG21 ' A' ' 64' ' ' VAL . 38.8 t -55.88 -59.9 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.923 . . . . 0.0 109.591 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.944 ' HB3' ' NE2' ' A' ' 134' ' ' HIS . . . -43.57 -57.62 3.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.436 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.466 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 98.0 mt-10 -53.98 -40.74 67.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.463 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.567 ' CB ' ' CZ3' ' A' ' 117' ' ' TRP . 50.0 m -47.26 -52.13 16.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.689 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -89.7 -0.98 57.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.673 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 44.5 t-20 -82.14 -72.67 0.43 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.652 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 96.3 mttt -126.5 -22.7 3.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.075 -1.016 . . . . 0.0 110.062 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 96.3 mt-10 -67.13 -25.6 66.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.039 . . . . 0.0 109.66 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.868 HD11 ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -54.57 -58.77 12.62 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.598 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 45.9 Cg_endo -67.16 -32.31 34.16 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.554 2.169 . . . . 0.0 111.464 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -66.01 -40.21 90.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 108.982 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 39.8 m0 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.475 -0.766 . . . . 0.0 109.192 179.688 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.71 ' HG2' ' CD2' ' A' ' 113' ' ' HIS . 51.9 tttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.71 ' CD2' ' HG2' ' A' ' 112' ' ' LYS . 93.6 m-70 62.35 27.81 16.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.399 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.1 mt -60.96 -41.21 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.9 m -55.47 -46.55 76.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.4 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -60.37 -47.06 87.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.502 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.567 ' CZ3' ' CB ' ' A' ' 90' ' ' SER . 88.1 m95 -68.03 -33.61 74.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -56.21 -44.28 79.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.481 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.457 ' HB2' ' OE2' ' A' ' 65' ' ' GLU . 36.2 m -58.2 -43.4 87.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.638 HG23 ' SG ' ' A' ' 68' ' ' CYS . 78.0 mt -66.38 -40.13 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.978 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.868 ' HB2' HD11 ' A' ' 95' ' ' LEU . . . -62.98 -35.27 79.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.44 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -56.65 -35.48 68.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.454 ' SG ' ' HG2' ' A' ' 69' ' ' LYS . 77.7 m -80.02 -49.2 12.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.469 HD23 HD12 ' A' ' 130' ' ' ILE . 51.9 mt -57.98 -37.0 73.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 25.5 m -58.77 -33.42 70.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.33 -0.856 . . . . 0.0 109.501 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 90.0 mtp -63.9 -37.67 88.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 177.3 143.44 0.26 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.1 Cg_endo -69.65 -1.35 8.23 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.722 2.281 . . . . 0.0 111.749 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 128' ' ' PRO . 88.3 m-20 -43.4 -35.22 1.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.441 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.584 HD11 ' HB2' ' A' ' 72' ' ' LEU . 67.5 mt -69.74 121.47 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.421 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.737 ' HB ' HD22 ' A' ' 79' ' ' LEU . 23.8 m -119.06 143.48 47.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.369 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.658 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 70.6 mt -122.78 130.72 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.446 ' HB2' HG12 ' A' ' 81' ' ' ILE . 89.9 mt-30 -125.01 153.54 42.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.392 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.944 ' NE2' ' HB3' ' A' ' 88' ' ' ALA . 37.3 m170 -89.74 133.33 34.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.605 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.631 ' HG2' HG22 ' A' ' 81' ' ' ILE . 96.2 mt-10 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.799 . . . . 0.0 109.519 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 95.2 m -58.56 -42.86 88.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -52.36 -45.25 65.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.595 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.41 -36.96 91.25 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -65.1 -33.84 76.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -1.169 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.427 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -64.98 -52.29 57.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.9 mp -65.45 -46.73 78.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.592 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.53 80.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.533 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -63.17 -34.93 78.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 69.5 mttt -63.03 -43.5 98.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.511 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.924 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.4 mp -71.82 -37.18 70.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.55 -43.09 91.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 109.56 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 36.6 m -63.79 -41.37 97.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.605 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.876 ' O ' HG23 ' A' ' 163' ' ' VAL . 94.2 mt-30 -61.74 -35.73 78.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.575 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.57 -51.45 58.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 164' ' ' VAL . 25.0 m -64.56 -37.19 86.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -1.182 . . . . 0.0 109.672 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -64.1 -33.96 76.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 159' ' ' GLN . 45.8 t -65.86 -15.05 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 161' ' ' SER . 47.3 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.469 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.63 ' CE2' ' CD2' ' A' ' 79' ' ' LEU . 17.8 m-85 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.41 ' HG3' HG22 ' A' ' 74' ' ' ILE . 77.1 mm-40 -69.58 -33.94 73.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 108.931 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.27 -168.75 38.77 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.907 ' CG1' ' HB3' ' A' ' 35' ' ' ALA . 7.8 p -123.0 145.19 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.241 -1.153 . . . . 0.0 109.115 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.869 ' CE1' HG21 ' A' ' 78' ' ' VAL . 9.4 m-85 -122.48 137.42 54.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 109.859 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.739 ' CE1' HD12 ' A' ' 81' ' ' ILE . 92.6 m-85 -118.24 126.75 52.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.317 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.937 HG22 HD12 ' A' ' 32' ' ' ILE . 27.5 p -117.75 144.22 45.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 43.8 t0 -143.2 149.92 38.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.407 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -129.69 123.18 4.01 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m -129.36 147.75 51.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -1.102 . . . . 0.0 109.313 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 27' ' ' ASN . . . -137.81 151.8 48.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -0.96 . . . . 0.0 109.628 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 20.4 mt . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.855 . . . . 0.0 109.262 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.586 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 85.5 m-20 -83.31 137.22 34.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -137.81 151.25 47.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.417 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.434 ' HA2' ' CD1' ' A' ' 51' ' ' LEU . . . -154.3 162.6 30.7 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.74 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 74.0 mtm -127.41 168.52 14.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -1.121 . . . . 0.0 109.479 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.711 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -152.96 113.76 0.59 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.937 HD12 HG22 ' A' ' 12' ' ' THR . 10.9 mm -119.44 114.09 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.166 . . . . 0.0 109.338 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.556 ' CG2' ' HG2' ' A' ' 46' ' ' GLN . 7.5 p -118.52 148.01 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.2 -0.938 . . . . 0.0 109.691 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.638 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 1.7 m-70 -101.62 145.01 29.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 109.118 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.907 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -136.9 166.81 22.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.109 -0.995 . . . . 0.0 109.677 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.748 ' HB ' HD11 ' A' ' 44' ' ' LEU . 9.9 t -123.24 165.41 16.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.352 -0.842 . . . . 0.0 109.458 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' LYS . 55.2 m-85 -105.94 10.84 32.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 3.1 mtpt -51.18 178.76 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.839 . . . . 0.0 109.103 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.5 Cg_endo -65.09 -6.19 12.47 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.187 1.925 . . . . 0.0 111.663 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -131.23 106.28 8.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 108.982 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 48.9 t80 -58.54 127.62 33.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 81.2 mt-30 -159.45 141.92 13.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.51 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 43' ' ' VAL . 25.0 m -78.93 122.38 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.748 HD11 ' HB ' ' A' ' 36' ' ' THR . 7.4 mp -67.09 -42.96 83.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' O ' HG23 ' A' ' 33' ' ' VAL . 74.3 m-20 -160.41 149.95 17.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.645 ' HB3' HD21 ' A' ' 156' ' ' LEU . 90.2 mt-30 -110.22 150.93 27.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.199 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.7 t-105 -133.31 137.16 45.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.005 . . . . 0.0 109.8 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.1 t -125.74 132.56 52.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.213 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.689 HD13 ' CD1' ' A' ' 66' ' ' PHE . 6.1 mt -135.53 89.8 21.49 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.951 . . . . 0.0 109.702 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.464 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.3 Cg_endo -71.05 144.57 47.54 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 122.63 2.22 . . . . 0.0 111.596 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.822 ' N ' HD12 ' A' ' 51' ' ' LEU . 3.7 mp -110.93 147.86 33.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.588 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.74 -75.59 1.26 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -98.56 61.74 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.127 . . . . 0.0 109.448 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.452 ' HA ' ' SD ' ' A' ' 58' ' ' MET . 76.6 m80 -131.62 -177.56 4.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.938 . . . . 0.0 109.529 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.416 HG22 ' HG3' ' A' ' 58' ' ' MET . 15.3 t -128.22 166.84 17.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 0.0 109.5 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -48.13 -44.73 32.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.94 . . . . 0.0 109.331 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 60' ' ' GLU . 86.2 mt-30 -55.2 -58.17 8.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.303 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.452 ' SD ' ' HA ' ' A' ' 54' ' ' HIS . 62.1 mtt -44.81 -34.62 2.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.266 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.4 -31.51 60.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.319 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 57' ' ' GLN . 96.5 mt-10 -72.66 -38.35 67.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.327 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.774 ' HA ' HG21 ' A' ' 87' ' ' VAL . 7.3 tt -81.53 -38.47 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.74 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -66.06 -36.48 83.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.352 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.56 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -55.91 -48.18 76.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.367 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.793 HG21 HG13 ' A' ' 87' ' ' VAL . 78.4 t -64.04 -48.98 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.8 tt0 -58.24 -43.94 88.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.689 ' CD1' HD13 ' A' ' 49' ' ' ILE . 13.0 t80 -54.63 -68.12 0.21 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.37 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HB3' HG11 ' A' ' 80' ' ' VAL . . . -56.48 -19.21 14.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.204 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.979 ' SG ' HG23 ' A' ' 120' ' ' ILE . 19.3 t -66.46 -64.94 0.75 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.269 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -58.66 -46.38 87.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -58.36 -30.08 66.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.907 . . . . 0.0 109.263 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.861 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -67.35 -63.87 0.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.562 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.941 ' HB2' HD11 ' A' ' 130' ' ' ILE . 22.8 tp -50.18 -44.06 52.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.173 -0.954 . . . . 0.0 109.334 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 72' ' ' LEU . 26.4 tttt -43.27 -48.71 6.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.1 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.681 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 10.6 mt -48.4 143.19 7.58 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.369 -0.832 . . . . 0.0 108.879 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 45.5 Cg_endo -66.36 -2.25 6.85 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.625 2.217 . . . . 0.0 112.124 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.43 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -139.98 167.9 25.24 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.411 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 47.7 Cg_endo -68.94 116.74 4.62 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.446 2.097 . . . . 0.0 111.578 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.869 HG21 ' CE1' ' A' ' 10' ' ' PHE . 6.5 p -109.25 148.53 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.349 -0.845 . . . . 0.0 109.403 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.63 ' CD2' ' CE2' ' A' ' 6' ' ' TYR . 7.4 mp -96.31 138.87 33.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 67' ' ' ALA . 29.9 t -115.78 135.13 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.371 -0.831 . . . . 0.0 109.149 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.739 HD12 ' CE1' ' A' ' 11' ' ' TYR . 15.0 mt -122.44 136.85 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.602 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 t -139.1 160.33 40.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.341 -0.849 . . . . 0.0 109.316 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -81.59 -13.07 58.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.924 . . . . 0.0 109.564 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.542 ' CB ' HG12 ' A' ' 87' ' ' VAL . 29.5 m -93.15 115.62 28.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.565 ' HB2' ' CG ' ' A' ' 134' ' ' HIS . 46.4 t80 -81.4 -38.58 26.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.365 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -55.42 -46.71 76.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.54 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.793 HG13 HG21 ' A' ' 64' ' ' VAL . 14.1 p -70.18 -46.49 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 109.499 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.599 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -56.57 -48.32 77.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.267 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -60.55 -37.34 80.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.537 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 50.2 m -52.47 -55.11 24.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.633 ' HB1' HD11 ' A' ' 124' ' ' LEU . . . -83.73 -0.89 52.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.903 . . . . 0.0 109.628 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 38.6 t-20 -83.15 -72.76 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.951 . . . . 0.0 109.729 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 87.0 mttt -126.71 -25.36 3.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 97.9 mt-10 -69.57 -24.47 63.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.131 -0.98 . . . . 0.0 109.731 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' A' ' 121' ' ' ALA . 0.2 OUTLIER -54.58 -57.34 19.32 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.644 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 46.1 Cg_endo -67.47 -34.36 26.52 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.507 2.138 . . . . 0.0 111.663 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -65.82 -38.68 89.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.118 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 43.0 m0 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.34 179.821 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.1 mttp . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 48.0 m80 61.53 34.44 17.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.489 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.7 mt -54.19 -45.39 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.423 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.6 m -50.82 -48.35 59.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.543 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.1 -35.94 76.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.48 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.537 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 20.1 m95 -70.45 -38.13 74.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 109.516 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -58.83 -39.4 81.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.426 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.6 m -62.51 -43.06 99.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.979 HG23 ' SG ' ' A' ' 68' ' ' CYS . 83.6 mt -71.72 -36.09 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.638 ' HB2' HD11 ' A' ' 95' ' ' LEU . . . -65.29 -34.95 79.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -56.06 -38.47 70.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 61.3 m -81.18 -49.37 10.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.877 . . . . 0.0 109.467 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.633 HD11 ' HB1' ' A' ' 91' ' ' ALA . 54.7 mt -60.52 -31.9 70.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.432 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.4 t -62.38 -33.0 73.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 94.9 mmm -64.73 -38.05 89.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.16 146.48 0.56 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.284 -0.885 . . . . 0.0 109.447 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 129' ' ' ASP . 50.1 Cg_endo -70.79 0.66 6.07 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.739 2.292 . . . . 0.0 111.899 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 128' ' ' PRO . 88.8 m-20 -44.09 -50.53 8.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.398 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.941 HD11 ' HB2' ' A' ' 72' ' ' LEU . 58.3 mt -55.25 113.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.777 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.481 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 54.9 m -110.54 144.18 39.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 108.986 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -124.29 141.45 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 109.83 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.4 mt-30 -128.58 159.56 35.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.389 -0.819 . . . . 0.0 109.184 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.565 ' CG ' ' HB2' ' A' ' 85' ' ' PHE . 32.2 t-80 -119.52 140.29 50.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 109.665 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.541 ' OE2' HG21 ' A' ' 81' ' ' ILE . 94.9 mt-10 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.334 -0.854 . . . . 0.0 109.218 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 57.2 m80 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.5 p -68.79 -41.51 78.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.94 -38.48 64.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.48 -37.62 94.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -64.44 -42.93 95.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.289 -1.124 . . . . 0.0 109.431 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.5 64.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.867 . . . . 0.0 109.461 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.479 ' O ' HD13 ' A' ' 156' ' ' LEU . 64.5 mt -60.38 -48.84 80.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.823 . . . . 0.0 109.485 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.402 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . . . -52.76 -40.3 63.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.566 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.424 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 54.3 t0 -60.06 -49.32 78.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -52.89 -37.96 61.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.533 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.645 HD21 ' HB3' ' A' ' 46' ' ' GLN . 7.1 mp -69.37 -41.53 76.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' MET . . . -69.55 -44.99 69.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.562 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 33.6 m -58.81 -42.18 88.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.539 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -61.94 -39.47 92.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.501 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -62.0 -45.75 95.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.536 ' HA ' HG12 ' A' ' 164' ' ' VAL . 85.2 p -69.53 -25.75 64.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -1.184 . . . . 0.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -67.68 -36.34 80.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.504 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.3 t -72.91 -19.08 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 161' ' ' SER . 14.8 p . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.524 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.993 ' CD2' HD11 ' A' ' 79' ' ' LEU . 18.4 p90 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.442 0.639 . . . . 0.0 109.898 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.452 ' OE1' HG22 ' A' ' 74' ' ' ILE . 21.2 tt0 -79.59 -45.14 19.71 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.422 -0.799 . . . . 0.0 108.996 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.836 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -161.21 178.52 37.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.585 HG23 ' HE2' ' A' ' 37' ' ' TYR . 67.9 t -129.73 146.27 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -1.14 . . . . 0.0 109.501 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.864 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.5 m-85 -118.4 155.39 30.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.781 ' CE1' HD12 ' A' ' 81' ' ' ILE . 96.3 m-85 -118.03 123.17 45.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.332 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.865 HG22 HD12 ' A' ' 32' ' ' ILE . 24.2 p -117.06 145.78 43.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.551 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 56.7 t0 -143.99 152.98 41.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -137.33 117.08 1.46 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 29' ' ' GLY . 47.0 t -133.49 155.18 50.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.319 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.712 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -137.95 158.68 43.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.595 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 65.0 mt . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.453 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 42.5 p-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 19.9 m120 -94.36 125.94 39.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 0.0 109.367 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . . . -103.5 156.07 18.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.534 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -147.22 148.38 19.94 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.656 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 63.6 mtm -124.02 165.11 18.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -1.2 . . . . 0.0 109.573 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.702 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -149.87 116.86 0.81 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.865 HD12 HG22 ' A' ' 12' ' ' THR . 15.1 mm -120.26 115.27 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -1.161 . . . . 0.0 109.486 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 45' ' ' ASN . 12.3 p -118.76 148.39 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.498 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.989 ' CD2' HD22 ' A' ' 44' ' ' LEU . 9.4 t60 -101.16 137.23 39.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.556 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.485 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -122.23 158.16 30.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.958 ' HB ' HD11 ' A' ' 44' ' ' LEU . 12.0 t -125.11 162.23 25.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.877 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.585 ' HE2' HG23 ' A' ' 9' ' ' VAL . 58.5 m-85 -108.64 11.47 26.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.968 . . . . 0.0 109.618 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.558 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 5.3 mttt -51.21 178.74 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.0 Cg_endo -64.43 -6.05 11.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.185 1.924 . . . . 0.0 111.704 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 40' ' ' GLU . 70.0 mm-40 -129.53 105.36 8.03 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.254 -0.904 . . . . 0.0 108.759 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -64.54 125.31 24.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.574 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -168.18 129.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 43' ' ' VAL . 22.6 m -58.7 126.04 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.457 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.989 HD22 ' CD2' ' A' ' 34' ' ' HIS . 6.1 mp -67.33 -42.79 83.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.654 ' O ' HG23 ' A' ' 33' ' ' VAL . 77.9 m-20 -160.61 154.41 22.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.617 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.596 ' HB3' HD21 ' A' ' 156' ' ' LEU . 90.9 mt-30 -113.1 148.22 35.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 109.131 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CB ' ' O ' ' A' ' 32' ' ' ILE . 11.6 t-105 -127.34 138.88 53.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.105 -0.997 . . . . 0.0 109.843 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.407 ' C ' HG13 ' A' ' 49' ' ' ILE . 51.5 m -126.96 136.73 52.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.118 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.418 HD12 ' HE3' ' A' ' 30' ' ' MET . 3.8 mt -144.03 92.05 6.38 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.733 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.1 Cg_endo -70.76 148.32 58.32 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.66 2.24 . . . . 0.0 111.557 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 51' ' ' LEU . 5.7 mp -119.65 145.5 46.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.95 -48.36 0.17 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -90.42 9.95 27.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -1.133 . . . . 0.0 109.393 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 48.1 m-70 -117.75 -176.08 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 0.0 109.522 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.409 HG22 ' HG3' ' A' ' 58' ' ' MET . 13.8 t -124.49 166.36 16.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.712 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -46.21 -45.51 16.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 0.0 109.346 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 60' ' ' GLU . 84.6 mt-30 -54.38 -59.34 4.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 109.428 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.429 ' SD ' ' HB3' ' A' ' 54' ' ' HIS . 61.2 mtt -44.08 -33.98 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.444 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.454 ' HB1' ' CG ' ' A' ' 30' ' ' MET . . . -71.85 -31.45 66.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.27 -0.893 . . . . 0.0 109.389 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 57' ' ' GLN . 96.8 mt-10 -70.88 -33.61 70.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.503 ' HA ' HG21 ' A' ' 87' ' ' VAL . 7.1 tt -86.92 -30.84 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 109.341 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.656 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -74.95 -29.71 61.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.417 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -64.98 -39.07 92.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.619 HG21 HG13 ' A' ' 87' ' ' VAL . 71.8 t -71.95 -45.6 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.489 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.519 ' HB2' HD11 ' A' ' 120' ' ' ILE . 87.3 tt0 -64.3 -37.01 85.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.6 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 13.7 t80 -56.07 -69.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -60.4 -15.82 29.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.903 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.66 ' SG ' HG23 ' A' ' 120' ' ' ILE . 44.8 t -67.66 -63.92 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HG2' ' SG ' ' A' ' 123' ' ' CYS . 23.6 mttm -58.64 -44.54 90.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.6 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 66.5 mttm -63.51 -38.54 91.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.832 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -54.83 -61.62 2.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.959 ' HB2' HD11 ' A' ' 130' ' ' ILE . 9.1 tt -51.55 -45.33 62.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 72' ' ' LEU . 65.0 tttm -43.64 -42.41 5.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.175 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.578 HG23 ' HD2' ' A' ' 75' ' ' PRO . 48.4 mm -48.93 143.21 8.68 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.331 -0.856 . . . . 0.0 108.806 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.578 ' HD2' HG23 ' A' ' 74' ' ' ILE . 41.8 Cg_endo -63.7 -4.71 7.52 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.669 2.246 . . . . 0.0 112.311 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.497 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -143.06 171.8 24.81 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.502 ' HG2' ' HA ' ' A' ' 6' ' ' TYR . 43.9 Cg_endo -67.22 118.61 5.7 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.495 2.13 . . . . 0.0 111.684 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.864 HG21 ' CE1' ' A' ' 10' ' ' PHE . 9.0 p -114.67 151.43 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.394 -0.816 . . . . 0.0 109.266 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.993 HD11 ' CD2' ' A' ' 6' ' ' TYR . 12.2 mt -96.82 154.73 17.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.83 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 131' ' ' THR . 38.9 t -125.87 133.07 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.536 -0.727 . . . . 0.0 109.049 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 11' ' ' TYR . 26.2 mt -120.04 133.8 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.61 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.46 HG21 ' CG2' ' A' ' 64' ' ' VAL . 7.1 t -136.5 161.72 35.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.511 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 13' ' ' ASP . 58.3 p30 -89.33 15.04 9.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.515 ' OG ' HG12 ' A' ' 87' ' ' VAL . 26.7 t -123.93 114.73 20.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.918 . . . . 0.0 109.487 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.567 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 61.3 t80 -77.16 -43.15 34.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.573 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -49.0 -48.26 43.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.619 HG13 HG21 ' A' ' 64' ' ' VAL . 8.9 p -68.03 -45.36 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.593 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.571 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -53.4 -49.69 66.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.925 . . . . 0.0 109.544 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 80.5 tt0 -60.55 -34.39 74.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.303 -0.873 . . . . 0.0 109.516 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.633 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 50.5 m -56.42 -55.87 28.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.728 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.68 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -82.02 -0.75 45.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 109.702 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 47.0 t-20 -84.66 -73.23 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 109.812 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 62.6 tttt -127.37 -30.98 2.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.092 -1.005 . . . . 0.0 109.924 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 58.9 mm-40 -56.75 -37.69 71.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.108 -0.995 . . . . 0.0 109.922 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -51.38 -61.56 3.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 109.628 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 95' ' ' LEU . 45.5 Cg_endo -67.76 -27.19 38.12 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.571 2.18 . . . . 0.0 111.449 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -73.47 -34.99 65.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 108.983 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.595 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 15.8 m0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.847 . . . . 0.0 109.19 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 21.4 mttp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.262 0.553 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 28.1 m80 68.75 31.76 4.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 109.553 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 75.8 mt -61.73 -41.36 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.296 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.9 m -53.27 -50.18 65.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 109.257 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -60.38 -38.4 83.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.334 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.633 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 25.3 m95 -72.35 -36.76 68.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -55.65 -44.97 77.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.325 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.2 m -60.41 -45.78 92.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.319 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.66 HG23 ' SG ' ' A' ' 68' ' ' CYS . 73.5 mt -69.34 -32.83 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.746 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -60.91 -38.07 84.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.931 . . . . 0.0 109.4 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 126' ' ' MET . 96.2 mt-10 -61.7 -40.51 95.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.332 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 130' ' ' ILE . 56.6 m -64.85 -51.02 64.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.847 ' O ' HD13 ' A' ' 124' ' ' LEU . 3.4 tm? -65.02 -37.05 86.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.0 109.231 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.2 t -56.1 -36.11 67.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.446 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 65.4 mtt -64.25 -32.88 74.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.293 -0.88 . . . . 0.0 109.369 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 167.78 153.3 0.12 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.3 Cg_endo -71.39 0.36 6.94 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.621 2.214 . . . . 0.0 111.702 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 128' ' ' PRO . 92.1 m-20 -43.07 -48.21 6.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.372 -0.83 . . . . 0.0 109.543 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.959 HD11 ' HB2' ' A' ' 72' ' ' LEU . 74.3 mt -65.38 122.12 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.589 ' HB ' HD22 ' A' ' 79' ' ' LEU . 32.6 m -116.98 149.58 40.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.193 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.68 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 55.4 mt -127.01 132.69 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.134 -0.979 . . . . 0.0 109.712 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.452 ' HB2' HG12 ' A' ' 81' ' ' ILE . 86.4 mt-30 -118.09 159.39 23.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.17 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.567 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 75.5 t60 -120.28 133.56 55.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.991 . . . . 0.0 109.683 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.419 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 62.5 m170 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.5 m -64.93 -41.71 95.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.23 -41.33 75.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.07 -36.16 87.22 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -66.56 -38.13 86.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -1.159 . . . . 0.0 109.395 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.16 -53.07 62.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.462 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.634 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.8 mp -67.39 -46.41 73.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.348 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.534 ' HA ' HD12 ' A' ' 156' ' ' LEU . . . -57.28 -38.26 73.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.455 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 81.5 m-20 -63.11 -43.63 97.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.526 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.88 -41.61 78.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.535 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.8 mt -64.43 -41.21 96.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.935 . . . . 0.0 109.399 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.54 96.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 37.2 m -55.78 -45.81 78.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.549 ' O ' HG23 ' A' ' 163' ' ' VAL . 95.5 mt-30 -62.32 -36.18 81.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -0.906 . . . . 0.0 109.482 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -53.31 -59.2 9.89 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 92.1 p -63.49 -33.63 75.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -1.135 . . . . 0.0 109.503 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -63.66 -37.37 87.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 159' ' ' GLN . 71.5 t -57.41 -37.01 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.494 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 0.0 109.483 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.63 ' CG ' HD13 ' A' ' 79' ' ' LEU . 36.6 m-85 . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 45.4 tp10 -66.75 -32.64 74.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.95 . . . . 0.0 109.043 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.742 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.0 -177.24 47.43 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.1 t -129.13 139.01 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -1.154 . . . . 0.0 109.232 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.792 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.9 m-85 -117.5 143.87 45.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.866 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 1.062 ' CE2' HD12 ' A' ' 81' ' ' ILE . 92.7 m-85 -117.38 121.76 41.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.143 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.749 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 18.8 p -111.83 150.28 30.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.074 -1.016 . . . . 0.0 109.632 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.4 ' OD2' ' OD1' ' A' ' 154' ' ' ASP . 45.5 t0 -152.51 146.8 25.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.88 136.39 10.95 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.439 ' HB3' ' HB1' ' A' ' 157' ' ' ALA . 17.9 t -138.69 142.69 38.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 109.612 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -135.01 150.13 50.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.291 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 27' ' ' ASN . 69.3 mt . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.672 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 38.7 p-10 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 17' ' ' ILE . 87.1 m-20 -85.8 139.09 31.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.164 -0.96 . . . . 0.0 109.555 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -125.32 151.36 46.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.933 . . . . 0.0 109.492 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -154.99 157.79 27.87 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.755 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 54.9 mtm -127.29 165.85 18.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.129 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' A' ' 156' ' ' LEU . . . -156.82 124.68 1.47 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 32' ' ' ILE . 4.8 mp -116.89 142.36 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -1.163 . . . . 0.0 109.382 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.491 HG21 ' N ' ' A' ' 153' ' ' ALA . 38.2 t -127.06 134.26 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 109.551 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.503 ' CE1' ' CD2' ' A' ' 10' ' ' PHE . 2.8 m-70 -106.87 138.65 42.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.615 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.42 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -140.4 164.62 29.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 0.0 109.527 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.653 ' HB ' HD11 ' A' ' 44' ' ' LEU . 13.2 t -133.64 164.96 26.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.0 109.447 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.418 ' O ' ' O ' ' A' ' 38' ' ' LYS . 44.5 m-85 -103.32 11.09 37.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 109.575 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.582 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.26 179.73 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.185 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 38' ' ' LYS . 44.8 Cg_endo -66.88 -5.64 13.87 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.203 1.935 . . . . 0.0 111.425 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.49 ' OE2' ' NE2' ' A' ' 42' ' ' GLN . 82.6 tt0 -132.74 105.49 7.2 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.377 -0.827 . . . . 0.0 108.947 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.451 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 43.1 t80 -64.28 122.01 15.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.49 ' NE2' ' OE2' ' A' ' 40' ' ' GLU . 66.5 mt-30 -159.0 136.38 9.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.124 -0.985 . . . . 0.0 109.753 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 37.5 t -62.5 125.99 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.893 . . . . 0.0 109.32 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.653 HD11 ' HB ' ' A' ' 36' ' ' THR . 7.4 mp -68.63 -38.69 80.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 109.336 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -175.62 155.04 1.68 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 109.343 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.964 ' HB3' HD21 ' A' ' 156' ' ' LEU . 94.0 mt-30 -110.01 138.4 46.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.407 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -122.75 125.95 46.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.676 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.2 m -121.14 138.91 53.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 109.271 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 2.4 mp -133.67 96.22 16.87 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.94 129.84 18.09 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.667 2.245 . . . . 0.0 111.741 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.548 ' O ' HG21 ' A' ' 164' ' ' VAL . 43.1 mt -108.39 145.36 34.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.331 -0.856 . . . . 0.0 109.384 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.33 -28.85 1.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.531 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 46.4 p-10 -121.94 34.67 5.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -1.213 . . . . 0.0 109.507 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.531 ' CE1' ' OD1' ' A' ' 53' ' ' ASN . 77.4 m80 -124.4 175.68 6.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 109.362 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 58' ' ' MET . 14.4 t -123.03 169.44 11.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.63 -38.93 72.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.419 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.0 -54.45 44.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.458 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.489 ' H ' HG23 ' A' ' 55' ' ' THR . 67.9 mtm -66.64 -30.32 70.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.551 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.7 86.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.459 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -64.28 -49.1 73.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.509 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.71 HD11 ' CZ2' ' A' ' 117' ' ' TRP . 13.0 tt -64.59 -39.62 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.755 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -59.41 -31.41 69.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.535 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.749 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -64.17 -41.45 97.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.481 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.79 HG22 HG21 ' A' ' 82' ' ' THR . 87.9 t -71.0 -38.67 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.47 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 86.4 tt0 -68.8 -39.05 80.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.106 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.537 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 22.3 t80 -61.17 -64.37 0.97 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.364 -0.835 . . . . 0.0 109.491 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 71' ' ' ALA . . . -58.26 -31.44 67.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.631 ' SG ' HG23 ' A' ' 120' ' ' ILE . 24.3 t -53.43 -54.7 33.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.607 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -62.03 -45.48 93.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 68.9 mttm -67.36 -29.75 69.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.951 . . . . 0.0 109.308 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.747 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -62.24 -64.48 0.92 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.824 ' HB2' HD11 ' A' ' 130' ' ' ILE . 27.8 tp -55.57 -43.29 75.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.883 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' LEU . 16.2 tttt -43.22 -43.14 4.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.254 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 26.4 mm -48.2 143.45 6.94 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 108.855 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.8 Cg_endo -65.87 -3.16 7.72 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.512 2.141 . . . . 0.0 111.896 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.407 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -142.07 170.82 24.8 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.468 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.2 Cg_endo -69.2 122.82 9.66 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.366 2.044 . . . . 0.0 111.74 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.792 HG21 ' CE1' ' A' ' 10' ' ' PHE . 7.1 p -116.24 150.18 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.451 -0.781 . . . . 0.0 109.288 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.63 HD13 ' CG ' ' A' ' 6' ' ' TYR . 6.7 mp -97.8 130.7 44.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.909 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 132' ' ' ILE . 47.6 t -106.46 131.09 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.36 -0.837 . . . . 0.0 109.122 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.062 HD12 ' CE2' ' A' ' 11' ' ' TYR . 4.4 mt -115.15 144.29 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.159 -0.963 . . . . 0.0 109.666 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.79 HG21 HG22 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -134.3 161.66 34.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 109.37 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -90.91 3.66 53.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.525 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.42 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 20.2 t -122.93 125.55 45.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.569 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 65.8 t80 -75.1 -40.6 59.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.433 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -50.5 -56.76 10.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.472 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.648 HG22 HG21 ' A' ' 64' ' ' VAL . 8.8 p -58.75 -47.69 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.364 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.603 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -58.25 -57.21 13.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 0.0 109.204 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 85.3 tt0 -51.13 -30.81 17.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.615 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 37.1 m -60.32 -59.65 5.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.433 -0.792 . . . . 0.0 109.67 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -77.24 -0.83 26.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 109.794 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 9.8 m120 -83.56 -72.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 0.0 109.796 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 80.5 mttt -126.56 -27.86 3.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.787 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.5 mt-10 -66.0 -24.33 66.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.616 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -58.51 -58.66 17.44 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.563 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.5 Cg_endo -66.91 -35.1 27.76 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.596 2.197 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -64.59 -42.01 95.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.897 . . . . 0.0 109.116 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.4 m0 . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.312 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.9 mttm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.402 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 70.2 m-70 60.4 37.64 19.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.198 -0.939 . . . . 0.0 109.482 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.434 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 82.1 mt -63.84 -44.81 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.321 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 t -60.01 -41.99 93.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -59.22 -40.61 86.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.71 ' CZ2' HD11 ' A' ' 61' ' ' ILE . 17.4 m95 -68.02 -37.96 82.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 31.2 mttt -57.41 -41.31 80.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.925 . . . . 0.0 109.371 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.47 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 19.9 m -61.62 -46.13 91.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.309 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.631 HG23 ' SG ' ' A' ' 68' ' ' CYS . 75.7 mt -71.21 -34.68 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.544 ' HB2' HD11 ' A' ' 95' ' ' LEU . . . -59.56 -42.35 92.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.394 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.03 -40.28 88.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 109.503 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 89.5 m -66.22 -49.21 68.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.425 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 128' ' ' PRO . 23.7 tp -63.82 -31.71 72.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.2 m -61.48 -31.7 71.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.499 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.446 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 92.6 mtp -68.56 -31.7 71.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HD3' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 170.47 147.78 0.14 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.44 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.442 ' HA ' ' CD1' ' A' ' 124' ' ' LEU . 50.5 Cg_endo -70.96 -0.95 8.71 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.688 2.259 . . . . 0.0 111.637 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 94.1 m-20 -43.05 -45.39 5.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.367 -0.833 . . . . 0.0 109.659 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 72' ' ' LEU . 46.4 mt -61.77 117.39 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.743 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.561 ' O ' HD13 ' A' ' 132' ' ' ILE . 97.4 m -109.81 144.9 37.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.186 -0.946 . . . . 0.0 109.069 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.561 HD13 ' O ' ' A' ' 131' ' ' THR . 32.5 mm -119.69 136.68 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 109.745 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.53 ' NE2' HD23 ' A' ' 79' ' ' LEU . 87.4 mt-30 -125.43 158.22 34.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.427 -0.795 . . . . 0.0 109.19 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.569 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 63.4 t60 -117.26 133.25 56.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.641 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.549 ' HG2' ' CG2' ' A' ' 81' ' ' ILE . 71.2 mm-40 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.425 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 57.5 m -55.56 -47.46 76.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.372 -0.83 . . . . 0.0 109.452 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.19 -52.18 28.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.409 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.18 -39.52 58.3 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -55.15 -48.8 73.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -1.108 . . . . 0.0 109.37 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.74 37.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.309 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 152' ' ' LEU . 6.8 mp -58.84 -47.97 82.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.491 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -55.42 -42.56 74.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 109.418 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.4 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 63.7 m-20 -55.69 -44.09 77.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.876 . . . . 0.0 109.394 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -57.75 -42.14 83.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.928 . . . . 0.0 109.412 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.964 HD21 ' HB3' ' A' ' 46' ' ' GLN . 7.0 mp -64.98 -40.15 94.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' A' ' 15' ' ' SER . . . -67.78 -51.67 46.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.358 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 42.0 m -59.83 -41.41 91.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.534 ' O ' HG23 ' A' ' 163' ' ' VAL . 46.8 tt0 -63.68 -38.41 91.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -62.54 -50.38 64.95 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.0 p -64.94 -34.24 77.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -1.183 . . . . 0.0 109.434 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -64.03 -37.68 88.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.431 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 159' ' ' GLN . 73.0 t -52.93 -39.67 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.548 HG21 ' O ' ' A' ' 51' ' ' LEU . 42.5 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.502 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.978 ' HB3' HD21 ' A' ' 79' ' ' LEU . 33.9 p90 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.293 0.568 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.514 ' OE1' HG22 ' A' ' 74' ' ' ILE . 21.3 tt0 -79.78 -42.76 23.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.806 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -159.88 176.52 36.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.519 HG23 ' HE2' ' A' ' 37' ' ' TYR . 82.1 t -124.96 141.1 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -1.18 . . . . 0.0 109.515 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.828 ' CD1' HG21 ' A' ' 78' ' ' VAL . 5.7 m-85 -117.33 151.7 36.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.622 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.771 ' HE1' HD12 ' A' ' 81' ' ' ILE . 85.3 m-85 -123.87 135.97 54.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.533 HG22 HD12 ' A' ' 32' ' ' ILE . 19.1 p -121.7 150.1 42.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.596 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.513 ' HB2' ' HB1' ' A' ' 153' ' ' ALA . 22.9 t70 -140.12 148.27 41.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.482 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.41 134.25 5.42 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.552 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 83.1 p -143.21 161.01 39.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -1.177 . . . . 0.0 109.457 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.891 ' HB1' ' ND2' ' A' ' 26' ' ' ASN . . . -137.9 150.51 47.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.566 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' ASN . 47.7 mt . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.515 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.891 ' ND2' ' HB1' ' A' ' 16' ' ' ALA . 48.1 p-10 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.634 ' OD1' HG11 ' A' ' 164' ' ' VAL . 83.0 m-20 -104.49 125.01 50.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.965 . . . . 0.0 109.393 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 15' ' ' SER . . . -132.16 158.51 41.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 109.768 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.32 165.2 26.77 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.644 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 69.7 mtm -126.28 156.54 40.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -1.168 . . . . 0.0 109.461 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -141.51 128.21 3.58 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.54 HG13 ' CD2' ' A' ' 66' ' ' PHE . 22.3 mm -113.16 134.41 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -1.132 . . . . 0.0 109.301 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.95 125.38 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.692 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.656 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 10.3 m170 -103.54 136.12 43.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.208 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.08 161.31 35.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.752 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.2 t -125.6 164.08 21.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 109.241 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.519 ' HE2' HG23 ' A' ' 9' ' ' VAL . 85.0 m-85 -107.91 13.95 25.79 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.104 -0.998 . . . . 0.0 109.534 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.583 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.27 -179.17 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.321 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.6 Cg_endo -65.42 -4.73 9.97 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.074 1.849 . . . . 0.0 111.849 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.436 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 71.8 mm-40 -134.1 106.09 7.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 108.785 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.507 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 66.9 t80 -57.81 123.89 17.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 109.534 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 84.4 mt-30 -159.62 152.25 21.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.85 . . . . 0.0 109.516 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.1 m -89.06 120.48 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.394 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 40.9 mt -58.28 -44.18 88.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.429 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 25.2 m-20 -168.76 157.4 8.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.433 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.592 ' HB3' HD21 ' A' ' 156' ' ' LEU . 92.4 mt-30 -116.2 149.6 38.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.444 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.474 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -132.16 137.96 47.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.625 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.9 p -123.61 144.8 49.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.286 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.461 HD12 ' HE3' ' A' ' 30' ' ' MET . 3.3 mt -146.52 94.55 4.76 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.198 -0.939 . . . . 0.0 109.648 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.764 ' HG3' HG21 ' A' ' 163' ' ' VAL . 51.0 Cg_endo -70.81 132.26 21.3 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.654 2.236 . . . . 0.0 111.67 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.722 HD12 ' CB ' ' A' ' 59' ' ' ALA . 43.8 mt -115.0 142.89 46.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.566 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.03 -42.86 0.21 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -90.97 8.85 33.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -1.114 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 91.5 m-70 -107.05 150.25 26.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.915 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.506 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.1 OUTLIER -91.65 170.04 10.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.884 . . . . 0.0 109.24 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.37 -30.09 17.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.319 -0.863 . . . . 0.0 109.123 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -79.5 -57.36 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.357 -0.84 . . . . 0.0 109.315 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.506 ' SD ' HG23 ' A' ' 55' ' ' THR . 93.4 mtp -47.78 -34.47 8.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 109.364 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.722 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -78.72 -33.94 46.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.442 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.787 ' HG2' HG21 ' A' ' 87' ' ' VAL . 82.1 tt0 -64.45 -40.11 95.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.603 HG21 ' HD3' ' A' ' 116' ' ' LYS . 19.5 tt -77.34 -29.59 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.374 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.644 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -68.77 -29.49 67.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.478 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.82 94.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.491 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.766 HG21 HG12 ' A' ' 87' ' ' VAL . 87.0 t -75.86 -48.29 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 98.1 mt-10 -51.87 -41.57 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.55 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 14.1 t80 -56.82 -67.86 0.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.647 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -63.67 -13.98 47.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.606 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.969 ' SG ' HG23 ' A' ' 120' ' ' ILE . 38.0 t -66.82 -66.04 0.6 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.521 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 73.9 tttt -60.01 -42.61 94.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.634 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 56.7 mttp -64.94 -35.62 81.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -58.3 -60.44 3.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.889 ' HB2' HD11 ' A' ' 130' ' ' ILE . 21.0 tp -56.71 -44.12 81.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 109.388 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 72' ' ' LEU . 55.6 tttp -43.59 -42.13 4.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.155 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 19.6 mm -48.39 142.76 7.95 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.86 . . . . 0.0 108.961 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.9 Cg_endo -65.49 -4.58 9.79 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.548 2.165 . . . . 0.0 111.937 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.02 167.28 25.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.474 ' HG2' ' HA ' ' A' ' 6' ' ' TYR . 45.2 Cg_endo -67.88 116.4 4.27 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.565 2.176 . . . . 0.0 111.699 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.828 HG21 ' CD1' ' A' ' 10' ' ' PHE . 7.2 p -111.31 149.82 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.333 -0.854 . . . . 0.0 109.578 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.978 HD21 ' HB3' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -104.51 137.41 42.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 109.59 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 43.7 t -110.27 130.46 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.145 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.771 HD12 ' HE1' ' A' ' 11' ' ' TYR . 15.8 mt -114.61 132.08 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.649 HG21 HG22 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -124.85 161.99 25.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 56.4 p30 -87.14 13.08 10.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.2 m -123.26 125.28 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.485 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.65 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 70.4 t80 -78.38 -41.89 31.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -58.54 -52.71 64.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.787 HG21 ' HG2' ' A' ' 60' ' ' GLU . 48.4 t -59.23 -51.8 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.68 -52.97 27.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.288 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 83.5 tt0 -60.08 -33.75 72.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.17 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.666 ' O ' HD23 ' A' ' 95' ' ' LEU . 34.1 m -52.72 -47.22 67.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.327 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.784 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -94.25 -0.75 54.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.612 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 50.1 t30 -86.93 -71.99 0.53 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.957 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 24.7 mttm -116.64 -35.53 4.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 109.831 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 91.4 mt-10 -59.84 -38.8 83.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.624 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -53.16 -60.18 7.4 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 47.4 Cg_endo -68.15 -32.37 27.49 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.71 2.273 . . . . 0.0 111.596 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -72.54 -40.6 66.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.28 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.434 ' CZ2' ' OE1' ' A' ' 94' ' ' GLU . 24.9 m0 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.358 -0.839 . . . . 0.0 109.371 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HD3' ' CE1' ' A' ' 113' ' ' HIS . 85.1 tttt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.571 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 33.8 m80 65.98 33.07 8.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.505 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.4 mt -62.33 -47.05 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.253 -0.904 . . . . 0.0 109.406 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.8 m -59.38 -43.57 92.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.603 ' HD3' HG21 ' A' ' 61' ' ' ILE . 35.7 mttp -58.49 -46.9 85.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.285 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.629 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 65.6 m95 -70.16 -30.08 67.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.406 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -60.25 -41.6 93.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.495 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -58.22 -40.7 82.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.969 HG23 ' SG ' ' A' ' 68' ' ' CYS . 77.8 mt -72.95 -32.84 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -64.91 -37.16 86.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -60.41 -34.27 73.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.476 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 6.8 m -79.21 -50.21 11.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.713 HD23 HD12 ' A' ' 130' ' ' ILE . 57.6 mt -61.04 -34.86 75.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.476 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.8 t -59.27 -34.13 71.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.435 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.685 ' CE ' HD23 ' A' ' 72' ' ' LEU . 71.7 mtm -67.76 -34.53 77.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.423 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -173.99 128.51 0.47 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.475 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.5 Cg_endo -69.74 -1.8 9.07 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.68 2.253 . . . . 0.0 111.638 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 90.9 m-20 -43.83 -43.13 6.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.316 -0.865 . . . . 0.0 109.458 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.889 HD11 ' HB2' ' A' ' 72' ' ' LEU . 40.3 mt -53.99 118.55 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.335 -0.853 . . . . 0.0 109.671 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.654 ' HB ' HD22 ' A' ' 79' ' ' LEU . 9.0 m -119.28 129.65 55.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 108.984 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.784 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 52.9 mt -110.47 144.4 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.06 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -132.58 154.32 50.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.343 -0.848 . . . . 0.0 109.163 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.65 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 52.9 t60 -104.05 128.28 51.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.618 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 83' ' ' ASP . 85.1 tt0 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 109.295 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.2 m80 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.428 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 70.0 p -64.12 -36.99 85.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.558 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -49.61 -45.81 48.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 109.552 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.07 -37.56 94.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -58.63 -41.5 86.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -1.142 . . . . 0.0 109.556 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.48 -51.7 66.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.55 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.463 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 52.5 mt -58.8 -45.7 89.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.527 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.513 ' HB1' ' HB2' ' A' ' 13' ' ' ASP . . . -56.88 -42.51 79.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.525 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.675 ' O ' HG23 ' A' ' 158' ' ' THR . 89.8 m-20 -59.23 -36.53 75.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -63.36 -42.26 98.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.628 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 156' ' ' LEU . 6.4 mp -74.17 -34.04 63.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.573 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.89 -40.86 97.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 154' ' ' ASP . 50.0 p -69.07 -39.52 79.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.532 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -62.32 -33.56 74.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -64.51 -31.85 82.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.5 p -65.96 -34.67 78.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -1.16 . . . . 0.0 109.535 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -68.23 -26.99 65.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.764 HG21 ' HG3' ' A' ' 50' ' ' PRO . 60.1 t -54.87 -40.4 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.88 . . . . 0.0 109.452 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.634 HG11 ' OD1' ' A' ' 27' ' ' ASN . 90.4 t . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.432 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.572 ' CG ' HD13 ' A' ' 79' ' ' LEU . 34.3 m-85 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.283 0.563 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -77.06 -31.91 56.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 108.872 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.6 -166.84 35.95 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.805 HG22 ' HB2' ' A' ' 79' ' ' LEU . 72.7 t -136.33 143.01 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -1.162 . . . . 0.0 108.978 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.792 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.1 m-85 -114.16 146.41 40.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.971 . . . . 0.0 109.907 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.877 ' CE1' HD12 ' A' ' 81' ' ' ILE . 66.9 m-85 -118.41 118.35 31.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.264 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.473 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 9.8 p -106.45 155.64 19.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 59.1 t0 -149.58 145.64 26.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.565 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -146.9 118.95 1.08 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 66.8 m -132.0 150.89 52.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -1.158 . . . . 0.0 109.588 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HA ' ' CB ' ' A' ' 28' ' ' ALA . . . -114.78 135.19 54.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.737 HD12 ' HB3' ' A' ' 161' ' ' SER . 58.3 mt . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.31 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -98.74 97.56 8.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.328 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 16' ' ' ALA . . . -110.85 155.91 21.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.7 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.44 154.71 25.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.819 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 33.2 mtm -115.39 156.76 24.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -1.113 . . . . 0.0 109.417 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.89 124.23 1.73 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 32' ' ' ILE . 5.4 mp -116.94 134.58 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -1.095 . . . . 0.0 109.102 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.0 t -127.09 131.39 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.77 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.69 ' NE2' HD22 ' A' ' 44' ' ' LEU . 3.5 t60 -102.15 131.0 48.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.196 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.34 159.37 37.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.759 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.702 ' HB ' HD11 ' A' ' 44' ' ' LEU . 7.7 t -117.46 161.45 19.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.863 . . . . 0.0 109.126 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.607 ' HE2' HG23 ' A' ' 9' ' ' VAL . 91.9 m-85 -104.66 8.75 35.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.134 -0.979 . . . . 0.0 109.634 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.576 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.8 -178.94 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.322 -0.861 . . . . 0.0 108.766 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.2 Cg_endo -66.5 -3.13 8.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.122 1.881 . . . . 0.0 111.945 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -132.36 105.78 7.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 108.706 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.5 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 63.3 t80 -66.57 125.5 25.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 109.329 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.5 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 73.0 mt-30 -160.62 152.72 20.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 0.0 109.391 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 43' ' ' VAL . 13.5 p -82.85 124.33 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.434 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.702 HD11 ' HB ' ' A' ' 36' ' ' THR . 6.4 mp -74.06 -42.33 60.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 80.5 m-20 -159.05 149.46 19.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.559 ' HB3' HD21 ' A' ' 156' ' ' LEU . 91.8 mt-30 -117.09 148.01 41.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -0.949 . . . . 0.0 109.398 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.489 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -130.92 131.38 44.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.188 -0.945 . . . . 0.0 109.587 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.646 ' C ' HD12 ' A' ' 49' ' ' ILE . 78.2 p -123.79 141.95 51.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.646 HD12 ' C ' ' A' ' 48' ' ' SER . 3.7 mp -149.52 95.67 3.73 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 49' ' ' ILE . 48.3 Cg_endo -69.27 128.16 16.06 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.683 2.256 . . . . 0.0 111.759 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 44.4 mt -111.74 142.9 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 0.0 109.534 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.12 -42.88 0.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -91.96 9.32 33.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 109.522 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 87.2 m-70 -110.47 147.31 34.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 0.0 109.467 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.547 HG22 ' HG3' ' A' ' 58' ' ' MET . 9.5 t -90.89 -178.54 5.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -57.29 -46.6 82.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 60' ' ' GLU . 87.8 mt-30 -63.11 -61.12 2.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.359 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.547 ' HG3' HG22 ' A' ' 55' ' ' THR . 94.2 mtp -44.01 -32.91 1.27 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.19 -30.36 58.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 0.0 109.526 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.675 ' HB3' HG21 ' A' ' 87' ' ' VAL . 95.4 mt-10 -70.34 -38.93 74.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.662 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 18.0 tt -72.49 -34.57 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.819 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -70.21 -32.5 70.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.409 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.473 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -65.03 -40.15 94.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.905 HG21 HG12 ' A' ' 87' ' ' VAL . 70.2 t -72.32 -39.7 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 109.49 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.23 -39.74 86.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.192 -0.942 . . . . 0.0 109.019 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.483 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 30.8 t80 -57.7 -63.59 1.19 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.369 -0.832 . . . . 0.0 109.528 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 68' ' ' CYS . . . -64.12 -39.55 94.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.601 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.55 ' SG ' HG23 ' A' ' 120' ' ' ILE . 37.2 t -43.06 -62.43 1.04 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.444 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 67.6 mttm -59.27 -46.09 89.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -0.929 . . . . 0.0 109.426 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 66' ' ' PHE . 30.9 mmtt -56.15 -38.18 70.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.389 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.896 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -59.94 -64.95 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.81 ' HB2' HD11 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -48.56 -47.12 39.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 109.461 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 72' ' ' LEU . 49.9 mttm -43.25 -42.46 4.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.33 -0.857 . . . . 0.0 109.097 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.556 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 30.1 mm -49.39 143.65 9.68 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.397 -0.814 . . . . 0.0 109.001 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.1 Cg_endo -65.11 -4.35 8.89 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.51 2.14 . . . . 0.0 111.895 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -143.61 172.31 24.97 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.1 Cg_endo -69.02 120.63 7.51 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 122.408 2.072 . . . . 0.0 111.677 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.896 HG11 ' HA ' ' A' ' 71' ' ' ALA . 7.2 p -114.89 153.76 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 109.141 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.805 ' HB2' HG22 ' A' ' 9' ' ' VAL . 6.6 mp -97.1 139.98 32.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.025 -1.047 . . . . 0.0 109.931 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 58.1 t -118.0 121.98 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.418 -0.801 . . . . 0.0 109.004 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.877 HD12 ' CE1' ' A' ' 11' ' ' TYR . 3.7 mt -107.29 142.44 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.117 -0.99 . . . . 0.0 109.62 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.714 HG21 HG22 ' A' ' 64' ' ' VAL . 0.7 OUTLIER -128.18 161.7 28.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.415 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -87.74 7.11 31.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 109.507 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -123.95 129.42 50.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.526 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.426 ' CE2' ' HG3' ' A' ' 89' ' ' GLU . 68.0 t80 -77.8 -39.3 44.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -63.35 -48.15 79.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.905 HG12 HG21 ' A' ' 64' ' ' VAL . 59.5 t -58.96 -53.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 0.0 109.369 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.51 ' HB1' HG22 ' A' ' 132' ' ' ILE . . . -48.35 -55.0 11.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.933 . . . . 0.0 109.314 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 77.1 mm-40 -56.35 -35.1 67.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 117' ' ' TRP . 38.6 m -53.39 -46.63 69.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.742 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -92.5 -0.88 57.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.87 . . . . 0.0 109.674 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 45.6 t-20 -89.03 -72.86 0.53 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.067 -1.021 . . . . 0.0 109.761 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 23.2 mttm -126.86 -29.55 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.904 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 88.4 mt-10 -59.58 -28.34 67.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -58.77 -60.88 8.99 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.124 -0.985 . . . . 0.0 109.552 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.1 Cg_endo -66.41 -31.44 42.68 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.724 2.283 . . . . 0.0 111.411 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -68.89 -38.46 79.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.236 -0.915 . . . . 0.0 108.883 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 35.3 m0 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.19 179.653 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HE3' ' NE2' ' A' ' 113' ' ' HIS . 33.8 tttp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.278 0.561 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.5 ' NE2' ' HE3' ' A' ' 112' ' ' LYS . 70.6 m-70 65.25 36.79 6.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.653 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 86.1 mt -53.93 -43.89 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.242 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.9 m -49.68 -45.89 49.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.267 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HD2' ' HB3' ' A' ' 113' ' ' HIS . 64.1 mttm -58.6 -48.09 82.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.307 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.662 ' CZ2' HD12 ' A' ' 61' ' ' ILE . 60.9 m95 -65.65 -38.14 88.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.839 . . . . 0.0 109.385 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -56.87 -46.64 81.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.479 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.4 p -57.67 -39.54 77.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 109.423 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.55 HG23 ' SG ' ' A' ' 68' ' ' CYS . 73.9 mt -66.75 -37.24 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.861 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.445 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -65.32 -32.66 74.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 126' ' ' MET . 83.9 tt0 -54.18 -38.15 65.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.329 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.87 -49.25 11.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.419 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 124' ' ' LEU . 22.7 tp -63.08 -31.86 73.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.8 m -66.12 -33.24 75.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.475 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 65.1 mtt -65.99 -34.5 78.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.47 140.82 0.52 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.501 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.0 Cg_endo -70.51 -0.8 8.08 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.655 2.236 . . . . 0.0 111.717 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 128' ' ' PRO . 84.8 m-20 -43.8 -47.98 8.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.81 HD11 ' HB2' ' A' ' 72' ' ' LEU . 58.5 mt -58.45 114.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.472 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 91.0 m -104.81 147.05 28.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.277 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.742 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 54.3 mt -122.82 142.68 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.615 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.422 ' NE2' HD23 ' A' ' 79' ' ' LEU . 89.8 mt-30 -135.71 164.96 26.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.268 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.6 t60 -113.57 138.55 50.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.558 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.62 ' HG3' HG22 ' A' ' 81' ' ' ILE . 96.9 mt-10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.463 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.208 0.528 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.2 m -63.23 -40.85 98.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.548 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.25 -36.9 76.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.593 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -67.25 -30.27 75.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.429 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 13.7 t-20 -72.45 -33.26 66.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -1.169 . . . . 0.0 109.524 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.12 -51.51 37.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.543 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 56.3 mt -59.19 -47.27 85.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -56.84 -38.75 73.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 109.564 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.27 -32.26 73.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.647 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 159' ' ' GLN . 24.7 mttm -67.84 -41.88 82.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.63 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 156' ' ' LEU . 6.3 mp -73.14 -31.59 64.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.94 . . . . 0.0 109.585 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.61 -62.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.589 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 35.5 m -59.25 -43.3 92.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' A' ' 155' ' ' LYS . 63.1 tp60 -61.32 -33.61 73.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.629 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -68.52 -31.16 73.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.737 ' HB3' HD12 ' A' ' 17' ' ' ILE . 19.0 m -66.71 -29.33 69.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -1.142 . . . . 0.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -75.37 -21.52 58.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.76 -43.95 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 161' ' ' SER . 4.6 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.526 ' CG ' HD13 ' A' ' 79' ' ' LEU . 99.7 m-85 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.27 0.557 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 31.7 tp10 -64.2 -37.89 89.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.362 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.569 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.48 -175.34 45.5 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 79' ' ' LEU . 72.2 t -134.47 142.86 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -1.121 . . . . 0.0 109.354 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.567 ' CE1' HG11 ' A' ' 78' ' ' VAL . 7.3 m-85 -123.06 140.36 53.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.634 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.875 ' CE2' HD12 ' A' ' 81' ' ' ILE . 42.9 m-85 -113.32 132.56 55.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.308 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.885 HG22 HD12 ' A' ' 32' ' ' ILE . 24.6 p -120.17 142.57 48.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.831 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.456 ' OD2' ' OD1' ' A' ' 154' ' ' ASP . 52.4 t0 -137.0 155.91 49.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.405 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -142.42 127.29 3.16 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 40.2 m -124.21 157.74 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -1.133 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.908 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -145.35 144.49 30.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 109.625 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.488 HD12 ' HB2' ' A' ' 161' ' ' SER . 47.7 mt . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 0.0 109.402 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 71.1 m-20 -92.14 113.37 25.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.943 . . . . 0.0 109.337 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 59' ' ' ALA . . . -112.14 145.68 39.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.775 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.62 165.46 23.3 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.556 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 67.9 mtm -133.46 150.94 51.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -1.184 . . . . 0.0 109.684 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.46 120.24 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.885 HD12 HG22 ' A' ' 12' ' ' THR . 23.4 mm -110.36 140.62 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -1.159 . . . . 0.0 109.547 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' A' ' 153' ' ' ALA . 42.4 t -124.82 130.41 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.353 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.489 ' CE1' ' CD2' ' A' ' 10' ' ' PHE . 2.3 m-70 -105.67 138.2 42.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 109.655 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.7 168.62 18.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.467 ' HB ' HD21 ' A' ' 44' ' ' LEU . 12.2 t -138.16 165.13 27.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.175 -0.953 . . . . 0.0 109.713 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 38' ' ' LYS . 68.8 m-85 -106.63 10.21 31.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.584 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.09 -179.96 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.039 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.584 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.6 Cg_endo -66.39 -4.57 10.93 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.159 1.906 . . . . 0.0 111.64 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -132.12 105.92 7.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.35 -0.844 . . . . 0.0 108.811 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.463 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 58.6 t80 -63.53 117.72 7.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 109.408 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 41' ' ' TYR . 85.7 mt-30 -157.98 144.79 17.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.684 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.3 m -72.78 124.73 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 68.3 mt -59.72 -39.14 83.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.94 . . . . 0.0 109.483 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 20.3 t-20 -179.57 157.02 0.74 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -108.39 139.33 43.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.873 . . . . 0.0 109.515 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.403 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 0.5 OUTLIER -118.86 139.93 50.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.264 -0.897 . . . . 0.0 109.483 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 t -130.81 125.45 33.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.449 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 2.2 mp -130.82 95.74 25.04 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.77 ' HG3' HG21 ' A' ' 163' ' ' VAL . 50.1 Cg_endo -69.93 134.98 28.92 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.785 2.323 . . . . 0.0 111.813 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.447 HD12 ' CB ' ' A' ' 59' ' ' ALA . 38.8 mt -113.21 152.01 30.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.57 -48.37 0.13 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -89.16 7.49 34.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -1.177 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 90.2 m-70 -111.18 142.08 43.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 58' ' ' MET . 9.6 t -87.43 -176.27 5.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.908 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -60.45 -44.7 95.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -62.06 -48.58 79.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.593 ' O ' HG22 ' A' ' 61' ' ' ILE . 96.3 mtp -61.63 -30.12 70.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.497 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HB2' ' HB1' ' A' ' 28' ' ' ALA . . . -71.02 -28.74 64.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.769 ' HB3' HG21 ' A' ' 87' ' ' VAL . 98.1 mt-10 -73.69 -45.2 53.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 58' ' ' MET . 16.1 tt -63.12 -32.03 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.875 . . . . 0.0 109.465 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.556 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -74.2 -34.52 63.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.329 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -56.24 -42.82 77.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.534 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.651 HG21 HG12 ' A' ' 87' ' ' VAL . 32.7 t -71.32 -45.5 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.51 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.524 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 97.8 mt-10 -55.76 -35.57 66.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.907 . . . . 0.0 109.56 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.524 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 8.8 t80 -62.11 -69.04 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.607 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 -13.95 51.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.492 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 41.4 t -66.08 -60.41 2.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.179 -0.951 . . . . 0.0 109.432 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -65.13 -40.12 93.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.463 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HE3' ' CE2' ' A' ' 66' ' ' PHE . 63.2 mttm -64.26 -34.96 79.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.416 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.414 ' O ' HG12 ' A' ' 74' ' ' ILE . . . -63.71 -65.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.468 HD21 ' SD ' ' A' ' 126' ' ' MET . 24.9 tp -51.23 -44.33 61.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.953 . . . . 0.0 109.589 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' LEU . 83.5 tttt -43.55 -47.35 7.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.284 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.56 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 9.5 mm -48.51 142.72 8.24 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.14 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.2 Cg_endo -65.88 -5.02 11.09 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.49 2.127 . . . . 0.0 111.556 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.74 168.22 23.67 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 47.7 Cg_endo -68.85 137.35 37.96 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.583 2.188 . . . . 0.0 111.585 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 8' ' ' GLY . 21.7 t -123.82 159.1 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.46 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.582 ' HB2' HG22 ' A' ' 9' ' ' VAL . 6.5 mp -105.92 123.8 48.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.863 . . . . 0.0 109.59 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 40.2 t -103.6 121.62 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.453 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.875 HD12 ' CE2' ' A' ' 11' ' ' TYR . 13.8 mt -106.85 139.05 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.311 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.86 161.74 29.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.406 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 135' ' ' GLU . 68.1 m-20 -93.43 -2.5 54.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.458 ' HB3' HG23 ' A' ' 87' ' ' VAL . 71.1 m -108.5 120.75 43.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.575 ' HA ' ' CD2' ' A' ' 134' ' ' HIS . 61.2 t80 -71.31 -28.64 64.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.345 -0.847 . . . . 0.0 109.541 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -78.98 -46.33 18.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.316 -0.865 . . . . 0.0 109.745 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.769 HG21 ' HB3' ' A' ' 60' ' ' GLU . 30.9 t -57.68 -60.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 109.437 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.995 ' HB1' ' CG2' ' A' ' 132' ' ' ILE . . . -53.19 -51.75 61.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 0.0 109.408 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -52.31 -38.27 58.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.52 ' HB3' ' CH2' ' A' ' 117' ' ' TRP . 19.2 t -56.91 -48.2 78.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.92 -0.91 45.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 109.765 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -92.68 -73.77 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.003 -1.06 . . . . 0.0 110.072 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 32.5 mmtp -127.52 -27.13 2.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.0 . . . . 0.0 110.239 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 53.8 mt-10 -62.75 -20.54 65.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 110.176 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.937 HD21 ' HB2' ' A' ' 121' ' ' ALA . 25.4 tp -64.86 -58.33 13.32 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.965 -1.084 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.2 Cg_endo -66.14 -36.12 30.45 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.545 2.163 . . . . 0.0 111.442 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -65.79 -34.61 78.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 108.935 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 23.1 m0 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.4 -0.812 . . . . 0.0 109.123 179.65 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.9 mttt . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 61.71 34.83 17.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.057 -1.027 . . . . 0.0 109.149 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.6 mm -48.86 -41.64 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 109.08 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.8 t -47.39 -44.01 23.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 108.784 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 40.3 mttm -63.38 -46.08 88.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 108.952 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.52 ' CH2' ' HB3' ' A' ' 90' ' ' SER . 47.9 m95 -62.17 -42.39 99.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -0.867 . . . . 0.0 109.216 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -51.66 -48.15 63.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.255 -0.903 . . . . 0.0 109.34 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.2 m -49.54 -39.8 35.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.24 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.524 ' CG1' ' HG2' ' A' ' 65' ' ' GLU . 61.9 mt -73.27 -33.32 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.268 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.937 ' HB2' HD21 ' A' ' 95' ' ' LEU . . . -64.96 -36.82 85.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -54.25 -40.3 67.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.407 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.92 -50.61 12.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.41 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.49 -35.98 75.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.357 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.2 t -58.96 -35.14 72.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.476 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.468 ' SD ' HD21 ' A' ' 72' ' ' LEU . 65.9 mtt -65.35 -34.78 79.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 172.37 152.72 0.22 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 0.0 109.557 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.7 Cg_endo -71.76 3.2 3.97 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.813 2.342 . . . . 0.0 112.059 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 128' ' ' PRO . 81.2 m-20 -42.36 -30.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 109.581 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 72' ' ' LEU . 38.1 mt -82.76 111.64 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.514 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 79' ' ' LEU . 32.9 m -97.72 151.16 20.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.391 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.995 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 63.7 mt -125.27 129.07 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.634 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.425 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.2 mt-30 -119.17 157.31 28.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.38 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.961 ' NE2' ' HB3' ' A' ' 88' ' ' ALA . 27.3 m170 -112.03 133.57 54.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.665 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.441 ' CD ' ' ND2' ' A' ' 150' ' ' ASN . 49.7 tp10 . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.873 . . . . 0.0 109.289 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.2 m -51.95 -48.49 64.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.439 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -47.59 -51.37 21.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -52.39 -40.4 53.68 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.441 ' ND2' ' CD ' ' A' ' 135' ' ' GLU . 87.9 m-20 -64.96 -39.26 93.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -1.141 . . . . 0.0 109.465 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.79 -48.54 72.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.819 ' O ' HD12 ' A' ' 156' ' ' LEU . 6.6 mp -64.17 -41.13 97.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.441 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.733 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -64.9 -36.97 86.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.456 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 76.4 m-20 -61.18 -42.74 99.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -60.8 -45.45 94.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.527 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.819 HD12 ' O ' ' A' ' 152' ' ' LEU . 1.0 OUTLIER -63.89 -38.19 90.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.23 93.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 109.465 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.663 HG22 ' HE1' ' A' ' 162' ' ' TYR . 56.2 m -64.7 -41.65 95.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.5 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.49 -33.14 72.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.89 . . . . 0.0 109.624 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.23 96.38 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.488 ' HB2' HD12 ' A' ' 17' ' ' ILE . 95.6 p -56.73 -28.68 61.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -1.171 . . . . 0.0 109.631 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.663 ' HE1' HG22 ' A' ' 158' ' ' THR . 87.9 m-85 -72.72 -25.11 61.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 109.524 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.77 HG21 ' HG3' ' A' ' 50' ' ' PRO . 77.1 t -64.17 -42.55 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.899 . . . . 0.0 109.411 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 161' ' ' SER . 41.0 t . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.413 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 7.9 p90 . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.493 ' OE2' ' CD ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -88.5 -31.41 18.74 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.289 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -177.24 -177.08 45.87 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 79' ' ' LEU . 59.4 t -124.8 142.63 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -1.133 . . . . 0.0 109.25 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.813 ' CE1' HG21 ' A' ' 78' ' ' VAL . 5.4 m-85 -114.3 146.58 40.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.861 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.594 ' CE2' HG13 ' A' ' 81' ' ' ILE . 67.8 m-85 -119.64 129.1 54.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.394 -0.817 . . . . 0.0 109.104 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.804 HG22 HD12 ' A' ' 32' ' ' ILE . 16.0 p -118.02 147.46 43.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.64 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 58.8 t0 -144.34 150.65 38.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.548 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -134.96 120.99 2.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.7 m -133.13 150.68 52.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -1.137 . . . . 0.0 109.625 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -119.75 154.46 34.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.479 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 161' ' ' SER . 66.6 mt . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.162 -0.961 . . . . 0.0 109.629 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 7.8 m120 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' ILE . 86.8 m-20 -99.53 113.7 26.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.413 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . . . -93.17 150.35 20.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.9 143.03 9.81 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 63.4 mtm -115.39 162.86 16.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -1.152 . . . . 0.0 109.359 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' A' ' 156' ' ' LEU . . . -151.27 130.22 3.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.804 HD12 HG22 ' A' ' 12' ' ' THR . 23.4 mm -114.76 140.65 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -1.116 . . . . 0.0 109.382 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 11' ' ' TYR . 40.6 t -127.88 130.2 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.546 ' CE1' ' CD2' ' A' ' 10' ' ' PHE . 2.5 m-70 -105.67 137.57 43.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.144 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.1 168.63 19.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.709 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -137.01 164.32 28.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.379 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 38' ' ' LYS . 59.4 m-85 -102.48 14.78 31.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.494 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.578 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -51.17 179.8 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 108.942 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.3 Cg_endo -66.1 -6.21 14.05 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.137 1.891 . . . . 0.0 111.447 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -135.16 106.55 6.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.427 -0.795 . . . . 0.0 109.066 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -58.38 122.96 14.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.258 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -154.14 148.17 25.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.683 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 43' ' ' VAL . 8.6 p -82.96 123.78 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 54.4 mt -64.27 -34.18 77.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 21.7 t-20 178.69 155.3 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.512 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.405 ' HB3' HD21 ' A' ' 156' ' ' LEU . 94.2 mt-30 -109.32 142.39 40.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.322 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.485 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -126.52 136.4 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.591 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.1 t -127.29 132.49 50.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.361 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.921 HD11 ' CE2' ' A' ' 66' ' ' PHE . 3.3 mt -132.77 91.73 28.72 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.74 136.22 29.89 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.713 2.275 . . . . 0.0 111.728 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.57 ' CD1' ' HB2' ' A' ' 59' ' ' ALA . 44.0 mt -101.48 143.98 30.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.41 -68.41 1.13 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -109.87 64.09 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.19 . . . . 0.0 109.537 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 83.7 m-70 -132.1 171.95 12.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.521 HG22 ' HG3' ' A' ' 58' ' ' MET . 11.7 t -121.0 174.22 6.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.83 -45.26 78.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' GLU . 90.1 mt-30 -60.35 -64.03 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.447 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.521 ' HG3' HG22 ' A' ' 55' ' ' THR . 97.1 mtp -44.35 -35.3 2.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 109.371 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.57 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . . . -80.39 -25.9 38.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 57' ' ' GLN . 78.0 tt0 -64.48 -40.56 95.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.404 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.651 HD11 ' CZ2' ' A' ' 117' ' ' TRP . 12.1 tt -84.1 -29.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.474 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -67.73 -25.84 65.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.465 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.38 81.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.512 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.574 HG22 HG21 ' A' ' 82' ' ' THR . 96.7 t -79.29 -38.97 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.569 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -66.8 -39.37 87.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.078 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.921 ' CE2' HD11 ' A' ' 49' ' ' ILE . 27.6 t80 -59.72 -64.54 0.91 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.447 -0.783 . . . . 0.0 109.608 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.94 -32.2 70.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.839 . . . . 0.0 109.751 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 1.051 ' SG ' HG23 ' A' ' 120' ' ' ILE . 50.8 t -54.82 -54.18 45.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -62.87 -45.67 91.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.581 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 62.9 mttm -63.38 -38.0 89.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 109.669 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.641 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -56.75 -63.05 1.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.57 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.941 ' HB2' HD11 ' A' ' 130' ' ' ILE . 25.2 tp -53.48 -45.74 69.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.489 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 72' ' ' LEU . 20.8 tttp -43.06 -43.21 4.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.371 -0.831 . . . . 0.0 109.23 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 8.0 mt -48.25 142.44 7.92 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 108.877 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.8 Cg_endo -66.11 -4.3 10.06 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.447 2.098 . . . . 0.0 111.696 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.409 ' HA3' ' CD ' ' A' ' 7' ' ' GLU . . . -140.77 166.96 25.76 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.493 ' CD ' ' OE2' ' A' ' 7' ' ' GLU . 46.7 Cg_endo -67.64 127.17 15.88 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.418 2.079 . . . . 0.0 111.591 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.813 HG21 ' CE1' ' A' ' 10' ' ' PHE . 7.3 p -123.47 151.41 28.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.165 -0.959 . . . . 0.0 109.495 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.66 ' HB2' HG22 ' A' ' 9' ' ' VAL . 15.5 mt -93.15 146.78 23.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.457 ' O ' HD13 ' A' ' 81' ' ' ILE . 65.1 t -118.09 135.84 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 109.396 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.594 HG13 ' CE2' ' A' ' 11' ' ' TYR . 26.1 mm -114.75 132.67 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.574 HG21 HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -129.77 161.62 30.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.953 . . . . 0.0 109.481 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 58.7 p30 -94.57 11.38 31.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.363 -0.835 . . . . 0.0 109.435 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.45 ' CB ' HG12 ' A' ' 87' ' ' VAL . 8.3 t -131.92 119.21 20.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.498 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.423 ' HB2' ' CG ' ' A' ' 134' ' ' HIS . 68.9 t80 -75.96 -34.3 59.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.339 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -57.95 -53.62 56.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 88' ' ' ALA . 13.7 p -61.06 -46.67 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.338 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.61 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -53.5 -51.72 61.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.204 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 84.4 tt0 -55.93 -36.5 67.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.623 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 67.8 m -54.87 -49.51 71.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.451 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.544 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -85.95 -1.0 56.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.719 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.459 ' OD1' ' HB ' ' A' ' 132' ' ' ILE . 81.3 m-20 -87.1 -73.32 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.072 -1.017 . . . . 0.0 109.722 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 67.6 mttm -127.08 -30.76 2.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -0.87 . . . . 0.0 109.835 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 69.4 mt-10 -58.09 -28.21 64.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.727 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -59.64 -61.23 8.29 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.0 109.458 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -66.3 -30.87 44.77 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.691 2.261 . . . . 0.0 111.572 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -67.55 -39.51 84.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.013 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.487 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 27.9 m0 . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.173 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 12.8 mmtp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 49.0 m80 65.61 34.56 7.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.517 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.424 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 35.8 mm -68.09 -42.73 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.444 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 23.2 m -55.96 -40.76 73.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 109.346 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -65.37 -39.21 92.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.651 ' CZ2' HD11 ' A' ' 61' ' ' ILE . 22.6 m95 -71.64 -39.15 70.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.317 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 115' ' ' SER . 55.3 mtmt -57.38 -42.16 81.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 109.383 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.3 m -58.41 -42.42 87.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 1.051 HG23 ' SG ' ' A' ' 68' ' ' CYS . 83.4 mt -76.36 -34.06 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.473 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -63.62 -40.05 95.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.941 . . . . 0.0 109.432 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -57.46 -42.53 82.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.4 m -67.53 -49.68 62.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.583 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 56.0 mt -62.71 -30.56 71.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.913 . . . . 0.0 109.571 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.0 m -56.04 -36.37 67.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.498 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.745 ' SD ' HD21 ' A' ' 72' ' ' LEU . 65.3 mtt -64.15 -34.85 79.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.985 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 126' ' ' MET . 1.3 mttp 170.76 156.53 0.21 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.626 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 129' ' ' ASP . 53.4 Cg_endo -71.82 2.65 4.51 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.823 2.349 . . . . 0.0 111.897 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 128' ' ' PRO . 91.3 m-20 -41.73 -43.97 3.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.875 . . . . 0.0 109.685 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.941 HD11 ' HB2' ' A' ' 72' ' ' LEU . 50.3 mt -68.35 115.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.51 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.598 ' HB ' HD22 ' A' ' 79' ' ' LEU . 24.5 m -107.52 142.95 36.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 0.0 109.095 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.544 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 61.8 mt -124.96 137.99 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 109.781 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.501 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 94.8 mt-30 -133.03 161.19 35.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.354 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.423 ' CG ' ' HB2' ' A' ' 85' ' ' PHE . 69.8 t60 -105.07 135.68 45.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 109.412 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 81' ' ' ILE . 99.4 mt-10 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 62.9 m80 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.326 0.584 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 51.9 m -56.86 -49.17 76.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 109.444 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.03 -48.3 64.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.433 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.6 -37.35 82.52 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -60.08 -40.06 88.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -1.119 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.06 -52.84 62.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.489 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.9 mt -57.31 -48.64 78.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.491 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.464 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -54.43 -40.44 68.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.453 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 88.8 m-20 -59.25 -40.29 85.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -60.58 -42.64 97.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 156' ' ' LEU . 6.6 mp -66.28 -39.86 89.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.527 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.72 -53.2 58.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.0 m -59.12 -42.83 91.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.572 ' O ' HG23 ' A' ' 163' ' ' VAL . 49.1 tt0 -63.11 -40.05 96.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.73 -51.29 58.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.547 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 30.3 m -61.92 -33.39 74.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -1.133 . . . . 0.0 109.465 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -62.99 -35.86 81.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.892 . . . . 0.0 109.46 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 159' ' ' GLN . 40.4 t -64.96 -16.76 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 51' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 1.032 ' CD2' HD11 ' A' ' 79' ' ' LEU . 64.8 m-85 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.516 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 76.6 mm-40 -63.0 -38.66 92.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.171 -0.956 . . . . 0.0 108.942 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.48 -170.71 41.64 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.98 HG21 ' OH ' ' A' ' 37' ' ' TYR . 73.8 t -133.26 139.1 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -1.082 . . . . 0.0 109.007 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.635 ' CD2' ' ND1' ' A' ' 34' ' ' HIS . 5.1 m-85 -113.8 138.6 50.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.905 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.873 ' CE1' HD12 ' A' ' 81' ' ' ILE . 75.2 m-85 -114.05 117.2 30.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.146 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 1.113 HG22 HG23 ' A' ' 32' ' ' ILE . 10.4 p -114.55 157.16 23.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.786 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 49.9 t0 -155.77 156.01 34.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.279 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.495 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -131.25 141.96 13.29 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.9 t -141.62 138.6 32.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.965 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -118.97 143.62 46.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.521 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 63.9 mt . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.378 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.801 ' HB3' HG23 ' A' ' 164' ' ' VAL . 21.8 m120 -91.68 114.97 27.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.485 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . . . -99.26 143.08 29.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.93 151.44 20.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.833 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 72.4 mtm -128.68 160.45 32.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -1.145 . . . . 0.0 109.518 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -153.34 115.67 0.69 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.113 HG23 HG22 ' A' ' 12' ' ' THR . 4.3 mp -123.54 120.53 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -1.175 . . . . 0.0 109.431 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.601 HG22 HG13 ' A' ' 43' ' ' VAL . 11.6 p -120.82 148.0 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.635 ' ND1' ' CD2' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -109.24 145.52 35.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.03 173.11 11.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -133.22 157.03 46.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 109.664 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.98 ' OH ' HG21 ' A' ' 9' ' ' VAL . 16.7 m-30 -103.48 12.79 34.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.51 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.591 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -50.82 -179.62 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 108.941 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.591 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.5 Cg_endo -65.11 -7.43 15.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.038 1.825 . . . . 0.0 111.288 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -128.11 106.25 8.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.429 -0.795 . . . . 0.0 108.965 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -61.82 127.37 31.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.149 -0.97 . . . . 0.0 109.237 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -161.42 154.24 20.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.925 . . . . 0.0 109.562 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.601 HG13 HG22 ' A' ' 33' ' ' VAL . 41.9 t -91.05 122.54 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 109.24 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 45.5 mt -62.46 -40.21 95.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 109.346 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 33' ' ' VAL . 64.2 t30 178.45 154.49 0.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.878 . . . . 0.0 109.684 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.722 ' OE1' HD21 ' A' ' 156' ' ' LEU . 56.2 mt-30 -107.58 143.06 36.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.054 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.2 t-105 -118.52 131.85 56.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 109.599 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.2 m -121.88 145.34 48.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.579 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 9.9 mt -149.56 96.88 3.57 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.554 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.0 Cg_endo -70.02 128.4 15.74 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.684 2.256 . . . . 0.0 111.661 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.669 ' HB2' ' HB3' ' A' ' 28' ' ' ALA . 49.0 mt -114.36 148.67 37.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 109.49 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.65 -46.89 0.2 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -87.47 11.11 15.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 90.9 m-70 -112.61 147.21 37.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.482 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.1 OUTLIER -89.58 168.47 12.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.9 . . . . 0.0 109.111 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.965 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -49.38 -38.76 29.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.1 -1.0 . . . . 0.0 109.056 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' MET . 89.2 mt-30 -70.09 -58.77 3.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.332 -0.855 . . . . 0.0 109.311 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.539 ' O ' HG22 ' A' ' 61' ' ' ILE . 93.3 mtp -45.43 -30.59 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.158 -0.964 . . . . 0.0 109.199 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.648 ' HB2' ' HB1' ' A' ' 28' ' ' ALA . . . -75.28 -37.35 60.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.416 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.452 ' HB3' ' OG ' ' A' ' 84' ' ' SER . 96.3 mt-10 -62.74 -44.9 95.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.358 -0.839 . . . . 0.0 109.562 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.63 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 8.2 tt -67.29 -35.09 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.833 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -65.89 -29.69 70.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.192 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.767 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -70.01 -44.79 68.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.44 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.779 HG21 HG13 ' A' ' 87' ' ' VAL . 68.6 t -63.13 -47.3 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.335 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' A' ' 120' ' ' ILE . 84.6 tt0 -64.83 -38.3 90.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 109.417 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 49' ' ' ILE . 16.3 t80 -53.66 -68.82 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.395 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -63.23 -15.94 58.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.369 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.69 ' SG ' HG23 ' A' ' 120' ' ' ILE . 39.8 t -70.79 -58.03 4.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.432 ' NZ ' ' OE2' ' A' ' 65' ' ' GLU . 25.5 mttt -59.76 -48.69 80.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.486 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 37.5 mttm -60.87 -38.48 85.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.227 -0.92 . . . . 0.0 109.505 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.794 ' HB1' ' CG1' ' A' ' 78' ' ' VAL . . . -55.74 -69.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.63 ' HB2' HD11 ' A' ' 130' ' ' ILE . 6.3 tp -44.89 -48.51 11.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 109.434 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 20.2 mttm -43.81 -44.36 6.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.281 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 9.7 mt -48.81 143.11 8.51 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.043 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.6 Cg_endo -66.29 -2.68 7.48 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.601 2.2 . . . . 0.0 111.921 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.516 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -141.64 166.4 26.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.3 Cg_endo -69.34 122.75 9.54 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 122.552 2.168 . . . . 0.0 111.714 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.794 ' CG1' ' HB1' ' A' ' 71' ' ' ALA . 2.8 p -112.77 156.44 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.032 HD11 ' CD2' ' A' ' 6' ' ' TYR . 19.3 mt -101.58 140.26 36.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.759 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 52.0 t -120.92 130.33 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.137 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.873 HD12 ' CE1' ' A' ' 11' ' ' TYR . 8.0 mt -118.71 136.23 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.742 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.8 t -140.97 143.26 34.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.237 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -66.69 -25.34 66.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.905 . . . . 0.0 109.57 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.58 ' CB ' ' CG1' ' A' ' 87' ' ' VAL . 3.6 m -64.69 110.93 2.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 109.286 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.659 ' CD2' ' CE1' ' A' ' 134' ' ' HIS . 49.2 t80 -78.05 -41.45 35.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.688 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -71.15 -35.98 71.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 0.0 109.908 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.779 HG13 HG21 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -67.36 -47.16 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.135 -0.978 . . . . 0.0 109.497 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.964 ' HB3' ' NE2' ' A' ' 134' ' ' HIS . . . -54.32 -51.4 64.8 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.229 -0.919 . . . . 0.0 108.964 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 72.6 tt0 -55.26 -33.39 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.332 -0.855 . . . . 0.0 108.967 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.637 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 16.6 m -57.3 -49.11 77.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.844 . . . . 0.0 109.352 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.798 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -85.71 -0.72 55.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.749 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' OD1' ' HB ' ' A' ' 132' ' ' ILE . 85.7 m-20 -88.48 -73.48 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 109.947 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 63.0 mttt -127.42 -30.07 2.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.017 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 37.5 mm-40 -57.04 -31.54 65.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.078 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.606 HD23 ' HB2' ' A' ' 121' ' ' ALA . 0.5 OUTLIER -58.32 -60.8 9.05 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 0.0 109.503 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -66.8 -26.33 45.12 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.642 2.228 . . . . 0.0 111.581 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -73.82 -36.83 65.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 108.977 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.1 m0 . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.35 -0.844 . . . . 0.0 109.239 179.663 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 80.8 tttt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.276 0.56 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.535 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 89.6 m-70 65.31 28.55 11.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.569 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.88 -45.48 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.167 -0.958 . . . . 0.0 109.399 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -55.67 -46.08 77.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.53 -45.48 91.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.637 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 54.3 m95 -66.42 -36.55 83.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.439 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -56.4 -46.17 80.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.484 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.6 m -59.96 -44.11 94.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.407 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.69 HG23 ' SG ' ' A' ' 68' ' ' CYS . 87.8 mt -68.79 -39.58 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.606 ' HB2' HD23 ' A' ' 95' ' ' LEU . . . -62.87 -36.24 82.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.472 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -56.2 -37.92 70.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 6.0 m -79.43 -51.34 9.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.387 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 124' ' ' LEU . 19.4 tp -58.56 -34.59 71.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.417 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.0 m -60.47 -31.88 70.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.549 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.78 -33.38 75.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.447 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.45 145.95 0.29 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 109.511 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.6 Cg_endo -72.35 2.72 4.76 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.741 2.294 . . . . 0.0 111.774 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 128' ' ' PRO . 79.5 m-20 -42.87 -46.16 5.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.504 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.63 HD11 ' HB2' ' A' ' 72' ' ' LEU . 52.8 mt -61.92 121.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.342 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.627 ' HB ' HD22 ' A' ' 79' ' ' LEU . 24.4 m -110.85 146.77 35.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.372 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.798 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 54.1 mt -125.12 128.13 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.462 ' HB2' HG12 ' A' ' 81' ' ' ILE . 79.9 mt-30 -127.24 154.9 44.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.964 ' NE2' ' HB3' ' A' ' 88' ' ' ALA . 34.1 m170 -90.67 141.01 29.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.791 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HG2' ' OD1' ' A' ' 150' ' ' ASN . 98.3 mt-10 . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 109.286 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.622 ' CD2' HD11 ' A' ' 81' ' ' ILE . 71.9 m80 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.1 m -51.35 -45.92 62.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.315 -0.866 . . . . 0.0 109.563 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -52.22 -49.81 63.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 109.506 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.43 -36.1 75.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.45 ' OD1' ' HG2' ' A' ' 135' ' ' GLU . 77.1 m-20 -60.42 -41.13 93.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -1.15 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.24 -48.48 79.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.402 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 26.0 tp -65.28 -42.26 93.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.32 -40.73 98.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 0.0 109.509 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.457 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 56.2 t0 -58.26 -43.17 87.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 0.0 109.559 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 78.6 tttt -62.19 -38.13 87.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.51 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.722 HD21 ' OE1' ' A' ' 46' ' ' GLN . 78.8 mt -64.29 -38.2 90.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.568 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.22 83.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.923 . . . . 0.0 109.463 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 36.3 m -61.59 -41.46 97.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.472 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.78 ' O ' HG23 ' A' ' 163' ' ' VAL . 95.2 mt-30 -62.4 -35.96 80.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -62.54 -55.94 24.38 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.1 p -67.48 -28.69 68.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -1.146 . . . . 0.0 109.516 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -63.85 -36.14 82.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.551 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 159' ' ' GLN . 39.1 t -64.95 -11.79 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.514 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.801 HG23 ' HB3' ' A' ' 27' ' ' ASN . 22.3 m . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.455 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.672 ' CB ' HD13 ' A' ' 79' ' ' LEU . 24.0 p90 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.274 0.559 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -94.72 -33.86 12.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 108.924 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.587 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -165.74 175.42 41.4 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.819 HG22 ' HB2' ' A' ' 79' ' ' LEU . 91.8 t -124.95 138.02 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.196 -1.179 . . . . 0.0 109.357 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE2' ' CG ' ' A' ' 34' ' ' HIS . 5.3 m-85 -111.38 139.55 46.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.558 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.795 ' CE1' HD12 ' A' ' 81' ' ' ILE . 82.2 m-85 -113.93 127.34 55.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.908 . . . . 0.0 109.39 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.818 HG22 HG23 ' A' ' 32' ' ' ILE . 16.3 p -118.49 152.6 35.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.574 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 53.7 t0 -151.36 152.87 33.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -135.08 118.0 1.84 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.8 m -122.18 150.28 42.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -1.149 . . . . 0.0 109.536 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -123.44 145.89 48.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.493 ' CD1' ' OG ' ' A' ' 161' ' ' SER . 74.5 mt . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 109.461 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.281 0.562 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 78.1 m-20 -92.9 115.55 28.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.477 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -99.19 148.29 24.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.4 ' HA3' ' N ' ' A' ' 161' ' ' SER . . . -141.83 153.18 24.05 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.943 ' CE ' HD21 ' A' ' 51' ' ' LEU . 70.9 mtm -119.95 161.5 20.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.449 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -154.42 117.48 0.79 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.818 HG23 HG22 ' A' ' 12' ' ' THR . 4.8 mp -125.74 120.29 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -1.138 . . . . 0.0 109.256 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.584 HG22 HG13 ' A' ' 43' ' ' VAL . 9.6 p -119.59 145.89 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.735 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.688 ' CG ' ' CE2' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -105.72 136.17 45.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.147 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.38 167.37 20.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.642 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.6 t -124.56 159.85 29.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.369 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.549 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 17.7 m-85 -106.71 16.9 23.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.71 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.589 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -51.28 -178.7 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.852 . . . . 0.0 108.711 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.589 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.5 Cg_endo -65.02 -6.37 12.73 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.964 1.776 . . . . 0.0 111.566 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -131.64 106.09 7.94 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.44 126.02 25.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.469 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -155.21 149.14 25.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -0.91 . . . . 0.0 109.534 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.584 HG13 HG22 ' A' ' 33' ' ' VAL . 51.4 t -91.49 121.06 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 109.523 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 53.1 mt -63.93 -38.89 92.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.536 ' O ' HG23 ' A' ' 33' ' ' VAL . 39.9 t30 -179.99 156.29 0.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.579 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.528 ' HG2' ' CG2' ' A' ' 33' ' ' VAL . 93.5 mt-30 -110.46 147.82 33.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.426 -0.796 . . . . 0.0 109.025 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -126.07 132.89 51.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.124 -0.985 . . . . 0.0 109.716 -179.592 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.7 t -126.22 132.11 51.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.242 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.476 ' HB ' ' CE ' ' A' ' 30' ' ' MET . 3.0 mt -135.51 111.64 10.69 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.722 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HB3' ' CG2' ' A' ' 163' ' ' VAL . 50.2 Cg_endo -70.87 134.92 26.65 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.729 2.286 . . . . 0.0 111.665 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.943 HD21 ' CE ' ' A' ' 30' ' ' MET . 49.9 mt -104.51 138.28 41.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.907 . . . . 0.0 109.617 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' O ' ' ND1' ' A' ' 54' ' ' HIS . . . -113.81 127.63 7.91 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 18.4 m120 64.44 38.55 7.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -1.181 . . . . 0.0 109.469 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 52' ' ' GLY . 75.9 m80 -124.74 165.46 17.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.492 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.581 HG23 ' HG3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -110.56 171.42 7.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 109.179 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -53.95 -39.72 66.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.094 -1.004 . . . . 0.0 109.231 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 60' ' ' GLU . 92.4 mt-30 -67.35 -53.66 27.48 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.871 . . . . 0.0 109.263 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.581 ' HG3' HG23 ' A' ' 55' ' ' THR . 69.7 mmm -44.73 -34.61 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.33 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.685 ' HB2' HD12 ' A' ' 51' ' ' LEU . . . -76.83 -32.49 57.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.399 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' GLN . 97.7 mt-10 -62.85 -40.61 97.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.58 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.571 HD11 ' CE2' ' A' ' 117' ' ' TRP . 17.7 tt -74.73 -35.12 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.549 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.606 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -71.02 -30.15 66.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.56 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -59.93 -39.29 84.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.555 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.685 HG21 HG12 ' A' ' 87' ' ' VAL . 44.3 t -77.14 -43.99 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.555 ' HG2' HD11 ' A' ' 120' ' ' ILE . 98.1 mt-10 -55.78 -36.83 67.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.548 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.586 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 10.8 t80 -59.87 -68.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.645 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -60.77 -13.58 16.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 109.602 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.676 ' SG ' HG23 ' A' ' 120' ' ' ILE . 40.2 t -66.3 -60.77 2.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.485 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -65.65 -40.99 93.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.586 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 54.3 mttm -65.86 -27.42 68.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.566 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 67' ' ' ALA . . . -69.14 -57.13 5.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 72' ' ' LEU . 24.7 tp -61.52 -39.25 90.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -47.07 -37.47 9.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 33.9 mm -61.66 142.8 94.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 108.958 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.5 Cg_endo -64.6 -5.94 11.19 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.575 2.183 . . . . 0.0 111.731 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.463 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -134.29 166.79 24.03 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.472 ' O ' ' HG2' ' A' ' 7' ' ' GLU . 47.5 Cg_endo -68.65 140.97 48.57 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.547 2.165 . . . . 0.0 111.679 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.628 HG11 ' CE1' ' A' ' 10' ' ' PHE . 21.8 t -126.32 159.31 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.537 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.819 ' HB2' HG22 ' A' ' 9' ' ' VAL . 1.9 mp -113.32 124.52 52.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.834 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 62.4 t -104.9 133.13 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.795 HD12 ' CE1' ' A' ' 11' ' ' TYR . 31.9 mt -119.97 135.71 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.935 . . . . 0.0 109.479 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.666 HG21 HG22 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -130.66 161.79 30.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 109.258 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 53.9 p-10 -90.02 10.86 22.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.945 . . . . 0.0 109.548 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.4 t -112.04 126.02 54.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.52 ' HD1' ' CD2' ' A' ' 134' ' ' HIS . 70.8 t80 -80.64 -40.23 25.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 90' ' ' SER . 96.0 m-85 -61.02 -49.56 76.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.685 HG12 HG21 ' A' ' 64' ' ' VAL . 48.4 t -61.7 -52.12 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.403 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.596 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -52.88 -61.04 2.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.895 . . . . 0.0 109.341 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 81.5 tt0 -57.82 -18.98 25.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.191 -0.943 . . . . 0.0 109.277 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.532 ' HA ' ' CG ' ' A' ' 94' ' ' GLU . 8.4 t -66.73 -65.09 0.72 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.557 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.883 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -69.82 -7.5 40.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.553 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 85.1 m-20 -86.58 -46.33 10.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.678 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 96' ' ' PRO . 62.6 mttp -126.46 -47.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 109.732 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.583 ' HB3' ' CE2' ' A' ' 98' ' ' TRP . 81.7 mt-10 -51.46 -44.22 62.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.694 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.883 HD23 ' HA ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -50.68 -63.45 1.87 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.912 . . . . 0.0 109.54 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.521 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 48.0 Cg_endo -68.69 -42.05 5.24 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.749 2.299 . . . . 0.0 112.035 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.31 -40.05 96.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.583 ' CE2' ' HB3' ' A' ' 94' ' ' GLU . 39.9 m0 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.59 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.2 mttt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.291 0.567 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 64.0 m80 60.23 27.05 16.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.444 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 80.5 mt -62.5 -38.33 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.361 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.9 t -56.27 -45.85 79.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.278 -0.889 . . . . 0.0 109.315 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.44 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 61.8 mttp -60.06 -54.06 50.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.571 ' CE2' HD11 ' A' ' 61' ' ' ILE . 91.9 m95 -65.21 -33.15 75.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 109.387 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -54.01 -45.95 71.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.378 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.9 m -53.29 -44.13 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.306 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.676 HG23 ' SG ' ' A' ' 68' ' ' CYS . 83.7 mt -72.01 -32.79 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.364 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.91 88.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.89 . . . . 0.0 109.358 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.91 -39.01 83.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.875 ' SG ' HD11 ' A' ' 130' ' ' ILE . 23.0 t -68.58 -44.09 75.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.563 HD23 HD12 ' A' ' 130' ' ' ILE . 55.1 mt -68.15 -34.15 75.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.5 t -59.64 -33.75 71.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.427 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.458 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 92.0 mtp -67.91 -33.96 75.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.6 OUTLIER 177.35 136.58 0.22 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.512 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.9 Cg_endo -71.56 2.45 4.55 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.728 2.285 . . . . 0.0 112.078 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 31.6 p-10 -43.71 -39.04 3.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.662 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.875 HD11 ' SG ' ' A' ' 123' ' ' CYS . 52.6 mt -59.3 115.57 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.741 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.0 m -111.6 134.05 53.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.025 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.795 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -116.44 135.9 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.081 -1.012 . . . . 0.0 109.887 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.8 mt-30 -126.0 154.22 43.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.359 -0.838 . . . . 0.0 109.3 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.52 ' CD2' ' HD1' ' A' ' 85' ' ' PHE . 56.2 t60 -108.34 127.0 53.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 179.968 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 54.2 m80 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.332 0.587 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.3 p -69.05 -40.24 78.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.478 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.07 -37.41 64.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -65.13 -34.54 89.98 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -65.73 -38.12 88.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -1.185 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.91 -48.8 67.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.551 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 mt -65.7 -44.32 86.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.92 -37.7 83.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.427 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 57.4 t0 -62.59 -41.24 98.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 69.0 mttm -63.4 -36.02 82.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.501 ' CD1' ' HB ' ' A' ' 33' ' ' VAL . 71.4 mt -69.31 -37.23 77.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.49 -43.94 68.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 31.7 m -60.14 -42.2 94.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.574 ' O ' HG13 ' A' ' 163' ' ' VAL . 95.1 mt-30 -65.23 -33.31 75.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 109.541 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.87 ' O ' HG22 ' A' ' 163' ' ' VAL . . . -61.84 -46.61 93.8 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.493 ' OG ' ' CD1' ' A' ' 17' ' ' ILE . 91.2 p -72.9 -26.19 61.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -68.36 -35.99 78.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 160' ' ' GLY . 18.1 m -70.87 -14.23 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.573 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.422 HG23 HG23 ' A' ' 163' ' ' VAL . 41.0 t . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.508 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 1.032 ' CD2' HD11 ' A' ' 79' ' ' LEU . 43.9 m-85 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.326 0.584 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -76.48 -36.3 57.91 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.256 -0.903 . . . . 0.0 109.19 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.47 -166.46 35.26 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.779 HG13 ' HB3' ' A' ' 35' ' ' ALA . 7.2 p -125.29 140.72 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -1.072 . . . . 0.0 108.996 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.858 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.6 m-85 -117.69 135.89 53.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 109.85 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.84 ' CE1' HD12 ' A' ' 81' ' ' ILE . 95.0 m-85 -114.08 118.72 34.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.994 HG22 HG23 ' A' ' 32' ' ' ILE . 19.0 p -115.79 151.61 34.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 0.0 109.728 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 53.1 t0 -147.51 156.15 42.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.351 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -163.21 117.11 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.463 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 68.7 m -138.85 147.98 43.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -1.163 . . . . 0.0 109.74 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -107.81 140.52 40.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.465 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.796 HD12 ' HB3' ' A' ' 161' ' ' SER . 68.6 mt . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.905 . . . . 0.0 109.524 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 96.0 m-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -93.65 129.2 40.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 108.987 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.643 ' CB ' ' CE1' ' A' ' 54' ' ' HIS . . . -119.46 164.47 15.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -0.99 . . . . 0.0 110.158 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.82 146.77 18.75 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.776 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 61.7 mtm -120.0 145.75 46.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.479 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.81 118.61 1.78 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.994 HG23 HG22 ' A' ' 12' ' ' THR . 4.6 mp -120.86 116.87 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -1.153 . . . . 0.0 109.255 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 45' ' ' ASN . 7.2 p -124.45 144.47 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.101 -1.0 . . . . 0.0 109.731 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.674 ' CG ' ' CE2' ' A' ' 10' ' ' PHE . 1.4 m-70 -101.59 141.72 34.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.852 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.779 ' HB3' HG13 ' A' ' 9' ' ' VAL . . . -129.81 165.81 21.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.44 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 t -126.16 165.25 19.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 38' ' ' LYS . 82.8 m-85 -107.92 10.16 28.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.58 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.18 179.72 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.007 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.2 Cg_endo -65.45 -5.38 11.31 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.183 1.922 . . . . 0.0 111.658 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -129.25 106.02 8.54 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -64.83 129.93 41.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -167.66 154.12 7.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.479 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 43' ' ' VAL . 32.6 m -89.37 120.59 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.887 . . . . 0.0 109.461 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 55.3 mt -57.78 -38.8 76.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.342 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.731 ' O ' HG23 ' A' ' 33' ' ' VAL . 60.9 t30 -169.6 155.43 6.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.918 . . . . 0.0 109.594 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.528 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 91.9 mt-30 -112.59 137.8 50.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.831 . . . . 0.0 109.103 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.52 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -118.01 133.38 55.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.142 -0.974 . . . . 0.0 109.659 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 t -119.85 140.17 51.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 109.31 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.645 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 1.7 mt -145.5 92.32 5.57 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 109.693 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.671 ' HG3' HG11 ' A' ' 163' ' ' VAL . 49.8 Cg_endo -70.39 147.5 58.98 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.682 2.254 . . . . 0.0 111.598 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 50' ' ' PRO . 43.1 mt -123.88 129.44 51.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.698 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.689 ' HA2' HG11 ' A' ' 164' ' ' VAL . . . -92.78 -73.57 1.24 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -102.22 87.98 3.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.165 . . . . 0.0 109.154 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.643 ' CE1' ' CB ' ' A' ' 28' ' ' ALA . 6.7 p-80 -132.29 -163.82 1.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.976 . . . . 0.0 109.949 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.841 HG23 ' HE3' ' A' ' 58' ' ' MET . 0.2 OUTLIER -128.93 144.8 51.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.039 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -44.69 -33.91 2.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.084 -1.01 . . . . 0.0 109.13 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 61' ' ' ILE . 85.5 mt-30 -77.79 -47.78 18.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.841 ' HE3' HG23 ' A' ' 55' ' ' THR . 24.2 ttm -48.79 -35.07 13.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.987 . . . . 0.0 109.23 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' A' ' 54' ' ' HIS . . . -74.18 -45.86 45.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.382 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.91 -34.83 77.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.577 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.669 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 18.7 tt -77.32 -37.28 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.557 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.776 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -65.9 -29.78 70.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.15 92.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.654 HG21 HG12 ' A' ' 87' ' ' VAL . 46.5 t -77.82 -49.97 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.524 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.2 tt0 -53.09 -39.79 63.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.632 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.645 ' CZ ' HD11 ' A' ' 49' ' ' ILE . 13.0 t80 -57.76 -69.11 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 109.57 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.528 ' HB3' HG11 ' A' ' 80' ' ' VAL . . . -62.34 -15.95 51.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 109.462 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 1.057 ' SG ' HG23 ' A' ' 120' ' ' ILE . 39.4 t -66.09 -63.07 1.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -60.99 -44.35 97.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.566 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 48.7 mttm -62.85 -36.52 83.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.856 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -59.28 -64.18 1.04 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.366 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 130' ' ' ILE . 20.0 tp -51.98 -46.73 64.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.922 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 72' ' ' LEU . 19.4 tttm -42.58 -41.1 2.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.0 109.276 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.555 HG23 ' HD2' ' A' ' 75' ' ' PRO . 34.8 mm -52.29 143.44 25.98 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.823 . . . . 0.0 108.802 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.555 ' HD2' HG23 ' A' ' 74' ' ' ILE . 43.1 Cg_endo -65.09 -2.47 5.73 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.632 2.221 . . . . 0.0 112.203 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.484 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -143.13 170.65 25.29 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 47.7 Cg_endo -69.46 119.86 6.77 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.445 2.097 . . . . 0.0 111.693 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.858 HG21 ' CE1' ' A' ' 10' ' ' PHE . 7.7 p -114.01 146.56 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.399 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.032 HD11 ' CD2' ' A' ' 6' ' ' TYR . 15.9 mt -93.05 143.28 26.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.737 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.528 HG11 ' HB3' ' A' ' 67' ' ' ALA . 49.6 t -124.13 126.33 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 109.183 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.84 HD12 ' CE1' ' A' ' 11' ' ' TYR . 33.6 mt -113.49 136.22 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.784 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.557 HG21 ' CG2' ' A' ' 64' ' ' VAL . 10.3 t -142.31 159.27 42.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.351 -0.843 . . . . 0.0 109.276 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.47 ' HB3' ' OE1' ' A' ' 135' ' ' GLU . 51.0 p-10 -92.69 20.22 6.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.152 -0.967 . . . . 0.0 109.466 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.49 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 41.9 m -105.57 104.48 14.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 109.347 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.676 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 74.8 t80 -69.37 -50.19 48.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 109.583 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -60.81 -40.57 93.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.654 HG12 HG21 ' A' ' 64' ' ' VAL . 92.5 t -62.84 -39.57 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.378 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.61 -60.66 3.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.567 ' OE2' ' CE2' ' A' ' 85' ' ' PHE . 94.0 mt-10 -50.93 -35.35 32.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.618 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 70.6 m -55.91 -47.24 77.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.612 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -88.6 -0.92 57.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.907 . . . . 0.0 109.805 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 84.2 m-20 -90.61 -73.61 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.122 -0.986 . . . . 0.0 109.953 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 96' ' ' PRO . 96.8 mttt -127.13 -31.66 2.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 109.842 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 57.0 mt-10 -52.18 -40.49 61.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.911 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.064 HD21 ' HB2' ' A' ' 121' ' ' ALA . 6.4 tp -62.93 -58.3 17.16 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.063 -1.023 . . . . 0.0 109.537 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -65.89 -26.02 52.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.521 2.147 . . . . 0.0 111.261 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -75.56 -35.74 60.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.345 -0.847 . . . . 0.0 108.72 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.9 m0 . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.291 -0.881 . . . . 0.0 108.979 179.407 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 20.6 mttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.277 0.561 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.568 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 48.1 m80 66.29 30.4 9.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.341 -0.849 . . . . 0.0 109.679 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.56 -50.35 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.133 -0.98 . . . . 0.0 109.308 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m -60.08 -44.18 94.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.233 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -59.19 -50.17 75.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.308 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.669 ' CZ2' HD12 ' A' ' 61' ' ' ILE . 53.0 m95 -69.27 -35.77 76.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.907 . . . . 0.0 109.325 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -56.88 -45.93 82.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.341 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.9 m -55.43 -45.36 76.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.375 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 1.057 HG23 ' SG ' ' A' ' 68' ' ' CYS . 69.0 mt -66.82 -36.62 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.409 -0.807 . . . . 0.0 109.411 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 1.064 ' HB2' HD21 ' A' ' 95' ' ' LEU . . . -57.42 -43.4 83.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.461 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.21 -45.84 75.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.506 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 93.4 m -66.52 -46.56 75.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.23 -32.51 73.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.365 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.4 m -61.65 -35.17 77.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.55 ' SD ' HD21 ' A' ' 72' ' ' LEU . 66.1 mtt -64.6 -34.38 78.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.423 ' HG2' ' C ' ' A' ' 126' ' ' MET . 0.2 OUTLIER 174.57 145.39 0.21 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.242 -0.911 . . . . 0.0 109.559 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.6 Cg_endo -72.17 2.33 5.07 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.698 2.265 . . . . 0.0 111.763 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 128' ' ' PRO . 76.9 m-20 -42.39 -46.79 4.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.559 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 72' ' ' LEU . 60.5 mt -56.6 122.14 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.527 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.658 ' CB ' HD22 ' A' ' 79' ' ' LEU . 24.6 m -112.2 141.55 45.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.154 -0.966 . . . . 0.0 109.337 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.612 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 70.8 mt -125.25 134.61 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.935 . . . . 0.0 109.669 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.444 ' HB2' HG12 ' A' ' 81' ' ' ILE . 91.4 mt-30 -124.94 157.89 34.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.676 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 83.6 t60 -113.48 127.75 56.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.499 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.489 ' O ' ' CD2' ' A' ' 134' ' ' HIS . 95.3 mt-10 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 65.8 m170 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.7 m -61.24 -47.01 88.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 109.52 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.15 -46.23 53.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -61.66 -36.82 93.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 154' ' ' ASP . 82.1 m-20 -63.55 -37.25 86.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -1.191 . . . . 0.0 109.418 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.89 -51.6 66.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.426 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 57.1 mt -66.32 -43.64 85.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.59 87.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.542 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.46 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 94.8 m-20 -66.35 -41.25 89.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.88 . . . . 0.0 109.534 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -59.45 -39.79 84.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.54 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 46' ' ' GLN . 70.8 mt -65.57 -37.43 86.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.91 93.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.926 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.707 HG22 ' HE2' ' A' ' 162' ' ' TYR . 50.6 m -61.76 -41.66 97.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.943 . . . . 0.0 109.667 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.538 ' O ' HG23 ' A' ' 163' ' ' VAL . 62.1 tt0 -63.34 -34.34 77.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.603 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.24 -42.37 88.21 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.796 ' HB3' HD12 ' A' ' 17' ' ' ILE . 17.3 m -61.47 -37.21 82.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -1.161 . . . . 0.0 109.581 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.707 ' HE2' HG22 ' A' ' 158' ' ' THR . 89.6 m-85 -69.53 -21.09 63.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 0.0 109.509 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.671 HG11 ' HG3' ' A' ' 50' ' ' PRO . 39.3 t -66.0 -29.6 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.689 HG11 ' HA2' ' A' ' 52' ' ' GLY . 47.5 t . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.507 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 1.053 ' CD2' HD11 ' A' ' 79' ' ' LEU . 98.2 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.515 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 74.5 mm-40 -68.45 -37.01 79.82 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.079 -1.013 . . . . 0.0 109.04 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.35 -177.06 47.5 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 79' ' ' LEU . 95.1 t -133.29 132.23 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.346 -1.09 . . . . 0.0 108.943 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.664 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.9 m-85 -113.23 140.1 48.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 110.058 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 1.071 ' CE2' HD12 ' A' ' 81' ' ' ILE . 70.9 m-85 -112.15 133.71 54.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.364 -0.835 . . . . 0.0 109.095 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 1.047 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 7.1 p -121.05 152.51 38.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.645 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -152.86 152.6 31.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.347 -0.846 . . . . 0.0 109.388 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.17 128.67 5.68 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.553 ' OG ' ' HB3' ' A' ' 157' ' ' ALA . 50.6 m -122.17 148.88 44.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -1.146 . . . . 0.0 109.307 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 27' ' ' ASN . . . -133.82 145.03 49.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 78.3 mt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.325 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 96.7 m-20 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 95.1 m-20 -96.12 129.12 43.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.406 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -112.2 156.35 22.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.736 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.25 160.48 26.82 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . 1.0 ' SD ' HD21 ' A' ' 51' ' ' LEU . 76.2 mtp -121.15 150.89 40.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -1.189 . . . . 0.0 109.678 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.53 117.76 0.84 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 32' ' ' ILE . 5.4 mp -121.73 139.89 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 109.638 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.448 ' CG1' HG13 ' A' ' 43' ' ' VAL . 21.3 t -114.73 139.64 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.323 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 2.6 m-70 -107.24 139.95 40.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.615 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.59 166.51 24.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.596 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.592 ' HB ' HD11 ' A' ' 44' ' ' LEU . 15.4 t -139.9 164.45 29.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.654 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.513 ' OH ' HG21 ' A' ' 9' ' ' VAL . 58.6 m-85 -97.69 14.17 27.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.645 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.574 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 2.2 mttt -50.88 178.57 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 108.776 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.574 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.5 Cg_endo -65.33 -6.46 13.4 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.179 1.92 . . . . 0.0 111.534 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.446 ' HG3' ' HG3' ' A' ' 42' ' ' GLN . 38.9 tp10 -137.75 106.43 5.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -0.846 . . . . 0.0 109.086 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -63.3 118.09 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.908 . . . . 0.0 109.297 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.446 ' HG3' ' HG3' ' A' ' 40' ' ' GLU . 93.5 mt-30 -151.9 145.61 25.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.582 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.448 HG13 ' CG1' ' A' ' 33' ' ' VAL . 24.5 t -63.56 117.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.3 -0.875 . . . . 0.0 109.512 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.592 HD11 ' HB ' ' A' ' 36' ' ' THR . 43.0 mt -63.51 -37.55 87.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -177.59 158.99 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.418 ' OE1' HD21 ' A' ' 152' ' ' LEU . 23.6 mt-30 -106.94 138.81 42.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.329 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -126.45 131.4 51.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.776 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.4 m -129.92 136.45 49.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.244 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.578 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 3.8 mt -134.95 112.12 11.28 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.53 138.06 34.57 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.744 2.296 . . . . 0.0 111.623 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.0 HD21 ' SD ' ' A' ' 30' ' ' MET . 61.6 mt -111.18 139.58 46.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.51 ' O ' ' ND1' ' A' ' 54' ' ' HIS . . . -115.17 132.03 10.11 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 72.3 m-20 62.94 38.02 11.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.151 . . . . 0.0 109.502 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 52' ' ' GLY . 74.3 m80 -124.61 159.56 30.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.58 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.1 OUTLIER -101.87 168.47 9.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 0.0 109.171 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.86 -33.57 66.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -0.981 . . . . 0.0 108.975 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.2 -50.89 24.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.319 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.58 ' SD ' HG23 ' A' ' 55' ' ' THR . 99.2 mtp -55.15 -28.84 55.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . . . -74.18 -40.42 62.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.493 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.17 -42.83 95.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.612 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.815 ' HA ' HG21 ' A' ' 87' ' ' VAL . 14.9 tt -69.62 -32.11 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.73 -27.7 67.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.327 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.047 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -71.27 -38.07 71.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.483 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.746 HG22 HG21 ' A' ' 82' ' ' THR . 89.8 t -69.44 -40.52 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.587 ' HG2' HD11 ' A' ' 120' ' ' ILE . 99.2 mt-10 -64.74 -41.95 95.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.016 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.596 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 27.8 t80 -59.73 -65.25 0.71 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.485 -0.759 . . . . 0.0 109.711 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.21 68.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 109.725 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.689 ' SG ' HG23 ' A' ' 120' ' ' ILE . 50.4 t -60.7 -53.49 56.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 109.485 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -59.12 -50.86 72.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.664 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.596 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 62.9 mttm -61.15 -36.31 79.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.862 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.882 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -57.0 -69.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.718 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.846 ' HB2' HD11 ' A' ' 130' ' ' ILE . 22.1 tp -46.83 -46.32 20.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.591 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 72' ' ' LEU . 14.4 tptt -44.19 -45.13 8.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.206 -0.934 . . . . 0.0 109.269 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.671 HD12 ' HB ' ' A' ' 78' ' ' VAL . 7.3 mt -48.36 142.87 7.79 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.023 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.8 Cg_endo -65.57 -4.77 10.25 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.573 2.182 . . . . 0.0 111.749 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.515 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -140.62 168.57 25.18 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.1 Cg_endo -68.4 122.11 9.11 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.411 2.074 . . . . 0.0 111.77 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.882 HG11 ' HA ' ' A' ' 71' ' ' ALA . 4.6 p -113.71 155.25 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.419 -0.801 . . . . 0.0 109.262 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.053 HD11 ' CD2' ' A' ' 6' ' ' TYR . 22.6 mt -99.8 149.04 23.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 109.833 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 76.0 t -130.35 135.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.38 -0.825 . . . . 0.0 109.066 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.071 HD12 ' CE2' ' A' ' 11' ' ' TYR . 20.4 mt -119.87 139.47 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.953 . . . . 0.0 109.649 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.746 HG21 HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -128.29 161.85 28.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.364 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 58.3 p30 -92.48 13.39 19.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.442 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 42.6 m -132.82 125.47 30.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.601 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 67.5 t80 -77.59 -42.02 36.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -49.9 -57.25 7.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.381 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.815 HG21 ' HA ' ' A' ' 61' ' ' ILE . 14.9 p -61.05 -46.61 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.291 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.615 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -55.52 -55.5 31.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.902 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 79.6 tt0 -54.75 -31.56 58.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.944 . . . . 0.0 109.184 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.604 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 18.0 t -56.68 -56.27 23.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -80.32 -0.83 38.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.729 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 89.8 m-20 -84.54 -73.35 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.094 -1.004 . . . . 0.0 110.038 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 74.5 mttt -127.34 -27.84 2.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.132 -0.98 . . . . 0.0 110.269 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 68.1 mm-40 -61.04 -30.87 70.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.095 -1.003 . . . . 0.0 109.89 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -61.41 -58.53 18.07 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.718 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 43.9 Cg_endo -66.02 -25.47 51.64 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.552 2.168 . . . . 0.0 111.694 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -71.46 -38.17 71.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.173 -0.954 . . . . 0.0 109.044 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 39.1 m0 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.257 179.704 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 18.9 mttp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.267 0.556 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.569 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 36.7 m80 67.48 31.07 6.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 78.5 mt -68.74 -39.0 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.366 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.6 m -62.07 -44.61 96.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.362 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.454 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 54.3 mttp -61.45 -41.36 97.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.624 ' HH2' HG23 ' A' ' 87' ' ' VAL . 40.2 m95 -76.75 -30.69 56.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.37 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -59.27 -39.25 82.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.8 m -62.54 -44.86 95.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.689 HG23 ' SG ' ' A' ' 68' ' ' CYS . 78.0 mt -72.58 -30.25 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.442 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.505 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -61.72 -41.62 97.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.416 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -59.04 -40.23 84.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 109.387 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 46.3 m -68.15 -47.11 68.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.2 tp -63.32 -32.4 73.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.34 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 m -61.59 -31.8 71.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.568 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.478 ' HB3' ' HE3' ' A' ' 127' ' ' LYS . 93.6 mmm -67.54 -34.17 76.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 126' ' ' MET . 0.0 OUTLIER 170.67 147.6 0.14 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.0 Cg_endo -71.63 -0.04 7.69 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.73 2.286 . . . . 0.0 111.633 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 128' ' ' PRO . 93.4 m-20 -42.49 -47.24 5.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.428 -0.795 . . . . 0.0 109.632 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.846 HD11 ' HB2' ' A' ' 72' ' ' LEU . 56.8 mt -58.89 119.14 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.618 ' HB ' HD22 ' A' ' 79' ' ' LEU . 24.8 m -112.42 140.44 47.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.689 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 58.8 mt -122.54 137.46 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 109.696 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.429 ' HB2' HG12 ' A' ' 81' ' ' ILE . 84.6 mt-30 -122.73 163.07 20.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.218 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.601 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 46.4 t60 -118.58 131.39 56.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 109.62 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.795 ' CD ' HG21 ' A' ' 81' ' ' ILE . 96.5 mt-10 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.403 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.516 ' CE1' HD11 ' A' ' 81' ' ' ILE . 13.1 m170 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.232 0.539 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 45.0 m -67.34 -45.27 76.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.0 109.679 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.99 -36.46 70.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.48 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -70.41 -28.51 71.14 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -69.38 -36.0 76.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 109.592 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -72.89 -52.8 13.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 25.0 tp -61.64 -37.71 85.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.172 -0.955 . . . . 0.0 109.626 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.76 82.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.664 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -67.68 -36.37 80.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.67 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.417 ' HE2' ' NE2' ' A' ' 159' ' ' GLN . 78.4 tttt -70.99 -36.11 72.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.775 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 66.4 mt -68.23 -34.77 76.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 109.658 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.553 ' HB3' ' OG ' ' A' ' 15' ' ' SER . . . -70.15 -39.73 75.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 44.7 m -66.06 -38.76 89.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.49 ' O ' HG23 ' A' ' 163' ' ' VAL . 94.6 mt-30 -66.35 -34.0 76.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 0.0 109.558 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.22 91.57 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.7 m -63.87 -37.42 87.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -62.85 -40.76 98.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.602 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 159' ' ' GLN . 95.4 t -53.79 -39.61 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.537 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 66.7 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.937 . . . . 0.0 109.546 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.82 69.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -1.166 . . . . 0.0 109.476 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.528 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 90.4 mtp -64.49 -33.62 76.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.27 -164.33 38.28 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -125.0 119.47 28.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.46 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.125 ' CD2' HD11 ' A' ' 79' ' ' LEU . 55.7 m-85 -116.24 158.22 23.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.467 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.472 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 78.2 mm-40 -55.51 -36.85 67.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.253 -0.904 . . . . 0.0 109.138 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.471 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.81 -167.71 36.88 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.481 HG11 ' CZ ' ' A' ' 11' ' ' TYR . 85.5 t -132.95 144.47 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.133 . . . . 0.0 109.154 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 34' ' ' HIS . 6.8 m-85 -118.21 121.38 40.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 109.925 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.799 ' CE1' HD12 ' A' ' 81' ' ' ILE . 52.7 m-85 -107.81 126.73 52.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 108.85 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 1.037 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 3.7 p -115.06 150.31 36.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 110.071 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.537 ' HB2' ' HB1' ' A' ' 153' ' ' ALA . 59.7 t0 -142.22 154.52 44.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.473 -0.767 . . . . 0.0 109.086 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -138.11 138.34 9.49 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.9 p -143.09 160.94 39.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -1.127 . . . . 0.0 109.437 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -146.26 150.44 35.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.668 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.763 HD12 ' HB2' ' A' ' 161' ' ' SER . 62.1 mt -126.54 137.98 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -108.08 139.26 42.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.499 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 1.0 OUTLIER -124.27 165.03 26.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.542 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.5 -30.85 18.22 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.706 2.271 . . . . 0.0 111.826 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.55 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -74.02 -64.14 0.78 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 49.6 Cg_endo -70.15 66.7 2.0 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.7 2.266 . . . . 0.0 111.817 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.5 m -56.03 -50.4 71.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.61 32.44 1.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 69.9 m -151.37 142.83 23.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.553 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 25' ' ' SER . 62.3 m-20 -136.82 152.34 50.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -99.86 122.02 42.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.338 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -129.58 154.85 46.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.67 163.69 26.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.768 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 42.2 mtm -122.61 140.84 52.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -1.143 . . . . 0.0 109.531 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -126.19 123.75 4.91 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.601 HD12 HG22 ' A' ' 12' ' ' THR . 26.3 mm -112.97 138.31 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -1.174 . . . . 0.0 109.516 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 11' ' ' TYR . 41.0 t -122.59 135.47 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 109.378 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.688 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 72.5 m-70 -108.02 135.98 48.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 109.547 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.466 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -129.2 170.84 13.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.411 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.986 ' HB ' HD11 ' A' ' 44' ' ' LEU . 14.2 t -133.99 165.01 26.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.541 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.658 ' OH ' HD12 ' A' ' 79' ' ' LEU . 49.6 m-85 -104.43 11.47 34.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.529 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.58 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 1.7 mtmt -51.46 179.46 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.034 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.4 Cg_endo -66.39 -5.15 12.04 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.183 1.922 . . . . 0.0 111.568 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 40' ' ' GLU . 71.0 mm-40 -135.49 106.21 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 0.0 109.128 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.76 123.75 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 109.468 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -158.11 148.55 20.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.602 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.6 p -77.87 122.27 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.986 HD11 ' HB ' ' A' ' 36' ' ' THR . 6.3 mp -65.01 -39.95 94.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.135 -0.978 . . . . 0.0 109.351 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -173.15 162.47 4.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.364 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.654 ' HB3' HD11 ' A' ' 156' ' ' LEU . 89.7 mt-30 -112.83 154.72 25.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.393 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.489 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -135.26 132.55 37.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 t -122.94 128.1 49.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 109.396 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.468 HD11 ' CE2' ' A' ' 66' ' ' PHE . 2.9 mp -129.43 91.55 40.99 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.543 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HG3' HG11 ' A' ' 163' ' ' VAL . 50.2 Cg_endo -70.64 133.18 23.41 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.698 2.266 . . . . 0.0 111.747 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.508 ' HB3' ' CD2' ' A' ' 54' ' ' HIS . 31.1 mt -99.73 147.14 25.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.65 -62.18 0.8 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -108.41 57.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -1.157 . . . . 0.0 109.531 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.508 ' CD2' ' HB3' ' A' ' 51' ' ' LEU . 77.7 m-70 -129.47 177.99 6.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.614 HG23 ' H ' ' A' ' 58' ' ' MET . 13.2 t -124.17 169.08 12.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 109.455 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.466 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -57.38 -41.09 79.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.417 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -61.61 -40.61 95.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.614 ' H ' HG23 ' A' ' 55' ' ' THR . 97.0 mtp -70.83 -32.43 69.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.883 . . . . 0.0 109.507 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.64 -33.44 74.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.522 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.85 -47.97 56.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.73 ' HA ' HG21 ' A' ' 87' ' ' VAL . 13.7 tt -69.42 -38.01 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 109.549 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.768 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -65.8 -31.75 72.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.471 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.037 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -65.98 -38.63 89.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.892 . . . . 0.0 109.554 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.74 HG22 HG21 ' A' ' 82' ' ' THR . 61.6 t -69.57 -38.11 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.667 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.432 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 71.8 tt0 -69.77 -38.04 76.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 109.123 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.584 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 26.3 t80 -55.75 -66.57 0.4 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.344 -0.847 . . . . 0.0 109.527 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 71' ' ' ALA . . . -59.94 -31.86 70.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.535 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' A' ' 120' ' ' ILE . 41.3 t -50.65 -56.86 9.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.509 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -64.86 -42.93 94.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.482 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.584 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 63.1 mttm -64.55 -31.5 72.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.468 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 67' ' ' ALA . . . -66.24 -65.44 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.666 ' HB2' HD11 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -54.98 -38.71 68.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.307 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 72' ' ' LEU . 25.6 tttt -44.44 -47.25 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.044 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.058 HD12 HG21 ' A' ' 78' ' ' VAL . 8.7 mt -52.29 143.06 27.28 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 108.842 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.1 Cg_endo -65.48 -5.96 12.59 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.459 2.106 . . . . 0.0 111.631 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.472 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -129.26 170.1 20.38 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.444 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 49.8 Cg_endo -69.97 140.0 40.84 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.587 2.192 . . . . 0.0 111.801 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.058 HG21 HD12 ' A' ' 74' ' ' ILE . 39.5 t -127.59 162.6 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.125 HD11 ' CD2' ' A' ' 6' ' ' TYR . 7.2 mt -110.96 130.78 55.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 10' ' ' PHE . 72.0 t -114.05 126.42 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.895 . . . . 0.0 109.527 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.799 HD12 ' CE1' ' A' ' 11' ' ' TYR . 13.8 mt -115.36 142.3 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.299 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.74 HG21 HG22 ' A' ' 64' ' ' VAL . 1.1 p -130.47 161.27 31.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 135' ' ' GLU . 55.0 p-10 -87.51 5.16 40.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.517 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.542 ' CB ' HG12 ' A' ' 87' ' ' VAL . 2.1 m -123.3 123.99 41.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 109.552 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.7 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 66.6 t80 -72.69 -41.62 65.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.349 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.447 ' O ' ' HB2' ' A' ' 90' ' ' SER . 67.7 t80 -54.01 -58.8 5.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 61' ' ' ILE . 12.7 p -58.31 -46.81 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.365 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.596 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -56.95 -63.6 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.205 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -57.24 -17.86 13.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.101 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.545 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 8.4 t -66.4 -65.53 0.67 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.299 -0.875 . . . . 0.0 109.258 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.766 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -66.47 -10.56 45.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.489 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -88.32 -42.03 12.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.775 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 96' ' ' PRO . 8.3 ttpp -126.42 -49.24 1.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.167 -0.958 . . . . 0.0 109.775 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.572 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 73.2 mm-40 -53.53 -41.02 65.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.672 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.766 HD23 ' HA ' ' A' ' 91' ' ' ALA . 0.4 OUTLIER -50.69 -63.98 1.57 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 49.8 Cg_endo -70.17 -36.6 9.44 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.708 2.272 . . . . 0.0 111.921 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -67.44 -42.41 83.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.572 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 18.9 m0 -63.91 -42.25 97.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.519 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -54.31 -42.05 69.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 m -58.59 -37.08 75.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.894 . . . . 0.0 109.496 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -91.83 16.66 10.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.454 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 72.52 41.5 51.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 111' ' ' LEU . 8.6 m-85 66.63 33.88 6.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -1.154 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.32 133.16 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.506 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -75.28 -70.72 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 109' ' ' LYS . 81.1 m-20 -129.39 154.66 46.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -62.92 -26.0 68.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.444 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -67.74 -38.28 83.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.354 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 106' ' ' ASN . 19.1 mttt -139.83 140.49 24.65 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.853 . . . . 0.0 109.45 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.26 169.72 18.88 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.687 2.258 . . . . 0.0 111.744 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.468 ' CB ' ' O ' ' A' ' 103' ' ' PHE . 36.4 tp -75.19 132.98 41.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -96.76 150.44 20.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.405 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.529 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 62.8 m80 60.88 37.68 18.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 111' ' ' LEU . 84.1 mt -63.42 -38.1 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.463 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 m -57.9 -45.47 86.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.464 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.42 -44.3 95.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.466 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.695 ' CZ2' HD11 ' A' ' 61' ' ' ILE . 69.8 m95 -69.4 -34.0 73.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.338 -0.852 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -58.01 -44.42 87.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.414 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.432 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 44.3 m -62.75 -43.42 98.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.362 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.461 HG23 ' SG ' ' A' ' 68' ' ' CYS . 71.9 mt -68.9 -34.21 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.421 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -61.87 -33.9 75.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -0.906 . . . . 0.0 109.42 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -64.76 -33.3 75.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.369 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.692 ' SG ' HD11 ' A' ' 130' ' ' ILE . 49.2 t -80.83 -52.12 7.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.883 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 128' ' ' PRO . 19.5 tp -62.54 -27.01 68.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.432 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.6 m -68.83 -26.61 65.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.483 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.1 mtt -71.25 -32.43 68.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 109.459 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.39 132.86 0.21 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 0.0 109.479 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.489 ' HA ' HD11 ' A' ' 124' ' ' LEU . 48.6 Cg_endo -69.78 -2.23 9.83 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.701 2.267 . . . . 0.0 111.719 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 96.8 m-20 -45.95 -26.88 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.439 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.692 HD11 ' SG ' ' A' ' 123' ' ' CYS . 64.9 mt -68.13 110.6 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.1 m -94.03 141.17 28.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.704 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 67.2 mt -118.84 137.33 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 109.521 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.471 ' HB2' HG23 ' A' ' 81' ' ' ILE . 86.2 mt-30 -134.84 157.38 46.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.7 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 38.9 t60 -112.81 126.46 55.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 82' ' ' THR . 96.3 mt-10 -62.33 151.91 35.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.443 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -96.15 38.16 1.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 92.51 -148.08 18.95 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 139' ' ' GLN . 84.3 t60 -114.48 127.39 55.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -1.139 . . . . 0.0 109.492 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 138' ' ' HIS . 32.8 tt0 44.36 64.52 7.15 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.384 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.58 -30.44 18.47 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.755 2.303 . . . . 0.0 111.911 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.1 p -129.81 164.96 22.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.604 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -49.44 -35.99 21.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.433 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.1 m -138.89 136.33 35.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.395 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 47.7 t -154.65 132.81 11.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 97.5 mt -77.49 -33.96 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.506 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -70.07 -33.51 72.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.0 m -55.38 -45.01 76.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.525 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -48.76 -49.83 36.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -60.04 -36.63 90.97 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -60.74 -38.07 83.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -1.151 . . . . 0.0 109.571 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.99 -46.69 77.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.564 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 74.8 mt -64.88 -38.92 92.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 13' ' ' ASP . . . -69.63 -35.74 75.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.512 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -60.7 -42.97 98.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.517 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 41.7 mttt -65.92 -40.61 91.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.654 HD11 ' HB3' ' A' ' 46' ' ' GLN . 77.2 mt -64.16 -41.47 97.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.541 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.67 96.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 109.584 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.791 HG22 ' HE2' ' A' ' 162' ' ' TYR . 29.0 m -65.53 -37.45 86.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.522 ' O ' HG23 ' A' ' 163' ' ' VAL . 93.2 mt-30 -65.56 -31.91 73.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.518 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.58 -33.57 87.61 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.763 ' HB2' HD12 ' A' ' 17' ' ' ILE . 86.0 p -68.07 -34.36 76.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -1.135 . . . . 0.0 109.508 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.791 ' HE2' HG22 ' A' ' 158' ' ' THR . 90.0 m-85 -72.08 -22.1 61.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 159' ' ' GLN . 48.9 t -70.03 -25.92 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.482 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.455 ' O ' ' OD1' ' A' ' 165' ' ' ASN . 46.9 t -129.22 157.13 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 0.0 109.471 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 164' ' ' VAL . 82.0 m-20 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.454 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.36 -31.93 69.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.218 -1.166 . . . . 0.0 109.431 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.717 ' HE1' ' CZ ' ' A' ' 37' ' ' TYR . 81.6 mtp -62.77 -38.87 92.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 0.0 109.387 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.26 -21.14 11.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -50.77 -36.61 37.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -1.093 . . . . 0.0 109.44 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.011 ' CD2' HD11 ' A' ' 79' ' ' LEU . 27.4 m-85 -90.74 166.84 12.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.521 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 76.2 mm-40 -71.6 -36.7 70.9 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.38 -0.825 . . . . 0.0 108.941 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.33 -166.36 35.01 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.75 HG21 ' OH ' ' A' ' 37' ' ' TYR . 85.5 t -140.61 140.68 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -1.111 . . . . 0.0 109.097 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.679 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 24.7 m-85 -117.89 150.78 38.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.995 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.595 ' CE1' HG13 ' A' ' 81' ' ' ILE . 78.3 m-85 -121.87 130.39 53.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 109.093 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.899 HG22 HD12 ' A' ' 32' ' ' ILE . 17.2 p -115.66 151.6 34.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.764 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 57.9 t0 -140.62 152.46 45.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 109.347 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -138.43 128.36 4.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 m -133.23 148.62 52.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -1.155 . . . . 0.0 109.349 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.578 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -136.58 146.88 46.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.618 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.786 HD12 ' HB2' ' A' ' 161' ' ' SER . 65.1 mt -123.51 140.04 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -105.67 137.32 43.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.509 ' HB3' ' CG ' ' A' ' 22' ' ' PRO . 5.3 t -119.34 154.35 53.95 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.381 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 48.2 Cg_endo -68.5 -24.69 35.94 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.576 2.184 . . . . 0.0 111.941 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.533 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -72.51 -63.3 1.2 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.274 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 50.5 Cg_endo -71.1 79.88 1.32 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.725 2.284 . . . . 0.0 111.757 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -57.17 -48.19 79.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.258 -0.901 . . . . 0.0 109.515 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -103.14 33.28 3.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 27.4 m -149.91 152.75 35.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.951 . . . . 0.0 109.615 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -149.59 169.93 19.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.851 . . . . 0.0 109.426 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 68.7 m-20 -104.67 144.08 32.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.428 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -142.97 147.94 36.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.96 157.86 26.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.725 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 63.2 mtm -128.23 147.99 50.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 0.0 109.584 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.7 122.39 2.35 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.899 HD12 HG22 ' A' ' 12' ' ' THR . 22.7 mm -110.2 133.68 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -1.186 . . . . 0.0 109.62 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 153' ' ' ALA . 44.6 t -124.33 132.1 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.381 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 1.03 ' CD2' HD12 ' A' ' 44' ' ' LEU . 9.0 t60 -108.21 142.18 38.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.693 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.23 158.99 38.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.514 ' HB ' HD21 ' A' ' 44' ' ' LEU . 11.9 t -122.4 162.64 21.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.75 ' OH ' HG21 ' A' ' 9' ' ' VAL . 27.1 m-85 -106.8 5.01 28.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 1.8 mtpt -51.39 178.79 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 108.959 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.0 Cg_endo -65.91 -5.04 11.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.171 1.914 . . . . 0.0 111.615 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -127.78 106.2 8.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.863 . . . . 0.0 108.946 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.457 ' CE1' ' CG2' ' A' ' 145' ' ' ILE . 61.6 t80 -73.96 123.76 24.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.913 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -168.21 133.85 1.86 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.379 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -52.39 118.76 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.03 HD12 ' CD2' ' A' ' 34' ' ' HIS . 46.9 mt -64.13 -45.27 89.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 79.0 m-20 -160.17 154.43 23.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.401 ' HB3' HD11 ' A' ' 156' ' ' LEU . 94.0 mt-30 -118.13 144.03 46.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.2 -0.937 . . . . 0.0 109.305 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -129.52 142.02 50.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.0 t -132.83 128.0 35.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.349 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 2.8 mp -125.91 89.29 52.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.64 ' HG3' HG11 ' A' ' 163' ' ' VAL . 48.2 Cg_endo -69.25 129.05 17.43 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.692 2.261 . . . . 0.0 111.83 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 37.0 mt -103.16 147.97 26.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.479 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -120.81 -35.7 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.488 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 41.0 p-10 -119.68 44.16 2.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -1.135 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.524 ' HA ' ' CE ' ' A' ' 58' ' ' MET . 76.1 m80 -129.11 -175.89 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.429 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 58' ' ' MET . 10.0 t -126.5 170.31 12.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.93 . . . . 0.0 109.479 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.578 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -56.59 -39.08 72.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.385 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 60' ' ' GLU . 77.4 mt-30 -64.08 -67.15 0.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.515 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.524 ' CE ' ' HA ' ' A' ' 54' ' ' HIS . 44.2 mtm -44.94 -28.05 0.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 0.0 109.21 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.39 -37.13 63.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.609 ' HB3' HG21 ' A' ' 87' ' ' VAL . 98.9 mt-10 -66.92 -41.93 86.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.654 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 20.7 tt -70.5 -38.53 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 109.196 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.725 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -64.49 -39.31 93.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.338 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -52.32 -46.82 66.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.461 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.728 HG21 HG12 ' A' ' 87' ' ' VAL . 87.4 t -70.76 -49.24 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.339 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HG3' HG12 ' A' ' 120' ' ' ILE . 87.4 tt0 -53.62 -43.4 68.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.273 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.594 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 10.9 t80 -55.84 -65.34 0.61 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.293 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -61.33 -15.91 40.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.497 ' SG ' HG23 ' A' ' 120' ' ' ILE . 48.5 t -68.62 -61.14 1.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.298 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.402 ' HB3' ' HE3' ' A' ' 69' ' ' LYS . 20.7 ttpp -57.67 -48.67 78.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.944 . . . . 0.0 109.354 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.594 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 67.9 mttm -60.65 -42.12 96.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.389 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.896 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -54.16 -72.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.409 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.819 ' HB2' HD11 ' A' ' 130' ' ' ILE . 10.0 tt -48.91 -42.56 37.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.949 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 72' ' ' LEU . 80.7 tttt -44.13 -41.93 5.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.94 . . . . 0.0 109.149 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.565 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 32.0 mt -54.03 143.88 40.68 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.4 -0.812 . . . . 0.0 108.875 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.565 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.5 Cg_endo -65.4 -2.18 5.68 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.58 2.186 . . . . 0.0 112.26 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.521 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -139.44 169.22 24.64 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.451 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 49.2 Cg_endo -69.8 117.06 4.86 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.57 2.18 . . . . 0.0 111.877 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.896 HG11 ' HA ' ' A' ' 71' ' ' ALA . 5.8 p -110.31 153.6 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.239 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.011 HD11 ' CD2' ' A' ' 6' ' ' TYR . 15.1 mt -96.79 153.07 18.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.588 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 131' ' ' THR . 45.0 t -125.74 128.62 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.639 HG21 ' CD ' ' A' ' 135' ' ' GLU . 22.5 mm -107.99 139.49 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.2 -0.937 . . . . 0.0 109.431 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.504 ' CG2' HG22 ' A' ' 64' ' ' VAL . 1.9 p -131.07 161.59 31.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.494 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 86.4 m-20 -96.17 2.75 53.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.903 . . . . 0.0 109.531 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.9 m -126.06 130.34 50.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -0.977 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.59 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 64.9 t80 -74.78 -39.79 61.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.411 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.74 -52.5 63.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.651 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.728 HG12 HG21 ' A' ' 64' ' ' VAL . 50.6 t -61.14 -54.23 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 109.508 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.521 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -50.77 -55.85 14.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.159 -0.963 . . . . 0.0 109.397 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 82.3 tt0 -56.56 -35.59 68.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.615 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 49.0 m -52.58 -51.37 60.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 109.506 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.707 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -88.18 -1.19 57.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.693 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 45.6 t-20 -84.18 -72.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -0.994 . . . . 0.0 109.506 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 21.0 tptp -126.57 -26.6 3.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 109.785 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 46.6 mm-40 -65.17 -29.89 70.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.677 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -53.69 -59.09 10.45 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 109.668 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 47.0 Cg_endo -67.7 -32.99 29.1 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.679 2.253 . . . . 0.0 111.657 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -67.49 -39.97 85.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.221 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.5 m0 -63.36 -49.82 72.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 109.269 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -52.08 -38.75 58.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 0.0 109.434 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.5 m -59.65 -41.61 90.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.219 -0.926 . . . . 0.0 109.38 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.593 ' O ' HG23 ' A' ' 104' ' ' VAL . 78.5 m-20 -83.82 10.03 10.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.525 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 71.56 40.15 59.79 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.517 ' CE1' ' HE2' ' A' ' 118' ' ' LYS . 38.6 m-85 65.46 34.35 8.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -1.16 . . . . 0.0 109.35 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 101' ' ' ASN . 42.4 t -107.59 134.76 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.463 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' ' 109' ' ' LYS . 59.4 t30 -84.62 129.26 34.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -54.01 -31.88 52.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.456 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -73.05 160.88 31.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -57.2 -34.45 68.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 8.4 mttt -69.59 140.45 89.61 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.87 163.3 38.88 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.746 2.298 . . . . 0.0 111.791 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.882 HD23 HG12 ' A' ' 114' ' ' ILE . 2.4 tp -81.07 128.72 34.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.475 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 68.7 mttm -99.72 154.31 18.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.502 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.457 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 46.7 m80 64.62 33.21 10.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.882 HG12 HD23 ' A' ' 111' ' ' LEU . 82.5 mt -60.94 -46.47 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -59.52 -46.37 89.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 109.409 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.433 ' HE2' ' SD ' ' A' ' 58' ' ' MET . 45.5 mttp -55.73 -46.44 77.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.863 . . . . 0.0 109.404 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.654 ' CZ2' HD12 ' A' ' 61' ' ' ILE . 53.5 m95 -61.37 -37.66 84.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.882 . . . . 0.0 109.396 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.517 ' HE2' ' CE1' ' A' ' 103' ' ' PHE . 23.9 mttt -56.82 -43.04 80.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.2 m -57.14 -45.86 83.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.336 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.497 HG23 ' SG ' ' A' ' 68' ' ' CYS . 68.0 mt -67.39 -36.77 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.838 . . . . 0.0 109.496 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -59.18 -36.86 76.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.56 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.38 -43.76 98.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.606 ' SG ' HD11 ' A' ' 130' ' ' ILE . 42.5 t -68.08 -44.14 76.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.683 HD11 ' HA ' ' A' ' 128' ' ' PRO . 20.8 tp -71.09 -30.49 66.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.249 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.2 t -62.39 -31.84 72.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.583 ' HB2' HD11 ' A' ' 72' ' ' LEU . 92.0 mtp -65.34 -31.05 71.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.461 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.37 135.65 0.21 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.582 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.683 ' HA ' HD11 ' A' ' 124' ' ' LEU . 48.9 Cg_endo -69.91 -1.81 9.22 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 122.614 2.209 . . . . 0.0 111.501 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 95.1 m-20 -44.02 -44.85 7.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.819 HD11 ' HB2' ' A' ' 72' ' ' LEU . 45.0 mt -55.27 123.4 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.654 ' HB ' HD22 ' A' ' 79' ' ' LEU . 25.4 m -113.87 140.84 48.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.28 -0.887 . . . . 0.0 109.086 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.707 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -125.23 137.22 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.098 -1.001 . . . . 0.0 109.631 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.469 ' HB2' HD12 ' A' ' 81' ' ' ILE . 95.2 mt-30 -127.4 165.78 19.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.249 -0.907 . . . . 0.0 109.395 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.59 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 37.4 t60 -111.57 138.25 48.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.639 ' CD ' HG21 ' A' ' 81' ' ' ILE . 71.0 mt-10 -137.64 139.49 40.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -98.8 134.45 41.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.49 -170.22 40.62 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.4 m80 47.65 32.77 2.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -1.144 . . . . 0.0 109.474 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -119.42 80.69 22.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.459 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.21 -27.55 24.19 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.711 2.274 . . . . 0.0 111.791 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.0 m -59.51 -39.05 82.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -108.36 117.24 33.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.185 -0.947 . . . . 0.0 109.528 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.8 m -121.49 140.49 52.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.575 ' OG ' HG23 ' A' ' 147' ' ' THR . 59.1 p -153.99 168.72 25.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.457 ' CG2' ' CE1' ' A' ' 41' ' ' TYR . 82.4 mt -59.43 -34.74 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.439 ' CD2' ' OH ' ' A' ' 11' ' ' TYR . 59.3 m170 -67.99 -38.92 83.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.333 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.575 HG23 ' OG ' ' A' ' 144' ' ' SER . 60.3 p -60.72 -39.46 88.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.48 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -48.89 -51.03 32.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.848 . . . . 0.0 109.38 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.49 -40.84 62.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.415 ' OD1' ' HA ' ' A' ' 147' ' ' THR . 23.1 m120 -56.52 -45.58 81.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -1.101 . . . . 0.0 109.337 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.0 -55.47 30.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.329 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.9 -45.97 82.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.349 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.4 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -58.67 -41.82 87.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.436 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.47 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 87.7 m-20 -54.08 -44.86 71.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 22.7 mttp -59.87 -42.04 92.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.309 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.401 HD11 ' HB3' ' A' ' 46' ' ' GLN . 64.8 mt -67.07 -37.04 83.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.83 88.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.861 . . . . 0.0 109.408 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 46.1 m -61.76 -39.87 93.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.362 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 163' ' ' VAL . 95.0 mt-30 -63.32 -33.3 75.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.439 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 50' ' ' PRO . . . -55.46 -40.04 75.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.786 ' HB2' HD12 ' A' ' 17' ' ' ILE . 83.8 p -64.02 -35.36 80.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.122 . . . . 0.0 109.494 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -69.93 -22.65 63.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.64 HG11 ' HG3' ' A' ' 50' ' ' PRO . 38.9 t -65.18 -25.63 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.4 m -131.61 143.37 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.54 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.59 -27.86 68.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -1.131 . . . . 0.0 109.518 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.545 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 98.4 mmm -66.82 -30.62 70.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.502 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 93.07 -14.75 64.51 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 92.7 mt-30 60.66 41.32 15.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.255 -1.144 . . . . 0.0 109.469 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.728 ' CE2' HD21 ' A' ' 79' ' ' LEU . 94.3 m-85 -55.69 173.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' HB3' HG22 ' A' ' 78' ' ' VAL . 24.5 tp10 -61.46 -35.03 76.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 109.381 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.59 -166.01 34.08 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.031 ' CG1' ' HB3' ' A' ' 35' ' ' ALA . 5.7 p -134.85 143.89 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -1.136 . . . . 0.0 109.223 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.73 ' CD2' HG11 ' A' ' 78' ' ' VAL . 32.3 m-85 -119.76 132.42 55.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.656 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.894 ' CE1' HD12 ' A' ' 81' ' ' ILE . 95.6 m-85 -112.14 125.09 53.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 109.052 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 1.036 HG22 HD12 ' A' ' 32' ' ' ILE . 28.3 p -115.99 146.11 42.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 109.812 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 30' ' ' MET . 66.5 t0 -144.93 137.97 26.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.438 -0.789 . . . . 0.0 109.341 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -139.61 126.14 3.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 t -143.48 154.06 43.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -1.162 . . . . 0.0 109.543 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -115.1 142.83 46.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.549 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.001 HD12 ' CB ' ' A' ' 161' ' ' SER . 70.1 mt -118.29 138.37 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -105.21 124.03 48.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -110.31 161.15 25.7 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.07 -33.99 14.38 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.771 2.314 . . . . 0.0 111.834 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.561 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -63.39 -64.82 2.54 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 109.483 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 49.0 Cg_endo -69.9 78.27 1.07 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.618 2.212 . . . . 0.0 111.749 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.0 m -55.04 -32.31 61.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.528 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 25' ' ' SER . 24.6 mttt -106.89 151.26 25.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.453 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 45.1 t 63.1 169.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 41.5 p30 -139.22 -177.82 5.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.361 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.402 ' HB2' ' HB ' ' A' ' 17' ' ' ILE . 88.9 m-20 -99.46 109.42 21.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.485 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -106.11 143.4 34.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.9 155.55 26.56 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.854 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 58.2 mtm -127.32 159.82 33.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -1.166 . . . . 0.0 109.512 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.693 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -143.95 122.16 1.77 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.036 HD12 HG22 ' A' ' 12' ' ' THR . 26.9 mm -124.0 111.98 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.354 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.54 ' CG2' ' HG2' ' A' ' 46' ' ' GLN . 10.9 p -115.66 160.21 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.753 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.881 ' CD2' HD12 ' A' ' 44' ' ' LEU . 20.7 t60 -116.05 144.98 43.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.364 -0.835 . . . . 0.0 109.346 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.031 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -132.3 169.49 16.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -125.95 166.58 16.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 0.0 109.369 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 38' ' ' LYS . 60.5 m-85 -105.28 10.13 33.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.573 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.37 179.59 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 109.1 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 44.0 Cg_endo -66.58 -4.53 11.1 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.128 1.885 . . . . 0.0 111.693 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -132.93 105.82 7.33 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.37 -0.831 . . . . 0.0 108.861 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.475 ' CD1' HD11 ' A' ' 145' ' ' ILE . 54.4 t80 -57.57 125.32 22.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.235 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 25.0 mt-30 -158.13 142.01 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.749 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.717 HG11 HD12 ' A' ' 152' ' ' LEU . 29.0 m -78.99 118.66 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -0.85 . . . . 0.0 109.391 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.881 HD12 ' CD2' ' A' ' 34' ' ' HIS . 24.4 mt -60.59 -46.2 91.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.171 -0.956 . . . . 0.0 109.317 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 35.3 m120 -159.96 146.59 16.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.368 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.697 ' HB3' HD21 ' A' ' 156' ' ' LEU . 78.4 mt-30 -107.6 148.2 29.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.393 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.52 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 5.6 t-105 -132.07 140.83 48.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -0.953 . . . . 0.0 109.755 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.1 p -128.43 141.92 51.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.263 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 3.4 mt -135.11 94.68 15.75 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.609 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' CG ' HG11 ' A' ' 163' ' ' VAL . 51.1 Cg_endo -70.85 134.82 26.5 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.688 2.259 . . . . 0.0 111.718 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.67 ' O ' HG11 ' A' ' 164' ' ' VAL . 45.4 mt -104.35 140.14 38.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.47 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.769 ' HA2' HG21 ' A' ' 164' ' ' VAL . . . -86.92 -69.56 1.32 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -122.51 79.38 1.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -1.133 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -133.55 179.07 6.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.41 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.618 HG23 ' H ' ' A' ' 58' ' ' MET . 12.5 t -116.86 168.89 9.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 0.0 109.538 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.453 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -63.38 -29.69 70.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -68.3 -42.78 78.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.618 ' H ' HG23 ' A' ' 55' ' ' THR . 52.8 mtm -76.46 -26.93 55.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.457 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.04 -35.05 61.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.511 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 56' ' ' ALA . 98.7 mt-10 -73.71 -38.71 64.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.625 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 20.2 tt -71.03 -28.17 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 0.0 109.586 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.854 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -74.81 -36.68 62.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.556 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.576 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -57.51 -39.19 75.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.14 -0.975 . . . . 0.0 109.677 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.593 ' CG2' HG21 ' A' ' 82' ' ' THR . 77.9 t -75.45 -46.83 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 0.0 109.805 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.536 ' HB2' HD11 ' A' ' 120' ' ' ILE . 84.0 tt0 -60.28 -35.75 76.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.668 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.542 ' CD2' HG13 ' A' ' 32' ' ' ILE . 11.4 t80 -57.79 -68.67 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.675 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.444 ' HB3' HG13 ' A' ' 80' ' ' VAL . . . -61.67 -14.18 29.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.66 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.854 ' SG ' HG23 ' A' ' 120' ' ' ILE . 41.8 t -69.86 -60.34 2.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.454 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.448 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 65.4 tttm -61.28 -45.26 95.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.641 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 32.5 mttp -60.39 -34.11 73.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.577 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.27 -58.92 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 109.443 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.977 ' HB2' HD11 ' A' ' 130' ' ' ILE . 2.9 tt -53.22 -46.36 69.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 72' ' ' LEU . 13.2 ttpt -42.88 -47.19 5.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 109.257 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 22.7 mm -48.9 141.93 9.84 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 108.794 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.7 Cg_endo -66.12 -4.9 11.16 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.514 2.143 . . . . 0.0 111.687 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.412 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -134.78 165.71 24.48 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 47.5 Cg_endo -68.87 131.44 22.52 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 122.545 2.164 . . . . 0.0 111.596 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.73 HG11 ' CD2' ' A' ' 10' ' ' PHE . 68.8 t -121.57 167.51 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.451 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 6' ' ' TYR . 7.0 mp -115.82 130.49 56.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.538 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 96.9 t -104.36 134.94 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.387 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.894 HD12 ' CE1' ' A' ' 11' ' ' TYR . 40.7 mt -120.58 137.33 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.528 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.593 HG21 ' CG2' ' A' ' 64' ' ' VAL . 8.9 t -143.48 161.68 37.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.429 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 58.8 p30 -89.79 25.14 2.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.462 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.528 ' H ' HG23 ' A' ' 82' ' ' THR . 49.2 m -128.54 117.08 20.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.216 -0.928 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.719 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 71.6 t80 -77.29 -44.98 27.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -58.44 -45.02 89.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.592 HG12 HG21 ' A' ' 64' ' ' VAL . 95.2 t -61.81 -49.66 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -57.33 -49.28 76.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.326 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 82.4 tt0 -61.43 -36.62 80.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.638 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 47.7 t -53.16 -47.35 68.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.472 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.673 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -92.48 -0.66 57.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 43.2 t-20 -87.17 -72.97 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.87 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 97.7 mttt -127.1 -23.95 3.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.55 ' HG2' ' CE2' ' A' ' 98' ' ' TRP . 42.6 tt0 -67.08 -27.48 67.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.961 -1.087 . . . . 0.0 109.755 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -57.09 -57.86 21.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 109.59 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 43.8 Cg_endo -66.64 -24.72 47.78 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.452 2.101 . . . . 0.0 111.136 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -72.15 -36.72 69.4 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.815 ' CE3' HD21 ' A' ' 111' ' ' LEU . 38.6 m0 -65.41 -50.04 66.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.507 -0.745 . . . . 0.0 108.991 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.557 ' HG2' ' CE1' ' A' ' 103' ' ' PHE . 26.1 mttt -43.63 -43.24 5.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.473 -0.767 . . . . 0.0 109.365 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -53.25 -44.42 68.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.371 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -86.89 11.27 13.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.324 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 82.07 37.98 14.36 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.557 ' CE1' ' HG2' ' A' ' 99' ' ' LYS . 37.5 m-85 67.07 28.13 8.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -1.134 . . . . 0.0 109.464 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.743 HG13 ' HA ' ' A' ' 110' ' ' PRO . 47.9 t -119.2 124.86 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.569 ' HB2' HD12 ' A' ' 111' ' ' LEU . 47.2 t30 -53.51 -39.03 64.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.483 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -170.64 144.69 2.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -53.12 -24.2 9.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.355 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -70.21 -38.38 75.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.77 138.32 18.22 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.452 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.743 ' HA ' HG13 ' A' ' 104' ' ' VAL . 50.2 Cg_endo -69.94 159.74 52.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.749 2.3 . . . . 0.0 111.814 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.815 HD21 ' CE3' ' A' ' 98' ' ' TRP . 15.4 tp -81.84 133.43 35.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.428 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 57.9 mttp -98.67 149.27 22.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.215 -0.928 . . . . 0.0 109.568 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.537 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 78.0 m-70 65.28 35.65 7.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.792 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.492 HG22 ' HE2' ' A' ' 118' ' ' LYS . 53.8 mt -67.36 -45.19 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.185 -0.947 . . . . 0.0 109.329 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 t -51.08 -47.62 61.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.22 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.66 -38.21 84.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.638 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 27.6 m95 -69.6 -40.28 76.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 109.351 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.492 ' HE2' HG22 ' A' ' 114' ' ' ILE . 64.0 mttm -55.06 -41.54 71.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.391 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.415 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 22.9 t -58.58 -45.77 88.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.854 HG23 ' SG ' ' A' ' 68' ' ' CYS . 79.4 mt -69.07 -36.22 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.378 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.81 93.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 126' ' ' MET . 83.1 tt0 -54.59 -40.61 69.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 109.409 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 1.3 m -76.6 -50.29 14.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.385 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 124' ' ' LEU . 9.1 tt -57.78 -37.44 73.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.464 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.8 m -59.93 -33.07 71.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.507 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.597 ' HB2' HD11 ' A' ' 72' ' ' LEU . 88.4 mtp -64.85 -36.06 83.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.85 . . . . 0.0 109.463 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.35 143.85 0.24 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 129' ' ' ASP . 48.6 Cg_endo -69.5 -2.12 9.43 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.738 2.292 . . . . 0.0 111.734 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 92.8 m-20 -43.18 -38.25 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.358 -0.839 . . . . 0.0 109.4 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.977 HD11 ' HB2' ' A' ' 72' ' ' LEU . 54.9 mt -68.59 109.44 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.475 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 97.2 m -110.03 146.94 34.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.273 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.478 HG21 ' HA ' ' A' ' 88' ' ' ALA . 64.2 mt -120.62 145.7 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.431 ' HB2' HG12 ' A' ' 81' ' ' ILE . 88.8 mt-30 -124.99 155.2 40.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.401 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.719 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 83.8 t60 -110.53 128.56 55.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HG2' ' CG2' ' A' ' 81' ' ' ILE . 74.6 mm-40 -122.9 146.6 47.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.384 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 139' ' ' GLN . 93.0 mttt -109.32 125.02 51.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.507 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.15 -29.83 61.88 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -62.29 -37.61 86.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -1.141 . . . . 0.0 109.408 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 136' ' ' LYS . 0.9 OUTLIER -117.52 159.23 42.8 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.533 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.53 155.14 67.5 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.798 2.332 . . . . 0.0 111.852 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 143' ' ' THR . 29.6 p -78.57 166.98 21.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.416 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -51.09 -38.85 54.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.619 HG22 ' H ' ' A' ' 145' ' ' ILE . 24.4 m -125.01 137.98 54.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.382 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 88.0 p -61.21 -23.63 65.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.619 ' H ' HG22 ' A' ' 143' ' ' THR . 19.9 tt -63.11 -40.11 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.5 ' N ' HG23 ' A' ' 145' ' ' ILE . 38.7 m80 -67.23 -27.09 66.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.92 . . . . 0.0 109.538 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 47.6 m -67.83 -35.47 78.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.53 -39.41 67.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -66.07 -37.86 93.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -65.09 -32.46 74.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -1.102 . . . . 0.0 109.361 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -66.76 -52.65 41.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.882 . . . . 0.0 109.514 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.717 HD12 HG11 ' A' ' 43' ' ' VAL . 59.1 mt -64.81 -46.78 80.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.56 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -54.48 -39.46 67.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.579 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -68.15 -36.99 80.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 66.3 mttm -56.43 -43.87 79.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.562 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.4 mp -72.11 -36.09 69.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.551 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.29 82.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.498 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.403 HG22 ' HE2' ' A' ' 162' ' ' TYR . 30.5 m -63.92 -41.57 97.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.56 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 94.5 mt-30 -66.17 -28.61 68.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.499 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.06 -39.67 97.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . 1.001 ' CB ' HD12 ' A' ' 17' ' ' ILE . 25.0 m -60.79 -38.87 86.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.115 . . . . 0.0 109.516 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.403 ' HE2' HG22 ' A' ' 158' ' ' THR . 91.5 m-85 -66.99 -30.02 70.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.487 HG11 ' CG ' ' A' ' 50' ' ' PRO . 63.4 t -58.56 -38.0 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.575 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.769 HG21 ' HA2' ' A' ' 52' ' ' GLY . 12.3 p -111.81 138.35 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.447 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.97 -26.59 68.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -1.166 . . . . 0.0 109.397 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.55 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 92.3 mtp -64.15 -36.72 84.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.489 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 102.88 -15.52 55.36 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 6' ' ' TYR . 90.6 mt-30 63.04 47.38 4.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -1.143 . . . . 0.0 109.525 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.056 ' CD2' HD11 ' A' ' 79' ' ' LEU . 99.0 m-85 -52.11 -174.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 109.469 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' A' ' 78' ' ' VAL . 70.0 mm-40 -68.57 -36.91 79.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.152 -0.967 . . . . 0.0 109.283 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.478 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.66 -174.13 44.61 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.589 HG22 ' HB2' ' A' ' 79' ' ' LEU . 90.4 t -137.98 136.34 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -1.106 . . . . 0.0 109.317 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.684 ' CE2' ' CG ' ' A' ' 34' ' ' HIS . 47.6 m-85 -118.88 137.76 53.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.742 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.58 ' CE2' HG13 ' A' ' 81' ' ' ILE . 23.2 m-85 -108.0 130.78 55.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.198 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.993 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 19.6 p -116.5 147.65 41.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 109.621 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CG ' ' OD1' ' A' ' 154' ' ' ASP . 23.3 t70 -148.56 153.51 38.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.6 126.23 3.38 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.6 m -128.68 153.51 47.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -1.148 . . . . 0.0 109.409 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . . . -139.94 144.63 37.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.868 HD12 ' HB3' ' A' ' 161' ' ' SER . 38.0 mt -117.76 147.86 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -100.55 164.97 11.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.555 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.548 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -125.65 176.63 2.34 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 109.094 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 47.6 Cg_endo -69.1 124.25 11.16 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.44 2.093 . . . . 0.0 111.413 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 2.5 m-20 61.49 57.76 3.2 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.913 . . . . 0.0 109.014 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 19' ' ' SER . 50.4 Cg_endo -70.71 63.43 2.34 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.869 2.379 . . . . 0.0 112.128 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.528 ' O ' ' CG ' ' A' ' 24' ' ' LYS . 35.2 m -56.72 -45.76 81.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 109.093 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 23' ' ' THR . 76.3 mttt -159.73 41.04 0.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.43 -0.794 . . . . 0.0 109.313 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 26' ' ' ASN . 20.0 m -137.19 140.76 41.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 109.476 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 25' ' ' SER . 77.2 m-20 -160.09 146.65 15.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 109.359 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.459 ' HB2' ' HB ' ' A' ' 17' ' ' ILE . 89.2 m-20 -95.55 136.81 35.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.434 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -145.71 149.47 34.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.759 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -157.78 164.44 33.16 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.893 ' HG3' HD11 ' A' ' 51' ' ' LEU . 66.2 mtm -123.19 163.51 20.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -1.156 . . . . 0.0 109.421 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -148.45 119.54 1.09 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.925 HD12 HG22 ' A' ' 12' ' ' THR . 24.8 mm -114.64 137.03 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -1.17 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.2 t -123.38 136.09 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.992 ' CD2' HD12 ' A' ' 44' ' ' LEU . 4.1 t60 -110.23 135.02 51.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.658 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.01 164.61 27.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.294 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.2 t -131.71 166.74 20.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 109.599 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.587 ' OH ' HG21 ' A' ' 9' ' ' VAL . 66.3 m-85 -100.64 11.63 39.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 109.406 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.571 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -51.29 179.65 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.328 -0.857 . . . . 0.0 109.05 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.571 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.6 Cg_endo -66.29 -5.0 11.56 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.122 1.881 . . . . 0.0 111.65 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -135.95 106.07 6.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.368 -0.832 . . . . 0.0 109.049 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 54.7 t80 -67.46 122.7 18.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.31 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 82.4 mt-30 -159.4 142.46 14.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.769 HG21 HD22 ' A' ' 152' ' ' LEU . 46.2 t -64.96 110.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.992 HD12 ' CD2' ' A' ' 34' ' ' HIS . 35.1 mt -57.14 -48.72 77.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 79.8 m-20 -159.76 153.74 23.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.483 ' HB3' HD11 ' A' ' 156' ' ' LEU . 91.0 mt-30 -109.48 146.47 34.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.485 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.4 t-105 -131.24 135.52 47.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 0.0 109.722 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.9 t -130.29 130.16 44.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 109.261 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.505 ' HB ' ' CE ' ' A' ' 30' ' ' MET . 3.1 mp -131.65 98.69 17.71 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 109.741 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 51.3 Cg_endo -71.57 136.48 28.42 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.601 2.201 . . . . 0.0 111.676 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.893 HD11 ' HG3' ' A' ' 30' ' ' MET . 3.3 mp -103.7 140.37 37.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 53' ' ' ASN . . . -103.34 113.38 4.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 52' ' ' GLY . 47.7 t30 75.63 36.64 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -1.157 . . . . 0.0 109.55 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 51' ' ' LEU . 76.9 m80 -120.26 171.55 8.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.585 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -111.17 170.18 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.26 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -56.98 -35.26 68.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.017 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 60' ' ' GLU . 89.7 mt-30 -70.14 -58.27 3.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 0.0 109.345 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.585 ' SD ' HG23 ' A' ' 55' ' ' THR . 97.6 mtp -44.77 -30.72 1.01 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.304 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 30' ' ' MET . . . -77.62 -34.57 53.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.379 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 57' ' ' GLN . 97.0 mt-10 -63.33 -41.9 98.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 109.567 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.72 ' HA ' HG21 ' A' ' 87' ' ' VAL . 12.8 tt -71.56 -37.36 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.769 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -67.14 -31.66 72.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.308 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.993 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -66.97 -38.6 86.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.426 HG22 HG21 ' A' ' 82' ' ' THR . 85.3 t -69.91 -40.34 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HB2' HD11 ' A' ' 120' ' ' ILE . 80.7 tt0 -69.11 -39.81 78.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.565 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 19.2 t80 -58.77 -64.35 0.96 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.359 -0.838 . . . . 0.0 109.477 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.82 -32.88 69.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 120' ' ' ILE . 43.0 t -51.63 -52.64 46.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 67.8 mttm -64.5 -42.25 95.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.565 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 64.3 mttm -62.62 -37.81 87.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.562 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.71 -61.9 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.919 ' HB2' HD11 ' A' ' 130' ' ' ILE . 18.9 tp -55.21 -42.01 72.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.459 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 72' ' ' LEU . 64.9 tttt -45.17 -40.95 7.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.29 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.633 HG13 HG21 ' A' ' 78' ' ' VAL . 32.6 mm -59.1 143.07 85.01 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 108.899 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.3 Cg_endo -64.08 -5.87 10.22 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.53 2.153 . . . . 0.0 111.871 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -134.85 170.6 22.74 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 49.7 Cg_endo -69.27 135.6 32.06 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.392 2.061 . . . . 0.0 111.771 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.633 HG21 HG13 ' A' ' 74' ' ' ILE . 58.0 t -124.4 158.14 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.875 . . . . 0.0 109.374 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.056 HD11 ' CD2' ' A' ' 6' ' ' TYR . 14.2 mt -108.32 144.71 35.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.213 -0.929 . . . . 0.0 109.424 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 132' ' ' ILE . 13.6 m -123.48 143.92 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.58 HG13 ' CE2' ' A' ' 11' ' ' TYR . 26.1 mm -114.01 133.56 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.339 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.426 HG21 HG22 ' A' ' 64' ' ' VAL . 1.2 p -127.18 161.76 27.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.476 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -98.99 14.16 30.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 109.523 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.582 ' HB3' HG12 ' A' ' 87' ' ' VAL . 27.2 t -137.96 125.77 22.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.67 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 48.8 p90 -77.2 -36.63 54.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.456 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -53.79 -50.18 66.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 61' ' ' ILE . 14.9 p -67.26 -44.72 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.907 . . . . 0.0 109.409 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.582 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -54.89 -47.92 73.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 77.3 mm-40 -62.22 -40.27 95.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.594 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 64.4 m -50.79 -44.96 58.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.675 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -94.51 -0.9 54.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.731 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 56.1 t30 -89.67 -72.93 0.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.581 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 65.0 tttm -127.05 -31.84 2.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 109.774 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 92.6 mt-10 -55.52 -34.23 64.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 0.0 109.743 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 91' ' ' ALA . 0.8 OUTLIER -56.18 -62.13 5.33 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 109.581 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 44.5 Cg_endo -66.93 -32.71 34.97 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.836 2.357 . . . . 0.0 111.746 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -67.75 -38.24 83.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.164 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -64.96 -48.95 72.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -0.883 . . . . 0.0 109.259 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.597 ' NZ ' ' HB1' ' A' ' 121' ' ' ALA . 32.4 mttt -47.87 -42.26 26.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.397 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.4 m -59.21 -40.74 86.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.619 ' O ' HG23 ' A' ' 104' ' ' VAL . 73.3 m-20 -87.64 12.21 13.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.869 . . . . 0.0 109.394 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 70.59 38.23 68.17 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.691 ' CA ' HD12 ' A' ' 111' ' ' LEU . 91.1 m-85 61.34 46.56 7.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -1.166 . . . . 0.0 109.434 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 101' ' ' ASN . 55.1 t -112.3 132.54 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.492 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.642 ' HB2' HD23 ' A' ' 111' ' ' LEU . 49.2 t-20 -93.73 142.58 27.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.413 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -49.96 -36.25 27.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.523 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -68.76 151.9 46.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -50.21 -33.43 19.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.4 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.99 140.7 74.05 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.29 173.78 10.94 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.666 2.244 . . . . 0.0 111.764 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.691 HD12 ' CA ' ' A' ' 103' ' ' PHE . 76.7 mt -65.84 137.97 57.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 73.6 mttt -107.56 153.93 22.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.6 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 55.8 m80 63.42 27.68 15.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.619 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.8 mt -57.51 -41.46 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.312 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.5 m -50.3 -47.3 55.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.264 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -60.57 -45.16 94.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.321 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.64 ' HH2' HG23 ' A' ' 87' ' ' VAL . 22.8 m95 -65.7 -40.6 92.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.349 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -52.34 -49.82 63.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.333 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.2 m -55.67 -45.55 77.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.294 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.548 HG23 ' SG ' ' A' ' 68' ' ' CYS . 76.8 mt -67.95 -37.99 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 109.374 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.597 ' HB1' ' NZ ' ' A' ' 99' ' ' LYS . . . -53.57 -42.38 67.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 126' ' ' MET . 76.3 mm-40 -54.6 -43.7 72.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 109.369 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 1.6 m -63.87 -49.16 73.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.425 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.5 tp -64.28 -33.05 74.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.3 m -61.8 -32.67 72.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.0 109.62 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.509 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 91.9 mmm -65.67 -28.94 69.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 163.37 146.87 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.559 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.5 Cg_endo -69.91 -1.87 9.33 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.672 2.248 . . . . 0.0 111.657 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 85.6 m-20 -43.42 -34.2 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -0.811 . . . . 0.0 109.503 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.919 HD11 ' HB2' ' A' ' 72' ' ' LEU . 45.9 mt -72.62 123.59 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.584 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.606 ' HB ' HD22 ' A' ' 79' ' ' LEU . 40.0 m -119.01 139.06 52.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 109.238 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.675 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 73.0 mt -119.76 137.33 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.664 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.524 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 94.8 mt-30 -120.62 155.63 33.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.365 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.67 ' CD2' ' HB3' ' A' ' 85' ' ' PHE . 63.8 t60 -114.7 135.87 53.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.452 ' OE1' ' ND2' ' A' ' 150' ' ' ASN . 65.5 tt0 -104.73 139.51 39.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.322 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -73.76 96.98 2.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.504 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.51 -20.39 77.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -60.35 -43.74 96.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -1.129 . . . . 0.0 109.328 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.64 82.36 6.78 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.315 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.99 137.76 35.53 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.704 2.269 . . . . 0.0 111.947 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.7 p -123.26 153.01 40.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -0.861 . . . . 0.0 109.313 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -90.7 8.08 36.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.5 p -66.58 -17.16 64.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.361 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 25.2 t -109.1 138.03 46.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.505 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.437 HD11 ' CD1' ' A' ' 41' ' ' TYR . 19.9 tt -66.36 -20.8 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.413 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 92.6 m-70 -69.5 -32.54 71.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 42.7 m -55.21 -48.81 73.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.5 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 152' ' ' LEU . 85.7 tt0 -49.04 -49.48 41.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -56.85 -39.08 87.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.452 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 87.7 m-20 -64.84 -35.8 82.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -1.123 . . . . 0.0 109.365 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.64 -47.11 86.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.769 HD22 HG21 ' A' ' 43' ' ' VAL . 6.5 mp -65.25 -37.05 86.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.409 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.0 -41.66 90.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.915 . . . . 0.0 109.544 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.404 ' OD1' ' CG ' ' A' ' 13' ' ' ASP . 83.0 m-20 -57.6 -47.92 80.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.545 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -55.25 -48.01 74.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.515 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.494 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 62.7 mt -60.52 -38.76 85.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.568 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.05 -42.53 72.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 47.4 p -70.02 -30.94 68.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.569 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 163' ' ' VAL . 60.3 tt0 -62.66 -36.89 84.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -60.13 -37.82 93.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.868 ' HB3' HD12 ' A' ' 17' ' ' ILE . 14.5 m -59.95 -42.11 93.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.477 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.44 -25.33 68.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 159' ' ' GLN . 40.9 t -68.72 -23.36 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.398 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 161' ' ' SER . 38.5 t -128.36 156.42 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.402 -179.923 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.61 147.37 37.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.419 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.5 mmm -62.95 -40.55 98.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.471 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.02 -160.74 27.49 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -138.44 110.93 7.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -1.117 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.032 ' CD2' HD11 ' A' ' 79' ' ' LEU . 54.6 m-85 -122.31 161.57 23.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.578 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.511 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 74.8 mm-40 -55.51 -38.27 68.97 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.217 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.478 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.82 -175.52 45.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.644 HG21 ' OH ' ' A' ' 37' ' ' TYR . 74.7 t -133.53 137.61 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -1.081 . . . . 0.0 109.167 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.682 ' CZ ' ' CD2' ' A' ' 34' ' ' HIS . 57.0 m-85 -117.67 134.76 54.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.126 -0.984 . . . . 0.0 110.014 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 1.026 ' CE2' HD12 ' A' ' 81' ' ' ILE . 38.1 m-85 -107.49 129.12 54.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.034 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.914 HG22 HD12 ' A' ' 32' ' ' ILE . 12.8 p -118.48 147.65 43.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.862 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 65.5 t0 -138.31 146.46 42.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.481 -0.762 . . . . 0.0 109.143 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -135.17 136.92 8.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.4 p -143.47 161.88 37.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -1.139 . . . . 0.0 109.301 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -153.39 145.85 24.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.1 mt -116.59 138.86 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.358 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -112.04 125.73 54.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.49 ' OG ' ' HD2' ' A' ' 20' ' ' PRO . 2.3 t -121.39 157.09 57.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.186 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.49 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 43.8 Cg_endo -66.38 -18.11 54.64 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.642 2.228 . . . . 0.0 112.054 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.601 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 1.0 OUTLIER -84.86 -67.9 0.17 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 109.243 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 53.5 Cg_endo -73.04 51.79 2.1 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.441 2.094 . . . . 0.0 111.562 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.8 m -54.5 -41.89 70.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.547 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -99.95 27.61 5.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.531 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 0.5 OUTLIER -125.4 -67.17 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 109.481 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 25' ' ' SER . 85.2 m-20 62.16 130.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.596 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 90.3 m-20 -105.31 135.96 45.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -139.36 146.44 40.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.708 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 50' ' ' PRO . . . -137.18 159.06 24.59 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 66.6 mtm -131.89 151.21 51.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -1.148 . . . . 0.0 109.483 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.517 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -134.03 127.96 4.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.914 HD12 HG22 ' A' ' 12' ' ' THR . 23.9 mm -115.6 135.72 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.489 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.0 t -126.25 135.01 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 1.138 ' CE1' HD12 ' A' ' 44' ' ' LEU . 14.0 t-160 -111.4 127.54 55.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 109.538 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.52 171.65 8.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -129.9 165.86 21.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.644 ' OH ' HG21 ' A' ' 9' ' ' VAL . 55.3 m-85 -100.2 13.07 35.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 109.449 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.583 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.32 179.94 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 108.939 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.0 Cg_endo -66.41 -4.85 11.45 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.136 1.89 . . . . 0.0 111.707 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.443 ' CD ' ' NE2' ' A' ' 42' ' ' GLN . 83.7 tt0 -138.11 106.16 5.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -0.847 . . . . 0.0 109.041 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -54.44 121.5 8.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.462 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.443 ' NE2' ' CD ' ' A' ' 40' ' ' GLU . 91.1 mt-30 -152.74 156.6 39.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 43' ' ' VAL . 21.0 m -89.62 118.13 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.138 HD12 ' CE1' ' A' ' 34' ' ' HIS . 39.5 mt -58.49 -45.62 88.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.362 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 74.9 m-20 -162.71 168.45 21.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.425 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -121.7 145.07 48.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.469 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 2.9 t-105 -128.85 140.03 51.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -125.35 128.8 48.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.462 HD11 ' CE2' ' A' ' 66' ' ' PHE . 2.7 mp -127.17 86.94 57.65 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.622 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.616 ' HB3' HG21 ' A' ' 163' ' ' VAL . 51.0 Cg_endo -70.65 130.53 18.39 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.746 2.297 . . . . 0.0 111.699 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 28' ' ' ALA . 43.9 mt -107.19 153.03 23.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 109.452 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -124.74 -40.95 0.4 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -108.0 32.07 5.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -1.113 . . . . 0.0 109.514 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 78.9 m80 -120.15 145.7 46.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.542 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.497 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -89.93 168.34 12.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.201 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -48.81 -38.95 23.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.135 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 60' ' ' GLU . 91.0 mt-30 -70.39 -58.26 3.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.548 ' O ' HG22 ' A' ' 61' ' ' ILE . 95.3 mtp -44.95 -30.48 1.02 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.352 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.67 -36.81 57.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' GLN . 98.8 mt-10 -65.49 -40.04 92.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 58' ' ' MET . 20.5 tt -70.79 -34.57 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.46 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -69.41 -33.7 73.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.854 . . . . 0.0 109.45 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.545 ' HB1' ' OG1' ' A' ' 12' ' ' THR . . . -59.0 -43.17 91.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.524 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.667 HG21 HG12 ' A' ' 87' ' ' VAL . 96.3 t -70.79 -50.46 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.561 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.468 ' HG3' HG12 ' A' ' 120' ' ' ILE . 86.7 tt0 -59.17 -40.43 85.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.593 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.558 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 17.0 t80 -53.89 -70.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.908 . . . . 0.0 109.632 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.711 ' HB3' HG13 ' A' ' 80' ' ' VAL . . . -64.19 -10.96 26.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -0.906 . . . . 0.0 109.648 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.871 ' SG ' HG23 ' A' ' 120' ' ' ILE . 37.7 t -75.51 -56.34 4.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -63.25 -41.23 99.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 44.4 mttp -66.02 -34.68 78.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HB1' ' HB ' ' A' ' 78' ' ' VAL . . . -59.94 -58.93 6.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.965 ' HB2' HD11 ' A' ' 130' ' ' ILE . 9.3 tt -55.4 -45.12 76.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 72' ' ' LEU . 58.2 tttm -43.27 -41.75 4.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.592 HG13 HG21 ' A' ' 78' ' ' VAL . 30.0 mm -56.52 143.15 68.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.304 -0.872 . . . . 0.0 108.736 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.1 Cg_endo -64.33 -5.01 8.93 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.729 2.286 . . . . 0.0 112.086 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.511 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -136.22 171.87 22.64 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 49.7 Cg_endo -70.1 132.33 22.57 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.44 2.094 . . . . 0.0 111.806 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.592 HG21 HG13 ' A' ' 74' ' ' ILE . 60.2 t -120.61 161.86 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.442 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.032 HD11 ' CD2' ' A' ' 6' ' ' TYR . 14.5 mt -107.83 137.73 45.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.711 HG13 ' HB3' ' A' ' 67' ' ' ALA . 45.6 t -116.62 130.22 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.026 HD12 ' CE2' ' A' ' 11' ' ' TYR . 35.4 mt -117.56 136.16 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.0 109.501 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 84' ' ' SER . 12.8 t -139.51 159.71 41.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -88.99 19.74 3.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.535 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.533 ' H ' HG23 ' A' ' 82' ' ' THR . 34.2 t -122.55 116.8 24.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 109.521 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.614 ' HB3' ' CE1' ' A' ' 134' ' ' HIS . 38.9 p90 -77.27 -45.31 26.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.489 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.567 ' N ' ' CG ' ' A' ' 85' ' ' PHE . 69.9 t80 -55.7 -48.87 74.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.667 HG12 HG21 ' A' ' 64' ' ' VAL . 86.8 t -60.13 -49.42 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.318 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -53.24 -55.01 27.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.221 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 96.1 mt-10 -58.5 -28.39 65.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.325 -0.859 . . . . 0.0 109.391 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.627 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 23.9 m -59.88 -45.97 90.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.655 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -92.36 -0.74 57.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 109.774 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 82.3 m-20 -86.96 -68.19 0.76 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.004 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 67.8 mttm -122.19 -34.58 3.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 109.9 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.533 ' OE1' ' CZ2' ' A' ' 98' ' ' TRP . 83.4 mt-10 -62.41 -32.95 73.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 109.612 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 90' ' ' SER . 0.1 OUTLIER -55.92 -59.65 11.0 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.416 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 46.1 Cg_endo -67.72 -32.53 29.97 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.707 2.272 . . . . 0.0 111.444 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -73.0 -37.31 67.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 108.954 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.533 ' CZ2' ' OE1' ' A' ' 94' ' ' GLU . 15.1 m0 -60.18 -52.98 63.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.369 -0.832 . . . . 0.0 109.17 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.501 ' HG3' ' CZ ' ' A' ' 103' ' ' PHE . 77.1 tttt -44.65 -42.58 7.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.333 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 82.4 p -73.57 -28.31 61.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 98' ' ' TRP . 54.4 t30 -87.19 9.73 19.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 104' ' ' VAL . . . 81.37 25.56 54.12 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.501 ' CZ ' ' HG3' ' A' ' 99' ' ' LYS . 61.2 m-85 60.38 34.35 20.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -1.16 . . . . 0.0 109.448 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 102' ' ' GLY . 60.9 t -123.87 127.99 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.443 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.615 ' HB2' HD12 ' A' ' 111' ' ' LEU . 40.7 t-20 -58.2 -40.9 82.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -175.69 156.36 1.86 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.454 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -60.44 -28.68 68.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.435 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 109' ' ' LYS . 23.2 mttm -67.01 -36.28 81.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 108' ' ' LYS . 5.4 mmtt -145.75 138.58 13.98 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.455 ' HA ' HG13 ' A' ' 104' ' ' VAL . 49.2 Cg_endo -69.74 165.34 31.26 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.673 2.249 . . . . 0.0 111.81 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 105' ' ' ASN . 13.7 tp -84.45 133.36 34.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -94.93 151.05 19.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.423 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.405 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 58.4 m80 59.77 42.99 15.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.88 . . . . 0.0 109.438 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.56 HG22 ' HE3' ' A' ' 118' ' ' LYS . 91.9 mt -65.04 -42.68 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.466 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -61.87 -39.84 93.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -60.66 -44.77 96.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.627 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 52.7 m95 -65.03 -38.53 91.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.427 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.56 ' HE3' HG22 ' A' ' 114' ' ' ILE . 52.0 mttt -58.69 -37.54 76.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.8 m -62.85 -43.48 98.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.372 -0.83 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.871 HG23 ' SG ' ' A' ' 68' ' ' CYS . 73.0 mt -69.86 -35.69 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -64.76 -34.37 78.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -53.03 -37.24 61.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.436 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.491 ' CA ' HD13 ' A' ' 72' ' ' LEU . 12.4 m -83.63 -45.37 13.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.49 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.466 ' CD2' ' HB ' ' A' ' 130' ' ' ILE . 53.1 mt -61.57 -31.44 71.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.437 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.0 m -56.41 -36.55 69.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.468 ' HB2' HD11 ' A' ' 72' ' ' LEU . 88.7 mtp -63.92 -36.8 85.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 171.24 157.32 0.22 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.5 Cg_endo -72.15 3.7 3.83 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.739 2.292 . . . . 0.0 112.061 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 128' ' ' PRO . 85.7 m-20 -42.36 -35.71 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.212 -0.93 . . . . 0.0 109.623 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.965 HD11 ' HB2' ' A' ' 72' ' ' LEU . 62.8 mt -75.17 116.26 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 109.402 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.574 ' HB ' HD22 ' A' ' 79' ' ' LEU . 31.3 m -110.88 142.55 42.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.368 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.655 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 62.0 mt -120.74 137.13 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.66 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB2' HG12 ' A' ' 81' ' ' ILE . 88.5 mt-30 -118.65 165.2 14.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -0.888 . . . . 0.0 109.36 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.614 ' CE1' ' HB3' ' A' ' 85' ' ' PHE . 74.9 t60 -120.56 133.64 55.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.513 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HG3' HG22 ' A' ' 81' ' ' ILE . 93.6 mt-10 -102.13 159.5 15.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.426 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 140' ' ' PRO . 24.0 mttm -96.03 34.27 1.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.19 -175.66 51.42 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.485 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 86.3 t60 -65.29 -36.75 85.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -1.126 . . . . 0.0 109.444 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -105.67 75.94 0.34 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 138' ' ' HIS . 49.2 Cg_endo -70.2 144.34 51.38 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.672 2.248 . . . . 0.0 111.805 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 49.1 m -57.08 -38.2 72.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.431 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -113.08 128.53 56.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.373 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.6 m -78.87 135.81 37.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.1 p -143.72 170.36 16.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.875 . . . . 0.0 109.461 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.85 -31.0 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.551 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -68.8 -26.2 65.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.411 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.1 m -55.29 -45.59 76.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -51.67 -43.38 62.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.04 -39.04 89.01 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.44 ' OD1' ' HA ' ' A' ' 138' ' ' HIS . 22.9 t-20 -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -1.139 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -57.93 -51.72 68.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 152' ' ' LEU . 7.0 mp -65.46 -44.73 86.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 109.526 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.2 87.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.577 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.46 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 58.4 t0 -61.81 -38.04 86.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 24.1 mttm -62.96 -40.58 98.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.568 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 61.7 mt -72.09 -37.22 69.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.537 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.22 -44.51 75.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.47 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.588 HG22 ' HE2' ' A' ' 162' ' ' TYR . 31.1 m -61.03 -41.84 97.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.54 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.574 ' O ' HG13 ' A' ' 163' ' ' VAL . 94.4 mt-30 -67.29 -26.66 66.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.485 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.962 ' O ' HG22 ' A' ' 163' ' ' VAL . . . -66.28 -26.73 72.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.6 p -76.06 -25.37 55.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -1.157 . . . . 0.0 109.457 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.588 ' HE2' HG22 ' A' ' 158' ' ' THR . 93.4 m-85 -81.36 -25.59 36.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.055 HG23 HG23 ' A' ' 164' ' ' VAL . 5.1 m -62.76 -24.92 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 1.055 HG23 HG23 ' A' ' 163' ' ' VAL . 41.3 t -124.08 136.35 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.468 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.05 69.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -1.152 . . . . 0.0 109.502 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.479 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 93.1 mtp -62.83 -34.26 76.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.61 -167.2 38.53 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -122.86 121.81 37.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -1.115 . . . . 0.0 109.485 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.027 ' CD2' HD11 ' A' ' 79' ' ' LEU . 50.1 m-85 -120.9 162.5 19.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.37 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.558 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.8 tp10 -59.47 -37.1 77.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.268 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.484 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.69 -169.45 39.39 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.829 HG21 ' CZ ' ' A' ' 37' ' ' TYR . 70.2 t -142.55 140.65 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -1.135 . . . . 0.0 109.253 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.686 ' CE1' ' CD2' ' A' ' 34' ' ' HIS . 31.3 m-85 -121.05 142.88 49.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.82 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CE1' HG13 ' A' ' 81' ' ' ILE . 49.7 m-85 -114.58 130.16 56.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 108.952 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.997 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 29.2 p -112.69 150.17 31.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.075 -1.015 . . . . 0.0 109.956 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 66.6 t0 -145.2 145.99 31.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.056 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -139.98 137.36 8.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.687 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 87.3 p -143.53 162.72 35.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -1.127 . . . . 0.0 109.17 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . . . -146.25 148.82 32.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.001 . . . . 0.0 109.757 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.418 HD12 ' HB2' ' A' ' 161' ' ' SER . 60.6 mt -117.88 141.87 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -103.22 125.32 49.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.54 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.486 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 4.9 t -117.89 154.56 51.3 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.304 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.469 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 45.6 Cg_endo -67.73 -7.3 19.05 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.662 2.242 . . . . 0.0 111.975 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.598 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -100.11 -69.76 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.456 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 54.2 Cg_endo -72.9 53.7 2.44 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.369 2.046 . . . . 0.0 111.657 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.7 m -54.79 -42.3 71.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 109.586 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -96.45 30.98 2.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -134.37 -58.31 0.84 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 109.499 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' SER . 82.1 m-20 62.36 129.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -99.41 125.66 45.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.443 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 15' ' ' SER . . . -135.65 158.41 44.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 50' ' ' PRO . . . -140.33 159.53 26.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.84 ' HE3' HD12 ' A' ' 49' ' ' ILE . 49.7 mtm -118.93 154.08 33.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -1.179 . . . . 0.0 109.399 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -139.68 120.04 1.77 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.928 HD12 HG22 ' A' ' 12' ' ' THR . 20.9 mm -111.13 133.08 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -1.154 . . . . 0.0 109.437 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' PHE . 42.7 t -118.64 137.89 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 1.137 ' CE1' HD22 ' A' ' 44' ' ' LEU . 23.6 t-160 -112.86 130.15 56.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.52 166.94 20.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.324 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.594 ' HB ' HD11 ' A' ' 44' ' ' LEU . 9.9 t -127.75 154.25 45.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.829 ' CZ ' HG21 ' A' ' 9' ' ' VAL . 11.8 m-30 -95.22 5.28 52.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.518 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.585 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.3 179.56 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.059 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.7 Cg_endo -66.39 -4.43 10.67 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.219 1.946 . . . . 0.0 111.825 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -130.38 105.93 8.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 108.745 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -71.22 130.3 41.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 109.554 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -167.99 151.83 6.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.429 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.6 p -76.96 125.59 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.878 . . . . 0.0 109.406 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.137 HD22 ' CE1' ' A' ' 34' ' ' HIS . 7.5 mp -72.23 -36.67 69.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.902 . . . . 0.0 109.387 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -173.05 158.46 3.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.457 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.856 ' HB3' HD21 ' A' ' 156' ' ' LEU . 91.8 mt-30 -113.49 138.64 49.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.279 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.465 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -121.25 135.42 55.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.657 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.7 t -128.71 129.95 46.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.196 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.84 HD12 ' HE3' ' A' ' 30' ' ' MET . 4.1 mt -134.45 93.17 19.23 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 109.691 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 50.5 Cg_endo -70.9 140.28 38.05 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.693 2.262 . . . . 0.0 111.658 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.772 HD11 ' HG3' ' A' ' 30' ' ' MET . 5.3 mp -109.0 154.84 21.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.531 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.04 -34.86 0.66 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.525 ' OD1' ' CD2' ' A' ' 54' ' ' HIS . 42.7 p-10 -118.47 36.67 4.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.161 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.556 ' CG ' HD23 ' A' ' 51' ' ' LEU . 92.8 m-70 -126.47 169.75 12.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.441 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.618 HG23 ' H ' ' A' ' 58' ' ' MET . 10.0 t -111.43 -176.27 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.459 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.645 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -67.52 -39.06 85.09 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.544 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -67.38 -45.23 76.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.557 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.618 ' H ' HG23 ' A' ' 55' ' ' THR . 96.0 mtp -65.15 -36.46 84.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.616 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.82 88.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 56' ' ' ALA . 96.1 mt-10 -67.12 -48.4 68.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.6 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.744 ' HA ' HG21 ' A' ' 87' ' ' VAL . 13.1 tt -66.21 -36.15 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.452 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.572 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -64.9 -28.64 69.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.997 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -68.16 -40.94 82.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.573 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.519 HG22 ' CG2' ' A' ' 82' ' ' THR . 61.4 t -70.34 -38.24 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.593 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.594 ' HG2' HD11 ' A' ' 120' ' ' ILE . 97.3 mt-10 -66.4 -37.46 85.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.071 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.637 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 24.1 t80 -63.26 -67.1 0.45 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.451 -0.781 . . . . 0.0 109.761 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 68' ' ' CYS . . . -58.2 -45.3 87.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 109.867 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.779 ' SG ' HG23 ' A' ' 120' ' ' ILE . 42.5 t -42.47 -62.57 0.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 109.738 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 42.7 mttp -54.83 -50.46 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.637 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 64.2 mttm -55.23 -36.84 66.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.597 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.03 -61.31 2.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.443 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.777 ' HB2' HD11 ' A' ' 130' ' ' ILE . 22.8 tp -51.53 -45.52 63.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 36.6 mmtt -43.82 -47.19 8.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.325 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.556 HG13 HG21 ' A' ' 78' ' ' VAL . 27.5 mm -48.39 142.73 7.97 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 108.923 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.6 Cg_endo -65.82 -3.91 9.01 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.553 2.169 . . . . 0.0 111.808 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.427 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -137.07 168.81 24.2 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 48.5 Cg_endo -69.44 130.53 19.9 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.53 2.154 . . . . 0.0 111.723 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.59 HG11 ' CE1' ' A' ' 10' ' ' PHE . 50.4 t -120.0 158.66 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.512 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.027 HD11 ' CD2' ' A' ' 6' ' ' TYR . 23.2 mt -101.74 143.85 31.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.9 t -119.48 130.4 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.527 HG13 ' CE1' ' A' ' 11' ' ' TYR . 24.4 mm -111.08 142.0 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.519 ' CG2' HG22 ' A' ' 64' ' ' VAL . 1.4 p -131.95 157.99 42.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.487 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.448 ' OD2' ' OD1' ' A' ' 13' ' ' ASP . 60.5 m-20 -82.17 -20.02 38.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.479 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.626 ' HB3' HG12 ' A' ' 87' ' ' VAL . 46.9 t -110.62 131.64 54.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.576 ' HB3' ' CG ' ' A' ' 134' ' ' HIS . 46.4 p90 -76.11 -35.03 59.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -57.06 -52.58 64.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.418 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.744 HG21 ' HA ' ' A' ' 61' ' ' ILE . 9.7 p -62.03 -47.31 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.341 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.771 ' HB1' HG22 ' A' ' 132' ' ' ILE . . . -55.76 -53.66 53.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 85' ' ' PHE . 76.0 mm-40 -60.01 -35.14 74.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.357 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.554 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 33.6 m -51.7 -48.04 63.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.461 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.874 ' HB1' HG21 ' A' ' 120' ' ' ILE . . . -91.37 -0.99 57.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.633 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 44.3 t-20 -85.61 -72.83 0.47 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.001 . . . . 0.0 109.744 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 21.4 mttt -126.72 -28.52 2.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.091 -1.005 . . . . 0.0 109.917 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.576 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 91.9 mt-10 -60.56 -31.98 71.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.033 . . . . 0.0 109.866 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -58.14 -59.88 11.91 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.503 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.8 Cg_endo -66.94 -33.23 33.48 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.664 2.242 . . . . 0.0 111.606 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.599 ' CE2' ' ND2' ' A' ' 101' ' ' ASN . 76.3 t80 -70.26 -35.43 73.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -0.887 . . . . 0.0 109.043 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.576 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 10.8 m0 -63.8 -50.78 67.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.374 -0.829 . . . . 0.0 109.192 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.568 ' HG2' ' CE1' ' A' ' 103' ' ' PHE . 4.5 mtpm? -47.97 -41.9 26.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 109.415 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 62.3 p -62.37 -34.33 76.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.599 ' ND2' ' CE2' ' A' ' 97' ' ' TYR . 78.1 m-20 -85.29 7.56 21.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 77.71 29.97 53.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.568 ' CE1' ' HG2' ' A' ' 99' ' ' LYS . 74.3 m-85 62.38 43.68 7.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 109.456 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 109' ' ' LYS . 13.1 p -118.18 135.7 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.875 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 109' ' ' LYS . 46.7 t30 -89.54 121.48 31.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.505 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -61.02 -32.5 72.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -59.28 -39.03 81.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -134.81 -73.26 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.629 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.2 OUTLIER 176.83 -66.32 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.448 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 109' ' ' LYS . 51.0 Cg_endo -70.99 122.2 8.57 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.723 2.282 . . . . 0.0 111.801 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.971 ' HB3' HD11 ' A' ' 114' ' ' ILE . 19.3 tp -61.16 -37.06 81.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.315 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 23.8 mttm 61.81 146.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.569 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.538 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 50.4 m80 64.61 41.14 5.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.519 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.971 HD11 ' HB3' ' A' ' 111' ' ' LEU . 40.6 mm -72.46 -42.84 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.305 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.7 m -62.12 -40.23 95.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.273 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 67.8 mttm -62.8 -44.27 96.61 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.387 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.714 ' HB3' HD21 ' A' ' 95' ' ' LEU . 24.0 m95 -78.7 -31.69 46.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.295 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -57.88 -41.09 81.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.976 . . . . 0.0 109.343 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.3 m -60.81 -48.1 83.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.333 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.874 HG21 ' HB1' ' A' ' 91' ' ' ALA . 76.7 mt -70.36 -35.32 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.435 ' O ' ' OG ' ' A' ' 125' ' ' SER . . . -63.77 -34.68 78.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.369 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 126' ' ' MET . 82.5 tt0 -62.44 -36.42 82.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 19.9 m -79.97 -48.97 12.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.412 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.07 -35.93 74.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.848 . . . . 0.0 109.391 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 121' ' ' ALA . 43.4 m -63.33 -32.93 74.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.422 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 89.8 mtp -66.88 -34.41 77.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.873 . . . . 0.0 109.476 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.81 135.64 0.36 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.404 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.0 Cg_endo -69.6 -2.49 10.15 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.694 2.263 . . . . 0.0 111.57 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 128' ' ' PRO . 88.4 m-20 -43.46 -36.88 2.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 109.344 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.777 HD11 ' HB2' ' A' ' 72' ' ' LEU . 50.0 mt -66.94 116.52 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.573 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.3 m -106.91 144.49 33.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 109.371 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.771 HG22 ' HB1' ' A' ' 88' ' ' ALA . 72.7 mt -125.23 137.46 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 109.496 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.527 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 95.1 mt-30 -135.35 159.3 42.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.576 ' CG ' ' HB3' ' A' ' 85' ' ' PHE . 72.0 t60 -101.6 132.67 47.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.576 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.52 ' HB2' ' CG2' ' A' ' 81' ' ' ILE . 43.6 tp10 -124.16 150.86 44.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.474 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 4.8 tttm 49.16 -149.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.446 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.15 -115.11 5.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -110.54 131.38 55.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -1.135 . . . . 0.0 109.511 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 47.93 70.65 1.95 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.566 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.432 ' HB3' ' HA ' ' A' ' 136' ' ' LYS . 50.3 Cg_endo -70.53 139.17 36.96 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.693 2.262 . . . . 0.0 111.744 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . 1.028 HG22 ' OG1' ' A' ' 143' ' ' THR . 46.2 m -63.29 -36.83 84.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.506 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 140' ' ' PRO . 72.2 m-20 57.0 43.11 25.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.028 ' OG1' HG22 ' A' ' 141' ' ' THR . 0.2 OUTLIER -144.15 14.1 1.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.486 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 89.7 p -116.62 154.14 31.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.431 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.9 pt -68.6 -16.26 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.513 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -65.9 -28.66 69.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.455 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.7 m -49.15 -52.67 24.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.02 -49.51 63.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.398 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.32 -38.77 57.75 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -59.37 -42.36 91.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.183 . . . . 0.0 109.397 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.94 79.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.6 mt -59.97 -46.66 88.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 0.0 109.452 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.663 ' HA ' HD12 ' A' ' 156' ' ' LEU . . . -59.65 -38.91 82.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.469 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 91.6 m-20 -57.28 -42.64 82.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.419 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 31.5 mttp -62.34 -40.65 97.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 109.449 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.856 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.5 mt -64.04 -43.52 95.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.443 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.41 -46.25 89.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 43.4 m -58.42 -41.92 86.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 96.3 mt-30 -63.07 -33.91 76.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -57.6 -41.74 93.76 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.418 ' HB2' HD12 ' A' ' 17' ' ' ILE . 70.5 p -65.19 -31.52 72.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -1.159 . . . . 0.0 109.45 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -68.67 -28.19 66.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 109.509 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.8 t -67.07 -22.18 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.954 . . . . 0.0 109.509 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.45 134.79 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.471 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.477 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.27 77.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -1.152 . . . . 0.0 109.483 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.617 ' HE2' ' CE2' ' A' ' 37' ' ' TYR . 88.6 mmm -62.68 -37.21 85.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.499 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.03 -24.73 51.79 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -49.77 -47.16 51.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -1.093 . . . . 0.0 109.46 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.511 ' CE2' HD21 ' A' ' 79' ' ' LEU . 29.6 m-85 -96.36 167.83 10.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -73.48 -34.16 65.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.868 . . . . 0.0 109.098 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.566 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -179.15 -166.84 35.7 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.626 HG22 ' HB2' ' A' ' 79' ' ' LEU . 77.5 t -133.51 140.87 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.276 -1.132 . . . . 0.0 109.055 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.632 ' CE2' ' ND1' ' A' ' 34' ' ' HIS . 5.4 m-85 -113.24 147.33 37.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.844 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE1' HG13 ' A' ' 81' ' ' ILE . 96.9 m-85 -116.87 130.22 56.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 108.935 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.786 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 33.5 p -119.39 149.8 41.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.993 . . . . 0.0 109.933 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.02 163.07 37.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.437 -0.789 . . . . 0.0 109.203 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.436 ' CA ' ' OE2' ' A' ' 60' ' ' GLU . . . -139.53 118.73 1.55 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.2 m -123.2 143.95 49.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -1.16 . . . . 0.0 109.468 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 27' ' ' ASN . . . -142.99 155.6 44.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.1 mt -119.9 138.33 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 109.401 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -114.94 144.21 43.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.945 . . . . 0.0 109.574 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -125.37 170.39 9.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.312 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 19' ' ' SER . 47.6 Cg_endo -68.38 -35.69 17.64 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.683 2.255 . . . . 0.0 111.596 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -120.88 70.37 18.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.175 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.09 60.54 1.33 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.768 2.312 . . . . 0.0 111.812 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.9 p -60.16 -26.56 66.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.357 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 25' ' ' SER . 88.5 mttt -112.2 30.42 7.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.442 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 24' ' ' LYS . 0.5 OUTLIER 68.72 163.5 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.615 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -69.01 163.39 24.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.53 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.643 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 80.7 m-20 -91.53 144.35 25.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.394 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -140.52 154.67 46.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -156.77 150.23 21.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.757 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 69.2 mtm -113.99 168.82 9.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -1.105 . . . . 0.0 109.432 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -152.96 115.45 0.68 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.604 HD13 ' CD1' ' A' ' 49' ' ' ILE . 5.4 mp -125.87 118.9 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.132 . . . . 0.0 109.253 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 45' ' ' ASN . 10.3 p -118.63 151.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.72 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.632 ' ND1' ' CE2' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -104.11 136.95 42.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 109.253 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.55 158.4 34.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.624 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.893 ' HB ' HD11 ' A' ' 44' ' ' LEU . 14.4 t -125.58 164.42 20.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 109.384 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.617 ' CE2' ' HE2' ' A' ' 3' ' ' MET . 86.5 m-85 -116.68 8.38 13.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.184 -0.947 . . . . 0.0 109.619 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.587 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.65 -179.42 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 108.946 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.8 Cg_endo -65.95 -5.12 11.39 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.08 1.853 . . . . 0.0 111.749 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -125.84 106.02 9.37 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.945 ' CD1' HD11 ' A' ' 145' ' ' ILE . 78.9 t80 -73.74 122.89 23.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.196 -0.94 . . . . 0.0 109.531 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -168.0 117.78 0.79 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.88 . . . . 0.0 109.203 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.627 HG11 HD13 ' A' ' 152' ' ' LEU . 1.4 m -47.94 123.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -0.93 . . . . 0.0 109.399 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.893 HD11 ' HB ' ' A' ' 36' ' ' THR . 5.8 mp -65.68 -38.31 88.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.661 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.576 ' O ' HG23 ' A' ' 33' ' ' VAL . 57.2 t-20 -175.27 155.02 1.82 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 109.88 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 89.8 mt-30 -112.37 150.55 30.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.809 . . . . 0.0 108.892 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.1 t-105 -128.78 131.16 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.989 . . . . 0.0 109.664 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -122.39 133.36 54.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.412 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.604 ' CD1' HD13 ' A' ' 32' ' ' ILE . 3.6 mp -134.1 88.42 31.43 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.88 139.22 39.28 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.728 2.286 . . . . 0.0 111.728 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.832 ' N ' HD12 ' A' ' 51' ' ' LEU . 3.0 mp -106.04 147.88 28.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.402 ' HA2' HG11 ' A' ' 164' ' ' VAL . . . -93.21 -67.58 1.08 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -104.89 60.87 0.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -1.145 . . . . 0.0 109.502 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.557 ' CD2' ' HB3' ' A' ' 51' ' ' LEU . 71.9 m-70 -133.16 173.06 11.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 58' ' ' MET . 8.9 t -117.11 173.16 6.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 109.474 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -55.91 -45.54 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.849 . . . . 0.0 109.261 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 60' ' ' GLU . 85.6 mt-30 -58.36 -63.82 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.416 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.471 ' H ' HG23 ' A' ' 55' ' ' THR . 97.9 mtp -43.55 -29.2 0.45 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.485 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.44 -29.17 30.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.372 -0.83 . . . . 0.0 109.611 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 57' ' ' GLN . 62.7 mm-40 -71.08 -34.81 71.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.704 HD11 ' CZ2' ' A' ' 117' ' ' TRP . 13.4 tt -82.1 -34.65 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 109.609 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.757 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -69.61 -26.09 64.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.786 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -67.09 -36.45 82.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.414 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.725 HG22 HG21 ' A' ' 82' ' ' THR . 84.9 t -75.57 -36.67 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 77.6 tt0 -70.4 -37.17 74.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.122 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.525 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 26.1 t80 -60.86 -66.33 0.55 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.398 -0.814 . . . . 0.0 109.508 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.66 -31.15 57.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.551 ' SG ' HD13 ' A' ' 130' ' ' ILE . 33.3 t -55.2 -57.63 10.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 31.9 tttt -63.7 -38.88 92.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 17.6 mmtt -59.84 -32.89 71.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.907 . . . . 0.0 109.47 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' LEU . . . -71.22 -59.8 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.291 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 130' ' ' ILE . 25.8 tp -45.18 -47.27 12.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.278 -0.889 . . . . 0.0 109.296 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 57.4 mttm -44.13 -48.79 9.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.195 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.068 HD12 HG21 ' A' ' 78' ' ' VAL . 4.8 mt -54.65 141.91 54.34 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.056 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.5 Cg_endo -66.07 -7.33 16.75 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.525 2.15 . . . . 0.0 111.483 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.94 161.19 21.88 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.0 Cg_endo -69.05 146.67 65.34 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.437 2.091 . . . . 0.0 111.747 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.068 HG21 HD12 ' A' ' 74' ' ' ILE . 25.4 t -134.78 159.36 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.335 -0.853 . . . . 0.0 109.562 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.632 HD12 ' C ' ' A' ' 78' ' ' VAL . 7.1 mp -109.02 132.41 54.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.542 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.5 t -103.18 133.15 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.203 -0.936 . . . . 0.0 109.433 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.813 HG21 ' OE2' ' A' ' 135' ' ' GLU . 21.2 mm -106.13 132.52 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.366 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.725 HG21 HG22 ' A' ' 64' ' ' VAL . 1.1 p -133.42 161.71 33.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.529 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -92.7 6.99 45.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.516 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.511 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 41.3 t -130.28 123.76 30.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.918 . . . . 0.0 109.603 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.723 ' HB3' ' CD2' ' A' ' 134' ' ' HIS . 40.3 p90 -77.05 -43.0 36.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.535 ' N ' ' CG ' ' A' ' 85' ' ' PHE . 69.9 t80 -47.16 -50.25 20.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.88 . . . . 0.0 109.447 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.726 HG23 ' HH2' ' A' ' 117' ' ' TRP . 7.2 p -66.71 -47.76 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.343 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.596 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -54.04 -46.96 72.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.26 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 98.2 mt-10 -65.22 -35.47 81.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.331 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.577 ' HB2' ' CH2' ' A' ' 117' ' ' TRP . 68.3 m -52.74 -44.48 66.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.472 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.747 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -96.43 -0.89 48.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 51.7 t30 -92.56 -72.74 0.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.031 . . . . 0.0 109.751 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 48.2 mttm -126.64 -27.67 3.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.49 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 87.3 mt-10 -61.23 -31.46 71.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.871 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 91' ' ' ALA . 0.6 OUTLIER -56.05 -60.2 9.56 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.681 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 45.6 Cg_endo -67.4 -34.55 26.3 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.727 2.285 . . . . 0.0 111.702 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -68.59 -36.45 78.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.227 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.673 ' CE3' HD21 ' A' ' 111' ' ' LEU . 13.8 m0 -65.05 -47.45 77.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.559 ' HG2' ' CE1' ' A' ' 103' ' ' PHE . 87.6 mttt -43.03 -43.97 4.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.865 . . . . 0.0 109.436 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.5 p -63.49 -34.81 78.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.387 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.848 ' O ' HG12 ' A' ' 104' ' ' VAL . 72.8 m-20 -84.58 7.84 18.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 82.77 30.49 32.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.559 ' CE1' ' HG2' ' A' ' 99' ' ' LYS . 56.4 m-85 64.29 27.3 13.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -1.182 . . . . 0.0 109.493 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 101' ' ' ASN . 9.9 p -125.52 125.63 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.471 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -59.59 -35.76 74.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.421 ' O ' ' O ' ' A' ' 109' ' ' LYS . 43.0 t-20 -173.39 150.05 1.8 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -57.71 -26.59 61.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.537 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -65.3 -36.07 82.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.423 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 106' ' ' ASN . 5.5 mttt -148.06 143.43 17.63 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.635 ' HA ' HG23 ' A' ' 104' ' ' VAL . 50.3 Cg_endo -70.29 151.5 66.07 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.646 2.23 . . . . 0.0 111.915 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.673 HD21 ' CE3' ' A' ' 98' ' ' TRP . 20.6 tp -57.06 -37.96 72.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.434 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 83.7 mttt 62.74 139.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.56 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 54.0 m80 65.52 26.51 11.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -0.819 . . . . 0.0 109.637 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.783 HG22 ' HE3' ' A' ' 118' ' ' LYS . 66.6 mt -64.29 -42.47 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.274 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -53.84 -46.23 71.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.161 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -58.51 -42.07 86.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.854 . . . . 0.0 109.251 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.726 ' HH2' HG23 ' A' ' 87' ' ' VAL . 16.3 m95 -67.67 -34.14 76.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.783 ' HE3' HG22 ' A' ' 114' ' ' ILE . 62.3 mttt -60.12 -36.37 77.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.332 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.428 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 25.3 m -66.28 -44.4 83.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.338 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.747 HG21 ' CB ' ' A' ' 91' ' ' ALA . 74.4 mt -66.64 -38.73 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.426 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.447 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -62.21 -35.88 80.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.387 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 126' ' ' MET . 82.9 tt0 -54.12 -39.84 66.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.872 . . . . 0.0 109.398 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.9 m -77.39 -46.5 22.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 0.0 109.4 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 59.9 mt -61.42 -36.83 81.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.417 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.5 m -60.53 -34.13 73.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.402 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.442 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 89.3 mtp -64.17 -30.77 71.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.915 . . . . 0.0 109.511 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 176.27 136.32 0.19 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.532 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.58 -0.09 7.06 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.74 2.293 . . . . 0.0 111.805 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 93.6 m-20 -50.2 -21.57 1.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 72' ' ' LEU . 68.0 mt -81.15 114.52 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.64 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 55.6 m -112.17 135.28 53.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.601 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 75.6 mt -116.57 138.75 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.105 -0.997 . . . . 0.0 109.682 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.587 ' NE2' HD23 ' A' ' 79' ' ' LEU . 94.7 mt-30 -124.68 159.45 30.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.723 ' CD2' ' HB3' ' A' ' 85' ' ' PHE . 60.7 t60 -119.54 142.18 48.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.813 ' OE2' HG21 ' A' ' 81' ' ' ILE . 92.9 mt-10 -106.0 145.06 31.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.451 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' HB2' ' HG2' ' A' ' 139' ' ' GLN . 80.8 mttt -92.6 37.86 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.69 -107.84 1.31 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -95.93 102.16 13.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -1.169 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.425 ' HB2' ' HD2' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -149.34 158.21 38.49 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.414 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 139' ' ' GLN . 50.2 Cg_endo -70.25 126.46 13.01 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.742 2.295 . . . . 0.0 111.854 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 143' ' ' THR . 62.1 m -122.33 144.75 48.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -52.65 -34.53 51.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.538 ' H ' HG22 ' A' ' 141' ' ' THR . 28.0 p -126.55 150.95 48.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 109.493 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.1 p -91.97 2.34 56.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.649 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.945 HD11 ' CD1' ' A' ' 41' ' ' TYR . 20.7 tt -69.62 -33.04 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.554 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -69.71 -29.88 67.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.605 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.8 m -67.18 -42.98 83.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.506 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.459 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 97.9 mt-10 -60.06 -36.66 77.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.51 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -69.3 -24.85 75.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -75.52 -33.88 60.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -1.118 . . . . 0.0 109.471 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -74.74 -41.45 60.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.627 HD13 HG11 ' A' ' 43' ' ' VAL . 68.9 mt -64.87 -38.2 90.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 0.0 109.55 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.13 -39.58 75.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -65.84 -39.38 90.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.125 -0.984 . . . . 0.0 109.464 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 66.8 mttm -64.85 -35.41 81.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.55 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 39.9 mt -68.19 -40.26 82.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 109.58 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.42 92.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.52 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 38.4 m -58.38 -44.06 88.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.519 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -61.94 -37.08 83.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.534 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.0 -48.2 84.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 164' ' ' VAL . 85.8 p -64.84 -33.45 76.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -1.148 . . . . 0.0 109.59 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -63.44 -38.41 91.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 68.7 t -57.06 -38.17 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 51' ' ' LEU . 41.2 t -105.37 134.69 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.517 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.515 ' HA ' ' ND2' ' A' ' 27' ' ' ASN . 84.4 m-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.453 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.19 146.23 44.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -1.16 . . . . 0.0 109.415 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.551 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 56.8 mtp -66.29 -28.12 68.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.37 -14.87 43.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.476 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 95.3 mt-30 -57.83 -44.49 86.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.177 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.856 ' CD2' HD11 ' A' ' 79' ' ' LEU . 49.5 p90 -91.75 154.41 18.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.481 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.744 ' HG3' HG22 ' A' ' 78' ' ' VAL . 2.6 pp20? -89.54 -27.08 20.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.589 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.4 -174.61 31.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.501 HG13 ' CE2' ' A' ' 11' ' ' TYR . 14.6 p -130.43 143.7 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -1.141 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.669 ' CD2' HG11 ' A' ' 78' ' ' VAL . 26.5 m-85 -119.44 123.6 44.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.932 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.643 ' CE1' HD12 ' A' ' 81' ' ' ILE . 87.7 m-85 -105.81 130.83 53.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.816 HG22 HD12 ' A' ' 32' ' ' ILE . 15.8 p -119.93 150.75 39.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.508 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 57.3 t0 -142.64 151.47 41.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -133.64 119.19 2.24 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.6 m -127.85 152.22 48.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -1.172 . . . . 0.0 109.5 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 27' ' ' ASN . . . -137.62 156.05 48.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 109.453 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.9 mt -123.7 140.84 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.928 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -107.21 132.66 52.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.52 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.513 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -119.31 162.05 33.98 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.235 -0.916 . . . . 0.0 109.33 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.94 -45.81 1.36 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.724 2.282 . . . . 0.0 111.765 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.469 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -56.79 -60.48 9.28 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.501 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.513 ' CG ' ' HB2' ' A' ' 19' ' ' SER . 50.6 Cg_endo -71.26 66.66 2.7 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.626 2.217 . . . . 0.0 111.626 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 m -54.81 -50.07 69.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.388 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -97.64 29.08 3.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.388 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.463 ' HB2' ' CB ' ' A' ' 22' ' ' PRO . 75.8 m -146.29 146.94 30.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.938 . . . . 0.0 109.532 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -143.39 152.99 42.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 70.3 m-20 -86.63 145.19 26.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.632 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -140.29 150.22 43.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.93 165.24 30.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.844 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 56.0 mtm -132.7 152.79 51.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -1.109 . . . . 0.0 109.291 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.37 125.22 2.97 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.816 HD12 HG22 ' A' ' 12' ' ' THR . 19.1 mm -111.08 142.51 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -1.154 . . . . 0.0 109.301 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.3 t -136.64 123.52 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.159 -0.963 . . . . 0.0 109.756 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 1.012 ' CD2' HD12 ' A' ' 44' ' ' LEU . 23.6 t60 -101.01 138.27 38.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.141 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.25 163.18 33.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 109.836 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.0 t -123.16 164.96 17.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.415 -0.803 . . . . 0.0 109.172 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 38' ' ' LYS . 83.8 m-85 -103.49 9.47 37.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.094 -1.004 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.578 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 2.0 mtmt -51.21 -179.25 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.8 Cg_endo -65.13 -5.78 11.7 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.039 1.826 . . . . 0.0 111.649 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -127.28 105.74 8.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.339 -0.85 . . . . 0.0 108.741 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -74.01 126.81 31.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.43 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -167.33 148.3 5.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 109.589 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.6 m -71.47 121.96 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.365 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.012 HD12 ' CD2' ' A' ' 34' ' ' HIS . 41.0 mt -65.06 -43.95 90.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.327 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 76.8 m-20 -159.17 147.79 18.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.377 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.924 ' HB3' HD21 ' A' ' 156' ' ' LEU . 90.6 mt-30 -106.85 144.26 33.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.402 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.81 138.53 45.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 0.0 109.714 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.413 ' C ' HD12 ' A' ' 49' ' ' ILE . 96.5 p -130.85 144.87 51.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.353 -0.842 . . . . 0.0 109.273 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 4.7 mp -138.35 97.28 9.55 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.554 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.81 137.43 32.38 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.641 2.227 . . . . 0.0 111.711 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' A' ' 28' ' ' ALA . 39.4 mt -103.67 141.02 36.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.63 -66.54 0.94 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -115.58 61.12 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.154 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 74.7 m80 -130.26 -176.66 4.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.409 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.514 HG22 ' HG3' ' A' ' 58' ' ' MET . 15.3 t -126.96 168.01 15.1 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.898 . . . . 0.0 109.542 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.69 -36.59 62.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.512 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -60.9 -41.06 95.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 55' ' ' THR . 65.6 mtt -65.62 -32.95 74.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' HG2' ' A' ' 30' ' ' MET . . . -66.91 -34.05 76.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.596 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.78 -41.69 68.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.885 . . . . 0.0 109.582 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 58' ' ' MET . 17.9 tt -73.71 -34.77 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.633 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.844 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -75.82 -30.13 58.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.592 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -65.27 -39.71 92.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.822 HG21 HG12 ' A' ' 87' ' ' VAL . 89.7 t -73.26 -40.4 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.636 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.469 ' HG3' HG12 ' A' ' 120' ' ' ILE . 83.7 tt0 -68.72 -40.06 80.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 109.231 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.63 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 31.3 t80 -52.37 -64.15 0.91 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 109.634 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.623 ' HB3' HG11 ' A' ' 80' ' ' VAL . . . -62.75 -27.63 69.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.675 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.638 ' SG ' HG23 ' A' ' 120' ' ' ILE . 48.8 t -58.1 -58.05 10.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.543 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.454 ' HG2' ' SG ' ' A' ' 123' ' ' CYS . 40.3 mttt -61.11 -46.42 90.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.571 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.63 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 65.2 mttm -63.95 -33.99 76.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.35 -60.25 3.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.512 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.584 ' HB2' HD11 ' A' ' 130' ' ' ILE . 18.8 tp -57.66 -36.01 71.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -51.81 -43.46 63.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -0.918 . . . . 0.0 109.369 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.704 HG13 HG21 ' A' ' 78' ' ' VAL . 35.5 mm -48.36 143.04 7.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.898 . . . . 0.0 108.886 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.6 Cg_endo -64.36 -6.06 11.04 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.541 2.161 . . . . 0.0 111.724 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.449 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -139.23 171.73 23.53 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.476 ' HG2' ' O ' ' A' ' 5' ' ' GLN . 48.3 Cg_endo -69.04 134.49 29.63 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.449 2.099 . . . . 0.0 111.676 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.744 HG22 ' HG3' ' A' ' 7' ' ' GLU . 32.1 t -127.41 167.67 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 109.26 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.856 HD11 ' CD2' ' A' ' 6' ' ' TYR . 3.9 mt -125.87 127.58 46.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.291 -0.881 . . . . 0.0 109.78 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.623 HG11 ' HB3' ' A' ' 67' ' ' ALA . 34.7 t -101.44 133.01 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 109.235 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.643 HD12 ' CE1' ' A' ' 11' ' ' TYR . 23.5 mt -117.04 134.13 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.5 t -142.81 159.96 41.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.248 -0.907 . . . . 0.0 109.503 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 50.6 p-10 -83.9 -4.65 58.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.516 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.518 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 63.5 m -77.95 97.23 5.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.386 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.584 ' HA ' ' CD2' ' A' ' 134' ' ' HIS . 97.6 m-85 -64.16 -49.57 71.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 109.381 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -63.23 -52.25 62.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.65 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.822 HG12 HG21 ' A' ' 64' ' ' VAL . 38.8 t -55.88 -59.9 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.923 . . . . 0.0 109.591 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.944 ' HB3' ' NE2' ' A' ' 134' ' ' HIS . . . -43.57 -57.62 3.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.436 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.466 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 98.0 mt-10 -53.98 -40.74 67.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.463 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.567 ' CB ' ' CZ3' ' A' ' 117' ' ' TRP . 50.0 m -47.26 -52.13 16.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.689 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -89.7 -0.98 57.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.673 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 44.5 t-20 -82.14 -72.67 0.43 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.652 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 96.3 mttt -126.5 -22.7 3.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.075 -1.016 . . . . 0.0 110.062 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 96.3 mt-10 -67.13 -25.6 66.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.039 . . . . 0.0 109.66 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.868 HD11 ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -54.57 -58.77 12.62 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.598 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 45.9 Cg_endo -67.16 -32.31 34.16 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.554 2.169 . . . . 0.0 111.464 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -66.01 -40.21 90.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 108.982 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.806 ' CE3' HD21 ' A' ' 111' ' ' LEU . 39.8 m0 -62.74 -50.48 70.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -0.766 . . . . 0.0 109.192 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.633 ' CD ' ' CZ ' ' A' ' 103' ' ' PHE . 22.6 tptm -43.03 -42.9 4.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.336 -0.852 . . . . 0.0 109.364 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 m -60.13 -39.18 85.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.375 -0.828 . . . . 0.0 109.361 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 98' ' ' TRP . 78.9 m-20 -87.48 11.43 14.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.449 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 104' ' ' VAL . . . 76.04 38.6 34.87 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.633 ' CZ ' ' CD ' ' A' ' 99' ' ' LYS . 75.0 m-85 63.7 32.35 13.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -1.174 . . . . 0.0 109.418 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 110' ' ' PRO . 45.2 t -128.64 123.13 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.491 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -59.6 -39.97 85.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.513 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 109' ' ' LYS . 41.7 t-20 -160.36 145.59 14.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -58.59 -23.22 58.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.315 -0.866 . . . . 0.0 109.425 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.27 -37.77 86.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.923 . . . . 0.0 109.391 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.451 ' O ' ' O ' ' A' ' 106' ' ' ASN . 0.3 OUTLIER -144.17 148.69 42.4 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.468 ' HA ' HG13 ' A' ' 104' ' ' VAL . 49.6 Cg_endo -70.56 154.97 64.2 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.682 2.255 . . . . 0.0 111.777 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.806 HD21 ' CE3' ' A' ' 98' ' ' TRP . 33.2 tp -62.4 -31.32 71.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.373 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.71 ' HG2' ' CD2' ' A' ' 113' ' ' HIS . 51.9 tttp 67.11 140.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.475 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.71 ' CD2' ' HG2' ' A' ' 112' ' ' LYS . 93.6 m-70 62.35 27.81 16.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.399 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.45 HG12 ' HB3' ' A' ' 111' ' ' LEU . 77.1 mt -60.96 -41.21 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 109.436 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.9 m -55.47 -46.55 76.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.4 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -60.37 -47.06 87.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.502 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.567 ' CZ3' ' CB ' ' A' ' 90' ' ' SER . 88.1 m95 -68.03 -33.61 74.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -56.21 -44.28 79.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.481 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.457 ' HB2' ' OE2' ' A' ' 65' ' ' GLU . 36.2 m -58.2 -43.4 87.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.638 HG23 ' SG ' ' A' ' 68' ' ' CYS . 78.0 mt -66.38 -40.13 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.978 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.868 ' HB2' HD11 ' A' ' 95' ' ' LEU . . . -62.98 -35.27 79.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.44 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -56.65 -35.48 68.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.454 ' SG ' ' HG2' ' A' ' 69' ' ' LYS . 77.7 m -80.02 -49.2 12.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.469 HD23 HD12 ' A' ' 130' ' ' ILE . 51.9 mt -57.98 -37.0 73.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 25.5 m -58.77 -33.42 70.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.33 -0.856 . . . . 0.0 109.501 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 90.0 mtp -63.9 -37.67 88.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 177.3 143.44 0.26 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.1 Cg_endo -69.65 -1.35 8.23 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.722 2.281 . . . . 0.0 111.749 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 128' ' ' PRO . 88.3 m-20 -43.4 -35.22 1.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.441 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.584 HD11 ' HB2' ' A' ' 72' ' ' LEU . 67.5 mt -69.74 121.47 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.421 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.737 ' HB ' HD22 ' A' ' 79' ' ' LEU . 23.8 m -119.06 143.48 47.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.369 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.658 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 70.6 mt -122.78 130.72 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.446 ' HB2' HG12 ' A' ' 81' ' ' ILE . 89.9 mt-30 -125.01 153.54 42.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.392 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.944 ' NE2' ' HB3' ' A' ' 88' ' ' ALA . 37.3 m170 -89.74 133.33 34.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.605 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.631 ' HG2' HG22 ' A' ' 81' ' ' ILE . 96.2 mt-10 -69.96 140.38 52.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.799 . . . . 0.0 109.519 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 137' ' ' GLY . 40.1 mttm -87.89 69.25 9.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 109.419 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -43.8 -88.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.517 ' O ' ' CB ' ' A' ' 139' ' ' GLN . 43.2 m80 -127.97 137.51 52.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.181 -1.188 . . . . 0.0 109.506 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.578 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.7 OUTLIER 164.29 -65.66 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 139' ' ' GLN . 48.2 Cg_endo -72.02 -59.84 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.587 2.191 . . . . 0.0 111.924 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 143' ' ' THR . 48.8 p -136.63 173.98 11.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.344 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -64.2 -40.21 95.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.296 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.418 ' O ' ' OG1' ' A' ' 141' ' ' THR . 17.7 p -134.31 160.88 36.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 109.289 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 147' ' ' THR . 56.6 p -146.01 162.3 38.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.566 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 80.6 mt -56.29 -46.29 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.535 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -66.57 -24.74 66.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.471 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 144' ' ' SER . 95.2 m -58.56 -42.86 88.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -52.36 -45.25 65.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.595 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.41 -36.96 91.25 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -65.1 -33.84 76.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -1.169 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.427 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -64.98 -52.29 57.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.9 mp -65.45 -46.73 78.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.592 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.53 80.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.533 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -63.17 -34.93 78.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 69.5 mttt -63.03 -43.5 98.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.511 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.924 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.4 mp -71.82 -37.18 70.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.55 -43.09 91.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 109.56 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 36.6 m -63.79 -41.37 97.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.605 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.876 ' O ' HG23 ' A' ' 163' ' ' VAL . 94.2 mt-30 -61.74 -35.73 78.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.575 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.57 -51.45 58.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 164' ' ' VAL . 25.0 m -64.56 -37.19 86.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -1.182 . . . . 0.0 109.672 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -64.1 -33.96 76.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 159' ' ' GLN . 45.8 t -65.86 -15.05 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 161' ' ' SER . 47.3 t -129.12 156.7 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.469 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 67.9 m-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.57 157.6 6.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -1.19 . . . . 0.0 109.457 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.435 ' HE1' ' CE1' ' A' ' 37' ' ' TYR . 68.7 mtm -69.3 -41.4 76.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.36 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.573 ' HA3' ' CZ ' ' A' ' 6' ' ' TYR . . . -120.51 24.82 7.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 95.1 mt-30 62.66 44.54 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -1.13 . . . . 0.0 109.752 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.63 ' CE2' ' CD2' ' A' ' 79' ' ' LEU . 17.8 m-85 -103.36 162.15 13.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.272 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.41 ' HG3' HG22 ' A' ' 74' ' ' ILE . 77.1 mm-40 -69.58 -33.94 73.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 108.931 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.27 -168.75 38.77 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.907 ' CG1' ' HB3' ' A' ' 35' ' ' ALA . 7.8 p -123.0 145.19 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.241 -1.153 . . . . 0.0 109.115 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.869 ' CE1' HG21 ' A' ' 78' ' ' VAL . 9.4 m-85 -122.48 137.42 54.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 109.859 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.739 ' CE1' HD12 ' A' ' 81' ' ' ILE . 92.6 m-85 -118.24 126.75 52.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.317 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.937 HG22 HD12 ' A' ' 32' ' ' ILE . 27.5 p -117.75 144.22 45.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 43.8 t0 -143.2 149.92 38.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.407 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -129.69 123.18 4.01 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m -129.36 147.75 51.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -1.102 . . . . 0.0 109.313 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 27' ' ' ASN . . . -137.81 151.8 48.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -0.96 . . . . 0.0 109.628 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 20.4 mt -120.23 149.06 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.855 . . . . 0.0 109.262 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -108.61 146.66 33.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.11 -0.994 . . . . 0.0 109.666 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.563 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.7 OUTLIER -94.48 179.95 1.11 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 0.0 109.053 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 50.5 Cg_endo -71.27 -23.71 23.94 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.233 1.955 . . . . 0.0 111.614 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.42 ' N ' ' HD3' ' A' ' 22' ' ' PRO . 1.3 m-20 -131.83 62.74 65.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 109.078 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 19' ' ' SER . 55.4 Cg_endo -81.87 62.67 8.24 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.768 2.312 . . . . 0.0 112.004 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.511 ' O ' ' CG ' ' A' ' 24' ' ' LYS . 48.8 m -55.06 -44.32 74.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.202 -0.936 . . . . 0.0 109.151 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 23' ' ' THR . 35.9 mttp -159.9 38.33 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 109.384 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 39.8 t -149.55 135.5 18.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 109.577 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 25' ' ' SER . 97.1 m-20 -143.41 155.51 44.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.4 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.586 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 85.5 m-20 -83.31 137.22 34.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -137.81 151.25 47.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.417 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.434 ' HA2' ' CD1' ' A' ' 51' ' ' LEU . . . -154.3 162.6 30.7 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.74 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 74.0 mtm -127.41 168.52 14.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -1.121 . . . . 0.0 109.479 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.711 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -152.96 113.76 0.59 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.937 HD12 HG22 ' A' ' 12' ' ' THR . 10.9 mm -119.44 114.09 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.166 . . . . 0.0 109.338 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.556 ' CG2' ' HG2' ' A' ' 46' ' ' GLN . 7.5 p -118.52 148.01 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.2 -0.938 . . . . 0.0 109.691 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.638 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 1.7 m-70 -101.62 145.01 29.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 109.118 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.907 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -136.9 166.81 22.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.109 -0.995 . . . . 0.0 109.677 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.748 ' HB ' HD11 ' A' ' 44' ' ' LEU . 9.9 t -123.24 165.41 16.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.352 -0.842 . . . . 0.0 109.458 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.435 ' CE1' ' HE1' ' A' ' 3' ' ' MET . 55.2 m-85 -105.94 10.84 32.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 3.1 mtpt -51.18 178.76 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.839 . . . . 0.0 109.103 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.5 Cg_endo -65.09 -6.19 12.47 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.187 1.925 . . . . 0.0 111.663 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -131.23 106.28 8.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 108.982 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 48.9 t80 -58.54 127.62 33.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 81.2 mt-30 -159.45 141.92 13.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.51 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 43' ' ' VAL . 25.0 m -78.93 122.38 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.748 HD11 ' HB ' ' A' ' 36' ' ' THR . 7.4 mp -67.09 -42.96 83.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' O ' HG23 ' A' ' 33' ' ' VAL . 74.3 m-20 -160.41 149.95 17.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.645 ' HB3' HD21 ' A' ' 156' ' ' LEU . 90.2 mt-30 -110.22 150.93 27.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.199 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.7 t-105 -133.31 137.16 45.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.005 . . . . 0.0 109.8 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.1 t -125.74 132.56 52.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.213 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.689 HD13 ' CD1' ' A' ' 66' ' ' PHE . 6.1 mt -135.53 89.8 21.49 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.951 . . . . 0.0 109.702 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.464 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.3 Cg_endo -71.05 144.57 47.54 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 122.63 2.22 . . . . 0.0 111.596 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.822 HD12 ' N ' ' A' ' 51' ' ' LEU . 3.7 mp -110.93 147.86 33.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.588 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.74 -75.59 1.26 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -98.56 61.74 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.127 . . . . 0.0 109.448 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.452 ' HA ' ' SD ' ' A' ' 58' ' ' MET . 76.6 m80 -131.62 -177.56 4.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.938 . . . . 0.0 109.529 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.416 HG22 ' HG3' ' A' ' 58' ' ' MET . 15.3 t -128.22 166.84 17.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 0.0 109.5 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -48.13 -44.73 32.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.94 . . . . 0.0 109.331 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 60' ' ' GLU . 86.2 mt-30 -55.2 -58.17 8.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.303 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.452 ' SD ' ' HA ' ' A' ' 54' ' ' HIS . 62.1 mtt -44.81 -34.62 2.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.266 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.4 -31.51 60.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.319 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 57' ' ' GLN . 96.5 mt-10 -72.66 -38.35 67.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.327 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.774 ' HA ' HG21 ' A' ' 87' ' ' VAL . 7.3 tt -81.53 -38.47 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.74 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -66.06 -36.48 83.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.352 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.56 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -55.91 -48.18 76.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.367 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.793 HG21 HG13 ' A' ' 87' ' ' VAL . 78.4 t -64.04 -48.98 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.8 tt0 -58.24 -43.94 88.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.689 ' CD1' HD13 ' A' ' 49' ' ' ILE . 13.0 t80 -54.63 -68.12 0.21 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.37 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HB3' HG11 ' A' ' 80' ' ' VAL . . . -56.48 -19.21 14.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.204 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.979 ' SG ' HG23 ' A' ' 120' ' ' ILE . 19.3 t -66.46 -64.94 0.75 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.269 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -58.66 -46.38 87.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -58.36 -30.08 66.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.907 . . . . 0.0 109.263 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.861 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -67.35 -63.87 0.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.562 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.941 ' HB2' HD11 ' A' ' 130' ' ' ILE . 22.8 tp -50.18 -44.06 52.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.173 -0.954 . . . . 0.0 109.334 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 72' ' ' LEU . 26.4 tttt -43.27 -48.71 6.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.1 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.681 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 10.6 mt -48.4 143.19 7.58 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.369 -0.832 . . . . 0.0 108.879 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 45.5 Cg_endo -66.36 -2.25 6.85 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.625 2.217 . . . . 0.0 112.124 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.43 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -139.98 167.9 25.24 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.411 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 47.7 Cg_endo -68.94 116.74 4.62 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.446 2.097 . . . . 0.0 111.578 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.869 HG21 ' CE1' ' A' ' 10' ' ' PHE . 6.5 p -109.25 148.53 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.349 -0.845 . . . . 0.0 109.403 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.63 ' CD2' ' CE2' ' A' ' 6' ' ' TYR . 7.4 mp -96.31 138.87 33.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 67' ' ' ALA . 29.9 t -115.78 135.13 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.371 -0.831 . . . . 0.0 109.149 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.739 HD12 ' CE1' ' A' ' 11' ' ' TYR . 15.0 mt -122.44 136.85 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.602 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 t -139.1 160.33 40.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.341 -0.849 . . . . 0.0 109.316 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -81.59 -13.07 58.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.924 . . . . 0.0 109.564 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.542 ' CB ' HG12 ' A' ' 87' ' ' VAL . 29.5 m -93.15 115.62 28.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.565 ' HB2' ' CG ' ' A' ' 134' ' ' HIS . 46.4 t80 -81.4 -38.58 26.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.365 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -55.42 -46.71 76.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.54 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.793 HG13 HG21 ' A' ' 64' ' ' VAL . 14.1 p -70.18 -46.49 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 109.499 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.599 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -56.57 -48.32 77.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.267 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -60.55 -37.34 80.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.537 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 50.2 m -52.47 -55.11 24.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.633 ' HB1' HD11 ' A' ' 124' ' ' LEU . . . -83.73 -0.89 52.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.903 . . . . 0.0 109.628 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 38.6 t-20 -83.15 -72.76 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.951 . . . . 0.0 109.729 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 87.0 mttt -126.71 -25.36 3.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 97.9 mt-10 -69.57 -24.47 63.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.131 -0.98 . . . . 0.0 109.731 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' A' ' 121' ' ' ALA . 0.2 OUTLIER -54.58 -57.34 19.32 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.644 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 46.1 Cg_endo -67.47 -34.36 26.52 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.507 2.138 . . . . 0.0 111.663 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.549 ' CE2' ' ND2' ' A' ' 101' ' ' ASN . 71.2 t80 -65.82 -38.68 89.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.118 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.451 ' CG ' HD11 ' A' ' 111' ' ' LEU . 43.0 m0 -64.72 -49.75 69.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.34 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -47.93 -42.44 27.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -61.08 -38.57 86.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.897 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.549 ' ND2' ' CE2' ' A' ' 97' ' ' TYR . 61.8 m-20 -87.85 11.6 15.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.49 41.71 50.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.635 ' C ' HD12 ' A' ' 111' ' ' LEU . 57.5 m-85 61.84 35.71 16.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.454 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.25 125.9 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 32.5 t30 -55.26 -42.47 73.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -177.07 -149.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.521 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -68.59 122.37 18.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.55 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.3 mttp 55.36 30.28 14.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.844 . . . . 0.0 109.533 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 105' ' ' ASN . 14.9 mttt -130.16 87.3 51.57 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.58 152.92 65.4 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.654 2.236 . . . . 0.0 111.804 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 103' ' ' PHE . 96.4 mt -85.3 139.59 31.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -93.18 148.69 21.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.574 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 48.0 m80 61.53 34.44 17.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.489 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.457 HG12 ' HB2' ' A' ' 111' ' ' LEU . 69.7 mt -54.19 -45.39 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.423 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.6 m -50.82 -48.35 59.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.543 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.1 -35.94 76.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.48 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.537 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 20.1 m95 -70.45 -38.13 74.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 109.516 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -58.83 -39.4 81.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.426 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.6 m -62.51 -43.06 99.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.979 HG23 ' SG ' ' A' ' 68' ' ' CYS . 83.6 mt -71.72 -36.09 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.638 ' HB2' HD11 ' A' ' 95' ' ' LEU . . . -65.29 -34.95 79.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -56.06 -38.47 70.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 61.3 m -81.18 -49.37 10.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.877 . . . . 0.0 109.467 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.633 HD11 ' HB1' ' A' ' 91' ' ' ALA . 54.7 mt -60.52 -31.9 70.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.432 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.4 t -62.38 -33.0 73.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 94.9 mmm -64.73 -38.05 89.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.16 146.48 0.56 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.284 -0.885 . . . . 0.0 109.447 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 129' ' ' ASP . 50.1 Cg_endo -70.79 0.66 6.07 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.739 2.292 . . . . 0.0 111.899 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 128' ' ' PRO . 88.8 m-20 -44.09 -50.53 8.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.398 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.941 HD11 ' HB2' ' A' ' 72' ' ' LEU . 58.3 mt -55.25 113.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.777 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.481 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 54.9 m -110.54 144.18 39.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 108.986 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -124.29 141.45 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 109.83 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.4 mt-30 -128.58 159.56 35.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.389 -0.819 . . . . 0.0 109.184 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.565 ' CG ' ' HB2' ' A' ' 85' ' ' PHE . 32.2 t-80 -119.52 140.29 50.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 109.665 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.541 ' OE2' HG21 ' A' ' 81' ' ' ILE . 94.9 mt-10 -128.4 139.88 52.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.334 -0.854 . . . . 0.0 109.218 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 139' ' ' GLN . 72.1 mttt -104.46 121.81 44.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 0.0 109.482 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.0 -33.52 84.1 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -64.08 -43.77 94.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -1.186 . . . . 0.0 109.361 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 136' ' ' LYS . 15.8 tp60 -109.75 128.35 25.55 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.54 144.23 49.31 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.758 2.305 . . . . 0.0 111.776 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 143' ' ' THR . 21.1 p -73.7 171.85 12.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -56.04 -36.84 68.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 109.529 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.679 HG22 ' H ' ' A' ' 145' ' ' ILE . 33.5 m -116.95 137.19 52.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.518 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 86.1 p -65.51 -23.75 66.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.161 -0.962 . . . . 0.0 109.435 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.679 ' H ' HG22 ' A' ' 143' ' ' THR . 82.5 mt -52.49 -45.89 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.93 . . . . 0.0 109.514 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -65.84 -38.0 87.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.93 . . . . 0.0 109.429 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.5 p -68.79 -41.51 78.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 144' ' ' SER . 97.8 mt-10 -53.94 -38.48 64.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.48 -37.62 94.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -64.44 -42.93 95.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.289 -1.124 . . . . 0.0 109.431 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.5 64.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.867 . . . . 0.0 109.461 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.479 ' O ' HD13 ' A' ' 156' ' ' LEU . 64.5 mt -60.38 -48.84 80.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.823 . . . . 0.0 109.485 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.402 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . . . -52.76 -40.3 63.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.566 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.424 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 54.3 t0 -60.06 -49.32 78.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -52.89 -37.96 61.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.533 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.645 HD21 ' HB3' ' A' ' 46' ' ' GLN . 7.1 mp -69.37 -41.53 76.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' MET . . . -69.55 -44.99 69.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.562 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 33.6 m -58.81 -42.18 88.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.539 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -61.94 -39.47 92.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.501 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -62.0 -45.75 95.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.536 ' HA ' HG12 ' A' ' 164' ' ' VAL . 85.2 p -69.53 -25.75 64.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -1.184 . . . . 0.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -67.68 -36.34 80.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.504 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.3 t -72.91 -19.08 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 161' ' ' SER . 14.8 p -113.93 134.37 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.524 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.464 ' HA ' ' ND2' ' A' ' 27' ' ' ASN . 44.2 t-20 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.64 70.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -1.139 . . . . 0.0 109.442 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.561 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 95.5 mmm -64.31 -38.65 91.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.83 -14.14 36.05 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -55.11 -26.29 37.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -1.17 . . . . 0.0 109.602 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.993 ' CD2' HD11 ' A' ' 79' ' ' LEU . 18.4 p90 -110.69 163.7 13.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 109.898 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.452 ' OE1' HG22 ' A' ' 74' ' ' ILE . 21.2 tt0 -79.59 -45.14 19.71 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.422 -0.799 . . . . 0.0 108.996 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.836 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -161.21 178.52 37.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.585 HG23 ' HE2' ' A' ' 37' ' ' TYR . 67.9 t -129.73 146.27 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -1.14 . . . . 0.0 109.501 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.864 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.5 m-85 -118.4 155.39 30.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.781 ' CE1' HD12 ' A' ' 81' ' ' ILE . 96.3 m-85 -118.03 123.17 45.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.332 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.865 HG22 HD12 ' A' ' 32' ' ' ILE . 24.2 p -117.06 145.78 43.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.551 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 56.7 t0 -143.99 152.98 41.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -137.33 117.08 1.46 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 29' ' ' GLY . 47.0 t -133.49 155.18 50.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.319 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.712 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -137.95 158.68 43.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.595 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 65.0 mt -118.13 140.19 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -102.6 136.41 42.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.503 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -113.26 173.18 3.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 48.5 Cg_endo -68.9 -33.57 19.77 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.713 2.275 . . . . 0.0 111.709 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.26 71.04 33.96 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.316 -0.865 . . . . 0.0 109.345 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.34 54.3 1.0 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.71 2.273 . . . . 0.0 111.731 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.8 m -59.58 -31.64 69.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.873 . . . . 0.0 109.349 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 25' ' ' SER . 67.7 mttt -110.11 29.91 7.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.414 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 24' ' ' LYS . 1.0 OUTLIER 71.84 164.3 0.28 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.689 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 42.5 p-10 -64.18 163.6 12.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 109.487 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 19.9 m120 -94.36 125.94 39.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 0.0 109.367 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . . . -103.5 156.07 18.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.534 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -147.22 148.38 19.94 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.656 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 63.6 mtm -124.02 165.11 18.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -1.2 . . . . 0.0 109.573 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.702 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -149.87 116.86 0.81 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.865 HD12 HG22 ' A' ' 12' ' ' THR . 15.1 mm -120.26 115.27 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -1.161 . . . . 0.0 109.486 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 45' ' ' ASN . 12.3 p -118.76 148.39 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.498 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.989 ' CD2' HD22 ' A' ' 44' ' ' LEU . 9.4 t60 -101.16 137.23 39.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.556 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.485 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -122.23 158.16 30.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.958 ' HB ' HD11 ' A' ' 44' ' ' LEU . 12.0 t -125.11 162.23 25.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.877 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.585 ' HE2' HG23 ' A' ' 9' ' ' VAL . 58.5 m-85 -108.64 11.47 26.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.968 . . . . 0.0 109.618 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.558 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 5.3 mttt -51.21 178.74 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.0 Cg_endo -64.43 -6.05 11.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.185 1.924 . . . . 0.0 111.704 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 40' ' ' GLU . 70.0 mm-40 -129.53 105.36 8.03 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.254 -0.904 . . . . 0.0 108.759 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -64.54 125.31 24.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.574 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -168.18 129.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.507 ' O ' HG23 ' A' ' 43' ' ' VAL . 22.6 m -58.7 126.04 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.457 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.989 HD22 ' CD2' ' A' ' 34' ' ' HIS . 6.1 mp -67.33 -42.79 83.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.654 ' O ' HG23 ' A' ' 33' ' ' VAL . 77.9 m-20 -160.61 154.41 22.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.617 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.596 ' HB3' HD21 ' A' ' 156' ' ' LEU . 90.9 mt-30 -113.1 148.22 35.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 109.131 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CB ' ' O ' ' A' ' 32' ' ' ILE . 11.6 t-105 -127.34 138.88 53.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.105 -0.997 . . . . 0.0 109.843 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.407 ' C ' HG13 ' A' ' 49' ' ' ILE . 51.5 m -126.96 136.73 52.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.118 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.418 HD12 ' HE3' ' A' ' 30' ' ' MET . 3.8 mt -144.03 92.05 6.38 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.733 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.1 Cg_endo -70.76 148.32 58.32 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.66 2.24 . . . . 0.0 111.557 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 51' ' ' LEU . 5.7 mp -119.65 145.5 46.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.95 -48.36 0.17 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -90.42 9.95 27.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -1.133 . . . . 0.0 109.393 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 48.1 m-70 -117.75 -176.08 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 0.0 109.522 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.409 HG22 ' HG3' ' A' ' 58' ' ' MET . 13.8 t -124.49 166.36 16.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.712 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -46.21 -45.51 16.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 0.0 109.346 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 60' ' ' GLU . 84.6 mt-30 -54.38 -59.34 4.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 109.428 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.429 ' SD ' ' HB3' ' A' ' 54' ' ' HIS . 61.2 mtt -44.08 -33.98 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.444 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.454 ' HB1' ' CG ' ' A' ' 30' ' ' MET . . . -71.85 -31.45 66.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.27 -0.893 . . . . 0.0 109.389 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 57' ' ' GLN . 96.8 mt-10 -70.88 -33.61 70.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.503 ' HA ' HG21 ' A' ' 87' ' ' VAL . 7.1 tt -86.92 -30.84 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 109.341 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.656 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -74.95 -29.71 61.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.417 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -64.98 -39.07 92.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.619 HG21 HG13 ' A' ' 87' ' ' VAL . 71.8 t -71.95 -45.6 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.489 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.519 ' HB2' HD11 ' A' ' 120' ' ' ILE . 87.3 tt0 -64.3 -37.01 85.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.6 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 13.7 t80 -56.07 -69.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -60.4 -15.82 29.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.903 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.66 ' SG ' HG23 ' A' ' 120' ' ' ILE . 44.8 t -67.66 -63.92 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HG2' ' SG ' ' A' ' 123' ' ' CYS . 23.6 mttm -58.64 -44.54 90.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.6 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 66.5 mttm -63.51 -38.54 91.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.832 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -54.83 -61.62 2.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.959 ' HB2' HD11 ' A' ' 130' ' ' ILE . 9.1 tt -51.55 -45.33 62.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 72' ' ' LEU . 65.0 tttm -43.64 -42.41 5.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.175 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.578 HG23 ' HD2' ' A' ' 75' ' ' PRO . 48.4 mm -48.93 143.21 8.68 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.331 -0.856 . . . . 0.0 108.806 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.578 ' HD2' HG23 ' A' ' 74' ' ' ILE . 41.8 Cg_endo -63.7 -4.71 7.52 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.669 2.246 . . . . 0.0 112.311 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.497 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -143.06 171.8 24.81 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.502 ' HG2' ' HA ' ' A' ' 6' ' ' TYR . 43.9 Cg_endo -67.22 118.61 5.7 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.495 2.13 . . . . 0.0 111.684 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.864 HG21 ' CE1' ' A' ' 10' ' ' PHE . 9.0 p -114.67 151.43 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.394 -0.816 . . . . 0.0 109.266 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.993 HD11 ' CD2' ' A' ' 6' ' ' TYR . 12.2 mt -96.82 154.73 17.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.83 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 131' ' ' THR . 38.9 t -125.87 133.07 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.536 -0.727 . . . . 0.0 109.049 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 11' ' ' TYR . 26.2 mt -120.04 133.8 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.61 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.46 HG21 ' CG2' ' A' ' 64' ' ' VAL . 7.1 t -136.5 161.72 35.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.511 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 13' ' ' ASP . 58.3 p30 -89.33 15.04 9.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.515 ' OG ' HG12 ' A' ' 87' ' ' VAL . 26.7 t -123.93 114.73 20.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.918 . . . . 0.0 109.487 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.567 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 61.3 t80 -77.16 -43.15 34.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.573 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -49.0 -48.26 43.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.619 HG13 HG21 ' A' ' 64' ' ' VAL . 8.9 p -68.03 -45.36 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.593 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.571 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -53.4 -49.69 66.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.925 . . . . 0.0 109.544 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 80.5 tt0 -60.55 -34.39 74.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.303 -0.873 . . . . 0.0 109.516 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.633 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 50.5 m -56.42 -55.87 28.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.728 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.68 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -82.02 -0.75 45.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 109.702 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 47.0 t-20 -84.66 -73.23 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 109.812 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 62.6 tttt -127.37 -30.98 2.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.092 -1.005 . . . . 0.0 109.924 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 58.9 mm-40 -56.75 -37.69 71.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.108 -0.995 . . . . 0.0 109.922 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -51.38 -61.56 3.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 109.628 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 95' ' ' LEU . 45.5 Cg_endo -67.76 -27.19 38.12 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.571 2.18 . . . . 0.0 111.449 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -73.47 -34.99 65.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 108.983 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.595 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 15.8 m0 -66.96 -48.35 68.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.847 . . . . 0.0 109.19 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 98' ' ' TRP . 25.2 mttt -43.5 -40.59 3.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.427 -0.796 . . . . 0.0 109.363 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.2 p -62.37 -39.83 94.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.311 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 98' ' ' TRP . 85.5 m-20 -85.79 10.58 13.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 109.379 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 80.04 38.16 19.9 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.517 ' O ' ' CB ' ' A' ' 111' ' ' LEU . 62.1 m-85 64.78 34.61 9.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -1.143 . . . . 0.0 109.393 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 1.092 HG13 ' HA ' ' A' ' 110' ' ' PRO . 50.5 t -122.25 123.07 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.508 ' HA ' ' NE1' ' A' ' 98' ' ' TRP . 32.2 t-20 -56.71 -49.27 75.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 109.364 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -148.59 160.59 42.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.422 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -65.1 -26.28 68.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -66.41 -43.51 85.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.31 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -139.15 146.54 49.64 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.367 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 1.092 ' HA ' HG13 ' A' ' 104' ' ' VAL . 49.8 Cg_endo -70.09 177.37 5.88 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.647 2.232 . . . . 0.0 111.805 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.56 HD21 ' CE3' ' A' ' 98' ' ' TRP . 19.2 tp -88.39 133.5 34.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.449 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 21.4 mttp -99.77 149.01 23.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 28.1 m80 68.75 31.76 4.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 109.553 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 75.8 mt -61.73 -41.36 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.296 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.9 m -53.27 -50.18 65.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 109.257 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -60.38 -38.4 83.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.334 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.633 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 25.3 m95 -72.35 -36.76 68.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -55.65 -44.97 77.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.325 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.2 m -60.41 -45.78 92.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.319 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.66 HG23 ' SG ' ' A' ' 68' ' ' CYS . 73.5 mt -69.34 -32.83 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.746 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -60.91 -38.07 84.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.931 . . . . 0.0 109.4 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 126' ' ' MET . 96.2 mt-10 -61.7 -40.51 95.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.332 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 130' ' ' ILE . 56.6 m -64.85 -51.02 64.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.847 ' O ' HD13 ' A' ' 124' ' ' LEU . 3.4 tm? -65.02 -37.05 86.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.0 109.231 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.2 t -56.1 -36.11 67.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.446 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 65.4 mtt -64.25 -32.88 74.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.293 -0.88 . . . . 0.0 109.369 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 167.78 153.3 0.12 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.3 Cg_endo -71.39 0.36 6.94 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.621 2.214 . . . . 0.0 111.702 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 128' ' ' PRO . 92.1 m-20 -43.07 -48.21 6.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.372 -0.83 . . . . 0.0 109.543 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.959 HD11 ' HB2' ' A' ' 72' ' ' LEU . 74.3 mt -65.38 122.12 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.589 ' HB ' HD22 ' A' ' 79' ' ' LEU . 32.6 m -116.98 149.58 40.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.193 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.68 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 55.4 mt -127.01 132.69 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.134 -0.979 . . . . 0.0 109.712 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.452 ' HB2' HG12 ' A' ' 81' ' ' ILE . 86.4 mt-30 -118.09 159.39 23.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.17 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.567 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 75.5 t60 -120.28 133.56 55.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.991 . . . . 0.0 109.683 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -94.19 145.61 24.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.419 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.517 ' CB ' ' HB2' ' A' ' 139' ' ' GLN . 59.3 mttp -90.41 29.32 1.29 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.499 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.41 -132.74 52.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -47.11 -46.43 22.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -1.172 . . . . 0.0 109.35 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.517 ' HB2' ' CB ' ' A' ' 136' ' ' LYS . 3.7 mt-30 -46.38 141.95 4.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.94 148.84 64.77 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.705 2.27 . . . . 0.0 111.848 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 143' ' ' THR . 18.7 p -91.36 170.02 10.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.396 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -51.13 -35.82 37.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.604 HG22 ' H ' ' A' ' 145' ' ' ILE . 33.4 m -125.63 134.01 52.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.549 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.9 p -63.6 -28.0 69.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.842 . . . . 0.0 109.47 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.604 ' H ' HG22 ' A' ' 143' ' ' THR . 84.3 mt -61.08 -40.38 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.557 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -65.5 -29.41 70.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.155 -0.965 . . . . 0.0 109.529 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.5 m -64.93 -41.71 95.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.23 -41.33 75.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.07 -36.16 87.22 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -66.56 -38.13 86.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -1.159 . . . . 0.0 109.395 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.16 -53.07 62.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.462 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 152' ' ' LEU . 6.8 mp -67.39 -46.41 73.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.348 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.534 ' HA ' HD12 ' A' ' 156' ' ' LEU . . . -57.28 -38.26 73.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.455 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 81.5 m-20 -63.11 -43.63 97.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.526 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.88 -41.61 78.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.535 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.8 mt -64.43 -41.21 96.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.935 . . . . 0.0 109.399 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.54 96.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 37.2 m -55.78 -45.81 78.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.549 ' O ' HG23 ' A' ' 163' ' ' VAL . 95.5 mt-30 -62.32 -36.18 81.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -0.906 . . . . 0.0 109.482 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -53.31 -59.2 9.89 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 92.1 p -63.49 -33.63 75.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -1.135 . . . . 0.0 109.503 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -63.66 -37.37 87.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 159' ' ' GLN . 71.5 t -57.41 -37.01 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.494 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 41.4 t -104.6 134.02 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 0.0 109.483 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.473 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.47 152.43 23.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -1.164 . . . . 0.0 109.545 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.57 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 29.3 mtm -63.92 -25.92 68.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -44.58 -30.56 2.2 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -50.62 -47.64 58.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.167 -1.196 . . . . 0.0 109.415 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.63 ' CG ' HD13 ' A' ' 79' ' ' LEU . 36.6 m-85 -47.05 157.94 0.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 109.186 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 45.4 tp10 -66.75 -32.64 74.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.95 . . . . 0.0 109.043 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.742 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.0 -177.24 47.43 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.1 t -129.13 139.01 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -1.154 . . . . 0.0 109.232 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.792 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.9 m-85 -117.5 143.87 45.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.866 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 1.062 ' CE2' HD12 ' A' ' 81' ' ' ILE . 92.7 m-85 -117.38 121.76 41.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.143 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.749 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 18.8 p -111.83 150.28 30.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.074 -1.016 . . . . 0.0 109.632 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.4 ' OD2' ' OD1' ' A' ' 154' ' ' ASP . 45.5 t0 -152.51 146.8 25.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.88 136.39 10.95 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.439 ' HB3' ' HB1' ' A' ' 157' ' ' ALA . 17.9 t -138.69 142.69 38.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 109.612 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -135.01 150.13 50.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.291 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 27' ' ' ASN . 69.3 mt -116.58 136.6 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.672 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -118.24 152.48 35.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.286 -0.884 . . . . 0.0 109.071 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.509 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -118.84 173.7 3.23 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.443 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 45.2 Cg_endo -67.93 -41.07 8.25 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.56 2.174 . . . . 0.0 111.175 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -111.11 69.86 0.69 Allowed Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.88 58.73 0.55 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.873 2.382 . . . . 0.0 112.149 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.2 p -55.01 -21.29 11.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.176 -0.953 . . . . 0.0 108.838 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -126.99 -174.22 3.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 0.0 109.326 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.5 m -68.36 138.19 55.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 109.734 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 38.7 p-10 -51.74 168.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.184 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.503 ' OD1' ' ND2' ' A' ' 165' ' ' ASN . 23.5 m120 -85.8 139.09 31.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.164 -0.96 . . . . 0.0 109.555 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -125.32 151.36 46.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.933 . . . . 0.0 109.492 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -154.99 157.79 27.87 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.755 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 54.9 mtm -127.29 165.85 18.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.129 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' A' ' 156' ' ' LEU . . . -156.82 124.68 1.47 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 32' ' ' ILE . 4.8 mp -116.89 142.36 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -1.163 . . . . 0.0 109.382 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.491 HG21 ' N ' ' A' ' 153' ' ' ALA . 38.2 t -127.06 134.26 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 109.551 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.503 ' CE1' ' CD2' ' A' ' 10' ' ' PHE . 2.8 m-70 -106.87 138.65 42.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.615 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.42 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -140.4 164.62 29.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 0.0 109.527 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.653 ' HB ' HD11 ' A' ' 44' ' ' LEU . 13.2 t -133.64 164.96 26.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.0 109.447 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.418 ' O ' ' O ' ' A' ' 38' ' ' LYS . 44.5 m-85 -103.32 11.09 37.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 109.575 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.582 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.26 179.73 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.185 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 38' ' ' LYS . 44.8 Cg_endo -66.88 -5.64 13.87 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.203 1.935 . . . . 0.0 111.425 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' OE2' ' NE2' ' A' ' 42' ' ' GLN . 82.6 tt0 -132.74 105.49 7.2 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.377 -0.827 . . . . 0.0 108.947 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.451 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 43.1 t80 -64.28 122.01 15.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.49 ' NE2' ' OE2' ' A' ' 40' ' ' GLU . 66.5 mt-30 -159.0 136.38 9.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.124 -0.985 . . . . 0.0 109.753 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 37.5 t -62.5 125.99 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.893 . . . . 0.0 109.32 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.653 HD11 ' HB ' ' A' ' 36' ' ' THR . 7.4 mp -68.63 -38.69 80.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 109.336 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -175.62 155.04 1.68 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 109.343 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.964 ' HB3' HD21 ' A' ' 156' ' ' LEU . 94.0 mt-30 -110.01 138.4 46.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.407 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -122.75 125.95 46.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.676 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.2 m -121.14 138.91 53.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 109.271 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 2.4 mp -133.67 96.22 16.87 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.94 129.84 18.09 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.667 2.245 . . . . 0.0 111.741 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.548 ' O ' HG21 ' A' ' 164' ' ' VAL . 43.1 mt -108.39 145.36 34.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.331 -0.856 . . . . 0.0 109.384 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.33 -28.85 1.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.531 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 46.4 p-10 -121.94 34.67 5.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -1.213 . . . . 0.0 109.507 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.531 ' CE1' ' OD1' ' A' ' 53' ' ' ASN . 77.4 m80 -124.4 175.68 6.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 109.362 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 58' ' ' MET . 14.4 t -123.03 169.44 11.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.63 -38.93 72.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.419 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.0 -54.45 44.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.458 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.489 ' H ' HG23 ' A' ' 55' ' ' THR . 67.9 mtm -66.64 -30.32 70.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.551 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.7 86.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.459 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -64.28 -49.1 73.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.509 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.71 HD11 ' CZ2' ' A' ' 117' ' ' TRP . 13.0 tt -64.59 -39.62 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.755 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -59.41 -31.41 69.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.535 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.749 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -64.17 -41.45 97.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.481 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.79 HG22 HG21 ' A' ' 82' ' ' THR . 87.9 t -71.0 -38.67 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.47 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 86.4 tt0 -68.8 -39.05 80.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.106 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.537 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 22.3 t80 -61.17 -64.37 0.97 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.364 -0.835 . . . . 0.0 109.491 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 71' ' ' ALA . . . -58.26 -31.44 67.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.631 ' SG ' HG23 ' A' ' 120' ' ' ILE . 24.3 t -53.43 -54.7 33.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.607 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -62.03 -45.48 93.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 68.9 mttm -67.36 -29.75 69.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.951 . . . . 0.0 109.308 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.747 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -62.24 -64.48 0.92 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.824 ' HB2' HD11 ' A' ' 130' ' ' ILE . 27.8 tp -55.57 -43.29 75.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.883 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' LEU . 16.2 tttt -43.22 -43.14 4.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.254 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 26.4 mm -48.2 143.45 6.94 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 108.855 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.8 Cg_endo -65.87 -3.16 7.72 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.512 2.141 . . . . 0.0 111.896 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.407 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -142.07 170.82 24.8 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.468 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.2 Cg_endo -69.2 122.82 9.66 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.366 2.044 . . . . 0.0 111.74 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.792 HG21 ' CE1' ' A' ' 10' ' ' PHE . 7.1 p -116.24 150.18 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.451 -0.781 . . . . 0.0 109.288 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.63 HD13 ' CG ' ' A' ' 6' ' ' TYR . 6.7 mp -97.8 130.7 44.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.909 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 132' ' ' ILE . 47.6 t -106.46 131.09 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.36 -0.837 . . . . 0.0 109.122 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.062 HD12 ' CE2' ' A' ' 11' ' ' TYR . 4.4 mt -115.15 144.29 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.159 -0.963 . . . . 0.0 109.666 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.79 HG21 HG22 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -134.3 161.66 34.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 109.37 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -90.91 3.66 53.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.525 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.42 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 20.2 t -122.93 125.55 45.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.569 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 65.8 t80 -75.1 -40.6 59.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.433 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -50.5 -56.76 10.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.472 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.648 HG22 HG21 ' A' ' 64' ' ' VAL . 8.8 p -58.75 -47.69 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.364 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.603 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -58.25 -57.21 13.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 0.0 109.204 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 85.3 tt0 -51.13 -30.81 17.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.615 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 37.1 m -60.32 -59.65 5.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.433 -0.792 . . . . 0.0 109.67 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -77.24 -0.83 26.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 109.794 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 9.8 m120 -83.56 -72.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 0.0 109.796 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 80.5 mttt -126.56 -27.86 3.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.787 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.5 mt-10 -66.0 -24.33 66.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.616 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -58.51 -58.66 17.44 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.563 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.5 Cg_endo -66.91 -35.1 27.76 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.596 2.197 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -64.59 -42.01 95.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.897 . . . . 0.0 109.116 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.467 ' CZ2' HD11 ' A' ' 111' ' ' LEU . 26.4 m0 -60.74 -50.23 74.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.312 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 98' ' ' TRP . 49.9 tttp -43.0 -43.49 4.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.3 -0.875 . . . . 0.0 109.474 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.4 m -56.74 -42.6 79.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 109.372 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -86.24 12.56 9.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 109.409 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 104' ' ' VAL . . . 72.81 41.44 49.59 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.555 ' HB3' HG23 ' A' ' 114' ' ' ILE . 70.7 m-85 61.23 33.38 19.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -1.131 . . . . 0.0 109.395 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 102' ' ' GLY . 42.6 t -119.22 134.06 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 0.0 109.519 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -63.3 139.66 58.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -51.85 -34.37 40.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -72.22 158.72 35.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.441 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -55.53 -29.31 58.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.89 . . . . 0.0 109.407 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -60.27 139.37 91.72 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.586 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.98 157.04 61.26 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.706 2.27 . . . . 0.0 111.663 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.544 HD23 HG12 ' A' ' 114' ' ' ILE . 9.3 tp -80.44 130.14 34.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.95 . . . . 0.0 109.478 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -92.61 153.82 18.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.89 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.402 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 70.2 m-70 60.4 37.64 19.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.198 -0.939 . . . . 0.0 109.482 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.555 HG23 ' HB3' ' A' ' 103' ' ' PHE . 82.1 mt -63.84 -44.81 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.321 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 t -60.01 -41.99 93.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -59.22 -40.61 86.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.71 ' CZ2' HD11 ' A' ' 61' ' ' ILE . 17.4 m95 -68.02 -37.96 82.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 31.2 mttt -57.41 -41.31 80.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.925 . . . . 0.0 109.371 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.47 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 19.9 m -61.62 -46.13 91.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.309 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.631 HG23 ' SG ' ' A' ' 68' ' ' CYS . 75.7 mt -71.21 -34.68 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.544 ' HB2' HD11 ' A' ' 95' ' ' LEU . . . -59.56 -42.35 92.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.394 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.03 -40.28 88.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 109.503 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 89.5 m -66.22 -49.21 68.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.425 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 128' ' ' PRO . 23.7 tp -63.82 -31.71 72.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.2 m -61.48 -31.7 71.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.499 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.446 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 92.6 mtp -68.56 -31.7 71.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HD3' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 170.47 147.78 0.14 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.44 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.442 ' HA ' ' CD1' ' A' ' 124' ' ' LEU . 50.5 Cg_endo -70.96 -0.95 8.71 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.688 2.259 . . . . 0.0 111.637 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 94.1 m-20 -43.05 -45.39 5.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.367 -0.833 . . . . 0.0 109.659 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 72' ' ' LEU . 46.4 mt -61.77 117.39 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.743 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.561 ' O ' HD13 ' A' ' 132' ' ' ILE . 97.4 m -109.81 144.9 37.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.186 -0.946 . . . . 0.0 109.069 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.561 HD13 ' O ' ' A' ' 131' ' ' THR . 32.5 mm -119.69 136.68 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 109.745 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.53 ' NE2' HD23 ' A' ' 79' ' ' LEU . 87.4 mt-30 -125.43 158.22 34.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.427 -0.795 . . . . 0.0 109.19 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.569 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 63.4 t60 -117.26 133.25 56.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.641 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.549 ' HG2' ' CG2' ' A' ' 81' ' ' ILE . 71.2 mm-40 -124.34 150.47 45.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.425 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -96.55 138.48 34.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.18 -35.15 68.89 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -117.87 139.72 50.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -1.125 . . . . 0.0 109.446 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.527 ' CG ' ' HD2' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -121.04 167.76 12.42 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.376 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.527 ' HD2' ' CG ' ' A' ' 139' ' ' GLN . 50.5 Cg_endo -69.69 -173.78 0.77 Allowed 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.689 2.26 . . . . 0.0 111.863 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.0 m -49.72 -39.68 38.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.84 155.56 32.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.564 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.0 p -120.07 160.44 22.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.6 m -121.07 149.35 42.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.538 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 87.7 mt -54.22 -37.53 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.589 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -65.17 -30.6 71.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.261 -0.9 . . . . 0.0 109.416 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 57.5 m -55.56 -47.46 76.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.372 -0.83 . . . . 0.0 109.452 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.19 -52.18 28.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.409 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.18 -39.52 58.3 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -55.15 -48.8 73.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -1.108 . . . . 0.0 109.37 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.74 37.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.309 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 152' ' ' LEU . 6.8 mp -58.84 -47.97 82.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.491 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -55.42 -42.56 74.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 109.418 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.4 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 63.7 m-20 -55.69 -44.09 77.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.876 . . . . 0.0 109.394 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -57.75 -42.14 83.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.928 . . . . 0.0 109.412 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.964 HD21 ' HB3' ' A' ' 46' ' ' GLN . 7.0 mp -64.98 -40.15 94.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' A' ' 15' ' ' SER . . . -67.78 -51.67 46.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.358 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 42.0 m -59.83 -41.41 91.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.534 ' O ' HG23 ' A' ' 163' ' ' VAL . 46.8 tt0 -63.68 -38.41 91.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -62.54 -50.38 64.95 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.0 p -64.94 -34.24 77.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -1.183 . . . . 0.0 109.434 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -64.03 -37.68 88.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.431 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 159' ' ' GLN . 73.0 t -52.93 -39.67 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.548 HG21 ' O ' ' A' ' 51' ' ' LEU . 42.5 t -65.48 -30.98 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.502 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.503 ' ND2' ' OD1' ' A' ' 27' ' ' ASN . 89.6 m-20 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.51 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.41 157.87 44.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -1.181 . . . . 0.0 109.523 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.568 ' O ' ' CD2' ' A' ' 6' ' ' TYR . 77.4 mtp -65.76 -27.1 68.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.552 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.15 -17.59 17.61 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 96.3 mt-30 -53.17 -33.57 53.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -1.166 . . . . 0.0 109.573 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.978 ' HB3' HD21 ' A' ' 79' ' ' LEU . 33.9 p90 -103.37 156.53 17.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.206 -0.934 . . . . 0.0 109.655 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.514 ' OE1' HG22 ' A' ' 74' ' ' ILE . 21.3 tt0 -79.78 -42.76 23.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.806 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -159.88 176.52 36.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.519 HG23 ' HE2' ' A' ' 37' ' ' TYR . 82.1 t -124.96 141.1 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -1.18 . . . . 0.0 109.515 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.828 ' CD1' HG21 ' A' ' 78' ' ' VAL . 5.7 m-85 -117.33 151.7 36.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.622 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.771 ' HE1' HD12 ' A' ' 81' ' ' ILE . 85.3 m-85 -123.87 135.97 54.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.533 HG22 HD12 ' A' ' 32' ' ' ILE . 19.1 p -121.7 150.1 42.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.596 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.513 ' HB2' ' HB1' ' A' ' 153' ' ' ALA . 22.9 t70 -140.12 148.27 41.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.482 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.41 134.25 5.42 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.552 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 83.1 p -143.21 161.01 39.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -1.177 . . . . 0.0 109.457 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.891 ' HB1' ' ND2' ' A' ' 26' ' ' ASN . . . -137.9 150.51 47.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.566 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' ASN . 47.7 mt -126.79 131.98 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.515 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -107.28 144.45 34.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.294 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.548 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -109.63 176.3 1.61 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.317 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 45.7 Cg_endo -67.87 -35.51 20.83 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 122.471 2.114 . . . . 0.0 111.38 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.87 70.36 5.0 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.381 -0.825 . . . . 0.0 108.876 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 19' ' ' SER . 45.0 Cg_endo -67.04 57.28 0.55 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.833 2.355 . . . . 0.0 111.968 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.0 p -59.46 -16.81 26.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.838 . . . . 0.0 109.018 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -129.76 -163.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.304 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 26' ' ' ASN . 33.2 m -78.06 140.76 39.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.676 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.891 ' ND2' ' HB1' ' A' ' 16' ' ' ALA . 48.1 p-10 -47.3 172.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 109.303 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.634 ' OD1' HG11 ' A' ' 164' ' ' VAL . 83.0 m-20 -104.49 125.01 50.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.965 . . . . 0.0 109.393 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 15' ' ' SER . . . -132.16 158.51 41.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 109.768 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.32 165.2 26.77 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.644 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 69.7 mtm -126.28 156.54 40.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -1.168 . . . . 0.0 109.461 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -141.51 128.21 3.58 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.54 HG13 ' CD2' ' A' ' 66' ' ' PHE . 22.3 mm -113.16 134.41 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -1.132 . . . . 0.0 109.301 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.95 125.38 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.692 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.656 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 10.3 m170 -103.54 136.12 43.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.208 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.08 161.31 35.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.752 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.2 t -125.6 164.08 21.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 109.241 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.519 ' HE2' HG23 ' A' ' 9' ' ' VAL . 85.0 m-85 -107.91 13.95 25.79 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.104 -0.998 . . . . 0.0 109.534 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.583 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.27 -179.17 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.321 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.6 Cg_endo -65.42 -4.73 9.97 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.074 1.849 . . . . 0.0 111.849 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.436 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 71.8 mm-40 -134.1 106.09 7.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 108.785 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 66.9 t80 -57.81 123.89 17.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 109.534 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 84.4 mt-30 -159.62 152.25 21.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.85 . . . . 0.0 109.516 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.1 m -89.06 120.48 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.394 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 40.9 mt -58.28 -44.18 88.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.429 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 25.2 m-20 -168.76 157.4 8.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.433 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.592 ' HB3' HD21 ' A' ' 156' ' ' LEU . 92.4 mt-30 -116.2 149.6 38.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.444 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.474 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -132.16 137.96 47.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.625 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.9 p -123.61 144.8 49.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.286 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.461 HD12 ' HE3' ' A' ' 30' ' ' MET . 3.3 mt -146.52 94.55 4.76 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.198 -0.939 . . . . 0.0 109.648 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.764 ' HG3' HG21 ' A' ' 163' ' ' VAL . 51.0 Cg_endo -70.81 132.26 21.3 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.654 2.236 . . . . 0.0 111.67 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.722 HD12 ' CB ' ' A' ' 59' ' ' ALA . 43.8 mt -115.0 142.89 46.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.566 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.03 -42.86 0.21 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -90.97 8.85 33.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -1.114 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 91.5 m-70 -107.05 150.25 26.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.915 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.506 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.1 OUTLIER -91.65 170.04 10.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.884 . . . . 0.0 109.24 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.37 -30.09 17.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.319 -0.863 . . . . 0.0 109.123 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -79.5 -57.36 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.357 -0.84 . . . . 0.0 109.315 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.506 ' SD ' HG23 ' A' ' 55' ' ' THR . 93.4 mtp -47.78 -34.47 8.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 109.364 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.722 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -78.72 -33.94 46.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.442 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.787 ' HG2' HG21 ' A' ' 87' ' ' VAL . 82.1 tt0 -64.45 -40.11 95.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.603 HG21 ' HD3' ' A' ' 116' ' ' LYS . 19.5 tt -77.34 -29.59 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.374 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.644 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -68.77 -29.49 67.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.478 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.82 94.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.491 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.766 HG21 HG12 ' A' ' 87' ' ' VAL . 87.0 t -75.86 -48.29 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 98.1 mt-10 -51.87 -41.57 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.55 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 14.1 t80 -56.82 -67.86 0.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.647 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -63.67 -13.98 47.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.606 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.969 ' SG ' HG23 ' A' ' 120' ' ' ILE . 38.0 t -66.82 -66.04 0.6 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.521 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 73.9 tttt -60.01 -42.61 94.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.634 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 56.7 mttp -64.94 -35.62 81.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -58.3 -60.44 3.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.889 ' HB2' HD11 ' A' ' 130' ' ' ILE . 21.0 tp -56.71 -44.12 81.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 109.388 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 72' ' ' LEU . 55.6 tttp -43.59 -42.13 4.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.155 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 19.6 mm -48.39 142.76 7.95 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.86 . . . . 0.0 108.961 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.9 Cg_endo -65.49 -4.58 9.79 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.548 2.165 . . . . 0.0 111.937 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.02 167.28 25.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.474 ' HG2' ' HA ' ' A' ' 6' ' ' TYR . 45.2 Cg_endo -67.88 116.4 4.27 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.565 2.176 . . . . 0.0 111.699 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.828 HG21 ' CD1' ' A' ' 10' ' ' PHE . 7.2 p -111.31 149.82 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.333 -0.854 . . . . 0.0 109.578 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.978 HD21 ' HB3' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -104.51 137.41 42.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 109.59 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 43.7 t -110.27 130.46 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.145 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.771 HD12 ' HE1' ' A' ' 11' ' ' TYR . 15.8 mt -114.61 132.08 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.649 HG21 HG22 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -124.85 161.99 25.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 56.4 p30 -87.14 13.08 10.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.2 m -123.26 125.28 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.485 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.65 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 70.4 t80 -78.38 -41.89 31.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -58.54 -52.71 64.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.787 HG21 ' HG2' ' A' ' 60' ' ' GLU . 48.4 t -59.23 -51.8 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.68 -52.97 27.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.288 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 83.5 tt0 -60.08 -33.75 72.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.17 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.666 ' O ' HD23 ' A' ' 95' ' ' LEU . 34.1 m -52.72 -47.22 67.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.327 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.784 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -94.25 -0.75 54.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.612 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 50.1 t30 -86.93 -71.99 0.53 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.957 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 24.7 mttm -116.64 -35.53 4.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 109.831 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 91.4 mt-10 -59.84 -38.8 83.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.624 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -53.16 -60.18 7.4 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 47.4 Cg_endo -68.15 -32.37 27.49 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.71 2.273 . . . . 0.0 111.596 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -72.54 -40.6 66.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.28 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.434 ' CZ2' ' OE1' ' A' ' 94' ' ' GLU . 24.9 m0 -61.66 -44.23 97.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.358 -0.839 . . . . 0.0 109.371 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.405 ' HA ' ' CE1' ' A' ' 103' ' ' PHE . 24.8 tttt -50.65 -50.38 54.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.865 . . . . 0.0 109.446 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.6 m -65.98 -34.93 79.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.497 ' OD1' ' CG1' ' A' ' 104' ' ' VAL . 53.6 t-20 -66.17 -26.17 67.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.525 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.3 28.26 8.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.405 ' CE1' ' HA ' ' A' ' 99' ' ' LYS . 8.3 m-85 61.85 30.82 18.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -1.158 . . . . 0.0 109.486 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.497 ' CG1' ' OD1' ' A' ' 101' ' ' ASN . 11.8 p -118.56 133.93 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 109' ' ' LYS . 44.8 t30 -84.75 143.29 29.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.469 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -51.7 -33.26 33.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.525 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -75.65 162.39 28.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 109.567 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -55.85 -31.71 62.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 1.5 tptp -70.81 138.8 85.54 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.428 ' HD2' ' HG3' ' A' ' 109' ' ' LYS . 50.0 Cg_endo -70.34 169.97 18.37 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.637 2.224 . . . . 0.0 111.866 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.742 HD23 HG12 ' A' ' 114' ' ' ILE . 5.3 tp -73.44 134.89 44.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 109.431 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HD3' ' CE1' ' A' ' 113' ' ' HIS . 85.1 tttt -96.13 149.55 21.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.571 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 33.8 m80 65.98 33.07 8.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.505 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.742 HG12 HD23 ' A' ' 111' ' ' LEU . 82.4 mt -62.33 -47.05 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.253 -0.904 . . . . 0.0 109.406 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.8 m -59.38 -43.57 92.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.603 ' HD3' HG21 ' A' ' 61' ' ' ILE . 35.7 mttp -58.49 -46.9 85.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.285 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.629 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 65.6 m95 -70.16 -30.08 67.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.406 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -60.25 -41.6 93.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.495 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -58.22 -40.7 82.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.969 HG23 ' SG ' ' A' ' 68' ' ' CYS . 77.8 mt -72.95 -32.84 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -64.91 -37.16 86.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -60.41 -34.27 73.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.476 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 6.8 m -79.21 -50.21 11.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.713 HD23 HD12 ' A' ' 130' ' ' ILE . 57.6 mt -61.04 -34.86 75.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.476 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.8 t -59.27 -34.13 71.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.435 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.685 ' CE ' HD23 ' A' ' 72' ' ' LEU . 71.7 mtm -67.76 -34.53 77.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.423 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -173.99 128.51 0.47 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.475 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.5 Cg_endo -69.74 -1.8 9.07 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.68 2.253 . . . . 0.0 111.638 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 90.9 m-20 -43.83 -43.13 6.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.316 -0.865 . . . . 0.0 109.458 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.889 HD11 ' HB2' ' A' ' 72' ' ' LEU . 40.3 mt -53.99 118.55 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.335 -0.853 . . . . 0.0 109.671 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.654 ' HB ' HD22 ' A' ' 79' ' ' LEU . 9.0 m -119.28 129.65 55.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 108.984 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.784 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 52.9 mt -110.47 144.4 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.06 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -132.58 154.32 50.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.343 -0.848 . . . . 0.0 109.163 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.65 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 52.9 t60 -104.05 128.28 51.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.618 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 83' ' ' ASP . 85.1 tt0 -122.11 142.87 49.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 109.295 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -108.18 131.68 54.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.643 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -115.34 4.03 21.89 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -60.09 -33.97 72.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -1.165 . . . . 0.0 109.479 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -92.69 111.46 51.12 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.99 -23.98 29.12 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.714 2.276 . . . . 0.0 111.79 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.0 p -82.28 171.98 13.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.473 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.2 m120 60.5 49.54 6.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.518 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.8 m -70.96 141.55 51.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.863 . . . . 0.0 109.467 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.687 ' OG ' HG23 ' A' ' 147' ' ' THR . 94.8 p -133.71 171.29 14.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 87.4 mt -55.17 -41.97 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -65.7 -38.71 90.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.687 HG23 ' OG ' ' A' ' 144' ' ' SER . 70.0 p -64.12 -36.99 85.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.558 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -49.61 -45.81 48.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 109.552 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.07 -37.56 94.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -58.63 -41.5 86.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -1.142 . . . . 0.0 109.556 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.48 -51.7 66.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.55 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.463 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 52.5 mt -58.8 -45.7 89.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.527 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.513 ' HB1' ' HB2' ' A' ' 13' ' ' ASP . . . -56.88 -42.51 79.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.525 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.675 ' O ' HG23 ' A' ' 158' ' ' THR . 89.8 m-20 -59.23 -36.53 75.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -63.36 -42.26 98.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.628 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 156' ' ' LEU . 6.4 mp -74.17 -34.04 63.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.573 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.89 -40.86 97.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 154' ' ' ASP . 50.0 p -69.07 -39.52 79.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.532 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -62.32 -33.56 74.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -64.51 -31.85 82.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.5 p -65.96 -34.67 78.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -1.16 . . . . 0.0 109.535 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 165' ' ' ASN . 95.8 m-85 -68.23 -26.99 65.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.764 HG21 ' HG3' ' A' ' 50' ' ' PRO . 60.1 t -54.87 -40.4 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.88 . . . . 0.0 109.452 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.634 HG11 ' OD1' ' A' ' 27' ' ' ASN . 90.4 t -58.31 -39.92 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.432 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 162' ' ' TYR . 83.3 m-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 5' ' ' GLN . . . -64.64 140.39 58.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.278 -1.131 . . . . 0.0 109.395 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.593 ' HE2' ' CE2' ' A' ' 37' ' ' TYR . 90.8 mmm -65.7 -29.96 70.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.571 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.79 -28.1 56.72 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 64.9 mt-30 -50.53 -40.12 50.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -1.161 . . . . 0.0 109.532 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.572 ' CG ' HD13 ' A' ' 79' ' ' LEU . 34.3 m-85 -103.91 165.94 10.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.561 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -77.06 -31.91 56.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 108.872 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.6 -166.84 35.95 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.805 HG22 ' HB2' ' A' ' 79' ' ' LEU . 72.7 t -136.33 143.01 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -1.162 . . . . 0.0 108.978 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.792 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.1 m-85 -114.16 146.41 40.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.971 . . . . 0.0 109.907 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.877 ' CE1' HD12 ' A' ' 81' ' ' ILE . 66.9 m-85 -118.41 118.35 31.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.264 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.473 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 9.8 p -106.45 155.64 19.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 59.1 t0 -149.58 145.64 26.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.565 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -146.9 118.95 1.08 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 66.8 m -132.0 150.89 52.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -1.158 . . . . 0.0 109.588 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HA ' ' CB ' ' A' ' 28' ' ' ALA . . . -114.78 135.19 54.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.737 HD12 ' HB3' ' A' ' 161' ' ' SER . 58.3 mt -110.82 142.54 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.31 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' CE ' ' HG3' ' A' ' 22' ' ' PRO . 78.8 tttt -92.49 139.61 30.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.581 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.567 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -99.26 179.27 1.08 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.111 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 50.8 Cg_endo -71.64 -23.24 23.21 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.381 2.054 . . . . 0.0 111.708 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' N ' ' HD3' ' A' ' 22' ' ' PRO . 2.8 p30 -128.93 61.35 56.0 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.303 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.538 ' HG3' ' CE ' ' A' ' 18' ' ' LYS . 55.2 Cg_endo -81.71 68.82 7.92 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.762 2.308 . . . . 0.0 111.915 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 79.6 m -54.72 -31.56 58.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.168 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 23' ' ' THR . 48.1 tttm 178.42 33.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.296 -0.877 . . . . 0.0 109.475 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -152.92 138.41 17.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.558 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -118.11 165.54 13.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.333 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -98.74 97.56 8.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.328 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 16' ' ' ALA . . . -110.85 155.91 21.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.7 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.44 154.71 25.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.819 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 33.2 mtm -115.39 156.76 24.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -1.113 . . . . 0.0 109.417 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.89 124.23 1.73 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.528 HD12 ' N ' ' A' ' 32' ' ' ILE . 5.4 mp -116.94 134.58 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -1.095 . . . . 0.0 109.102 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.0 t -127.09 131.39 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.77 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.69 ' NE2' HD22 ' A' ' 44' ' ' LEU . 3.5 t60 -102.15 131.0 48.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.196 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.34 159.37 37.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.759 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.702 ' HB ' HD11 ' A' ' 44' ' ' LEU . 7.7 t -117.46 161.45 19.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.863 . . . . 0.0 109.126 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.607 ' HE2' HG23 ' A' ' 9' ' ' VAL . 91.9 m-85 -104.66 8.75 35.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.134 -0.979 . . . . 0.0 109.634 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.576 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.8 -178.94 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.322 -0.861 . . . . 0.0 108.766 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.2 Cg_endo -66.5 -3.13 8.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.122 1.881 . . . . 0.0 111.945 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -132.36 105.78 7.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 108.706 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 1.092 ' CD1' HD11 ' A' ' 145' ' ' ILE . 63.3 t80 -66.57 125.5 25.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 109.329 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.5 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 73.0 mt-30 -160.62 152.72 20.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 0.0 109.391 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 43' ' ' VAL . 13.5 p -82.85 124.33 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.434 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.702 HD11 ' HB ' ' A' ' 36' ' ' THR . 6.4 mp -74.06 -42.33 60.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 80.5 m-20 -159.05 149.46 19.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.559 ' HB3' HD21 ' A' ' 156' ' ' LEU . 91.8 mt-30 -117.09 148.01 41.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -0.949 . . . . 0.0 109.398 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.489 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -130.92 131.38 44.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.188 -0.945 . . . . 0.0 109.587 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.646 ' C ' HD12 ' A' ' 49' ' ' ILE . 78.2 p -123.79 141.95 51.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.646 HD12 ' C ' ' A' ' 48' ' ' SER . 3.7 mp -149.52 95.67 3.73 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 49' ' ' ILE . 48.3 Cg_endo -69.27 128.16 16.06 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.683 2.256 . . . . 0.0 111.759 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 44.4 mt -111.74 142.9 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 0.0 109.534 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.12 -42.88 0.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -91.96 9.32 33.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 109.522 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 87.2 m-70 -110.47 147.31 34.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 0.0 109.467 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.547 HG22 ' HG3' ' A' ' 58' ' ' MET . 9.5 t -90.89 -178.54 5.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -57.29 -46.6 82.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 60' ' ' GLU . 87.8 mt-30 -63.11 -61.12 2.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.359 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.547 ' HG3' HG22 ' A' ' 55' ' ' THR . 94.2 mtp -44.01 -32.91 1.27 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.19 -30.36 58.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 0.0 109.526 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.675 ' HB3' HG21 ' A' ' 87' ' ' VAL . 95.4 mt-10 -70.34 -38.93 74.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.662 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 18.0 tt -72.49 -34.57 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.819 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -70.21 -32.5 70.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.409 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.473 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -65.03 -40.15 94.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.905 HG21 HG12 ' A' ' 87' ' ' VAL . 70.2 t -72.32 -39.7 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 109.49 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.23 -39.74 86.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.192 -0.942 . . . . 0.0 109.019 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.483 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 30.8 t80 -57.7 -63.59 1.19 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.369 -0.832 . . . . 0.0 109.528 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 68' ' ' CYS . . . -64.12 -39.55 94.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.601 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.55 ' SG ' HG23 ' A' ' 120' ' ' ILE . 37.2 t -43.06 -62.43 1.04 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.444 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 67.6 mttm -59.27 -46.09 89.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -0.929 . . . . 0.0 109.426 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 66' ' ' PHE . 30.9 mmtt -56.15 -38.18 70.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.389 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.896 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -59.94 -64.95 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.81 ' HB2' HD11 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -48.56 -47.12 39.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 109.461 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 72' ' ' LEU . 49.9 mttm -43.25 -42.46 4.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.33 -0.857 . . . . 0.0 109.097 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.556 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 30.1 mm -49.39 143.65 9.68 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.397 -0.814 . . . . 0.0 109.001 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.1 Cg_endo -65.11 -4.35 8.89 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.51 2.14 . . . . 0.0 111.895 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -143.61 172.31 24.97 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.1 Cg_endo -69.02 120.63 7.51 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 122.408 2.072 . . . . 0.0 111.677 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.896 HG11 ' HA ' ' A' ' 71' ' ' ALA . 7.2 p -114.89 153.76 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 109.141 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.805 ' HB2' HG22 ' A' ' 9' ' ' VAL . 6.6 mp -97.1 139.98 32.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.025 -1.047 . . . . 0.0 109.931 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 58.1 t -118.0 121.98 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.418 -0.801 . . . . 0.0 109.004 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.877 HD12 ' CE1' ' A' ' 11' ' ' TYR . 3.7 mt -107.29 142.44 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.117 -0.99 . . . . 0.0 109.62 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.714 HG21 HG22 ' A' ' 64' ' ' VAL . 0.7 OUTLIER -128.18 161.7 28.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.415 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -87.74 7.11 31.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 109.507 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -123.95 129.42 50.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.526 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.426 ' CE2' ' HG3' ' A' ' 89' ' ' GLU . 68.0 t80 -77.8 -39.3 44.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -63.35 -48.15 79.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.905 HG12 HG21 ' A' ' 64' ' ' VAL . 59.5 t -58.96 -53.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 0.0 109.369 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.51 ' HB1' HG22 ' A' ' 132' ' ' ILE . . . -48.35 -55.0 11.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.933 . . . . 0.0 109.314 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 77.1 mm-40 -56.35 -35.1 67.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 117' ' ' TRP . 38.6 m -53.39 -46.63 69.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.742 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -92.5 -0.88 57.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.87 . . . . 0.0 109.674 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 45.6 t-20 -89.03 -72.86 0.53 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.067 -1.021 . . . . 0.0 109.761 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 23.2 mttm -126.86 -29.55 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.904 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 88.4 mt-10 -59.58 -28.34 67.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -58.77 -60.88 8.99 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.124 -0.985 . . . . 0.0 109.552 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.1 Cg_endo -66.41 -31.44 42.68 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.724 2.283 . . . . 0.0 111.411 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -68.89 -38.46 79.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.236 -0.915 . . . . 0.0 108.883 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.618 ' CG ' HD11 ' A' ' 111' ' ' LEU . 35.3 m0 -61.96 -52.91 62.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.19 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 98' ' ' TRP . 46.6 tttt -43.54 -41.66 4.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.365 -0.835 . . . . 0.0 109.496 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.2 m -58.95 -42.21 89.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.915 . . . . 0.0 109.415 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.747 ' O ' HG12 ' A' ' 104' ' ' VAL . 76.5 m-20 -84.48 7.35 20.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.142 -0.974 . . . . 0.0 109.524 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 82.55 32.42 27.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.721 ' C ' HD12 ' A' ' 111' ' ' LEU . 89.5 m-85 63.31 34.05 13.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -1.129 . . . . 0.0 109.473 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.829 HG23 ' HA ' ' A' ' 110' ' ' PRO . 7.4 p -121.67 121.4 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 109.555 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.47 ' HB2' HD23 ' A' ' 111' ' ' LEU . 53.3 t30 -53.7 -46.97 70.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.482 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.578 ' O ' HG22 ' A' ' 104' ' ' VAL . 81.9 m-20 -147.73 175.16 11.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.522 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -57.85 -31.68 66.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.515 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.416 ' C ' ' HG2' ' A' ' 109' ' ' LYS . 44.7 mttt -118.69 13.54 13.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.515 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 1.9 mmtt -133.02 89.28 34.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.85 . . . . 0.0 109.439 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.829 ' HA ' HG23 ' A' ' 104' ' ' VAL . 49.8 Cg_endo -70.34 152.22 66.17 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.777 2.318 . . . . 0.0 111.784 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.721 HD12 ' C ' ' A' ' 103' ' ' PHE . 91.6 mt -74.27 146.79 42.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.374 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HE3' ' NE2' ' A' ' 113' ' ' HIS . 33.8 tttp -104.9 139.72 39.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.636 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.5 ' NE2' ' HE3' ' A' ' 112' ' ' LYS . 70.6 m-70 65.25 36.79 6.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.653 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.634 HD13 ' HB3' ' A' ' 103' ' ' PHE . 86.1 mt -53.93 -43.89 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.242 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.9 m -49.68 -45.89 49.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.267 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HD2' ' HB3' ' A' ' 113' ' ' HIS . 64.1 mttm -58.6 -48.09 82.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.307 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.662 ' CZ2' HD12 ' A' ' 61' ' ' ILE . 60.9 m95 -65.65 -38.14 88.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.839 . . . . 0.0 109.385 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -56.87 -46.64 81.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.479 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.4 p -57.67 -39.54 77.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 109.423 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.55 HG23 ' SG ' ' A' ' 68' ' ' CYS . 73.9 mt -66.75 -37.24 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.861 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.445 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -65.32 -32.66 74.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 126' ' ' MET . 83.9 tt0 -54.18 -38.15 65.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.329 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.87 -49.25 11.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.419 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 124' ' ' LEU . 22.7 tp -63.08 -31.86 73.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.8 m -66.12 -33.24 75.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.475 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 65.1 mtt -65.99 -34.5 78.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.47 140.82 0.52 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.501 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.0 Cg_endo -70.51 -0.8 8.08 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.655 2.236 . . . . 0.0 111.717 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 128' ' ' PRO . 84.8 m-20 -43.8 -47.98 8.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.81 HD11 ' HB2' ' A' ' 72' ' ' LEU . 58.5 mt -58.45 114.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.472 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 91.0 m -104.81 147.05 28.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.277 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.742 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 54.3 mt -122.82 142.68 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.615 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.422 ' NE2' HD23 ' A' ' 79' ' ' LEU . 89.8 mt-30 -135.71 164.96 26.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.268 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 61.6 t60 -113.57 138.55 50.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.558 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.62 ' HG3' HG22 ' A' ' 81' ' ' ILE . 96.9 mt-10 -88.04 154.84 20.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.463 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.469 ' HB2' ' NE2' ' A' ' 139' ' ' GLN . 21.1 mttp -96.86 34.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.2 -122.63 30.53 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -109.66 145.66 36.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -1.184 . . . . 0.0 109.469 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.469 ' NE2' ' HB2' ' A' ' 136' ' ' LYS . 1.4 mt-30 -118.24 162.05 31.89 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.461 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 139' ' ' GLN . 50.6 Cg_endo -70.48 -16.94 34.58 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.627 2.218 . . . . 0.0 111.647 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.792 HG22 ' H ' ' A' ' 143' ' ' THR . 57.6 m -129.13 128.94 44.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 109.413 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -92.97 9.59 34.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.498 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.792 ' H ' HG22 ' A' ' 141' ' ' THR . 46.4 m -59.1 -38.23 79.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.415 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 62.6 m -57.22 138.93 54.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.141 -0.974 . . . . 0.0 109.439 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.092 HD11 ' CD1' ' A' ' 41' ' ' TYR . 18.9 tt -71.18 -27.71 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -67.33 -33.7 75.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.2 m -63.23 -40.85 98.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.548 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.25 -36.9 76.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.593 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -67.25 -30.27 75.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.429 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 13.7 t-20 -72.45 -33.26 66.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -1.169 . . . . 0.0 109.524 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.12 -51.51 37.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.543 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 56.3 mt -59.19 -47.27 85.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -56.84 -38.75 73.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 109.564 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.27 -32.26 73.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.647 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 159' ' ' GLN . 24.7 mttm -67.84 -41.88 82.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.63 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.61 ' N ' HD12 ' A' ' 156' ' ' LEU . 6.3 mp -73.14 -31.59 64.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.94 . . . . 0.0 109.585 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.61 -62.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.589 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 35.5 m -59.25 -43.3 92.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' A' ' 155' ' ' LYS . 63.1 tp60 -61.32 -33.61 73.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.629 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -68.52 -31.16 73.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.737 ' HB3' HD12 ' A' ' 17' ' ' ILE . 19.0 m -66.71 -29.33 69.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -1.142 . . . . 0.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.451 ' O ' ' OD1' ' A' ' 165' ' ' ASN . 28.1 m-85 -75.37 -21.52 58.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.434 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.76 -43.95 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 161' ' ' SER . 4.6 p -64.05 -32.09 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 164' ' ' VAL . 79.7 m-20 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.504 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.34 -22.54 66.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -1.118 . . . . 0.0 109.465 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.523 ' CE ' ' OH ' ' A' ' 37' ' ' TYR . 96.2 mmm -66.51 -30.76 71.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 90.07 -16.7 56.5 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 92.7 mt-30 61.76 36.65 16.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -1.141 . . . . 0.0 109.526 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.526 ' CG ' HD13 ' A' ' 79' ' ' LEU . 99.7 m-85 -57.04 177.87 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.523 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 31.7 tp10 -64.2 -37.89 89.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.362 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.569 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.48 -175.34 45.5 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 79' ' ' LEU . 72.2 t -134.47 142.86 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -1.121 . . . . 0.0 109.354 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.567 ' CE1' HG11 ' A' ' 78' ' ' VAL . 7.3 m-85 -123.06 140.36 53.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.634 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.875 ' CE2' HD12 ' A' ' 81' ' ' ILE . 42.9 m-85 -113.32 132.56 55.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.308 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.885 HG22 HD12 ' A' ' 32' ' ' ILE . 24.6 p -120.17 142.57 48.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.831 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.456 ' OD2' ' OD1' ' A' ' 154' ' ' ASP . 52.4 t0 -137.0 155.91 49.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.405 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -142.42 127.29 3.16 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 40.2 m -124.21 157.74 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -1.133 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.908 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -145.35 144.49 30.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 109.625 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.488 HD12 ' HB2' ' A' ' 161' ' ' SER . 47.7 mt -122.14 135.32 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 0.0 109.402 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -103.26 133.94 47.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.495 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -117.66 161.86 31.77 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.926 . . . . 0.0 109.538 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.28 -24.39 27.35 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.684 2.256 . . . . 0.0 111.826 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -79.87 -66.58 0.26 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 49.2 Cg_endo -70.13 65.16 2.02 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.554 2.17 . . . . 0.0 111.786 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.4 m -56.03 -45.14 79.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 109.419 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -94.86 28.73 2.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 109.457 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 30.6 t -154.52 144.68 21.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.935 . . . . 0.0 109.485 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 25' ' ' SER . 58.4 m-20 -137.9 154.76 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.44 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 71.1 m-20 -92.14 113.37 25.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.943 . . . . 0.0 109.337 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 59' ' ' ALA . . . -112.14 145.68 39.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.775 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.62 165.46 23.3 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.556 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 67.9 mtm -133.46 150.94 51.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -1.184 . . . . 0.0 109.684 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.46 120.24 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.885 HD12 HG22 ' A' ' 12' ' ' THR . 23.4 mm -110.36 140.62 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -1.159 . . . . 0.0 109.547 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' A' ' 153' ' ' ALA . 42.4 t -124.82 130.41 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.353 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.489 ' CE1' ' CD2' ' A' ' 10' ' ' PHE . 2.3 m-70 -105.67 138.2 42.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 109.655 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.7 168.62 18.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.467 ' HB ' HD21 ' A' ' 44' ' ' LEU . 12.2 t -138.16 165.13 27.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.175 -0.953 . . . . 0.0 109.713 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.523 ' OH ' ' CE ' ' A' ' 3' ' ' MET . 68.8 m-85 -106.63 10.21 31.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.584 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.09 -179.96 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.039 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.584 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.6 Cg_endo -66.39 -4.57 10.93 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.159 1.906 . . . . 0.0 111.64 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -132.12 105.92 7.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.35 -0.844 . . . . 0.0 108.811 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.463 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 58.6 t80 -63.53 117.72 7.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 109.408 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 41' ' ' TYR . 85.7 mt-30 -157.98 144.79 17.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.684 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.3 m -72.78 124.73 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 68.3 mt -59.72 -39.14 83.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.94 . . . . 0.0 109.483 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 20.3 t-20 -179.57 157.02 0.74 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -108.39 139.33 43.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.873 . . . . 0.0 109.515 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.403 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 0.5 OUTLIER -118.86 139.93 50.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.264 -0.897 . . . . 0.0 109.483 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 t -130.81 125.45 33.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.449 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 2.2 mp -130.82 95.74 25.04 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.77 ' HG3' HG21 ' A' ' 163' ' ' VAL . 50.1 Cg_endo -69.93 134.98 28.92 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.785 2.323 . . . . 0.0 111.813 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.447 HD12 ' CB ' ' A' ' 59' ' ' ALA . 38.8 mt -113.21 152.01 30.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.57 -48.37 0.13 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -89.16 7.49 34.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -1.177 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 90.2 m-70 -111.18 142.08 43.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 58' ' ' MET . 9.6 t -87.43 -176.27 5.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.908 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -60.45 -44.7 95.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -62.06 -48.58 79.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.593 ' O ' HG22 ' A' ' 61' ' ' ILE . 96.3 mtp -61.63 -30.12 70.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.497 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HB2' ' HB1' ' A' ' 28' ' ' ALA . . . -71.02 -28.74 64.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.769 ' HB3' HG21 ' A' ' 87' ' ' VAL . 98.1 mt-10 -73.69 -45.2 53.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 58' ' ' MET . 16.1 tt -63.12 -32.03 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.875 . . . . 0.0 109.465 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.556 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -74.2 -34.52 63.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.329 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -56.24 -42.82 77.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.534 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.651 HG21 HG12 ' A' ' 87' ' ' VAL . 32.7 t -71.32 -45.5 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.51 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.524 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 97.8 mt-10 -55.76 -35.57 66.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.907 . . . . 0.0 109.56 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.524 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 8.8 t80 -62.11 -69.04 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.607 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 -13.95 51.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.492 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 41.4 t -66.08 -60.41 2.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.179 -0.951 . . . . 0.0 109.432 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -65.13 -40.12 93.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.463 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HE3' ' CE2' ' A' ' 66' ' ' PHE . 63.2 mttm -64.26 -34.96 79.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.416 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.414 ' O ' HG12 ' A' ' 74' ' ' ILE . . . -63.71 -65.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.468 HD21 ' SD ' ' A' ' 126' ' ' MET . 24.9 tp -51.23 -44.33 61.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.953 . . . . 0.0 109.589 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' LEU . 83.5 tttt -43.55 -47.35 7.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.284 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.56 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 9.5 mm -48.51 142.72 8.24 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.14 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.2 Cg_endo -65.88 -5.02 11.09 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.49 2.127 . . . . 0.0 111.556 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.74 168.22 23.67 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 47.7 Cg_endo -68.85 137.35 37.96 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.583 2.188 . . . . 0.0 111.585 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 8' ' ' GLY . 21.7 t -123.82 159.1 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.46 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.582 ' HB2' HG22 ' A' ' 9' ' ' VAL . 6.5 mp -105.92 123.8 48.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.863 . . . . 0.0 109.59 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 40.2 t -103.6 121.62 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.453 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.875 HD12 ' CE2' ' A' ' 11' ' ' TYR . 13.8 mt -106.85 139.05 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.311 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.86 161.74 29.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.406 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 135' ' ' GLU . 68.1 m-20 -93.43 -2.5 54.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.458 ' HB3' HG23 ' A' ' 87' ' ' VAL . 71.1 m -108.5 120.75 43.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.575 ' HA ' ' CD2' ' A' ' 134' ' ' HIS . 61.2 t80 -71.31 -28.64 64.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.345 -0.847 . . . . 0.0 109.541 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -78.98 -46.33 18.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.316 -0.865 . . . . 0.0 109.745 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.769 HG21 ' HB3' ' A' ' 60' ' ' GLU . 30.9 t -57.68 -60.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 109.437 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.995 ' HB1' ' CG2' ' A' ' 132' ' ' ILE . . . -53.19 -51.75 61.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 0.0 109.408 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -52.31 -38.27 58.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.52 ' HB3' ' CH2' ' A' ' 117' ' ' TRP . 19.2 t -56.91 -48.2 78.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.92 -0.91 45.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 109.765 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -92.68 -73.77 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.003 -1.06 . . . . 0.0 110.072 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 32.5 mmtp -127.52 -27.13 2.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.0 . . . . 0.0 110.239 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 53.8 mt-10 -62.75 -20.54 65.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 110.176 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.937 HD21 ' HB2' ' A' ' 121' ' ' ALA . 25.4 tp -64.86 -58.33 13.32 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.965 -1.084 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.2 Cg_endo -66.14 -36.12 30.45 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.545 2.163 . . . . 0.0 111.442 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -65.79 -34.61 78.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 108.935 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.851 ' NE1' HD11 ' A' ' 111' ' ' LEU . 23.1 m0 -64.74 -50.41 67.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.4 -0.812 . . . . 0.0 109.123 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 98' ' ' TRP . 79.2 mttt -44.11 -31.31 0.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 109.609 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -29.06 62.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.194 -0.941 . . . . 0.0 109.587 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 98' ' ' TRP . 77.0 m-20 -99.31 23.11 9.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 109.606 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.66 ' O ' HG23 ' A' ' 104' ' ' VAL . . . 64.23 35.26 91.75 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.568 ' CG ' ' O ' ' A' ' 102' ' ' GLY . 9.4 p90 40.75 34.26 0.25 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -1.04 . . . . 0.0 109.903 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 102' ' ' GLY . 21.5 t -99.81 114.04 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.969 . . . . 0.0 109.631 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.584 ' HA ' HD13 ' A' ' 111' ' ' LEU . 53.7 p30 -51.32 173.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.421 -0.8 . . . . 0.0 109.71 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -129.73 -111.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.324 -0.86 . . . . 0.0 109.024 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -64.37 -30.09 71.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.759 -1.213 . . . . 0.0 108.849 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.529 ' CB ' ' HD3' ' A' ' 110' ' ' PRO . 42.4 mttt -109.2 -160.99 0.74 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 108.927 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -133.96 43.18 0.94 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 0.0 109.837 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 109' ' ' LYS . 50.5 Cg_endo -73.1 -18.63 23.68 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.409 2.072 . . . . 0.0 111.99 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.851 HD11 ' NE1' ' A' ' 98' ' ' TRP . 7.7 mp -91.84 21.21 5.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 0.0 109.469 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.518 ' CD ' ' HB2' ' A' ' 109' ' ' LYS . 45.9 mttt -89.24 157.37 18.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 108.847 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 61.71 34.83 17.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.057 -1.027 . . . . 0.0 109.149 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.659 HD11 ' O ' ' A' ' 111' ' ' LEU . 45.6 mm -48.86 -41.64 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 109.08 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.8 t -47.39 -44.01 23.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 108.784 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 40.3 mttm -63.38 -46.08 88.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 108.952 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.52 ' CH2' ' HB3' ' A' ' 90' ' ' SER . 47.9 m95 -62.17 -42.39 99.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -0.867 . . . . 0.0 109.216 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -51.66 -48.15 63.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.255 -0.903 . . . . 0.0 109.34 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.2 m -49.54 -39.8 35.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.24 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.524 ' CG1' ' HG2' ' A' ' 65' ' ' GLU . 61.9 mt -73.27 -33.32 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.268 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.937 ' HB2' HD21 ' A' ' 95' ' ' LEU . . . -64.96 -36.82 85.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -54.25 -40.3 67.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.407 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.92 -50.61 12.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.41 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.49 -35.98 75.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.357 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.2 t -58.96 -35.14 72.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.476 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.468 ' SD ' HD21 ' A' ' 72' ' ' LEU . 65.9 mtt -65.35 -34.78 79.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 172.37 152.72 0.22 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 0.0 109.557 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.7 Cg_endo -71.76 3.2 3.97 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.813 2.342 . . . . 0.0 112.059 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 128' ' ' PRO . 81.2 m-20 -42.36 -30.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 109.581 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 72' ' ' LEU . 38.1 mt -82.76 111.64 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.514 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 79' ' ' LEU . 32.9 m -97.72 151.16 20.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.391 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.995 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 63.7 mt -125.27 129.07 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.634 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.425 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.2 mt-30 -119.17 157.31 28.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.38 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.961 ' NE2' ' HB3' ' A' ' 88' ' ' ALA . 27.3 m170 -112.03 133.57 54.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.665 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.441 ' CD ' ' ND2' ' A' ' 150' ' ' ASN . 49.7 tp10 -90.64 146.08 24.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.873 . . . . 0.0 109.289 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -90.05 32.02 0.94 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -0.943 . . . . 0.0 109.523 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.27 -47.44 55.84 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -54.95 -44.23 74.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -1.17 . . . . 0.0 109.445 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -124.23 84.75 55.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.533 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.26 54.28 1.35 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.649 2.233 . . . . 0.0 111.822 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.1 m -60.98 -37.18 81.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 109.331 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -139.36 -179.53 5.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 0.0 109.396 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 p -127.8 158.16 38.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.527 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 79.2 p -145.78 162.19 38.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.3 tt -55.54 -31.38 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.857 . . . . 0.0 109.554 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -66.33 -31.77 72.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.435 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.2 m -51.95 -48.49 64.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.439 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -47.59 -51.37 21.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -52.39 -40.4 53.68 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.441 ' ND2' ' CD ' ' A' ' 135' ' ' GLU . 87.9 m-20 -64.96 -39.26 93.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -1.141 . . . . 0.0 109.465 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.79 -48.54 72.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.819 ' O ' HD12 ' A' ' 156' ' ' LEU . 6.6 mp -64.17 -41.13 97.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.441 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.733 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -64.9 -36.97 86.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.456 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 76.4 m-20 -61.18 -42.74 99.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -60.8 -45.45 94.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.527 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.819 HD12 ' O ' ' A' ' 152' ' ' LEU . 1.0 OUTLIER -63.89 -38.19 90.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.23 93.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 109.465 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.663 HG22 ' HE1' ' A' ' 162' ' ' TYR . 56.2 m -64.7 -41.65 95.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.5 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.49 -33.14 72.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.89 . . . . 0.0 109.624 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.23 96.38 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.488 ' HB2' HD12 ' A' ' 17' ' ' ILE . 95.6 p -56.73 -28.68 61.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -1.171 . . . . 0.0 109.631 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.663 ' HE1' HG22 ' A' ' 158' ' ' THR . 87.9 m-85 -72.72 -25.11 61.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 109.524 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.77 HG21 ' HG3' ' A' ' 50' ' ' PRO . 77.1 t -64.17 -42.55 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.899 . . . . 0.0 109.411 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 161' ' ' SER . 41.0 t -122.43 158.63 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.413 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.441 ' N ' HG12 ' A' ' 164' ' ' VAL . 47.9 t-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.471 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.27 -25.85 68.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -1.155 . . . . 0.0 109.504 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.798 ' HE2' HD12 ' A' ' 79' ' ' LEU . 89.3 mtp -62.67 -35.86 81.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.147 -0.971 . . . . 0.0 109.498 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . -42.7 164.39 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 74.2 mt-30 66.36 39.84 3.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.121 . . . . 0.0 109.63 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 3' ' ' MET . 7.9 p90 -135.62 152.7 51.5 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.312 -0.868 . . . . 0.0 109.35 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.493 ' OE2' ' CD ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -88.5 -31.41 18.74 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.289 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -177.24 -177.08 45.87 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 79' ' ' LEU . 59.4 t -124.8 142.63 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -1.133 . . . . 0.0 109.25 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.813 ' CE1' HG21 ' A' ' 78' ' ' VAL . 5.4 m-85 -114.3 146.58 40.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.861 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.594 ' CE2' HG13 ' A' ' 81' ' ' ILE . 67.8 m-85 -119.64 129.1 54.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.394 -0.817 . . . . 0.0 109.104 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.804 HG22 HD12 ' A' ' 32' ' ' ILE . 16.0 p -118.02 147.46 43.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.64 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 58.8 t0 -144.34 150.65 38.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.548 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -134.96 120.99 2.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.7 m -133.13 150.68 52.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -1.137 . . . . 0.0 109.625 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -119.75 154.46 34.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.479 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 161' ' ' SER . 66.6 mt -122.55 134.17 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.162 -0.961 . . . . 0.0 109.629 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HG2' ' CG ' ' A' ' 26' ' ' ASN . 37.2 mttp -103.12 152.31 21.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.557 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -124.61 176.35 2.4 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.362 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 46.4 Cg_endo -68.78 128.62 17.22 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.497 2.131 . . . . 0.0 111.321 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 53.75 60.32 11.59 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 108.917 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 19' ' ' SER . 46.7 Cg_endo -67.75 69.5 0.79 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.938 2.425 . . . . 0.0 112.013 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 p -57.67 -16.94 12.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.858 . . . . 0.0 109.2 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -118.26 -174.97 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 m -70.37 151.64 44.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 7.8 m120 -60.43 -178.99 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.843 . . . . 0.0 109.431 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' ILE . 86.8 m-20 -99.53 113.7 26.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.413 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . . . -93.17 150.35 20.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.9 143.03 9.81 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 63.4 mtm -115.39 162.86 16.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -1.152 . . . . 0.0 109.359 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' A' ' 156' ' ' LEU . . . -151.27 130.22 3.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.804 HD12 HG22 ' A' ' 12' ' ' THR . 23.4 mm -114.76 140.65 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -1.116 . . . . 0.0 109.382 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 11' ' ' TYR . 40.6 t -127.88 130.2 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.546 ' CE1' ' CD2' ' A' ' 10' ' ' PHE . 2.5 m-70 -105.67 137.57 43.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.144 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.1 168.63 19.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.709 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -137.01 164.32 28.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.379 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.499 ' CE2' ' HE1' ' A' ' 3' ' ' MET . 59.4 m-85 -102.48 14.78 31.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.494 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.578 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -51.17 179.8 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 108.942 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.3 Cg_endo -66.1 -6.21 14.05 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.137 1.891 . . . . 0.0 111.447 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -135.16 106.55 6.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.427 -0.795 . . . . 0.0 109.066 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -58.38 122.96 14.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.258 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -154.14 148.17 25.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.683 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 43' ' ' VAL . 8.6 p -82.96 123.78 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 54.4 mt -64.27 -34.18 77.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 21.7 t-20 178.69 155.3 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.512 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.405 ' HB3' HD21 ' A' ' 156' ' ' LEU . 94.2 mt-30 -109.32 142.39 40.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.322 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.485 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -126.52 136.4 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.591 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.1 t -127.29 132.49 50.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.361 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.921 HD11 ' CE2' ' A' ' 66' ' ' PHE . 3.3 mt -132.77 91.73 28.72 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.74 136.22 29.89 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.713 2.275 . . . . 0.0 111.728 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.57 ' CD1' ' HB2' ' A' ' 59' ' ' ALA . 44.0 mt -101.48 143.98 30.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.41 -68.41 1.13 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -109.87 64.09 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.19 . . . . 0.0 109.537 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 83.7 m-70 -132.1 171.95 12.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.521 HG22 ' HG3' ' A' ' 58' ' ' MET . 11.7 t -121.0 174.22 6.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.83 -45.26 78.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' GLU . 90.1 mt-30 -60.35 -64.03 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.447 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.521 ' HG3' HG22 ' A' ' 55' ' ' THR . 97.1 mtp -44.35 -35.3 2.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 109.371 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.57 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . . . -80.39 -25.9 38.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 57' ' ' GLN . 78.0 tt0 -64.48 -40.56 95.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.404 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.651 HD11 ' CZ2' ' A' ' 117' ' ' TRP . 12.1 tt -84.1 -29.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.474 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -67.73 -25.84 65.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.465 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.38 81.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.512 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.574 HG22 HG21 ' A' ' 82' ' ' THR . 96.7 t -79.29 -38.97 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.569 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -66.8 -39.37 87.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.078 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.921 ' CE2' HD11 ' A' ' 49' ' ' ILE . 27.6 t80 -59.72 -64.54 0.91 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.447 -0.783 . . . . 0.0 109.608 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.94 -32.2 70.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.839 . . . . 0.0 109.751 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 1.051 ' SG ' HG23 ' A' ' 120' ' ' ILE . 50.8 t -54.82 -54.18 45.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -62.87 -45.67 91.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.581 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 62.9 mttm -63.38 -38.0 89.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 109.669 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.641 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -56.75 -63.05 1.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.57 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.941 ' HB2' HD11 ' A' ' 130' ' ' ILE . 25.2 tp -53.48 -45.74 69.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.489 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 72' ' ' LEU . 20.8 tttp -43.06 -43.21 4.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.371 -0.831 . . . . 0.0 109.23 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 8.0 mt -48.25 142.44 7.92 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 108.877 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.8 Cg_endo -66.11 -4.3 10.06 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.447 2.098 . . . . 0.0 111.696 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.409 ' HA3' ' CD ' ' A' ' 7' ' ' GLU . . . -140.77 166.96 25.76 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.493 ' CD ' ' OE2' ' A' ' 7' ' ' GLU . 46.7 Cg_endo -67.64 127.17 15.88 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.418 2.079 . . . . 0.0 111.591 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.813 HG21 ' CE1' ' A' ' 10' ' ' PHE . 7.3 p -123.47 151.41 28.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.165 -0.959 . . . . 0.0 109.495 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.798 HD12 ' HE2' ' A' ' 3' ' ' MET . 15.5 mt -93.15 146.78 23.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.457 ' O ' HD13 ' A' ' 81' ' ' ILE . 65.1 t -118.09 135.84 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 109.396 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.594 HG13 ' CE2' ' A' ' 11' ' ' TYR . 26.1 mm -114.75 132.67 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.574 HG21 HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -129.77 161.62 30.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.953 . . . . 0.0 109.481 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 58.7 p30 -94.57 11.38 31.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.363 -0.835 . . . . 0.0 109.435 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.45 ' CB ' HG12 ' A' ' 87' ' ' VAL . 8.3 t -131.92 119.21 20.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.498 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.423 ' HB2' ' CG ' ' A' ' 134' ' ' HIS . 68.9 t80 -75.96 -34.3 59.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.339 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -57.95 -53.62 56.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 88' ' ' ALA . 13.7 p -61.06 -46.67 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.338 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.61 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -53.5 -51.72 61.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.204 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 84.4 tt0 -55.93 -36.5 67.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.623 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 67.8 m -54.87 -49.51 71.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.451 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.544 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -85.95 -1.0 56.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.719 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.459 ' OD1' ' HB ' ' A' ' 132' ' ' ILE . 81.3 m-20 -87.1 -73.32 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.072 -1.017 . . . . 0.0 109.722 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 67.6 mttm -127.08 -30.76 2.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -0.87 . . . . 0.0 109.835 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 69.4 mt-10 -58.09 -28.21 64.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.727 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -59.64 -61.23 8.29 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.0 109.458 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -66.3 -30.87 44.77 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.691 2.261 . . . . 0.0 111.572 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -67.55 -39.51 84.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.013 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.487 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 27.9 m0 -63.46 -51.38 65.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.173 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 98' ' ' TRP . 15.3 tttp -45.0 -41.98 7.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 m -57.91 -41.55 82.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -86.09 10.82 13.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.465 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 75.99 39.79 31.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 85.9 m-85 62.42 43.56 7.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -1.168 . . . . 0.0 109.48 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.81 135.11 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.551 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 109' ' ' LYS . 41.0 t-20 -67.57 141.51 56.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.45 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -51.66 -35.29 41.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -77.54 164.24 25.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -55.61 -31.34 62.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 2.1 mptp? -61.43 141.82 94.25 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.516 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.11 154.69 66.11 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.732 2.288 . . . . 0.0 111.742 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.015 HD23 ' CD1' ' A' ' 114' ' ' ILE . 10.1 tp -81.92 134.2 35.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 12.8 mmtp -115.24 167.08 11.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.56 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 49.0 m80 65.61 34.56 7.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.517 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.015 ' CD1' HD23 ' A' ' 111' ' ' LEU . 35.8 mm -68.09 -42.73 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.444 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 23.2 m -55.96 -40.76 73.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 109.346 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -65.37 -39.21 92.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.651 ' CZ2' HD11 ' A' ' 61' ' ' ILE . 22.6 m95 -71.64 -39.15 70.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.317 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 115' ' ' SER . 55.3 mtmt -57.38 -42.16 81.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 109.383 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.3 m -58.41 -42.42 87.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 1.051 HG23 ' SG ' ' A' ' 68' ' ' CYS . 83.4 mt -76.36 -34.06 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.473 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -63.62 -40.05 95.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.941 . . . . 0.0 109.432 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -57.46 -42.53 82.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.4 m -67.53 -49.68 62.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.583 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 56.0 mt -62.71 -30.56 71.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.913 . . . . 0.0 109.571 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.0 m -56.04 -36.37 67.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.498 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.745 ' SD ' HD21 ' A' ' 72' ' ' LEU . 65.3 mtt -64.15 -34.85 79.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.985 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 126' ' ' MET . 1.3 mttp 170.76 156.53 0.21 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.626 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 129' ' ' ASP . 53.4 Cg_endo -71.82 2.65 4.51 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.823 2.349 . . . . 0.0 111.897 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 128' ' ' PRO . 91.3 m-20 -41.73 -43.97 3.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.875 . . . . 0.0 109.685 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.941 HD11 ' HB2' ' A' ' 72' ' ' LEU . 50.3 mt -68.35 115.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.51 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.598 ' HB ' HD22 ' A' ' 79' ' ' LEU . 24.5 m -107.52 142.95 36.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 0.0 109.095 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.544 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 61.8 mt -124.96 137.99 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 109.781 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.501 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 94.8 mt-30 -133.03 161.19 35.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.354 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.423 ' CG ' ' HB2' ' A' ' 85' ' ' PHE . 69.8 t60 -105.07 135.68 45.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 109.412 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 81' ' ' ILE . 99.4 mt-10 -75.16 154.54 37.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.84 33.66 1.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.476 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.13 -164.17 40.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -118.93 132.87 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -1.131 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.439 ' HG2' ' HD2' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -143.3 138.46 15.59 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.168 -0.957 . . . . 0.0 109.526 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.439 ' HD2' ' HG2' ' A' ' 139' ' ' GLN . 49.6 Cg_endo -70.71 -24.51 25.25 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.733 2.288 . . . . 0.0 111.695 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.6 m -64.53 -35.46 81.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.454 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 56.63 49.33 14.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.6 p -70.44 -20.26 62.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.483 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.9 p -117.62 152.02 36.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.462 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.4 HD13 ' CE1' ' A' ' 37' ' ' TYR . 12.9 tt -67.01 -28.69 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.515 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -65.41 -34.38 78.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.902 . . . . 0.0 109.467 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 51.9 m -56.86 -49.17 76.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 109.444 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.03 -48.3 64.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.433 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.6 -37.35 82.52 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -60.08 -40.06 88.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -1.119 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.06 -52.84 62.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.489 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.9 mt -57.31 -48.64 78.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.491 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.464 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -54.43 -40.44 68.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.453 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 88.8 m-20 -59.25 -40.29 85.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -60.58 -42.64 97.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 156' ' ' LEU . 6.6 mp -66.28 -39.86 89.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.527 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.72 -53.2 58.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.0 m -59.12 -42.83 91.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.572 ' O ' HG23 ' A' ' 163' ' ' VAL . 49.1 tt0 -63.11 -40.05 96.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.73 -51.29 58.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.547 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 30.3 m -61.92 -33.39 74.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -1.133 . . . . 0.0 109.465 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -62.99 -35.86 81.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.892 . . . . 0.0 109.46 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 159' ' ' GLN . 40.4 t -64.96 -16.76 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 51' ' ' LEU . 40.2 t -109.34 134.76 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.472 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.32 79.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.448 ' O ' ' OH ' ' A' ' 6' ' ' TYR . 59.4 mtm -62.72 -33.01 74.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.88 177.26 19.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -103.73 116.14 31.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -1.149 . . . . 0.0 109.511 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.032 ' CD2' HD11 ' A' ' 79' ' ' LEU . 64.8 m-85 -119.47 168.65 10.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.352 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 76.6 mm-40 -63.0 -38.66 92.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.171 -0.956 . . . . 0.0 108.942 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.48 -170.71 41.64 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.98 HG21 ' OH ' ' A' ' 37' ' ' TYR . 73.8 t -133.26 139.1 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -1.082 . . . . 0.0 109.007 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.635 ' CD2' ' ND1' ' A' ' 34' ' ' HIS . 5.1 m-85 -113.8 138.6 50.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.905 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.873 ' CE1' HD12 ' A' ' 81' ' ' ILE . 75.2 m-85 -114.05 117.2 30.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.146 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 1.113 HG22 HG23 ' A' ' 32' ' ' ILE . 10.4 p -114.55 157.16 23.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.786 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 49.9 t0 -155.77 156.01 34.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.279 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.495 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -131.25 141.96 13.29 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.9 t -141.62 138.6 32.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.965 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -118.97 143.62 46.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.521 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 63.9 mt -119.82 134.96 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.378 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -97.35 127.02 42.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.485 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 3.7 m -115.21 158.77 40.29 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.435 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.47 -28.33 21.99 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.747 2.298 . . . . 0.0 111.855 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.591 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -72.61 -66.44 0.6 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.528 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 50.0 Cg_endo -69.7 65.7 1.75 Allowed 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.671 2.247 . . . . 0.0 111.804 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 m -54.72 -43.14 72.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -97.88 33.43 2.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.44 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 22' ' ' PRO . 35.2 t -162.69 147.98 12.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -131.24 159.96 36.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.801 ' HB3' HG23 ' A' ' 164' ' ' VAL . 21.8 m120 -91.68 114.97 27.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.485 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . . . -99.26 143.08 29.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.93 151.44 20.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.833 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 72.4 mtm -128.68 160.45 32.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -1.145 . . . . 0.0 109.518 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -153.34 115.67 0.69 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.113 HG23 HG22 ' A' ' 12' ' ' THR . 4.3 mp -123.54 120.53 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -1.175 . . . . 0.0 109.431 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.601 HG22 HG13 ' A' ' 43' ' ' VAL . 11.6 p -120.82 148.0 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.635 ' ND1' ' CD2' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -109.24 145.52 35.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.03 173.11 11.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -133.22 157.03 46.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 109.664 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.98 ' OH ' HG21 ' A' ' 9' ' ' VAL . 16.7 m-30 -103.48 12.79 34.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.51 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.591 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -50.82 -179.62 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 108.941 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.591 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.5 Cg_endo -65.11 -7.43 15.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.038 1.825 . . . . 0.0 111.288 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -128.11 106.25 8.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.429 -0.795 . . . . 0.0 108.965 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -61.82 127.37 31.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.149 -0.97 . . . . 0.0 109.237 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -161.42 154.24 20.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.925 . . . . 0.0 109.562 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.601 HG13 HG22 ' A' ' 33' ' ' VAL . 41.9 t -91.05 122.54 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 109.24 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 45.5 mt -62.46 -40.21 95.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 109.346 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 33' ' ' VAL . 64.2 t30 178.45 154.49 0.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.878 . . . . 0.0 109.684 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.722 ' OE1' HD21 ' A' ' 156' ' ' LEU . 56.2 mt-30 -107.58 143.06 36.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.054 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.2 t-105 -118.52 131.85 56.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 109.599 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.2 m -121.88 145.34 48.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.579 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 9.9 mt -149.56 96.88 3.57 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.554 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.0 Cg_endo -70.02 128.4 15.74 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.684 2.256 . . . . 0.0 111.661 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.669 ' HB2' ' HB3' ' A' ' 28' ' ' ALA . 49.0 mt -114.36 148.67 37.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 109.49 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.65 -46.89 0.2 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -87.47 11.11 15.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 90.9 m-70 -112.61 147.21 37.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.482 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.1 OUTLIER -89.58 168.47 12.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.9 . . . . 0.0 109.111 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.965 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -49.38 -38.76 29.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.1 -1.0 . . . . 0.0 109.056 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' MET . 89.2 mt-30 -70.09 -58.77 3.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.332 -0.855 . . . . 0.0 109.311 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.539 ' O ' HG22 ' A' ' 61' ' ' ILE . 93.3 mtp -45.43 -30.59 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.158 -0.964 . . . . 0.0 109.199 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.648 ' HB2' ' HB1' ' A' ' 28' ' ' ALA . . . -75.28 -37.35 60.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.416 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.452 ' HB3' ' OG ' ' A' ' 84' ' ' SER . 96.3 mt-10 -62.74 -44.9 95.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.358 -0.839 . . . . 0.0 109.562 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.63 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 8.2 tt -67.29 -35.09 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.833 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -65.89 -29.69 70.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.192 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.767 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -70.01 -44.79 68.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.44 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.779 HG21 HG13 ' A' ' 87' ' ' VAL . 68.6 t -63.13 -47.3 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.335 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' A' ' 120' ' ' ILE . 84.6 tt0 -64.83 -38.3 90.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 109.417 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 49' ' ' ILE . 16.3 t80 -53.66 -68.82 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.395 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -63.23 -15.94 58.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.369 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.69 ' SG ' HG23 ' A' ' 120' ' ' ILE . 39.8 t -70.79 -58.03 4.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.432 ' NZ ' ' OE2' ' A' ' 65' ' ' GLU . 25.5 mttt -59.76 -48.69 80.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.486 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 37.5 mttm -60.87 -38.48 85.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.227 -0.92 . . . . 0.0 109.505 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.794 ' HB1' ' CG1' ' A' ' 78' ' ' VAL . . . -55.74 -69.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.63 ' HB2' HD11 ' A' ' 130' ' ' ILE . 6.3 tp -44.89 -48.51 11.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 109.434 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 20.2 mttm -43.81 -44.36 6.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.281 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 9.7 mt -48.81 143.11 8.51 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.043 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.6 Cg_endo -66.29 -2.68 7.48 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.601 2.2 . . . . 0.0 111.921 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.516 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -141.64 166.4 26.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.3 Cg_endo -69.34 122.75 9.54 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 122.552 2.168 . . . . 0.0 111.714 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.794 ' CG1' ' HB1' ' A' ' 71' ' ' ALA . 2.8 p -112.77 156.44 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.032 HD11 ' CD2' ' A' ' 6' ' ' TYR . 19.3 mt -101.58 140.26 36.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.759 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 52.0 t -120.92 130.33 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.137 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.873 HD12 ' CE1' ' A' ' 11' ' ' TYR . 8.0 mt -118.71 136.23 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.742 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.8 t -140.97 143.26 34.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.237 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -66.69 -25.34 66.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.905 . . . . 0.0 109.57 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.58 ' CB ' ' CG1' ' A' ' 87' ' ' VAL . 3.6 m -64.69 110.93 2.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 109.286 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.659 ' CD2' ' CE1' ' A' ' 134' ' ' HIS . 49.2 t80 -78.05 -41.45 35.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.688 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -71.15 -35.98 71.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 0.0 109.908 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.779 HG13 HG21 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -67.36 -47.16 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.135 -0.978 . . . . 0.0 109.497 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.964 ' HB3' ' NE2' ' A' ' 134' ' ' HIS . . . -54.32 -51.4 64.8 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.229 -0.919 . . . . 0.0 108.964 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 72.6 tt0 -55.26 -33.39 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.332 -0.855 . . . . 0.0 108.967 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.637 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 16.6 m -57.3 -49.11 77.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.844 . . . . 0.0 109.352 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.798 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -85.71 -0.72 55.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.749 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.48 ' OD1' ' HB ' ' A' ' 132' ' ' ILE . 85.7 m-20 -88.48 -73.48 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 109.947 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 63.0 mttt -127.42 -30.07 2.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.017 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 37.5 mm-40 -57.04 -31.54 65.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.078 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.606 HD23 ' HB2' ' A' ' 121' ' ' ALA . 0.5 OUTLIER -58.32 -60.8 9.05 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 0.0 109.503 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -66.8 -26.33 45.12 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.642 2.228 . . . . 0.0 111.581 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.657 ' CE2' ' ND2' ' A' ' 101' ' ' ASN . 77.7 t80 -73.82 -36.83 65.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 108.977 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.1 m0 -65.33 -50.35 65.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.35 -0.844 . . . . 0.0 109.239 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -51.03 -40.09 57.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.382 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 82.7 p -63.46 -35.99 82.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.389 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.657 ' ND2' ' CE2' ' A' ' 97' ' ' TYR . 79.2 m-20 -85.73 8.37 20.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 77.41 37.16 32.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 87.3 m-85 63.25 48.8 3.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -1.173 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 109' ' ' LYS . 46.7 t -110.14 134.89 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.54 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 1.041 ' HB2' HD12 ' A' ' 111' ' ' LEU . 48.8 t30 -98.89 136.3 39.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.464 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -57.47 -38.78 75.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.4 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -67.66 -46.46 72.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.396 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 105' ' ' ASN . 33.7 mttm -132.86 145.22 50.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.9 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.657 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -44.71 -65.2 0.66 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 109.531 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 109' ' ' LYS . 49.3 Cg_endo -70.1 138.4 36.67 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.686 2.257 . . . . 0.0 111.873 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.041 HD12 ' HB2' ' A' ' 105' ' ' ASN . 11.3 tp -85.96 142.25 28.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.393 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 80.8 tttt -101.23 151.88 21.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.591 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.535 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 89.6 m-70 65.31 28.55 11.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.569 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.585 HG12 HD23 ' A' ' 111' ' ' LEU . 80.0 mt -62.88 -45.48 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.167 -0.958 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -55.67 -46.08 77.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.53 -45.48 91.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.637 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 54.3 m95 -66.42 -36.55 83.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.439 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -56.4 -46.17 80.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.484 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.6 m -59.96 -44.11 94.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.407 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.69 HG23 ' SG ' ' A' ' 68' ' ' CYS . 87.8 mt -68.79 -39.58 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.606 ' HB2' HD23 ' A' ' 95' ' ' LEU . . . -62.87 -36.24 82.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.472 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -56.2 -37.92 70.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 6.0 m -79.43 -51.34 9.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.387 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 124' ' ' LEU . 19.4 tp -58.56 -34.59 71.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.417 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.0 m -60.47 -31.88 70.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.549 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.78 -33.38 75.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.447 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.45 145.95 0.29 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 109.511 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.6 Cg_endo -72.35 2.72 4.76 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.741 2.294 . . . . 0.0 111.774 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 128' ' ' PRO . 79.5 m-20 -42.87 -46.16 5.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.504 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.63 HD11 ' HB2' ' A' ' 72' ' ' LEU . 52.8 mt -61.92 121.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.342 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.627 ' HB ' HD22 ' A' ' 79' ' ' LEU . 24.4 m -110.85 146.77 35.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.372 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.798 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 54.1 mt -125.12 128.13 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.462 ' HB2' HG12 ' A' ' 81' ' ' ILE . 79.9 mt-30 -127.24 154.9 44.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.964 ' NE2' ' HB3' ' A' ' 88' ' ' ALA . 34.1 m170 -90.67 141.01 29.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.791 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HG2' ' OD1' ' A' ' 150' ' ' ASN . 98.3 mt-10 -75.71 147.03 39.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 109.286 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -101.55 37.85 1.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.559 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -46.26 -33.96 5.94 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -91.32 135.2 33.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 0.0 109.428 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.479 ' O ' ' CG2' ' A' ' 143' ' ' THR . 2.2 tp60 67.11 73.02 0.39 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.506 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.533 ' HA ' HG21 ' A' ' 143' ' ' THR . 50.0 Cg_endo -70.63 -16.94 33.92 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.704 2.27 . . . . 0.0 111.719 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.6 m -76.3 139.89 41.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.496 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 60.74 44.51 11.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.448 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.533 HG21 ' HA ' ' A' ' 140' ' ' PRO . 27.1 p -119.31 159.05 24.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.463 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.3 m -70.99 174.52 6.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.535 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 24.3 pt -70.2 -10.04 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.893 . . . . 0.0 109.476 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.622 ' CD2' HD11 ' A' ' 81' ' ' ILE . 71.9 m80 -65.31 -27.09 68.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.1 m -51.35 -45.92 62.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.315 -0.866 . . . . 0.0 109.563 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -52.22 -49.81 63.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 109.506 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.43 -36.1 75.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.45 ' OD1' ' HG2' ' A' ' 135' ' ' GLU . 77.1 m-20 -60.42 -41.13 93.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -1.15 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.24 -48.48 79.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.402 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 26.0 tp -65.28 -42.26 93.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.32 -40.73 98.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 0.0 109.509 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.457 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 56.2 t0 -58.26 -43.17 87.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 0.0 109.559 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 78.6 tttt -62.19 -38.13 87.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.51 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.722 HD21 ' OE1' ' A' ' 46' ' ' GLN . 78.8 mt -64.29 -38.2 90.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.568 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.22 83.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.923 . . . . 0.0 109.463 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 36.3 m -61.59 -41.46 97.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.472 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.78 ' O ' HG23 ' A' ' 163' ' ' VAL . 95.2 mt-30 -62.4 -35.96 80.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -62.54 -55.94 24.38 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.1 p -67.48 -28.69 68.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -1.146 . . . . 0.0 109.516 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -63.85 -36.14 82.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.551 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 159' ' ' GLN . 39.1 t -64.95 -11.79 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.514 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.801 HG23 ' HB3' ' A' ' 27' ' ' ASN . 22.3 m -126.98 155.55 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.455 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.443 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 71.3 m-20 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.539 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.5 146.22 49.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -1.157 . . . . 0.0 109.55 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 77.9 mtm -63.92 -40.27 96.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 68.5 -172.21 35.67 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 75.0 mm-40 82.55 -24.91 0.16 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.724 -0.868 . . . . 0.0 110.259 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.672 ' CB ' HD13 ' A' ' 79' ' ' LEU . 24.0 p90 -129.22 166.74 18.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.902 -1.124 . . . . 0.0 109.565 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -94.72 -33.86 12.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 108.924 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.587 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -165.74 175.42 41.4 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.819 HG22 ' HB2' ' A' ' 79' ' ' LEU . 91.8 t -124.95 138.02 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.196 -1.179 . . . . 0.0 109.357 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE2' ' CG ' ' A' ' 34' ' ' HIS . 5.3 m-85 -111.38 139.55 46.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.558 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.795 ' CE1' HD12 ' A' ' 81' ' ' ILE . 82.2 m-85 -113.93 127.34 55.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.908 . . . . 0.0 109.39 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.818 HG22 HG23 ' A' ' 32' ' ' ILE . 16.3 p -118.49 152.6 35.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.574 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 53.7 t0 -151.36 152.87 33.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -135.08 118.0 1.84 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.8 m -122.18 150.28 42.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -1.149 . . . . 0.0 109.536 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -123.44 145.89 48.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.493 ' CD1' ' OG ' ' A' ' 161' ' ' SER . 74.5 mt -117.73 141.48 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 109.461 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 pttm -104.62 136.43 44.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.587 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.486 ' OG ' ' HD2' ' A' ' 22' ' ' PRO . 4.0 t -120.04 155.1 55.81 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.479 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 46.4 Cg_endo -67.67 -18.51 48.11 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.621 2.214 . . . . 0.0 112.009 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.582 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -82.38 -66.4 0.22 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.223 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 52.3 Cg_endo -71.91 68.4 3.11 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.592 2.195 . . . . 0.0 111.56 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.0 m -54.61 -43.64 72.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.374 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -98.41 36.06 1.68 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.312 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' A' ' 22' ' ' PRO . 16.2 t -161.5 138.12 8.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.371 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -126.36 159.13 34.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.559 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 78.1 m-20 -92.9 115.55 28.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.477 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -99.19 148.29 24.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.4 ' HA3' ' N ' ' A' ' 161' ' ' SER . . . -141.83 153.18 24.05 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.943 ' CE ' HD21 ' A' ' 51' ' ' LEU . 70.9 mtm -119.95 161.5 20.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.449 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -154.42 117.48 0.79 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.818 HG23 HG22 ' A' ' 12' ' ' THR . 4.8 mp -125.74 120.29 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -1.138 . . . . 0.0 109.256 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.584 HG22 HG13 ' A' ' 43' ' ' VAL . 9.6 p -119.59 145.89 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.735 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.688 ' CG ' ' CE2' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -105.72 136.17 45.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.147 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.38 167.37 20.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.642 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.6 t -124.56 159.85 29.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.369 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.549 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 17.7 m-85 -106.71 16.9 23.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.71 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.589 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -51.28 -178.7 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.852 . . . . 0.0 108.711 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.589 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.5 Cg_endo -65.02 -6.37 12.73 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.964 1.776 . . . . 0.0 111.566 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -131.64 106.09 7.94 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.736 ' CE1' HG23 ' A' ' 145' ' ' ILE . 60.5 t80 -57.44 126.02 25.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.469 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -155.21 149.14 25.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -0.91 . . . . 0.0 109.534 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.584 HG13 HG22 ' A' ' 33' ' ' VAL . 51.4 t -91.49 121.06 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 109.523 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 53.1 mt -63.93 -38.89 92.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.536 ' O ' HG23 ' A' ' 33' ' ' VAL . 39.9 t30 -179.99 156.29 0.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.579 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.528 ' HG2' ' CG2' ' A' ' 33' ' ' VAL . 93.5 mt-30 -110.46 147.82 33.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.426 -0.796 . . . . 0.0 109.025 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -126.07 132.89 51.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.124 -0.985 . . . . 0.0 109.716 -179.592 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.7 t -126.22 132.11 51.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.242 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.476 ' HB ' ' CE ' ' A' ' 30' ' ' MET . 3.0 mt -135.51 111.64 10.69 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.722 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HB3' ' CG2' ' A' ' 163' ' ' VAL . 50.2 Cg_endo -70.87 134.92 26.65 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.729 2.286 . . . . 0.0 111.665 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.943 HD21 ' CE ' ' A' ' 30' ' ' MET . 49.9 mt -104.51 138.28 41.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.907 . . . . 0.0 109.617 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' O ' ' ND1' ' A' ' 54' ' ' HIS . . . -113.81 127.63 7.91 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 18.4 m120 64.44 38.55 7.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -1.181 . . . . 0.0 109.469 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 52' ' ' GLY . 75.9 m80 -124.74 165.46 17.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.492 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.581 HG23 ' HG3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -110.56 171.42 7.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 109.179 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -53.95 -39.72 66.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.094 -1.004 . . . . 0.0 109.231 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 60' ' ' GLU . 92.4 mt-30 -67.35 -53.66 27.48 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.871 . . . . 0.0 109.263 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.581 ' HG3' HG23 ' A' ' 55' ' ' THR . 69.7 mmm -44.73 -34.61 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.33 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.685 ' HB2' HD12 ' A' ' 51' ' ' LEU . . . -76.83 -32.49 57.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.399 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' GLN . 97.7 mt-10 -62.85 -40.61 97.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.58 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.571 HD11 ' CE2' ' A' ' 117' ' ' TRP . 17.7 tt -74.73 -35.12 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.549 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.606 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -71.02 -30.15 66.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.56 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -59.93 -39.29 84.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.555 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.685 HG21 HG12 ' A' ' 87' ' ' VAL . 44.3 t -77.14 -43.99 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.555 ' HG2' HD11 ' A' ' 120' ' ' ILE . 98.1 mt-10 -55.78 -36.83 67.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.548 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.586 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 10.8 t80 -59.87 -68.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.645 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -60.77 -13.58 16.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 109.602 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.676 ' SG ' HG23 ' A' ' 120' ' ' ILE . 40.2 t -66.3 -60.77 2.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.485 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -65.65 -40.99 93.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.586 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 54.3 mttm -65.86 -27.42 68.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.566 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 67' ' ' ALA . . . -69.14 -57.13 5.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 72' ' ' LEU . 24.7 tp -61.52 -39.25 90.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -47.07 -37.47 9.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 33.9 mm -61.66 142.8 94.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 108.958 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.5 Cg_endo -64.6 -5.94 11.19 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.575 2.183 . . . . 0.0 111.731 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.463 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -134.29 166.79 24.03 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.497 ' HG2' ' O ' ' A' ' 5' ' ' GLN . 47.5 Cg_endo -68.65 140.97 48.57 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.547 2.165 . . . . 0.0 111.679 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.628 HG11 ' CE1' ' A' ' 10' ' ' PHE . 21.8 t -126.32 159.31 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.537 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.819 ' HB2' HG22 ' A' ' 9' ' ' VAL . 1.9 mp -113.32 124.52 52.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.834 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 62.4 t -104.9 133.13 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.795 HD12 ' CE1' ' A' ' 11' ' ' TYR . 31.9 mt -119.97 135.71 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.935 . . . . 0.0 109.479 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.666 HG21 HG22 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -130.66 161.79 30.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 109.258 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 53.9 p-10 -90.02 10.86 22.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.945 . . . . 0.0 109.548 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.4 t -112.04 126.02 54.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.52 ' HD1' ' CD2' ' A' ' 134' ' ' HIS . 70.8 t80 -80.64 -40.23 25.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 90' ' ' SER . 96.0 m-85 -61.02 -49.56 76.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.685 HG12 HG21 ' A' ' 64' ' ' VAL . 48.4 t -61.7 -52.12 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.403 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.596 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -52.88 -61.04 2.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.895 . . . . 0.0 109.341 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 81.5 tt0 -57.82 -18.98 25.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.191 -0.943 . . . . 0.0 109.277 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.532 ' HA ' ' CG ' ' A' ' 94' ' ' GLU . 8.4 t -66.73 -65.09 0.72 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.557 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.883 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -69.82 -7.5 40.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.553 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 85.1 m-20 -86.58 -46.33 10.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.678 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 96' ' ' PRO . 62.6 mttp -126.46 -47.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 109.732 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.583 ' HB3' ' CE2' ' A' ' 98' ' ' TRP . 81.7 mt-10 -51.46 -44.22 62.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.694 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.883 HD23 ' HA ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -50.68 -63.45 1.87 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.912 . . . . 0.0 109.54 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.521 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 48.0 Cg_endo -68.69 -42.05 5.24 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.749 2.299 . . . . 0.0 112.035 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.31 -40.05 96.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.622 ' CE2' ' CD2' ' A' ' 111' ' ' LEU . 39.9 m0 -65.07 -43.71 91.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.59 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -50.18 -39.89 45.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.565 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.1 p -66.02 -29.95 70.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -90.31 8.57 32.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.511 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.68 33.24 71.23 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.97 ' C ' HD12 ' A' ' 111' ' ' LEU . 20.8 m-85 68.21 32.59 4.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -1.108 . . . . 0.0 109.457 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.24 127.26 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.406 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.503 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 18.7 t-20 -87.8 -73.64 0.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.538 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 105' ' ' ASN . 25.1 m120 -144.25 157.11 44.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.524 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -60.94 -32.52 72.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.94 -37.45 84.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.207 -0.933 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.86 127.24 3.96 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.467 ' HG2' ' HE2' ' A' ' 112' ' ' LYS . 50.4 Cg_endo -70.25 167.19 25.79 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.593 2.195 . . . . 0.0 111.739 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.97 HD12 ' C ' ' A' ' 103' ' ' PHE . 21.0 mt -59.51 -39.03 82.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.452 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.467 ' HE2' ' HG2' ' A' ' 110' ' ' PRO . 34.2 mttt 59.74 152.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 64.0 m80 60.23 27.05 16.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.444 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 80.5 mt -62.5 -38.33 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.361 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.9 t -56.27 -45.85 79.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.278 -0.889 . . . . 0.0 109.315 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.44 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 61.8 mttp -60.06 -54.06 50.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.571 ' CE2' HD11 ' A' ' 61' ' ' ILE . 91.9 m95 -65.21 -33.15 75.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 109.387 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -54.01 -45.95 71.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.378 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.9 m -53.29 -44.13 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.306 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.676 HG23 ' SG ' ' A' ' 68' ' ' CYS . 83.7 mt -72.01 -32.79 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.364 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.91 88.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.89 . . . . 0.0 109.358 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.91 -39.01 83.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.875 ' SG ' HD11 ' A' ' 130' ' ' ILE . 23.0 t -68.58 -44.09 75.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.563 HD23 HD12 ' A' ' 130' ' ' ILE . 55.1 mt -68.15 -34.15 75.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.5 t -59.64 -33.75 71.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.427 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.458 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 92.0 mtp -67.91 -33.96 75.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.6 OUTLIER 177.35 136.58 0.22 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.512 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.9 Cg_endo -71.56 2.45 4.55 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.728 2.285 . . . . 0.0 112.078 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 31.6 p-10 -43.71 -39.04 3.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.662 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.875 HD11 ' SG ' ' A' ' 123' ' ' CYS . 52.6 mt -59.3 115.57 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.741 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.0 m -111.6 134.05 53.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.025 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.795 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -116.44 135.9 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.081 -1.012 . . . . 0.0 109.887 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.8 mt-30 -126.0 154.22 43.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.359 -0.838 . . . . 0.0 109.3 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.52 ' CD2' ' HD1' ' A' ' 85' ' ' PHE . 56.2 t60 -108.34 127.0 53.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.48 145.8 50.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.727 ' CE ' HG23 ' A' ' 141' ' ' THR . 30.8 mttm -96.25 35.4 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.418 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.74 -154.27 41.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -56.28 -40.75 74.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -1.136 . . . . 0.0 109.511 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -64.94 125.83 89.9 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.46 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.72 ' HB3' HG23 ' A' ' 147' ' ' THR . 50.3 Cg_endo -70.43 136.74 31.94 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.641 2.227 . . . . 0.0 111.761 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.727 HG23 ' CE ' ' A' ' 136' ' ' LYS . 45.3 m -57.15 -44.27 83.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.404 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 141' ' ' THR . 96.5 m-20 -139.3 -43.17 0.46 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 140' ' ' PRO . 17.3 p -130.17 159.87 35.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.466 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 82.5 p -70.15 -14.16 62.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.736 HG23 ' CE1' ' A' ' 41' ' ' TYR . 88.4 mt -61.93 -35.38 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.583 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -69.15 -36.85 77.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.509 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.72 HG23 ' HB3' ' A' ' 140' ' ' PRO . 58.3 p -69.05 -40.24 78.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.478 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 144' ' ' SER . 97.3 mt-10 -54.07 -37.41 64.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.54 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -65.13 -34.54 89.98 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -65.73 -38.12 88.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -1.185 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.91 -48.8 67.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.551 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 mt -65.7 -44.32 86.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.92 -37.7 83.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.427 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 57.4 t0 -62.59 -41.24 98.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 69.0 mttm -63.4 -36.02 82.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.501 ' CD1' ' HB ' ' A' ' 33' ' ' VAL . 71.4 mt -69.31 -37.23 77.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.49 -43.94 68.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 31.7 m -60.14 -42.2 94.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.574 ' O ' HG13 ' A' ' 163' ' ' VAL . 95.1 mt-30 -65.23 -33.31 75.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 109.541 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.87 ' O ' HG22 ' A' ' 163' ' ' VAL . . . -61.84 -46.61 93.8 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.493 ' OG ' ' CD1' ' A' ' 17' ' ' ILE . 91.2 p -72.9 -26.19 61.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -68.36 -35.99 78.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 160' ' ' GLY . 18.1 m -70.87 -14.23 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.573 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.422 HG23 HG23 ' A' ' 163' ' ' VAL . 41.0 t -105.34 134.69 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.508 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 51.3 t30 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.472 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 5' ' ' GLN . . . -63.78 -31.2 72.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -1.185 . . . . 0.0 109.475 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.766 ' HE2' ' CZ ' ' A' ' 37' ' ' TYR . 92.7 mmm -62.6 -32.95 74.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.513 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.94 -18.15 32.08 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 97.3 mt-30 -52.12 -33.24 38.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -1.138 . . . . 0.0 109.525 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.032 ' CD2' HD11 ' A' ' 79' ' ' LEU . 43.9 m-85 -100.76 176.09 5.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.611 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -76.48 -36.3 57.91 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.256 -0.903 . . . . 0.0 109.19 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.47 -166.46 35.26 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.779 HG13 ' HB3' ' A' ' 35' ' ' ALA . 7.2 p -125.29 140.72 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -1.072 . . . . 0.0 108.996 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.858 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.6 m-85 -117.69 135.89 53.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 109.85 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.84 ' CE1' HD12 ' A' ' 81' ' ' ILE . 95.0 m-85 -114.08 118.72 34.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.994 HG22 HG23 ' A' ' 32' ' ' ILE . 19.0 p -115.79 151.61 34.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 0.0 109.728 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 53.1 t0 -147.51 156.15 42.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.351 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -163.21 117.11 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.463 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 68.7 m -138.85 147.98 43.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -1.163 . . . . 0.0 109.74 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -107.81 140.52 40.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.465 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.796 HD12 ' HB3' ' A' ' 161' ' ' SER . 68.6 mt -107.58 137.52 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.905 . . . . 0.0 109.524 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 36.6 tttp -93.08 145.3 24.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.266 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.542 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -125.53 176.38 2.49 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.346 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 44.9 Cg_endo -68.27 -7.74 20.9 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.463 2.109 . . . . 0.0 111.284 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -134.81 70.63 70.89 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.455 -0.778 . . . . 0.0 109.091 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.78 7.22 0.6 Allowed 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.95 2.433 . . . . 0.0 112.773 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 m -57.61 -25.14 59.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.903 -1.123 . . . . 0.0 109.147 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 25' ' ' SER . 42.9 mttt -103.68 25.91 9.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.369 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 8.2 t 66.63 164.01 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 109.651 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 18' ' ' LYS . 96.0 m-20 -77.31 149.56 35.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.464 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -93.65 129.2 40.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 108.987 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.643 ' CB ' ' CE1' ' A' ' 54' ' ' HIS . . . -119.46 164.47 15.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -0.99 . . . . 0.0 110.158 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.82 146.77 18.75 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.776 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 61.7 mtm -120.0 145.75 46.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.479 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.81 118.61 1.78 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.994 HG23 HG22 ' A' ' 12' ' ' THR . 4.6 mp -120.86 116.87 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -1.153 . . . . 0.0 109.255 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 45' ' ' ASN . 7.2 p -124.45 144.47 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.101 -1.0 . . . . 0.0 109.731 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.674 ' CG ' ' CE2' ' A' ' 10' ' ' PHE . 1.4 m-70 -101.59 141.72 34.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.852 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.779 ' HB3' HG13 ' A' ' 9' ' ' VAL . . . -129.81 165.81 21.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.44 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 t -126.16 165.25 19.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.766 ' CZ ' ' HE2' ' A' ' 3' ' ' MET . 82.8 m-85 -107.92 10.16 28.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.58 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.18 179.72 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.007 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.2 Cg_endo -65.45 -5.38 11.31 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.183 1.922 . . . . 0.0 111.658 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -129.25 106.02 8.54 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -64.83 129.93 41.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -167.66 154.12 7.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.479 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 43' ' ' VAL . 32.6 m -89.37 120.59 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.887 . . . . 0.0 109.461 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 55.3 mt -57.78 -38.8 76.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.342 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.731 ' O ' HG23 ' A' ' 33' ' ' VAL . 60.9 t30 -169.6 155.43 6.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.918 . . . . 0.0 109.594 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.528 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 91.9 mt-30 -112.59 137.8 50.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.831 . . . . 0.0 109.103 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.52 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -118.01 133.38 55.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.142 -0.974 . . . . 0.0 109.659 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 t -119.85 140.17 51.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 109.31 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.645 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 1.7 mt -145.5 92.32 5.57 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 109.693 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.671 ' HG3' HG11 ' A' ' 163' ' ' VAL . 49.8 Cg_endo -70.39 147.5 58.98 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.682 2.254 . . . . 0.0 111.598 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 50' ' ' PRO . 43.1 mt -123.88 129.44 51.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.698 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.689 ' HA2' HG11 ' A' ' 164' ' ' VAL . . . -92.78 -73.57 1.24 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -102.22 87.98 3.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.165 . . . . 0.0 109.154 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.643 ' CE1' ' CB ' ' A' ' 28' ' ' ALA . 6.7 p-80 -132.29 -163.82 1.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.976 . . . . 0.0 109.949 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.841 HG23 ' HE3' ' A' ' 58' ' ' MET . 0.2 OUTLIER -128.93 144.8 51.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.039 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -44.69 -33.91 2.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.084 -1.01 . . . . 0.0 109.13 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 61' ' ' ILE . 85.5 mt-30 -77.79 -47.78 18.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.841 ' HE3' HG23 ' A' ' 55' ' ' THR . 24.2 ttm -48.79 -35.07 13.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.987 . . . . 0.0 109.23 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' A' ' 54' ' ' HIS . . . -74.18 -45.86 45.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.382 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.91 -34.83 77.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.577 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.669 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 18.7 tt -77.32 -37.28 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.557 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.776 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -65.9 -29.78 70.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.15 92.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.654 HG21 HG12 ' A' ' 87' ' ' VAL . 46.5 t -77.82 -49.97 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.524 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.2 tt0 -53.09 -39.79 63.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.632 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.645 ' CZ ' HD11 ' A' ' 49' ' ' ILE . 13.0 t80 -57.76 -69.11 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 109.57 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.528 ' HB3' HG11 ' A' ' 80' ' ' VAL . . . -62.34 -15.95 51.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 109.462 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 1.057 ' SG ' HG23 ' A' ' 120' ' ' ILE . 39.4 t -66.09 -63.07 1.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -60.99 -44.35 97.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.566 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 48.7 mttm -62.85 -36.52 83.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.856 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -59.28 -64.18 1.04 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.366 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 130' ' ' ILE . 20.0 tp -51.98 -46.73 64.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.922 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 72' ' ' LEU . 19.4 tttm -42.58 -41.1 2.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.0 109.276 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.555 HG23 ' HD2' ' A' ' 75' ' ' PRO . 34.8 mm -52.29 143.44 25.98 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.823 . . . . 0.0 108.802 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.555 ' HD2' HG23 ' A' ' 74' ' ' ILE . 43.1 Cg_endo -65.09 -2.47 5.73 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.632 2.221 . . . . 0.0 112.203 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.484 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -143.13 170.65 25.29 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 47.7 Cg_endo -69.46 119.86 6.77 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.445 2.097 . . . . 0.0 111.693 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.858 HG21 ' CE1' ' A' ' 10' ' ' PHE . 7.7 p -114.01 146.56 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.399 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.032 HD11 ' CD2' ' A' ' 6' ' ' TYR . 15.9 mt -93.05 143.28 26.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.737 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.528 HG11 ' HB3' ' A' ' 67' ' ' ALA . 49.6 t -124.13 126.33 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 109.183 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.84 HD12 ' CE1' ' A' ' 11' ' ' TYR . 33.6 mt -113.49 136.22 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.784 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.557 HG21 ' CG2' ' A' ' 64' ' ' VAL . 10.3 t -142.31 159.27 42.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.351 -0.843 . . . . 0.0 109.276 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.47 ' HB3' ' OE1' ' A' ' 135' ' ' GLU . 51.0 p-10 -92.69 20.22 6.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.152 -0.967 . . . . 0.0 109.466 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.49 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 41.9 m -105.57 104.48 14.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 109.347 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.676 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 74.8 t80 -69.37 -50.19 48.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 109.583 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -60.81 -40.57 93.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.654 HG12 HG21 ' A' ' 64' ' ' VAL . 92.5 t -62.84 -39.57 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.378 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.61 -60.66 3.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.567 ' OE2' ' CE2' ' A' ' 85' ' ' PHE . 94.0 mt-10 -50.93 -35.35 32.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.618 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 70.6 m -55.91 -47.24 77.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.612 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -88.6 -0.92 57.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.907 . . . . 0.0 109.805 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 84.2 m-20 -90.61 -73.61 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.122 -0.986 . . . . 0.0 109.953 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 96' ' ' PRO . 96.8 mttt -127.13 -31.66 2.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 109.842 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 57.0 mt-10 -52.18 -40.49 61.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.911 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.064 HD21 ' HB2' ' A' ' 121' ' ' ALA . 6.4 tp -62.93 -58.3 17.16 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.063 -1.023 . . . . 0.0 109.537 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -65.89 -26.02 52.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.521 2.147 . . . . 0.0 111.261 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -75.56 -35.74 60.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.345 -0.847 . . . . 0.0 108.72 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.568 ' CD2' HD21 ' A' ' 111' ' ' LEU . 15.9 m0 -63.05 -48.31 79.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.291 -0.881 . . . . 0.0 108.979 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 98' ' ' TRP . 4.6 mtmt -43.57 -44.03 5.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 109.418 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.4 m -64.2 -42.17 96.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.4 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -68.72 -14.14 62.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.332 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 84.53 34.11 17.44 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 40.4 m-85 67.22 37.97 3.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -1.148 . . . . 0.0 109.375 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 60.9 t -117.07 129.33 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.499 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 109' ' ' LYS . 40.0 t-20 -86.23 117.31 24.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.89 . . . . 0.0 109.446 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -58.57 -35.67 72.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.433 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -58.17 -37.19 74.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 109.463 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.476 ' O ' ' CG ' ' A' ' 109' ' ' LYS . 85.4 mttt -135.17 -82.57 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.418 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.591 ' CB ' ' CD ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -172.53 -67.44 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.168 -0.957 . . . . 0.0 109.529 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 109' ' ' LYS . 52.6 Cg_endo -71.85 141.35 36.96 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.598 2.199 . . . . 0.0 111.933 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.568 HD21 ' CD2' ' A' ' 98' ' ' TRP . 19.0 tp -93.65 133.98 36.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.239 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 20.6 mttt -97.61 149.14 22.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.667 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.568 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 48.1 m80 66.29 30.4 9.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.341 -0.849 . . . . 0.0 109.679 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 111' ' ' LEU . 91.1 mt -64.56 -50.35 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.133 -0.98 . . . . 0.0 109.308 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m -60.08 -44.18 94.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.233 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -59.19 -50.17 75.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.308 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.669 ' CZ2' HD12 ' A' ' 61' ' ' ILE . 53.0 m95 -69.27 -35.77 76.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.907 . . . . 0.0 109.325 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -56.88 -45.93 82.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.341 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.9 m -55.43 -45.36 76.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.375 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 1.057 HG23 ' SG ' ' A' ' 68' ' ' CYS . 69.0 mt -66.82 -36.62 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.409 -0.807 . . . . 0.0 109.411 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 1.064 ' HB2' HD21 ' A' ' 95' ' ' LEU . . . -57.42 -43.4 83.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.461 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.21 -45.84 75.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.506 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 93.4 m -66.52 -46.56 75.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.23 -32.51 73.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.365 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.4 m -61.65 -35.17 77.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.55 ' SD ' HD21 ' A' ' 72' ' ' LEU . 66.1 mtt -64.6 -34.38 78.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.423 ' HG2' ' C ' ' A' ' 126' ' ' MET . 0.2 OUTLIER 174.57 145.39 0.21 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.242 -0.911 . . . . 0.0 109.559 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.6 Cg_endo -72.17 2.33 5.07 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.698 2.265 . . . . 0.0 111.763 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 128' ' ' PRO . 76.9 m-20 -42.39 -46.79 4.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.559 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 72' ' ' LEU . 60.5 mt -56.6 122.14 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.527 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.658 ' CB ' HD22 ' A' ' 79' ' ' LEU . 24.6 m -112.2 141.55 45.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.154 -0.966 . . . . 0.0 109.337 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.612 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 70.8 mt -125.25 134.61 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.935 . . . . 0.0 109.669 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.444 ' HB2' HG12 ' A' ' 81' ' ' ILE . 91.4 mt-30 -124.94 157.89 34.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.676 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 83.6 t60 -113.48 127.75 56.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.499 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.489 ' O ' ' CD2' ' A' ' 134' ' ' HIS . 95.3 mt-10 -58.05 151.68 18.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 140' ' ' PRO . 65.6 mttm -93.65 33.71 1.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.41 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.95 -164.21 29.81 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -78.11 -27.34 48.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.289 -1.124 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -116.39 76.19 6.9 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.885 . . . . 0.0 109.419 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.474 ' CG ' ' OG1' ' A' ' 147' ' ' THR . 49.1 Cg_endo -69.93 153.9 67.65 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.722 2.282 . . . . 0.0 111.738 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 37.8 m -120.15 142.82 48.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 109.362 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.794 ' O ' HG23 ' A' ' 143' ' ' THR . 81.4 m-20 55.85 48.03 18.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 142' ' ' ASN . 0.1 OUTLIER 176.6 35.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.448 ' O ' ' HB ' ' A' ' 147' ' ' THR . 86.8 p -64.67 -23.65 67.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 83.4 mt -58.36 -55.29 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -65.4 -21.46 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.474 ' OG1' ' CG ' ' A' ' 140' ' ' PRO . 97.7 m -61.24 -47.01 88.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 109.52 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.15 -46.23 53.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -61.66 -36.82 93.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 154' ' ' ASP . 82.1 m-20 -63.55 -37.25 86.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -1.191 . . . . 0.0 109.418 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.89 -51.6 66.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.426 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 57.1 mt -66.32 -43.64 85.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.59 87.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.542 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.46 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 94.8 m-20 -66.35 -41.25 89.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.88 . . . . 0.0 109.534 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -59.45 -39.79 84.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.54 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 46' ' ' GLN . 70.8 mt -65.57 -37.43 86.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.91 93.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.926 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.707 HG22 ' HE2' ' A' ' 162' ' ' TYR . 50.6 m -61.76 -41.66 97.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.943 . . . . 0.0 109.667 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.538 ' O ' HG23 ' A' ' 163' ' ' VAL . 62.1 tt0 -63.34 -34.34 77.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.603 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.24 -42.37 88.21 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.796 ' HB3' HD12 ' A' ' 17' ' ' ILE . 17.3 m -61.47 -37.21 82.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -1.161 . . . . 0.0 109.581 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.707 ' HE2' HG22 ' A' ' 158' ' ' THR . 89.6 m-85 -69.53 -21.09 63.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 0.0 109.509 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.671 HG11 ' HG3' ' A' ' 50' ' ' PRO . 39.3 t -66.0 -29.6 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.689 HG11 ' HA2' ' A' ' 52' ' ' GLY . 47.5 t -112.82 137.63 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.507 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.446 179.965 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.88 142.73 53.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -1.158 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.575 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 88.5 mtp -62.9 -37.17 85.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.487 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 106.86 -14.37 41.28 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 92.3 mt-30 62.99 44.85 5.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -1.101 . . . . 0.0 109.488 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.053 ' CD2' HD11 ' A' ' 79' ' ' LEU . 98.2 m-85 -50.4 -179.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.135 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.515 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 74.5 mm-40 -68.45 -37.01 79.82 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.079 -1.013 . . . . 0.0 109.04 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.35 -177.06 47.5 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 79' ' ' LEU . 95.1 t -133.29 132.23 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.346 -1.09 . . . . 0.0 108.943 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.664 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.9 m-85 -113.23 140.1 48.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 110.058 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 1.071 ' CE2' HD12 ' A' ' 81' ' ' ILE . 70.9 m-85 -112.15 133.71 54.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.364 -0.835 . . . . 0.0 109.095 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 1.047 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 7.1 p -121.05 152.51 38.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.645 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -152.86 152.6 31.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.347 -0.846 . . . . 0.0 109.388 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.17 128.67 5.68 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.553 ' OG ' ' HB3' ' A' ' 157' ' ' ALA . 50.6 m -122.17 148.88 44.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -1.146 . . . . 0.0 109.307 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 27' ' ' ASN . . . -133.82 145.03 49.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 78.3 mt -119.69 137.7 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.325 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HG3' ' OD1' ' A' ' 26' ' ' ASN . 20.8 tttt -99.97 158.17 16.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.506 ' CB ' ' CD ' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -126.55 -177.71 0.63 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.459 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 19' ' ' SER . 55.3 Cg_endo -85.95 104.8 0.77 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.798 2.332 . . . . 0.0 111.668 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.596 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER 58.89 41.36 0.61 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.149 -0.969 . . . . 0.0 110.151 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 21' ' ' ASP . 54.6 Cg_endo -74.03 91.1 0.94 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.061 1.841 . . . . 0.0 111.229 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.1 m -52.44 -20.23 2.72 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.621 -0.832 . . . . 0.0 108.93 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 25' ' ' SER . 14.5 ttpt -93.57 140.41 29.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 0.0 108.699 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 26' ' ' ASN . 26.4 t -41.61 147.79 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.102 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 25' ' ' SER . 96.7 m-20 -47.51 174.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.446 -0.784 . . . . 0.0 109.279 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 95.1 m-20 -96.12 129.12 43.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.406 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -112.2 156.35 22.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.736 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.25 160.48 26.82 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . 1.0 ' SD ' HD21 ' A' ' 51' ' ' LEU . 76.2 mtp -121.15 150.89 40.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -1.189 . . . . 0.0 109.678 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.53 117.76 0.84 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 32' ' ' ILE . 5.4 mp -121.73 139.89 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 109.638 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' CG1' HG13 ' A' ' 43' ' ' VAL . 21.3 t -114.73 139.64 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.323 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 2.6 m-70 -107.24 139.95 40.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.615 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.59 166.51 24.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.596 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.592 ' HB ' HD11 ' A' ' 44' ' ' LEU . 15.4 t -139.9 164.45 29.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.654 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.513 ' OH ' HG21 ' A' ' 9' ' ' VAL . 58.6 m-85 -97.69 14.17 27.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.645 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.574 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 2.2 mttt -50.88 178.57 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 108.776 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.574 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.5 Cg_endo -65.33 -6.46 13.4 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.179 1.92 . . . . 0.0 111.534 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.446 ' HG3' ' HG3' ' A' ' 42' ' ' GLN . 38.9 tp10 -137.75 106.43 5.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -0.846 . . . . 0.0 109.086 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.434 ' CZ ' ' CG2' ' A' ' 145' ' ' ILE . 51.7 t80 -63.3 118.09 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.908 . . . . 0.0 109.297 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.446 ' HG3' ' HG3' ' A' ' 40' ' ' GLU . 93.5 mt-30 -151.9 145.61 25.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.582 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.448 HG13 ' CG1' ' A' ' 33' ' ' VAL . 24.5 t -63.56 117.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.3 -0.875 . . . . 0.0 109.512 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.592 HD11 ' HB ' ' A' ' 36' ' ' THR . 43.0 mt -63.51 -37.55 87.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -177.59 158.99 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.418 ' OE1' HD21 ' A' ' 152' ' ' LEU . 23.6 mt-30 -106.94 138.81 42.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.329 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -126.45 131.4 51.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.776 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.4 m -129.92 136.45 49.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.244 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.578 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 3.8 mt -134.95 112.12 11.28 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.53 138.06 34.57 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.744 2.296 . . . . 0.0 111.623 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.0 HD21 ' SD ' ' A' ' 30' ' ' MET . 61.6 mt -111.18 139.58 46.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.51 ' O ' ' ND1' ' A' ' 54' ' ' HIS . . . -115.17 132.03 10.11 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 72.3 m-20 62.94 38.02 11.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.151 . . . . 0.0 109.502 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 52' ' ' GLY . 74.3 m80 -124.61 159.56 30.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.58 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.1 OUTLIER -101.87 168.47 9.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 0.0 109.171 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.86 -33.57 66.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -0.981 . . . . 0.0 108.975 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.2 -50.89 24.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.319 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.58 ' SD ' HG23 ' A' ' 55' ' ' THR . 99.2 mtp -55.15 -28.84 55.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . . . -74.18 -40.42 62.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.493 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.17 -42.83 95.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.612 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.815 ' HA ' HG21 ' A' ' 87' ' ' VAL . 14.9 tt -69.62 -32.11 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.73 -27.7 67.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.327 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.047 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -71.27 -38.07 71.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.483 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.746 HG22 HG21 ' A' ' 82' ' ' THR . 89.8 t -69.44 -40.52 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.587 ' HG2' HD11 ' A' ' 120' ' ' ILE . 99.2 mt-10 -64.74 -41.95 95.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.016 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.596 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 27.8 t80 -59.73 -65.25 0.71 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.485 -0.759 . . . . 0.0 109.711 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.21 68.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 109.725 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.689 ' SG ' HG23 ' A' ' 120' ' ' ILE . 50.4 t -60.7 -53.49 56.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 109.485 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -59.12 -50.86 72.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.664 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.596 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 62.9 mttm -61.15 -36.31 79.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.862 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.882 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -57.0 -69.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.718 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.846 ' HB2' HD11 ' A' ' 130' ' ' ILE . 22.1 tp -46.83 -46.32 20.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.591 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 72' ' ' LEU . 14.4 tptt -44.19 -45.13 8.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.206 -0.934 . . . . 0.0 109.269 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.671 HD12 ' HB ' ' A' ' 78' ' ' VAL . 7.3 mt -48.36 142.87 7.79 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.023 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.8 Cg_endo -65.57 -4.77 10.25 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.573 2.182 . . . . 0.0 111.749 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.515 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -140.62 168.57 25.18 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.1 Cg_endo -68.4 122.11 9.11 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.411 2.074 . . . . 0.0 111.77 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.882 HG11 ' HA ' ' A' ' 71' ' ' ALA . 4.6 p -113.71 155.25 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.419 -0.801 . . . . 0.0 109.262 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.053 HD11 ' CD2' ' A' ' 6' ' ' TYR . 22.6 mt -99.8 149.04 23.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 109.833 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 76.0 t -130.35 135.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.38 -0.825 . . . . 0.0 109.066 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.071 HD12 ' CE2' ' A' ' 11' ' ' TYR . 20.4 mt -119.87 139.47 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.953 . . . . 0.0 109.649 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.746 HG21 HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -128.29 161.85 28.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.364 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 58.3 p30 -92.48 13.39 19.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.442 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 42.6 m -132.82 125.47 30.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.601 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 67.5 t80 -77.59 -42.02 36.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -49.9 -57.25 7.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.381 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.815 HG21 ' HA ' ' A' ' 61' ' ' ILE . 14.9 p -61.05 -46.61 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.291 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.615 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -55.52 -55.5 31.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.902 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 79.6 tt0 -54.75 -31.56 58.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.944 . . . . 0.0 109.184 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.604 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 18.0 t -56.68 -56.27 23.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -80.32 -0.83 38.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.729 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 89.8 m-20 -84.54 -73.35 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.094 -1.004 . . . . 0.0 110.038 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 74.5 mttt -127.34 -27.84 2.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.132 -0.98 . . . . 0.0 110.269 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 68.1 mm-40 -61.04 -30.87 70.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.095 -1.003 . . . . 0.0 109.89 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -61.41 -58.53 18.07 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.718 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 43.9 Cg_endo -66.02 -25.47 51.64 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.552 2.168 . . . . 0.0 111.694 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -71.46 -38.17 71.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.173 -0.954 . . . . 0.0 109.044 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.456 ' CE3' HD21 ' A' ' 111' ' ' LEU . 39.1 m0 -67.01 -47.89 70.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.257 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -47.38 -42.67 22.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.856 . . . . 0.0 109.472 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.6 m -57.42 -39.2 75.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.373 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -90.28 10.45 24.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.436 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 72.65 40.92 52.31 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.47 ' CD1' HG23 ' A' ' 114' ' ' ILE . 97.9 m-85 60.69 33.08 20.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -1.123 . . . . 0.0 109.444 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.57 133.99 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -77.44 148.2 35.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.939 . . . . 0.0 109.521 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -50.13 -32.26 15.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.365 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -77.02 158.26 30.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -56.22 -31.45 63.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -63.19 143.84 97.55 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.495 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.71 165.82 29.64 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.659 2.239 . . . . 0.0 111.811 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.834 HD23 HG12 ' A' ' 114' ' ' ILE . 10.4 tp -78.92 135.6 37.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.465 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 18.9 mttp -98.81 152.45 19.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.569 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 36.7 m80 67.48 31.07 6.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.834 HG12 HD23 ' A' ' 111' ' ' LEU . 78.5 mt -68.74 -39.0 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.366 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.6 m -62.07 -44.61 96.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.362 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.454 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 54.3 mttp -61.45 -41.36 97.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.624 ' HH2' HG23 ' A' ' 87' ' ' VAL . 40.2 m95 -76.75 -30.69 56.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.37 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -59.27 -39.25 82.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.8 m -62.54 -44.86 95.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.689 HG23 ' SG ' ' A' ' 68' ' ' CYS . 78.0 mt -72.58 -30.25 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.442 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.505 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -61.72 -41.62 97.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.416 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -59.04 -40.23 84.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 109.387 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 46.3 m -68.15 -47.11 68.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.2 tp -63.32 -32.4 73.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.34 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 m -61.59 -31.8 71.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.568 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.478 ' HB3' ' HE3' ' A' ' 127' ' ' LYS . 93.6 mmm -67.54 -34.17 76.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 126' ' ' MET . 0.0 OUTLIER 170.67 147.6 0.14 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.0 Cg_endo -71.63 -0.04 7.69 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.73 2.286 . . . . 0.0 111.633 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 128' ' ' PRO . 93.4 m-20 -42.49 -47.24 5.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.428 -0.795 . . . . 0.0 109.632 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.846 HD11 ' HB2' ' A' ' 72' ' ' LEU . 56.8 mt -58.89 119.14 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.618 ' HB ' HD22 ' A' ' 79' ' ' LEU . 24.8 m -112.42 140.44 47.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.689 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 58.8 mt -122.54 137.46 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 109.696 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.429 ' HB2' HG12 ' A' ' 81' ' ' ILE . 84.6 mt-30 -122.73 163.07 20.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.218 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.601 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 46.4 t60 -118.58 131.39 56.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 109.62 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.795 ' CD ' HG21 ' A' ' 81' ' ' ILE . 96.5 mt-10 -129.22 138.45 51.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.403 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.438 ' CE ' ' HB3' ' A' ' 138' ' ' HIS . 20.8 tttp -118.29 125.68 50.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.78 -41.54 96.01 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.438 ' HB3' ' CE ' ' A' ' 136' ' ' LYS . 84.9 t60 -58.36 -44.26 88.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.12 . . . . 0.0 109.569 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -85.89 151.8 55.49 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 109.502 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.53 143.01 50.52 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.752 2.301 . . . . 0.0 111.818 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.608 HG21 ' HB2' ' A' ' 146' ' ' HIS . 40.5 m -74.99 139.8 43.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -51.74 -40.23 59.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.535 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.413 ' H ' HG22 ' A' ' 141' ' ' THR . 24.3 p -126.77 152.06 47.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.166 -0.959 . . . . 0.0 109.517 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.4 m -69.85 -26.49 64.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.66 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.434 ' CG2' ' CZ ' ' A' ' 41' ' ' TYR . 92.4 mt -60.9 -45.65 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 109.599 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.608 ' HB2' HG21 ' A' ' 141' ' ' THR . 13.1 m170 -68.77 -23.23 64.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.562 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.41 ' OG1' ' HB ' ' A' ' 141' ' ' THR . 45.0 m -67.34 -45.27 76.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.0 109.679 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.99 -36.46 70.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.48 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -70.41 -28.51 71.14 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -69.38 -36.0 76.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 109.592 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -72.89 -52.8 13.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 25.0 tp -61.64 -37.71 85.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.172 -0.955 . . . . 0.0 109.626 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.76 82.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.664 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -67.68 -36.37 80.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.67 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.417 ' HE2' ' NE2' ' A' ' 159' ' ' GLN . 78.4 tttt -70.99 -36.11 72.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.775 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 66.4 mt -68.23 -34.77 76.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 109.658 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.553 ' HB3' ' OG ' ' A' ' 15' ' ' SER . . . -70.15 -39.73 75.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 44.7 m -66.06 -38.76 89.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.49 ' O ' HG23 ' A' ' 163' ' ' VAL . 94.6 mt-30 -66.35 -34.0 76.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 0.0 109.558 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.22 91.57 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.7 m -63.87 -37.42 87.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.418 ' O ' ' OD1' ' A' ' 165' ' ' ASN . 62.3 t80 -62.85 -40.76 98.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.602 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 159' ' ' GLN . 95.4 t -53.79 -39.61 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.537 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 66.7 t -55.95 -44.62 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.937 . . . . 0.0 109.546 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 162' ' ' TYR . 93.0 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.417 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 1.125 ' CD2' HD11 ' A' ' 79' ' ' LEU . 55.7 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.313 0.578 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.472 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 78.2 mm-40 -55.51 -36.85 67.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.253 -0.904 . . . . 0.0 109.138 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.471 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.81 -167.71 36.88 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.481 HG11 ' CZ ' ' A' ' 11' ' ' TYR . 85.5 t -132.95 144.47 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.133 . . . . 0.0 109.154 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 34' ' ' HIS . 6.8 m-85 -118.21 121.38 40.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 109.925 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.799 ' CE1' HD12 ' A' ' 81' ' ' ILE . 52.7 m-85 -107.81 126.73 52.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 108.85 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 1.037 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 3.7 p -115.06 150.31 36.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 110.071 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.537 ' HB2' ' HB1' ' A' ' 153' ' ' ALA . 59.7 t0 -142.22 154.52 44.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.473 -0.767 . . . . 0.0 109.086 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -138.11 138.34 9.49 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.9 p -143.09 160.94 39.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -1.127 . . . . 0.0 109.437 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -146.26 150.44 35.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.668 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.763 HD12 ' HB2' ' A' ' 161' ' ' SER . 62.1 mt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.43 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -99.86 122.02 42.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.338 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -129.58 154.85 46.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.67 163.69 26.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.768 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 42.2 mtm -122.61 140.84 52.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -1.143 . . . . 0.0 109.531 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -126.19 123.75 4.91 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.601 HD12 HG22 ' A' ' 12' ' ' THR . 26.3 mm -112.97 138.31 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -1.174 . . . . 0.0 109.516 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 11' ' ' TYR . 41.0 t -122.59 135.47 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 109.378 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.688 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 72.5 m-70 -108.02 135.98 48.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 109.547 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.466 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -129.2 170.84 13.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.411 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.986 ' HB ' HD11 ' A' ' 44' ' ' LEU . 14.2 t -133.99 165.01 26.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.541 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.658 ' OH ' HD12 ' A' ' 79' ' ' LEU . 49.6 m-85 -104.43 11.47 34.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.529 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.58 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 1.7 mtmt -51.46 179.46 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.034 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.4 Cg_endo -66.39 -5.15 12.04 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.183 1.922 . . . . 0.0 111.568 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 71.0 mm-40 -135.49 106.21 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 0.0 109.128 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.76 123.75 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 109.468 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -158.11 148.55 20.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.602 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.6 p -77.87 122.27 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.986 HD11 ' HB ' ' A' ' 36' ' ' THR . 6.3 mp -65.01 -39.95 94.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.135 -0.978 . . . . 0.0 109.351 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -173.15 162.47 4.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.364 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.654 ' HB3' HD11 ' A' ' 156' ' ' LEU . 89.7 mt-30 -112.83 154.72 25.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.393 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.489 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -135.26 132.55 37.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 t -122.94 128.1 49.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 109.396 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.468 HD11 ' CE2' ' A' ' 66' ' ' PHE . 2.9 mp -129.43 91.55 40.99 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.543 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HG3' HG11 ' A' ' 163' ' ' VAL . 50.2 Cg_endo -70.64 133.18 23.41 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.698 2.266 . . . . 0.0 111.747 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 31.1 mt -99.73 147.14 25.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.65 -62.18 0.8 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -108.41 57.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -1.157 . . . . 0.0 109.531 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 80.6 m80 -129.47 177.99 6.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.614 HG23 ' H ' ' A' ' 58' ' ' MET . 13.2 t -124.17 169.08 12.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 109.455 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.466 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -57.38 -41.09 79.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.417 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -61.61 -40.61 95.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.614 ' H ' HG23 ' A' ' 55' ' ' THR . 97.0 mtp -70.83 -32.43 69.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.883 . . . . 0.0 109.507 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.64 -33.44 74.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.522 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.85 -47.97 56.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.73 ' HA ' HG21 ' A' ' 87' ' ' VAL . 13.7 tt -69.42 -38.01 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 109.549 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.768 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -65.8 -31.75 72.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.471 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.037 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -65.98 -38.63 89.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.892 . . . . 0.0 109.554 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.74 HG22 HG21 ' A' ' 82' ' ' THR . 61.6 t -69.57 -38.11 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.667 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.432 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 71.8 tt0 -69.77 -38.04 76.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 109.123 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.584 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 26.3 t80 -55.75 -66.57 0.4 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.344 -0.847 . . . . 0.0 109.527 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 71' ' ' ALA . . . -59.94 -31.86 70.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.535 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' A' ' 120' ' ' ILE . 41.3 t -50.65 -56.86 9.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.509 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -64.86 -42.93 94.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.482 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.584 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 63.1 mttm -64.55 -31.5 72.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.468 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 67' ' ' ALA . . . -66.24 -65.44 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.666 ' HB2' HD11 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -54.98 -38.71 68.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.307 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 72' ' ' LEU . 25.6 tttt -44.44 -47.25 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.044 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.058 HD12 HG21 ' A' ' 78' ' ' VAL . 8.7 mt -52.29 143.06 27.28 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 108.842 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.1 Cg_endo -65.48 -5.96 12.59 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.459 2.106 . . . . 0.0 111.631 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.472 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -129.26 170.1 20.38 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.444 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 49.8 Cg_endo -69.97 140.0 40.84 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.587 2.192 . . . . 0.0 111.801 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.058 HG21 HD12 ' A' ' 74' ' ' ILE . 39.5 t -127.59 162.6 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.125 HD11 ' CD2' ' A' ' 6' ' ' TYR . 7.2 mt -110.96 130.78 55.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 10' ' ' PHE . 72.0 t -114.05 126.42 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.895 . . . . 0.0 109.527 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.799 HD12 ' CE1' ' A' ' 11' ' ' TYR . 13.8 mt -115.36 142.3 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.299 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.74 HG21 HG22 ' A' ' 64' ' ' VAL . 1.1 p -130.47 161.27 31.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 135' ' ' GLU . 55.0 p-10 -87.51 5.16 40.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.517 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.542 ' CB ' HG12 ' A' ' 87' ' ' VAL . 2.1 m -123.3 123.99 41.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 109.552 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.594 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 66.6 t80 -72.69 -41.62 65.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.349 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.447 ' O ' ' HB2' ' A' ' 90' ' ' SER . 67.7 t80 -54.01 -58.8 5.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 61' ' ' ILE . 12.7 p -58.31 -46.81 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.365 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.596 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -56.95 -63.6 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.205 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -57.24 -17.86 13.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.101 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.545 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 8.4 t -66.4 -65.53 0.67 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.299 -0.875 . . . . 0.0 109.258 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.766 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -66.47 -10.56 45.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.489 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -88.32 -42.03 12.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.775 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 96' ' ' PRO . 8.3 ttpp -126.42 -49.24 1.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.167 -0.958 . . . . 0.0 109.775 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.572 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 73.2 mm-40 -53.53 -41.02 65.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.672 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.766 HD23 ' HA ' ' A' ' 91' ' ' ALA . 0.4 OUTLIER -50.69 -63.98 1.57 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 49.8 Cg_endo -70.17 -36.6 9.44 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.708 2.272 . . . . 0.0 111.921 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -67.44 -42.41 83.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.572 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 18.9 m0 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.519 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.529 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 62.8 m80 60.88 37.68 18.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.42 -38.1 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.463 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 m -57.9 -45.47 86.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.464 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.42 -44.3 95.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.466 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.695 ' CZ2' HD11 ' A' ' 61' ' ' ILE . 69.8 m95 -69.4 -34.0 73.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.338 -0.852 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -58.01 -44.42 87.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.414 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.432 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 44.3 m -62.75 -43.42 98.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.362 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.461 HG23 ' SG ' ' A' ' 68' ' ' CYS . 71.9 mt -68.9 -34.21 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.421 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -61.87 -33.9 75.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -0.906 . . . . 0.0 109.42 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -64.76 -33.3 75.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.369 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.692 ' SG ' HD11 ' A' ' 130' ' ' ILE . 49.2 t -80.83 -52.12 7.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.883 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 128' ' ' PRO . 19.5 tp -62.54 -27.01 68.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.432 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.6 m -68.83 -26.61 65.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.483 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.1 mtt -71.25 -32.43 68.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 109.459 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.39 132.86 0.21 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 0.0 109.479 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.489 ' HA ' HD11 ' A' ' 124' ' ' LEU . 48.6 Cg_endo -69.78 -2.23 9.83 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.701 2.267 . . . . 0.0 111.719 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 96.8 m-20 -45.95 -26.88 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.439 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.692 HD11 ' SG ' ' A' ' 123' ' ' CYS . 64.9 mt -68.13 110.6 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.1 m -94.03 141.17 28.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.704 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 67.2 mt -118.84 137.33 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 109.521 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.471 ' HB2' HG23 ' A' ' 81' ' ' ILE . 86.2 mt-30 -134.84 157.38 46.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.594 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 12.8 t-80 -112.81 126.46 55.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 82' ' ' THR . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.0 m -55.38 -45.01 76.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.525 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -48.76 -49.83 36.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -60.04 -36.63 90.97 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -60.74 -38.07 83.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -1.151 . . . . 0.0 109.571 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.99 -46.69 77.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.564 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 74.8 mt -64.88 -38.92 92.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 13' ' ' ASP . . . -69.63 -35.74 75.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.512 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -60.7 -42.97 98.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.517 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 41.7 mttt -65.92 -40.61 91.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.654 HD11 ' HB3' ' A' ' 46' ' ' GLN . 77.2 mt -64.16 -41.47 97.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.541 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.67 96.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 109.584 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.791 HG22 ' HE2' ' A' ' 162' ' ' TYR . 29.0 m -65.53 -37.45 86.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.522 ' O ' HG23 ' A' ' 163' ' ' VAL . 93.2 mt-30 -65.56 -31.91 73.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.518 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.58 -33.57 87.61 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.763 ' HB2' HD12 ' A' ' 17' ' ' ILE . 86.0 p -68.07 -34.36 76.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -1.135 . . . . 0.0 109.508 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.791 ' HE2' HG22 ' A' ' 158' ' ' THR . 90.0 m-85 -72.08 -22.1 61.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 159' ' ' GLN . 48.9 t -70.03 -25.92 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.482 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 0.0 109.471 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 1.011 ' CD2' HD11 ' A' ' 79' ' ' LEU . 27.4 m-85 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.39 0.614 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.521 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 76.2 mm-40 -71.6 -36.7 70.9 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.38 -0.825 . . . . 0.0 108.941 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.33 -166.36 35.01 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.75 HG21 ' OH ' ' A' ' 37' ' ' TYR . 85.5 t -140.61 140.68 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -1.111 . . . . 0.0 109.097 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.679 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 24.7 m-85 -117.89 150.78 38.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.995 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.595 ' CE1' HG13 ' A' ' 81' ' ' ILE . 78.3 m-85 -121.87 130.39 53.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 109.093 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.899 HG22 HD12 ' A' ' 32' ' ' ILE . 17.2 p -115.66 151.6 34.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.764 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 57.9 t0 -140.62 152.46 45.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 109.347 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -138.43 128.36 4.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 m -133.23 148.62 52.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -1.155 . . . . 0.0 109.349 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.578 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -136.58 146.88 46.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.618 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.786 HD12 ' HB2' ' A' ' 161' ' ' SER . 65.1 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 16.5 m120 -104.67 144.08 32.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.428 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -142.97 147.94 36.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.96 157.86 26.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.725 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 63.2 mtm -128.23 147.99 50.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 0.0 109.584 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.7 122.39 2.35 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.899 HD12 HG22 ' A' ' 12' ' ' THR . 22.7 mm -110.2 133.68 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -1.186 . . . . 0.0 109.62 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 153' ' ' ALA . 44.6 t -124.33 132.1 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.381 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 1.03 ' CD2' HD12 ' A' ' 44' ' ' LEU . 9.0 t60 -108.21 142.18 38.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.693 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.23 158.99 38.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.514 ' HB ' HD21 ' A' ' 44' ' ' LEU . 11.9 t -122.4 162.64 21.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.75 ' OH ' HG21 ' A' ' 9' ' ' VAL . 27.1 m-85 -106.8 5.01 28.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 1.8 mtpt -51.39 178.79 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 108.959 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.0 Cg_endo -65.91 -5.04 11.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.171 1.914 . . . . 0.0 111.615 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -127.78 106.2 8.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.863 . . . . 0.0 108.946 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -73.96 123.76 24.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.913 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -168.21 133.85 1.86 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.379 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -52.39 118.76 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.03 HD12 ' CD2' ' A' ' 34' ' ' HIS . 46.9 mt -64.13 -45.27 89.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 79.0 m-20 -160.17 154.43 23.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.401 ' HB3' HD11 ' A' ' 156' ' ' LEU . 94.0 mt-30 -118.13 144.03 46.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.2 -0.937 . . . . 0.0 109.305 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -129.52 142.02 50.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.0 t -132.83 128.0 35.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.349 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 2.8 mp -125.91 89.29 52.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.64 ' HG3' HG11 ' A' ' 163' ' ' VAL . 48.2 Cg_endo -69.25 129.05 17.43 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.692 2.261 . . . . 0.0 111.83 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 37.0 mt -103.16 147.97 26.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.479 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -120.81 -35.7 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.488 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 41.0 p-10 -119.68 44.16 2.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -1.135 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.524 ' HA ' ' CE ' ' A' ' 58' ' ' MET . 76.1 m80 -129.11 -175.89 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.429 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 58' ' ' MET . 10.0 t -126.5 170.31 12.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.93 . . . . 0.0 109.479 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.578 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -56.59 -39.08 72.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.385 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 60' ' ' GLU . 77.4 mt-30 -64.08 -67.15 0.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.515 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.524 ' CE ' ' HA ' ' A' ' 54' ' ' HIS . 44.2 mtm -44.94 -28.05 0.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 0.0 109.21 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.39 -37.13 63.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.609 ' HB3' HG21 ' A' ' 87' ' ' VAL . 98.9 mt-10 -66.92 -41.93 86.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.654 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 20.7 tt -70.5 -38.53 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 109.196 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.725 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -64.49 -39.31 93.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.338 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -52.32 -46.82 66.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.461 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.728 HG21 HG12 ' A' ' 87' ' ' VAL . 87.4 t -70.76 -49.24 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.339 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HG3' HG12 ' A' ' 120' ' ' ILE . 87.4 tt0 -53.62 -43.4 68.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.273 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.594 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 10.9 t80 -55.84 -65.34 0.61 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.293 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -61.33 -15.91 40.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.497 ' SG ' HG23 ' A' ' 120' ' ' ILE . 48.5 t -68.62 -61.14 1.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.298 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.402 ' HB3' ' HE3' ' A' ' 69' ' ' LYS . 20.7 ttpp -57.67 -48.67 78.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.944 . . . . 0.0 109.354 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.594 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 67.9 mttm -60.65 -42.12 96.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.389 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.896 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -54.16 -72.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.409 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.819 ' HB2' HD11 ' A' ' 130' ' ' ILE . 10.0 tt -48.91 -42.56 37.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.949 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 72' ' ' LEU . 80.7 tttt -44.13 -41.93 5.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.94 . . . . 0.0 109.149 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.565 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 32.0 mt -54.03 143.88 40.68 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.4 -0.812 . . . . 0.0 108.875 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.565 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.5 Cg_endo -65.4 -2.18 5.68 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.58 2.186 . . . . 0.0 112.26 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.521 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -139.44 169.22 24.64 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.451 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 49.2 Cg_endo -69.8 117.06 4.86 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.57 2.18 . . . . 0.0 111.877 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.896 HG11 ' HA ' ' A' ' 71' ' ' ALA . 5.8 p -110.31 153.6 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.239 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.011 HD11 ' CD2' ' A' ' 6' ' ' TYR . 15.1 mt -96.79 153.07 18.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.588 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 131' ' ' THR . 45.0 t -125.74 128.62 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.639 HG21 ' CD ' ' A' ' 135' ' ' GLU . 22.5 mm -107.99 139.49 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.2 -0.937 . . . . 0.0 109.431 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.504 ' CG2' HG22 ' A' ' 64' ' ' VAL . 1.9 p -131.07 161.59 31.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.494 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 86.4 m-20 -96.17 2.75 53.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.903 . . . . 0.0 109.531 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.409 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 48.9 m -126.06 130.34 50.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -0.977 . . . . 0.0 109.477 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.588 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 64.9 t80 -74.78 -39.79 61.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.411 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.74 -52.5 63.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.651 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.728 HG12 HG21 ' A' ' 64' ' ' VAL . 50.6 t -61.14 -54.23 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 109.508 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.521 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -50.77 -55.85 14.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.159 -0.963 . . . . 0.0 109.397 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 82.3 tt0 -56.56 -35.59 68.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.615 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 49.0 m -52.58 -51.37 60.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 109.506 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.707 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -88.18 -1.19 57.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.693 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 45.6 t-20 -84.18 -72.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -0.994 . . . . 0.0 109.506 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 21.0 tptp -126.57 -26.6 3.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 109.785 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 46.6 mm-40 -65.17 -29.89 70.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.677 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -53.69 -59.09 10.45 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 109.668 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 47.0 Cg_endo -67.7 -32.99 29.1 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.679 2.253 . . . . 0.0 111.657 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -67.49 -39.97 85.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.221 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.5 m0 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 109.269 179.773 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 68.7 mttm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.457 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 46.7 m80 64.62 33.21 10.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.43 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 82.5 mt -60.94 -46.47 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -59.52 -46.37 89.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 109.409 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.433 ' HE2' ' SD ' ' A' ' 58' ' ' MET . 45.5 mttp -55.73 -46.44 77.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.863 . . . . 0.0 109.404 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.654 ' CZ2' HD12 ' A' ' 61' ' ' ILE . 53.5 m95 -61.37 -37.66 84.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.882 . . . . 0.0 109.396 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 23.9 mttt -56.82 -43.04 80.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.2 m -57.14 -45.86 83.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.336 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.497 HG23 ' SG ' ' A' ' 68' ' ' CYS . 68.0 mt -67.39 -36.77 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.838 . . . . 0.0 109.496 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -59.18 -36.86 76.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.56 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.38 -43.76 98.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.606 ' SG ' HD11 ' A' ' 130' ' ' ILE . 42.5 t -68.08 -44.14 76.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.683 HD11 ' HA ' ' A' ' 128' ' ' PRO . 20.8 tp -71.09 -30.49 66.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.249 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.2 t -62.39 -31.84 72.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.583 ' HB2' HD11 ' A' ' 72' ' ' LEU . 92.0 mtp -65.34 -31.05 71.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.461 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.37 135.65 0.21 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.582 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.683 ' HA ' HD11 ' A' ' 124' ' ' LEU . 48.9 Cg_endo -69.91 -1.81 9.22 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 122.614 2.209 . . . . 0.0 111.501 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 95.1 m-20 -44.02 -44.85 7.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.819 HD11 ' HB2' ' A' ' 72' ' ' LEU . 45.0 mt -55.27 123.4 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.654 ' HB ' HD22 ' A' ' 79' ' ' LEU . 25.4 m -113.87 140.84 48.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.28 -0.887 . . . . 0.0 109.086 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.707 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -125.23 137.22 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.098 -1.001 . . . . 0.0 109.631 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.469 ' HB2' HD12 ' A' ' 81' ' ' ILE . 95.2 mt-30 -127.4 165.78 19.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.249 -0.907 . . . . 0.0 109.395 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 12.5 t-80 -111.57 138.25 48.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.639 ' CD ' HG21 ' A' ' 81' ' ' ILE . 71.0 mt-10 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.439 ' CD2' ' OH ' ' A' ' 11' ' ' TYR . 59.3 m170 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.415 ' HA ' ' OD1' ' A' ' 150' ' ' ASN . 60.3 p -60.72 -39.46 88.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.48 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -48.89 -51.03 32.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.848 . . . . 0.0 109.38 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.49 -40.84 62.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.415 ' OD1' ' HA ' ' A' ' 147' ' ' THR . 23.1 m120 -56.52 -45.58 81.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -1.101 . . . . 0.0 109.337 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.0 -55.47 30.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.329 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.9 -45.97 82.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.349 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.4 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -58.67 -41.82 87.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.436 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.47 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 87.7 m-20 -54.08 -44.86 71.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 22.7 mttp -59.87 -42.04 92.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.309 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.401 HD11 ' HB3' ' A' ' 46' ' ' GLN . 64.8 mt -67.07 -37.04 83.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.83 88.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.861 . . . . 0.0 109.408 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 46.1 m -61.76 -39.87 93.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.362 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 163' ' ' VAL . 95.0 mt-30 -63.32 -33.3 75.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.439 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 50' ' ' PRO . . . -55.46 -40.04 75.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.786 ' HB2' HD12 ' A' ' 17' ' ' ILE . 83.8 p -64.02 -35.36 80.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.122 . . . . 0.0 109.494 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -69.93 -22.65 63.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.64 HG11 ' HG3' ' A' ' 50' ' ' PRO . 38.9 t -65.18 -25.63 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.516 -179.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.728 ' CE2' HD21 ' A' ' 79' ' ' LEU . 94.3 m-85 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' HB3' HG22 ' A' ' 78' ' ' VAL . 24.5 tp10 -61.46 -35.03 76.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 109.381 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.59 -166.01 34.08 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.031 ' CG1' ' HB3' ' A' ' 35' ' ' ALA . 5.7 p -134.85 143.89 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -1.136 . . . . 0.0 109.223 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.73 ' CD2' HG11 ' A' ' 78' ' ' VAL . 32.3 m-85 -119.76 132.42 55.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.656 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.894 ' CE1' HD12 ' A' ' 81' ' ' ILE . 95.6 m-85 -112.14 125.09 53.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 109.052 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 1.036 HG22 HD12 ' A' ' 32' ' ' ILE . 28.3 p -115.99 146.11 42.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 109.812 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 30' ' ' MET . 66.5 t0 -144.93 137.97 26.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.438 -0.789 . . . . 0.0 109.341 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -139.61 126.14 3.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 t -143.48 154.06 43.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -1.162 . . . . 0.0 109.543 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -115.1 142.83 46.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.549 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.001 HD12 ' CB ' ' A' ' 161' ' ' SER . 70.1 mt . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 41.5 p30 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.402 ' HB2' ' HB ' ' A' ' 17' ' ' ILE . 88.9 m-20 -99.46 109.42 21.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.485 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -106.11 143.4 34.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.9 155.55 26.56 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.854 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 58.2 mtm -127.32 159.82 33.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -1.166 . . . . 0.0 109.512 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.693 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -143.95 122.16 1.77 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.036 HD12 HG22 ' A' ' 12' ' ' THR . 26.9 mm -124.0 111.98 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.354 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.54 ' CG2' ' HG2' ' A' ' 46' ' ' GLN . 10.9 p -115.66 160.21 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.753 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.692 ' ND1' HD12 ' A' ' 44' ' ' LEU . 7.4 t-160 -116.05 144.98 43.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.364 -0.835 . . . . 0.0 109.346 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.031 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -132.3 169.49 16.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -125.95 166.58 16.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 0.0 109.369 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 38' ' ' LYS . 60.5 m-85 -105.28 10.13 33.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.573 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.37 179.59 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 109.1 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 44.0 Cg_endo -66.58 -4.53 11.1 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.128 1.885 . . . . 0.0 111.693 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.438 ' OE2' ' NE2' ' A' ' 42' ' ' GLN . 80.4 tt0 -132.93 105.82 7.33 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.37 -0.831 . . . . 0.0 108.861 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 54.4 t80 -57.57 125.32 22.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.235 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 80.5 mt-30 -158.13 142.01 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.749 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.717 HG11 HD12 ' A' ' 152' ' ' LEU . 29.0 m -78.99 118.66 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -0.85 . . . . 0.0 109.391 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.692 HD12 ' ND1' ' A' ' 34' ' ' HIS . 24.4 mt -60.59 -46.2 91.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.171 -0.956 . . . . 0.0 109.317 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 35.3 m120 -159.96 146.59 16.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.368 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.697 ' HB3' HD21 ' A' ' 156' ' ' LEU . 78.4 mt-30 -107.6 148.2 29.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.393 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.52 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 5.6 t-105 -132.07 140.83 48.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -0.953 . . . . 0.0 109.755 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.1 p -128.43 141.92 51.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.263 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 3.4 mt -135.11 94.68 15.75 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.609 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' CG ' HG11 ' A' ' 163' ' ' VAL . 51.1 Cg_endo -70.85 134.82 26.5 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.688 2.259 . . . . 0.0 111.718 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.67 ' O ' HG11 ' A' ' 164' ' ' VAL . 45.4 mt -104.35 140.14 38.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.47 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.769 ' HA2' HG21 ' A' ' 164' ' ' VAL . . . -86.92 -69.56 1.32 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -122.51 79.38 1.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -1.133 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -133.55 179.07 6.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.41 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.618 HG23 ' H ' ' A' ' 58' ' ' MET . 12.5 t -116.86 168.89 9.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 0.0 109.538 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.453 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -63.38 -29.69 70.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -68.3 -42.78 78.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.618 ' H ' HG23 ' A' ' 55' ' ' THR . 52.8 mtm -76.46 -26.93 55.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.457 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.04 -35.05 61.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.511 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 56' ' ' ALA . 98.7 mt-10 -73.71 -38.71 64.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.625 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 20.2 tt -71.03 -28.17 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 0.0 109.586 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.854 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -74.81 -36.68 62.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.556 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.576 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -57.51 -39.19 75.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.14 -0.975 . . . . 0.0 109.677 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.593 ' CG2' HG21 ' A' ' 82' ' ' THR . 77.9 t -75.45 -46.83 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 0.0 109.805 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.536 ' HB2' HD11 ' A' ' 120' ' ' ILE . 84.0 tt0 -60.28 -35.75 76.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.668 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.542 ' CD2' HG13 ' A' ' 32' ' ' ILE . 11.4 t80 -57.79 -68.67 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.675 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.444 ' HB3' HG13 ' A' ' 80' ' ' VAL . . . -61.67 -14.18 29.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.66 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.854 ' SG ' HG23 ' A' ' 120' ' ' ILE . 41.8 t -69.86 -60.34 2.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.454 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.448 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 65.4 tttm -61.28 -45.26 95.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.641 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 32.5 mttp -60.39 -34.11 73.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.577 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.27 -58.92 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 109.443 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.977 ' HB2' HD11 ' A' ' 130' ' ' ILE . 2.9 tt -53.22 -46.36 69.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 72' ' ' LEU . 13.2 ttpt -42.88 -47.19 5.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 109.257 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 22.7 mm -48.9 141.93 9.84 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 108.794 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.7 Cg_endo -66.12 -4.9 11.16 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.514 2.143 . . . . 0.0 111.687 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.412 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -134.78 165.71 24.48 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 47.5 Cg_endo -68.87 131.44 22.52 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 122.545 2.164 . . . . 0.0 111.596 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.73 HG11 ' CD2' ' A' ' 10' ' ' PHE . 68.8 t -121.57 167.51 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.451 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 6' ' ' TYR . 7.0 mp -115.82 130.49 56.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.538 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 96.9 t -104.36 134.94 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.387 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.894 HD12 ' CE1' ' A' ' 11' ' ' TYR . 40.7 mt -120.58 137.33 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.528 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.593 HG21 ' CG2' ' A' ' 64' ' ' VAL . 8.9 t -143.48 161.68 37.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.429 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 58.8 p30 -89.79 25.14 2.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.462 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.528 ' H ' HG23 ' A' ' 82' ' ' THR . 49.2 m -128.54 117.08 20.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.216 -0.928 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.536 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 71.6 t80 -77.29 -44.98 27.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -58.44 -45.02 89.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.592 HG12 HG21 ' A' ' 64' ' ' VAL . 95.2 t -61.81 -49.66 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -57.33 -49.28 76.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.326 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 82.4 tt0 -61.43 -36.62 80.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.638 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 47.7 t -53.16 -47.35 68.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.472 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.673 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -92.48 -0.66 57.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 43.2 t-20 -87.17 -72.97 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.87 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 97.7 mttt -127.1 -23.95 3.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.55 ' HG2' ' CE2' ' A' ' 98' ' ' TRP . 42.6 tt0 -67.08 -27.48 67.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.961 -1.087 . . . . 0.0 109.755 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -57.09 -57.86 21.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 109.59 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 43.8 Cg_endo -66.64 -24.72 47.78 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.452 2.101 . . . . 0.0 111.136 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -72.15 -36.72 69.4 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.55 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 38.6 m0 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.507 -0.745 . . . . 0.0 108.991 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 57.9 mttp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.294 0.569 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.537 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 55.4 m80 65.28 35.65 7.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.792 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.492 HG22 ' HE2' ' A' ' 118' ' ' LYS . 53.8 mt -67.36 -45.19 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.185 -0.947 . . . . 0.0 109.329 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 t -51.08 -47.62 61.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.22 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.66 -38.21 84.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.638 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 27.6 m95 -69.6 -40.28 76.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 109.351 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.492 ' HE2' HG22 ' A' ' 114' ' ' ILE . 64.0 mttm -55.06 -41.54 71.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.391 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.415 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 22.9 t -58.58 -45.77 88.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.854 HG23 ' SG ' ' A' ' 68' ' ' CYS . 79.4 mt -69.07 -36.22 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.378 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.81 93.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 126' ' ' MET . 83.1 tt0 -54.59 -40.61 69.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 109.409 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 1.3 m -76.6 -50.29 14.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.385 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 124' ' ' LEU . 9.1 tt -57.78 -37.44 73.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.464 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.8 m -59.93 -33.07 71.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.507 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.597 ' HB2' HD11 ' A' ' 72' ' ' LEU . 88.4 mtp -64.85 -36.06 83.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.85 . . . . 0.0 109.463 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.35 143.85 0.24 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 129' ' ' ASP . 48.6 Cg_endo -69.5 -2.12 9.43 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.738 2.292 . . . . 0.0 111.734 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 92.8 m-20 -43.18 -38.25 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.358 -0.839 . . . . 0.0 109.4 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.977 HD11 ' HB2' ' A' ' 72' ' ' LEU . 54.9 mt -68.59 109.44 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.475 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 97.2 m -110.03 146.94 34.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.273 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.478 HG21 ' HA ' ' A' ' 88' ' ' ALA . 64.2 mt -120.62 145.7 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.431 ' HB2' HG12 ' A' ' 81' ' ' ILE . 88.8 mt-30 -124.99 155.2 40.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.401 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.536 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 32.3 t-80 -110.53 128.56 55.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HG2' ' CG2' ' A' ' 81' ' ' ILE . 74.6 mm-40 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.26 0.552 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 47.6 m -67.83 -35.47 78.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.53 -39.41 67.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -66.07 -37.86 93.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -65.09 -32.46 74.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -1.102 . . . . 0.0 109.361 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -66.76 -52.65 41.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.882 . . . . 0.0 109.514 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.717 HD12 HG11 ' A' ' 43' ' ' VAL . 59.1 mt -64.81 -46.78 80.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.56 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -54.48 -39.46 67.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.579 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -68.15 -36.99 80.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 66.3 mttm -56.43 -43.87 79.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.562 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.4 mp -72.11 -36.09 69.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.551 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.29 82.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.498 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.403 HG22 ' HE2' ' A' ' 162' ' ' TYR . 30.5 m -63.92 -41.57 97.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.56 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 94.5 mt-30 -66.17 -28.61 68.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.499 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.06 -39.67 97.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 1.001 ' CB ' HD12 ' A' ' 17' ' ' ILE . 25.0 m -60.79 -38.87 86.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.115 . . . . 0.0 109.516 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.403 ' HE2' HG22 ' A' ' 158' ' ' THR . 91.5 m-85 -66.99 -30.02 70.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.487 HG11 ' CG ' ' A' ' 50' ' ' PRO . 63.4 t -58.56 -38.0 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.575 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.769 HG21 ' HA2' ' A' ' 52' ' ' GLY . 12.3 p . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 1.056 ' CD2' HD11 ' A' ' 79' ' ' LEU . 99.0 m-85 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' A' ' 78' ' ' VAL . 70.0 mm-40 -68.57 -36.91 79.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.152 -0.967 . . . . 0.0 109.283 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.478 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.66 -174.13 44.61 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.589 HG22 ' HB2' ' A' ' 79' ' ' LEU . 90.4 t -137.98 136.34 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -1.106 . . . . 0.0 109.317 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.684 ' CE2' ' CG ' ' A' ' 34' ' ' HIS . 47.6 m-85 -118.88 137.76 53.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.742 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.58 ' CE2' HG13 ' A' ' 81' ' ' ILE . 23.2 m-85 -108.0 130.78 55.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.198 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.993 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 19.6 p -116.5 147.65 41.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 109.621 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CG ' ' OD1' ' A' ' 154' ' ' ASP . 23.3 t70 -148.56 153.51 38.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.6 126.23 3.38 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.6 m -128.68 153.51 47.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -1.148 . . . . 0.0 109.409 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . . . -139.94 144.63 37.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.868 HD12 ' HB3' ' A' ' 161' ' ' SER . 38.0 mt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.459 ' HB2' ' HB ' ' A' ' 17' ' ' ILE . 89.2 m-20 -95.55 136.81 35.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.434 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -145.71 149.47 34.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.759 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -157.78 164.44 33.16 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.893 ' HG3' HD11 ' A' ' 51' ' ' LEU . 66.2 mtm -123.19 163.51 20.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -1.156 . . . . 0.0 109.421 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -148.45 119.54 1.09 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.925 HD12 HG22 ' A' ' 12' ' ' THR . 24.8 mm -114.64 137.03 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -1.17 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.2 t -123.38 136.09 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.992 ' CD2' HD12 ' A' ' 44' ' ' LEU . 4.1 t60 -110.23 135.02 51.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.658 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.01 164.61 27.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.294 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.2 t -131.71 166.74 20.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 109.599 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.587 ' OH ' HG21 ' A' ' 9' ' ' VAL . 66.3 m-85 -100.64 11.63 39.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 109.406 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.571 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -51.29 179.65 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.328 -0.857 . . . . 0.0 109.05 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.571 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.6 Cg_endo -66.29 -5.0 11.56 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.122 1.881 . . . . 0.0 111.65 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -135.95 106.07 6.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.368 -0.832 . . . . 0.0 109.049 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 54.7 t80 -67.46 122.7 18.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.31 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 82.4 mt-30 -159.4 142.46 14.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.769 HG21 HD22 ' A' ' 152' ' ' LEU . 46.2 t -64.96 110.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.992 HD12 ' CD2' ' A' ' 34' ' ' HIS . 35.1 mt -57.14 -48.72 77.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 79.8 m-20 -159.76 153.74 23.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.483 ' HB3' HD11 ' A' ' 156' ' ' LEU . 91.0 mt-30 -109.48 146.47 34.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.485 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.4 t-105 -131.24 135.52 47.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 0.0 109.722 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.9 t -130.29 130.16 44.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 109.261 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.505 ' HB ' ' CE ' ' A' ' 30' ' ' MET . 3.1 mp -131.65 98.69 17.71 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 109.741 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 51.3 Cg_endo -71.57 136.48 28.42 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.601 2.201 . . . . 0.0 111.676 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.893 HD11 ' HG3' ' A' ' 30' ' ' MET . 3.3 mp -103.7 140.37 37.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 53' ' ' ASN . . . -103.34 113.38 4.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 52' ' ' GLY . 47.7 t30 75.63 36.64 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -1.157 . . . . 0.0 109.55 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 51' ' ' LEU . 76.9 m80 -120.26 171.55 8.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.585 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -111.17 170.18 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.26 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -56.98 -35.26 68.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.017 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 60' ' ' GLU . 89.7 mt-30 -70.14 -58.27 3.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 0.0 109.345 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.585 ' SD ' HG23 ' A' ' 55' ' ' THR . 97.6 mtp -44.77 -30.72 1.01 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.304 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 30' ' ' MET . . . -77.62 -34.57 53.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.379 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 57' ' ' GLN . 97.0 mt-10 -63.33 -41.9 98.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 109.567 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.72 ' HA ' HG21 ' A' ' 87' ' ' VAL . 12.8 tt -71.56 -37.36 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.769 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -67.14 -31.66 72.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.308 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.993 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -66.97 -38.6 86.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.426 HG22 HG21 ' A' ' 82' ' ' THR . 85.3 t -69.91 -40.34 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HB2' HD11 ' A' ' 120' ' ' ILE . 80.7 tt0 -69.11 -39.81 78.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.565 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 19.2 t80 -58.77 -64.35 0.96 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.359 -0.838 . . . . 0.0 109.477 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.82 -32.88 69.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 120' ' ' ILE . 43.0 t -51.63 -52.64 46.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 67.8 mttm -64.5 -42.25 95.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.565 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 64.3 mttm -62.62 -37.81 87.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.562 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.71 -61.9 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.919 ' HB2' HD11 ' A' ' 130' ' ' ILE . 18.9 tp -55.21 -42.01 72.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.459 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 72' ' ' LEU . 64.9 tttt -45.17 -40.95 7.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.29 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.633 HG13 HG21 ' A' ' 78' ' ' VAL . 32.6 mm -59.1 143.07 85.01 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 108.899 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.3 Cg_endo -64.08 -5.87 10.22 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.53 2.153 . . . . 0.0 111.871 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -134.85 170.6 22.74 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 49.7 Cg_endo -69.27 135.6 32.06 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.392 2.061 . . . . 0.0 111.771 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.633 HG21 HG13 ' A' ' 74' ' ' ILE . 58.0 t -124.4 158.14 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.875 . . . . 0.0 109.374 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.056 HD11 ' CD2' ' A' ' 6' ' ' TYR . 14.2 mt -108.32 144.71 35.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.213 -0.929 . . . . 0.0 109.424 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 132' ' ' ILE . 13.6 m -123.48 143.92 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.58 HG13 ' CE2' ' A' ' 11' ' ' TYR . 26.1 mm -114.01 133.56 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.339 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.426 HG21 HG22 ' A' ' 64' ' ' VAL . 1.2 p -127.18 161.76 27.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.476 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -98.99 14.16 30.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 109.523 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.582 ' HB3' HG12 ' A' ' 87' ' ' VAL . 27.2 t -137.96 125.77 22.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.618 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 48.8 p90 -77.2 -36.63 54.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.456 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -53.79 -50.18 66.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 61' ' ' ILE . 14.9 p -67.26 -44.72 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.907 . . . . 0.0 109.409 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.582 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -54.89 -47.92 73.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 77.3 mm-40 -62.22 -40.27 95.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.594 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 64.4 m -50.79 -44.96 58.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.675 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -94.51 -0.9 54.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.731 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 56.1 t30 -89.67 -72.93 0.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.581 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 65.0 tttm -127.05 -31.84 2.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 109.774 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 92.6 mt-10 -55.52 -34.23 64.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 0.0 109.743 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 91' ' ' ALA . 0.8 OUTLIER -56.18 -62.13 5.33 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 109.581 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 44.5 Cg_endo -66.93 -32.71 34.97 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.836 2.357 . . . . 0.0 111.746 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -67.75 -38.24 83.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.164 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.9 m0 . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.288 -0.883 . . . . 0.0 109.259 179.779 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 73.6 mttt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.218 0.532 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 55.8 m80 63.42 27.68 15.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.619 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.8 mt -57.51 -41.46 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.312 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.5 m -50.3 -47.3 55.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.264 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -60.57 -45.16 94.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.321 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.64 ' HH2' HG23 ' A' ' 87' ' ' VAL . 22.8 m95 -65.7 -40.6 92.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.349 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -52.34 -49.82 63.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.333 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.2 m -55.67 -45.55 77.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.294 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.548 HG23 ' SG ' ' A' ' 68' ' ' CYS . 76.8 mt -67.95 -37.99 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 109.374 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.458 ' HA ' HD13 ' A' ' 95' ' ' LEU . . . -53.57 -42.38 67.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 126' ' ' MET . 76.3 mm-40 -54.6 -43.7 72.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 109.369 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 1.6 m -63.87 -49.16 73.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.425 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.5 tp -64.28 -33.05 74.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.3 m -61.8 -32.67 72.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.0 109.62 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.509 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 91.9 mmm -65.67 -28.94 69.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 163.37 146.87 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.559 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.5 Cg_endo -69.91 -1.87 9.33 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.672 2.248 . . . . 0.0 111.657 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 85.6 m-20 -43.42 -34.2 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -0.811 . . . . 0.0 109.503 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.919 HD11 ' HB2' ' A' ' 72' ' ' LEU . 45.9 mt -72.62 123.59 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.584 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.606 ' HB ' HD22 ' A' ' 79' ' ' LEU . 40.0 m -119.01 139.06 52.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 109.238 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.675 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 73.0 mt -119.76 137.33 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.664 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.524 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 94.8 mt-30 -120.62 155.63 33.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.365 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.618 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 19.9 t-80 -114.7 135.87 53.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.452 ' OE1' ' ND2' ' A' ' 150' ' ' ASN . 65.5 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.322 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.413 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 92.6 m-70 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 42.7 m -55.21 -48.81 73.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.5 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 152' ' ' LEU . 85.7 tt0 -49.04 -49.48 41.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -56.85 -39.08 87.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.452 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 87.7 m-20 -64.84 -35.8 82.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -1.123 . . . . 0.0 109.365 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.64 -47.11 86.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.769 HD22 HG21 ' A' ' 43' ' ' VAL . 6.5 mp -65.25 -37.05 86.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.409 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.0 -41.66 90.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.915 . . . . 0.0 109.544 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.404 ' OD1' ' CG ' ' A' ' 13' ' ' ASP . 83.0 m-20 -57.6 -47.92 80.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.545 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -55.25 -48.01 74.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.515 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.494 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 62.7 mt -60.52 -38.76 85.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.568 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.05 -42.53 72.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 47.4 p -70.02 -30.94 68.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.569 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 163' ' ' VAL . 60.3 tt0 -62.66 -36.89 84.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -60.13 -37.82 93.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.868 ' HB3' HD12 ' A' ' 17' ' ' ILE . 14.5 m -59.95 -42.11 93.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.477 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.44 -25.33 68.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 159' ' ' GLN . 40.9 t -68.72 -23.36 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.398 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 161' ' ' SER . 38.5 t . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 109.499 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 1.032 ' CD2' HD11 ' A' ' 79' ' ' LEU . 54.6 m-85 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.289 0.566 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.511 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 74.8 mm-40 -55.51 -38.27 68.97 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.217 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.478 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.82 -175.52 45.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.644 HG21 ' OH ' ' A' ' 37' ' ' TYR . 74.7 t -133.53 137.61 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -1.081 . . . . 0.0 109.167 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.682 ' CZ ' ' CD2' ' A' ' 34' ' ' HIS . 57.0 m-85 -117.67 134.76 54.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.126 -0.984 . . . . 0.0 110.014 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 1.026 ' CE2' HD12 ' A' ' 81' ' ' ILE . 38.1 m-85 -107.49 129.12 54.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.034 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.914 HG22 HD12 ' A' ' 32' ' ' ILE . 12.8 p -118.48 147.65 43.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.862 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 65.5 t0 -138.31 146.46 42.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.481 -0.762 . . . . 0.0 109.143 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -135.17 136.92 8.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.4 p -143.47 161.88 37.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -1.139 . . . . 0.0 109.301 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -153.39 145.85 24.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.1 mt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.358 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.236 0.541 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 90.3 m-20 -105.31 135.96 45.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -139.36 146.44 40.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.708 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 50' ' ' PRO . . . -137.18 159.06 24.59 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 66.6 mtm -131.89 151.21 51.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -1.148 . . . . 0.0 109.483 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.517 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -134.03 127.96 4.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.914 HD12 HG22 ' A' ' 12' ' ' THR . 23.9 mm -115.6 135.72 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.489 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.0 t -126.25 135.01 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 1.138 ' CE1' HD12 ' A' ' 44' ' ' LEU . 14.0 t-160 -111.4 127.54 55.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 109.538 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.52 171.65 8.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -129.9 165.86 21.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.644 ' OH ' HG21 ' A' ' 9' ' ' VAL . 55.3 m-85 -100.2 13.07 35.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 109.449 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.583 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.32 179.94 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 108.939 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.0 Cg_endo -66.41 -4.85 11.45 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.136 1.89 . . . . 0.0 111.707 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.443 ' CD ' ' NE2' ' A' ' 42' ' ' GLN . 83.7 tt0 -138.11 106.16 5.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -0.847 . . . . 0.0 109.041 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -54.44 121.5 8.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.462 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.443 ' NE2' ' CD ' ' A' ' 40' ' ' GLU . 91.1 mt-30 -152.74 156.6 39.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 43' ' ' VAL . 21.0 m -89.62 118.13 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.138 HD12 ' CE1' ' A' ' 34' ' ' HIS . 39.5 mt -58.49 -45.62 88.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.362 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 74.9 m-20 -162.71 168.45 21.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.425 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -121.7 145.07 48.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.469 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 2.9 t-105 -128.85 140.03 51.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -125.35 128.8 48.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.462 HD11 ' CE2' ' A' ' 66' ' ' PHE . 2.7 mp -127.17 86.94 57.65 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.622 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.616 ' HB3' HG21 ' A' ' 163' ' ' VAL . 51.0 Cg_endo -70.65 130.53 18.39 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.746 2.297 . . . . 0.0 111.699 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 28' ' ' ALA . 43.9 mt -107.19 153.03 23.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 109.452 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -124.74 -40.95 0.4 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -108.0 32.07 5.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -1.113 . . . . 0.0 109.514 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 78.9 m80 -120.15 145.7 46.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.542 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.497 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -89.93 168.34 12.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.201 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -48.81 -38.95 23.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.135 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 60' ' ' GLU . 91.0 mt-30 -70.39 -58.26 3.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.548 ' O ' HG22 ' A' ' 61' ' ' ILE . 95.3 mtp -44.95 -30.48 1.02 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.352 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.67 -36.81 57.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' GLN . 98.8 mt-10 -65.49 -40.04 92.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 58' ' ' MET . 20.5 tt -70.79 -34.57 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.46 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -69.41 -33.7 73.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.854 . . . . 0.0 109.45 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.545 ' HB1' ' OG1' ' A' ' 12' ' ' THR . . . -59.0 -43.17 91.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.524 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.667 HG21 HG12 ' A' ' 87' ' ' VAL . 96.3 t -70.79 -50.46 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.561 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.468 ' HG3' HG12 ' A' ' 120' ' ' ILE . 86.7 tt0 -59.17 -40.43 85.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.593 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.558 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 17.0 t80 -53.89 -70.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.908 . . . . 0.0 109.632 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.711 ' HB3' HG13 ' A' ' 80' ' ' VAL . . . -64.19 -10.96 26.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -0.906 . . . . 0.0 109.648 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.871 ' SG ' HG23 ' A' ' 120' ' ' ILE . 37.7 t -75.51 -56.34 4.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -63.25 -41.23 99.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 44.4 mttp -66.02 -34.68 78.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HB1' ' HB ' ' A' ' 78' ' ' VAL . . . -59.94 -58.93 6.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.965 ' HB2' HD11 ' A' ' 130' ' ' ILE . 9.3 tt -55.4 -45.12 76.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 72' ' ' LEU . 58.2 tttm -43.27 -41.75 4.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.592 HG13 HG21 ' A' ' 78' ' ' VAL . 30.0 mm -56.52 143.15 68.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.304 -0.872 . . . . 0.0 108.736 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.1 Cg_endo -64.33 -5.01 8.93 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.729 2.286 . . . . 0.0 112.086 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.511 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -136.22 171.87 22.64 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 49.7 Cg_endo -70.1 132.33 22.57 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.44 2.094 . . . . 0.0 111.806 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.592 HG21 HG13 ' A' ' 74' ' ' ILE . 60.2 t -120.61 161.86 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.442 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.032 HD11 ' CD2' ' A' ' 6' ' ' TYR . 14.5 mt -107.83 137.73 45.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.711 HG13 ' HB3' ' A' ' 67' ' ' ALA . 45.6 t -116.62 130.22 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.026 HD12 ' CE2' ' A' ' 11' ' ' TYR . 35.4 mt -117.56 136.16 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.0 109.501 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 84' ' ' SER . 12.8 t -139.51 159.71 41.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -88.99 19.74 3.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.535 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.533 ' H ' HG23 ' A' ' 82' ' ' THR . 34.2 t -122.55 116.8 24.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 109.521 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.567 ' CG ' ' N ' ' A' ' 86' ' ' TYR . 38.9 p90 -77.27 -45.31 26.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.489 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.567 ' N ' ' CG ' ' A' ' 85' ' ' PHE . 69.9 t80 -55.7 -48.87 74.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.667 HG12 HG21 ' A' ' 64' ' ' VAL . 86.8 t -60.13 -49.42 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.318 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -53.24 -55.01 27.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.221 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 96.1 mt-10 -58.5 -28.39 65.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.325 -0.859 . . . . 0.0 109.391 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.627 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 23.9 m -59.88 -45.97 90.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.655 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -92.36 -0.74 57.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 109.774 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 82.3 m-20 -86.96 -68.19 0.76 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.004 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 67.8 mttm -122.19 -34.58 3.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 109.9 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.533 ' OE1' ' CZ2' ' A' ' 98' ' ' TRP . 83.4 mt-10 -62.41 -32.95 73.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 109.612 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 90' ' ' SER . 0.1 OUTLIER -55.92 -59.65 11.0 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.416 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 46.1 Cg_endo -67.72 -32.53 29.97 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.707 2.272 . . . . 0.0 111.444 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -73.0 -37.31 67.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 108.954 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.533 ' CZ2' ' OE1' ' A' ' 94' ' ' GLU . 15.1 m0 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.369 -0.832 . . . . 0.0 109.17 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.405 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 58.4 m80 59.77 42.99 15.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.88 . . . . 0.0 109.438 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.56 HG22 ' HE3' ' A' ' 118' ' ' LYS . 91.9 mt -65.04 -42.68 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.466 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -61.87 -39.84 93.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -60.66 -44.77 96.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.627 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 52.7 m95 -65.03 -38.53 91.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.427 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.56 ' HE3' HG22 ' A' ' 114' ' ' ILE . 52.0 mttt -58.69 -37.54 76.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.8 m -62.85 -43.48 98.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.372 -0.83 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.871 HG23 ' SG ' ' A' ' 68' ' ' CYS . 73.0 mt -69.86 -35.69 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -64.76 -34.37 78.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -53.03 -37.24 61.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.436 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.491 ' CA ' HD13 ' A' ' 72' ' ' LEU . 12.4 m -83.63 -45.37 13.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.49 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.466 ' CD2' ' HB ' ' A' ' 130' ' ' ILE . 53.1 mt -61.57 -31.44 71.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.437 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.0 m -56.41 -36.55 69.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.468 ' HB2' HD11 ' A' ' 72' ' ' LEU . 88.7 mtp -63.92 -36.8 85.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 171.24 157.32 0.22 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.5 Cg_endo -72.15 3.7 3.83 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.739 2.292 . . . . 0.0 112.061 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 128' ' ' PRO . 85.7 m-20 -42.36 -35.71 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.212 -0.93 . . . . 0.0 109.623 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.965 HD11 ' HB2' ' A' ' 72' ' ' LEU . 62.8 mt -75.17 116.26 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 109.402 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.574 ' HB ' HD22 ' A' ' 79' ' ' LEU . 31.3 m -110.88 142.55 42.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.368 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.655 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 62.0 mt -120.74 137.13 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.66 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB2' HG12 ' A' ' 81' ' ' ILE . 88.5 mt-30 -118.65 165.2 14.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -0.888 . . . . 0.0 109.36 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.528 ' CD2' ' HB3' ' A' ' 85' ' ' PHE . 29.4 t-80 -120.56 133.64 55.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.513 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HG3' HG22 ' A' ' 81' ' ' ILE . 93.6 mt-10 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.426 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.1 m -55.29 -45.59 76.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -51.67 -43.38 62.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.04 -39.04 89.01 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -1.139 . . . . 0.0 109.512 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -57.93 -51.72 68.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 152' ' ' LEU . 7.0 mp -65.46 -44.73 86.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 109.526 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.2 87.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.577 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.46 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 58.4 t0 -61.81 -38.04 86.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 24.1 mttm -62.96 -40.58 98.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.568 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 61.7 mt -72.09 -37.22 69.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.537 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.22 -44.51 75.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.47 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.588 HG22 ' HE2' ' A' ' 162' ' ' TYR . 31.1 m -61.03 -41.84 97.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.54 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.574 ' O ' HG13 ' A' ' 163' ' ' VAL . 94.4 mt-30 -67.29 -26.66 66.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.485 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.962 ' O ' HG22 ' A' ' 163' ' ' VAL . . . -66.28 -26.73 72.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.6 p -76.06 -25.37 55.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -1.157 . . . . 0.0 109.457 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.588 ' HE2' HG22 ' A' ' 158' ' ' THR . 93.4 m-85 -81.36 -25.59 36.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.055 HG23 HG23 ' A' ' 164' ' ' VAL . 5.1 m -62.76 -24.92 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 1.055 HG23 HG23 ' A' ' 163' ' ' VAL . 41.3 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 1.027 ' CD2' HD11 ' A' ' 79' ' ' LEU . 50.1 m-85 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.558 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.8 tp10 -59.47 -37.1 77.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.268 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.484 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.69 -169.45 39.39 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.829 HG21 ' CZ ' ' A' ' 37' ' ' TYR . 70.2 t -142.55 140.65 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -1.135 . . . . 0.0 109.253 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.686 ' CE1' ' CD2' ' A' ' 34' ' ' HIS . 31.3 m-85 -121.05 142.88 49.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.82 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CE1' HG13 ' A' ' 81' ' ' ILE . 49.7 m-85 -114.58 130.16 56.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 108.952 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.997 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 29.2 p -112.69 150.17 31.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.075 -1.015 . . . . 0.0 109.956 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 66.6 t0 -145.2 145.99 31.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.056 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -139.98 137.36 8.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.687 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 87.3 p -143.53 162.72 35.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -1.127 . . . . 0.0 109.17 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . . . -146.25 148.82 32.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.001 . . . . 0.0 109.757 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.418 HD12 ' HB2' ' A' ' 161' ' ' SER . 60.6 mt . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -99.41 125.66 45.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.443 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 15' ' ' SER . . . -135.65 158.41 44.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 50' ' ' PRO . . . -140.33 159.53 26.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.84 ' HE3' HD12 ' A' ' 49' ' ' ILE . 49.7 mtm -118.93 154.08 33.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -1.179 . . . . 0.0 109.399 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -139.68 120.04 1.77 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.928 HD12 HG22 ' A' ' 12' ' ' THR . 20.9 mm -111.13 133.08 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -1.154 . . . . 0.0 109.437 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' PHE . 42.7 t -118.64 137.89 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 1.137 ' CE1' HD22 ' A' ' 44' ' ' LEU . 23.6 t-160 -112.86 130.15 56.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.52 166.94 20.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.324 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.594 ' HB ' HD11 ' A' ' 44' ' ' LEU . 9.9 t -127.75 154.25 45.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.829 ' CZ ' HG21 ' A' ' 9' ' ' VAL . 11.8 m-30 -95.22 5.28 52.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.518 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.585 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.3 179.56 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.059 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.7 Cg_endo -66.39 -4.43 10.67 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.219 1.946 . . . . 0.0 111.825 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -130.38 105.93 8.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 108.745 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -71.22 130.3 41.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 109.554 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -167.99 151.83 6.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.429 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.6 p -76.96 125.59 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.878 . . . . 0.0 109.406 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.137 HD22 ' CE1' ' A' ' 34' ' ' HIS . 7.5 mp -72.23 -36.67 69.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.902 . . . . 0.0 109.387 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -173.05 158.46 3.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.457 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.856 ' HB3' HD21 ' A' ' 156' ' ' LEU . 91.8 mt-30 -113.49 138.64 49.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.279 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.465 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -121.25 135.42 55.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.657 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.7 t -128.71 129.95 46.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.196 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.84 HD12 ' HE3' ' A' ' 30' ' ' MET . 4.1 mt -134.45 93.17 19.23 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 109.691 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 50.5 Cg_endo -70.9 140.28 38.05 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.693 2.262 . . . . 0.0 111.658 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.772 HD11 ' HG3' ' A' ' 30' ' ' MET . 5.3 mp -109.0 154.84 21.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.531 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.04 -34.86 0.66 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.547 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 42.7 p-10 -118.47 36.67 4.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.161 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.556 ' CG ' HD23 ' A' ' 51' ' ' LEU . 77.7 m80 -126.47 169.75 12.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.441 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.618 HG23 ' H ' ' A' ' 58' ' ' MET . 10.0 t -111.43 -176.27 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.459 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.645 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -67.52 -39.06 85.09 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.544 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -67.38 -45.23 76.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.557 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.618 ' H ' HG23 ' A' ' 55' ' ' THR . 96.0 mtp -65.15 -36.46 84.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.616 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.82 88.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 56' ' ' ALA . 96.1 mt-10 -67.12 -48.4 68.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.6 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.744 ' HA ' HG21 ' A' ' 87' ' ' VAL . 13.1 tt -66.21 -36.15 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.452 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.572 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -64.9 -28.64 69.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.997 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -68.16 -40.94 82.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.573 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.519 HG22 ' CG2' ' A' ' 82' ' ' THR . 61.4 t -70.34 -38.24 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.593 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.594 ' HG2' HD11 ' A' ' 120' ' ' ILE . 97.3 mt-10 -66.4 -37.46 85.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.071 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.637 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 24.1 t80 -63.26 -67.1 0.45 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.451 -0.781 . . . . 0.0 109.761 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 68' ' ' CYS . . . -58.2 -45.3 87.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 109.867 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.779 ' SG ' HG23 ' A' ' 120' ' ' ILE . 42.5 t -42.47 -62.57 0.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 109.738 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 42.7 mttp -54.83 -50.46 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.637 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 64.2 mttm -55.23 -36.84 66.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.597 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.03 -61.31 2.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.443 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.777 ' HB2' HD11 ' A' ' 130' ' ' ILE . 22.8 tp -51.53 -45.52 63.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 36.6 mmtt -43.82 -47.19 8.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.325 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.556 HG13 HG21 ' A' ' 78' ' ' VAL . 27.5 mm -48.39 142.73 7.97 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 108.923 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.6 Cg_endo -65.82 -3.91 9.01 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.553 2.169 . . . . 0.0 111.808 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.427 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -137.07 168.81 24.2 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 48.5 Cg_endo -69.44 130.53 19.9 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.53 2.154 . . . . 0.0 111.723 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.59 HG11 ' CE1' ' A' ' 10' ' ' PHE . 50.4 t -120.0 158.66 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.512 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.027 HD11 ' CD2' ' A' ' 6' ' ' TYR . 23.2 mt -101.74 143.85 31.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.9 t -119.48 130.4 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.527 HG13 ' CE1' ' A' ' 11' ' ' TYR . 24.4 mm -111.08 142.0 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.519 ' CG2' HG22 ' A' ' 64' ' ' VAL . 1.4 p -131.95 157.99 42.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.487 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.448 ' OD2' ' OD1' ' A' ' 13' ' ' ASP . 60.5 m-20 -82.17 -20.02 38.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.479 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.626 ' HB3' HG12 ' A' ' 87' ' ' VAL . 46.9 t -110.62 131.64 54.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.576 ' HB3' ' CG ' ' A' ' 134' ' ' HIS . 46.4 p90 -76.11 -35.03 59.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -57.06 -52.58 64.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.418 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.744 HG21 ' HA ' ' A' ' 61' ' ' ILE . 9.7 p -62.03 -47.31 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.341 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.771 ' HB1' HG22 ' A' ' 132' ' ' ILE . . . -55.76 -53.66 53.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 85' ' ' PHE . 76.0 mm-40 -60.01 -35.14 74.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.357 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.554 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 33.6 m -51.7 -48.04 63.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.461 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.874 ' HB1' HG21 ' A' ' 120' ' ' ILE . . . -91.37 -0.99 57.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.633 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 44.3 t-20 -85.61 -72.83 0.47 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.001 . . . . 0.0 109.744 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 21.4 mttt -126.72 -28.52 2.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.091 -1.005 . . . . 0.0 109.917 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.576 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 91.9 mt-10 -60.56 -31.98 71.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.033 . . . . 0.0 109.866 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -58.14 -59.88 11.91 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.503 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.8 Cg_endo -66.94 -33.23 33.48 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.664 2.242 . . . . 0.0 111.606 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -70.26 -35.43 73.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -0.887 . . . . 0.0 109.043 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.576 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 10.8 m0 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.374 -0.829 . . . . 0.0 109.192 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 23.8 mttm . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.303 0.573 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.538 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 50.4 m80 64.61 41.14 5.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.519 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 40.6 mm -72.46 -42.84 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.305 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.7 m -62.12 -40.23 95.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.273 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 67.8 mttm -62.8 -44.27 96.61 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.387 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.714 ' HB3' HD21 ' A' ' 95' ' ' LEU . 24.0 m95 -78.7 -31.69 46.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.295 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -57.88 -41.09 81.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.976 . . . . 0.0 109.343 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.3 m -60.81 -48.1 83.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.333 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.874 HG21 ' HB1' ' A' ' 91' ' ' ALA . 76.7 mt -70.36 -35.32 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.435 ' O ' ' OG ' ' A' ' 125' ' ' SER . . . -63.77 -34.68 78.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.369 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 126' ' ' MET . 82.5 tt0 -62.44 -36.42 82.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 19.9 m -79.97 -48.97 12.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.412 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.07 -35.93 74.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.848 . . . . 0.0 109.391 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 121' ' ' ALA . 43.4 m -63.33 -32.93 74.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.422 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 89.8 mtp -66.88 -34.41 77.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.873 . . . . 0.0 109.476 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.81 135.64 0.36 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.404 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.0 Cg_endo -69.6 -2.49 10.15 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.694 2.263 . . . . 0.0 111.57 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 128' ' ' PRO . 88.4 m-20 -43.46 -36.88 2.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 109.344 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.777 HD11 ' HB2' ' A' ' 72' ' ' LEU . 50.0 mt -66.94 116.52 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.573 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.3 m -106.91 144.49 33.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 109.371 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.771 HG22 ' HB1' ' A' ' 88' ' ' ALA . 72.7 mt -125.23 137.46 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 109.496 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.527 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 95.1 mt-30 -135.35 159.3 42.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.576 ' CG ' ' HB3' ' A' ' 85' ' ' PHE . 22.4 t-80 -101.6 132.67 47.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.576 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.52 ' HB2' ' CG2' ' A' ' 81' ' ' ILE . 43.6 tp10 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 37.3 m80 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.7 m -49.15 -52.67 24.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.02 -49.51 63.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.398 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.32 -38.77 57.75 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -59.37 -42.36 91.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.183 . . . . 0.0 109.397 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.94 79.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.6 mt -59.97 -46.66 88.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 0.0 109.452 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.663 ' HA ' HD12 ' A' ' 156' ' ' LEU . . . -59.65 -38.91 82.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.469 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 91.6 m-20 -57.28 -42.64 82.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.419 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 31.5 mttp -62.34 -40.65 97.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 109.449 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.856 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.5 mt -64.04 -43.52 95.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.443 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.41 -46.25 89.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 43.4 m -58.42 -41.92 86.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 96.3 mt-30 -63.07 -33.91 76.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -57.6 -41.74 93.76 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.418 ' HB2' HD12 ' A' ' 17' ' ' ILE . 70.5 p -65.19 -31.52 72.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -1.159 . . . . 0.0 109.45 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -68.67 -28.19 66.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 109.509 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.8 t -67.07 -22.18 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.954 . . . . 0.0 109.509 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.471 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.511 ' CE2' HD21 ' A' ' 79' ' ' LEU . 29.6 m-85 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.454 0.645 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -73.48 -34.16 65.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.868 . . . . 0.0 109.098 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.566 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -179.15 -166.84 35.7 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.626 HG22 ' HB2' ' A' ' 79' ' ' LEU . 77.5 t -133.51 140.87 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.276 -1.132 . . . . 0.0 109.055 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.632 ' CE2' ' ND1' ' A' ' 34' ' ' HIS . 5.4 m-85 -113.24 147.33 37.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.844 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE1' HG13 ' A' ' 81' ' ' ILE . 96.9 m-85 -116.87 130.22 56.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 108.935 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.786 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 33.5 p -119.39 149.8 41.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.993 . . . . 0.0 109.933 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.02 163.07 37.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.437 -0.789 . . . . 0.0 109.203 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.436 ' CA ' ' OE2' ' A' ' 60' ' ' GLU . . . -139.53 118.73 1.55 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.2 m -123.2 143.95 49.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -1.16 . . . . 0.0 109.468 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 27' ' ' ASN . . . -142.99 155.6 44.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.1 mt . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 109.401 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.257 0.551 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.643 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 80.7 m-20 -91.53 144.35 25.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.394 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -140.52 154.67 46.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -156.77 150.23 21.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.757 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 69.2 mtm -113.99 168.82 9.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -1.105 . . . . 0.0 109.432 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -152.96 115.45 0.68 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.604 HD13 ' CD1' ' A' ' 49' ' ' ILE . 5.4 mp -125.87 118.9 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.132 . . . . 0.0 109.253 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 45' ' ' ASN . 10.3 p -118.63 151.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.72 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.632 ' ND1' ' CE2' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -104.11 136.95 42.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 109.253 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.55 158.4 34.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.624 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.893 ' HB ' HD11 ' A' ' 44' ' ' LEU . 14.4 t -125.58 164.42 20.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 109.384 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.548 ' HE2' HG23 ' A' ' 9' ' ' VAL . 86.5 m-85 -116.68 8.38 13.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.184 -0.947 . . . . 0.0 109.619 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.587 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.65 -179.42 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 108.946 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.8 Cg_endo -65.95 -5.12 11.39 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.08 1.853 . . . . 0.0 111.749 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -125.84 106.02 9.37 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -73.74 122.89 23.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.196 -0.94 . . . . 0.0 109.531 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -168.0 117.78 0.79 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.88 . . . . 0.0 109.203 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.627 HG11 HD13 ' A' ' 152' ' ' LEU . 1.4 m -47.94 123.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -0.93 . . . . 0.0 109.399 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.893 HD11 ' HB ' ' A' ' 36' ' ' THR . 5.8 mp -65.68 -38.31 88.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.661 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.576 ' O ' HG23 ' A' ' 33' ' ' VAL . 57.2 t-20 -175.27 155.02 1.82 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 109.88 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 89.8 mt-30 -112.37 150.55 30.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.809 . . . . 0.0 108.892 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.1 t-105 -128.78 131.16 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.989 . . . . 0.0 109.664 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -122.39 133.36 54.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.412 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.604 ' CD1' HD13 ' A' ' 32' ' ' ILE . 3.6 mp -134.1 88.42 31.43 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.88 139.22 39.28 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.728 2.286 . . . . 0.0 111.728 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.832 HD12 ' N ' ' A' ' 51' ' ' LEU . 3.0 mp -106.04 147.88 28.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.402 ' HA2' HG11 ' A' ' 164' ' ' VAL . . . -93.21 -67.58 1.08 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -104.89 60.87 0.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -1.145 . . . . 0.0 109.502 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 78.0 m80 -133.16 173.06 11.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 58' ' ' MET . 8.9 t -117.11 173.16 6.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 109.474 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -55.91 -45.54 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.849 . . . . 0.0 109.261 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 60' ' ' GLU . 85.6 mt-30 -58.36 -63.82 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.416 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.471 ' H ' HG23 ' A' ' 55' ' ' THR . 97.9 mtp -43.55 -29.2 0.45 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.485 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.44 -29.17 30.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.372 -0.83 . . . . 0.0 109.611 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 57' ' ' GLN . 62.7 mm-40 -71.08 -34.81 71.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.704 HD11 ' CZ2' ' A' ' 117' ' ' TRP . 13.4 tt -82.1 -34.65 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 109.609 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.757 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -69.61 -26.09 64.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.786 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -67.09 -36.45 82.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.414 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.725 HG22 HG21 ' A' ' 82' ' ' THR . 84.9 t -75.57 -36.67 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.428 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 77.6 tt0 -70.4 -37.17 74.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.122 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.525 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 26.1 t80 -60.86 -66.33 0.55 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.398 -0.814 . . . . 0.0 109.508 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.66 -31.15 57.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.551 ' SG ' HD13 ' A' ' 130' ' ' ILE . 33.3 t -55.2 -57.63 10.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 31.9 tttt -63.7 -38.88 92.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 17.6 mmtt -59.84 -32.89 71.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.907 . . . . 0.0 109.47 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' LEU . . . -71.22 -59.8 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.291 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 130' ' ' ILE . 25.8 tp -45.18 -47.27 12.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.278 -0.889 . . . . 0.0 109.296 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 57.4 mttm -44.13 -48.79 9.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.195 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.068 HD12 HG21 ' A' ' 78' ' ' VAL . 4.8 mt -54.65 141.91 54.34 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.056 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.5 Cg_endo -66.07 -7.33 16.75 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.525 2.15 . . . . 0.0 111.483 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.94 161.19 21.88 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.0 Cg_endo -69.05 146.67 65.34 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.437 2.091 . . . . 0.0 111.747 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.068 HG21 HD12 ' A' ' 74' ' ' ILE . 25.4 t -134.78 159.36 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.335 -0.853 . . . . 0.0 109.562 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.632 HD12 ' C ' ' A' ' 78' ' ' VAL . 7.1 mp -109.02 132.41 54.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.542 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.5 t -103.18 133.15 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.203 -0.936 . . . . 0.0 109.433 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.813 HG21 ' OE2' ' A' ' 135' ' ' GLU . 21.2 mm -106.13 132.52 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.366 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.725 HG21 HG22 ' A' ' 64' ' ' VAL . 1.1 p -133.42 161.71 33.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.529 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -92.7 6.99 45.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.516 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.522 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 41.3 t -130.28 123.76 30.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.918 . . . . 0.0 109.603 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.618 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 40.3 p90 -77.05 -43.0 36.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.535 ' N ' ' CG ' ' A' ' 85' ' ' PHE . 69.9 t80 -47.16 -50.25 20.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.88 . . . . 0.0 109.447 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.726 HG23 ' HH2' ' A' ' 117' ' ' TRP . 7.2 p -66.71 -47.76 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.343 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.596 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -54.04 -46.96 72.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.26 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 98.2 mt-10 -65.22 -35.47 81.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.331 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.577 ' HB2' ' CH2' ' A' ' 117' ' ' TRP . 68.3 m -52.74 -44.48 66.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.472 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.747 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -96.43 -0.89 48.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 51.7 t30 -92.56 -72.74 0.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.031 . . . . 0.0 109.751 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 48.2 mttm -126.64 -27.67 3.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.49 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 87.3 mt-10 -61.23 -31.46 71.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.871 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 91' ' ' ALA . 0.6 OUTLIER -56.05 -60.2 9.56 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.681 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 45.6 Cg_endo -67.4 -34.55 26.3 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.727 2.285 . . . . 0.0 111.702 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -68.59 -36.45 78.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.227 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.43 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 13.8 m0 . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 83.7 mttt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.223 0.535 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 54.0 m80 65.52 26.51 11.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -0.819 . . . . 0.0 109.637 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.783 HG22 ' HE3' ' A' ' 118' ' ' LYS . 66.6 mt -64.29 -42.47 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.274 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -53.84 -46.23 71.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.161 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -58.51 -42.07 86.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.854 . . . . 0.0 109.251 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.726 ' HH2' HG23 ' A' ' 87' ' ' VAL . 16.3 m95 -67.67 -34.14 76.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.783 ' HE3' HG22 ' A' ' 114' ' ' ILE . 62.3 mttt -60.12 -36.37 77.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.332 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.428 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 25.3 m -66.28 -44.4 83.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.338 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.747 HG21 ' CB ' ' A' ' 91' ' ' ALA . 74.4 mt -66.64 -38.73 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.426 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.447 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -62.21 -35.88 80.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.387 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 126' ' ' MET . 82.9 tt0 -54.12 -39.84 66.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.872 . . . . 0.0 109.398 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.9 m -77.39 -46.5 22.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 0.0 109.4 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 59.9 mt -61.42 -36.83 81.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.417 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.5 m -60.53 -34.13 73.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.402 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.442 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 89.3 mtp -64.17 -30.77 71.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.915 . . . . 0.0 109.511 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 176.27 136.32 0.19 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.532 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.58 -0.09 7.06 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.74 2.293 . . . . 0.0 111.805 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 93.6 m-20 -50.2 -21.57 1.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 72' ' ' LEU . 68.0 mt -81.15 114.52 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.64 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 55.6 m -112.17 135.28 53.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.601 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 75.6 mt -116.57 138.75 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.105 -0.997 . . . . 0.0 109.682 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.587 ' NE2' HD23 ' A' ' 79' ' ' LEU . 94.7 mt-30 -124.68 159.45 30.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.618 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 19.8 t-80 -119.54 142.18 48.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.813 ' OE2' HG21 ' A' ' 81' ' ' ILE . 92.9 mt-10 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.451 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.259 0.552 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.8 m -67.18 -42.98 83.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.506 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.459 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 97.9 mt-10 -60.06 -36.66 77.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.51 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -69.3 -24.85 75.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -75.52 -33.88 60.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -1.118 . . . . 0.0 109.471 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -74.74 -41.45 60.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.627 HD13 HG11 ' A' ' 43' ' ' VAL . 68.9 mt -64.87 -38.2 90.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 0.0 109.55 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.13 -39.58 75.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -65.84 -39.38 90.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.125 -0.984 . . . . 0.0 109.464 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 66.8 mttm -64.85 -35.41 81.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.55 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 39.9 mt -68.19 -40.26 82.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 109.58 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.42 92.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.52 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 38.4 m -58.38 -44.06 88.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.519 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -61.94 -37.08 83.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.534 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.0 -48.2 84.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 164' ' ' VAL . 85.8 p -64.84 -33.45 76.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -1.148 . . . . 0.0 109.59 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -63.44 -38.41 91.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 68.7 t -57.06 -38.17 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 51' ' ' LEU . 41.2 t . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.517 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.856 ' CD2' HD11 ' A' ' 79' ' ' LEU . 49.5 p90 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.744 ' HG3' HG22 ' A' ' 78' ' ' VAL . 2.6 pp20? -89.54 -27.08 20.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.589 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.4 -174.61 31.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.501 HG13 ' CE2' ' A' ' 11' ' ' TYR . 14.6 p -130.43 143.7 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -1.141 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.669 ' CD2' HG11 ' A' ' 78' ' ' VAL . 26.5 m-85 -119.44 123.6 44.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.932 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.643 ' CE1' HD12 ' A' ' 81' ' ' ILE . 87.7 m-85 -105.81 130.83 53.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.816 HG22 HD12 ' A' ' 32' ' ' ILE . 15.8 p -119.93 150.75 39.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.508 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 57.3 t0 -142.64 151.47 41.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -133.64 119.19 2.24 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.6 m -127.85 152.22 48.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -1.172 . . . . 0.0 109.5 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 27' ' ' ASN . . . -137.62 156.05 48.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 109.453 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.928 . . . . 0.0 109.504 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 70.3 m-20 -86.63 145.19 26.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.632 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -140.29 150.22 43.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.93 165.24 30.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.844 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 56.0 mtm -132.7 152.79 51.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -1.109 . . . . 0.0 109.291 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.37 125.22 2.97 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.816 HD12 HG22 ' A' ' 12' ' ' THR . 19.1 mm -111.08 142.51 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -1.154 . . . . 0.0 109.301 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.3 t -136.64 123.52 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.159 -0.963 . . . . 0.0 109.756 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 1.012 ' CD2' HD12 ' A' ' 44' ' ' LEU . 23.6 t60 -101.01 138.27 38.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.141 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.25 163.18 33.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 109.836 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.0 t -123.16 164.96 17.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.415 -0.803 . . . . 0.0 109.172 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 38' ' ' LYS . 83.8 m-85 -103.49 9.47 37.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.094 -1.004 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.578 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 2.0 mtmt -51.21 -179.25 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.8 Cg_endo -65.13 -5.78 11.7 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.039 1.826 . . . . 0.0 111.649 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -127.28 105.74 8.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.339 -0.85 . . . . 0.0 108.741 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -74.01 126.81 31.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.43 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -167.33 148.3 5.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 109.589 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.6 m -71.47 121.96 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.365 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.012 HD12 ' CD2' ' A' ' 34' ' ' HIS . 41.0 mt -65.06 -43.95 90.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.327 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 76.8 m-20 -159.17 147.79 18.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.377 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.924 ' HB3' HD21 ' A' ' 156' ' ' LEU . 90.6 mt-30 -106.85 144.26 33.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.402 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.81 138.53 45.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 0.0 109.714 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.413 ' C ' HD12 ' A' ' 49' ' ' ILE . 96.5 p -130.85 144.87 51.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.353 -0.842 . . . . 0.0 109.273 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 4.7 mp -138.35 97.28 9.55 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.554 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.81 137.43 32.38 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.641 2.227 . . . . 0.0 111.711 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' A' ' 28' ' ' ALA . 39.4 mt -103.67 141.02 36.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.63 -66.54 0.94 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -115.58 61.12 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.154 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 74.7 m80 -130.26 -176.66 4.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.409 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.514 HG22 ' HG3' ' A' ' 58' ' ' MET . 15.3 t -126.96 168.01 15.1 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.898 . . . . 0.0 109.542 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.69 -36.59 62.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.512 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -60.9 -41.06 95.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 55' ' ' THR . 65.6 mtt -65.62 -32.95 74.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' HG2' ' A' ' 30' ' ' MET . . . -66.91 -34.05 76.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.596 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.78 -41.69 68.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.885 . . . . 0.0 109.582 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 58' ' ' MET . 17.9 tt -73.71 -34.77 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.633 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.844 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -75.82 -30.13 58.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.592 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -65.27 -39.71 92.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.822 HG21 HG12 ' A' ' 87' ' ' VAL . 89.7 t -73.26 -40.4 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.636 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.469 ' HG3' HG12 ' A' ' 120' ' ' ILE . 83.7 tt0 -68.72 -40.06 80.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 109.231 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.63 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 31.3 t80 -52.37 -64.15 0.91 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 109.634 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.623 ' HB3' HG11 ' A' ' 80' ' ' VAL . . . -62.75 -27.63 69.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.675 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.638 ' SG ' HG23 ' A' ' 120' ' ' ILE . 48.8 t -58.1 -58.05 10.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.543 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.454 ' HG2' ' SG ' ' A' ' 123' ' ' CYS . 40.3 mttt -61.11 -46.42 90.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.571 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.63 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 65.2 mttm -63.95 -33.99 76.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.35 -60.25 3.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.512 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.584 ' HB2' HD11 ' A' ' 130' ' ' ILE . 18.8 tp -57.66 -36.01 71.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -51.81 -43.46 63.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -0.918 . . . . 0.0 109.369 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.704 HG13 HG21 ' A' ' 78' ' ' VAL . 35.5 mm -48.36 143.04 7.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.898 . . . . 0.0 108.886 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.6 Cg_endo -64.36 -6.06 11.04 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.541 2.161 . . . . 0.0 111.724 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.449 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -139.23 171.73 23.53 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.04 134.49 29.63 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.449 2.099 . . . . 0.0 111.676 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.744 HG22 ' HG3' ' A' ' 7' ' ' GLU . 32.1 t -127.41 167.67 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 109.26 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.856 HD11 ' CD2' ' A' ' 6' ' ' TYR . 3.9 mt -125.87 127.58 46.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.291 -0.881 . . . . 0.0 109.78 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.623 HG11 ' HB3' ' A' ' 67' ' ' ALA . 34.7 t -101.44 133.01 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 109.235 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.643 HD12 ' CE1' ' A' ' 11' ' ' TYR . 23.5 mt -117.04 134.13 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.5 t -142.81 159.96 41.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.248 -0.907 . . . . 0.0 109.503 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 50.6 p-10 -83.9 -4.65 58.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.516 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.518 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 63.5 m -77.95 97.23 5.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.386 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.584 ' HA ' ' CD2' ' A' ' 134' ' ' HIS . 97.6 m-85 -64.16 -49.57 71.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 109.381 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -63.23 -52.25 62.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.65 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.822 HG12 HG21 ' A' ' 64' ' ' VAL . 38.8 t -55.88 -59.9 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.923 . . . . 0.0 109.591 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.944 ' HB3' ' NE2' ' A' ' 134' ' ' HIS . . . -43.57 -57.62 3.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.436 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.466 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 98.0 mt-10 -53.98 -40.74 67.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.463 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.567 ' CB ' ' CZ3' ' A' ' 117' ' ' TRP . 50.0 m -47.26 -52.13 16.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.689 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -89.7 -0.98 57.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.673 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 44.5 t-20 -82.14 -72.67 0.43 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.652 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 96.3 mttt -126.5 -22.7 3.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.075 -1.016 . . . . 0.0 110.062 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 96.3 mt-10 -67.13 -25.6 66.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.039 . . . . 0.0 109.66 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.868 HD11 ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -54.57 -58.77 12.62 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.598 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 45.9 Cg_endo -67.16 -32.31 34.16 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.554 2.169 . . . . 0.0 111.464 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -66.01 -40.21 90.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 108.982 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 39.8 m0 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.475 -0.766 . . . . 0.0 109.192 179.688 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.562 ' HE3' ' CE1' ' A' ' 113' ' ' HIS . 51.9 tttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.562 ' CE1' ' HE3' ' A' ' 112' ' ' LYS . 59.4 m80 62.35 27.81 16.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.399 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.1 mt -60.96 -41.21 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.9 m -55.47 -46.55 76.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.4 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -60.37 -47.06 87.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.502 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.567 ' CZ3' ' CB ' ' A' ' 90' ' ' SER . 88.1 m95 -68.03 -33.61 74.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -56.21 -44.28 79.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.481 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.457 ' HB2' ' OE2' ' A' ' 65' ' ' GLU . 36.2 m -58.2 -43.4 87.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.638 HG23 ' SG ' ' A' ' 68' ' ' CYS . 78.0 mt -66.38 -40.13 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.978 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.868 ' HB2' HD11 ' A' ' 95' ' ' LEU . . . -62.98 -35.27 79.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.44 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -56.65 -35.48 68.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.454 ' SG ' ' HG2' ' A' ' 69' ' ' LYS . 77.7 m -80.02 -49.2 12.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.469 HD23 HD12 ' A' ' 130' ' ' ILE . 51.9 mt -57.98 -37.0 73.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 25.5 m -58.77 -33.42 70.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.33 -0.856 . . . . 0.0 109.501 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 90.0 mtp -63.9 -37.67 88.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 177.3 143.44 0.26 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.1 Cg_endo -69.65 -1.35 8.23 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.722 2.281 . . . . 0.0 111.749 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 128' ' ' PRO . 88.3 m-20 -43.4 -35.22 1.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.441 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.584 HD11 ' HB2' ' A' ' 72' ' ' LEU . 67.5 mt -69.74 121.47 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.421 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.737 ' HB ' HD22 ' A' ' 79' ' ' LEU . 23.8 m -119.06 143.48 47.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.369 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.658 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 70.6 mt -122.78 130.72 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.446 ' HB2' HG12 ' A' ' 81' ' ' ILE . 89.9 mt-30 -125.01 153.54 42.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.392 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.944 ' NE2' ' HB3' ' A' ' 88' ' ' ALA . 37.3 m170 -89.74 133.33 34.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.605 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.631 ' HG2' HG22 ' A' ' 81' ' ' ILE . 96.2 mt-10 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.799 . . . . 0.0 109.519 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 68.2 m80 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 95.2 m -58.56 -42.86 88.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -52.36 -45.25 65.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.595 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.41 -36.96 91.25 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -65.1 -33.84 76.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -1.169 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.427 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -64.98 -52.29 57.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.9 mp -65.45 -46.73 78.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.592 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.53 80.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.533 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -63.17 -34.93 78.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 69.5 mttt -63.03 -43.5 98.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.511 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.924 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.4 mp -71.82 -37.18 70.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.55 -43.09 91.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 109.56 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 36.6 m -63.79 -41.37 97.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.605 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.876 ' O ' HG23 ' A' ' 163' ' ' VAL . 94.2 mt-30 -61.74 -35.73 78.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.575 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.57 -51.45 58.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 164' ' ' VAL . 25.0 m -64.56 -37.19 86.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -1.182 . . . . 0.0 109.672 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -64.1 -33.96 76.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 159' ' ' GLN . 45.8 t -65.86 -15.05 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 161' ' ' SER . 47.3 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.469 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.63 ' CE2' ' CD2' ' A' ' 79' ' ' LEU . 17.8 m-85 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.41 ' HG3' HG22 ' A' ' 74' ' ' ILE . 77.1 mm-40 -69.58 -33.94 73.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 108.931 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.27 -168.75 38.77 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.907 ' CG1' ' HB3' ' A' ' 35' ' ' ALA . 7.8 p -123.0 145.19 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.241 -1.153 . . . . 0.0 109.115 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.869 ' CE1' HG21 ' A' ' 78' ' ' VAL . 9.4 m-85 -122.48 137.42 54.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 109.859 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.739 ' CE1' HD12 ' A' ' 81' ' ' ILE . 92.6 m-85 -118.24 126.75 52.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.317 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.937 HG22 HD12 ' A' ' 32' ' ' ILE . 27.5 p -117.75 144.22 45.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 43.8 t0 -143.2 149.92 38.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.407 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -129.69 123.18 4.01 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m -129.36 147.75 51.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -1.102 . . . . 0.0 109.313 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 27' ' ' ASN . . . -137.81 151.8 48.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -0.96 . . . . 0.0 109.628 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 20.4 mt . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.855 . . . . 0.0 109.262 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.586 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 85.5 m-20 -83.31 137.22 34.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -137.81 151.25 47.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.417 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.434 ' HA2' ' CD1' ' A' ' 51' ' ' LEU . . . -154.3 162.6 30.7 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.74 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 74.0 mtm -127.41 168.52 14.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -1.121 . . . . 0.0 109.479 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.711 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -152.96 113.76 0.59 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.937 HD12 HG22 ' A' ' 12' ' ' THR . 10.9 mm -119.44 114.09 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.166 . . . . 0.0 109.338 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.556 ' CG2' ' HG2' ' A' ' 46' ' ' GLN . 7.5 p -118.52 148.01 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.2 -0.938 . . . . 0.0 109.691 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.687 ' CD2' ' CE2' ' A' ' 10' ' ' PHE . 7.4 m170 -101.62 145.01 29.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 109.118 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.907 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -136.9 166.81 22.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.109 -0.995 . . . . 0.0 109.677 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.748 ' HB ' HD11 ' A' ' 44' ' ' LEU . 9.9 t -123.24 165.41 16.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.352 -0.842 . . . . 0.0 109.458 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' LYS . 55.2 m-85 -105.94 10.84 32.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 3.1 mtpt -51.18 178.76 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.839 . . . . 0.0 109.103 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.5 Cg_endo -65.09 -6.19 12.47 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.187 1.925 . . . . 0.0 111.663 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -131.23 106.28 8.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 108.982 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 48.9 t80 -58.54 127.62 33.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 81.2 mt-30 -159.45 141.92 13.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.51 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 43' ' ' VAL . 25.0 m -78.93 122.38 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.748 HD11 ' HB ' ' A' ' 36' ' ' THR . 7.4 mp -67.09 -42.96 83.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' O ' HG23 ' A' ' 33' ' ' VAL . 29.8 m120 -160.41 149.95 17.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.645 ' HB3' HD21 ' A' ' 156' ' ' LEU . 90.2 mt-30 -110.22 150.93 27.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.199 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.7 t-105 -133.31 137.16 45.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.005 . . . . 0.0 109.8 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.1 t -125.74 132.56 52.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.213 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.689 HD13 ' CD1' ' A' ' 66' ' ' PHE . 6.1 mt -135.53 89.8 21.49 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.951 . . . . 0.0 109.702 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.464 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.3 Cg_endo -71.05 144.57 47.54 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 122.63 2.22 . . . . 0.0 111.596 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.822 HD12 ' N ' ' A' ' 51' ' ' LEU . 3.7 mp -110.93 147.86 33.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.588 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.74 -75.59 1.26 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -98.56 61.74 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.127 . . . . 0.0 109.448 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.452 ' HA ' ' SD ' ' A' ' 58' ' ' MET . 76.6 m80 -131.62 -177.56 4.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.938 . . . . 0.0 109.529 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.416 HG22 ' HG3' ' A' ' 58' ' ' MET . 15.3 t -128.22 166.84 17.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 0.0 109.5 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -48.13 -44.73 32.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.94 . . . . 0.0 109.331 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 60' ' ' GLU . 86.2 mt-30 -55.2 -58.17 8.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.303 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.452 ' SD ' ' HA ' ' A' ' 54' ' ' HIS . 62.1 mtt -44.81 -34.62 2.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.266 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.4 -31.51 60.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.319 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 57' ' ' GLN . 96.5 mt-10 -72.66 -38.35 67.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.327 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.774 ' HA ' HG21 ' A' ' 87' ' ' VAL . 7.3 tt -81.53 -38.47 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.74 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -66.06 -36.48 83.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.352 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.56 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -55.91 -48.18 76.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.367 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.793 HG21 HG13 ' A' ' 87' ' ' VAL . 78.4 t -64.04 -48.98 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.8 tt0 -58.24 -43.94 88.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.689 ' CD1' HD13 ' A' ' 49' ' ' ILE . 13.0 t80 -54.63 -68.12 0.21 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.37 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HB3' HG11 ' A' ' 80' ' ' VAL . . . -56.48 -19.21 14.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.204 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.979 ' SG ' HG23 ' A' ' 120' ' ' ILE . 19.3 t -66.46 -64.94 0.75 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.269 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -58.66 -46.38 87.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -58.36 -30.08 66.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.907 . . . . 0.0 109.263 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.861 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -67.35 -63.87 0.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.562 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.941 ' HB2' HD11 ' A' ' 130' ' ' ILE . 22.8 tp -50.18 -44.06 52.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.173 -0.954 . . . . 0.0 109.334 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 72' ' ' LEU . 26.4 tttt -43.27 -48.71 6.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.1 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.681 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 10.6 mt -48.4 143.19 7.58 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.369 -0.832 . . . . 0.0 108.879 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 45.5 Cg_endo -66.36 -2.25 6.85 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.625 2.217 . . . . 0.0 112.124 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.43 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -139.98 167.9 25.24 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.411 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 47.7 Cg_endo -68.94 116.74 4.62 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.446 2.097 . . . . 0.0 111.578 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.869 HG21 ' CE1' ' A' ' 10' ' ' PHE . 6.5 p -109.25 148.53 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.349 -0.845 . . . . 0.0 109.403 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.63 ' CD2' ' CE2' ' A' ' 6' ' ' TYR . 7.4 mp -96.31 138.87 33.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 67' ' ' ALA . 29.9 t -115.78 135.13 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.371 -0.831 . . . . 0.0 109.149 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.739 HD12 ' CE1' ' A' ' 11' ' ' TYR . 15.0 mt -122.44 136.85 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.602 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 t -139.1 160.33 40.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.341 -0.849 . . . . 0.0 109.316 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -81.59 -13.07 58.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.924 . . . . 0.0 109.564 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.542 ' CB ' HG12 ' A' ' 87' ' ' VAL . 29.5 m -93.15 115.62 28.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.565 ' HB2' ' CG ' ' A' ' 134' ' ' HIS . 46.4 t80 -81.4 -38.58 26.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.365 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -55.42 -46.71 76.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.54 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.793 HG13 HG21 ' A' ' 64' ' ' VAL . 14.1 p -70.18 -46.49 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 109.499 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.599 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -56.57 -48.32 77.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.267 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -60.55 -37.34 80.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.537 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 50.2 m -52.47 -55.11 24.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.633 ' HB1' HD11 ' A' ' 124' ' ' LEU . . . -83.73 -0.89 52.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.903 . . . . 0.0 109.628 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 38.6 t-20 -83.15 -72.76 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.951 . . . . 0.0 109.729 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 87.0 mttt -126.71 -25.36 3.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 97.9 mt-10 -69.57 -24.47 63.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.131 -0.98 . . . . 0.0 109.731 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' A' ' 121' ' ' ALA . 0.2 OUTLIER -54.58 -57.34 19.32 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.644 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 46.1 Cg_endo -67.47 -34.36 26.52 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.507 2.138 . . . . 0.0 111.663 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -65.82 -38.68 89.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.118 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 43.0 m0 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.34 179.821 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.1 mttp . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 48.0 m80 61.53 34.44 17.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.489 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 69.7 mt -54.19 -45.39 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.423 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.6 m -50.82 -48.35 59.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.543 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.1 -35.94 76.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.48 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.537 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 20.1 m95 -70.45 -38.13 74.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 109.516 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -58.83 -39.4 81.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.426 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.6 m -62.51 -43.06 99.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.979 HG23 ' SG ' ' A' ' 68' ' ' CYS . 83.6 mt -71.72 -36.09 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.638 ' HB2' HD11 ' A' ' 95' ' ' LEU . . . -65.29 -34.95 79.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -56.06 -38.47 70.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 61.3 m -81.18 -49.37 10.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.877 . . . . 0.0 109.467 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.633 HD11 ' HB1' ' A' ' 91' ' ' ALA . 54.7 mt -60.52 -31.9 70.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.432 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.4 t -62.38 -33.0 73.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 94.9 mmm -64.73 -38.05 89.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.16 146.48 0.56 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.284 -0.885 . . . . 0.0 109.447 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 129' ' ' ASP . 50.1 Cg_endo -70.79 0.66 6.07 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.739 2.292 . . . . 0.0 111.899 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 128' ' ' PRO . 88.8 m-20 -44.09 -50.53 8.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.398 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.941 HD11 ' HB2' ' A' ' 72' ' ' LEU . 58.3 mt -55.25 113.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.777 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.481 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 54.9 m -110.54 144.18 39.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 108.986 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -124.29 141.45 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 109.83 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.4 mt-30 -128.58 159.56 35.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.389 -0.819 . . . . 0.0 109.184 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.565 ' CG ' ' HB2' ' A' ' 85' ' ' PHE . 32.2 t-80 -119.52 140.29 50.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 109.665 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.541 ' OE2' HG21 ' A' ' 81' ' ' ILE . 94.9 mt-10 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.334 -0.854 . . . . 0.0 109.218 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 57.2 m80 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.5 p -68.79 -41.51 78.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.94 -38.48 64.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.48 -37.62 94.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -64.44 -42.93 95.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.289 -1.124 . . . . 0.0 109.431 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.5 64.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.867 . . . . 0.0 109.461 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.479 ' O ' HD13 ' A' ' 156' ' ' LEU . 64.5 mt -60.38 -48.84 80.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.823 . . . . 0.0 109.485 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.402 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . . . -52.76 -40.3 63.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.566 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.424 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 54.3 t0 -60.06 -49.32 78.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -52.89 -37.96 61.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.533 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.645 HD21 ' HB3' ' A' ' 46' ' ' GLN . 7.1 mp -69.37 -41.53 76.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' MET . . . -69.55 -44.99 69.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.562 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 33.6 m -58.81 -42.18 88.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.539 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -61.94 -39.47 92.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.501 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -62.0 -45.75 95.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.536 ' HA ' HG12 ' A' ' 164' ' ' VAL . 85.2 p -69.53 -25.75 64.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -1.184 . . . . 0.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -67.68 -36.34 80.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.504 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.3 t -72.91 -19.08 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 161' ' ' SER . 14.8 p . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.524 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.993 ' CD2' HD11 ' A' ' 79' ' ' LEU . 18.4 p90 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.442 0.639 . . . . 0.0 109.898 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.452 ' OE1' HG22 ' A' ' 74' ' ' ILE . 21.2 tt0 -79.59 -45.14 19.71 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.422 -0.799 . . . . 0.0 108.996 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.836 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -161.21 178.52 37.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.585 HG23 ' HE2' ' A' ' 37' ' ' TYR . 67.9 t -129.73 146.27 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -1.14 . . . . 0.0 109.501 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.864 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.5 m-85 -118.4 155.39 30.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.781 ' CE1' HD12 ' A' ' 81' ' ' ILE . 96.3 m-85 -118.03 123.17 45.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.332 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.865 HG22 HD12 ' A' ' 32' ' ' ILE . 24.2 p -117.06 145.78 43.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.551 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 56.7 t0 -143.99 152.98 41.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -137.33 117.08 1.46 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 29' ' ' GLY . 47.0 t -133.49 155.18 50.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.319 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.712 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -137.95 158.68 43.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.595 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 65.0 mt . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.453 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 42.5 p-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 19.9 m120 -94.36 125.94 39.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 0.0 109.367 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . . . -103.5 156.07 18.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.534 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -147.22 148.38 19.94 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.656 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 63.6 mtm -124.02 165.11 18.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -1.2 . . . . 0.0 109.573 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.702 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -149.87 116.86 0.81 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.865 HD12 HG22 ' A' ' 12' ' ' THR . 15.1 mm -120.26 115.27 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -1.161 . . . . 0.0 109.486 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 45' ' ' ASN . 12.3 p -118.76 148.39 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.498 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.989 ' CD2' HD22 ' A' ' 44' ' ' LEU . 9.4 t60 -101.16 137.23 39.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.556 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.485 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -122.23 158.16 30.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.958 ' HB ' HD11 ' A' ' 44' ' ' LEU . 12.0 t -125.11 162.23 25.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.877 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.585 ' HE2' HG23 ' A' ' 9' ' ' VAL . 58.5 m-85 -108.64 11.47 26.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.968 . . . . 0.0 109.618 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.558 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 5.3 mttt -51.21 178.74 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.0 Cg_endo -64.43 -6.05 11.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.185 1.924 . . . . 0.0 111.704 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 70.0 mm-40 -129.53 105.36 8.03 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.254 -0.904 . . . . 0.0 108.759 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -64.54 125.31 24.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.574 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -168.18 129.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 43' ' ' VAL . 22.6 m -58.7 126.04 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.457 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.989 HD22 ' CD2' ' A' ' 34' ' ' HIS . 6.1 mp -67.33 -42.79 83.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.654 ' O ' HG23 ' A' ' 33' ' ' VAL . 77.9 m-20 -160.61 154.41 22.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.617 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.596 ' HB3' HD21 ' A' ' 156' ' ' LEU . 90.9 mt-30 -113.1 148.22 35.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 109.131 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CB ' ' O ' ' A' ' 32' ' ' ILE . 11.6 t-105 -127.34 138.88 53.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.105 -0.997 . . . . 0.0 109.843 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.407 ' C ' HG13 ' A' ' 49' ' ' ILE . 51.5 m -126.96 136.73 52.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.118 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.418 HD12 ' HE3' ' A' ' 30' ' ' MET . 3.8 mt -144.03 92.05 6.38 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.733 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.1 Cg_endo -70.76 148.32 58.32 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.66 2.24 . . . . 0.0 111.557 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 51' ' ' LEU . 5.7 mp -119.65 145.5 46.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.95 -48.36 0.17 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -90.42 9.95 27.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -1.133 . . . . 0.0 109.393 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 56.7 m80 -117.75 -176.08 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 0.0 109.522 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.409 HG22 ' HG3' ' A' ' 58' ' ' MET . 13.8 t -124.49 166.36 16.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.712 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -46.21 -45.51 16.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 0.0 109.346 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 60' ' ' GLU . 84.6 mt-30 -54.38 -59.34 4.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 109.428 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.429 ' SD ' ' HB3' ' A' ' 54' ' ' HIS . 61.2 mtt -44.08 -33.98 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.444 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.454 ' HB1' ' CG ' ' A' ' 30' ' ' MET . . . -71.85 -31.45 66.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.27 -0.893 . . . . 0.0 109.389 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 57' ' ' GLN . 96.8 mt-10 -70.88 -33.61 70.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.503 ' HA ' HG21 ' A' ' 87' ' ' VAL . 7.1 tt -86.92 -30.84 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 109.341 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.656 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -74.95 -29.71 61.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.417 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -64.98 -39.07 92.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.619 HG21 HG13 ' A' ' 87' ' ' VAL . 71.8 t -71.95 -45.6 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.489 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.519 ' HB2' HD11 ' A' ' 120' ' ' ILE . 87.3 tt0 -64.3 -37.01 85.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.6 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 13.7 t80 -56.07 -69.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -60.4 -15.82 29.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.903 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.66 ' SG ' HG23 ' A' ' 120' ' ' ILE . 44.8 t -67.66 -63.92 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HG2' ' SG ' ' A' ' 123' ' ' CYS . 23.6 mttm -58.64 -44.54 90.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.6 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 66.5 mttm -63.51 -38.54 91.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.832 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -54.83 -61.62 2.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.959 ' HB2' HD11 ' A' ' 130' ' ' ILE . 9.1 tt -51.55 -45.33 62.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 72' ' ' LEU . 65.0 tttm -43.64 -42.41 5.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.175 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.578 HG23 ' HD2' ' A' ' 75' ' ' PRO . 48.4 mm -48.93 143.21 8.68 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.331 -0.856 . . . . 0.0 108.806 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.578 ' HD2' HG23 ' A' ' 74' ' ' ILE . 41.8 Cg_endo -63.7 -4.71 7.52 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.669 2.246 . . . . 0.0 112.311 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.497 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -143.06 171.8 24.81 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.502 ' HG2' ' HA ' ' A' ' 6' ' ' TYR . 43.9 Cg_endo -67.22 118.61 5.7 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.495 2.13 . . . . 0.0 111.684 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.864 HG21 ' CE1' ' A' ' 10' ' ' PHE . 9.0 p -114.67 151.43 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.394 -0.816 . . . . 0.0 109.266 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.993 HD11 ' CD2' ' A' ' 6' ' ' TYR . 12.2 mt -96.82 154.73 17.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.83 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 131' ' ' THR . 38.9 t -125.87 133.07 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.536 -0.727 . . . . 0.0 109.049 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 11' ' ' TYR . 26.2 mt -120.04 133.8 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.61 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.46 HG21 ' CG2' ' A' ' 64' ' ' VAL . 7.1 t -136.5 161.72 35.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.511 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 13' ' ' ASP . 58.3 p30 -89.33 15.04 9.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.515 ' OG ' HG12 ' A' ' 87' ' ' VAL . 26.7 t -123.93 114.73 20.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.918 . . . . 0.0 109.487 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.568 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 61.3 t80 -77.16 -43.15 34.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.573 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -49.0 -48.26 43.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.619 HG13 HG21 ' A' ' 64' ' ' VAL . 8.9 p -68.03 -45.36 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.593 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.571 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -53.4 -49.69 66.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.925 . . . . 0.0 109.544 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 80.5 tt0 -60.55 -34.39 74.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.303 -0.873 . . . . 0.0 109.516 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.633 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 50.5 m -56.42 -55.87 28.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.728 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.68 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -82.02 -0.75 45.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 109.702 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 47.0 t-20 -84.66 -73.23 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 109.812 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 62.6 tttt -127.37 -30.98 2.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.092 -1.005 . . . . 0.0 109.924 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 58.9 mm-40 -56.75 -37.69 71.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.108 -0.995 . . . . 0.0 109.922 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -51.38 -61.56 3.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 109.628 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 95' ' ' LEU . 45.5 Cg_endo -67.76 -27.19 38.12 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.571 2.18 . . . . 0.0 111.449 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -73.47 -34.99 65.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 108.983 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.595 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 15.8 m0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.847 . . . . 0.0 109.19 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 21.4 mttp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.262 0.553 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 28.1 m80 68.75 31.76 4.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 109.553 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 75.8 mt -61.73 -41.36 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.296 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.9 m -53.27 -50.18 65.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 109.257 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -60.38 -38.4 83.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.334 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.633 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 25.3 m95 -72.35 -36.76 68.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -55.65 -44.97 77.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.325 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.2 m -60.41 -45.78 92.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.319 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.66 HG23 ' SG ' ' A' ' 68' ' ' CYS . 73.5 mt -69.34 -32.83 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.746 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -60.91 -38.07 84.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.931 . . . . 0.0 109.4 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 126' ' ' MET . 96.2 mt-10 -61.7 -40.51 95.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.332 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 130' ' ' ILE . 56.6 m -64.85 -51.02 64.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.847 HD13 ' O ' ' A' ' 124' ' ' LEU . 3.4 tm? -65.02 -37.05 86.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.0 109.231 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.2 t -56.1 -36.11 67.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.446 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 65.4 mtt -64.25 -32.88 74.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.293 -0.88 . . . . 0.0 109.369 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 167.78 153.3 0.12 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.3 Cg_endo -71.39 0.36 6.94 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.621 2.214 . . . . 0.0 111.702 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 128' ' ' PRO . 92.1 m-20 -43.07 -48.21 6.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.372 -0.83 . . . . 0.0 109.543 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.959 HD11 ' HB2' ' A' ' 72' ' ' LEU . 74.3 mt -65.38 122.12 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.589 ' HB ' HD22 ' A' ' 79' ' ' LEU . 32.6 m -116.98 149.58 40.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.193 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.68 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 55.4 mt -127.01 132.69 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.134 -0.979 . . . . 0.0 109.712 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.452 ' HB2' HG12 ' A' ' 81' ' ' ILE . 86.4 mt-30 -118.09 159.39 23.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.17 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.568 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 28.2 t-80 -120.28 133.56 55.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.991 . . . . 0.0 109.683 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.419 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 62.5 m170 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.5 m -64.93 -41.71 95.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.23 -41.33 75.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.07 -36.16 87.22 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -66.56 -38.13 86.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -1.159 . . . . 0.0 109.395 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.16 -53.07 62.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.462 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.634 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.8 mp -67.39 -46.41 73.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.348 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.534 ' HA ' HD12 ' A' ' 156' ' ' LEU . . . -57.28 -38.26 73.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.455 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 81.5 m-20 -63.11 -43.63 97.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.526 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.88 -41.61 78.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.535 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.8 mt -64.43 -41.21 96.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.935 . . . . 0.0 109.399 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.54 96.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 37.2 m -55.78 -45.81 78.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.549 ' O ' HG23 ' A' ' 163' ' ' VAL . 95.5 mt-30 -62.32 -36.18 81.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -0.906 . . . . 0.0 109.482 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -53.31 -59.2 9.89 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 92.1 p -63.49 -33.63 75.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -1.135 . . . . 0.0 109.503 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -63.66 -37.37 87.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 159' ' ' GLN . 71.5 t -57.41 -37.01 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.494 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 0.0 109.483 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.63 ' CG ' HD13 ' A' ' 79' ' ' LEU . 36.6 m-85 . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 45.4 tp10 -66.75 -32.64 74.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.95 . . . . 0.0 109.043 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.742 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.0 -177.24 47.43 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.1 t -129.13 139.01 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -1.154 . . . . 0.0 109.232 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.792 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.9 m-85 -117.5 143.87 45.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.866 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 1.062 ' CE2' HD12 ' A' ' 81' ' ' ILE . 92.7 m-85 -117.38 121.76 41.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.143 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.749 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 18.8 p -111.83 150.28 30.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.074 -1.016 . . . . 0.0 109.632 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.4 ' OD2' ' OD1' ' A' ' 154' ' ' ASP . 45.5 t0 -152.51 146.8 25.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.88 136.39 10.95 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.439 ' HB3' ' HB1' ' A' ' 157' ' ' ALA . 17.9 t -138.69 142.69 38.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 109.612 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -135.01 150.13 50.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.291 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 27' ' ' ASN . 69.3 mt . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.672 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 38.7 p-10 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 17' ' ' ILE . 23.5 m120 -85.8 139.09 31.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.164 -0.96 . . . . 0.0 109.555 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -125.32 151.36 46.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.933 . . . . 0.0 109.492 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -154.99 157.79 27.87 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.755 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 54.9 mtm -127.29 165.85 18.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.129 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' A' ' 156' ' ' LEU . . . -156.82 124.68 1.47 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 32' ' ' ILE . 4.8 mp -116.89 142.36 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -1.163 . . . . 0.0 109.382 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.491 HG21 ' N ' ' A' ' 153' ' ' ALA . 38.2 t -127.06 134.26 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 109.551 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.668 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 27.1 m170 -106.87 138.65 42.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.615 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.42 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -140.4 164.62 29.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 0.0 109.527 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.653 ' HB ' HD11 ' A' ' 44' ' ' LEU . 13.2 t -133.64 164.96 26.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.0 109.447 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.418 ' O ' ' O ' ' A' ' 38' ' ' LYS . 44.5 m-85 -103.32 11.09 37.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 109.575 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.582 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.26 179.73 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.185 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 38' ' ' LYS . 44.8 Cg_endo -66.88 -5.64 13.87 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.203 1.935 . . . . 0.0 111.425 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.49 ' OE2' ' NE2' ' A' ' 42' ' ' GLN . 82.6 tt0 -132.74 105.49 7.2 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.377 -0.827 . . . . 0.0 108.947 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.451 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 43.1 t80 -64.28 122.01 15.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.49 ' NE2' ' OE2' ' A' ' 40' ' ' GLU . 66.5 mt-30 -159.0 136.38 9.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.124 -0.985 . . . . 0.0 109.753 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 37.5 t -62.5 125.99 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.893 . . . . 0.0 109.32 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.653 HD11 ' HB ' ' A' ' 36' ' ' THR . 7.4 mp -68.63 -38.69 80.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 109.336 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -175.62 155.04 1.68 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 109.343 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.964 ' HB3' HD21 ' A' ' 156' ' ' LEU . 94.0 mt-30 -110.01 138.4 46.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.407 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -122.75 125.95 46.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.676 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.2 m -121.14 138.91 53.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 109.271 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 2.4 mp -133.67 96.22 16.87 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.94 129.84 18.09 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.667 2.245 . . . . 0.0 111.741 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.548 ' O ' HG21 ' A' ' 164' ' ' VAL . 43.1 mt -108.39 145.36 34.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.331 -0.856 . . . . 0.0 109.384 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.33 -28.85 1.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.531 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 46.4 p-10 -121.94 34.67 5.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -1.213 . . . . 0.0 109.507 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.531 ' CE1' ' OD1' ' A' ' 53' ' ' ASN . 77.4 m80 -124.4 175.68 6.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 109.362 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 58' ' ' MET . 14.4 t -123.03 169.44 11.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.63 -38.93 72.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.419 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.0 -54.45 44.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.458 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.489 ' H ' HG23 ' A' ' 55' ' ' THR . 67.9 mtm -66.64 -30.32 70.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.551 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.7 86.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.459 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -64.28 -49.1 73.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.509 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.71 HD11 ' CZ2' ' A' ' 117' ' ' TRP . 13.0 tt -64.59 -39.62 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.755 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -59.41 -31.41 69.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.535 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.749 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -64.17 -41.45 97.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.481 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.79 HG22 HG21 ' A' ' 82' ' ' THR . 87.9 t -71.0 -38.67 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.47 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 86.4 tt0 -68.8 -39.05 80.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.106 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.537 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 22.3 t80 -61.17 -64.37 0.97 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.364 -0.835 . . . . 0.0 109.491 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 71' ' ' ALA . . . -58.26 -31.44 67.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.631 ' SG ' HG23 ' A' ' 120' ' ' ILE . 24.3 t -53.43 -54.7 33.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.607 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -62.03 -45.48 93.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 68.9 mttm -67.36 -29.75 69.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.951 . . . . 0.0 109.308 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.747 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -62.24 -64.48 0.92 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.824 ' HB2' HD11 ' A' ' 130' ' ' ILE . 27.8 tp -55.57 -43.29 75.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.883 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' LEU . 16.2 tttt -43.22 -43.14 4.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.254 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 26.4 mm -48.2 143.45 6.94 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 108.855 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.8 Cg_endo -65.87 -3.16 7.72 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.512 2.141 . . . . 0.0 111.896 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.407 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -142.07 170.82 24.8 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.468 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.2 Cg_endo -69.2 122.82 9.66 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.366 2.044 . . . . 0.0 111.74 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.792 HG21 ' CE1' ' A' ' 10' ' ' PHE . 7.1 p -116.24 150.18 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.451 -0.781 . . . . 0.0 109.288 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.63 HD13 ' CG ' ' A' ' 6' ' ' TYR . 6.7 mp -97.8 130.7 44.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.909 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 132' ' ' ILE . 47.6 t -106.46 131.09 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.36 -0.837 . . . . 0.0 109.122 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.062 HD12 ' CE2' ' A' ' 11' ' ' TYR . 4.4 mt -115.15 144.29 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.159 -0.963 . . . . 0.0 109.666 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.79 HG21 HG22 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -134.3 161.66 34.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 109.37 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -90.91 3.66 53.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.525 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.42 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 20.2 t -122.93 125.55 45.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.546 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 65.8 t80 -75.1 -40.6 59.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.433 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -50.5 -56.76 10.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.472 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.648 HG22 HG21 ' A' ' 64' ' ' VAL . 8.8 p -58.75 -47.69 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.364 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.603 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -58.25 -57.21 13.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 0.0 109.204 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 85.3 tt0 -51.13 -30.81 17.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.615 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 37.1 m -60.32 -59.65 5.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.433 -0.792 . . . . 0.0 109.67 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -77.24 -0.83 26.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 109.794 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 9.8 m120 -83.56 -72.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 0.0 109.796 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 80.5 mttt -126.56 -27.86 3.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.787 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.5 mt-10 -66.0 -24.33 66.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.616 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -58.51 -58.66 17.44 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.563 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.5 Cg_endo -66.91 -35.1 27.76 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.596 2.197 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -64.59 -42.01 95.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.897 . . . . 0.0 109.116 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.4 m0 . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.312 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.9 mttm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.402 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 43.4 m80 60.4 37.64 19.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.198 -0.939 . . . . 0.0 109.482 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.434 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 82.1 mt -63.84 -44.81 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.321 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 t -60.01 -41.99 93.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -59.22 -40.61 86.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.71 ' CZ2' HD11 ' A' ' 61' ' ' ILE . 17.4 m95 -68.02 -37.96 82.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 31.2 mttt -57.41 -41.31 80.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.925 . . . . 0.0 109.371 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.47 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 19.9 m -61.62 -46.13 91.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.309 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.631 HG23 ' SG ' ' A' ' 68' ' ' CYS . 75.7 mt -71.21 -34.68 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.544 ' HB2' HD11 ' A' ' 95' ' ' LEU . . . -59.56 -42.35 92.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.394 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.03 -40.28 88.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 109.503 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 89.5 m -66.22 -49.21 68.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.425 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 128' ' ' PRO . 23.7 tp -63.82 -31.71 72.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.2 m -61.48 -31.7 71.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.499 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.446 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 92.6 mtp -68.56 -31.7 71.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HD3' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 170.47 147.78 0.14 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.44 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.442 ' HA ' ' CD1' ' A' ' 124' ' ' LEU . 50.5 Cg_endo -70.96 -0.95 8.71 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.688 2.259 . . . . 0.0 111.637 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 94.1 m-20 -43.05 -45.39 5.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.367 -0.833 . . . . 0.0 109.659 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 72' ' ' LEU . 46.4 mt -61.77 117.39 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.743 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.561 ' O ' HD13 ' A' ' 132' ' ' ILE . 97.4 m -109.81 144.9 37.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.186 -0.946 . . . . 0.0 109.069 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.561 HD13 ' O ' ' A' ' 131' ' ' THR . 32.5 mm -119.69 136.68 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 109.745 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.53 ' NE2' HD23 ' A' ' 79' ' ' LEU . 87.4 mt-30 -125.43 158.22 34.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.427 -0.795 . . . . 0.0 109.19 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.546 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 20.3 t-80 -117.26 133.25 56.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.641 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.549 ' HG2' ' CG2' ' A' ' 81' ' ' ILE . 71.2 mm-40 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.425 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 57.5 m -55.56 -47.46 76.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.372 -0.83 . . . . 0.0 109.452 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.19 -52.18 28.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.409 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.18 -39.52 58.3 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -55.15 -48.8 73.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -1.108 . . . . 0.0 109.37 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.74 37.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.309 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 152' ' ' LEU . 6.8 mp -58.84 -47.97 82.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.491 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -55.42 -42.56 74.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 109.418 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.4 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 63.7 m-20 -55.69 -44.09 77.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.876 . . . . 0.0 109.394 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -57.75 -42.14 83.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.928 . . . . 0.0 109.412 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.964 HD21 ' HB3' ' A' ' 46' ' ' GLN . 7.0 mp -64.98 -40.15 94.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' A' ' 15' ' ' SER . . . -67.78 -51.67 46.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.358 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 42.0 m -59.83 -41.41 91.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.534 ' O ' HG23 ' A' ' 163' ' ' VAL . 46.8 tt0 -63.68 -38.41 91.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -62.54 -50.38 64.95 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.0 p -64.94 -34.24 77.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -1.183 . . . . 0.0 109.434 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -64.03 -37.68 88.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.431 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 159' ' ' GLN . 73.0 t -52.93 -39.67 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.548 HG21 ' O ' ' A' ' 51' ' ' LEU . 42.5 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.502 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.978 ' HB3' HD21 ' A' ' 79' ' ' LEU . 33.9 p90 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.293 0.568 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.514 ' OE1' HG22 ' A' ' 74' ' ' ILE . 21.3 tt0 -79.78 -42.76 23.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.806 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -159.88 176.52 36.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.519 HG23 ' HE2' ' A' ' 37' ' ' TYR . 82.1 t -124.96 141.1 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -1.18 . . . . 0.0 109.515 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.828 ' CD1' HG21 ' A' ' 78' ' ' VAL . 5.7 m-85 -117.33 151.7 36.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.622 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.771 ' HE1' HD12 ' A' ' 81' ' ' ILE . 85.3 m-85 -123.87 135.97 54.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.533 HG22 HD12 ' A' ' 32' ' ' ILE . 19.1 p -121.7 150.1 42.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.596 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.513 ' HB2' ' HB1' ' A' ' 153' ' ' ALA . 22.9 t70 -140.12 148.27 41.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.482 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.41 134.25 5.42 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.552 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 83.1 p -143.21 161.01 39.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -1.177 . . . . 0.0 109.457 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.891 ' HB1' ' ND2' ' A' ' 26' ' ' ASN . . . -137.9 150.51 47.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.566 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' ASN . 47.7 mt . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.515 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.891 ' ND2' ' HB1' ' A' ' 16' ' ' ALA . 48.1 p-10 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.793 ' ND2' HG11 ' A' ' 164' ' ' VAL . 23.3 m120 -104.49 125.01 50.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.965 . . . . 0.0 109.393 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 15' ' ' SER . . . -132.16 158.51 41.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 109.768 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.32 165.2 26.77 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.644 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 69.7 mtm -126.28 156.54 40.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -1.168 . . . . 0.0 109.461 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -141.51 128.21 3.58 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.54 HG13 ' CD2' ' A' ' 66' ' ' PHE . 22.3 mm -113.16 134.41 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -1.132 . . . . 0.0 109.301 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.95 125.38 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.692 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.656 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 10.3 m170 -103.54 136.12 43.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.208 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.08 161.31 35.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.752 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.2 t -125.6 164.08 21.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 109.241 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.519 ' HE2' HG23 ' A' ' 9' ' ' VAL . 85.0 m-85 -107.91 13.95 25.79 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.104 -0.998 . . . . 0.0 109.534 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.583 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.27 -179.17 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.6 Cg_endo -65.42 -4.73 9.97 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.074 1.849 . . . . 0.0 111.849 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.436 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 71.8 mm-40 -134.1 106.09 7.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 108.785 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.507 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 66.9 t80 -57.81 123.89 17.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 109.534 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 84.4 mt-30 -159.62 152.25 21.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.85 . . . . 0.0 109.516 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.1 m -89.06 120.48 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.394 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 40.9 mt -58.28 -44.18 88.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.429 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 25.2 m-20 -168.76 157.4 8.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.433 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.592 ' HB3' HD21 ' A' ' 156' ' ' LEU . 92.4 mt-30 -116.2 149.6 38.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.444 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.474 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -132.16 137.96 47.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.625 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.9 p -123.61 144.8 49.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.286 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.461 HD12 ' HE3' ' A' ' 30' ' ' MET . 3.3 mt -146.52 94.55 4.76 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.198 -0.939 . . . . 0.0 109.648 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.764 ' HG3' HG21 ' A' ' 163' ' ' VAL . 51.0 Cg_endo -70.81 132.26 21.3 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.654 2.236 . . . . 0.0 111.67 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.722 HD12 ' CB ' ' A' ' 59' ' ' ALA . 43.8 mt -115.0 142.89 46.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.566 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.03 -42.86 0.21 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -90.97 8.85 33.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -1.114 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 77.3 m80 -107.05 150.25 26.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.915 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.506 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.1 OUTLIER -91.65 170.04 10.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.884 . . . . 0.0 109.24 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.37 -30.09 17.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.319 -0.863 . . . . 0.0 109.123 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -79.5 -57.36 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.357 -0.84 . . . . 0.0 109.315 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.506 ' SD ' HG23 ' A' ' 55' ' ' THR . 93.4 mtp -47.78 -34.47 8.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 109.364 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.722 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -78.72 -33.94 46.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.442 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.787 ' HG2' HG21 ' A' ' 87' ' ' VAL . 82.1 tt0 -64.45 -40.11 95.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.603 HG21 ' HD3' ' A' ' 116' ' ' LYS . 19.5 tt -77.34 -29.59 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.374 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.644 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -68.77 -29.49 67.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.478 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.82 94.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.491 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.766 HG21 HG12 ' A' ' 87' ' ' VAL . 87.0 t -75.86 -48.29 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 98.1 mt-10 -51.87 -41.57 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.55 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 14.1 t80 -56.82 -67.86 0.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.647 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -63.67 -13.98 47.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.606 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.969 ' SG ' HG23 ' A' ' 120' ' ' ILE . 38.0 t -66.82 -66.04 0.6 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.521 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 73.9 tttt -60.01 -42.61 94.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.634 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 56.7 mttp -64.94 -35.62 81.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -58.3 -60.44 3.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.889 ' HB2' HD11 ' A' ' 130' ' ' ILE . 21.0 tp -56.71 -44.12 81.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 109.388 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 72' ' ' LEU . 55.6 tttp -43.59 -42.13 4.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.155 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 19.6 mm -48.39 142.76 7.95 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.86 . . . . 0.0 108.961 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.9 Cg_endo -65.49 -4.58 9.79 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.548 2.165 . . . . 0.0 111.937 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.02 167.28 25.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.474 ' HG2' ' HA ' ' A' ' 6' ' ' TYR . 45.2 Cg_endo -67.88 116.4 4.27 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.565 2.176 . . . . 0.0 111.699 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.828 HG21 ' CD1' ' A' ' 10' ' ' PHE . 7.2 p -111.31 149.82 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.333 -0.854 . . . . 0.0 109.578 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.978 HD21 ' HB3' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -104.51 137.41 42.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 109.59 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 43.7 t -110.27 130.46 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.145 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.771 HD12 ' HE1' ' A' ' 11' ' ' TYR . 15.8 mt -114.61 132.08 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.649 HG21 HG22 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -124.85 161.99 25.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 56.4 p30 -87.14 13.08 10.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.499 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 67.2 m -123.26 125.28 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.485 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.572 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 70.4 t80 -78.38 -41.89 31.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -58.54 -52.71 64.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.787 HG21 ' HG2' ' A' ' 60' ' ' GLU . 48.4 t -59.23 -51.8 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.68 -52.97 27.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.288 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 83.5 tt0 -60.08 -33.75 72.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.17 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.666 ' O ' HD23 ' A' ' 95' ' ' LEU . 34.1 m -52.72 -47.22 67.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.327 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.784 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -94.25 -0.75 54.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.612 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 50.1 t30 -86.93 -71.99 0.53 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.957 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 24.7 mttm -116.64 -35.53 4.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 109.831 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 91.4 mt-10 -59.84 -38.8 83.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.624 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -53.16 -60.18 7.4 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 47.4 Cg_endo -68.15 -32.37 27.49 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.71 2.273 . . . . 0.0 111.596 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -72.54 -40.6 66.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.28 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.434 ' CZ2' ' OE1' ' A' ' 94' ' ' GLU . 24.9 m0 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.358 -0.839 . . . . 0.0 109.371 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HD3' ' CE1' ' A' ' 113' ' ' HIS . 85.1 tttt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.571 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 33.8 m80 65.98 33.07 8.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.505 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.4 mt -62.33 -47.05 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.253 -0.904 . . . . 0.0 109.406 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.8 m -59.38 -43.57 92.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.603 ' HD3' HG21 ' A' ' 61' ' ' ILE . 35.7 mttp -58.49 -46.9 85.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.285 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.629 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 65.6 m95 -70.16 -30.08 67.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.406 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -60.25 -41.6 93.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.495 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -58.22 -40.7 82.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.969 HG23 ' SG ' ' A' ' 68' ' ' CYS . 77.8 mt -72.95 -32.84 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -64.91 -37.16 86.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -60.41 -34.27 73.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.476 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 6.8 m -79.21 -50.21 11.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.713 HD23 HD12 ' A' ' 130' ' ' ILE . 57.6 mt -61.04 -34.86 75.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.476 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.8 t -59.27 -34.13 71.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.435 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.685 ' CE ' HD23 ' A' ' 72' ' ' LEU . 71.7 mtm -67.76 -34.53 77.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.423 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -173.99 128.51 0.47 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.475 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.5 Cg_endo -69.74 -1.8 9.07 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.68 2.253 . . . . 0.0 111.638 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 90.9 m-20 -43.83 -43.13 6.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.316 -0.865 . . . . 0.0 109.458 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.889 HD11 ' HB2' ' A' ' 72' ' ' LEU . 40.3 mt -53.99 118.55 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.335 -0.853 . . . . 0.0 109.671 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.654 ' HB ' HD22 ' A' ' 79' ' ' LEU . 9.0 m -119.28 129.65 55.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 108.984 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.784 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 52.9 mt -110.47 144.4 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.06 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -132.58 154.32 50.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.343 -0.848 . . . . 0.0 109.163 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.572 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 15.8 t-80 -104.05 128.28 51.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.618 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 83' ' ' ASP . 85.1 tt0 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 109.295 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.428 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 70.0 p -64.12 -36.99 85.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.558 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -49.61 -45.81 48.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 109.552 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.07 -37.56 94.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -58.63 -41.5 86.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -1.142 . . . . 0.0 109.556 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.48 -51.7 66.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.55 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.463 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 52.5 mt -58.8 -45.7 89.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.527 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.513 ' HB1' ' HB2' ' A' ' 13' ' ' ASP . . . -56.88 -42.51 79.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.525 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.675 ' O ' HG23 ' A' ' 158' ' ' THR . 89.8 m-20 -59.23 -36.53 75.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -63.36 -42.26 98.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.628 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 156' ' ' LEU . 6.4 mp -74.17 -34.04 63.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.573 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.89 -40.86 97.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 154' ' ' ASP . 50.0 p -69.07 -39.52 79.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.532 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -62.32 -33.56 74.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -64.51 -31.85 82.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.5 p -65.96 -34.67 78.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -1.16 . . . . 0.0 109.535 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -68.23 -26.99 65.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.764 HG21 ' HG3' ' A' ' 50' ' ' PRO . 60.1 t -54.87 -40.4 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.88 . . . . 0.0 109.452 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.793 HG11 ' ND2' ' A' ' 27' ' ' ASN . 90.4 t . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.432 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.572 ' CG ' HD13 ' A' ' 79' ' ' LEU . 34.3 m-85 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.283 0.563 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -77.06 -31.91 56.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 108.872 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.6 -166.84 35.95 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.805 HG22 ' HB2' ' A' ' 79' ' ' LEU . 72.7 t -136.33 143.01 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -1.162 . . . . 0.0 108.978 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.792 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.1 m-85 -114.16 146.41 40.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.971 . . . . 0.0 109.907 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.877 ' CE1' HD12 ' A' ' 81' ' ' ILE . 66.9 m-85 -118.41 118.35 31.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.264 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.473 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 9.8 p -106.45 155.64 19.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 59.1 t0 -149.58 145.64 26.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.565 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -146.9 118.95 1.08 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 66.8 m -132.0 150.89 52.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -1.158 . . . . 0.0 109.588 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HA ' ' CB ' ' A' ' 28' ' ' ALA . . . -114.78 135.19 54.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.737 HD12 ' HB3' ' A' ' 161' ' ' SER . 58.3 mt . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.31 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -98.74 97.56 8.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.328 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 16' ' ' ALA . . . -110.85 155.91 21.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.7 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.44 154.71 25.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.819 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 33.2 mtm -115.39 156.76 24.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -1.113 . . . . 0.0 109.417 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.89 124.23 1.73 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.528 HD12 ' N ' ' A' ' 32' ' ' ILE . 5.4 mp -116.94 134.58 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -1.095 . . . . 0.0 109.102 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.0 t -127.09 131.39 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.77 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.69 ' NE2' HD22 ' A' ' 44' ' ' LEU . 3.5 t60 -102.15 131.0 48.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.196 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.34 159.37 37.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.759 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.702 ' HB ' HD11 ' A' ' 44' ' ' LEU . 7.7 t -117.46 161.45 19.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.863 . . . . 0.0 109.126 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.607 ' HE2' HG23 ' A' ' 9' ' ' VAL . 91.9 m-85 -104.66 8.75 35.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.134 -0.979 . . . . 0.0 109.634 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.576 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.8 -178.94 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.322 -0.861 . . . . 0.0 108.766 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.2 Cg_endo -66.5 -3.13 8.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.122 1.881 . . . . 0.0 111.945 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -132.36 105.78 7.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 108.706 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.5 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 63.3 t80 -66.57 125.5 25.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 109.329 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.5 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 73.0 mt-30 -160.62 152.72 20.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 0.0 109.391 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 43' ' ' VAL . 13.5 p -82.85 124.33 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.434 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.702 HD11 ' HB ' ' A' ' 36' ' ' THR . 6.4 mp -74.06 -42.33 60.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 80.5 m-20 -159.05 149.46 19.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.559 ' HB3' HD21 ' A' ' 156' ' ' LEU . 91.8 mt-30 -117.09 148.01 41.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -0.949 . . . . 0.0 109.398 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.489 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -130.92 131.38 44.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.188 -0.945 . . . . 0.0 109.587 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.646 ' C ' HD12 ' A' ' 49' ' ' ILE . 78.2 p -123.79 141.95 51.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.646 HD12 ' C ' ' A' ' 48' ' ' SER . 3.7 mp -149.52 95.67 3.73 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 49' ' ' ILE . 48.3 Cg_endo -69.27 128.16 16.06 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.683 2.256 . . . . 0.0 111.759 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 44.4 mt -111.74 142.9 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 0.0 109.534 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.12 -42.88 0.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -91.96 9.32 33.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 109.522 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 79.4 m80 -110.47 147.31 34.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 0.0 109.467 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.547 HG22 ' HG3' ' A' ' 58' ' ' MET . 9.5 t -90.89 -178.54 5.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -57.29 -46.6 82.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 60' ' ' GLU . 87.8 mt-30 -63.11 -61.12 2.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.359 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.547 ' HG3' HG22 ' A' ' 55' ' ' THR . 94.2 mtp -44.01 -32.91 1.27 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.19 -30.36 58.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 0.0 109.526 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.675 ' HB3' HG21 ' A' ' 87' ' ' VAL . 95.4 mt-10 -70.34 -38.93 74.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.662 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 18.0 tt -72.49 -34.57 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.819 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -70.21 -32.5 70.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.409 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.473 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -65.03 -40.15 94.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.905 HG21 HG12 ' A' ' 87' ' ' VAL . 70.2 t -72.32 -39.7 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 109.49 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.23 -39.74 86.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.192 -0.942 . . . . 0.0 109.019 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.483 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 30.8 t80 -57.7 -63.59 1.19 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.369 -0.832 . . . . 0.0 109.528 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 68' ' ' CYS . . . -64.12 -39.55 94.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.601 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.55 ' SG ' HG23 ' A' ' 120' ' ' ILE . 37.2 t -43.06 -62.43 1.04 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.444 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 67.6 mttm -59.27 -46.09 89.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -0.929 . . . . 0.0 109.426 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 66' ' ' PHE . 30.9 mmtt -56.15 -38.18 70.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.389 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.896 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -59.94 -64.95 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.81 ' HB2' HD11 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -48.56 -47.12 39.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 109.461 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 72' ' ' LEU . 49.9 mttm -43.25 -42.46 4.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.33 -0.857 . . . . 0.0 109.097 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.556 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 30.1 mm -49.39 143.65 9.68 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.397 -0.814 . . . . 0.0 109.001 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.1 Cg_endo -65.11 -4.35 8.89 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.51 2.14 . . . . 0.0 111.895 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -143.61 172.31 24.97 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.1 Cg_endo -69.02 120.63 7.51 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 122.408 2.072 . . . . 0.0 111.677 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.896 HG11 ' HA ' ' A' ' 71' ' ' ALA . 7.2 p -114.89 153.76 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 109.141 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.805 ' HB2' HG22 ' A' ' 9' ' ' VAL . 6.6 mp -97.1 139.98 32.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.025 -1.047 . . . . 0.0 109.931 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 58.1 t -118.0 121.98 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.418 -0.801 . . . . 0.0 109.004 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.877 HD12 ' CE1' ' A' ' 11' ' ' TYR . 3.7 mt -107.29 142.44 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.117 -0.99 . . . . 0.0 109.62 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.714 HG21 HG22 ' A' ' 64' ' ' VAL . 0.7 OUTLIER -128.18 161.7 28.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.415 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -87.74 7.11 31.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 109.507 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -123.95 129.42 50.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.526 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.454 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 68.0 t80 -77.8 -39.3 44.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -63.35 -48.15 79.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.905 HG12 HG21 ' A' ' 64' ' ' VAL . 59.5 t -58.96 -53.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 0.0 109.369 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.51 ' HB1' HG22 ' A' ' 132' ' ' ILE . . . -48.35 -55.0 11.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.933 . . . . 0.0 109.314 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 77.1 mm-40 -56.35 -35.1 67.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 117' ' ' TRP . 38.6 m -53.39 -46.63 69.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.742 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -92.5 -0.88 57.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.87 . . . . 0.0 109.674 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 45.6 t-20 -89.03 -72.86 0.53 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.067 -1.021 . . . . 0.0 109.761 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 23.2 mttm -126.86 -29.55 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.904 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 88.4 mt-10 -59.58 -28.34 67.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -58.77 -60.88 8.99 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.124 -0.985 . . . . 0.0 109.552 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.1 Cg_endo -66.41 -31.44 42.68 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.724 2.283 . . . . 0.0 111.411 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -68.89 -38.46 79.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.236 -0.915 . . . . 0.0 108.883 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 35.3 m0 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.19 179.653 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HE3' ' NE2' ' A' ' 113' ' ' HIS . 33.8 tttp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.278 0.561 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.5 ' NE2' ' HE3' ' A' ' 112' ' ' LYS . 70.6 m-70 65.25 36.79 6.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.653 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 86.1 mt -53.93 -43.89 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.242 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.9 m -49.68 -45.89 49.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.267 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HD2' ' HB3' ' A' ' 113' ' ' HIS . 64.1 mttm -58.6 -48.09 82.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.307 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.662 ' CZ2' HD12 ' A' ' 61' ' ' ILE . 60.9 m95 -65.65 -38.14 88.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.839 . . . . 0.0 109.385 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -56.87 -46.64 81.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.479 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.4 p -57.67 -39.54 77.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 109.423 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.55 HG23 ' SG ' ' A' ' 68' ' ' CYS . 73.9 mt -66.75 -37.24 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.861 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.445 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -65.32 -32.66 74.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 126' ' ' MET . 83.9 tt0 -54.18 -38.15 65.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.329 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.87 -49.25 11.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.419 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 124' ' ' LEU . 22.7 tp -63.08 -31.86 73.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.8 m -66.12 -33.24 75.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.475 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 65.1 mtt -65.99 -34.5 78.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.47 140.82 0.52 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.501 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.0 Cg_endo -70.51 -0.8 8.08 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.655 2.236 . . . . 0.0 111.717 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 128' ' ' PRO . 84.8 m-20 -43.8 -47.98 8.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.81 HD11 ' HB2' ' A' ' 72' ' ' LEU . 58.5 mt -58.45 114.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.472 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 91.0 m -104.81 147.05 28.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.277 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.742 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 54.3 mt -122.82 142.68 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.615 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.422 ' NE2' HD23 ' A' ' 79' ' ' LEU . 89.8 mt-30 -135.71 164.96 26.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.268 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 18.0 t-80 -113.57 138.55 50.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.558 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.62 ' HG3' HG22 ' A' ' 81' ' ' ILE . 96.9 mt-10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.463 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.208 0.528 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.2 m -63.23 -40.85 98.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.548 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.25 -36.9 76.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.593 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -67.25 -30.27 75.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -72.45 -33.26 66.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -1.169 . . . . 0.0 109.524 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.12 -51.51 37.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.543 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 56.3 mt -59.19 -47.27 85.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -56.84 -38.75 73.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 109.564 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.27 -32.26 73.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.647 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 159' ' ' GLN . 24.7 mttm -67.84 -41.88 82.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.63 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.61 ' N ' HD12 ' A' ' 156' ' ' LEU . 6.3 mp -73.14 -31.59 64.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.94 . . . . 0.0 109.585 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.61 -62.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.589 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 35.5 m -59.25 -43.3 92.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' A' ' 155' ' ' LYS . 63.1 tp60 -61.32 -33.61 73.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.629 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -68.52 -31.16 73.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.737 ' HB3' HD12 ' A' ' 17' ' ' ILE . 19.0 m -66.71 -29.33 69.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -1.142 . . . . 0.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -75.37 -21.52 58.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.76 -43.95 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 161' ' ' SER . 4.6 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.526 ' CG ' HD13 ' A' ' 79' ' ' LEU . 99.7 m-85 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.27 0.557 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 31.7 tp10 -64.2 -37.89 89.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.362 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.569 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.48 -175.34 45.5 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 79' ' ' LEU . 72.2 t -134.47 142.86 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -1.121 . . . . 0.0 109.354 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.659 ' CD2' ' CD2' ' A' ' 34' ' ' HIS . 7.3 m-85 -123.06 140.36 53.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.634 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.875 ' CE2' HD12 ' A' ' 81' ' ' ILE . 42.9 m-85 -113.32 132.56 55.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.308 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.885 HG22 HD12 ' A' ' 32' ' ' ILE . 24.6 p -120.17 142.57 48.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.831 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.456 ' OD2' ' OD1' ' A' ' 154' ' ' ASP . 52.4 t0 -137.0 155.91 49.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.405 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -142.42 127.29 3.16 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 40.2 m -124.21 157.74 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -1.133 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.908 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -145.35 144.49 30.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 109.625 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.488 HD12 ' HB2' ' A' ' 161' ' ' SER . 47.7 mt . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 0.0 109.402 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 71.1 m-20 -92.14 113.37 25.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.943 . . . . 0.0 109.337 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 59' ' ' ALA . . . -112.14 145.68 39.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.775 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.62 165.46 23.3 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.556 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 67.9 mtm -133.46 150.94 51.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -1.184 . . . . 0.0 109.684 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.46 120.24 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.885 HD12 HG22 ' A' ' 12' ' ' THR . 23.4 mm -110.36 140.62 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -1.159 . . . . 0.0 109.547 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' A' ' 153' ' ' ALA . 42.4 t -124.82 130.41 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.353 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.659 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 25.4 m170 -105.67 138.2 42.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 109.655 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.7 168.62 18.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.467 ' HB ' HD21 ' A' ' 44' ' ' LEU . 12.2 t -138.16 165.13 27.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.175 -0.953 . . . . 0.0 109.713 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 38' ' ' LYS . 68.8 m-85 -106.63 10.21 31.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.584 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.09 -179.96 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.039 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.584 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.6 Cg_endo -66.39 -4.57 10.93 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.159 1.906 . . . . 0.0 111.64 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -132.12 105.92 7.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.35 -0.844 . . . . 0.0 108.811 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.463 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 58.6 t80 -63.53 117.72 7.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 109.408 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 41' ' ' TYR . 85.7 mt-30 -157.98 144.79 17.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.684 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.3 m -72.78 124.73 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 68.3 mt -59.72 -39.14 83.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.94 . . . . 0.0 109.483 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 20.3 t-20 -179.57 157.02 0.74 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -108.39 139.33 43.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.873 . . . . 0.0 109.515 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.403 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 0.5 OUTLIER -118.86 139.93 50.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.264 -0.897 . . . . 0.0 109.483 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 t -130.81 125.45 33.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.449 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 2.2 mp -130.82 95.74 25.04 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.77 ' HG3' HG21 ' A' ' 163' ' ' VAL . 50.1 Cg_endo -69.93 134.98 28.92 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.785 2.323 . . . . 0.0 111.813 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.447 HD12 ' CB ' ' A' ' 59' ' ' ALA . 38.8 mt -113.21 152.01 30.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.57 -48.37 0.13 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -89.16 7.49 34.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -1.177 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 74.4 m80 -111.18 142.08 43.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 58' ' ' MET . 9.6 t -87.43 -176.27 5.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.908 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -60.45 -44.7 95.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -62.06 -48.58 79.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.593 ' O ' HG22 ' A' ' 61' ' ' ILE . 96.3 mtp -61.63 -30.12 70.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.497 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HB2' ' HB1' ' A' ' 28' ' ' ALA . . . -71.02 -28.74 64.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.769 ' HB3' HG21 ' A' ' 87' ' ' VAL . 98.1 mt-10 -73.69 -45.2 53.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 58' ' ' MET . 16.1 tt -63.12 -32.03 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.875 . . . . 0.0 109.465 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.556 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -74.2 -34.52 63.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.329 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -56.24 -42.82 77.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.534 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.651 HG21 HG12 ' A' ' 87' ' ' VAL . 32.7 t -71.32 -45.5 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.51 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.524 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 97.8 mt-10 -55.76 -35.57 66.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.907 . . . . 0.0 109.56 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.524 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 8.8 t80 -62.11 -69.04 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.607 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 -13.95 51.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.492 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 41.4 t -66.08 -60.41 2.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.179 -0.951 . . . . 0.0 109.432 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -65.13 -40.12 93.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.463 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HE3' ' CE2' ' A' ' 66' ' ' PHE . 63.2 mttm -64.26 -34.96 79.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.416 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.414 ' O ' HG12 ' A' ' 74' ' ' ILE . . . -63.71 -65.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.468 HD21 ' SD ' ' A' ' 126' ' ' MET . 24.9 tp -51.23 -44.33 61.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.953 . . . . 0.0 109.589 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' LEU . 83.5 tttt -43.55 -47.35 7.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.284 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.56 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 9.5 mm -48.51 142.72 8.24 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.14 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.2 Cg_endo -65.88 -5.02 11.09 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.49 2.127 . . . . 0.0 111.556 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.74 168.22 23.67 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 47.7 Cg_endo -68.85 137.35 37.96 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.583 2.188 . . . . 0.0 111.585 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 8' ' ' GLY . 21.7 t -123.82 159.1 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.46 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.582 ' HB2' HG22 ' A' ' 9' ' ' VAL . 6.5 mp -105.92 123.8 48.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.863 . . . . 0.0 109.59 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 40.2 t -103.6 121.62 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.453 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.875 HD12 ' CE2' ' A' ' 11' ' ' TYR . 13.8 mt -106.85 139.05 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.311 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.86 161.74 29.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.406 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 135' ' ' GLU . 68.1 m-20 -93.43 -2.5 54.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.458 ' HB3' HG23 ' A' ' 87' ' ' VAL . 71.1 m -108.5 120.75 43.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.575 ' HA ' ' CD2' ' A' ' 134' ' ' HIS . 61.2 t80 -71.31 -28.64 64.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.345 -0.847 . . . . 0.0 109.541 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -78.98 -46.33 18.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.316 -0.865 . . . . 0.0 109.745 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.769 HG21 ' HB3' ' A' ' 60' ' ' GLU . 30.9 t -57.68 -60.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 109.437 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.995 ' HB1' ' CG2' ' A' ' 132' ' ' ILE . . . -53.19 -51.75 61.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 0.0 109.408 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -52.31 -38.27 58.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.52 ' HB3' ' CH2' ' A' ' 117' ' ' TRP . 19.2 t -56.91 -48.2 78.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.92 -0.91 45.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 109.765 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -92.68 -73.77 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.003 -1.06 . . . . 0.0 110.072 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 32.5 mmtp -127.52 -27.13 2.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.0 . . . . 0.0 110.239 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 53.8 mt-10 -62.75 -20.54 65.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 110.176 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.937 HD21 ' HB2' ' A' ' 121' ' ' ALA . 25.4 tp -64.86 -58.33 13.32 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.965 -1.084 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.2 Cg_endo -66.14 -36.12 30.45 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.545 2.163 . . . . 0.0 111.442 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -65.79 -34.61 78.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 108.935 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 23.1 m0 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.4 -0.812 . . . . 0.0 109.123 179.65 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.9 mttt . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 61.71 34.83 17.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.057 -1.027 . . . . 0.0 109.149 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.6 mm -48.86 -41.64 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 109.08 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.8 t -47.39 -44.01 23.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 108.784 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 40.3 mttm -63.38 -46.08 88.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 108.952 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.52 ' CH2' ' HB3' ' A' ' 90' ' ' SER . 47.9 m95 -62.17 -42.39 99.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -0.867 . . . . 0.0 109.216 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -51.66 -48.15 63.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.255 -0.903 . . . . 0.0 109.34 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.2 m -49.54 -39.8 35.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.24 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.524 ' CG1' ' HG2' ' A' ' 65' ' ' GLU . 61.9 mt -73.27 -33.32 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.268 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.937 ' HB2' HD21 ' A' ' 95' ' ' LEU . . . -64.96 -36.82 85.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -54.25 -40.3 67.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.407 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.92 -50.61 12.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.41 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.49 -35.98 75.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.357 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.2 t -58.96 -35.14 72.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.476 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.468 ' SD ' HD21 ' A' ' 72' ' ' LEU . 65.9 mtt -65.35 -34.78 79.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 172.37 152.72 0.22 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 0.0 109.557 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.7 Cg_endo -71.76 3.2 3.97 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.813 2.342 . . . . 0.0 112.059 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 128' ' ' PRO . 81.2 m-20 -42.36 -30.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 109.581 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 72' ' ' LEU . 38.1 mt -82.76 111.64 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.514 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 79' ' ' LEU . 32.9 m -97.72 151.16 20.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.391 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.995 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 63.7 mt -125.27 129.07 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.634 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.425 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.2 mt-30 -119.17 157.31 28.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.38 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.961 ' NE2' ' HB3' ' A' ' 88' ' ' ALA . 27.3 m170 -112.03 133.57 54.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.665 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.441 ' CD ' ' ND2' ' A' ' 150' ' ' ASN . 49.7 tp10 . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.873 . . . . 0.0 109.289 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.2 m -51.95 -48.49 64.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.439 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -47.59 -51.37 21.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -52.39 -40.4 53.68 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.441 ' ND2' ' CD ' ' A' ' 135' ' ' GLU . 87.9 m-20 -64.96 -39.26 93.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -1.141 . . . . 0.0 109.465 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.79 -48.54 72.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.819 ' O ' HD12 ' A' ' 156' ' ' LEU . 6.6 mp -64.17 -41.13 97.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.441 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.733 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -64.9 -36.97 86.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.456 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 76.4 m-20 -61.18 -42.74 99.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -60.8 -45.45 94.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.527 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.819 HD12 ' O ' ' A' ' 152' ' ' LEU . 1.0 OUTLIER -63.89 -38.19 90.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.23 93.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 109.465 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.663 HG22 ' HE1' ' A' ' 162' ' ' TYR . 56.2 m -64.7 -41.65 95.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.5 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.49 -33.14 72.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.89 . . . . 0.0 109.624 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.23 96.38 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.488 ' HB2' HD12 ' A' ' 17' ' ' ILE . 95.6 p -56.73 -28.68 61.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -1.171 . . . . 0.0 109.631 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.663 ' HE1' HG22 ' A' ' 158' ' ' THR . 87.9 m-85 -72.72 -25.11 61.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 109.524 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.77 HG21 ' HG3' ' A' ' 50' ' ' PRO . 77.1 t -64.17 -42.55 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.899 . . . . 0.0 109.411 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 161' ' ' SER . 41.0 t . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.413 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' PRO . 7.9 p90 . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.493 ' OE2' ' CD ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -88.5 -31.41 18.74 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -177.24 -177.08 45.87 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 79' ' ' LEU . 59.4 t -124.8 142.63 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -1.133 . . . . 0.0 109.25 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.813 ' CE1' HG21 ' A' ' 78' ' ' VAL . 5.4 m-85 -114.3 146.58 40.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.861 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.594 ' CE2' HG13 ' A' ' 81' ' ' ILE . 67.8 m-85 -119.64 129.1 54.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.394 -0.817 . . . . 0.0 109.104 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.804 HG22 HD12 ' A' ' 32' ' ' ILE . 16.0 p -118.02 147.46 43.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.64 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 58.8 t0 -144.34 150.65 38.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.548 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -134.96 120.99 2.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.7 m -133.13 150.68 52.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -1.137 . . . . 0.0 109.625 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -119.75 154.46 34.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.479 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 161' ' ' SER . 66.6 mt . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.162 -0.961 . . . . 0.0 109.629 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 7.8 m120 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' ILE . 23.7 m120 -99.53 113.7 26.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.413 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . . . -93.17 150.35 20.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.9 143.03 9.81 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 63.4 mtm -115.39 162.86 16.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -1.152 . . . . 0.0 109.359 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' A' ' 156' ' ' LEU . . . -151.27 130.22 3.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.804 HD12 HG22 ' A' ' 12' ' ' THR . 23.4 mm -114.76 140.65 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -1.116 . . . . 0.0 109.382 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 11' ' ' TYR . 40.6 t -127.88 130.2 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.676 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 19.6 m170 -105.67 137.57 43.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.144 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.1 168.63 19.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.709 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -137.01 164.32 28.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.379 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 38' ' ' LYS . 59.4 m-85 -102.48 14.78 31.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.494 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.578 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -51.17 179.8 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 108.942 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.3 Cg_endo -66.1 -6.21 14.05 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.137 1.891 . . . . 0.0 111.447 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.469 ' CD ' ' NE2' ' A' ' 42' ' ' GLN . 79.7 tt0 -135.16 106.55 6.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.427 -0.795 . . . . 0.0 109.066 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -58.38 122.96 14.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.258 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.469 ' NE2' ' CD ' ' A' ' 40' ' ' GLU . 45.1 mt-30 -154.14 148.17 25.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.683 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 43' ' ' VAL . 8.6 p -82.96 123.78 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 54.4 mt -64.27 -34.18 77.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 21.7 t-20 178.69 155.3 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.512 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.405 ' HB3' HD21 ' A' ' 156' ' ' LEU . 94.2 mt-30 -109.32 142.39 40.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.322 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.485 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -126.52 136.4 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.591 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.1 t -127.29 132.49 50.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.361 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.921 HD11 ' CE2' ' A' ' 66' ' ' PHE . 3.3 mt -132.77 91.73 28.72 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.74 136.22 29.89 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.713 2.275 . . . . 0.0 111.728 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.57 ' CD1' ' HB2' ' A' ' 59' ' ' ALA . 44.0 mt -101.48 143.98 30.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.41 -68.41 1.13 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -109.87 64.09 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.19 . . . . 0.0 109.537 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 81.0 m80 -132.1 171.95 12.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.521 HG22 ' HG3' ' A' ' 58' ' ' MET . 11.7 t -121.0 174.22 6.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.83 -45.26 78.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' GLU . 90.1 mt-30 -60.35 -64.03 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.447 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.521 ' HG3' HG22 ' A' ' 55' ' ' THR . 97.1 mtp -44.35 -35.3 2.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 109.371 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.57 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . . . -80.39 -25.9 38.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 57' ' ' GLN . 78.0 tt0 -64.48 -40.56 95.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.404 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.651 HD11 ' CZ2' ' A' ' 117' ' ' TRP . 12.1 tt -84.1 -29.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.474 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -67.73 -25.84 65.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.465 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.38 81.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.512 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.574 HG22 HG21 ' A' ' 82' ' ' THR . 96.7 t -79.29 -38.97 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.569 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -66.8 -39.37 87.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.078 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.921 ' CE2' HD11 ' A' ' 49' ' ' ILE . 27.6 t80 -59.72 -64.54 0.91 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.447 -0.783 . . . . 0.0 109.608 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.94 -32.2 70.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.839 . . . . 0.0 109.751 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 1.051 ' SG ' HG23 ' A' ' 120' ' ' ILE . 50.8 t -54.82 -54.18 45.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -62.87 -45.67 91.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.581 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 62.9 mttm -63.38 -38.0 89.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 109.669 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.641 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -56.75 -63.05 1.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.57 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.941 ' HB2' HD11 ' A' ' 130' ' ' ILE . 25.2 tp -53.48 -45.74 69.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.489 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 72' ' ' LEU . 20.8 tttp -43.06 -43.21 4.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.371 -0.831 . . . . 0.0 109.23 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 8.0 mt -48.25 142.44 7.92 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 108.877 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.8 Cg_endo -66.11 -4.3 10.06 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.447 2.098 . . . . 0.0 111.696 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.409 ' HA3' ' CD ' ' A' ' 7' ' ' GLU . . . -140.77 166.96 25.76 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.493 ' CD ' ' OE2' ' A' ' 7' ' ' GLU . 46.7 Cg_endo -67.64 127.17 15.88 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.418 2.079 . . . . 0.0 111.591 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.813 HG21 ' CE1' ' A' ' 10' ' ' PHE . 7.3 p -123.47 151.41 28.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.165 -0.959 . . . . 0.0 109.495 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.66 ' HB2' HG22 ' A' ' 9' ' ' VAL . 15.5 mt -93.15 146.78 23.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.457 ' O ' HD13 ' A' ' 81' ' ' ILE . 65.1 t -118.09 135.84 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 109.396 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.594 HG13 ' CE2' ' A' ' 11' ' ' TYR . 26.1 mm -114.75 132.67 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.574 HG21 HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -129.77 161.62 30.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.953 . . . . 0.0 109.481 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 58.7 p30 -94.57 11.38 31.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.363 -0.835 . . . . 0.0 109.435 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.45 ' CB ' HG12 ' A' ' 87' ' ' VAL . 8.3 t -131.92 119.21 20.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.498 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.528 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 68.9 t80 -75.96 -34.3 59.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.339 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -57.95 -53.62 56.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 88' ' ' ALA . 13.7 p -61.06 -46.67 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.338 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.61 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -53.5 -51.72 61.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.204 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 84.4 tt0 -55.93 -36.5 67.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.623 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 67.8 m -54.87 -49.51 71.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.451 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.544 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -85.95 -1.0 56.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.719 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.459 ' OD1' ' HB ' ' A' ' 132' ' ' ILE . 81.3 m-20 -87.1 -73.32 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.072 -1.017 . . . . 0.0 109.722 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 67.6 mttm -127.08 -30.76 2.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -0.87 . . . . 0.0 109.835 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 69.4 mt-10 -58.09 -28.21 64.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.727 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -59.64 -61.23 8.29 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.0 109.458 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -66.3 -30.87 44.77 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.691 2.261 . . . . 0.0 111.572 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -67.55 -39.51 84.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.013 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.487 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 27.9 m0 . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.173 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 12.8 mmtp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 49.0 m80 65.61 34.56 7.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.517 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.424 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 35.8 mm -68.09 -42.73 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.444 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 23.2 m -55.96 -40.76 73.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 109.346 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -65.37 -39.21 92.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.651 ' CZ2' HD11 ' A' ' 61' ' ' ILE . 22.6 m95 -71.64 -39.15 70.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.317 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 115' ' ' SER . 55.3 mtmt -57.38 -42.16 81.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 109.383 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.3 m -58.41 -42.42 87.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 1.051 HG23 ' SG ' ' A' ' 68' ' ' CYS . 83.4 mt -76.36 -34.06 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.473 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -63.62 -40.05 95.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.941 . . . . 0.0 109.432 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -57.46 -42.53 82.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.4 m -67.53 -49.68 62.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.583 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 56.0 mt -62.71 -30.56 71.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.913 . . . . 0.0 109.571 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.0 m -56.04 -36.37 67.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.498 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.745 ' SD ' HD21 ' A' ' 72' ' ' LEU . 65.3 mtt -64.15 -34.85 79.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.985 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 126' ' ' MET . 1.3 mttp 170.76 156.53 0.21 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.626 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 129' ' ' ASP . 53.4 Cg_endo -71.82 2.65 4.51 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.823 2.349 . . . . 0.0 111.897 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 128' ' ' PRO . 91.3 m-20 -41.73 -43.97 3.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.875 . . . . 0.0 109.685 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.941 HD11 ' HB2' ' A' ' 72' ' ' LEU . 50.3 mt -68.35 115.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.51 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.598 ' HB ' HD22 ' A' ' 79' ' ' LEU . 24.5 m -107.52 142.95 36.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 0.0 109.095 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.544 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 61.8 mt -124.96 137.99 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 109.781 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.501 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 94.8 mt-30 -133.03 161.19 35.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.354 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.528 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 20.0 t-80 -105.07 135.68 45.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 109.412 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 81' ' ' ILE . 99.4 mt-10 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 62.9 m80 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.326 0.584 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 51.9 m -56.86 -49.17 76.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 109.444 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.03 -48.3 64.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.433 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.6 -37.35 82.52 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -60.08 -40.06 88.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -1.119 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.06 -52.84 62.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.489 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.9 mt -57.31 -48.64 78.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.491 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.464 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -54.43 -40.44 68.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.453 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 88.8 m-20 -59.25 -40.29 85.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -60.58 -42.64 97.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 156' ' ' LEU . 6.6 mp -66.28 -39.86 89.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.527 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.72 -53.2 58.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.0 m -59.12 -42.83 91.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.572 ' O ' HG23 ' A' ' 163' ' ' VAL . 49.1 tt0 -63.11 -40.05 96.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.73 -51.29 58.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.547 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 30.3 m -61.92 -33.39 74.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -1.133 . . . . 0.0 109.465 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -62.99 -35.86 81.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.892 . . . . 0.0 109.46 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 159' ' ' GLN . 40.4 t -64.96 -16.76 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 51' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 1.032 ' CD2' HD11 ' A' ' 79' ' ' LEU . 64.8 m-85 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.516 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 76.6 mm-40 -63.0 -38.66 92.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.171 -0.956 . . . . 0.0 108.942 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.48 -170.71 41.64 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.98 HG21 ' OH ' ' A' ' 37' ' ' TYR . 73.8 t -133.26 139.1 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -1.082 . . . . 0.0 109.007 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.635 ' CD2' ' ND1' ' A' ' 34' ' ' HIS . 5.1 m-85 -113.8 138.6 50.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.905 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.873 ' CE1' HD12 ' A' ' 81' ' ' ILE . 75.2 m-85 -114.05 117.2 30.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.146 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 1.113 HG22 HG23 ' A' ' 32' ' ' ILE . 10.4 p -114.55 157.16 23.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.786 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 49.9 t0 -155.77 156.01 34.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.279 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.495 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -131.25 141.96 13.29 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.9 t -141.62 138.6 32.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.965 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -118.97 143.62 46.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.521 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 63.9 mt . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.378 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.801 ' HB3' HG23 ' A' ' 164' ' ' VAL . 21.8 m120 -91.68 114.97 27.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.485 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . . . -99.26 143.08 29.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.93 151.44 20.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.833 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 72.4 mtm -128.68 160.45 32.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -1.145 . . . . 0.0 109.518 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -153.34 115.67 0.69 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.113 HG23 HG22 ' A' ' 12' ' ' THR . 4.3 mp -123.54 120.53 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -1.175 . . . . 0.0 109.431 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.601 HG22 HG13 ' A' ' 43' ' ' VAL . 11.6 p -120.82 148.0 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.635 ' ND1' ' CD2' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -109.24 145.52 35.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.03 173.11 11.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -133.22 157.03 46.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 109.664 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.98 ' OH ' HG21 ' A' ' 9' ' ' VAL . 16.7 m-30 -103.48 12.79 34.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.51 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.591 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -50.82 -179.62 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 108.941 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.591 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.5 Cg_endo -65.11 -7.43 15.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.038 1.825 . . . . 0.0 111.288 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -128.11 106.25 8.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.429 -0.795 . . . . 0.0 108.965 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -61.82 127.37 31.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.149 -0.97 . . . . 0.0 109.237 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -161.42 154.24 20.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.925 . . . . 0.0 109.562 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.601 HG13 HG22 ' A' ' 33' ' ' VAL . 41.9 t -91.05 122.54 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 109.24 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 45.5 mt -62.46 -40.21 95.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 109.346 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 33' ' ' VAL . 64.2 t30 178.45 154.49 0.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.878 . . . . 0.0 109.684 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.722 ' OE1' HD21 ' A' ' 156' ' ' LEU . 56.2 mt-30 -107.58 143.06 36.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.054 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.2 t-105 -118.52 131.85 56.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 109.599 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.2 m -121.88 145.34 48.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.579 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 9.9 mt -149.56 96.88 3.57 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.554 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.0 Cg_endo -70.02 128.4 15.74 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.684 2.256 . . . . 0.0 111.661 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.669 ' HB2' ' HB3' ' A' ' 28' ' ' ALA . 49.0 mt -114.36 148.67 37.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 109.49 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.65 -46.89 0.2 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -87.47 11.11 15.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 78.2 m80 -112.61 147.21 37.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.482 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.1 OUTLIER -89.58 168.47 12.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.9 . . . . 0.0 109.111 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.965 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -49.38 -38.76 29.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.1 -1.0 . . . . 0.0 109.056 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' MET . 89.2 mt-30 -70.09 -58.77 3.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.332 -0.855 . . . . 0.0 109.311 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.539 ' O ' HG22 ' A' ' 61' ' ' ILE . 93.3 mtp -45.43 -30.59 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.158 -0.964 . . . . 0.0 109.199 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.648 ' HB2' ' HB1' ' A' ' 28' ' ' ALA . . . -75.28 -37.35 60.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.416 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.452 ' HB3' ' OG ' ' A' ' 84' ' ' SER . 96.3 mt-10 -62.74 -44.9 95.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.358 -0.839 . . . . 0.0 109.562 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.63 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 8.2 tt -67.29 -35.09 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.833 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -65.89 -29.69 70.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.192 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.767 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -70.01 -44.79 68.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.44 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.779 HG21 HG13 ' A' ' 87' ' ' VAL . 68.6 t -63.13 -47.3 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.335 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' A' ' 120' ' ' ILE . 84.6 tt0 -64.83 -38.3 90.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 109.417 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 49' ' ' ILE . 16.3 t80 -53.66 -68.82 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.395 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -63.23 -15.94 58.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.369 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.69 ' SG ' HG23 ' A' ' 120' ' ' ILE . 39.8 t -70.79 -58.03 4.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.432 ' NZ ' ' OE2' ' A' ' 65' ' ' GLU . 25.5 mttt -59.76 -48.69 80.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.486 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 37.5 mttm -60.87 -38.48 85.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.227 -0.92 . . . . 0.0 109.505 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.794 ' HB1' ' CG1' ' A' ' 78' ' ' VAL . . . -55.74 -69.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.63 ' HB2' HD11 ' A' ' 130' ' ' ILE . 6.3 tp -44.89 -48.51 11.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 109.434 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 20.2 mttm -43.81 -44.36 6.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.281 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 9.7 mt -48.81 143.11 8.51 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.043 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.6 Cg_endo -66.29 -2.68 7.48 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.601 2.2 . . . . 0.0 111.921 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.516 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -141.64 166.4 26.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.3 Cg_endo -69.34 122.75 9.54 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 122.552 2.168 . . . . 0.0 111.714 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.794 ' CG1' ' HB1' ' A' ' 71' ' ' ALA . 2.8 p -112.77 156.44 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.032 HD11 ' CD2' ' A' ' 6' ' ' TYR . 19.3 mt -101.58 140.26 36.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.759 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 52.0 t -120.92 130.33 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.137 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.873 HD12 ' CE1' ' A' ' 11' ' ' TYR . 8.0 mt -118.71 136.23 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.742 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.8 t -140.97 143.26 34.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.237 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -66.69 -25.34 66.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.905 . . . . 0.0 109.57 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.58 ' CB ' ' CG1' ' A' ' 87' ' ' VAL . 3.6 m -64.69 110.93 2.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 109.286 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.659 ' CD2' ' CE1' ' A' ' 134' ' ' HIS . 49.2 t80 -78.05 -41.45 35.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.688 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -71.15 -35.98 71.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 0.0 109.908 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.779 HG13 HG21 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -67.36 -47.16 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.135 -0.978 . . . . 0.0 109.497 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.964 ' HB3' ' NE2' ' A' ' 134' ' ' HIS . . . -54.32 -51.4 64.8 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.229 -0.919 . . . . 0.0 108.964 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 72.6 tt0 -55.26 -33.39 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.332 -0.855 . . . . 0.0 108.967 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.637 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 16.6 m -57.3 -49.11 77.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.844 . . . . 0.0 109.352 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.798 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -85.71 -0.72 55.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.749 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.48 ' OD1' ' HB ' ' A' ' 132' ' ' ILE . 85.7 m-20 -88.48 -73.48 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 109.947 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 63.0 mttt -127.42 -30.07 2.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.017 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 37.5 mm-40 -57.04 -31.54 65.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.078 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.606 HD23 ' HB2' ' A' ' 121' ' ' ALA . 0.5 OUTLIER -58.32 -60.8 9.05 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 0.0 109.503 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -66.8 -26.33 45.12 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.642 2.228 . . . . 0.0 111.581 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -73.82 -36.83 65.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 108.977 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.1 m0 . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.35 -0.844 . . . . 0.0 109.239 179.663 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.532 ' HD3' ' CE1' ' A' ' 113' ' ' HIS . 80.8 tttt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.276 0.56 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.535 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 39.5 m80 65.31 28.55 11.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.569 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.88 -45.48 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.167 -0.958 . . . . 0.0 109.399 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -55.67 -46.08 77.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.53 -45.48 91.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.637 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 54.3 m95 -66.42 -36.55 83.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.439 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -56.4 -46.17 80.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.484 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.6 m -59.96 -44.11 94.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.407 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.69 HG23 ' SG ' ' A' ' 68' ' ' CYS . 87.8 mt -68.79 -39.58 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.606 ' HB2' HD23 ' A' ' 95' ' ' LEU . . . -62.87 -36.24 82.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.472 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -56.2 -37.92 70.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 6.0 m -79.43 -51.34 9.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.387 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 124' ' ' LEU . 19.4 tp -58.56 -34.59 71.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.417 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.0 m -60.47 -31.88 70.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.549 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.78 -33.38 75.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.447 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.45 145.95 0.29 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 109.511 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.6 Cg_endo -72.35 2.72 4.76 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.741 2.294 . . . . 0.0 111.774 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 128' ' ' PRO . 79.5 m-20 -42.87 -46.16 5.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.504 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.63 HD11 ' HB2' ' A' ' 72' ' ' LEU . 52.8 mt -61.92 121.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.342 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.627 ' HB ' HD22 ' A' ' 79' ' ' LEU . 24.4 m -110.85 146.77 35.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.372 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.798 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 54.1 mt -125.12 128.13 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.462 ' HB2' HG12 ' A' ' 81' ' ' ILE . 79.9 mt-30 -127.24 154.9 44.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.964 ' NE2' ' HB3' ' A' ' 88' ' ' ALA . 34.1 m170 -90.67 141.01 29.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.791 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HG2' ' OD1' ' A' ' 150' ' ' ASN . 98.3 mt-10 . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 109.286 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.622 ' CD2' HD11 ' A' ' 81' ' ' ILE . 71.9 m80 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.1 m -51.35 -45.92 62.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.315 -0.866 . . . . 0.0 109.563 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -52.22 -49.81 63.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 109.506 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.43 -36.1 75.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.45 ' OD1' ' HG2' ' A' ' 135' ' ' GLU . 77.1 m-20 -60.42 -41.13 93.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -1.15 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.24 -48.48 79.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.402 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 26.0 tp -65.28 -42.26 93.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.32 -40.73 98.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 0.0 109.509 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.457 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 56.2 t0 -58.26 -43.17 87.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 0.0 109.559 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 78.6 tttt -62.19 -38.13 87.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.51 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.722 HD21 ' OE1' ' A' ' 46' ' ' GLN . 78.8 mt -64.29 -38.2 90.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.568 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.22 83.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.923 . . . . 0.0 109.463 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 36.3 m -61.59 -41.46 97.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.472 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.78 ' O ' HG23 ' A' ' 163' ' ' VAL . 95.2 mt-30 -62.4 -35.96 80.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -62.54 -55.94 24.38 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.1 p -67.48 -28.69 68.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -1.146 . . . . 0.0 109.516 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -63.85 -36.14 82.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.551 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 159' ' ' GLN . 39.1 t -64.95 -11.79 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.514 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.801 HG23 ' HB3' ' A' ' 27' ' ' ASN . 22.3 m . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.455 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.672 ' CB ' HD13 ' A' ' 79' ' ' LEU . 24.0 p90 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.274 0.559 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.489 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -94.72 -33.86 12.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 108.924 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.587 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -165.74 175.42 41.4 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.819 HG22 ' HB2' ' A' ' 79' ' ' LEU . 91.8 t -124.95 138.02 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.196 -1.179 . . . . 0.0 109.357 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE2' ' CG ' ' A' ' 34' ' ' HIS . 5.3 m-85 -111.38 139.55 46.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.558 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.795 ' CE1' HD12 ' A' ' 81' ' ' ILE . 82.2 m-85 -113.93 127.34 55.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.908 . . . . 0.0 109.39 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.818 HG22 HG23 ' A' ' 32' ' ' ILE . 16.3 p -118.49 152.6 35.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.574 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 53.7 t0 -151.36 152.87 33.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -135.08 118.0 1.84 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.8 m -122.18 150.28 42.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -1.149 . . . . 0.0 109.536 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -123.44 145.89 48.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.493 ' CD1' ' OG ' ' A' ' 161' ' ' SER . 74.5 mt . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 109.461 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.281 0.562 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 78.1 m-20 -92.9 115.55 28.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.477 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -99.19 148.29 24.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.4 ' HA3' ' N ' ' A' ' 161' ' ' SER . . . -141.83 153.18 24.05 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.943 ' CE ' HD21 ' A' ' 51' ' ' LEU . 70.9 mtm -119.95 161.5 20.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.449 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -154.42 117.48 0.79 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.818 HG23 HG22 ' A' ' 12' ' ' THR . 4.8 mp -125.74 120.29 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -1.138 . . . . 0.0 109.256 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.584 HG22 HG13 ' A' ' 43' ' ' VAL . 9.6 p -119.59 145.89 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.735 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.688 ' CG ' ' CE2' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -105.72 136.17 45.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.147 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.38 167.37 20.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.642 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.6 t -124.56 159.85 29.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.369 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.549 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 17.7 m-85 -106.71 16.9 23.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.71 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.589 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -51.28 -178.7 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.852 . . . . 0.0 108.711 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.589 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.5 Cg_endo -65.02 -6.37 12.73 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.964 1.776 . . . . 0.0 111.566 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -131.64 106.09 7.94 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.44 126.02 25.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.469 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -155.21 149.14 25.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -0.91 . . . . 0.0 109.534 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.584 HG13 HG22 ' A' ' 33' ' ' VAL . 51.4 t -91.49 121.06 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 109.523 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 53.1 mt -63.93 -38.89 92.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.536 ' O ' HG23 ' A' ' 33' ' ' VAL . 39.9 t30 -179.99 156.29 0.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.579 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.528 ' HG2' ' CG2' ' A' ' 33' ' ' VAL . 93.5 mt-30 -110.46 147.82 33.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.426 -0.796 . . . . 0.0 109.025 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -126.07 132.89 51.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.124 -0.985 . . . . 0.0 109.716 -179.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.7 t -126.22 132.11 51.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.242 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.476 ' HB ' ' CE ' ' A' ' 30' ' ' MET . 3.0 mt -135.51 111.64 10.69 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.722 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HB3' ' CG2' ' A' ' 163' ' ' VAL . 50.2 Cg_endo -70.87 134.92 26.65 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.729 2.286 . . . . 0.0 111.665 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.943 HD21 ' CE ' ' A' ' 30' ' ' MET . 49.9 mt -104.51 138.28 41.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.907 . . . . 0.0 109.617 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' O ' ' ND1' ' A' ' 54' ' ' HIS . . . -113.81 127.63 7.91 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 18.4 m120 64.44 38.55 7.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -1.181 . . . . 0.0 109.469 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 52' ' ' GLY . 75.9 m80 -124.74 165.46 17.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.492 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.581 HG23 ' HG3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -110.56 171.42 7.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 109.179 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -53.95 -39.72 66.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.094 -1.004 . . . . 0.0 109.231 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 60' ' ' GLU . 92.4 mt-30 -67.35 -53.66 27.48 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.871 . . . . 0.0 109.263 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.581 ' HG3' HG23 ' A' ' 55' ' ' THR . 69.7 mmm -44.73 -34.61 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.33 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.685 ' HB2' HD12 ' A' ' 51' ' ' LEU . . . -76.83 -32.49 57.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.399 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' GLN . 97.7 mt-10 -62.85 -40.61 97.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.58 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.571 HD11 ' CE2' ' A' ' 117' ' ' TRP . 17.7 tt -74.73 -35.12 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.549 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.606 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -71.02 -30.15 66.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.56 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -59.93 -39.29 84.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.555 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.685 HG21 HG12 ' A' ' 87' ' ' VAL . 44.3 t -77.14 -43.99 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.555 ' HG2' HD11 ' A' ' 120' ' ' ILE . 98.1 mt-10 -55.78 -36.83 67.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.548 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.586 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 10.8 t80 -59.87 -68.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.645 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -60.77 -13.58 16.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 109.602 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.676 ' SG ' HG23 ' A' ' 120' ' ' ILE . 40.2 t -66.3 -60.77 2.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.485 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -65.65 -40.99 93.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.586 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 54.3 mttm -65.86 -27.42 68.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.566 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 67' ' ' ALA . . . -69.14 -57.13 5.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 72' ' ' LEU . 24.7 tp -61.52 -39.25 90.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -47.07 -37.47 9.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 33.9 mm -61.66 142.8 94.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 108.958 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.5 Cg_endo -64.6 -5.94 11.19 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.575 2.183 . . . . 0.0 111.731 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.463 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -134.29 166.79 24.03 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.472 ' O ' ' HG2' ' A' ' 7' ' ' GLU . 47.5 Cg_endo -68.65 140.97 48.57 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.547 2.165 . . . . 0.0 111.679 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.628 HG11 ' CE1' ' A' ' 10' ' ' PHE . 21.8 t -126.32 159.31 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.537 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.819 ' HB2' HG22 ' A' ' 9' ' ' VAL . 1.9 mp -113.32 124.52 52.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.834 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 62.4 t -104.9 133.13 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.795 HD12 ' CE1' ' A' ' 11' ' ' TYR . 31.9 mt -119.97 135.71 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.935 . . . . 0.0 109.479 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.666 HG21 HG22 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -130.66 161.79 30.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 109.258 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 53.9 p-10 -90.02 10.86 22.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.945 . . . . 0.0 109.548 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.4 t -112.04 126.02 54.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.579 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 70.8 t80 -80.64 -40.23 25.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 90' ' ' SER . 96.0 m-85 -61.02 -49.56 76.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.685 HG12 HG21 ' A' ' 64' ' ' VAL . 48.4 t -61.7 -52.12 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.403 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.596 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -52.88 -61.04 2.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.895 . . . . 0.0 109.341 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 81.5 tt0 -57.82 -18.98 25.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.191 -0.943 . . . . 0.0 109.277 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.532 ' HA ' ' CG ' ' A' ' 94' ' ' GLU . 8.4 t -66.73 -65.09 0.72 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.557 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.883 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -69.82 -7.5 40.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.553 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 85.1 m-20 -86.58 -46.33 10.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.678 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 96' ' ' PRO . 62.6 mttp -126.46 -47.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 109.732 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.583 ' HB3' ' CE2' ' A' ' 98' ' ' TRP . 81.7 mt-10 -51.46 -44.22 62.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.694 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.883 HD23 ' HA ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -50.68 -63.45 1.87 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.912 . . . . 0.0 109.54 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.521 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 48.0 Cg_endo -68.69 -42.05 5.24 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.749 2.299 . . . . 0.0 112.035 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.31 -40.05 96.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.583 ' CE2' ' HB3' ' A' ' 94' ' ' GLU . 39.9 m0 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.59 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.2 mttt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.291 0.567 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 64.0 m80 60.23 27.05 16.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.444 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 80.5 mt -62.5 -38.33 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.361 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.9 t -56.27 -45.85 79.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.278 -0.889 . . . . 0.0 109.315 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.44 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 61.8 mttp -60.06 -54.06 50.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.571 ' CE2' HD11 ' A' ' 61' ' ' ILE . 91.9 m95 -65.21 -33.15 75.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 109.387 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -54.01 -45.95 71.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.378 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.9 m -53.29 -44.13 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.306 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.676 HG23 ' SG ' ' A' ' 68' ' ' CYS . 83.7 mt -72.01 -32.79 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.364 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.91 88.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.89 . . . . 0.0 109.358 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.91 -39.01 83.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.875 ' SG ' HD11 ' A' ' 130' ' ' ILE . 23.0 t -68.58 -44.09 75.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.563 HD23 HD12 ' A' ' 130' ' ' ILE . 55.1 mt -68.15 -34.15 75.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.5 t -59.64 -33.75 71.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.427 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.458 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 92.0 mtp -67.91 -33.96 75.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.6 OUTLIER 177.35 136.58 0.22 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.512 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.9 Cg_endo -71.56 2.45 4.55 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.728 2.285 . . . . 0.0 112.078 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 31.6 p-10 -43.71 -39.04 3.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.662 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.875 HD11 ' SG ' ' A' ' 123' ' ' CYS . 52.6 mt -59.3 115.57 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.741 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.0 m -111.6 134.05 53.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.025 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.795 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -116.44 135.9 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.081 -1.012 . . . . 0.0 109.887 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.8 mt-30 -126.0 154.22 43.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.359 -0.838 . . . . 0.0 109.3 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.579 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 17.4 t-80 -108.34 127.0 53.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 179.968 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.332 0.587 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.3 p -69.05 -40.24 78.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.478 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.07 -37.41 64.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -65.13 -34.54 89.98 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -65.73 -38.12 88.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -1.185 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.91 -48.8 67.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.551 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 mt -65.7 -44.32 86.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.92 -37.7 83.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.427 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 57.4 t0 -62.59 -41.24 98.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 69.0 mttm -63.4 -36.02 82.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.501 ' CD1' ' HB ' ' A' ' 33' ' ' VAL . 71.4 mt -69.31 -37.23 77.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.49 -43.94 68.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 31.7 m -60.14 -42.2 94.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.574 ' O ' HG13 ' A' ' 163' ' ' VAL . 95.1 mt-30 -65.23 -33.31 75.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 109.541 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.87 ' O ' HG22 ' A' ' 163' ' ' VAL . . . -61.84 -46.61 93.8 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.493 ' OG ' ' CD1' ' A' ' 17' ' ' ILE . 91.2 p -72.9 -26.19 61.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -68.36 -35.99 78.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 160' ' ' GLY . 18.1 m -70.87 -14.23 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.573 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.422 HG23 HG23 ' A' ' 163' ' ' VAL . 41.0 t . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.508 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 1.032 ' CD2' HD11 ' A' ' 79' ' ' LEU . 43.9 m-85 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.326 0.584 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -76.48 -36.3 57.91 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.256 -0.903 . . . . 0.0 109.19 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.47 -166.46 35.26 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.779 HG13 ' HB3' ' A' ' 35' ' ' ALA . 7.2 p -125.29 140.72 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -1.072 . . . . 0.0 108.996 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.858 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.6 m-85 -117.69 135.89 53.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 109.85 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.84 ' CE1' HD12 ' A' ' 81' ' ' ILE . 95.0 m-85 -114.08 118.72 34.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.994 HG22 HG23 ' A' ' 32' ' ' ILE . 19.0 p -115.79 151.61 34.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 0.0 109.728 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 53.1 t0 -147.51 156.15 42.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.351 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -163.21 117.11 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.463 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 68.7 m -138.85 147.98 43.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -1.163 . . . . 0.0 109.74 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -107.81 140.52 40.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.465 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.796 HD12 ' HB3' ' A' ' 161' ' ' SER . 68.6 mt . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.905 . . . . 0.0 109.524 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 96.0 m-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -93.65 129.2 40.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 108.987 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.643 ' CB ' ' CE1' ' A' ' 54' ' ' HIS . . . -119.46 164.47 15.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -0.99 . . . . 0.0 110.158 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.82 146.77 18.75 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.776 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 61.7 mtm -120.0 145.75 46.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.479 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.81 118.61 1.78 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.994 HG23 HG22 ' A' ' 12' ' ' THR . 4.6 mp -120.86 116.87 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -1.153 . . . . 0.0 109.255 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 45' ' ' ASN . 7.2 p -124.45 144.47 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.101 -1.0 . . . . 0.0 109.731 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.674 ' CG ' ' CE2' ' A' ' 10' ' ' PHE . 1.4 m-70 -101.59 141.72 34.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.852 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.779 ' HB3' HG13 ' A' ' 9' ' ' VAL . . . -129.81 165.81 21.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.44 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 t -126.16 165.25 19.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 38' ' ' LYS . 82.8 m-85 -107.92 10.16 28.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.58 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.18 179.72 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.007 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.2 Cg_endo -65.45 -5.38 11.31 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.183 1.922 . . . . 0.0 111.658 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -129.25 106.02 8.54 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -64.83 129.93 41.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -167.66 154.12 7.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.479 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 43' ' ' VAL . 32.6 m -89.37 120.59 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.887 . . . . 0.0 109.461 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 55.3 mt -57.78 -38.8 76.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.342 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.731 ' O ' HG23 ' A' ' 33' ' ' VAL . 60.9 t30 -169.6 155.43 6.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.918 . . . . 0.0 109.594 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.528 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 91.9 mt-30 -112.59 137.8 50.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.831 . . . . 0.0 109.103 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.52 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -118.01 133.38 55.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.142 -0.974 . . . . 0.0 109.659 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 t -119.85 140.17 51.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 109.31 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.645 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 1.7 mt -145.5 92.32 5.57 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 109.693 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.671 ' HG3' HG11 ' A' ' 163' ' ' VAL . 49.8 Cg_endo -70.39 147.5 58.98 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.682 2.254 . . . . 0.0 111.598 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 50' ' ' PRO . 43.1 mt -123.88 129.44 51.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.698 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.689 ' HA2' HG11 ' A' ' 164' ' ' VAL . . . -92.78 -73.57 1.24 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -102.22 87.98 3.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.165 . . . . 0.0 109.154 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.643 ' CE1' ' CB ' ' A' ' 28' ' ' ALA . 6.7 p-80 -132.29 -163.82 1.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.976 . . . . 0.0 109.949 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.841 HG23 ' HE3' ' A' ' 58' ' ' MET . 0.2 OUTLIER -128.93 144.8 51.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -44.69 -33.91 2.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.084 -1.01 . . . . 0.0 109.13 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 61' ' ' ILE . 85.5 mt-30 -77.79 -47.78 18.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.841 ' HE3' HG23 ' A' ' 55' ' ' THR . 24.2 ttm -48.79 -35.07 13.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.987 . . . . 0.0 109.23 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' A' ' 54' ' ' HIS . . . -74.18 -45.86 45.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.382 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.91 -34.83 77.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.577 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.669 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 18.7 tt -77.32 -37.28 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.557 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.776 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -65.9 -29.78 70.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.15 92.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.654 HG21 HG12 ' A' ' 87' ' ' VAL . 46.5 t -77.82 -49.97 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.524 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.2 tt0 -53.09 -39.79 63.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.632 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.645 ' CZ ' HD11 ' A' ' 49' ' ' ILE . 13.0 t80 -57.76 -69.11 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 109.57 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.528 ' HB3' HG11 ' A' ' 80' ' ' VAL . . . -62.34 -15.95 51.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 109.462 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 1.057 ' SG ' HG23 ' A' ' 120' ' ' ILE . 39.4 t -66.09 -63.07 1.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -60.99 -44.35 97.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.566 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 48.7 mttm -62.85 -36.52 83.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.856 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -59.28 -64.18 1.04 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.366 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 130' ' ' ILE . 20.0 tp -51.98 -46.73 64.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.922 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 72' ' ' LEU . 19.4 tttm -42.58 -41.1 2.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.0 109.276 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.555 HG23 ' HD2' ' A' ' 75' ' ' PRO . 34.8 mm -52.29 143.44 25.98 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.823 . . . . 0.0 108.802 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.555 ' HD2' HG23 ' A' ' 74' ' ' ILE . 43.1 Cg_endo -65.09 -2.47 5.73 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.632 2.221 . . . . 0.0 112.203 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.484 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -143.13 170.65 25.29 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 47.7 Cg_endo -69.46 119.86 6.77 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.445 2.097 . . . . 0.0 111.693 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.858 HG21 ' CE1' ' A' ' 10' ' ' PHE . 7.7 p -114.01 146.56 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.399 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.032 HD11 ' CD2' ' A' ' 6' ' ' TYR . 15.9 mt -93.05 143.28 26.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.737 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.528 HG11 ' HB3' ' A' ' 67' ' ' ALA . 49.6 t -124.13 126.33 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 109.183 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.84 HD12 ' CE1' ' A' ' 11' ' ' TYR . 33.6 mt -113.49 136.22 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.784 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.557 HG21 ' CG2' ' A' ' 64' ' ' VAL . 10.3 t -142.31 159.27 42.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.351 -0.843 . . . . 0.0 109.276 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.47 ' HB3' ' OE1' ' A' ' 135' ' ' GLU . 51.0 p-10 -92.69 20.22 6.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.152 -0.967 . . . . 0.0 109.466 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.49 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 41.9 m -105.57 104.48 14.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 109.347 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.567 ' CE2' ' OE2' ' A' ' 89' ' ' GLU . 74.8 t80 -69.37 -50.19 48.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 109.583 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -60.81 -40.57 93.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.654 HG12 HG21 ' A' ' 64' ' ' VAL . 92.5 t -62.84 -39.57 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.378 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.61 -60.66 3.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.567 ' OE2' ' CE2' ' A' ' 85' ' ' PHE . 94.0 mt-10 -50.93 -35.35 32.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.618 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 70.6 m -55.91 -47.24 77.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.612 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -88.6 -0.92 57.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.907 . . . . 0.0 109.805 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 84.2 m-20 -90.61 -73.61 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.122 -0.986 . . . . 0.0 109.953 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 96' ' ' PRO . 96.8 mttt -127.13 -31.66 2.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 109.842 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 57.0 mt-10 -52.18 -40.49 61.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.911 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.064 HD21 ' HB2' ' A' ' 121' ' ' ALA . 6.4 tp -62.93 -58.3 17.16 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.063 -1.023 . . . . 0.0 109.537 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -65.89 -26.02 52.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.521 2.147 . . . . 0.0 111.261 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -75.56 -35.74 60.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.345 -0.847 . . . . 0.0 108.72 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.9 m0 . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.291 -0.881 . . . . 0.0 108.979 179.407 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 20.6 mttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.277 0.561 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.568 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 48.1 m80 66.29 30.4 9.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.341 -0.849 . . . . 0.0 109.679 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.56 -50.35 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.133 -0.98 . . . . 0.0 109.308 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m -60.08 -44.18 94.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.233 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -59.19 -50.17 75.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.308 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.669 ' CZ2' HD12 ' A' ' 61' ' ' ILE . 53.0 m95 -69.27 -35.77 76.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.907 . . . . 0.0 109.325 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -56.88 -45.93 82.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.341 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.9 m -55.43 -45.36 76.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.375 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 1.057 HG23 ' SG ' ' A' ' 68' ' ' CYS . 69.0 mt -66.82 -36.62 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.409 -0.807 . . . . 0.0 109.411 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 1.064 ' HB2' HD21 ' A' ' 95' ' ' LEU . . . -57.42 -43.4 83.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.461 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.21 -45.84 75.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.506 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 93.4 m -66.52 -46.56 75.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.23 -32.51 73.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.365 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.4 m -61.65 -35.17 77.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.55 ' SD ' HD21 ' A' ' 72' ' ' LEU . 66.1 mtt -64.6 -34.38 78.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.423 ' HG2' ' C ' ' A' ' 126' ' ' MET . 0.2 OUTLIER 174.57 145.39 0.21 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.242 -0.911 . . . . 0.0 109.559 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.6 Cg_endo -72.17 2.33 5.07 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.698 2.265 . . . . 0.0 111.763 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 128' ' ' PRO . 76.9 m-20 -42.39 -46.79 4.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.559 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 72' ' ' LEU . 60.5 mt -56.6 122.14 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.527 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.658 ' CB ' HD22 ' A' ' 79' ' ' LEU . 24.6 m -112.2 141.55 45.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.154 -0.966 . . . . 0.0 109.337 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.612 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 70.8 mt -125.25 134.61 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.935 . . . . 0.0 109.669 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.444 ' HB2' HG12 ' A' ' 81' ' ' ILE . 91.4 mt-30 -124.94 157.89 34.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.477 ' NE2' ' HB2' ' A' ' 85' ' ' PHE . 46.4 t-80 -113.48 127.75 56.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.499 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.47 ' OE1' ' HB3' ' A' ' 83' ' ' ASP . 95.3 mt-10 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 65.8 m170 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.7 m -61.24 -47.01 88.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 109.52 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.15 -46.23 53.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -61.66 -36.82 93.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 154' ' ' ASP . 82.1 m-20 -63.55 -37.25 86.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -1.191 . . . . 0.0 109.418 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.89 -51.6 66.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.426 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 57.1 mt -66.32 -43.64 85.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.59 87.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.542 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.46 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 94.8 m-20 -66.35 -41.25 89.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.88 . . . . 0.0 109.534 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -59.45 -39.79 84.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.54 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 46' ' ' GLN . 70.8 mt -65.57 -37.43 86.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.91 93.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.926 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.707 HG22 ' HE2' ' A' ' 162' ' ' TYR . 50.6 m -61.76 -41.66 97.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.943 . . . . 0.0 109.667 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.538 ' O ' HG23 ' A' ' 163' ' ' VAL . 62.1 tt0 -63.34 -34.34 77.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.603 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.24 -42.37 88.21 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.796 ' HB3' HD12 ' A' ' 17' ' ' ILE . 17.3 m -61.47 -37.21 82.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -1.161 . . . . 0.0 109.581 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.707 ' HE2' HG22 ' A' ' 158' ' ' THR . 89.6 m-85 -69.53 -21.09 63.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 0.0 109.509 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.671 HG11 ' HG3' ' A' ' 50' ' ' PRO . 39.3 t -66.0 -29.6 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.689 HG11 ' HA2' ' A' ' 52' ' ' GLY . 47.5 t . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.507 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 1.053 ' CD2' HD11 ' A' ' 79' ' ' LEU . 98.2 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.515 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 74.5 mm-40 -68.45 -37.01 79.82 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.079 -1.013 . . . . 0.0 109.04 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.35 -177.06 47.5 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 79' ' ' LEU . 95.1 t -133.29 132.23 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.346 -1.09 . . . . 0.0 108.943 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.664 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.9 m-85 -113.23 140.1 48.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 110.058 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 1.071 ' CE2' HD12 ' A' ' 81' ' ' ILE . 70.9 m-85 -112.15 133.71 54.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.364 -0.835 . . . . 0.0 109.095 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 1.047 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 7.1 p -121.05 152.51 38.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.645 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -152.86 152.6 31.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.347 -0.846 . . . . 0.0 109.388 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.17 128.67 5.68 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.553 ' OG ' ' HB3' ' A' ' 157' ' ' ALA . 50.6 m -122.17 148.88 44.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -1.146 . . . . 0.0 109.307 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 27' ' ' ASN . . . -133.82 145.03 49.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 78.3 mt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.325 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 96.7 m-20 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 95.1 m-20 -96.12 129.12 43.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.406 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -112.2 156.35 22.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.736 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.25 160.48 26.82 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 1.0 ' SD ' HD21 ' A' ' 51' ' ' LEU . 76.2 mtp -121.15 150.89 40.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -1.189 . . . . 0.0 109.678 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.53 117.76 0.84 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 32' ' ' ILE . 5.4 mp -121.73 139.89 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 109.638 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.448 ' CG1' HG13 ' A' ' 43' ' ' VAL . 21.3 t -114.73 139.64 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.323 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.559 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 40.5 m170 -107.24 139.95 40.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.615 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.59 166.51 24.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.596 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.592 ' HB ' HD11 ' A' ' 44' ' ' LEU . 15.4 t -139.9 164.45 29.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.654 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.513 ' OH ' HG21 ' A' ' 9' ' ' VAL . 58.6 m-85 -97.69 14.17 27.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.645 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.574 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 2.2 mttt -50.88 178.57 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 108.776 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.574 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.5 Cg_endo -65.33 -6.46 13.4 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.179 1.92 . . . . 0.0 111.534 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.446 ' HG3' ' HG3' ' A' ' 42' ' ' GLN . 38.9 tp10 -137.75 106.43 5.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -0.846 . . . . 0.0 109.086 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -63.3 118.09 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.908 . . . . 0.0 109.297 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.446 ' HG3' ' HG3' ' A' ' 40' ' ' GLU . 93.5 mt-30 -151.9 145.61 25.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.582 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.448 HG13 ' CG1' ' A' ' 33' ' ' VAL . 24.5 t -63.56 117.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.3 -0.875 . . . . 0.0 109.512 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.592 HD11 ' HB ' ' A' ' 36' ' ' THR . 43.0 mt -63.51 -37.55 87.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -177.59 158.99 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.667 HE21 HD21 ' A' ' 152' ' ' LEU . 90.1 mt-30 -106.94 138.81 42.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.329 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -126.45 131.4 51.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.776 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.4 m -129.92 136.45 49.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.244 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.578 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 3.8 mt -134.95 112.12 11.28 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.53 138.06 34.57 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.744 2.296 . . . . 0.0 111.623 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.0 HD21 ' SD ' ' A' ' 30' ' ' MET . 61.6 mt -111.18 139.58 46.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.51 ' O ' ' ND1' ' A' ' 54' ' ' HIS . . . -115.17 132.03 10.11 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 72.3 m-20 62.94 38.02 11.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.151 . . . . 0.0 109.502 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 52' ' ' GLY . 74.3 m80 -124.61 159.56 30.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.58 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.1 OUTLIER -101.87 168.47 9.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 0.0 109.171 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.86 -33.57 66.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -0.981 . . . . 0.0 108.975 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.2 -50.89 24.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.319 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.58 ' SD ' HG23 ' A' ' 55' ' ' THR . 99.2 mtp -55.15 -28.84 55.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . . . -74.18 -40.42 62.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.493 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.17 -42.83 95.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.612 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.815 ' HA ' HG21 ' A' ' 87' ' ' VAL . 14.9 tt -69.62 -32.11 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.73 -27.7 67.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.327 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.047 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -71.27 -38.07 71.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.483 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.746 HG22 HG21 ' A' ' 82' ' ' THR . 89.8 t -69.44 -40.52 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.587 ' HG2' HD11 ' A' ' 120' ' ' ILE . 99.2 mt-10 -64.74 -41.95 95.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.016 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.596 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 27.8 t80 -59.73 -65.25 0.71 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.485 -0.759 . . . . 0.0 109.711 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.21 68.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 109.725 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.689 ' SG ' HG23 ' A' ' 120' ' ' ILE . 50.4 t -60.7 -53.49 56.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 109.485 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -59.12 -50.86 72.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.664 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.596 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 62.9 mttm -61.15 -36.31 79.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.862 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.882 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -57.0 -69.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.718 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.846 ' HB2' HD11 ' A' ' 130' ' ' ILE . 22.1 tp -46.83 -46.32 20.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.591 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 72' ' ' LEU . 14.4 tptt -44.19 -45.13 8.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.206 -0.934 . . . . 0.0 109.269 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.671 HD12 ' HB ' ' A' ' 78' ' ' VAL . 7.3 mt -48.36 142.87 7.79 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.023 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.8 Cg_endo -65.57 -4.77 10.25 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.573 2.182 . . . . 0.0 111.749 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.515 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -140.62 168.57 25.18 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.1 Cg_endo -68.4 122.11 9.11 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.411 2.074 . . . . 0.0 111.77 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.882 HG11 ' HA ' ' A' ' 71' ' ' ALA . 4.6 p -113.71 155.25 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.419 -0.801 . . . . 0.0 109.262 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.053 HD11 ' CD2' ' A' ' 6' ' ' TYR . 22.6 mt -99.8 149.04 23.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 109.833 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 76.0 t -130.35 135.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.38 -0.825 . . . . 0.0 109.066 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.071 HD12 ' CE2' ' A' ' 11' ' ' TYR . 20.4 mt -119.87 139.47 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.953 . . . . 0.0 109.649 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.746 HG21 HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -128.29 161.85 28.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.364 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 58.3 p30 -92.48 13.39 19.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.442 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 42.6 m -132.82 125.47 30.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.59 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 67.5 t80 -77.59 -42.02 36.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -49.9 -57.25 7.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.381 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.815 HG21 ' HA ' ' A' ' 61' ' ' ILE . 14.9 p -61.05 -46.61 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.291 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.615 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -55.52 -55.5 31.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.902 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 79.6 tt0 -54.75 -31.56 58.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.944 . . . . 0.0 109.184 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.604 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 18.0 t -56.68 -56.27 23.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -80.32 -0.83 38.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.729 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 89.8 m-20 -84.54 -73.35 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.094 -1.004 . . . . 0.0 110.038 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 74.5 mttt -127.34 -27.84 2.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.132 -0.98 . . . . 0.0 110.269 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 68.1 mm-40 -61.04 -30.87 70.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.095 -1.003 . . . . 0.0 109.89 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -61.41 -58.53 18.07 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.718 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 43.9 Cg_endo -66.02 -25.47 51.64 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.552 2.168 . . . . 0.0 111.694 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -71.46 -38.17 71.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.173 -0.954 . . . . 0.0 109.044 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 39.1 m0 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.257 179.704 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 18.9 mttp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.267 0.556 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.569 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 36.7 m80 67.48 31.07 6.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 78.5 mt -68.74 -39.0 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.366 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.6 m -62.07 -44.61 96.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.362 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.454 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 54.3 mttp -61.45 -41.36 97.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.624 ' HH2' HG23 ' A' ' 87' ' ' VAL . 40.2 m95 -76.75 -30.69 56.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.37 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -59.27 -39.25 82.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.8 m -62.54 -44.86 95.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.689 HG23 ' SG ' ' A' ' 68' ' ' CYS . 78.0 mt -72.58 -30.25 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.442 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.505 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -61.72 -41.62 97.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.416 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -59.04 -40.23 84.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 109.387 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 46.3 m -68.15 -47.11 68.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.2 tp -63.32 -32.4 73.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.34 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 m -61.59 -31.8 71.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.568 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.478 ' HB3' ' HE3' ' A' ' 127' ' ' LYS . 93.6 mmm -67.54 -34.17 76.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 126' ' ' MET . 0.0 OUTLIER 170.67 147.6 0.14 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.0 Cg_endo -71.63 -0.04 7.69 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.73 2.286 . . . . 0.0 111.633 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 128' ' ' PRO . 93.4 m-20 -42.49 -47.24 5.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.428 -0.795 . . . . 0.0 109.632 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.846 HD11 ' HB2' ' A' ' 72' ' ' LEU . 56.8 mt -58.89 119.14 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.618 ' HB ' HD22 ' A' ' 79' ' ' LEU . 24.8 m -112.42 140.44 47.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.689 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 58.8 mt -122.54 137.46 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 109.696 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.429 ' HB2' HG12 ' A' ' 81' ' ' ILE . 84.6 mt-30 -122.73 163.07 20.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.218 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.59 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 14.8 t-80 -118.58 131.39 56.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 109.62 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.795 ' CD ' HG21 ' A' ' 81' ' ' ILE . 96.5 mt-10 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.403 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.516 ' CE1' HD11 ' A' ' 81' ' ' ILE . 13.1 m170 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.232 0.539 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 45.0 m -67.34 -45.27 76.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.0 109.679 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.99 -36.46 70.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.48 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -70.41 -28.51 71.14 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -69.38 -36.0 76.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 109.592 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -72.89 -52.8 13.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.667 HD21 HE21 ' A' ' 46' ' ' GLN . 25.0 tp -61.64 -37.71 85.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.172 -0.955 . . . . 0.0 109.626 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.76 82.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.664 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -67.68 -36.37 80.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.67 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.417 ' HE2' ' NE2' ' A' ' 159' ' ' GLN . 78.4 tttt -70.99 -36.11 72.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.775 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 66.4 mt -68.23 -34.77 76.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 109.658 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.553 ' HB3' ' OG ' ' A' ' 15' ' ' SER . . . -70.15 -39.73 75.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 44.7 m -66.06 -38.76 89.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.49 ' O ' HG23 ' A' ' 163' ' ' VAL . 94.6 mt-30 -66.35 -34.0 76.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 0.0 109.558 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.22 91.57 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.7 m -63.87 -37.42 87.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -62.85 -40.76 98.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.602 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 159' ' ' GLN . 95.4 t -53.79 -39.61 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.537 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 66.7 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.937 . . . . 0.0 109.546 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.94 -27.82 69.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -1.166 . . . . 0.0 109.476 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.528 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 90.4 mtp -64.49 -33.62 76.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.27 -164.33 38.28 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -125.0 119.47 28.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.46 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 1.125 ' CD2' HD11 ' A' ' 79' ' ' LEU . 55.7 m-85 -116.24 158.22 23.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.467 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.472 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 78.2 mm-40 -55.51 -36.85 67.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.253 -0.904 . . . . 0.0 109.138 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.471 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.81 -167.71 36.88 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.481 HG11 ' CZ ' ' A' ' 11' ' ' TYR . 85.5 t -132.95 144.47 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.133 . . . . 0.0 109.154 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 34' ' ' HIS . 6.8 m-85 -118.21 121.38 40.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 109.925 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.799 ' CE1' HD12 ' A' ' 81' ' ' ILE . 52.7 m-85 -107.81 126.73 52.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 108.85 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 1.037 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 3.7 p -115.06 150.31 36.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 110.071 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.537 ' HB2' ' HB1' ' A' ' 153' ' ' ALA . 59.7 t0 -142.22 154.52 44.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.473 -0.767 . . . . 0.0 109.086 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -138.11 138.34 9.49 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.9 p -143.09 160.94 39.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -1.127 . . . . 0.0 109.437 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -146.26 150.44 35.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.668 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.763 HD12 ' HB2' ' A' ' 161' ' ' SER . 62.1 mt -126.54 137.98 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -108.08 139.26 42.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.499 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 1.0 OUTLIER -124.27 165.03 26.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.542 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.5 -30.85 18.22 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.706 2.271 . . . . 0.0 111.826 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.55 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -74.02 -64.14 0.78 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 49.6 Cg_endo -70.15 66.7 2.0 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.7 2.266 . . . . 0.0 111.817 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.5 m -56.03 -50.4 71.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.61 32.44 1.82 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.449 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 69.9 m -151.37 142.83 23.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.553 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 25' ' ' SER . 62.3 m-20 -136.82 152.34 50.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -99.86 122.02 42.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.338 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -129.58 154.85 46.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.67 163.69 26.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.768 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 42.2 mtm -122.61 140.84 52.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -1.143 . . . . 0.0 109.531 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -126.19 123.75 4.91 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.601 HD12 HG22 ' A' ' 12' ' ' THR . 26.3 mm -112.97 138.31 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -1.174 . . . . 0.0 109.516 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 11' ' ' TYR . 41.0 t -122.59 135.47 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 109.378 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.688 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 72.5 m-70 -108.02 135.98 48.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 109.547 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.466 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -129.2 170.84 13.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.411 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.986 ' HB ' HD11 ' A' ' 44' ' ' LEU . 14.2 t -133.99 165.01 26.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.541 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.658 ' OH ' HD12 ' A' ' 79' ' ' LEU . 49.6 m-85 -104.43 11.47 34.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.529 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.58 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 1.7 mtmt -51.46 179.46 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.034 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.4 Cg_endo -66.39 -5.15 12.04 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.183 1.922 . . . . 0.0 111.568 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 71.0 mm-40 -135.49 106.21 6.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 0.0 109.128 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.76 123.75 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 109.468 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -158.11 148.55 20.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.602 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.6 p -77.87 122.27 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.986 HD11 ' HB ' ' A' ' 36' ' ' THR . 6.3 mp -65.01 -39.95 94.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.135 -0.978 . . . . 0.0 109.351 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -173.15 162.47 4.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.364 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.654 ' HB3' HD11 ' A' ' 156' ' ' LEU . 89.7 mt-30 -112.83 154.72 25.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.393 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.489 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -135.26 132.55 37.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 t -122.94 128.1 49.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 109.396 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.468 HD11 ' CE2' ' A' ' 66' ' ' PHE . 2.9 mp -129.43 91.55 40.99 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 0.0 109.543 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HG3' HG11 ' A' ' 163' ' ' VAL . 50.2 Cg_endo -70.64 133.18 23.41 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.698 2.266 . . . . 0.0 111.747 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 31.1 mt -99.73 147.14 25.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.65 -62.18 0.8 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -108.41 57.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -1.157 . . . . 0.0 109.531 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 80.6 m80 -129.47 177.99 6.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.614 HG23 ' H ' ' A' ' 58' ' ' MET . 13.2 t -124.17 169.08 12.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 109.455 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.466 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -57.38 -41.09 79.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.417 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -61.61 -40.61 95.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.467 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.614 ' H ' HG23 ' A' ' 55' ' ' THR . 97.0 mtp -70.83 -32.43 69.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.883 . . . . 0.0 109.507 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.64 -33.44 74.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.522 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.85 -47.97 56.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.507 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.73 ' HA ' HG21 ' A' ' 87' ' ' VAL . 13.7 tt -69.42 -38.01 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 109.549 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.768 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -65.8 -31.75 72.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.471 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.037 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -65.98 -38.63 89.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.892 . . . . 0.0 109.554 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.74 HG22 HG21 ' A' ' 82' ' ' THR . 61.6 t -69.57 -38.11 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.667 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.432 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 71.8 tt0 -69.77 -38.04 76.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 109.123 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.584 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 26.3 t80 -55.75 -66.57 0.4 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.344 -0.847 . . . . 0.0 109.527 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 71' ' ' ALA . . . -59.94 -31.86 70.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.535 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' A' ' 120' ' ' ILE . 41.3 t -50.65 -56.86 9.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.509 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -64.86 -42.93 94.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.482 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.584 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 63.1 mttm -64.55 -31.5 72.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.468 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 67' ' ' ALA . . . -66.24 -65.44 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.666 ' HB2' HD11 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -54.98 -38.71 68.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.307 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 72' ' ' LEU . 25.6 tttt -44.44 -47.25 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.044 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.058 HD12 HG21 ' A' ' 78' ' ' VAL . 8.7 mt -52.29 143.06 27.28 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 108.842 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.1 Cg_endo -65.48 -5.96 12.59 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.459 2.106 . . . . 0.0 111.631 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.472 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -129.26 170.1 20.38 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.444 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 49.8 Cg_endo -69.97 140.0 40.84 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.587 2.192 . . . . 0.0 111.801 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.058 HG21 HD12 ' A' ' 74' ' ' ILE . 39.5 t -127.59 162.6 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.125 HD11 ' CD2' ' A' ' 6' ' ' TYR . 7.2 mt -110.96 130.78 55.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 10' ' ' PHE . 72.0 t -114.05 126.42 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.895 . . . . 0.0 109.527 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.799 HD12 ' CE1' ' A' ' 11' ' ' TYR . 13.8 mt -115.36 142.3 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.299 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.74 HG21 HG22 ' A' ' 64' ' ' VAL . 1.1 p -130.47 161.27 31.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 135' ' ' GLU . 55.0 p-10 -87.51 5.16 40.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.517 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.542 ' CB ' HG12 ' A' ' 87' ' ' VAL . 2.1 m -123.3 123.99 41.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 109.552 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.594 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 66.6 t80 -72.69 -41.62 65.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.349 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.447 ' O ' ' HB2' ' A' ' 90' ' ' SER . 67.7 t80 -54.01 -58.8 5.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.73 HG21 ' HA ' ' A' ' 61' ' ' ILE . 12.7 p -58.31 -46.81 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.365 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.596 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -56.95 -63.6 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.205 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -57.24 -17.86 13.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.101 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.545 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 8.4 t -66.4 -65.53 0.67 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.299 -0.875 . . . . 0.0 109.258 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.766 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -66.47 -10.56 45.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.489 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -88.32 -42.03 12.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.775 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 96' ' ' PRO . 8.3 ttpp -126.42 -49.24 1.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.167 -0.958 . . . . 0.0 109.775 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.572 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 73.2 mm-40 -53.53 -41.02 65.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.672 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.766 HD23 ' HA ' ' A' ' 91' ' ' ALA . 0.4 OUTLIER -50.69 -63.98 1.57 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 49.8 Cg_endo -70.17 -36.6 9.44 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.708 2.272 . . . . 0.0 111.921 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -67.44 -42.41 83.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.572 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 18.9 m0 -63.91 -42.25 97.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 109.519 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -54.31 -42.05 69.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 m -58.59 -37.08 75.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.894 . . . . 0.0 109.496 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -91.83 16.66 10.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.454 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 72.52 41.5 51.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 111' ' ' LEU . 8.6 m-85 66.63 33.88 6.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -1.154 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.32 133.16 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.506 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -75.28 -70.72 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 109' ' ' LYS . 81.1 m-20 -129.39 154.66 46.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -62.92 -26.0 68.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.444 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -67.74 -38.28 83.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.354 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 106' ' ' ASN . 19.1 mttt -139.83 140.49 24.65 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.853 . . . . 0.0 109.45 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.26 169.72 18.88 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.687 2.258 . . . . 0.0 111.744 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.468 ' CB ' ' O ' ' A' ' 103' ' ' PHE . 36.4 tp -75.19 132.98 41.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -96.76 150.44 20.7 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.405 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.529 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 62.8 m80 60.88 37.68 18.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 111' ' ' LEU . 84.1 mt -63.42 -38.1 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.463 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 m -57.9 -45.47 86.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.464 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -63.42 -44.3 95.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.466 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.695 ' CZ2' HD11 ' A' ' 61' ' ' ILE . 69.8 m95 -69.4 -34.0 73.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.338 -0.852 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 tttm -58.01 -44.42 87.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.414 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.432 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 44.3 m -62.75 -43.42 98.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.362 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.461 HG23 ' SG ' ' A' ' 68' ' ' CYS . 71.9 mt -68.9 -34.21 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.421 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -61.87 -33.9 75.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -0.906 . . . . 0.0 109.42 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -64.76 -33.3 75.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.369 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.692 ' SG ' HD11 ' A' ' 130' ' ' ILE . 49.2 t -80.83 -52.12 7.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.883 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 128' ' ' PRO . 19.5 tp -62.54 -27.01 68.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.432 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 34.6 m -68.83 -26.61 65.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.483 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 64.1 mtt -71.25 -32.43 68.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 109.459 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.39 132.86 0.21 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 0.0 109.479 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.489 ' HA ' HD11 ' A' ' 124' ' ' LEU . 48.6 Cg_endo -69.78 -2.23 9.83 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.701 2.267 . . . . 0.0 111.719 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 96.8 m-20 -45.95 -26.88 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.439 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.692 HD11 ' SG ' ' A' ' 123' ' ' CYS . 64.9 mt -68.13 110.6 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.1 m -94.03 141.17 28.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.704 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 67.2 mt -118.84 137.33 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 109.521 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.471 ' HB2' HG23 ' A' ' 81' ' ' ILE . 86.2 mt-30 -134.84 157.38 46.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.594 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 12.8 t-80 -112.81 126.46 55.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 82' ' ' THR . 96.3 mt-10 -62.33 151.91 35.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.443 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -96.15 38.16 1.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 92.51 -148.08 18.95 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.402 ' O ' ' C ' ' A' ' 139' ' ' GLN . 84.3 t60 -114.48 127.39 55.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -1.139 . . . . 0.0 109.492 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 138' ' ' HIS . 32.8 tt0 44.36 64.52 7.15 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.384 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.58 -30.44 18.47 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.755 2.303 . . . . 0.0 111.911 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.1 p -129.81 164.96 22.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.604 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -49.44 -35.99 21.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.433 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 69.1 m -138.89 136.33 35.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.395 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 47.7 t -154.65 132.81 11.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 97.5 mt -77.49 -33.96 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.506 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -70.07 -33.51 72.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.0 m -55.38 -45.01 76.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.525 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -48.76 -49.83 36.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -60.04 -36.63 90.97 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -60.74 -38.07 83.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -1.151 . . . . 0.0 109.571 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.99 -46.69 77.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.564 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 74.8 mt -64.88 -38.92 92.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.531 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 13' ' ' ASP . . . -69.63 -35.74 75.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.512 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -60.7 -42.97 98.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.517 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 41.7 mttt -65.92 -40.61 91.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.654 HD11 ' HB3' ' A' ' 46' ' ' GLN . 77.2 mt -64.16 -41.47 97.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.541 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.67 96.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.897 . . . . 0.0 109.584 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.791 HG22 ' HE2' ' A' ' 162' ' ' TYR . 29.0 m -65.53 -37.45 86.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.522 ' O ' HG23 ' A' ' 163' ' ' VAL . 93.2 mt-30 -65.56 -31.91 73.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.518 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.58 -33.57 87.61 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.763 ' HB2' HD12 ' A' ' 17' ' ' ILE . 86.0 p -68.07 -34.36 76.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -1.135 . . . . 0.0 109.508 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.791 ' HE2' HG22 ' A' ' 158' ' ' THR . 90.0 m-85 -72.08 -22.1 61.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 159' ' ' GLN . 48.9 t -70.03 -25.92 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.482 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.455 ' O ' ' OD1' ' A' ' 165' ' ' ASN . 46.9 t -129.22 157.13 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.938 . . . . 0.0 109.471 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 164' ' ' VAL . 82.0 m-20 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.454 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.36 -31.93 69.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.218 -1.166 . . . . 0.0 109.431 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.717 ' HE1' ' CZ ' ' A' ' 37' ' ' TYR . 81.6 mtp -62.77 -38.87 92.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.93 . . . . 0.0 109.387 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.26 -21.14 11.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -50.77 -36.61 37.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -1.093 . . . . 0.0 109.44 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 1.011 ' CD2' HD11 ' A' ' 79' ' ' LEU . 27.4 m-85 -90.74 166.84 12.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.521 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 76.2 mm-40 -71.6 -36.7 70.9 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.38 -0.825 . . . . 0.0 108.941 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.33 -166.36 35.01 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.75 HG21 ' OH ' ' A' ' 37' ' ' TYR . 85.5 t -140.61 140.68 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -1.111 . . . . 0.0 109.097 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.679 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 24.7 m-85 -117.89 150.78 38.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.995 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.595 ' CE1' HG13 ' A' ' 81' ' ' ILE . 78.3 m-85 -121.87 130.39 53.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 109.093 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.899 HG22 HD12 ' A' ' 32' ' ' ILE . 17.2 p -115.66 151.6 34.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.764 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 57.9 t0 -140.62 152.46 45.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 109.347 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.51 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -138.43 128.36 4.12 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.3 m -133.23 148.62 52.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -1.155 . . . . 0.0 109.349 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.578 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -136.58 146.88 46.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.618 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.786 HD12 ' HB2' ' A' ' 161' ' ' SER . 65.1 mt -123.51 140.04 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -105.67 137.32 43.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.509 ' HB3' ' CG ' ' A' ' 22' ' ' PRO . 5.3 t -119.34 154.35 53.95 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.381 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 48.2 Cg_endo -68.5 -24.69 35.94 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.576 2.184 . . . . 0.0 111.941 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.533 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -72.51 -63.3 1.2 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.274 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 50.5 Cg_endo -71.1 79.88 1.32 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.725 2.284 . . . . 0.0 111.757 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.4 m -57.17 -48.19 79.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.258 -0.901 . . . . 0.0 109.515 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -103.14 33.28 3.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.541 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 27.4 m -149.91 152.75 35.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.951 . . . . 0.0 109.615 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -149.59 169.93 19.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.851 . . . . 0.0 109.426 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 16.5 m120 -104.67 144.08 32.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.846 . . . . 0.0 109.428 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -142.97 147.94 36.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.96 157.86 26.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.725 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 63.2 mtm -128.23 147.99 50.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 0.0 109.584 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -138.7 122.39 2.35 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.899 HD12 HG22 ' A' ' 12' ' ' THR . 22.7 mm -110.2 133.68 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -1.186 . . . . 0.0 109.62 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 153' ' ' ALA . 44.6 t -124.33 132.1 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.381 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 1.03 ' CD2' HD12 ' A' ' 44' ' ' LEU . 9.0 t60 -108.21 142.18 38.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.693 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.23 158.99 38.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.514 ' HB ' HD21 ' A' ' 44' ' ' LEU . 11.9 t -122.4 162.64 21.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.923 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.75 ' OH ' HG21 ' A' ' 9' ' ' VAL . 27.1 m-85 -106.8 5.01 28.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 1.8 mtpt -51.39 178.79 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 108.959 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.0 Cg_endo -65.91 -5.04 11.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.171 1.914 . . . . 0.0 111.615 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -127.78 106.2 8.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.863 . . . . 0.0 108.946 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.457 ' CE1' ' CG2' ' A' ' 145' ' ' ILE . 61.6 t80 -73.96 123.76 24.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 109.913 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -168.21 133.85 1.86 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.379 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.0 t -52.39 118.76 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.03 HD12 ' CD2' ' A' ' 34' ' ' HIS . 46.9 mt -64.13 -45.27 89.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 79.0 m-20 -160.17 154.43 23.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.523 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.401 ' HB3' HD11 ' A' ' 156' ' ' LEU . 94.0 mt-30 -118.13 144.03 46.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.2 -0.937 . . . . 0.0 109.305 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -129.52 142.02 50.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.0 t -132.83 128.0 35.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.349 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 2.8 mp -125.91 89.29 52.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.64 ' HG3' HG11 ' A' ' 163' ' ' VAL . 48.2 Cg_endo -69.25 129.05 17.43 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.692 2.261 . . . . 0.0 111.83 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 37.0 mt -103.16 147.97 26.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.479 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -120.81 -35.7 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.488 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 41.0 p-10 -119.68 44.16 2.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -1.135 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.524 ' HA ' ' CE ' ' A' ' 58' ' ' MET . 76.1 m80 -129.11 -175.89 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.429 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 58' ' ' MET . 10.0 t -126.5 170.31 12.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.93 . . . . 0.0 109.479 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.578 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -56.59 -39.08 72.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.385 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 60' ' ' GLU . 77.4 mt-30 -64.08 -67.15 0.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.515 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.524 ' CE ' ' HA ' ' A' ' 54' ' ' HIS . 44.2 mtm -44.94 -28.05 0.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 0.0 109.21 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.39 -37.13 63.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.609 ' HB3' HG21 ' A' ' 87' ' ' VAL . 98.9 mt-10 -66.92 -41.93 86.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.654 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 20.7 tt -70.5 -38.53 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 109.196 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.725 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -64.49 -39.31 93.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.338 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -52.32 -46.82 66.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.461 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.728 HG21 HG12 ' A' ' 87' ' ' VAL . 87.4 t -70.76 -49.24 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.339 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HG3' HG12 ' A' ' 120' ' ' ILE . 87.4 tt0 -53.62 -43.4 68.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.273 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.594 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 10.9 t80 -55.84 -65.34 0.61 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.293 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -61.33 -15.91 40.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.497 ' SG ' HG23 ' A' ' 120' ' ' ILE . 48.5 t -68.62 -61.14 1.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.298 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.402 ' HB3' ' HE3' ' A' ' 69' ' ' LYS . 20.7 ttpp -57.67 -48.67 78.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.944 . . . . 0.0 109.354 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.594 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 67.9 mttm -60.65 -42.12 96.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.389 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.896 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -54.16 -72.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.409 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.819 ' HB2' HD11 ' A' ' 130' ' ' ILE . 10.0 tt -48.91 -42.56 37.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.949 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 72' ' ' LEU . 80.7 tttt -44.13 -41.93 5.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.94 . . . . 0.0 109.149 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.565 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 32.0 mt -54.03 143.88 40.68 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.4 -0.812 . . . . 0.0 108.875 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.565 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.5 Cg_endo -65.4 -2.18 5.68 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.58 2.186 . . . . 0.0 112.26 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.521 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -139.44 169.22 24.64 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.451 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 49.2 Cg_endo -69.8 117.06 4.86 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.57 2.18 . . . . 0.0 111.877 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.896 HG11 ' HA ' ' A' ' 71' ' ' ALA . 5.8 p -110.31 153.6 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.239 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.011 HD11 ' CD2' ' A' ' 6' ' ' TYR . 15.1 mt -96.79 153.07 18.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.588 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 131' ' ' THR . 45.0 t -125.74 128.62 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.639 HG21 ' CD ' ' A' ' 135' ' ' GLU . 22.5 mm -107.99 139.49 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.2 -0.937 . . . . 0.0 109.431 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.504 ' CG2' HG22 ' A' ' 64' ' ' VAL . 1.9 p -131.07 161.59 31.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.494 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 86.4 m-20 -96.17 2.75 53.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.256 -0.903 . . . . 0.0 109.531 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.409 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 48.9 m -126.06 130.34 50.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -0.977 . . . . 0.0 109.477 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.588 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 64.9 t80 -74.78 -39.79 61.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.411 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.74 -52.5 63.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.651 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.728 HG12 HG21 ' A' ' 64' ' ' VAL . 50.6 t -61.14 -54.23 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 109.508 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.521 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -50.77 -55.85 14.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.159 -0.963 . . . . 0.0 109.397 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 82.3 tt0 -56.56 -35.59 68.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.615 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 49.0 m -52.58 -51.37 60.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 109.506 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.707 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -88.18 -1.19 57.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.693 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 45.6 t-20 -84.18 -72.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -0.994 . . . . 0.0 109.506 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 21.0 tptp -126.57 -26.6 3.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 109.785 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 46.6 mm-40 -65.17 -29.89 70.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.677 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -53.69 -59.09 10.45 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 109.668 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 47.0 Cg_endo -67.7 -32.99 29.1 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.679 2.253 . . . . 0.0 111.657 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -67.49 -39.97 85.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.221 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.5 m0 -63.36 -49.82 72.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 109.269 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -52.08 -38.75 58.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 0.0 109.434 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.5 m -59.65 -41.61 90.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.219 -0.926 . . . . 0.0 109.38 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.593 ' O ' HG23 ' A' ' 104' ' ' VAL . 78.5 m-20 -83.82 10.03 10.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.525 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 71.56 40.15 59.79 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.517 ' CE1' ' HE2' ' A' ' 118' ' ' LYS . 38.6 m-85 65.46 34.35 8.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -1.16 . . . . 0.0 109.35 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 101' ' ' ASN . 42.4 t -107.59 134.76 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.463 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' ' 109' ' ' LYS . 59.4 t30 -84.62 129.26 34.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -54.01 -31.88 52.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.456 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -73.05 160.88 31.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -57.2 -34.45 68.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.431 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 8.4 mttt -69.59 140.45 89.61 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.87 163.3 38.88 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.746 2.298 . . . . 0.0 111.791 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.882 HD23 HG12 ' A' ' 114' ' ' ILE . 2.4 tp -81.07 128.72 34.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.475 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 68.7 mttm -99.72 154.31 18.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.502 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.457 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 46.7 m80 64.62 33.21 10.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.882 HG12 HD23 ' A' ' 111' ' ' LEU . 82.5 mt -60.94 -46.47 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -59.52 -46.37 89.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 109.409 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.433 ' HE2' ' SD ' ' A' ' 58' ' ' MET . 45.5 mttp -55.73 -46.44 77.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.863 . . . . 0.0 109.404 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.654 ' CZ2' HD12 ' A' ' 61' ' ' ILE . 53.5 m95 -61.37 -37.66 84.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.882 . . . . 0.0 109.396 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.517 ' HE2' ' CE1' ' A' ' 103' ' ' PHE . 23.9 mttt -56.82 -43.04 80.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.2 m -57.14 -45.86 83.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.336 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.497 HG23 ' SG ' ' A' ' 68' ' ' CYS . 68.0 mt -67.39 -36.77 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.838 . . . . 0.0 109.496 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -59.18 -36.86 76.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.56 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.38 -43.76 98.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.606 ' SG ' HD11 ' A' ' 130' ' ' ILE . 42.5 t -68.08 -44.14 76.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.683 HD11 ' HA ' ' A' ' 128' ' ' PRO . 20.8 tp -71.09 -30.49 66.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.249 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.2 t -62.39 -31.84 72.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.468 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.583 ' HB2' HD11 ' A' ' 72' ' ' LEU . 92.0 mtp -65.34 -31.05 71.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.461 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.37 135.65 0.21 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.582 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.683 ' HA ' HD11 ' A' ' 124' ' ' LEU . 48.9 Cg_endo -69.91 -1.81 9.22 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 122.614 2.209 . . . . 0.0 111.501 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 95.1 m-20 -44.02 -44.85 7.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.819 HD11 ' HB2' ' A' ' 72' ' ' LEU . 45.0 mt -55.27 123.4 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.654 ' HB ' HD22 ' A' ' 79' ' ' LEU . 25.4 m -113.87 140.84 48.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.28 -0.887 . . . . 0.0 109.086 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.707 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -125.23 137.22 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.098 -1.001 . . . . 0.0 109.631 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.469 ' HB2' HD12 ' A' ' 81' ' ' ILE . 95.2 mt-30 -127.4 165.78 19.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.249 -0.907 . . . . 0.0 109.395 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.588 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 12.5 t-80 -111.57 138.25 48.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.639 ' CD ' HG21 ' A' ' 81' ' ' ILE . 71.0 mt-10 -137.64 139.49 40.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -98.8 134.45 41.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.49 -170.22 40.62 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.4 m80 47.65 32.77 2.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -1.144 . . . . 0.0 109.474 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -119.42 80.69 22.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.34 -0.85 . . . . 0.0 109.459 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.21 -27.55 24.19 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.711 2.274 . . . . 0.0 111.791 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.0 m -59.51 -39.05 82.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -108.36 117.24 33.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.185 -0.947 . . . . 0.0 109.528 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.8 m -121.49 140.49 52.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.575 ' OG ' HG23 ' A' ' 147' ' ' THR . 59.1 p -153.99 168.72 25.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.457 ' CG2' ' CE1' ' A' ' 41' ' ' TYR . 82.4 mt -59.43 -34.74 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.439 ' CD2' ' OH ' ' A' ' 11' ' ' TYR . 59.3 m170 -67.99 -38.92 83.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.333 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.575 HG23 ' OG ' ' A' ' 144' ' ' SER . 60.3 p -60.72 -39.46 88.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.48 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -48.89 -51.03 32.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.848 . . . . 0.0 109.38 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.49 -40.84 62.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.415 ' OD1' ' HA ' ' A' ' 147' ' ' THR . 23.1 m120 -56.52 -45.58 81.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -1.101 . . . . 0.0 109.337 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.0 -55.47 30.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.329 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.9 -45.97 82.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.308 -0.87 . . . . 0.0 109.349 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.4 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -58.67 -41.82 87.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.436 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.47 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 87.7 m-20 -54.08 -44.86 71.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 22.7 mttp -59.87 -42.04 92.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.309 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.401 HD11 ' HB3' ' A' ' 46' ' ' GLN . 64.8 mt -67.07 -37.04 83.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.56 -45.83 88.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.861 . . . . 0.0 109.408 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 46.1 m -61.76 -39.87 93.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.362 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 163' ' ' VAL . 95.0 mt-30 -63.32 -33.3 75.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.439 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 50' ' ' PRO . . . -55.46 -40.04 75.95 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.786 ' HB2' HD12 ' A' ' 17' ' ' ILE . 83.8 p -64.02 -35.36 80.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.122 . . . . 0.0 109.494 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -69.93 -22.65 63.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.64 HG11 ' HG3' ' A' ' 50' ' ' PRO . 38.9 t -65.18 -25.63 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.4 m -131.61 143.37 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.45 ' OD1' ' ND2' ' A' ' 27' ' ' ASN . 21.8 m120 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.54 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.59 -27.86 68.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.278 -1.131 . . . . 0.0 109.518 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.545 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 98.4 mmm -66.82 -30.62 70.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.502 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 93.07 -14.75 64.51 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 92.7 mt-30 60.66 41.32 15.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.255 -1.144 . . . . 0.0 109.469 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.728 ' CE2' HD21 ' A' ' 79' ' ' LEU . 94.3 m-85 -55.69 173.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' HB3' HG22 ' A' ' 78' ' ' VAL . 24.5 tp10 -61.46 -35.03 76.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.419 -0.8 . . . . 0.0 109.381 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.59 -166.01 34.08 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.031 ' CG1' ' HB3' ' A' ' 35' ' ' ALA . 5.7 p -134.85 143.89 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -1.136 . . . . 0.0 109.223 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.73 ' CD2' HG11 ' A' ' 78' ' ' VAL . 32.3 m-85 -119.76 132.42 55.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.656 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.894 ' CE1' HD12 ' A' ' 81' ' ' ILE . 95.6 m-85 -112.14 125.09 53.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 109.052 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 1.036 HG22 HD12 ' A' ' 32' ' ' ILE . 28.3 p -115.99 146.11 42.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 109.812 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 30' ' ' MET . 66.5 t0 -144.93 137.97 26.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.438 -0.789 . . . . 0.0 109.341 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -139.61 126.14 3.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 t -143.48 154.06 43.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -1.162 . . . . 0.0 109.543 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -115.1 142.83 46.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.549 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.001 HD12 ' CB ' ' A' ' 161' ' ' SER . 70.1 mt -118.29 138.37 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -105.21 124.03 48.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.6 m -110.31 161.15 25.7 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.07 -33.99 14.38 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.771 2.314 . . . . 0.0 111.834 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.561 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -63.39 -64.82 2.54 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 109.483 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.561 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 49.0 Cg_endo -69.9 78.27 1.07 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.618 2.212 . . . . 0.0 111.749 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.0 m -55.04 -32.31 61.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.528 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 25' ' ' SER . 24.6 mttt -106.89 151.26 25.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.453 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 45.1 t 63.1 169.61 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 41.5 p30 -139.22 -177.82 5.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.361 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.402 ' HB2' ' HB ' ' A' ' 17' ' ' ILE . 88.9 m-20 -99.46 109.42 21.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.485 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -106.11 143.4 34.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.9 155.55 26.56 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.854 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 58.2 mtm -127.32 159.82 33.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -1.166 . . . . 0.0 109.512 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.693 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -143.95 122.16 1.77 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.036 HD12 HG22 ' A' ' 12' ' ' THR . 26.9 mm -124.0 111.98 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.354 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.54 ' CG2' ' HG2' ' A' ' 46' ' ' GLN . 10.9 p -115.66 160.21 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.753 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.692 ' ND1' HD12 ' A' ' 44' ' ' LEU . 7.4 t-160 -116.05 144.98 43.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.364 -0.835 . . . . 0.0 109.346 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.031 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -132.3 169.49 16.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -125.95 166.58 16.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 0.0 109.369 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 38' ' ' LYS . 60.5 m-85 -105.28 10.13 33.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.908 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.573 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.37 179.59 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 109.1 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 44.0 Cg_endo -66.58 -4.53 11.1 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.128 1.885 . . . . 0.0 111.693 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.438 ' OE2' ' NE2' ' A' ' 42' ' ' GLN . 80.4 tt0 -132.93 105.82 7.33 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.37 -0.831 . . . . 0.0 108.861 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.475 ' CD1' HD11 ' A' ' 145' ' ' ILE . 54.4 t80 -57.57 125.32 22.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.235 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 80.5 mt-30 -158.13 142.01 15.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.749 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.717 HG11 HD12 ' A' ' 152' ' ' LEU . 29.0 m -78.99 118.66 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -0.85 . . . . 0.0 109.391 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.692 HD12 ' ND1' ' A' ' 34' ' ' HIS . 24.4 mt -60.59 -46.2 91.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.171 -0.956 . . . . 0.0 109.317 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 35.3 m120 -159.96 146.59 16.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.368 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.697 ' HB3' HD21 ' A' ' 156' ' ' LEU . 78.4 mt-30 -107.6 148.2 29.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.393 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.52 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 5.6 t-105 -132.07 140.83 48.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -0.953 . . . . 0.0 109.755 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.1 p -128.43 141.92 51.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.263 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 3.4 mt -135.11 94.68 15.75 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.609 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' CG ' HG11 ' A' ' 163' ' ' VAL . 51.1 Cg_endo -70.85 134.82 26.5 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.688 2.259 . . . . 0.0 111.718 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.67 ' O ' HG11 ' A' ' 164' ' ' VAL . 45.4 mt -104.35 140.14 38.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.47 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.769 ' HA2' HG21 ' A' ' 164' ' ' VAL . . . -86.92 -69.56 1.32 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -122.51 79.38 1.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -1.133 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -133.55 179.07 6.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.41 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.618 HG23 ' H ' ' A' ' 58' ' ' MET . 12.5 t -116.86 168.89 9.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 0.0 109.538 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.453 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -63.38 -29.69 70.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -68.3 -42.78 78.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.618 ' H ' HG23 ' A' ' 55' ' ' THR . 52.8 mtm -76.46 -26.93 55.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.457 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.04 -35.05 61.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.511 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 56' ' ' ALA . 98.7 mt-10 -73.71 -38.71 64.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.625 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 20.2 tt -71.03 -28.17 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 0.0 109.586 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.854 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -74.81 -36.68 62.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.556 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.576 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -57.51 -39.19 75.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.14 -0.975 . . . . 0.0 109.677 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.593 ' CG2' HG21 ' A' ' 82' ' ' THR . 77.9 t -75.45 -46.83 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.149 -0.969 . . . . 0.0 109.805 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.536 ' HB2' HD11 ' A' ' 120' ' ' ILE . 84.0 tt0 -60.28 -35.75 76.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.668 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.542 ' CD2' HG13 ' A' ' 32' ' ' ILE . 11.4 t80 -57.79 -68.67 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.675 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.444 ' HB3' HG13 ' A' ' 80' ' ' VAL . . . -61.67 -14.18 29.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.66 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.854 ' SG ' HG23 ' A' ' 120' ' ' ILE . 41.8 t -69.86 -60.34 2.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.454 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.448 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 65.4 tttm -61.28 -45.26 95.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.641 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 32.5 mttp -60.39 -34.11 73.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.577 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.27 -58.92 6.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 109.443 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.977 ' HB2' HD11 ' A' ' 130' ' ' ILE . 2.9 tt -53.22 -46.36 69.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 72' ' ' LEU . 13.2 ttpt -42.88 -47.19 5.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 109.257 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 22.7 mm -48.9 141.93 9.84 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 108.794 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.7 Cg_endo -66.12 -4.9 11.16 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.514 2.143 . . . . 0.0 111.687 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.412 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -134.78 165.71 24.48 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 47.5 Cg_endo -68.87 131.44 22.52 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 122.545 2.164 . . . . 0.0 111.596 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.73 HG11 ' CD2' ' A' ' 10' ' ' PHE . 68.8 t -121.57 167.51 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.451 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 6' ' ' TYR . 7.0 mp -115.82 130.49 56.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.538 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 96.9 t -104.36 134.94 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.387 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.894 HD12 ' CE1' ' A' ' 11' ' ' TYR . 40.7 mt -120.58 137.33 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.23 -0.919 . . . . 0.0 109.528 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.593 HG21 ' CG2' ' A' ' 64' ' ' VAL . 8.9 t -143.48 161.68 37.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.429 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 58.8 p30 -89.79 25.14 2.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.462 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.528 ' H ' HG23 ' A' ' 82' ' ' THR . 49.2 m -128.54 117.08 20.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.216 -0.928 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.536 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 71.6 t80 -77.29 -44.98 27.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -58.44 -45.02 89.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.425 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.592 HG12 HG21 ' A' ' 64' ' ' VAL . 95.2 t -61.81 -49.66 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -57.33 -49.28 76.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.326 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 82.4 tt0 -61.43 -36.62 80.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.638 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 47.7 t -53.16 -47.35 68.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.472 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.673 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -92.48 -0.66 57.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.659 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 43.2 t-20 -87.17 -72.97 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.87 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 97.7 mttt -127.1 -23.95 3.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.55 ' HG2' ' CE2' ' A' ' 98' ' ' TRP . 42.6 tt0 -67.08 -27.48 67.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.961 -1.087 . . . . 0.0 109.755 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 117' ' ' TRP . 0.5 OUTLIER -57.09 -57.86 21.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 109.59 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 43.8 Cg_endo -66.64 -24.72 47.78 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.452 2.101 . . . . 0.0 111.136 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -72.15 -36.72 69.4 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.815 ' CE3' HD21 ' A' ' 111' ' ' LEU . 38.6 m0 -65.41 -50.04 66.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.507 -0.745 . . . . 0.0 108.991 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.557 ' HG2' ' CE1' ' A' ' 103' ' ' PHE . 26.1 mttt -43.63 -43.24 5.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.473 -0.767 . . . . 0.0 109.365 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -53.25 -44.42 68.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.371 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -86.89 11.27 13.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.324 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 82.07 37.98 14.36 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.557 ' CE1' ' HG2' ' A' ' 99' ' ' LYS . 37.5 m-85 67.07 28.13 8.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -1.134 . . . . 0.0 109.464 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.743 HG13 ' HA ' ' A' ' 110' ' ' PRO . 47.9 t -119.2 124.86 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.569 ' HB2' HD12 ' A' ' 111' ' ' LEU . 47.2 t30 -53.51 -39.03 64.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.483 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -170.64 144.69 2.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -53.12 -24.2 9.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.355 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -70.21 -38.38 75.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.77 138.32 18.22 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.452 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.743 ' HA ' HG13 ' A' ' 104' ' ' VAL . 50.2 Cg_endo -69.94 159.74 52.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.749 2.3 . . . . 0.0 111.814 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.815 HD21 ' CE3' ' A' ' 98' ' ' TRP . 15.4 tp -81.84 133.43 35.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.428 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 57.9 mttp -98.67 149.27 22.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.215 -0.928 . . . . 0.0 109.568 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.537 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 55.4 m80 65.28 35.65 7.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.32 -0.863 . . . . 0.0 109.792 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.492 HG22 ' HE2' ' A' ' 118' ' ' LYS . 53.8 mt -67.36 -45.19 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.185 -0.947 . . . . 0.0 109.329 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 t -51.08 -47.62 61.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.22 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.66 -38.21 84.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.638 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 27.6 m95 -69.6 -40.28 76.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 109.351 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.492 ' HE2' HG22 ' A' ' 114' ' ' ILE . 64.0 mttm -55.06 -41.54 71.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.391 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.415 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 22.9 t -58.58 -45.77 88.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.854 HG23 ' SG ' ' A' ' 68' ' ' CYS . 79.4 mt -69.07 -36.22 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.378 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.81 93.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 126' ' ' MET . 83.1 tt0 -54.59 -40.61 69.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 109.409 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 1.3 m -76.6 -50.29 14.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.385 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 124' ' ' LEU . 9.1 tt -57.78 -37.44 73.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.464 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.8 m -59.93 -33.07 71.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.507 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.597 ' HB2' HD11 ' A' ' 72' ' ' LEU . 88.4 mtp -64.85 -36.06 83.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.85 . . . . 0.0 109.463 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.35 143.85 0.24 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 129' ' ' ASP . 48.6 Cg_endo -69.5 -2.12 9.43 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.738 2.292 . . . . 0.0 111.734 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 92.8 m-20 -43.18 -38.25 2.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.358 -0.839 . . . . 0.0 109.4 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.977 HD11 ' HB2' ' A' ' 72' ' ' LEU . 54.9 mt -68.59 109.44 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.475 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 97.2 m -110.03 146.94 34.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.273 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.478 HG21 ' HA ' ' A' ' 88' ' ' ALA . 64.2 mt -120.62 145.7 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.431 ' HB2' HG12 ' A' ' 81' ' ' ILE . 88.8 mt-30 -124.99 155.2 40.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.401 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.536 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 32.3 t-80 -110.53 128.56 55.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HG2' ' CG2' ' A' ' 81' ' ' ILE . 74.6 mm-40 -122.9 146.6 47.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.384 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 139' ' ' GLN . 93.0 mttt -109.32 125.02 51.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.507 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.15 -29.83 61.88 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -62.29 -37.61 86.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -1.141 . . . . 0.0 109.408 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.437 ' O ' ' O ' ' A' ' 136' ' ' LYS . 0.9 OUTLIER -117.52 159.23 42.8 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.533 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.53 155.14 67.5 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.798 2.332 . . . . 0.0 111.852 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 143' ' ' THR . 29.6 p -78.57 166.98 21.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.416 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -51.09 -38.85 54.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.619 HG22 ' H ' ' A' ' 145' ' ' ILE . 24.4 m -125.01 137.98 54.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.382 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 88.0 p -61.21 -23.63 65.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.619 ' H ' HG22 ' A' ' 143' ' ' THR . 19.9 tt -63.11 -40.11 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.56 ' CD2' ' HB ' ' A' ' 143' ' ' THR . 88.2 m-70 -67.23 -27.09 66.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.92 . . . . 0.0 109.538 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 47.6 m -67.83 -35.47 78.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.53 -39.41 67.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.399 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -66.07 -37.86 93.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -65.09 -32.46 74.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -1.102 . . . . 0.0 109.361 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -66.76 -52.65 41.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.882 . . . . 0.0 109.514 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.717 HD12 HG11 ' A' ' 43' ' ' VAL . 59.1 mt -64.81 -46.78 80.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.56 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -54.48 -39.46 67.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.579 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -68.15 -36.99 80.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 66.3 mttm -56.43 -43.87 79.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.562 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.4 mp -72.11 -36.09 69.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.551 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.1 -43.29 82.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.498 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.403 HG22 ' HE2' ' A' ' 162' ' ' TYR . 30.5 m -63.92 -41.57 97.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.56 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 94.5 mt-30 -66.17 -28.61 68.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.499 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.06 -39.67 97.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 1.001 ' CB ' HD12 ' A' ' 17' ' ' ILE . 25.0 m -60.79 -38.87 86.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.115 . . . . 0.0 109.516 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.403 ' HE2' HG22 ' A' ' 158' ' ' THR . 91.5 m-85 -66.99 -30.02 70.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.474 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.487 HG11 ' CG ' ' A' ' 50' ' ' PRO . 63.4 t -58.56 -38.0 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.575 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.769 HG21 ' HA2' ' A' ' 52' ' ' GLY . 12.3 p -111.81 138.35 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.447 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.97 -26.59 68.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -1.166 . . . . 0.0 109.397 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.55 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 92.3 mtp -64.15 -36.72 84.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.489 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 102.88 -15.52 55.36 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 6' ' ' TYR . 90.6 mt-30 63.04 47.38 4.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -1.143 . . . . 0.0 109.525 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 1.056 ' CD2' HD11 ' A' ' 79' ' ' LEU . 99.0 m-85 -52.11 -174.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 109.469 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' A' ' 78' ' ' VAL . 70.0 mm-40 -68.57 -36.91 79.4 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.152 -0.967 . . . . 0.0 109.283 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.478 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.66 -174.13 44.61 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.589 HG22 ' HB2' ' A' ' 79' ' ' LEU . 90.4 t -137.98 136.34 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -1.106 . . . . 0.0 109.317 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.684 ' CE2' ' CG ' ' A' ' 34' ' ' HIS . 47.6 m-85 -118.88 137.76 53.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.742 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.58 ' CE2' HG13 ' A' ' 81' ' ' ILE . 23.2 m-85 -108.0 130.78 55.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.402 -0.811 . . . . 0.0 109.198 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.993 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 19.6 p -116.5 147.65 41.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 109.621 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CG ' ' OD1' ' A' ' 154' ' ' ASP . 23.3 t70 -148.56 153.51 38.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.6 126.23 3.38 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.6 m -128.68 153.51 47.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -1.148 . . . . 0.0 109.409 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . . . -139.94 144.63 37.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.868 HD12 ' HB3' ' A' ' 161' ' ' SER . 38.0 mt -117.76 147.86 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -100.55 164.97 11.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.555 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.548 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -125.65 176.63 2.34 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 109.094 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 47.6 Cg_endo -69.1 124.25 11.16 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.44 2.093 . . . . 0.0 111.413 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 2.5 m-20 61.49 57.76 3.2 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.913 . . . . 0.0 109.014 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 19' ' ' SER . 50.4 Cg_endo -70.71 63.43 2.34 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.869 2.379 . . . . 0.0 112.128 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.528 ' O ' ' CG ' ' A' ' 24' ' ' LYS . 35.2 m -56.72 -45.76 81.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 109.093 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 23' ' ' THR . 76.3 mttt -159.73 41.04 0.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.43 -0.794 . . . . 0.0 109.313 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 26' ' ' ASN . 20.0 m -137.19 140.76 41.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 109.476 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 25' ' ' SER . 77.2 m-20 -160.09 146.65 15.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 109.359 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.459 ' HB2' ' HB ' ' A' ' 17' ' ' ILE . 89.2 m-20 -95.55 136.81 35.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.434 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -145.71 149.47 34.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.759 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -157.78 164.44 33.16 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.893 ' HG3' HD11 ' A' ' 51' ' ' LEU . 66.2 mtm -123.19 163.51 20.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -1.156 . . . . 0.0 109.421 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -148.45 119.54 1.09 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.925 HD12 HG22 ' A' ' 12' ' ' THR . 24.8 mm -114.64 137.03 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -1.17 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.2 t -123.38 136.09 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.433 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.992 ' CD2' HD12 ' A' ' 44' ' ' LEU . 4.1 t60 -110.23 135.02 51.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.658 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.01 164.61 27.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.294 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.2 t -131.71 166.74 20.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.935 . . . . 0.0 109.599 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.587 ' OH ' HG21 ' A' ' 9' ' ' VAL . 66.3 m-85 -100.64 11.63 39.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 109.406 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.571 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -51.29 179.65 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.328 -0.857 . . . . 0.0 109.05 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.571 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.6 Cg_endo -66.29 -5.0 11.56 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.122 1.881 . . . . 0.0 111.65 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -135.95 106.07 6.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.368 -0.832 . . . . 0.0 109.049 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 54.7 t80 -67.46 122.7 18.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 109.31 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 82.4 mt-30 -159.4 142.46 14.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.769 HG21 HD22 ' A' ' 152' ' ' LEU . 46.2 t -64.96 110.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.992 HD12 ' CD2' ' A' ' 34' ' ' HIS . 35.1 mt -57.14 -48.72 77.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 79.8 m-20 -159.76 153.74 23.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.453 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.483 ' HB3' HD11 ' A' ' 156' ' ' LEU . 91.0 mt-30 -109.48 146.47 34.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.485 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.4 t-105 -131.24 135.52 47.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 0.0 109.722 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.9 t -130.29 130.16 44.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 109.261 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.505 ' HB ' ' CE ' ' A' ' 30' ' ' MET . 3.1 mp -131.65 98.69 17.71 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 109.741 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 51.3 Cg_endo -71.57 136.48 28.42 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.601 2.201 . . . . 0.0 111.676 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.893 HD11 ' HG3' ' A' ' 30' ' ' MET . 3.3 mp -103.7 140.37 37.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.513 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 53' ' ' ASN . . . -103.34 113.38 4.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 52' ' ' GLY . 47.7 t30 75.63 36.64 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -1.157 . . . . 0.0 109.55 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 51' ' ' LEU . 76.9 m80 -120.26 171.55 8.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.585 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -111.17 170.18 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.26 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -56.98 -35.26 68.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.017 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 60' ' ' GLU . 89.7 mt-30 -70.14 -58.27 3.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 0.0 109.345 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.585 ' SD ' HG23 ' A' ' 55' ' ' THR . 97.6 mtp -44.77 -30.72 1.01 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.304 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 30' ' ' MET . . . -77.62 -34.57 53.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.379 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 57' ' ' GLN . 97.0 mt-10 -63.33 -41.9 98.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 109.567 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.72 ' HA ' HG21 ' A' ' 87' ' ' VAL . 12.8 tt -71.56 -37.36 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.769 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -67.14 -31.66 72.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.308 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.993 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -66.97 -38.6 86.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.426 HG22 HG21 ' A' ' 82' ' ' THR . 85.3 t -69.91 -40.34 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.581 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HB2' HD11 ' A' ' 120' ' ' ILE . 80.7 tt0 -69.11 -39.81 78.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.565 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 19.2 t80 -58.77 -64.35 0.96 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.359 -0.838 . . . . 0.0 109.477 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.82 -32.88 69.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 120' ' ' ILE . 43.0 t -51.63 -52.64 46.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 67.8 mttm -64.5 -42.25 95.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.565 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 64.3 mttm -62.62 -37.81 87.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.562 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.71 -61.9 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.919 ' HB2' HD11 ' A' ' 130' ' ' ILE . 18.9 tp -55.21 -42.01 72.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.459 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 72' ' ' LEU . 64.9 tttt -45.17 -40.95 7.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 109.29 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.633 HG13 HG21 ' A' ' 78' ' ' VAL . 32.6 mm -59.1 143.07 85.01 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 108.899 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.3 Cg_endo -64.08 -5.87 10.22 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.53 2.153 . . . . 0.0 111.871 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -134.85 170.6 22.74 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 49.7 Cg_endo -69.27 135.6 32.06 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.392 2.061 . . . . 0.0 111.771 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.633 HG21 HG13 ' A' ' 74' ' ' ILE . 58.0 t -124.4 158.14 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.875 . . . . 0.0 109.374 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.056 HD11 ' CD2' ' A' ' 6' ' ' TYR . 14.2 mt -108.32 144.71 35.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.213 -0.929 . . . . 0.0 109.424 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 132' ' ' ILE . 13.6 m -123.48 143.92 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.58 HG13 ' CE2' ' A' ' 11' ' ' TYR . 26.1 mm -114.01 133.56 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 109.339 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.426 HG21 HG22 ' A' ' 64' ' ' VAL . 1.2 p -127.18 161.76 27.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.476 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -98.99 14.16 30.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 109.523 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.582 ' HB3' HG12 ' A' ' 87' ' ' VAL . 27.2 t -137.96 125.77 22.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.618 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 48.8 p90 -77.2 -36.63 54.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.456 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -53.79 -50.18 66.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 61' ' ' ILE . 14.9 p -67.26 -44.72 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.907 . . . . 0.0 109.409 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.582 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -54.89 -47.92 73.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 77.3 mm-40 -62.22 -40.27 95.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.594 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 64.4 m -50.79 -44.96 58.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.675 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -94.51 -0.9 54.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.731 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 56.1 t30 -89.67 -72.93 0.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.143 -0.973 . . . . 0.0 109.581 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 65.0 tttm -127.05 -31.84 2.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 109.774 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 92.6 mt-10 -55.52 -34.23 64.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 0.0 109.743 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 91' ' ' ALA . 0.8 OUTLIER -56.18 -62.13 5.33 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 109.581 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 44.5 Cg_endo -66.93 -32.71 34.97 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.836 2.357 . . . . 0.0 111.746 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -67.75 -38.24 83.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.164 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -64.96 -48.95 72.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -0.883 . . . . 0.0 109.259 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.597 ' NZ ' ' HB1' ' A' ' 121' ' ' ALA . 32.4 mttt -47.87 -42.26 26.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.397 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.4 m -59.21 -40.74 86.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.619 ' O ' HG23 ' A' ' 104' ' ' VAL . 73.3 m-20 -87.64 12.21 13.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.869 . . . . 0.0 109.394 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 70.59 38.23 68.17 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.691 ' CA ' HD12 ' A' ' 111' ' ' LEU . 91.1 m-85 61.34 46.56 7.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -1.166 . . . . 0.0 109.434 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 101' ' ' ASN . 55.1 t -112.3 132.54 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.492 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.642 ' HB2' HD23 ' A' ' 111' ' ' LEU . 49.2 t-20 -93.73 142.58 27.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.413 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -49.96 -36.25 27.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.523 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -68.76 151.9 46.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -50.21 -33.43 19.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.4 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.99 140.7 74.05 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.478 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.29 173.78 10.94 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.666 2.244 . . . . 0.0 111.764 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.691 HD12 ' CA ' ' A' ' 103' ' ' PHE . 76.7 mt -65.84 137.97 57.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 73.6 mttt -107.56 153.93 22.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.6 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 55.8 m80 63.42 27.68 15.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.619 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.8 mt -57.51 -41.46 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.312 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.5 m -50.3 -47.3 55.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.264 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -60.57 -45.16 94.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.251 -0.906 . . . . 0.0 109.321 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.64 ' HH2' HG23 ' A' ' 87' ' ' VAL . 22.8 m95 -65.7 -40.6 92.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.349 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -52.34 -49.82 63.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.333 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.2 m -55.67 -45.55 77.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.294 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.548 HG23 ' SG ' ' A' ' 68' ' ' CYS . 76.8 mt -67.95 -37.99 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.263 -0.898 . . . . 0.0 109.374 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.597 ' HB1' ' NZ ' ' A' ' 99' ' ' LYS . . . -53.57 -42.38 67.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 109.399 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 126' ' ' MET . 76.3 mm-40 -54.6 -43.7 72.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 109.369 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 1.6 m -63.87 -49.16 73.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.425 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.5 tp -64.28 -33.05 74.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.3 m -61.8 -32.67 72.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.0 109.62 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.509 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 91.9 mmm -65.67 -28.94 69.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 163.37 146.87 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.559 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.5 Cg_endo -69.91 -1.87 9.33 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.672 2.248 . . . . 0.0 111.657 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 85.6 m-20 -43.42 -34.2 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -0.811 . . . . 0.0 109.503 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.919 HD11 ' HB2' ' A' ' 72' ' ' LEU . 45.9 mt -72.62 123.59 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.584 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.606 ' HB ' HD22 ' A' ' 79' ' ' LEU . 40.0 m -119.01 139.06 52.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 109.238 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.675 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 73.0 mt -119.76 137.33 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.664 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.524 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 94.8 mt-30 -120.62 155.63 33.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.365 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.618 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 19.9 t-80 -114.7 135.87 53.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.452 ' OE1' ' ND2' ' A' ' 150' ' ' ASN . 65.5 tt0 -104.73 139.51 39.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.322 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -73.76 96.98 2.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.504 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -70.51 -20.39 77.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -60.35 -43.74 96.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -1.129 . . . . 0.0 109.328 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.64 82.36 6.78 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.315 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.99 137.76 35.53 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.704 2.269 . . . . 0.0 111.947 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.7 p -123.26 153.01 40.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -0.861 . . . . 0.0 109.313 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -90.7 8.08 36.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.5 p -66.58 -17.16 64.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.361 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 25.2 t -109.1 138.03 46.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.505 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.437 HD11 ' CD1' ' A' ' 41' ' ' TYR . 19.9 tt -66.36 -20.8 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.413 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 92.6 m-70 -69.5 -32.54 71.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.529 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 42.7 m -55.21 -48.81 73.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.5 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 152' ' ' LEU . 85.7 tt0 -49.04 -49.48 41.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.457 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -56.85 -39.08 87.31 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.452 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 87.7 m-20 -64.84 -35.8 82.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -1.123 . . . . 0.0 109.365 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.64 -47.11 86.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.56 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.769 HD22 HG21 ' A' ' 43' ' ' VAL . 6.5 mp -65.25 -37.05 86.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.409 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.0 -41.66 90.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.915 . . . . 0.0 109.544 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.404 ' OD1' ' CG ' ' A' ' 13' ' ' ASP . 83.0 m-20 -57.6 -47.92 80.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.545 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -55.25 -48.01 74.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.515 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.494 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 62.7 mt -60.52 -38.76 85.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.568 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.05 -42.53 72.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 47.4 p -70.02 -30.94 68.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.569 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 163' ' ' VAL . 60.3 tt0 -62.66 -36.89 84.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -60.13 -37.82 93.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.868 ' HB3' HD12 ' A' ' 17' ' ' ILE . 14.5 m -59.95 -42.11 93.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.477 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.44 -25.33 68.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 159' ' ' GLN . 40.9 t -68.72 -23.36 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.398 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 161' ' ' SER . 38.5 t -128.36 156.42 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.187 -0.946 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.402 -179.923 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.61 147.37 37.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.419 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.5 mmm -62.95 -40.55 98.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 109.471 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.02 -160.74 27.49 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -138.44 110.93 7.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -1.117 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 1.032 ' CD2' HD11 ' A' ' 79' ' ' LEU . 54.6 m-85 -122.31 161.57 23.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.578 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.511 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 74.8 mm-40 -55.51 -38.27 68.97 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.217 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.478 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.82 -175.52 45.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.644 HG21 ' OH ' ' A' ' 37' ' ' TYR . 74.7 t -133.53 137.61 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.363 -1.081 . . . . 0.0 109.167 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.682 ' CZ ' ' CD2' ' A' ' 34' ' ' HIS . 57.0 m-85 -117.67 134.76 54.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.126 -0.984 . . . . 0.0 110.014 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 1.026 ' CE2' HD12 ' A' ' 81' ' ' ILE . 38.1 m-85 -107.49 129.12 54.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 109.034 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.914 HG22 HD12 ' A' ' 32' ' ' ILE . 12.8 p -118.48 147.65 43.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.862 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 65.5 t0 -138.31 146.46 42.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.481 -0.762 . . . . 0.0 109.143 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -135.17 136.92 8.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 83.4 p -143.47 161.88 37.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -1.139 . . . . 0.0 109.301 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -153.39 145.85 24.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.1 mt -116.59 138.86 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.311 -0.868 . . . . 0.0 109.358 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -112.04 125.73 54.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.895 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.49 ' OG ' ' HD2' ' A' ' 20' ' ' PRO . 2.3 t -121.39 157.09 57.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.186 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.49 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 43.8 Cg_endo -66.38 -18.11 54.64 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.642 2.228 . . . . 0.0 112.054 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.601 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 1.0 OUTLIER -84.86 -67.9 0.17 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 109.243 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 53.5 Cg_endo -73.04 51.79 2.1 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.441 2.094 . . . . 0.0 111.562 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.8 m -54.5 -41.89 70.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.547 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -99.95 27.61 5.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.531 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 0.5 OUTLIER -125.4 -67.17 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 109.481 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 25' ' ' SER . 85.2 m-20 62.16 130.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.596 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 90.3 m-20 -105.31 135.96 45.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -139.36 146.44 40.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.708 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 50' ' ' PRO . . . -137.18 159.06 24.59 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 66.6 mtm -131.89 151.21 51.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -1.148 . . . . 0.0 109.483 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.517 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -134.03 127.96 4.76 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.914 HD12 HG22 ' A' ' 12' ' ' THR . 23.9 mm -115.6 135.72 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -1.182 . . . . 0.0 109.489 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.0 t -126.25 135.01 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 1.138 ' CE1' HD12 ' A' ' 44' ' ' LEU . 14.0 t-160 -111.4 127.54 55.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 109.538 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.52 171.65 8.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -129.9 165.86 21.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.644 ' OH ' HG21 ' A' ' 9' ' ' VAL . 55.3 m-85 -100.2 13.07 35.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 109.449 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.583 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.32 179.94 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 108.939 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.0 Cg_endo -66.41 -4.85 11.45 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.136 1.89 . . . . 0.0 111.707 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.443 ' CD ' ' NE2' ' A' ' 42' ' ' GLN . 83.7 tt0 -138.11 106.16 5.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -0.847 . . . . 0.0 109.041 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -54.44 121.5 8.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.462 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.443 ' NE2' ' CD ' ' A' ' 40' ' ' GLU . 91.1 mt-30 -152.74 156.6 39.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 43' ' ' VAL . 21.0 m -89.62 118.13 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.138 HD12 ' CE1' ' A' ' 34' ' ' HIS . 39.5 mt -58.49 -45.62 88.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.362 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 74.9 m-20 -162.71 168.45 21.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.425 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -121.7 145.07 48.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.469 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 2.9 t-105 -128.85 140.03 51.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -125.35 128.8 48.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.462 HD11 ' CE2' ' A' ' 66' ' ' PHE . 2.7 mp -127.17 86.94 57.65 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.622 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.616 ' HB3' HG21 ' A' ' 163' ' ' VAL . 51.0 Cg_endo -70.65 130.53 18.39 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 122.746 2.297 . . . . 0.0 111.699 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 28' ' ' ALA . 43.9 mt -107.19 153.03 23.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 109.452 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -124.74 -40.95 0.4 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -108.0 32.07 5.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -1.113 . . . . 0.0 109.514 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 78.9 m80 -120.15 145.7 46.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.542 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.497 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -89.93 168.34 12.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.201 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -48.81 -38.95 23.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.135 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 60' ' ' GLU . 91.0 mt-30 -70.39 -58.26 3.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.854 . . . . 0.0 109.369 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.548 ' O ' HG22 ' A' ' 61' ' ' ILE . 95.3 mtp -44.95 -30.48 1.02 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.352 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.67 -36.81 57.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' GLN . 98.8 mt-10 -65.49 -40.04 92.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.451 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 58' ' ' MET . 20.5 tt -70.79 -34.57 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.46 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -69.41 -33.7 73.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.854 . . . . 0.0 109.45 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.545 ' HB1' ' OG1' ' A' ' 12' ' ' THR . . . -59.0 -43.17 91.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.524 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.667 HG21 HG12 ' A' ' 87' ' ' VAL . 96.3 t -70.79 -50.46 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.561 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.468 ' HG3' HG12 ' A' ' 120' ' ' ILE . 86.7 tt0 -59.17 -40.43 85.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.333 -0.854 . . . . 0.0 109.593 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.558 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 17.0 t80 -53.89 -70.73 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.908 . . . . 0.0 109.632 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.711 ' HB3' HG13 ' A' ' 80' ' ' VAL . . . -64.19 -10.96 26.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -0.906 . . . . 0.0 109.648 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.871 ' SG ' HG23 ' A' ' 120' ' ' ILE . 37.7 t -75.51 -56.34 4.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -63.25 -41.23 99.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 44.4 mttp -66.02 -34.68 78.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HB1' ' HB ' ' A' ' 78' ' ' VAL . . . -59.94 -58.93 6.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.965 ' HB2' HD11 ' A' ' 130' ' ' ILE . 9.3 tt -55.4 -45.12 76.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 72' ' ' LEU . 58.2 tttm -43.27 -41.75 4.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.592 HG13 HG21 ' A' ' 78' ' ' VAL . 30.0 mm -56.52 143.15 68.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.304 -0.872 . . . . 0.0 108.736 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.1 Cg_endo -64.33 -5.01 8.93 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.729 2.286 . . . . 0.0 112.086 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.511 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -136.22 171.87 22.64 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.949 -1.661 . . . . 0.0 108.949 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 49.7 Cg_endo -70.1 132.33 22.57 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.44 2.094 . . . . 0.0 111.806 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.592 HG21 HG13 ' A' ' 74' ' ' ILE . 60.2 t -120.61 161.86 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.442 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.032 HD11 ' CD2' ' A' ' 6' ' ' TYR . 14.5 mt -107.83 137.73 45.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.711 HG13 ' HB3' ' A' ' 67' ' ' ALA . 45.6 t -116.62 130.22 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.026 HD12 ' CE2' ' A' ' 11' ' ' TYR . 35.4 mt -117.56 136.16 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.0 109.501 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 84' ' ' SER . 12.8 t -139.51 159.71 41.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -88.99 19.74 3.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.535 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.533 ' H ' HG23 ' A' ' 82' ' ' THR . 34.2 t -122.55 116.8 24.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 109.521 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.567 ' CG ' ' N ' ' A' ' 86' ' ' TYR . 38.9 p90 -77.27 -45.31 26.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.489 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.567 ' N ' ' CG ' ' A' ' 85' ' ' PHE . 69.9 t80 -55.7 -48.87 74.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.667 HG12 HG21 ' A' ' 64' ' ' VAL . 86.8 t -60.13 -49.42 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.877 . . . . 0.0 109.318 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -53.24 -55.01 27.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.221 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 96.1 mt-10 -58.5 -28.39 65.34 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.325 -0.859 . . . . 0.0 109.391 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.627 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 23.9 m -59.88 -45.97 90.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.655 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -92.36 -0.74 57.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 109.774 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 82.3 m-20 -86.96 -68.19 0.76 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.004 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 67.8 mttm -122.19 -34.58 3.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.197 -0.939 . . . . 0.0 109.9 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.533 ' OE1' ' CZ2' ' A' ' 98' ' ' TRP . 83.4 mt-10 -62.41 -32.95 73.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 109.612 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 90' ' ' SER . 0.1 OUTLIER -55.92 -59.65 11.0 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.416 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 46.1 Cg_endo -67.72 -32.53 29.97 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.707 2.272 . . . . 0.0 111.444 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -73.0 -37.31 67.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 108.954 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.533 ' CZ2' ' OE1' ' A' ' 94' ' ' GLU . 15.1 m0 -60.18 -52.98 63.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.369 -0.832 . . . . 0.0 109.17 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.501 ' HG3' ' CZ ' ' A' ' 103' ' ' PHE . 77.1 tttt -44.65 -42.58 7.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.333 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 82.4 p -73.57 -28.31 61.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 98' ' ' TRP . 54.4 t30 -87.19 9.73 19.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 104' ' ' VAL . . . 81.37 25.56 54.12 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.501 ' CZ ' ' HG3' ' A' ' 99' ' ' LYS . 61.2 m-85 60.38 34.35 20.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -1.16 . . . . 0.0 109.448 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 102' ' ' GLY . 60.9 t -123.87 127.99 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.443 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.615 ' HB2' HD12 ' A' ' 111' ' ' LEU . 40.7 t-20 -58.2 -40.9 82.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 0.0 109.527 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -175.69 156.36 1.86 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.454 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -60.44 -28.68 68.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.435 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 109' ' ' LYS . 23.2 mttm -67.01 -36.28 81.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 108' ' ' LYS . 5.4 mmtt -145.75 138.58 13.98 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.455 ' HA ' HG13 ' A' ' 104' ' ' VAL . 49.2 Cg_endo -69.74 165.34 31.26 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.673 2.249 . . . . 0.0 111.81 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 105' ' ' ASN . 13.7 tp -84.45 133.36 34.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.534 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -94.93 151.05 19.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.423 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.405 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 58.4 m80 59.77 42.99 15.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.88 . . . . 0.0 109.438 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.56 HG22 ' HE3' ' A' ' 118' ' ' LYS . 91.9 mt -65.04 -42.68 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -0.866 . . . . 0.0 109.466 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -61.87 -39.84 93.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -60.66 -44.77 96.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.627 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 52.7 m95 -65.03 -38.53 91.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.427 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.56 ' HE3' HG22 ' A' ' 114' ' ' ILE . 52.0 mttt -58.69 -37.54 76.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.8 m -62.85 -43.48 98.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.372 -0.83 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.871 HG23 ' SG ' ' A' ' 68' ' ' CYS . 73.0 mt -69.86 -35.69 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.455 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -64.76 -34.37 78.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -53.03 -37.24 61.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.436 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.491 ' CA ' HD13 ' A' ' 72' ' ' LEU . 12.4 m -83.63 -45.37 13.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.49 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.466 ' CD2' ' HB ' ' A' ' 130' ' ' ILE . 53.1 mt -61.57 -31.44 71.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.437 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.0 m -56.41 -36.55 69.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.468 ' HB2' HD11 ' A' ' 72' ' ' LEU . 88.7 mtp -63.92 -36.8 85.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 171.24 157.32 0.22 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.5 Cg_endo -72.15 3.7 3.83 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.739 2.292 . . . . 0.0 112.061 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 128' ' ' PRO . 85.7 m-20 -42.36 -35.71 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.212 -0.93 . . . . 0.0 109.623 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.965 HD11 ' HB2' ' A' ' 72' ' ' LEU . 62.8 mt -75.17 116.26 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 109.402 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.574 ' HB ' HD22 ' A' ' 79' ' ' LEU . 31.3 m -110.88 142.55 42.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.368 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.655 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 62.0 mt -120.74 137.13 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.66 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB2' HG12 ' A' ' 81' ' ' ILE . 88.5 mt-30 -118.65 165.2 14.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -0.888 . . . . 0.0 109.36 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.528 ' CD2' ' HB3' ' A' ' 85' ' ' PHE . 29.4 t-80 -120.56 133.64 55.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.513 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HG3' HG22 ' A' ' 81' ' ' ILE . 93.6 mt-10 -102.13 159.5 15.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.335 -0.853 . . . . 0.0 109.426 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 140' ' ' PRO . 24.0 mttm -96.03 34.27 1.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.19 -175.66 51.42 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.485 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 86.3 t60 -65.29 -36.75 85.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -1.126 . . . . 0.0 109.444 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -105.67 75.94 0.34 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 138' ' ' HIS . 49.2 Cg_endo -70.2 144.34 51.38 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.672 2.248 . . . . 0.0 111.805 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 49.1 m -57.08 -38.2 72.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.431 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -113.08 128.53 56.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.373 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.6 m -78.87 135.81 37.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.1 p -143.72 170.36 16.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.875 . . . . 0.0 109.461 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.85 -31.0 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.551 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -68.8 -26.2 65.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.411 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.1 m -55.29 -45.59 76.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -51.67 -43.38 62.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.04 -39.04 89.01 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.44 ' OD1' ' HA ' ' A' ' 138' ' ' HIS . 22.9 t-20 -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -1.139 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -57.93 -51.72 68.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.608 ' N ' HD12 ' A' ' 152' ' ' LEU . 7.0 mp -65.46 -44.73 86.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 109.526 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.2 87.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.577 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.46 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 58.4 t0 -61.81 -38.04 86.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.541 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 24.1 mttm -62.96 -40.58 98.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.568 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 61.7 mt -72.09 -37.22 69.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.537 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.22 -44.51 75.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.47 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.588 HG22 ' HE2' ' A' ' 162' ' ' TYR . 31.1 m -61.03 -41.84 97.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.54 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.574 ' O ' HG13 ' A' ' 163' ' ' VAL . 94.4 mt-30 -67.29 -26.66 66.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.485 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.962 ' O ' HG22 ' A' ' 163' ' ' VAL . . . -66.28 -26.73 72.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.6 p -76.06 -25.37 55.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -1.157 . . . . 0.0 109.457 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.588 ' HE2' HG22 ' A' ' 158' ' ' THR . 93.4 m-85 -81.36 -25.59 36.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.055 HG23 HG23 ' A' ' 164' ' ' VAL . 5.1 m -62.76 -24.92 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.502 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 1.055 HG23 HG23 ' A' ' 163' ' ' VAL . 41.3 t -124.08 136.35 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.468 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.05 69.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -1.152 . . . . 0.0 109.502 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.479 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 93.1 mtp -62.83 -34.26 76.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.61 -167.2 38.53 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -122.86 121.81 37.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -1.115 . . . . 0.0 109.485 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 1.027 ' CD2' HD11 ' A' ' 79' ' ' LEU . 50.1 m-85 -120.9 162.5 19.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.37 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.558 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.8 tp10 -59.47 -37.1 77.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.268 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.484 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.69 -169.45 39.39 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.829 HG21 ' CZ ' ' A' ' 37' ' ' TYR . 70.2 t -142.55 140.65 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -1.135 . . . . 0.0 109.253 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.686 ' CE1' ' CD2' ' A' ' 34' ' ' HIS . 31.3 m-85 -121.05 142.88 49.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.82 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.527 ' CE1' HG13 ' A' ' 81' ' ' ILE . 49.7 m-85 -114.58 130.16 56.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 108.952 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.997 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 29.2 p -112.69 150.17 31.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.075 -1.015 . . . . 0.0 109.956 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 66.6 t0 -145.2 145.99 31.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.056 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -139.98 137.36 8.37 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.687 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 87.3 p -143.53 162.72 35.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -1.127 . . . . 0.0 109.17 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . . . -146.25 148.82 32.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.001 . . . . 0.0 109.757 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.418 HD12 ' HB2' ' A' ' 161' ' ' SER . 60.6 mt -117.88 141.87 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 109.278 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -103.22 125.32 49.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.54 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.486 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 4.9 t -117.89 154.56 51.3 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.304 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.469 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 45.6 Cg_endo -67.73 -7.3 19.05 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.662 2.242 . . . . 0.0 111.975 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.598 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -100.11 -69.76 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.456 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 54.2 Cg_endo -72.9 53.7 2.44 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.369 2.046 . . . . 0.0 111.657 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.7 m -54.79 -42.3 71.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 109.586 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -96.45 30.98 2.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -134.37 -58.31 0.84 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 109.499 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' SER . 82.1 m-20 62.36 129.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -99.41 125.66 45.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.443 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 15' ' ' SER . . . -135.65 158.41 44.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 50' ' ' PRO . . . -140.33 159.53 26.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.84 ' HE3' HD12 ' A' ' 49' ' ' ILE . 49.7 mtm -118.93 154.08 33.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -1.179 . . . . 0.0 109.399 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 156' ' ' LEU . . . -139.68 120.04 1.77 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.928 HD12 HG22 ' A' ' 12' ' ' THR . 20.9 mm -111.13 133.08 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -1.154 . . . . 0.0 109.437 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' PHE . 42.7 t -118.64 137.89 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 1.137 ' CE1' HD22 ' A' ' 44' ' ' LEU . 23.6 t-160 -112.86 130.15 56.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.52 166.94 20.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.324 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.594 ' HB ' HD11 ' A' ' 44' ' ' LEU . 9.9 t -127.75 154.25 45.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.829 ' CZ ' HG21 ' A' ' 9' ' ' VAL . 11.8 m-30 -95.22 5.28 52.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.518 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.585 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.3 179.56 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.059 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.7 Cg_endo -66.39 -4.43 10.67 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.219 1.946 . . . . 0.0 111.825 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -130.38 105.93 8.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 108.745 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -71.22 130.3 41.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 109.554 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -167.99 151.83 6.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.429 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.6 p -76.96 125.59 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.878 . . . . 0.0 109.406 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.137 HD22 ' CE1' ' A' ' 34' ' ' HIS . 7.5 mp -72.23 -36.67 69.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.902 . . . . 0.0 109.387 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -173.05 158.46 3.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.457 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.856 ' HB3' HD21 ' A' ' 156' ' ' LEU . 91.8 mt-30 -113.49 138.64 49.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.279 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.465 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -121.25 135.42 55.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.657 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.7 t -128.71 129.95 46.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.196 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.84 HD12 ' HE3' ' A' ' 30' ' ' MET . 4.1 mt -134.45 93.17 19.23 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.115 -0.991 . . . . 0.0 109.691 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 50.5 Cg_endo -70.9 140.28 38.05 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.693 2.262 . . . . 0.0 111.658 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.772 HD11 ' HG3' ' A' ' 30' ' ' MET . 5.3 mp -109.0 154.84 21.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.531 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -125.04 -34.86 0.66 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.547 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 42.7 p-10 -118.47 36.67 4.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.161 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.556 ' CG ' HD23 ' A' ' 51' ' ' LEU . 77.7 m80 -126.47 169.75 12.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.441 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.618 HG23 ' H ' ' A' ' 58' ' ' MET . 10.0 t -111.43 -176.27 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -0.871 . . . . 0.0 109.459 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.645 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -67.52 -39.06 85.09 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.544 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -67.38 -45.23 76.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.557 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.618 ' H ' HG23 ' A' ' 55' ' ' THR . 96.0 mtp -65.15 -36.46 84.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.616 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.82 88.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 56' ' ' ALA . 96.1 mt-10 -67.12 -48.4 68.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.6 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.744 ' HA ' HG21 ' A' ' 87' ' ' VAL . 13.1 tt -66.21 -36.15 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.452 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.572 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -64.9 -28.64 69.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.997 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -68.16 -40.94 82.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.573 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.519 HG22 ' CG2' ' A' ' 82' ' ' THR . 61.4 t -70.34 -38.24 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.593 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.594 ' HG2' HD11 ' A' ' 120' ' ' ILE . 97.3 mt-10 -66.4 -37.46 85.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.071 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.637 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 24.1 t80 -63.26 -67.1 0.45 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.451 -0.781 . . . . 0.0 109.761 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 68' ' ' CYS . . . -58.2 -45.3 87.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 109.867 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.779 ' SG ' HG23 ' A' ' 120' ' ' ILE . 42.5 t -42.47 -62.57 0.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 109.738 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 42.7 mttp -54.83 -50.46 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -0.949 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.637 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 64.2 mttm -55.23 -36.84 66.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.597 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.03 -61.31 2.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.443 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.777 ' HB2' HD11 ' A' ' 130' ' ' ILE . 22.8 tp -51.53 -45.52 63.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 36.6 mmtt -43.82 -47.19 8.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.325 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.556 HG13 HG21 ' A' ' 78' ' ' VAL . 27.5 mm -48.39 142.73 7.97 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 108.923 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.6 Cg_endo -65.82 -3.91 9.01 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.553 2.169 . . . . 0.0 111.808 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.427 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -137.07 168.81 24.2 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 129' ' ' ASP . 48.5 Cg_endo -69.44 130.53 19.9 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.53 2.154 . . . . 0.0 111.723 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.59 HG11 ' CE1' ' A' ' 10' ' ' PHE . 50.4 t -120.0 158.66 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.512 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.027 HD11 ' CD2' ' A' ' 6' ' ' TYR . 23.2 mt -101.74 143.85 31.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.9 t -119.48 130.4 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.527 HG13 ' CE1' ' A' ' 11' ' ' TYR . 24.4 mm -111.08 142.0 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.519 ' CG2' HG22 ' A' ' 64' ' ' VAL . 1.4 p -131.95 157.99 42.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.487 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.448 ' OD2' ' OD1' ' A' ' 13' ' ' ASP . 60.5 m-20 -82.17 -20.02 38.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.479 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.626 ' HB3' HG12 ' A' ' 87' ' ' VAL . 46.9 t -110.62 131.64 54.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.576 ' HB3' ' CG ' ' A' ' 134' ' ' HIS . 46.4 p90 -76.11 -35.03 59.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -57.06 -52.58 64.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.418 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.744 HG21 ' HA ' ' A' ' 61' ' ' ILE . 9.7 p -62.03 -47.31 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.341 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.771 ' HB1' HG22 ' A' ' 132' ' ' ILE . . . -55.76 -53.66 53.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 85' ' ' PHE . 76.0 mm-40 -60.01 -35.14 74.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.357 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.554 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 33.6 m -51.7 -48.04 63.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.461 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.874 ' HB1' HG21 ' A' ' 120' ' ' ILE . . . -91.37 -0.99 57.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.633 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 44.3 t-20 -85.61 -72.83 0.47 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.001 . . . . 0.0 109.744 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 21.4 mttt -126.72 -28.52 2.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.091 -1.005 . . . . 0.0 109.917 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.576 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 91.9 mt-10 -60.56 -31.98 71.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.033 . . . . 0.0 109.866 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -58.14 -59.88 11.91 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.503 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.8 Cg_endo -66.94 -33.23 33.48 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.664 2.242 . . . . 0.0 111.606 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.492 ' CE2' ' OD1' ' A' ' 101' ' ' ASN . 76.3 t80 -70.26 -35.43 73.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -0.887 . . . . 0.0 109.043 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.576 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 10.8 m0 -63.8 -50.78 67.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.374 -0.829 . . . . 0.0 109.192 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.568 ' HG2' ' CE1' ' A' ' 103' ' ' PHE . 4.5 mtpm? -47.97 -41.9 26.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 109.415 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 62.3 p -62.37 -34.33 76.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.563 ' O ' HG12 ' A' ' 104' ' ' VAL . 23.2 m120 -85.29 7.56 21.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 77.71 29.97 53.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.568 ' CE1' ' HG2' ' A' ' 99' ' ' LYS . 74.3 m-85 62.38 43.68 7.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 109.456 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 109' ' ' LYS . 13.1 p -118.18 135.7 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.875 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 109' ' ' LYS . 46.7 t30 -89.54 121.48 31.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.505 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -61.02 -32.5 72.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -59.28 -39.03 81.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.1 tttm -134.81 -73.26 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.629 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.2 OUTLIER 176.83 -66.32 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 109.448 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 109' ' ' LYS . 51.0 Cg_endo -70.99 122.2 8.57 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.723 2.282 . . . . 0.0 111.801 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.971 ' HB3' HD11 ' A' ' 114' ' ' ILE . 19.3 tp -61.16 -37.06 81.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.315 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 23.8 mttm 61.81 146.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.569 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.538 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 50.4 m80 64.61 41.14 5.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.519 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.971 HD11 ' HB3' ' A' ' 111' ' ' LEU . 40.6 mm -72.46 -42.84 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.305 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.7 m -62.12 -40.23 95.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.273 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 67.8 mttm -62.8 -44.27 96.61 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.387 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.714 ' HB3' HD21 ' A' ' 95' ' ' LEU . 24.0 m95 -78.7 -31.69 46.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.295 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -57.88 -41.09 81.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.139 -0.976 . . . . 0.0 109.343 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.3 m -60.81 -48.1 83.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.333 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.874 HG21 ' HB1' ' A' ' 91' ' ' ALA . 76.7 mt -70.36 -35.32 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.435 ' O ' ' OG ' ' A' ' 125' ' ' SER . . . -63.77 -34.68 78.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.369 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 126' ' ' MET . 82.5 tt0 -62.44 -36.42 82.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 19.9 m -79.97 -48.97 12.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.412 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.07 -35.93 74.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.848 . . . . 0.0 109.391 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 121' ' ' ALA . 43.4 m -63.33 -32.93 74.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.422 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 89.8 mtp -66.88 -34.41 77.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.873 . . . . 0.0 109.476 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.81 135.64 0.36 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.404 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.0 Cg_endo -69.6 -2.49 10.15 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.694 2.263 . . . . 0.0 111.57 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 128' ' ' PRO . 88.4 m-20 -43.46 -36.88 2.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.846 . . . . 0.0 109.344 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.777 HD11 ' HB2' ' A' ' 72' ' ' LEU . 50.0 mt -66.94 116.52 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.282 -0.886 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.573 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.3 m -106.91 144.49 33.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 109.371 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.771 HG22 ' HB1' ' A' ' 88' ' ' ALA . 72.7 mt -125.23 137.46 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 109.496 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.527 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 95.1 mt-30 -135.35 159.3 42.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.576 ' CG ' ' HB3' ' A' ' 85' ' ' PHE . 22.4 t-80 -101.6 132.67 47.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.576 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.52 ' HB2' ' CG2' ' A' ' 81' ' ' ILE . 43.6 tp10 -124.16 150.86 44.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.474 ' N ' ' HG3' ' A' ' 135' ' ' GLU . 4.8 tttm 49.16 -149.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 109.446 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.15 -115.11 5.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -110.54 131.38 55.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -1.135 . . . . 0.0 109.511 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 47.93 70.65 1.95 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.566 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.432 ' HB3' ' HA ' ' A' ' 136' ' ' LYS . 50.3 Cg_endo -70.53 139.17 36.96 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.693 2.262 . . . . 0.0 111.744 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 1.028 HG22 ' OG1' ' A' ' 143' ' ' THR . 46.2 m -63.29 -36.83 84.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.506 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 140' ' ' PRO . 72.2 m-20 57.0 43.11 25.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.028 ' OG1' HG22 ' A' ' 141' ' ' THR . 0.2 OUTLIER -144.15 14.1 1.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.486 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 89.7 p -116.62 154.14 31.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.431 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.9 pt -68.6 -16.26 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.513 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -65.9 -28.66 69.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.455 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.7 m -49.15 -52.67 24.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.02 -49.51 63.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.398 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.32 -38.77 57.75 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -59.37 -42.36 91.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.183 . . . . 0.0 109.397 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.94 79.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.6 mt -59.97 -46.66 88.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.254 -0.904 . . . . 0.0 109.452 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.663 ' HA ' HD12 ' A' ' 156' ' ' LEU . . . -59.65 -38.91 82.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.469 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 91.6 m-20 -57.28 -42.64 82.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.419 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 31.5 mttp -62.34 -40.65 97.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 109.449 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.856 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.5 mt -64.04 -43.52 95.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.443 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.41 -46.25 89.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 43.4 m -58.42 -41.92 86.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 155' ' ' LYS . 96.3 mt-30 -63.07 -33.91 76.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -57.6 -41.74 93.76 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.418 ' HB2' HD12 ' A' ' 17' ' ' ILE . 70.5 p -65.19 -31.52 72.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -1.159 . . . . 0.0 109.45 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -68.67 -28.19 66.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 109.509 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.8 t -67.07 -22.18 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.954 . . . . 0.0 109.509 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.45 134.79 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.471 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.477 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.27 77.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -1.152 . . . . 0.0 109.483 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.617 ' HE2' ' CE2' ' A' ' 37' ' ' TYR . 88.6 mmm -62.68 -37.21 85.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.499 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.03 -24.73 51.79 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -49.77 -47.16 51.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -1.093 . . . . 0.0 109.46 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.511 ' CE2' HD21 ' A' ' 79' ' ' LEU . 29.6 m-85 -96.36 167.83 10.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -73.48 -34.16 65.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.868 . . . . 0.0 109.098 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.566 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -179.15 -166.84 35.7 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.626 HG22 ' HB2' ' A' ' 79' ' ' LEU . 77.5 t -133.51 140.87 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.276 -1.132 . . . . 0.0 109.055 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.632 ' CE2' ' ND1' ' A' ' 34' ' ' HIS . 5.4 m-85 -113.24 147.33 37.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.844 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE1' HG13 ' A' ' 81' ' ' ILE . 96.9 m-85 -116.87 130.22 56.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 108.935 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.786 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 33.5 p -119.39 149.8 41.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.993 . . . . 0.0 109.933 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -147.02 163.07 37.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.437 -0.789 . . . . 0.0 109.203 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.436 ' CA ' ' OE2' ' A' ' 60' ' ' GLU . . . -139.53 118.73 1.55 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.2 m -123.2 143.95 49.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -1.16 . . . . 0.0 109.468 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 27' ' ' ASN . . . -142.99 155.6 44.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.1 mt -119.9 138.33 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 109.401 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -114.94 144.21 43.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.189 -0.945 . . . . 0.0 109.574 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -125.37 170.39 9.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.312 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 19' ' ' SER . 47.6 Cg_endo -68.38 -35.69 17.64 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.683 2.255 . . . . 0.0 111.596 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -120.88 70.37 18.7 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.175 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.09 60.54 1.33 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.768 2.312 . . . . 0.0 111.812 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.9 p -60.16 -26.56 66.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.357 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 25' ' ' SER . 88.5 mttt -112.2 30.42 7.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.442 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 24' ' ' LYS . 0.5 OUTLIER 68.72 163.5 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.615 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -69.01 163.39 24.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.53 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.643 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 80.7 m-20 -91.53 144.35 25.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.394 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -140.52 154.67 46.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -156.77 150.23 21.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.757 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 69.2 mtm -113.99 168.82 9.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -1.105 . . . . 0.0 109.432 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -152.96 115.45 0.68 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.604 HD13 ' CD1' ' A' ' 49' ' ' ILE . 5.4 mp -125.87 118.9 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.132 . . . . 0.0 109.253 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 45' ' ' ASN . 10.3 p -118.63 151.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.72 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.632 ' ND1' ' CE2' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -104.11 136.95 42.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 109.253 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.55 158.4 34.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.624 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.893 ' HB ' HD11 ' A' ' 44' ' ' LEU . 14.4 t -125.58 164.42 20.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 109.384 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.617 ' CE2' ' HE2' ' A' ' 3' ' ' MET . 86.5 m-85 -116.68 8.38 13.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.184 -0.947 . . . . 0.0 109.619 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.587 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.65 -179.42 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 108.946 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.8 Cg_endo -65.95 -5.12 11.39 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.08 1.853 . . . . 0.0 111.749 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -125.84 106.02 9.37 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.945 ' CD1' HD11 ' A' ' 145' ' ' ILE . 78.9 t80 -73.74 122.89 23.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.196 -0.94 . . . . 0.0 109.531 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -168.0 117.78 0.79 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.88 . . . . 0.0 109.203 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.627 HG11 HD13 ' A' ' 152' ' ' LEU . 1.4 m -47.94 123.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -0.93 . . . . 0.0 109.399 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.893 HD11 ' HB ' ' A' ' 36' ' ' THR . 5.8 mp -65.68 -38.31 88.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.661 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.576 ' O ' HG23 ' A' ' 33' ' ' VAL . 57.2 t-20 -175.27 155.02 1.82 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 109.88 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 156' ' ' LEU . 89.8 mt-30 -112.37 150.55 30.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -0.809 . . . . 0.0 108.892 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.525 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.1 t-105 -128.78 131.16 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.989 . . . . 0.0 109.664 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.9 t -122.39 133.36 54.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.412 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.604 ' CD1' HD13 ' A' ' 32' ' ' ILE . 3.6 mp -134.1 88.42 31.43 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.88 139.22 39.28 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.728 2.286 . . . . 0.0 111.728 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.832 HD12 ' N ' ' A' ' 51' ' ' LEU . 3.0 mp -106.04 147.88 28.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.402 ' HA2' HG11 ' A' ' 164' ' ' VAL . . . -93.21 -67.58 1.08 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -104.89 60.87 0.69 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -1.145 . . . . 0.0 109.502 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 78.0 m80 -133.16 173.06 11.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 58' ' ' MET . 8.9 t -117.11 173.16 6.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 109.474 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -55.91 -45.54 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.849 . . . . 0.0 109.261 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 60' ' ' GLU . 85.6 mt-30 -58.36 -63.82 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.416 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.471 ' H ' HG23 ' A' ' 55' ' ' THR . 97.9 mtp -43.55 -29.2 0.45 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.335 -0.853 . . . . 0.0 109.485 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.44 -29.17 30.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.372 -0.83 . . . . 0.0 109.611 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 57' ' ' GLN . 62.7 mm-40 -71.08 -34.81 71.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.704 HD11 ' CZ2' ' A' ' 117' ' ' TRP . 13.4 tt -82.1 -34.65 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 109.609 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.757 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -69.61 -26.09 64.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.786 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -67.09 -36.45 82.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.414 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.725 HG22 HG21 ' A' ' 82' ' ' THR . 84.9 t -75.57 -36.67 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.466 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 77.6 tt0 -70.4 -37.17 74.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.122 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.525 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 26.1 t80 -60.86 -66.33 0.55 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.398 -0.814 . . . . 0.0 109.508 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.66 -31.15 57.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.551 ' SG ' HD13 ' A' ' 130' ' ' ILE . 33.3 t -55.2 -57.63 10.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 31.9 tttt -63.7 -38.88 92.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 17.6 mmtt -59.84 -32.89 71.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.907 . . . . 0.0 109.47 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' LEU . . . -71.22 -59.8 2.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.291 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 130' ' ' ILE . 25.8 tp -45.18 -47.27 12.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.278 -0.889 . . . . 0.0 109.296 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 57.4 mttm -44.13 -48.79 9.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.195 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.068 HD12 HG21 ' A' ' 78' ' ' VAL . 4.8 mt -54.65 141.91 54.34 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 109.056 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.5 Cg_endo -66.07 -7.33 16.75 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.525 2.15 . . . . 0.0 111.483 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -127.94 161.19 21.88 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.0 Cg_endo -69.05 146.67 65.34 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.437 2.091 . . . . 0.0 111.747 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.068 HG21 HD12 ' A' ' 74' ' ' ILE . 25.4 t -134.78 159.36 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.335 -0.853 . . . . 0.0 109.562 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.632 HD12 ' C ' ' A' ' 78' ' ' VAL . 7.1 mp -109.02 132.41 54.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.542 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.5 t -103.18 133.15 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.203 -0.936 . . . . 0.0 109.433 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.813 HG21 ' OE2' ' A' ' 135' ' ' GLU . 21.2 mm -106.13 132.52 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.366 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.725 HG21 HG22 ' A' ' 64' ' ' VAL . 1.1 p -133.42 161.71 33.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.529 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -92.7 6.99 45.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.516 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.522 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 41.3 t -130.28 123.76 30.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.918 . . . . 0.0 109.603 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.618 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 40.3 p90 -77.05 -43.0 36.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.535 ' N ' ' CG ' ' A' ' 85' ' ' PHE . 69.9 t80 -47.16 -50.25 20.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.88 . . . . 0.0 109.447 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.726 HG23 ' HH2' ' A' ' 117' ' ' TRP . 7.2 p -66.71 -47.76 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.343 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.596 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -54.04 -46.96 72.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.26 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 98.2 mt-10 -65.22 -35.47 81.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.331 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.577 ' HB2' ' CH2' ' A' ' 117' ' ' TRP . 68.3 m -52.74 -44.48 66.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.472 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.747 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -96.43 -0.89 48.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 51.7 t30 -92.56 -72.74 0.58 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.031 . . . . 0.0 109.751 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 48.2 mttm -126.64 -27.67 3.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.859 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.49 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 87.3 mt-10 -61.23 -31.46 71.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.871 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 91' ' ' ALA . 0.6 OUTLIER -56.05 -60.2 9.56 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.681 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 45.6 Cg_endo -67.4 -34.55 26.3 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.727 2.285 . . . . 0.0 111.702 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -68.59 -36.45 78.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.227 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.673 ' CE3' HD21 ' A' ' 111' ' ' LEU . 13.8 m0 -65.05 -47.45 77.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.559 ' HG2' ' CE1' ' A' ' 103' ' ' PHE . 87.6 mttt -43.03 -43.97 4.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.865 . . . . 0.0 109.436 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.5 p -63.49 -34.81 78.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.387 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.848 ' O ' HG12 ' A' ' 104' ' ' VAL . 19.9 m120 -84.58 7.84 18.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 82.77 30.49 32.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.559 ' CE1' ' HG2' ' A' ' 99' ' ' LYS . 56.4 m-85 64.29 27.3 13.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -1.182 . . . . 0.0 109.493 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 101' ' ' ASN . 9.9 p -125.52 125.63 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.471 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -59.59 -35.76 74.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.421 ' O ' ' O ' ' A' ' 109' ' ' LYS . 43.0 t-20 -173.39 150.05 1.8 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -57.71 -26.59 61.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.537 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -65.3 -36.07 82.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.423 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 106' ' ' ASN . 5.5 mttt -148.06 143.43 17.63 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.635 ' HA ' HG23 ' A' ' 104' ' ' VAL . 50.3 Cg_endo -70.29 151.5 66.07 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.646 2.23 . . . . 0.0 111.915 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.673 HD21 ' CE3' ' A' ' 98' ' ' TRP . 20.6 tp -57.06 -37.96 72.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.434 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 83.7 mttt 62.74 139.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.56 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 54.0 m80 65.52 26.51 11.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -0.819 . . . . 0.0 109.637 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.783 HG22 ' HE3' ' A' ' 118' ' ' LYS . 66.6 mt -64.29 -42.47 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.274 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -53.84 -46.23 71.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.161 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -58.51 -42.07 86.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.854 . . . . 0.0 109.251 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.726 ' HH2' HG23 ' A' ' 87' ' ' VAL . 16.3 m95 -67.67 -34.14 76.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.783 ' HE3' HG22 ' A' ' 114' ' ' ILE . 62.3 mttt -60.12 -36.37 77.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.332 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.428 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 25.3 m -66.28 -44.4 83.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.338 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.747 HG21 ' CB ' ' A' ' 91' ' ' ALA . 74.4 mt -66.64 -38.73 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.426 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.447 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -62.21 -35.88 80.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.387 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 126' ' ' MET . 82.9 tt0 -54.12 -39.84 66.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.872 . . . . 0.0 109.398 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.9 m -77.39 -46.5 22.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 0.0 109.4 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 59.9 mt -61.42 -36.83 81.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.417 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.5 m -60.53 -34.13 73.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.402 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.442 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 89.3 mtp -64.17 -30.77 71.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.235 -0.915 . . . . 0.0 109.511 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 176.27 136.32 0.19 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.532 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.58 -0.09 7.06 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.74 2.293 . . . . 0.0 111.805 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 93.6 m-20 -50.2 -21.57 1.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 72' ' ' LEU . 68.0 mt -81.15 114.52 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.64 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 55.6 m -112.17 135.28 53.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.601 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 75.6 mt -116.57 138.75 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.105 -0.997 . . . . 0.0 109.682 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.587 ' NE2' HD23 ' A' ' 79' ' ' LEU . 94.7 mt-30 -124.68 159.45 30.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.618 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 19.8 t-80 -119.54 142.18 48.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.813 ' OE2' HG21 ' A' ' 81' ' ' ILE . 92.9 mt-10 -106.0 145.06 31.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.451 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' HB2' ' HG2' ' A' ' 139' ' ' GLN . 80.8 mttt -92.6 37.86 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.49 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.69 -107.84 1.31 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -95.93 102.16 13.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -1.169 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.425 ' HB2' ' HD2' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -149.34 158.21 38.49 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.414 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 139' ' ' GLN . 50.2 Cg_endo -70.25 126.46 13.01 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.742 2.295 . . . . 0.0 111.854 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 143' ' ' THR . 62.1 m -122.33 144.75 48.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -52.65 -34.53 51.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.538 ' H ' HG22 ' A' ' 141' ' ' THR . 28.0 p -126.55 150.95 48.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 109.493 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.1 p -91.97 2.34 56.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 109.649 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.945 HD11 ' CD1' ' A' ' 41' ' ' TYR . 20.7 tt -69.62 -33.04 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.554 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -69.71 -29.88 67.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.605 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.8 m -67.18 -42.98 83.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.506 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.459 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 97.9 mt-10 -60.06 -36.66 77.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.51 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -69.3 -24.85 75.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -75.52 -33.88 60.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -1.118 . . . . 0.0 109.471 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -74.74 -41.45 60.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.627 HD13 HG11 ' A' ' 43' ' ' VAL . 68.9 mt -64.87 -38.2 90.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.94 . . . . 0.0 109.55 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.13 -39.58 75.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -65.84 -39.38 90.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.125 -0.984 . . . . 0.0 109.464 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 66.8 mttm -64.85 -35.41 81.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.55 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 46' ' ' GLN . 39.9 mt -68.19 -40.26 82.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 109.58 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.42 92.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.52 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 38.4 m -58.38 -44.06 88.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.519 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -61.94 -37.08 83.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.534 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.0 -48.2 84.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 164' ' ' VAL . 85.8 p -64.84 -33.45 76.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -1.148 . . . . 0.0 109.59 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -63.44 -38.41 91.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 68.7 t -57.06 -38.17 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 51' ' ' LEU . 41.2 t -105.37 134.69 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.517 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.515 ' HA ' ' ND2' ' A' ' 27' ' ' ASN . 84.4 m-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.453 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.19 146.23 44.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -1.16 . . . . 0.0 109.415 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.551 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 56.8 mtp -66.29 -28.12 68.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.37 -14.87 43.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.476 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 95.3 mt-30 -57.83 -44.49 86.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -1.177 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.856 ' CD2' HD11 ' A' ' 79' ' ' LEU . 49.5 p90 -91.75 154.41 18.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 109.481 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.744 ' HG3' HG22 ' A' ' 78' ' ' VAL . 2.6 pp20? -89.54 -27.08 20.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.212 -0.93 . . . . 0.0 109.589 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.4 -174.61 31.47 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.501 HG13 ' CE2' ' A' ' 11' ' ' TYR . 14.6 p -130.43 143.7 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -1.141 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.669 ' CD2' HG11 ' A' ' 78' ' ' VAL . 26.5 m-85 -119.44 123.6 44.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.932 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.643 ' CE1' HD12 ' A' ' 81' ' ' ILE . 87.7 m-85 -105.81 130.83 53.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.409 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.816 HG22 HD12 ' A' ' 32' ' ' ILE . 15.8 p -119.93 150.75 39.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.508 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 57.3 t0 -142.64 151.47 41.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.455 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -133.64 119.19 2.24 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.6 m -127.85 152.22 48.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -1.172 . . . . 0.0 109.5 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 27' ' ' ASN . . . -137.62 156.05 48.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.903 . . . . 0.0 109.453 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.9 mt -123.7 140.84 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.928 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -107.21 132.66 52.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.52 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.513 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -119.31 162.05 33.98 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.235 -0.916 . . . . 0.0 109.33 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.94 -45.81 1.36 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.724 2.282 . . . . 0.0 111.765 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.469 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -56.79 -60.48 9.28 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.501 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.513 ' CG ' ' HB2' ' A' ' 19' ' ' SER . 50.6 Cg_endo -71.26 66.66 2.7 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.626 2.217 . . . . 0.0 111.626 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.9 m -54.81 -50.07 69.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.388 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -97.64 29.08 3.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.388 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.511 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 75.8 m -146.29 146.94 30.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.938 . . . . 0.0 109.532 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 25' ' ' SER . 12.2 m120 -143.39 152.99 42.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 70.3 m-20 -86.63 145.19 26.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.632 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -140.29 150.22 43.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -151.93 165.24 30.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.844 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 56.0 mtm -132.7 152.79 51.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -1.109 . . . . 0.0 109.291 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.37 125.22 2.97 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.816 HD12 HG22 ' A' ' 12' ' ' THR . 19.1 mm -111.08 142.51 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -1.154 . . . . 0.0 109.301 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.3 t -136.64 123.52 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.159 -0.963 . . . . 0.0 109.756 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 1.012 ' CD2' HD12 ' A' ' 44' ' ' LEU . 23.6 t60 -101.01 138.27 38.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.141 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.25 163.18 33.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 109.836 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.0 t -123.16 164.96 17.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.415 -0.803 . . . . 0.0 109.172 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' A' ' 38' ' ' LYS . 83.8 m-85 -103.49 9.47 37.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.094 -1.004 . . . . 0.0 109.639 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.578 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 2.0 mtmt -51.21 -179.25 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.8 Cg_endo -65.13 -5.78 11.7 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.039 1.826 . . . . 0.0 111.649 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -127.28 105.74 8.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.339 -0.85 . . . . 0.0 108.741 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -74.01 126.81 31.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.43 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -167.33 148.3 5.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 109.589 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.6 m -71.47 121.96 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.365 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.012 HD12 ' CD2' ' A' ' 34' ' ' HIS . 41.0 mt -65.06 -43.95 90.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.327 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 76.8 m-20 -159.17 147.79 18.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.377 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.924 ' HB3' HD21 ' A' ' 156' ' ' LEU . 90.6 mt-30 -106.85 144.26 33.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.402 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.81 138.53 45.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 0.0 109.714 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.413 ' C ' HD12 ' A' ' 49' ' ' ILE . 96.5 p -130.85 144.87 51.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.353 -0.842 . . . . 0.0 109.273 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 4.7 mp -138.35 97.28 9.55 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.554 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.81 137.43 32.38 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.641 2.227 . . . . 0.0 111.711 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' A' ' 28' ' ' ALA . 39.4 mt -103.67 141.02 36.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.63 -66.54 0.94 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -115.58 61.12 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.154 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 74.7 m80 -130.26 -176.66 4.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.409 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.514 HG22 ' HG3' ' A' ' 58' ' ' MET . 15.3 t -126.96 168.01 15.1 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.898 . . . . 0.0 109.542 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.69 -36.59 62.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.512 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -60.9 -41.06 95.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.438 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 55' ' ' THR . 65.6 mtt -65.62 -32.95 74.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' HG2' ' A' ' 30' ' ' MET . . . -66.91 -34.05 76.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.876 . . . . 0.0 109.596 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.78 -41.69 68.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.885 . . . . 0.0 109.582 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 58' ' ' MET . 17.9 tt -73.71 -34.77 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.633 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.844 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -75.82 -30.13 58.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.592 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -65.27 -39.71 92.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.822 HG21 HG12 ' A' ' 87' ' ' VAL . 89.7 t -73.26 -40.4 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.636 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.469 ' HG3' HG12 ' A' ' 120' ' ' ILE . 83.7 tt0 -68.72 -40.06 80.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 109.231 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.63 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 31.3 t80 -52.37 -64.15 0.91 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 109.634 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.623 ' HB3' HG11 ' A' ' 80' ' ' VAL . . . -62.75 -27.63 69.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.675 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.638 ' SG ' HG23 ' A' ' 120' ' ' ILE . 48.8 t -58.1 -58.05 10.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.543 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.454 ' HG2' ' SG ' ' A' ' 123' ' ' CYS . 40.3 mttt -61.11 -46.42 90.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.571 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.63 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 65.2 mttm -63.95 -33.99 76.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.942 . . . . 0.0 109.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.35 -60.25 3.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.512 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.584 ' HB2' HD11 ' A' ' 130' ' ' ILE . 18.8 tp -57.66 -36.01 71.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 109.508 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -51.81 -43.46 63.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -0.918 . . . . 0.0 109.369 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.704 HG13 HG21 ' A' ' 78' ' ' VAL . 35.5 mm -48.36 143.04 7.63 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.898 . . . . 0.0 108.886 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.6 Cg_endo -64.36 -6.06 11.04 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.541 2.161 . . . . 0.0 111.724 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.449 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -139.23 171.73 23.53 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.476 ' HG2' ' O ' ' A' ' 5' ' ' GLN . 48.3 Cg_endo -69.04 134.49 29.63 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.449 2.099 . . . . 0.0 111.676 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.744 HG22 ' HG3' ' A' ' 7' ' ' GLU . 32.1 t -127.41 167.67 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 109.26 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.856 HD11 ' CD2' ' A' ' 6' ' ' TYR . 3.9 mt -125.87 127.58 46.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.291 -0.881 . . . . 0.0 109.78 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.623 HG11 ' HB3' ' A' ' 67' ' ' ALA . 34.7 t -101.44 133.01 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 109.235 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.643 HD12 ' CE1' ' A' ' 11' ' ' TYR . 23.5 mt -117.04 134.13 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.5 t -142.81 159.96 41.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.248 -0.907 . . . . 0.0 109.503 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 50.6 p-10 -83.9 -4.65 58.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.516 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.518 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 63.5 m -77.95 97.23 5.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.386 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.584 ' HA ' ' CD2' ' A' ' 134' ' ' HIS . 97.6 m-85 -64.16 -49.57 71.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.151 -0.968 . . . . 0.0 109.381 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -63.23 -52.25 62.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.65 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.822 HG12 HG21 ' A' ' 64' ' ' VAL . 38.8 t -55.88 -59.9 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -0.923 . . . . 0.0 109.591 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.944 ' HB3' ' NE2' ' A' ' 134' ' ' HIS . . . -43.57 -57.62 3.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.436 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.466 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 98.0 mt-10 -53.98 -40.74 67.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.463 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.567 ' CB ' ' CZ3' ' A' ' 117' ' ' TRP . 50.0 m -47.26 -52.13 16.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.689 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -89.7 -0.98 57.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.171 -0.956 . . . . 0.0 109.673 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 44.5 t-20 -82.14 -72.67 0.43 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.652 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 96.3 mttt -126.5 -22.7 3.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.075 -1.016 . . . . 0.0 110.062 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 96.3 mt-10 -67.13 -25.6 66.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.039 . . . . 0.0 109.66 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.868 HD11 ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -54.57 -58.77 12.62 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.598 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 45.9 Cg_endo -67.16 -32.31 34.16 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.554 2.169 . . . . 0.0 111.464 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -66.01 -40.21 90.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 108.982 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.806 ' CE3' HD21 ' A' ' 111' ' ' LEU . 39.8 m0 -62.74 -50.48 70.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.475 -0.766 . . . . 0.0 109.192 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.633 ' CD ' ' CZ ' ' A' ' 103' ' ' PHE . 22.6 tptm -43.03 -42.9 4.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.336 -0.852 . . . . 0.0 109.364 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 m -60.13 -39.18 85.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.375 -0.828 . . . . 0.0 109.361 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 98' ' ' TRP . 21.7 m120 -87.48 11.43 14.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.449 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 104' ' ' VAL . . . 76.04 38.6 34.87 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.633 ' CZ ' ' CD ' ' A' ' 99' ' ' LYS . 75.0 m-85 63.7 32.35 13.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -1.174 . . . . 0.0 109.418 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 110' ' ' PRO . 45.2 t -128.64 123.13 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.491 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -59.6 -39.97 85.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.513 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 109' ' ' LYS . 41.7 t-20 -160.36 145.59 14.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -58.59 -23.22 58.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.315 -0.866 . . . . 0.0 109.425 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.27 -37.77 86.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.923 . . . . 0.0 109.391 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.451 ' O ' ' O ' ' A' ' 106' ' ' ASN . 0.3 OUTLIER -144.17 148.69 42.4 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.468 ' HA ' HG13 ' A' ' 104' ' ' VAL . 49.6 Cg_endo -70.56 154.97 64.2 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.682 2.255 . . . . 0.0 111.777 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.806 HD21 ' CE3' ' A' ' 98' ' ' TRP . 33.2 tp -62.4 -31.32 71.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.373 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.562 ' HE3' ' CE1' ' A' ' 113' ' ' HIS . 51.9 tttp 67.11 140.03 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.475 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.562 ' CE1' ' HE3' ' A' ' 112' ' ' LYS . 59.4 m80 62.35 27.81 16.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.399 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.45 HG12 ' HB3' ' A' ' 111' ' ' LEU . 77.1 mt -60.96 -41.21 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 109.436 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.9 m -55.47 -46.55 76.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.4 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -60.37 -47.06 87.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.502 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.567 ' CZ3' ' CB ' ' A' ' 90' ' ' SER . 88.1 m95 -68.03 -33.61 74.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -56.21 -44.28 79.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.481 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.457 ' HB2' ' OE2' ' A' ' 65' ' ' GLU . 36.2 m -58.2 -43.4 87.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.638 HG23 ' SG ' ' A' ' 68' ' ' CYS . 78.0 mt -66.38 -40.13 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.978 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.868 ' HB2' HD11 ' A' ' 95' ' ' LEU . . . -62.98 -35.27 79.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.44 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -56.65 -35.48 68.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.454 ' SG ' ' HG2' ' A' ' 69' ' ' LYS . 77.7 m -80.02 -49.2 12.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.469 HD23 HD12 ' A' ' 130' ' ' ILE . 51.9 mt -57.98 -37.0 73.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 25.5 m -58.77 -33.42 70.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.33 -0.856 . . . . 0.0 109.501 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 90.0 mtp -63.9 -37.67 88.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 177.3 143.44 0.26 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.1 Cg_endo -69.65 -1.35 8.23 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.722 2.281 . . . . 0.0 111.749 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 128' ' ' PRO . 88.3 m-20 -43.4 -35.22 1.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.441 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.584 HD11 ' HB2' ' A' ' 72' ' ' LEU . 67.5 mt -69.74 121.47 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.421 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.737 ' HB ' HD22 ' A' ' 79' ' ' LEU . 23.8 m -119.06 143.48 47.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.369 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.658 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 70.6 mt -122.78 130.72 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.446 ' HB2' HG12 ' A' ' 81' ' ' ILE . 89.9 mt-30 -125.01 153.54 42.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.392 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.944 ' NE2' ' HB3' ' A' ' 88' ' ' ALA . 37.3 m170 -89.74 133.33 34.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.605 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.631 ' HG2' HG22 ' A' ' 81' ' ' ILE . 96.2 mt-10 -69.96 140.38 52.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.799 . . . . 0.0 109.519 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 137' ' ' GLY . 40.1 mttm -87.89 69.25 9.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 109.419 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -43.8 -88.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.517 ' O ' ' CB ' ' A' ' 139' ' ' GLN . 43.2 m80 -127.97 137.51 52.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.181 -1.188 . . . . 0.0 109.506 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.578 ' CB ' ' CD ' ' A' ' 140' ' ' PRO . 0.7 OUTLIER 164.29 -65.66 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 139' ' ' GLN . 48.2 Cg_endo -72.02 -59.84 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.587 2.191 . . . . 0.0 111.924 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 143' ' ' THR . 48.8 p -136.63 173.98 11.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.344 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -64.2 -40.21 95.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.296 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.418 ' O ' ' OG1' ' A' ' 141' ' ' THR . 17.7 p -134.31 160.88 36.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 109.289 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 147' ' ' THR . 56.6 p -146.01 162.3 38.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.566 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 80.6 mt -56.29 -46.29 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.535 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -66.57 -24.74 66.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.471 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 144' ' ' SER . 95.2 m -58.56 -42.86 88.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -52.36 -45.25 65.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.595 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.41 -36.96 91.25 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -65.1 -33.84 76.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -1.169 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.427 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -64.98 -52.29 57.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 152' ' ' LEU . 6.9 mp -65.45 -46.73 78.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.592 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.53 80.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.533 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -63.17 -34.93 78.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 69.5 mttt -63.03 -43.5 98.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.511 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.924 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.4 mp -71.82 -37.18 70.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.55 -43.09 91.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 109.56 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 36.6 m -63.79 -41.37 97.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.605 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.876 ' O ' HG23 ' A' ' 163' ' ' VAL . 94.2 mt-30 -61.74 -35.73 78.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.575 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.57 -51.45 58.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 164' ' ' VAL . 25.0 m -64.56 -37.19 86.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -1.182 . . . . 0.0 109.672 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -64.1 -33.96 76.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 159' ' ' GLN . 45.8 t -65.86 -15.05 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.553 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 161' ' ' SER . 47.3 t -129.12 156.7 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.469 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 16.1 m120 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.57 157.6 6.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -1.19 . . . . 0.0 109.457 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.435 ' HE1' ' CE1' ' A' ' 37' ' ' TYR . 68.7 mtm -69.3 -41.4 76.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.36 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.573 ' HA3' ' CZ ' ' A' ' 6' ' ' TYR . . . -120.51 24.82 7.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 95.1 mt-30 62.66 44.54 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -1.13 . . . . 0.0 109.752 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.63 ' CE2' ' CD2' ' A' ' 79' ' ' LEU . 17.8 m-85 -103.36 162.15 13.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.272 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.41 ' HG3' HG22 ' A' ' 74' ' ' ILE . 77.1 mm-40 -69.58 -33.94 73.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 108.931 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.27 -168.75 38.77 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.907 ' CG1' ' HB3' ' A' ' 35' ' ' ALA . 7.8 p -123.0 145.19 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.241 -1.153 . . . . 0.0 109.115 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.869 ' CE1' HG21 ' A' ' 78' ' ' VAL . 9.4 m-85 -122.48 137.42 54.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 109.859 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.739 ' CE1' HD12 ' A' ' 81' ' ' ILE . 92.6 m-85 -118.24 126.75 52.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.317 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.937 HG22 HD12 ' A' ' 32' ' ' ILE . 27.5 p -117.75 144.22 45.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 43.8 t0 -143.2 149.92 38.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.407 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -129.69 123.18 4.01 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m -129.36 147.75 51.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -1.102 . . . . 0.0 109.313 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 27' ' ' ASN . . . -137.81 151.8 48.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.164 -0.96 . . . . 0.0 109.628 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 20.4 mt -120.23 149.06 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.855 . . . . 0.0 109.262 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -108.61 146.66 33.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.11 -0.994 . . . . 0.0 109.666 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.563 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.7 OUTLIER -94.48 179.95 1.11 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 0.0 109.053 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 50.5 Cg_endo -71.27 -23.71 23.94 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.233 1.955 . . . . 0.0 111.614 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.42 ' N ' ' HD3' ' A' ' 22' ' ' PRO . 1.3 m-20 -131.83 62.74 65.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 109.078 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 19' ' ' SER . 55.4 Cg_endo -81.87 62.67 8.24 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.768 2.312 . . . . 0.0 112.004 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.511 ' O ' ' CG ' ' A' ' 24' ' ' LYS . 48.8 m -55.06 -44.32 74.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.202 -0.936 . . . . 0.0 109.151 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 23' ' ' THR . 35.9 mttp -159.9 38.33 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.863 . . . . 0.0 109.384 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 39.8 t -149.55 135.5 18.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 109.577 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 25' ' ' SER . 97.1 m-20 -143.41 155.51 44.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.4 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.586 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 85.5 m-20 -83.31 137.22 34.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -137.81 151.25 47.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.417 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.434 ' HA2' ' CD1' ' A' ' 51' ' ' LEU . . . -154.3 162.6 30.7 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.74 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 74.0 mtm -127.41 168.52 14.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -1.121 . . . . 0.0 109.479 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.711 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -152.96 113.76 0.59 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.937 HD12 HG22 ' A' ' 12' ' ' THR . 10.9 mm -119.44 114.09 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.166 . . . . 0.0 109.338 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.556 ' CG2' ' HG2' ' A' ' 46' ' ' GLN . 7.5 p -118.52 148.01 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.2 -0.938 . . . . 0.0 109.691 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.687 ' CD2' ' CE2' ' A' ' 10' ' ' PHE . 7.4 m170 -101.62 145.01 29.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 109.118 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.907 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . . . -136.9 166.81 22.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.109 -0.995 . . . . 0.0 109.677 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.748 ' HB ' HD11 ' A' ' 44' ' ' LEU . 9.9 t -123.24 165.41 16.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.352 -0.842 . . . . 0.0 109.458 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.435 ' CE1' ' HE1' ' A' ' 3' ' ' MET . 55.2 m-85 -105.94 10.84 32.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.342 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 3.1 mtpt -51.18 178.76 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.839 . . . . 0.0 109.103 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.5 Cg_endo -65.09 -6.19 12.47 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.187 1.925 . . . . 0.0 111.663 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -131.23 106.28 8.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 108.982 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 48.9 t80 -58.54 127.62 33.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 81.2 mt-30 -159.45 141.92 13.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.51 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 43' ' ' VAL . 25.0 m -78.93 122.38 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.426 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.748 HD11 ' HB ' ' A' ' 36' ' ' THR . 7.4 mp -67.09 -42.96 83.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' O ' HG23 ' A' ' 33' ' ' VAL . 29.8 m120 -160.41 149.95 17.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.645 ' HB3' HD21 ' A' ' 156' ' ' LEU . 90.2 mt-30 -110.22 150.93 27.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.199 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.7 t-105 -133.31 137.16 45.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.005 . . . . 0.0 109.8 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.1 t -125.74 132.56 52.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.213 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.689 HD13 ' CD1' ' A' ' 66' ' ' PHE . 6.1 mt -135.53 89.8 21.49 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.179 -0.951 . . . . 0.0 109.702 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.464 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.3 Cg_endo -71.05 144.57 47.54 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 122.63 2.22 . . . . 0.0 111.596 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.822 ' N ' HD12 ' A' ' 51' ' ' LEU . 3.7 mp -110.93 147.86 33.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.588 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.74 -75.59 1.26 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -98.56 61.74 1.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.127 . . . . 0.0 109.448 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.452 ' HA ' ' SD ' ' A' ' 58' ' ' MET . 76.6 m80 -131.62 -177.56 4.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.938 . . . . 0.0 109.529 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.416 HG22 ' HG3' ' A' ' 58' ' ' MET . 15.3 t -128.22 166.84 17.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 0.0 109.5 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -48.13 -44.73 32.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.94 . . . . 0.0 109.331 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 60' ' ' GLU . 86.2 mt-30 -55.2 -58.17 8.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.303 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.452 ' SD ' ' HA ' ' A' ' 54' ' ' HIS . 62.1 mtt -44.81 -34.62 2.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.266 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.4 -31.51 60.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.319 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 57' ' ' GLN . 96.5 mt-10 -72.66 -38.35 67.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.327 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.774 ' HA ' HG21 ' A' ' 87' ' ' VAL . 7.3 tt -81.53 -38.47 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.74 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -66.06 -36.48 83.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.352 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.56 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -55.91 -48.18 76.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.367 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.793 HG21 HG13 ' A' ' 87' ' ' VAL . 78.4 t -64.04 -48.98 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.8 tt0 -58.24 -43.94 88.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.689 ' CD1' HD13 ' A' ' 49' ' ' ILE . 13.0 t80 -54.63 -68.12 0.21 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.37 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HB3' HG11 ' A' ' 80' ' ' VAL . . . -56.48 -19.21 14.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.204 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.979 ' SG ' HG23 ' A' ' 120' ' ' ILE . 19.3 t -66.46 -64.94 0.75 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.269 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -58.66 -46.38 87.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -58.36 -30.08 66.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.907 . . . . 0.0 109.263 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.861 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -67.35 -63.87 0.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.562 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.941 ' HB2' HD11 ' A' ' 130' ' ' ILE . 22.8 tp -50.18 -44.06 52.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.173 -0.954 . . . . 0.0 109.334 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 72' ' ' LEU . 26.4 tttt -43.27 -48.71 6.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.275 -0.891 . . . . 0.0 109.1 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.681 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 10.6 mt -48.4 143.19 7.58 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.369 -0.832 . . . . 0.0 108.879 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 45.5 Cg_endo -66.36 -2.25 6.85 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.625 2.217 . . . . 0.0 112.124 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.43 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -139.98 167.9 25.24 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.411 ' HB3' ' HB3' ' A' ' 129' ' ' ASP . 47.7 Cg_endo -68.94 116.74 4.62 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.446 2.097 . . . . 0.0 111.578 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.869 HG21 ' CE1' ' A' ' 10' ' ' PHE . 6.5 p -109.25 148.53 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.349 -0.845 . . . . 0.0 109.403 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.63 ' CD2' ' CE2' ' A' ' 6' ' ' TYR . 7.4 mp -96.31 138.87 33.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 67' ' ' ALA . 29.9 t -115.78 135.13 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.371 -0.831 . . . . 0.0 109.149 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.739 HD12 ' CE1' ' A' ' 11' ' ' TYR . 15.0 mt -122.44 136.85 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.602 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 t -139.1 160.33 40.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.341 -0.849 . . . . 0.0 109.316 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -81.59 -13.07 58.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.924 . . . . 0.0 109.564 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.542 ' CB ' HG12 ' A' ' 87' ' ' VAL . 29.5 m -93.15 115.62 28.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.565 ' HB2' ' CG ' ' A' ' 134' ' ' HIS . 46.4 t80 -81.4 -38.58 26.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.365 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -55.42 -46.71 76.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.54 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.793 HG13 HG21 ' A' ' 64' ' ' VAL . 14.1 p -70.18 -46.49 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 109.499 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.599 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -56.57 -48.32 77.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.267 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -60.55 -37.34 80.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.537 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 50.2 m -52.47 -55.11 24.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.194 -0.941 . . . . 0.0 109.372 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.633 ' HB1' HD11 ' A' ' 124' ' ' LEU . . . -83.73 -0.89 52.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.903 . . . . 0.0 109.628 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 38.6 t-20 -83.15 -72.76 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.951 . . . . 0.0 109.729 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 87.0 mttt -126.71 -25.36 3.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 97.9 mt-10 -69.57 -24.47 63.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.131 -0.98 . . . . 0.0 109.731 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' A' ' 121' ' ' ALA . 0.2 OUTLIER -54.58 -57.34 19.32 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 109.644 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 46.1 Cg_endo -67.47 -34.36 26.52 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.507 2.138 . . . . 0.0 111.663 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -65.82 -38.68 89.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.118 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.451 ' CG ' HD11 ' A' ' 111' ' ' LEU . 43.0 m0 -64.72 -49.75 69.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.34 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -47.93 -42.44 27.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -61.08 -38.57 86.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.897 . . . . 0.0 109.41 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -87.85 11.6 15.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.49 41.71 50.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.635 ' C ' HD12 ' A' ' 111' ' ' LEU . 57.5 m-85 61.84 35.71 16.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.454 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.25 125.9 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.494 ' HB3' ' HB3' ' A' ' 109' ' ' LYS . 32.5 t30 -55.26 -42.47 73.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -177.07 -149.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.521 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -68.59 122.37 18.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.55 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.3 mttp 55.36 30.28 14.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.844 . . . . 0.0 109.533 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 105' ' ' ASN . 14.9 mttt -130.16 87.3 51.57 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.58 152.92 65.4 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.654 2.236 . . . . 0.0 111.804 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 103' ' ' PHE . 96.4 mt -85.3 139.59 31.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -93.18 148.69 21.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.574 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 48.0 m80 61.53 34.44 17.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.489 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.457 HG12 ' HB2' ' A' ' 111' ' ' LEU . 69.7 mt -54.19 -45.39 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.423 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.6 m -50.82 -48.35 59.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.543 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.1 -35.94 76.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.48 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.537 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 20.1 m95 -70.45 -38.13 74.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 109.516 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -58.83 -39.4 81.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.426 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.6 m -62.51 -43.06 99.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.979 HG23 ' SG ' ' A' ' 68' ' ' CYS . 83.6 mt -71.72 -36.09 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.638 ' HB2' HD11 ' A' ' 95' ' ' LEU . . . -65.29 -34.95 79.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -56.06 -38.47 70.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 61.3 m -81.18 -49.37 10.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.877 . . . . 0.0 109.467 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.633 HD11 ' HB1' ' A' ' 91' ' ' ALA . 54.7 mt -60.52 -31.9 70.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.432 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.4 t -62.38 -33.0 73.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 94.9 mmm -64.73 -38.05 89.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.16 146.48 0.56 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.284 -0.885 . . . . 0.0 109.447 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 129' ' ' ASP . 50.1 Cg_endo -70.79 0.66 6.07 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.739 2.292 . . . . 0.0 111.899 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 128' ' ' PRO . 88.8 m-20 -44.09 -50.53 8.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.398 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.941 HD11 ' HB2' ' A' ' 72' ' ' LEU . 58.3 mt -55.25 113.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.777 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.481 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 54.9 m -110.54 144.18 39.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 108.986 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -124.29 141.45 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 109.83 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.441 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.4 mt-30 -128.58 159.56 35.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.389 -0.819 . . . . 0.0 109.184 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.565 ' CG ' ' HB2' ' A' ' 85' ' ' PHE . 32.2 t-80 -119.52 140.29 50.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 109.665 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.541 ' OE2' HG21 ' A' ' 81' ' ' ILE . 94.9 mt-10 -128.4 139.88 52.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.334 -0.854 . . . . 0.0 109.218 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 139' ' ' GLN . 72.1 mttt -104.46 121.81 44.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 0.0 109.482 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.0 -33.52 84.1 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -64.08 -43.77 94.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -1.186 . . . . 0.0 109.361 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 136' ' ' LYS . 15.8 tp60 -109.75 128.35 25.55 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.54 144.23 49.31 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.758 2.305 . . . . 0.0 111.776 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 143' ' ' THR . 21.1 p -73.7 171.85 12.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -56.04 -36.84 68.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 109.529 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.679 HG22 ' H ' ' A' ' 145' ' ' ILE . 33.5 m -116.95 137.19 52.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.518 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 86.1 p -65.51 -23.75 66.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.161 -0.962 . . . . 0.0 109.435 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.679 ' H ' HG22 ' A' ' 143' ' ' THR . 82.5 mt -52.49 -45.89 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.93 . . . . 0.0 109.514 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -65.84 -38.0 87.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.93 . . . . 0.0 109.429 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.5 p -68.79 -41.51 78.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 144' ' ' SER . 97.8 mt-10 -53.94 -38.48 64.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.48 -37.62 94.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -64.44 -42.93 95.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.289 -1.124 . . . . 0.0 109.431 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.92 -52.5 64.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.867 . . . . 0.0 109.461 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.479 ' O ' HD13 ' A' ' 156' ' ' LEU . 64.5 mt -60.38 -48.84 80.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.823 . . . . 0.0 109.485 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.402 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . . . -52.76 -40.3 63.01 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.566 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.424 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 54.3 t0 -60.06 -49.32 78.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.611 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -52.89 -37.96 61.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.533 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.645 HD21 ' HB3' ' A' ' 46' ' ' GLN . 7.1 mp -69.37 -41.53 76.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' MET . . . -69.55 -44.99 69.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.562 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 33.6 m -58.81 -42.18 88.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.539 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -61.94 -39.47 92.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.501 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -62.0 -45.75 95.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.536 ' HA ' HG12 ' A' ' 164' ' ' VAL . 85.2 p -69.53 -25.75 64.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -1.184 . . . . 0.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -67.68 -36.34 80.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.504 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.3 t -72.91 -19.08 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 161' ' ' SER . 14.8 p -113.93 134.37 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.524 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.464 ' HA ' ' ND2' ' A' ' 27' ' ' ASN . 44.2 t-20 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.64 70.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -1.139 . . . . 0.0 109.442 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.561 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 95.5 mmm -64.31 -38.65 91.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.47 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.83 -14.14 36.05 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -55.11 -26.29 37.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -1.17 . . . . 0.0 109.602 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.993 ' CD2' HD11 ' A' ' 79' ' ' LEU . 18.4 p90 -110.69 163.7 13.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 109.898 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.452 ' OE1' HG22 ' A' ' 74' ' ' ILE . 21.2 tt0 -79.59 -45.14 19.71 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.422 -0.799 . . . . 0.0 108.996 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.836 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -161.21 178.52 37.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.585 HG23 ' HE2' ' A' ' 37' ' ' TYR . 67.9 t -129.73 146.27 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -1.14 . . . . 0.0 109.501 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.864 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.5 m-85 -118.4 155.39 30.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.781 ' CE1' HD12 ' A' ' 81' ' ' ILE . 96.3 m-85 -118.03 123.17 45.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.332 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.865 HG22 HD12 ' A' ' 32' ' ' ILE . 24.2 p -117.06 145.78 43.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.551 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 56.7 t0 -143.99 152.98 41.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -137.33 117.08 1.46 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 29' ' ' GLY . 47.0 t -133.49 155.18 50.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.319 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.712 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -137.95 158.68 43.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.595 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 65.0 mt -118.13 140.19 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -102.6 136.41 42.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.503 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -113.26 173.18 3.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 48.5 Cg_endo -68.9 -33.57 19.77 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.713 2.275 . . . . 0.0 111.709 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.26 71.04 33.96 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.316 -0.865 . . . . 0.0 109.345 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -69.34 54.3 1.0 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.71 2.273 . . . . 0.0 111.731 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.8 m -59.58 -31.64 69.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.873 . . . . 0.0 109.349 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 25' ' ' SER . 67.7 mttt -110.11 29.91 7.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.414 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 24' ' ' LYS . 1.0 OUTLIER 71.84 164.3 0.28 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.689 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 42.5 p-10 -64.18 163.6 12.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 109.487 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 19.9 m120 -94.36 125.94 39.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 0.0 109.367 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . . . -103.5 156.07 18.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.534 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -147.22 148.38 19.94 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.656 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 63.6 mtm -124.02 165.11 18.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -1.2 . . . . 0.0 109.573 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.702 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -149.87 116.86 0.81 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.865 HD12 HG22 ' A' ' 12' ' ' THR . 15.1 mm -120.26 115.27 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -1.161 . . . . 0.0 109.486 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 45' ' ' ASN . 12.3 p -118.76 148.39 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.498 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.989 ' CD2' HD22 ' A' ' 44' ' ' LEU . 9.4 t60 -101.16 137.23 39.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.556 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.485 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -122.23 158.16 30.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.958 ' HB ' HD11 ' A' ' 44' ' ' LEU . 12.0 t -125.11 162.23 25.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.877 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.585 ' HE2' HG23 ' A' ' 9' ' ' VAL . 58.5 m-85 -108.64 11.47 26.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.968 . . . . 0.0 109.618 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.558 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 5.3 mttt -51.21 178.74 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.0 Cg_endo -64.43 -6.05 11.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.185 1.924 . . . . 0.0 111.704 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 40' ' ' GLU . 70.0 mm-40 -129.53 105.36 8.03 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.254 -0.904 . . . . 0.0 108.759 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -64.54 125.31 24.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.574 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -168.18 129.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.507 ' O ' HG23 ' A' ' 43' ' ' VAL . 22.6 m -58.7 126.04 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.457 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.989 HD22 ' CD2' ' A' ' 34' ' ' HIS . 6.1 mp -67.33 -42.79 83.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.654 ' O ' HG23 ' A' ' 33' ' ' VAL . 77.9 m-20 -160.61 154.41 22.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.617 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.596 ' HB3' HD21 ' A' ' 156' ' ' LEU . 90.9 mt-30 -113.1 148.22 35.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 109.131 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CB ' ' O ' ' A' ' 32' ' ' ILE . 11.6 t-105 -127.34 138.88 53.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.105 -0.997 . . . . 0.0 109.843 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.407 ' C ' HG13 ' A' ' 49' ' ' ILE . 51.5 m -126.96 136.73 52.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.118 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.418 HD12 ' HE3' ' A' ' 30' ' ' MET . 3.8 mt -144.03 92.05 6.38 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.733 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.1 Cg_endo -70.76 148.32 58.32 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.66 2.24 . . . . 0.0 111.557 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 51' ' ' LEU . 5.7 mp -119.65 145.5 46.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.95 -48.36 0.17 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -90.42 9.95 27.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -1.133 . . . . 0.0 109.393 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 56.7 m80 -117.75 -176.08 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.887 . . . . 0.0 109.522 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.409 HG22 ' HG3' ' A' ' 58' ' ' MET . 13.8 t -124.49 166.36 16.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.712 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -46.21 -45.51 16.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 0.0 109.346 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 60' ' ' GLU . 84.6 mt-30 -54.38 -59.34 4.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 109.428 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.429 ' SD ' ' HB3' ' A' ' 54' ' ' HIS . 61.2 mtt -44.08 -33.98 1.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.444 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.454 ' HB1' ' CG ' ' A' ' 30' ' ' MET . . . -71.85 -31.45 66.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.27 -0.893 . . . . 0.0 109.389 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 57' ' ' GLN . 96.8 mt-10 -70.88 -33.61 70.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.503 ' HA ' HG21 ' A' ' 87' ' ' VAL . 7.1 tt -86.92 -30.84 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 109.341 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.656 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -74.95 -29.71 61.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.417 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -64.98 -39.07 92.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.86 . . . . 0.0 109.497 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.619 HG21 HG13 ' A' ' 87' ' ' VAL . 71.8 t -71.95 -45.6 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.489 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.519 ' HB2' HD11 ' A' ' 120' ' ' ILE . 87.3 tt0 -64.3 -37.01 85.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.6 ' CE2' ' CE ' ' A' ' 70' ' ' LYS . 13.7 t80 -56.07 -69.04 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -60.4 -15.82 29.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.903 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.66 ' SG ' HG23 ' A' ' 120' ' ' ILE . 44.8 t -67.66 -63.92 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 109.454 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HG2' ' SG ' ' A' ' 123' ' ' CYS . 23.6 mttm -58.64 -44.54 90.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.6 ' CE ' ' CE2' ' A' ' 66' ' ' PHE . 66.5 mttm -63.51 -38.54 91.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.832 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -54.83 -61.62 2.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.959 ' HB2' HD11 ' A' ' 130' ' ' ILE . 9.1 tt -51.55 -45.33 62.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 72' ' ' LEU . 65.0 tttm -43.64 -42.41 5.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.175 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.578 HG23 ' HD2' ' A' ' 75' ' ' PRO . 48.4 mm -48.93 143.21 8.68 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.331 -0.856 . . . . 0.0 108.806 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.578 ' HD2' HG23 ' A' ' 74' ' ' ILE . 41.8 Cg_endo -63.7 -4.71 7.52 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.669 2.246 . . . . 0.0 112.311 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.497 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -143.06 171.8 24.81 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.502 ' HG2' ' HA ' ' A' ' 6' ' ' TYR . 43.9 Cg_endo -67.22 118.61 5.7 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.495 2.13 . . . . 0.0 111.684 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.864 HG21 ' CE1' ' A' ' 10' ' ' PHE . 9.0 p -114.67 151.43 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.394 -0.816 . . . . 0.0 109.266 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.993 HD11 ' CD2' ' A' ' 6' ' ' TYR . 12.2 mt -96.82 154.73 17.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.83 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' A' ' 131' ' ' THR . 38.9 t -125.87 133.07 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.536 -0.727 . . . . 0.0 109.049 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 11' ' ' TYR . 26.2 mt -120.04 133.8 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.61 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.46 HG21 ' CG2' ' A' ' 64' ' ' VAL . 7.1 t -136.5 161.72 35.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.511 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.455 ' OD2' ' OD1' ' A' ' 13' ' ' ASP . 58.3 p30 -89.33 15.04 9.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.515 ' OG ' HG12 ' A' ' 87' ' ' VAL . 26.7 t -123.93 114.73 20.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.918 . . . . 0.0 109.487 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.568 ' HB2' ' CD2' ' A' ' 134' ' ' HIS . 61.3 t80 -77.16 -43.15 34.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.573 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -49.0 -48.26 43.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.619 HG13 HG21 ' A' ' 64' ' ' VAL . 8.9 p -68.03 -45.36 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.593 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.571 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -53.4 -49.69 66.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.925 . . . . 0.0 109.544 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 80.5 tt0 -60.55 -34.39 74.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.303 -0.873 . . . . 0.0 109.516 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.633 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 50.5 m -56.42 -55.87 28.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.728 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.68 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -82.02 -0.75 45.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.904 . . . . 0.0 109.702 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 47.0 t-20 -84.66 -73.23 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 109.812 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 62.6 tttt -127.37 -30.98 2.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.092 -1.005 . . . . 0.0 109.924 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 58.9 mm-40 -56.75 -37.69 71.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.108 -0.995 . . . . 0.0 109.922 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -51.38 -61.56 3.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 109.628 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 95' ' ' LEU . 45.5 Cg_endo -67.76 -27.19 38.12 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.571 2.18 . . . . 0.0 111.449 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -73.47 -34.99 65.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 108.983 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.595 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 15.8 m0 -66.96 -48.35 68.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.847 . . . . 0.0 109.19 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 98' ' ' TRP . 25.2 mttt -43.5 -40.59 3.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.427 -0.796 . . . . 0.0 109.363 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.2 p -62.37 -39.83 94.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.311 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 98' ' ' TRP . 85.5 m-20 -85.79 10.58 13.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 109.379 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 80.04 38.16 19.9 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.517 ' O ' ' CB ' ' A' ' 111' ' ' LEU . 62.1 m-85 64.78 34.61 9.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -1.143 . . . . 0.0 109.393 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 1.092 HG13 ' HA ' ' A' ' 110' ' ' PRO . 50.5 t -122.25 123.07 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.508 ' HA ' ' NE1' ' A' ' 98' ' ' TRP . 32.2 t-20 -56.71 -49.27 75.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 109.364 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -148.59 160.59 42.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.422 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -65.1 -26.28 68.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -66.41 -43.51 85.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.31 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -139.15 146.54 49.64 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.367 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 1.092 ' HA ' HG13 ' A' ' 104' ' ' VAL . 49.8 Cg_endo -70.09 177.37 5.88 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.647 2.232 . . . . 0.0 111.805 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.56 HD21 ' CE3' ' A' ' 98' ' ' TRP . 19.2 tp -88.39 133.5 34.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.449 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 21.4 mttp -99.77 149.01 23.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 28.1 m80 68.75 31.76 4.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 109.553 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 75.8 mt -61.73 -41.36 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.296 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.9 m -53.27 -50.18 65.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 109.257 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -60.38 -38.4 83.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 109.334 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.633 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 25.3 m95 -72.35 -36.76 68.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -55.65 -44.97 77.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.325 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.2 m -60.41 -45.78 92.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.319 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.66 HG23 ' SG ' ' A' ' 68' ' ' CYS . 73.5 mt -69.34 -32.83 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.746 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -60.91 -38.07 84.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.931 . . . . 0.0 109.4 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 126' ' ' MET . 96.2 mt-10 -61.7 -40.51 95.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.332 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 130' ' ' ILE . 56.6 m -64.85 -51.02 64.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.847 ' O ' HD13 ' A' ' 124' ' ' LEU . 3.4 tm? -65.02 -37.05 86.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.0 109.231 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.2 t -56.1 -36.11 67.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.446 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 65.4 mtt -64.25 -32.88 74.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.293 -0.88 . . . . 0.0 109.369 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 126' ' ' MET . 0.4 OUTLIER 167.78 153.3 0.12 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.3 Cg_endo -71.39 0.36 6.94 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.621 2.214 . . . . 0.0 111.702 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 128' ' ' PRO . 92.1 m-20 -43.07 -48.21 6.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.372 -0.83 . . . . 0.0 109.543 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.959 HD11 ' HB2' ' A' ' 72' ' ' LEU . 74.3 mt -65.38 122.12 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -0.881 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.589 ' HB ' HD22 ' A' ' 79' ' ' LEU . 32.6 m -116.98 149.58 40.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.193 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.68 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 55.4 mt -127.01 132.69 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.134 -0.979 . . . . 0.0 109.712 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.452 ' HB2' HG12 ' A' ' 81' ' ' ILE . 86.4 mt-30 -118.09 159.39 23.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.17 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.568 ' CD2' ' HB2' ' A' ' 85' ' ' PHE . 28.2 t-80 -120.28 133.56 55.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.991 . . . . 0.0 109.683 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -94.19 145.61 24.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.419 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.517 ' CB ' ' HB2' ' A' ' 139' ' ' GLN . 59.3 mttp -90.41 29.32 1.29 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.499 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.41 -132.74 52.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -47.11 -46.43 22.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -1.172 . . . . 0.0 109.35 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.517 ' HB2' ' CB ' ' A' ' 136' ' ' LYS . 3.7 mt-30 -46.38 141.95 4.65 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.94 148.84 64.77 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.705 2.27 . . . . 0.0 111.848 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 143' ' ' THR . 18.7 p -91.36 170.02 10.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.396 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -51.13 -35.82 37.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.604 HG22 ' H ' ' A' ' 145' ' ' ILE . 33.4 m -125.63 134.01 52.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.549 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.9 p -63.6 -28.0 69.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.842 . . . . 0.0 109.47 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.604 ' H ' HG22 ' A' ' 143' ' ' THR . 84.3 mt -61.08 -40.38 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.557 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -65.5 -29.41 70.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.155 -0.965 . . . . 0.0 109.529 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.5 m -64.93 -41.71 95.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.472 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.23 -41.33 75.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.07 -36.16 87.22 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -66.56 -38.13 86.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -1.159 . . . . 0.0 109.395 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.16 -53.07 62.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.462 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 152' ' ' LEU . 6.8 mp -67.39 -46.41 73.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.348 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.534 ' HA ' HD12 ' A' ' 156' ' ' LEU . . . -57.28 -38.26 73.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.455 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 81.5 m-20 -63.11 -43.63 97.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.526 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.88 -41.61 78.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.535 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 46' ' ' GLN . 6.8 mt -64.43 -41.21 96.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.935 . . . . 0.0 109.399 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.99 -44.54 96.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 37.2 m -55.78 -45.81 78.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.549 ' O ' HG23 ' A' ' 163' ' ' VAL . 95.5 mt-30 -62.32 -36.18 81.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -0.906 . . . . 0.0 109.482 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -53.31 -59.2 9.89 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 92.1 p -63.49 -33.63 75.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -1.135 . . . . 0.0 109.503 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -63.66 -37.37 87.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 159' ' ' GLN . 71.5 t -57.41 -37.01 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.494 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 41.4 t -104.6 134.02 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 0.0 109.483 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.473 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.47 152.43 23.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -1.164 . . . . 0.0 109.545 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.57 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 29.3 mtm -63.92 -25.92 68.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -44.58 -30.56 2.2 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -50.62 -47.64 58.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.167 -1.196 . . . . 0.0 109.415 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.63 ' CG ' HD13 ' A' ' 79' ' ' LEU . 36.6 m-85 -47.05 157.94 0.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 109.186 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 45.4 tp10 -66.75 -32.64 74.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.181 -0.95 . . . . 0.0 109.043 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.742 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.0 -177.24 47.43 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.1 t -129.13 139.01 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -1.154 . . . . 0.0 109.232 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.792 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.9 m-85 -117.5 143.87 45.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.866 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 1.062 ' CE2' HD12 ' A' ' 81' ' ' ILE . 92.7 m-85 -117.38 121.76 41.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.143 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.749 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 18.8 p -111.83 150.28 30.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.074 -1.016 . . . . 0.0 109.632 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.4 ' OD2' ' OD1' ' A' ' 154' ' ' ASP . 45.5 t0 -152.51 146.8 25.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.88 136.39 10.95 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.439 ' HB3' ' HB1' ' A' ' 157' ' ' ALA . 17.9 t -138.69 142.69 38.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 109.612 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -135.01 150.13 50.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.291 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 27' ' ' ASN . 69.3 mt -116.58 136.6 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.672 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -118.24 152.48 35.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.286 -0.884 . . . . 0.0 109.071 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.509 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -118.84 173.7 3.23 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.443 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 45.2 Cg_endo -67.93 -41.07 8.25 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.56 2.174 . . . . 0.0 111.175 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -111.11 69.86 0.69 Allowed Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.88 58.73 0.55 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.873 2.382 . . . . 0.0 112.149 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.2 p -55.01 -21.29 11.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.176 -0.953 . . . . 0.0 108.838 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -126.99 -174.22 3.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 0.0 109.326 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.5 m -68.36 138.19 55.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 109.734 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 17' ' ' ILE . 38.7 p-10 -51.74 168.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.184 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.503 ' OD1' ' ND2' ' A' ' 165' ' ' ASN . 23.5 m120 -85.8 139.09 31.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.164 -0.96 . . . . 0.0 109.555 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -125.32 151.36 46.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.933 . . . . 0.0 109.492 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 15' ' ' SER . . . -154.99 157.79 27.87 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.755 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 54.9 mtm -127.29 165.85 18.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.129 . . . . 0.0 109.37 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' A' ' 156' ' ' LEU . . . -156.82 124.68 1.47 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 32' ' ' ILE . 4.8 mp -116.89 142.36 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -1.163 . . . . 0.0 109.382 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.491 HG21 ' N ' ' A' ' 153' ' ' ALA . 38.2 t -127.06 134.26 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 109.551 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.668 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 27.1 m170 -106.87 138.65 42.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.615 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.42 ' C ' ' CD1' ' A' ' 44' ' ' LEU . . . -140.4 164.62 29.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.9 . . . . 0.0 109.527 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.653 ' HB ' HD11 ' A' ' 44' ' ' LEU . 13.2 t -133.64 164.96 26.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.0 109.447 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.418 ' O ' ' O ' ' A' ' 38' ' ' LYS . 44.5 m-85 -103.32 11.09 37.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.352 -0.842 . . . . 0.0 109.575 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.582 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.26 179.73 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.185 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 38' ' ' LYS . 44.8 Cg_endo -66.88 -5.64 13.87 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.203 1.935 . . . . 0.0 111.425 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' OE2' ' NE2' ' A' ' 42' ' ' GLN . 82.6 tt0 -132.74 105.49 7.2 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.377 -0.827 . . . . 0.0 108.947 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.451 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 43.1 t80 -64.28 122.01 15.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.49 ' NE2' ' OE2' ' A' ' 40' ' ' GLU . 66.5 mt-30 -159.0 136.38 9.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.124 -0.985 . . . . 0.0 109.753 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 37.5 t -62.5 125.99 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.893 . . . . 0.0 109.32 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.653 HD11 ' HB ' ' A' ' 36' ' ' THR . 7.4 mp -68.63 -38.69 80.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 109.336 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -175.62 155.04 1.68 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 109.343 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.964 ' HB3' HD21 ' A' ' 156' ' ' LEU . 94.0 mt-30 -110.01 138.4 46.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.407 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -122.75 125.95 46.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.919 . . . . 0.0 109.676 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.2 m -121.14 138.91 53.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 109.271 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 2.4 mp -133.67 96.22 16.87 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.94 129.84 18.09 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.667 2.245 . . . . 0.0 111.741 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.548 ' O ' HG21 ' A' ' 164' ' ' VAL . 43.1 mt -108.39 145.36 34.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.331 -0.856 . . . . 0.0 109.384 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.33 -28.85 1.56 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.531 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 46.4 p-10 -121.94 34.67 5.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -1.213 . . . . 0.0 109.507 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.531 ' CE1' ' OD1' ' A' ' 53' ' ' ASN . 77.4 m80 -124.4 175.68 6.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 109.362 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 58' ' ' MET . 14.4 t -123.03 169.44 11.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.63 -38.93 72.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.419 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -61.0 -54.45 44.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.458 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.489 ' H ' HG23 ' A' ' 55' ' ' THR . 67.9 mtm -66.64 -30.32 70.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.551 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.7 86.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.459 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -64.28 -49.1 73.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.509 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.71 HD11 ' CZ2' ' A' ' 117' ' ' TRP . 13.0 tt -64.59 -39.62 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.499 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.755 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -59.41 -31.41 69.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.535 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.749 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -64.17 -41.45 97.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.481 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.79 HG22 HG21 ' A' ' 82' ' ' THR . 87.9 t -71.0 -38.67 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.47 ' OE2' ' CB ' ' A' ' 119' ' ' SER . 86.4 tt0 -68.8 -39.05 80.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.106 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.537 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 22.3 t80 -61.17 -64.37 0.97 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.364 -0.835 . . . . 0.0 109.491 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 71' ' ' ALA . . . -58.26 -31.44 67.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.631 ' SG ' HG23 ' A' ' 120' ' ' ILE . 24.3 t -53.43 -54.7 33.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.607 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -62.03 -45.48 93.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 68.9 mttm -67.36 -29.75 69.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.951 . . . . 0.0 109.308 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.747 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -62.24 -64.48 0.92 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.824 ' HB2' HD11 ' A' ' 130' ' ' ILE . 27.8 tp -55.57 -43.29 75.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.883 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' LEU . 16.2 tttt -43.22 -43.14 4.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.254 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 26.4 mm -48.2 143.45 6.94 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 108.855 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.8 Cg_endo -65.87 -3.16 7.72 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.512 2.141 . . . . 0.0 111.896 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.407 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -142.07 170.82 24.8 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.468 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.2 Cg_endo -69.2 122.82 9.66 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.366 2.044 . . . . 0.0 111.74 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.792 HG21 ' CE1' ' A' ' 10' ' ' PHE . 7.1 p -116.24 150.18 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.451 -0.781 . . . . 0.0 109.288 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.63 HD13 ' CG ' ' A' ' 6' ' ' TYR . 6.7 mp -97.8 130.7 44.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.909 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 132' ' ' ILE . 47.6 t -106.46 131.09 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.36 -0.837 . . . . 0.0 109.122 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.062 HD12 ' CE2' ' A' ' 11' ' ' TYR . 4.4 mt -115.15 144.29 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.159 -0.963 . . . . 0.0 109.666 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.79 HG21 HG22 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -134.3 161.66 34.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 109.37 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -90.91 3.66 53.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.525 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.42 ' HB3' ' CG1' ' A' ' 87' ' ' VAL . 20.2 t -122.93 125.55 45.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.546 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 65.8 t80 -75.1 -40.6 59.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.433 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -50.5 -56.76 10.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.472 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.648 HG22 HG21 ' A' ' 64' ' ' VAL . 8.8 p -58.75 -47.69 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.364 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.603 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -58.25 -57.21 13.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 0.0 109.204 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 85.3 tt0 -51.13 -30.81 17.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.371 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.615 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 37.1 m -60.32 -59.65 5.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.433 -0.792 . . . . 0.0 109.67 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -77.24 -0.83 26.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 109.794 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 9.8 m120 -83.56 -72.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.089 -1.007 . . . . 0.0 109.796 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 80.5 mttt -126.56 -27.86 3.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.787 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.5 mt-10 -66.0 -24.33 66.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.616 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -58.51 -58.66 17.44 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.563 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.5 Cg_endo -66.91 -35.1 27.76 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.596 2.197 . . . . 0.0 111.497 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -64.59 -42.01 95.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.897 . . . . 0.0 109.116 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.467 ' CZ2' HD11 ' A' ' 111' ' ' LEU . 26.4 m0 -60.74 -50.23 74.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.259 -0.901 . . . . 0.0 109.312 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 98' ' ' TRP . 49.9 tttp -43.0 -43.49 4.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.3 -0.875 . . . . 0.0 109.474 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.4 m -56.74 -42.6 79.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 109.372 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -86.24 12.56 9.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 109.409 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 104' ' ' VAL . . . 72.81 41.44 49.59 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.555 ' HB3' HG23 ' A' ' 114' ' ' ILE . 70.7 m-85 61.23 33.38 19.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -1.131 . . . . 0.0 109.395 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 102' ' ' GLY . 42.6 t -119.22 134.06 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.876 . . . . 0.0 109.519 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -63.3 139.66 58.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -51.85 -34.37 40.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -72.22 158.72 35.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.441 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -55.53 -29.31 58.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.89 . . . . 0.0 109.407 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -60.27 139.37 91.72 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.586 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.98 157.04 61.26 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.706 2.27 . . . . 0.0 111.663 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.544 HD23 HG12 ' A' ' 114' ' ' ILE . 9.3 tp -80.44 130.14 34.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.95 . . . . 0.0 109.478 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -92.61 153.82 18.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.89 . . . . 0.0 109.442 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.402 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 43.4 m80 60.4 37.64 19.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.198 -0.939 . . . . 0.0 109.482 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.555 HG23 ' HB3' ' A' ' 103' ' ' PHE . 82.1 mt -63.84 -44.81 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.321 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.3 t -60.01 -41.99 93.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -59.22 -40.61 86.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.71 ' CZ2' HD11 ' A' ' 61' ' ' ILE . 17.4 m95 -68.02 -37.96 82.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 31.2 mttt -57.41 -41.31 80.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.925 . . . . 0.0 109.371 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.47 ' CB ' ' OE2' ' A' ' 65' ' ' GLU . 19.9 m -61.62 -46.13 91.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.309 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.631 HG23 ' SG ' ' A' ' 68' ' ' CYS . 75.7 mt -71.21 -34.68 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.544 ' HB2' HD11 ' A' ' 95' ' ' LEU . . . -59.56 -42.35 92.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.394 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.03 -40.28 88.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 109.503 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 89.5 m -66.22 -49.21 68.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.425 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 128' ' ' PRO . 23.7 tp -63.82 -31.71 72.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.2 m -61.48 -31.7 71.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.499 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.446 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 92.6 mtp -68.56 -31.7 71.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HD3' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 170.47 147.78 0.14 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.44 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.442 ' HA ' ' CD1' ' A' ' 124' ' ' LEU . 50.5 Cg_endo -70.96 -0.95 8.71 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.688 2.259 . . . . 0.0 111.637 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 94.1 m-20 -43.05 -45.39 5.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.367 -0.833 . . . . 0.0 109.659 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 72' ' ' LEU . 46.4 mt -61.77 117.39 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.743 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.561 ' O ' HD13 ' A' ' 132' ' ' ILE . 97.4 m -109.81 144.9 37.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.186 -0.946 . . . . 0.0 109.069 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.561 HD13 ' O ' ' A' ' 131' ' ' THR . 32.5 mm -119.69 136.68 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 109.745 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.53 ' NE2' HD23 ' A' ' 79' ' ' LEU . 87.4 mt-30 -125.43 158.22 34.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.427 -0.795 . . . . 0.0 109.19 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.546 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 20.3 t-80 -117.26 133.25 56.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.641 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.549 ' HG2' ' CG2' ' A' ' 81' ' ' ILE . 71.2 mm-40 -124.34 150.47 45.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.425 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -96.55 138.48 34.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.18 -35.15 68.89 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -117.87 139.72 50.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -1.125 . . . . 0.0 109.446 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.527 ' CG ' ' HD2' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -121.04 167.76 12.42 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.376 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.527 ' HD2' ' CG ' ' A' ' 139' ' ' GLN . 50.5 Cg_endo -69.69 -173.78 0.77 Allowed 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.689 2.26 . . . . 0.0 111.863 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.0 m -49.72 -39.68 38.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.84 155.56 32.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.564 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.0 p -120.07 160.44 22.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.437 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.6 m -121.07 149.35 42.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.538 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 87.7 mt -54.22 -37.53 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.589 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -65.17 -30.6 71.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.261 -0.9 . . . . 0.0 109.416 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 57.5 m -55.56 -47.46 76.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.372 -0.83 . . . . 0.0 109.452 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -49.19 -52.18 28.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.895 . . . . 0.0 109.409 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -53.18 -39.52 58.3 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -55.15 -48.8 73.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -1.108 . . . . 0.0 109.37 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.74 37.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.309 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 152' ' ' LEU . 6.8 mp -58.84 -47.97 82.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.491 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -55.42 -42.56 74.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 109.418 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.4 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 63.7 m-20 -55.69 -44.09 77.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.876 . . . . 0.0 109.394 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -57.75 -42.14 83.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.216 -0.928 . . . . 0.0 109.412 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.964 HD21 ' HB3' ' A' ' 46' ' ' GLN . 7.0 mp -64.98 -40.15 94.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' A' ' 15' ' ' SER . . . -67.78 -51.67 46.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.358 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 42.0 m -59.83 -41.41 91.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.534 ' O ' HG23 ' A' ' 163' ' ' VAL . 46.8 tt0 -63.68 -38.41 91.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -62.54 -50.38 64.95 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 86.0 p -64.94 -34.24 77.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -1.183 . . . . 0.0 109.434 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -64.03 -37.68 88.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.431 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 159' ' ' GLN . 73.0 t -52.93 -39.67 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.548 HG21 ' O ' ' A' ' 51' ' ' LEU . 42.5 t -65.48 -30.98 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.502 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.503 ' ND2' ' OD1' ' A' ' 27' ' ' ASN . 89.6 m-20 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.51 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.41 157.87 44.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.193 -1.181 . . . . 0.0 109.523 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.568 ' O ' ' CD2' ' A' ' 6' ' ' TYR . 77.4 mtp -65.76 -27.1 68.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.552 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.15 -17.59 17.61 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 96.3 mt-30 -53.17 -33.57 53.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -1.166 . . . . 0.0 109.573 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.978 ' HB3' HD21 ' A' ' 79' ' ' LEU . 33.9 p90 -103.37 156.53 17.67 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.206 -0.934 . . . . 0.0 109.655 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.514 ' OE1' HG22 ' A' ' 74' ' ' ILE . 21.3 tt0 -79.78 -42.76 23.79 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.806 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -159.88 176.52 36.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.519 HG23 ' HE2' ' A' ' 37' ' ' TYR . 82.1 t -124.96 141.1 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -1.18 . . . . 0.0 109.515 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.828 ' CD1' HG21 ' A' ' 78' ' ' VAL . 5.7 m-85 -117.33 151.7 36.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.622 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.771 ' HE1' HD12 ' A' ' 81' ' ' ILE . 85.3 m-85 -123.87 135.97 54.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.533 HG22 HD12 ' A' ' 32' ' ' ILE . 19.1 p -121.7 150.1 42.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.596 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.513 ' HB2' ' HB1' ' A' ' 153' ' ' ALA . 22.9 t70 -140.12 148.27 41.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.482 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.41 134.25 5.42 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.552 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 83.1 p -143.21 161.01 39.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -1.177 . . . . 0.0 109.457 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.891 ' HB1' ' ND2' ' A' ' 26' ' ' ASN . . . -137.9 150.51 47.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.566 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' ASN . 47.7 mt -126.79 131.98 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.515 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -107.28 144.45 34.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.294 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.548 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -109.63 176.3 1.61 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.317 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 45.7 Cg_endo -67.87 -35.51 20.83 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 122.471 2.114 . . . . 0.0 111.38 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.87 70.36 5.0 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.381 -0.825 . . . . 0.0 108.876 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 19' ' ' SER . 45.0 Cg_endo -67.04 57.28 0.55 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.833 2.355 . . . . 0.0 111.968 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 73.0 p -59.46 -16.81 26.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.838 . . . . 0.0 109.018 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -129.76 -163.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.863 . . . . 0.0 109.304 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 26' ' ' ASN . 33.2 m -78.06 140.76 39.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.676 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.891 ' ND2' ' HB1' ' A' ' 16' ' ' ALA . 48.1 p-10 -47.3 172.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.307 -0.871 . . . . 0.0 109.303 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.793 ' ND2' HG11 ' A' ' 164' ' ' VAL . 23.3 m120 -104.49 125.01 50.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.155 -0.965 . . . . 0.0 109.393 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 15' ' ' SER . . . -132.16 158.51 41.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 109.768 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -142.32 165.2 26.77 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.644 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 69.7 mtm -126.28 156.54 40.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -1.168 . . . . 0.0 109.461 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' HD13 ' A' ' 32' ' ' ILE . . . -141.51 128.21 3.58 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.54 HG13 ' CD2' ' A' ' 66' ' ' PHE . 22.3 mm -113.16 134.41 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -1.132 . . . . 0.0 109.301 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.95 125.38 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.233 -0.917 . . . . 0.0 109.692 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.656 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 10.3 m170 -103.54 136.12 43.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.208 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.08 161.31 35.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.752 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.2 t -125.6 164.08 21.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 109.241 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.519 ' HE2' HG23 ' A' ' 9' ' ' VAL . 85.0 m-85 -107.91 13.95 25.79 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.104 -0.998 . . . . 0.0 109.534 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.583 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.27 -179.17 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.6 Cg_endo -65.42 -4.73 9.97 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.074 1.849 . . . . 0.0 111.849 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.436 ' OE1' ' HA ' ' A' ' 40' ' ' GLU . 71.8 mm-40 -134.1 106.09 7.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 108.785 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' O ' ' CG ' ' A' ' 42' ' ' GLN . 66.9 t80 -57.81 123.89 17.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 109.534 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 84.4 mt-30 -159.62 152.25 21.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.85 . . . . 0.0 109.516 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.1 m -89.06 120.48 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.394 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.429 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 40.9 mt -58.28 -44.18 88.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.429 ' CG ' ' O ' ' A' ' 44' ' ' LEU . 25.2 m-20 -168.76 157.4 8.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.433 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.592 ' HB3' HD21 ' A' ' 156' ' ' LEU . 92.4 mt-30 -116.2 149.6 38.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.444 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.474 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -132.16 137.96 47.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.625 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.9 p -123.61 144.8 49.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 109.286 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.461 HD12 ' HE3' ' A' ' 30' ' ' MET . 3.3 mt -146.52 94.55 4.76 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.198 -0.939 . . . . 0.0 109.648 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.764 ' HG3' HG21 ' A' ' 163' ' ' VAL . 51.0 Cg_endo -70.81 132.26 21.3 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.654 2.236 . . . . 0.0 111.67 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.722 HD12 ' CB ' ' A' ' 59' ' ' ALA . 43.8 mt -115.0 142.89 46.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.566 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.03 -42.86 0.21 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -90.97 8.85 33.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.306 -1.114 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 77.3 m80 -107.05 150.25 26.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.915 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.506 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.1 OUTLIER -91.65 170.04 10.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.884 . . . . 0.0 109.24 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.37 -30.09 17.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.319 -0.863 . . . . 0.0 109.123 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -79.5 -57.36 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.357 -0.84 . . . . 0.0 109.315 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.506 ' SD ' HG23 ' A' ' 55' ' ' THR . 93.4 mtp -47.78 -34.47 8.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 109.364 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.722 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -78.72 -33.94 46.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.442 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.787 ' HG2' HG21 ' A' ' 87' ' ' VAL . 82.1 tt0 -64.45 -40.11 95.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.603 HG21 ' HD3' ' A' ' 116' ' ' LYS . 19.5 tt -77.34 -29.59 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.374 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.644 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -68.77 -29.49 67.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.478 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.82 94.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.491 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.766 HG21 HG12 ' A' ' 87' ' ' VAL . 87.0 t -75.86 -48.29 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.558 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 98.1 mt-10 -51.87 -41.57 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.55 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 14.1 t80 -56.82 -67.86 0.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.647 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -63.67 -13.98 47.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.606 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.969 ' SG ' HG23 ' A' ' 120' ' ' ILE . 38.0 t -66.82 -66.04 0.6 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.521 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 73.9 tttt -60.01 -42.61 94.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.634 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HE2' ' CE2' ' A' ' 66' ' ' PHE . 56.7 mttp -64.94 -35.62 81.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -58.3 -60.44 3.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.889 ' HB2' HD11 ' A' ' 130' ' ' ILE . 21.0 tp -56.71 -44.12 81.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.215 -0.928 . . . . 0.0 109.388 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 72' ' ' LEU . 55.6 tttp -43.59 -42.13 4.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.155 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 19.6 mm -48.39 142.76 7.95 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.86 . . . . 0.0 108.961 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.9 Cg_endo -65.49 -4.58 9.79 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.548 2.165 . . . . 0.0 111.937 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.02 167.28 25.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.474 ' HG2' ' HA ' ' A' ' 6' ' ' TYR . 45.2 Cg_endo -67.88 116.4 4.27 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.565 2.176 . . . . 0.0 111.699 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.828 HG21 ' CD1' ' A' ' 10' ' ' PHE . 7.2 p -111.31 149.82 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.333 -0.854 . . . . 0.0 109.578 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.978 HD21 ' HB3' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -104.51 137.41 42.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 109.59 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 43.7 t -110.27 130.46 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.145 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.771 HD12 ' HE1' ' A' ' 11' ' ' TYR . 15.8 mt -114.61 132.08 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.649 HG21 HG22 ' A' ' 64' ' ' VAL . 0.4 OUTLIER -124.85 161.99 25.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 56.4 p30 -87.14 13.08 10.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.499 ' C ' ' CD2' ' A' ' 134' ' ' HIS . 67.2 m -123.26 125.28 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.485 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.572 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 70.4 t80 -78.38 -41.89 31.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -58.54 -52.71 64.51 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.787 HG21 ' HG2' ' A' ' 60' ' ' GLU . 48.4 t -59.23 -51.8 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.68 -52.97 27.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.288 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 83.5 tt0 -60.08 -33.75 72.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.17 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.666 ' O ' HD23 ' A' ' 95' ' ' LEU . 34.1 m -52.72 -47.22 67.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.305 -0.872 . . . . 0.0 109.327 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.784 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -94.25 -0.75 54.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.612 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 50.1 t30 -86.93 -71.99 0.53 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.148 -0.97 . . . . 0.0 109.957 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 24.7 mttm -116.64 -35.53 4.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.238 -0.914 . . . . 0.0 109.831 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 91.4 mt-10 -59.84 -38.8 83.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.624 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 90' ' ' SER . 0.2 OUTLIER -53.16 -60.18 7.4 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 47.4 Cg_endo -68.15 -32.37 27.49 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.71 2.273 . . . . 0.0 111.596 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -72.54 -40.6 66.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.28 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.434 ' CZ2' ' OE1' ' A' ' 94' ' ' GLU . 24.9 m0 -61.66 -44.23 97.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.358 -0.839 . . . . 0.0 109.371 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.405 ' HA ' ' CE1' ' A' ' 103' ' ' PHE . 24.8 tttt -50.65 -50.38 54.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.865 . . . . 0.0 109.446 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.6 m -65.98 -34.93 79.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.497 ' OD1' ' CG1' ' A' ' 104' ' ' VAL . 53.6 t-20 -66.17 -26.17 67.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.525 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.3 28.26 8.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.405 ' CE1' ' HA ' ' A' ' 99' ' ' LYS . 8.3 m-85 61.85 30.82 18.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -1.158 . . . . 0.0 109.486 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.497 ' CG1' ' OD1' ' A' ' 101' ' ' ASN . 11.8 p -118.56 133.93 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 109' ' ' LYS . 44.8 t30 -84.75 143.29 29.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.469 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -51.7 -33.26 33.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.525 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -75.65 162.39 28.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 109.567 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -55.85 -31.71 62.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 1.5 tptp -70.81 138.8 85.54 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.498 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.428 ' HD2' ' HG3' ' A' ' 109' ' ' LYS . 50.0 Cg_endo -70.34 169.97 18.37 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.637 2.224 . . . . 0.0 111.866 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.742 HD23 HG12 ' A' ' 114' ' ' ILE . 5.3 tp -73.44 134.89 44.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 109.431 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HD3' ' CE1' ' A' ' 113' ' ' HIS . 85.1 tttt -96.13 149.55 21.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.571 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 33.8 m80 65.98 33.07 8.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.505 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.742 HG12 HD23 ' A' ' 111' ' ' LEU . 82.4 mt -62.33 -47.05 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.253 -0.904 . . . . 0.0 109.406 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.8 m -59.38 -43.57 92.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.603 ' HD3' HG21 ' A' ' 61' ' ' ILE . 35.7 mttp -58.49 -46.9 85.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.285 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.629 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 65.6 m95 -70.16 -30.08 67.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.406 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -60.25 -41.6 93.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.495 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -58.22 -40.7 82.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.969 HG23 ' SG ' ' A' ' 68' ' ' CYS . 77.8 mt -72.95 -32.84 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 95' ' ' LEU . . . -64.91 -37.16 86.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.426 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -60.41 -34.27 73.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.231 -0.918 . . . . 0.0 109.476 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 69' ' ' LYS . 6.8 m -79.21 -50.21 11.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.713 HD23 HD12 ' A' ' 130' ' ' ILE . 57.6 mt -61.04 -34.86 75.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.476 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.8 t -59.27 -34.13 71.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.435 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.685 ' CE ' HD23 ' A' ' 72' ' ' LEU . 71.7 mtm -67.76 -34.53 77.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.423 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -173.99 128.51 0.47 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.475 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.5 Cg_endo -69.74 -1.8 9.07 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.68 2.253 . . . . 0.0 111.638 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' A' ' 77' ' ' PRO . 90.9 m-20 -43.83 -43.13 6.07 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.316 -0.865 . . . . 0.0 109.458 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.889 HD11 ' HB2' ' A' ' 72' ' ' LEU . 40.3 mt -53.99 118.55 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.335 -0.853 . . . . 0.0 109.671 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.654 ' HB ' HD22 ' A' ' 79' ' ' LEU . 9.0 m -119.28 129.65 55.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 108.984 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.784 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 52.9 mt -110.47 144.4 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 110.06 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -132.58 154.32 50.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.343 -0.848 . . . . 0.0 109.163 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.572 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 15.8 t-80 -104.05 128.28 51.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.618 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 83' ' ' ASP . 85.1 tt0 -122.11 142.87 49.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 109.295 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -108.18 131.68 54.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.643 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -115.34 4.03 21.89 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -60.09 -33.97 72.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -1.165 . . . . 0.0 109.479 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -92.69 111.46 51.12 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.99 -23.98 29.12 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.714 2.276 . . . . 0.0 111.79 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.0 p -82.28 171.98 13.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.951 . . . . 0.0 109.473 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.2 m120 60.5 49.54 6.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.518 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.8 m -70.96 141.55 51.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.863 . . . . 0.0 109.467 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.687 ' OG ' HG23 ' A' ' 147' ' ' THR . 94.8 p -133.71 171.29 14.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 87.4 mt -55.17 -41.97 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -65.7 -38.71 90.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.687 HG23 ' OG ' ' A' ' 144' ' ' SER . 70.0 p -64.12 -36.99 85.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.558 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -49.61 -45.81 48.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 109.552 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.07 -37.56 94.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -58.63 -41.5 86.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -1.142 . . . . 0.0 109.556 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.48 -51.7 66.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.55 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.463 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 52.5 mt -58.8 -45.7 89.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.527 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.513 ' HB1' ' HB2' ' A' ' 13' ' ' ASP . . . -56.88 -42.51 79.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.525 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.675 ' O ' HG23 ' A' ' 158' ' ' THR . 89.8 m-20 -59.23 -36.53 75.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.551 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -63.36 -42.26 98.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.628 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.597 ' N ' HD12 ' A' ' 156' ' ' LEU . 6.4 mp -74.17 -34.04 63.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.573 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.89 -40.86 97.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.528 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 154' ' ' ASP . 50.0 p -69.07 -39.52 79.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.532 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -62.32 -33.56 74.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -64.51 -31.85 82.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.5 p -65.96 -34.67 78.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -1.16 . . . . 0.0 109.535 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 165' ' ' ASN . 95.8 m-85 -68.23 -26.99 65.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.564 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.764 HG21 ' HG3' ' A' ' 50' ' ' PRO . 60.1 t -54.87 -40.4 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.88 . . . . 0.0 109.452 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.793 HG11 ' ND2' ' A' ' 27' ' ' ASN . 90.4 t -58.31 -39.92 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.432 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 162' ' ' TYR . 83.3 m-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.441 ' N ' ' NE2' ' A' ' 5' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 5' ' ' GLN . . . -64.64 140.39 58.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.278 -1.131 . . . . 0.0 109.395 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.593 ' HE2' ' CE2' ' A' ' 37' ' ' TYR . 90.8 mmm -65.7 -29.96 70.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.571 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.79 -28.1 56.72 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.441 ' NE2' ' N ' ' A' ' 1' ' ' GLY . 20.0 mt-30 -50.53 -40.12 50.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -1.161 . . . . 0.0 109.532 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.572 ' CG ' HD13 ' A' ' 79' ' ' LEU . 34.3 m-85 -103.91 165.94 10.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.561 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -77.06 -31.91 56.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 108.872 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.6 -166.84 35.95 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.805 HG22 ' HB2' ' A' ' 79' ' ' LEU . 72.7 t -136.33 143.01 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -1.162 . . . . 0.0 108.978 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.792 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.1 m-85 -114.16 146.41 40.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.971 . . . . 0.0 109.907 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.877 ' CE1' HD12 ' A' ' 81' ' ' ILE . 66.9 m-85 -118.41 118.35 31.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.264 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.473 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 9.8 p -106.45 155.64 19.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 59.1 t0 -149.58 145.64 26.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.565 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -146.9 118.95 1.08 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 66.8 m -132.0 150.89 52.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -1.158 . . . . 0.0 109.588 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HA ' ' CB ' ' A' ' 28' ' ' ALA . . . -114.78 135.19 54.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.737 HD12 ' HB3' ' A' ' 161' ' ' SER . 58.3 mt -110.82 142.54 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.31 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' CE ' ' HG3' ' A' ' 22' ' ' PRO . 78.8 tttt -92.49 139.61 30.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.581 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.567 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -99.26 179.27 1.08 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.279 -0.888 . . . . 0.0 109.111 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 50.8 Cg_endo -71.64 -23.24 23.21 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.381 2.054 . . . . 0.0 111.708 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' N ' ' HD3' ' A' ' 22' ' ' PRO . 2.8 p30 -128.93 61.35 56.0 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.303 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.538 ' HG3' ' CE ' ' A' ' 18' ' ' LYS . 55.2 Cg_endo -81.71 68.82 7.92 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.762 2.308 . . . . 0.0 111.915 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 79.6 m -54.72 -31.56 58.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.168 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 23' ' ' THR . 48.1 tttm 178.42 33.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.296 -0.877 . . . . 0.0 109.475 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -152.92 138.41 17.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.558 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -118.11 165.54 13.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.924 . . . . 0.0 109.333 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -98.74 97.56 8.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.328 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 16' ' ' ALA . . . -110.85 155.91 21.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.7 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -144.44 154.71 25.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.819 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 33.2 mtm -115.39 156.76 24.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -1.113 . . . . 0.0 109.417 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.89 124.23 1.73 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 32' ' ' ILE . 5.4 mp -116.94 134.58 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -1.095 . . . . 0.0 109.102 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.0 t -127.09 131.39 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.77 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.69 ' NE2' HD22 ' A' ' 44' ' ' LEU . 3.5 t60 -102.15 131.0 48.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.196 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.34 159.37 37.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.94 . . . . 0.0 109.759 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.702 ' HB ' HD11 ' A' ' 44' ' ' LEU . 7.7 t -117.46 161.45 19.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.863 . . . . 0.0 109.126 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.607 ' HE2' HG23 ' A' ' 9' ' ' VAL . 91.9 m-85 -104.66 8.75 35.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.134 -0.979 . . . . 0.0 109.634 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.576 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -51.8 -178.94 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.322 -0.861 . . . . 0.0 108.766 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.2 Cg_endo -66.5 -3.13 8.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.122 1.881 . . . . 0.0 111.945 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -132.36 105.78 7.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 108.706 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 1.092 ' CD1' HD11 ' A' ' 145' ' ' ILE . 63.3 t80 -66.57 125.5 25.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.935 . . . . 0.0 109.329 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.5 ' CG ' ' O ' ' A' ' 41' ' ' TYR . 73.0 mt-30 -160.62 152.72 20.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 0.0 109.391 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 43' ' ' VAL . 13.5 p -82.85 124.33 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.434 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.702 HD11 ' HB ' ' A' ' 36' ' ' THR . 6.4 mp -74.06 -42.33 60.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 44' ' ' LEU . 80.5 m-20 -159.05 149.46 19.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.559 ' HB3' HD21 ' A' ' 156' ' ' LEU . 91.8 mt-30 -117.09 148.01 41.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -0.949 . . . . 0.0 109.398 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.489 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -130.92 131.38 44.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.188 -0.945 . . . . 0.0 109.587 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.646 ' C ' HD12 ' A' ' 49' ' ' ILE . 78.2 p -123.79 141.95 51.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.646 HD12 ' C ' ' A' ' 48' ' ' SER . 3.7 mp -149.52 95.67 3.73 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 49' ' ' ILE . 48.3 Cg_endo -69.27 128.16 16.06 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.683 2.256 . . . . 0.0 111.759 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 44.4 mt -111.74 142.9 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 0.0 109.534 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.12 -42.88 0.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -91.96 9.32 33.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 109.522 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 79.4 m80 -110.47 147.31 34.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 0.0 109.467 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.547 HG22 ' HG3' ' A' ' 58' ' ' MET . 9.5 t -90.89 -178.54 5.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . . . -57.29 -46.6 82.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 60' ' ' GLU . 87.8 mt-30 -63.11 -61.12 2.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.359 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.547 ' HG3' HG22 ' A' ' 55' ' ' THR . 94.2 mtp -44.01 -32.91 1.27 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.19 -30.36 58.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 0.0 109.526 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.675 ' HB3' HG21 ' A' ' 87' ' ' VAL . 95.4 mt-10 -70.34 -38.93 74.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.662 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 18.0 tt -72.49 -34.57 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.819 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -70.21 -32.5 70.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.409 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.473 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -65.03 -40.15 94.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.931 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.905 HG21 HG12 ' A' ' 87' ' ' VAL . 70.2 t -72.32 -39.7 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 109.49 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.23 -39.74 86.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.192 -0.942 . . . . 0.0 109.019 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.483 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 30.8 t80 -57.7 -63.59 1.19 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.369 -0.832 . . . . 0.0 109.528 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 68' ' ' CYS . . . -64.12 -39.55 94.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.601 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.55 ' SG ' HG23 ' A' ' 120' ' ' ILE . 37.2 t -43.06 -62.43 1.04 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.444 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 67.6 mttm -59.27 -46.09 89.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -0.929 . . . . 0.0 109.426 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 66' ' ' PHE . 30.9 mmtt -56.15 -38.18 70.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.389 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.896 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -59.94 -64.95 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.81 ' HB2' HD11 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -48.56 -47.12 39.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 109.461 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 72' ' ' LEU . 49.9 mttm -43.25 -42.46 4.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.33 -0.857 . . . . 0.0 109.097 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.556 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 30.1 mm -49.39 143.65 9.68 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.397 -0.814 . . . . 0.0 109.001 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.1 Cg_endo -65.11 -4.35 8.89 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.51 2.14 . . . . 0.0 111.895 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.439 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -143.61 172.31 24.97 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.465 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.1 Cg_endo -69.02 120.63 7.51 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 122.408 2.072 . . . . 0.0 111.677 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.896 HG11 ' HA ' ' A' ' 71' ' ' ALA . 7.2 p -114.89 153.76 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 109.141 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.805 ' HB2' HG22 ' A' ' 9' ' ' VAL . 6.6 mp -97.1 139.98 32.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.025 -1.047 . . . . 0.0 109.931 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 58.1 t -118.0 121.98 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.418 -0.801 . . . . 0.0 109.004 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.877 HD12 ' CE1' ' A' ' 11' ' ' TYR . 3.7 mt -107.29 142.44 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.117 -0.99 . . . . 0.0 109.62 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.714 HG21 HG22 ' A' ' 64' ' ' VAL . 0.7 OUTLIER -128.18 161.7 28.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.415 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -87.74 7.11 31.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.842 . . . . 0.0 109.507 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 t -123.95 129.42 50.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.526 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.454 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 68.0 t80 -77.8 -39.3 44.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -63.35 -48.15 79.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.905 HG12 HG21 ' A' ' 64' ' ' VAL . 59.5 t -58.96 -53.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.86 . . . . 0.0 109.369 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.51 ' HB1' HG22 ' A' ' 132' ' ' ILE . . . -48.35 -55.0 11.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.933 . . . . 0.0 109.314 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 77.1 mm-40 -56.35 -35.1 67.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 117' ' ' TRP . 38.6 m -53.39 -46.63 69.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.453 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.742 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -92.5 -0.88 57.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.307 -0.87 . . . . 0.0 109.674 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' HB3' ' HA ' ' A' ' 89' ' ' GLU . 45.6 t-20 -89.03 -72.86 0.53 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.067 -1.021 . . . . 0.0 109.761 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 23.2 mttm -126.86 -29.55 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.904 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 88.4 mt-10 -59.58 -28.34 67.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -58.77 -60.88 8.99 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.124 -0.985 . . . . 0.0 109.552 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.1 Cg_endo -66.41 -31.44 42.68 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.724 2.283 . . . . 0.0 111.411 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -68.89 -38.46 79.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.236 -0.915 . . . . 0.0 108.883 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.618 ' CG ' HD11 ' A' ' 111' ' ' LEU . 35.3 m0 -61.96 -52.91 62.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.19 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 98' ' ' TRP . 46.6 tttt -43.54 -41.66 4.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.365 -0.835 . . . . 0.0 109.496 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.2 m -58.95 -42.21 89.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.915 . . . . 0.0 109.415 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.747 ' O ' HG12 ' A' ' 104' ' ' VAL . 76.5 m-20 -84.48 7.35 20.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.142 -0.974 . . . . 0.0 109.524 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 82.55 32.42 27.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.721 ' C ' HD12 ' A' ' 111' ' ' LEU . 89.5 m-85 63.31 34.05 13.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -1.129 . . . . 0.0 109.473 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.829 HG23 ' HA ' ' A' ' 110' ' ' PRO . 7.4 p -121.67 121.4 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 109.555 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.47 ' HB2' HD23 ' A' ' 111' ' ' LEU . 53.3 t30 -53.7 -46.97 70.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.482 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.578 ' O ' HG22 ' A' ' 104' ' ' VAL . 81.9 m-20 -147.73 175.16 11.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.522 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -57.85 -31.68 66.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.515 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.416 ' C ' ' HG2' ' A' ' 109' ' ' LYS . 44.7 mttt -118.69 13.54 13.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.515 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 1.9 mmtt -133.02 89.28 34.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.85 . . . . 0.0 109.439 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.829 ' HA ' HG23 ' A' ' 104' ' ' VAL . 49.8 Cg_endo -70.34 152.22 66.17 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.777 2.318 . . . . 0.0 111.784 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.721 HD12 ' C ' ' A' ' 103' ' ' PHE . 91.6 mt -74.27 146.79 42.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.374 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HE3' ' NE2' ' A' ' 113' ' ' HIS . 33.8 tttp -104.9 139.72 39.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.636 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.5 ' NE2' ' HE3' ' A' ' 112' ' ' LYS . 70.6 m-70 65.25 36.79 6.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.653 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.634 HD13 ' HB3' ' A' ' 103' ' ' PHE . 86.1 mt -53.93 -43.89 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.242 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 30.9 m -49.68 -45.89 49.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.267 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HD2' ' HB3' ' A' ' 113' ' ' HIS . 64.1 mttm -58.6 -48.09 82.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 0.0 109.307 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.662 ' CZ2' HD12 ' A' ' 61' ' ' ILE . 60.9 m95 -65.65 -38.14 88.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.839 . . . . 0.0 109.385 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -56.87 -46.64 81.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.479 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.4 p -57.67 -39.54 77.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 109.423 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.55 HG23 ' SG ' ' A' ' 68' ' ' CYS . 73.9 mt -66.75 -37.24 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.861 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.445 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -65.32 -32.66 74.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 126' ' ' MET . 83.9 tt0 -54.18 -38.15 65.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.329 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.87 -49.25 11.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.419 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 124' ' ' LEU . 22.7 tp -63.08 -31.86 73.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.8 m -66.12 -33.24 75.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.475 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 122' ' ' GLU . 65.1 mtt -65.99 -34.5 78.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -0.93 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.47 140.82 0.52 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.501 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 129' ' ' ASP . 49.0 Cg_endo -70.51 -0.8 8.08 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.655 2.236 . . . . 0.0 111.717 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 128' ' ' PRO . 84.8 m-20 -43.8 -47.98 8.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.81 HD11 ' HB2' ' A' ' 72' ' ' LEU . 58.5 mt -58.45 114.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.472 ' HB ' ' HG ' ' A' ' 79' ' ' LEU . 91.0 m -104.81 147.05 28.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.277 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.742 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 54.3 mt -122.82 142.68 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.615 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.422 ' NE2' HD23 ' A' ' 79' ' ' LEU . 89.8 mt-30 -135.71 164.96 26.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.268 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 18.0 t-80 -113.57 138.55 50.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 109.558 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.62 ' HG3' HG22 ' A' ' 81' ' ' ILE . 96.9 mt-10 -88.04 154.84 20.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.463 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.469 ' HB2' ' NE2' ' A' ' 139' ' ' GLN . 21.1 mttp -96.86 34.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.2 -122.63 30.53 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -109.66 145.66 36.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -1.184 . . . . 0.0 109.469 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.469 ' NE2' ' HB2' ' A' ' 136' ' ' LYS . 1.4 mt-30 -118.24 162.05 31.89 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.461 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 139' ' ' GLN . 50.6 Cg_endo -70.48 -16.94 34.58 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.627 2.218 . . . . 0.0 111.647 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.792 HG22 ' H ' ' A' ' 143' ' ' THR . 57.6 m -129.13 128.94 44.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 109.413 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -92.97 9.59 34.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.498 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.792 ' H ' HG22 ' A' ' 141' ' ' THR . 46.4 m -59.1 -38.23 79.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.415 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 62.6 m -57.22 138.93 54.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.141 -0.974 . . . . 0.0 109.439 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.092 HD11 ' CD1' ' A' ' 41' ' ' TYR . 18.9 tt -71.18 -27.71 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -67.33 -33.7 75.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.2 m -63.23 -40.85 98.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.548 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.25 -36.9 76.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.593 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -67.25 -30.27 75.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -72.45 -33.26 66.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -1.169 . . . . 0.0 109.524 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.12 -51.51 37.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.543 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 156' ' ' LEU . 56.3 mt -59.19 -47.27 85.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -56.84 -38.75 73.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.9 . . . . 0.0 109.564 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.27 -32.26 73.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.647 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 159' ' ' GLN . 24.7 mttm -67.84 -41.88 82.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.63 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.61 ' N ' HD12 ' A' ' 156' ' ' LEU . 6.3 mp -73.14 -31.59 64.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.94 . . . . 0.0 109.585 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -71.61 -62.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.589 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 35.5 m -59.25 -43.3 92.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' A' ' 155' ' ' LYS . 63.1 tp60 -61.32 -33.61 73.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.629 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -68.52 -31.16 73.41 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.737 ' HB3' HD12 ' A' ' 17' ' ' ILE . 19.0 m -66.71 -29.33 69.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -1.142 . . . . 0.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.451 ' O ' ' OD1' ' A' ' 165' ' ' ASN . 28.1 m-85 -75.37 -21.52 58.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.434 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.76 -43.95 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.466 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 161' ' ' SER . 4.6 p -64.05 -32.09 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.447 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 164' ' ' VAL . 79.7 m-20 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.504 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.34 -22.54 66.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -1.118 . . . . 0.0 109.465 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.523 ' CE ' ' OH ' ' A' ' 37' ' ' TYR . 96.2 mmm -66.51 -30.76 71.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.92 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 90.07 -16.7 56.5 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 92.7 mt-30 61.76 36.65 16.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -1.141 . . . . 0.0 109.526 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.526 ' CG ' HD13 ' A' ' 79' ' ' LEU . 99.7 m-85 -57.04 177.87 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.523 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' HG2' ' CG2' ' A' ' 74' ' ' ILE . 31.7 tp10 -64.2 -37.89 89.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.362 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.569 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -178.48 -175.34 45.5 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 79' ' ' LEU . 72.2 t -134.47 142.86 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -1.121 . . . . 0.0 109.354 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.659 ' CD2' ' CD2' ' A' ' 34' ' ' HIS . 7.3 m-85 -123.06 140.36 53.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.634 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.875 ' CE2' HD12 ' A' ' 81' ' ' ILE . 42.9 m-85 -113.32 132.56 55.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.308 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.885 HG22 HD12 ' A' ' 32' ' ' ILE . 24.6 p -120.17 142.57 48.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.831 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.456 ' OD2' ' OD1' ' A' ' 154' ' ' ASP . 52.4 t0 -137.0 155.91 49.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.405 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -142.42 127.29 3.16 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 40.2 m -124.21 157.74 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -1.133 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.908 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -145.35 144.49 30.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.954 . . . . 0.0 109.625 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.488 HD12 ' HB2' ' A' ' 161' ' ' SER . 47.7 mt -122.14 135.32 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 0.0 109.402 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -103.26 133.94 47.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.449 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.495 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -117.66 161.86 31.77 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.926 . . . . 0.0 109.538 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.28 -24.39 27.35 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.684 2.256 . . . . 0.0 111.826 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.579 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -79.87 -66.58 0.26 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 49.2 Cg_endo -70.13 65.16 2.02 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.554 2.17 . . . . 0.0 111.786 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.4 m -56.03 -45.14 79.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 109.419 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -94.86 28.73 2.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.283 -0.885 . . . . 0.0 109.457 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.458 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 30.6 t -154.52 144.68 21.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.935 . . . . 0.0 109.485 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 25' ' ' SER . 58.4 m-20 -137.9 154.76 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.44 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 71.1 m-20 -92.14 113.37 25.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.943 . . . . 0.0 109.337 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 59' ' ' ALA . . . -112.14 145.68 39.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.775 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.62 165.46 23.3 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.556 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 67.9 mtm -133.46 150.94 51.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -1.184 . . . . 0.0 109.684 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.46 120.24 1.22 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.885 HD12 HG22 ' A' ' 12' ' ' THR . 23.4 mm -110.36 140.62 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -1.159 . . . . 0.0 109.547 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' A' ' 153' ' ' ALA . 42.4 t -124.82 130.41 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.353 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.659 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 25.4 m170 -105.67 138.2 42.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 109.655 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.7 168.62 18.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.467 ' HB ' HD21 ' A' ' 44' ' ' LEU . 12.2 t -138.16 165.13 27.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.175 -0.953 . . . . 0.0 109.713 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.523 ' OH ' ' CE ' ' A' ' 3' ' ' MET . 68.8 m-85 -106.63 10.21 31.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.584 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.09 -179.96 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.039 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.584 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.6 Cg_endo -66.39 -4.57 10.93 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.159 1.906 . . . . 0.0 111.64 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -132.12 105.92 7.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.35 -0.844 . . . . 0.0 108.811 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.463 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 58.6 t80 -63.53 117.72 7.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 109.408 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 41' ' ' TYR . 85.7 mt-30 -157.98 144.79 17.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.684 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.3 m -72.78 124.73 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 68.3 mt -59.72 -39.14 83.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.94 . . . . 0.0 109.483 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 20.3 t-20 -179.57 157.02 0.74 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.468 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -108.39 139.33 43.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.873 . . . . 0.0 109.515 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.403 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 0.5 OUTLIER -118.86 139.93 50.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.264 -0.897 . . . . 0.0 109.483 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.3 t -130.81 125.45 33.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.449 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 30' ' ' MET . 2.2 mp -130.82 95.74 25.04 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.275 -0.891 . . . . 0.0 109.421 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.77 ' HG3' HG21 ' A' ' 163' ' ' VAL . 50.1 Cg_endo -69.93 134.98 28.92 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.785 2.323 . . . . 0.0 111.813 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.447 HD12 ' CB ' ' A' ' 59' ' ' ALA . 38.8 mt -113.21 152.01 30.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.57 -48.37 0.13 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -89.16 7.49 34.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -1.177 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 74.4 m80 -111.18 142.08 43.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.435 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 58' ' ' MET . 9.6 t -87.43 -176.27 5.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.908 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -60.45 -44.7 95.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -62.06 -48.58 79.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.473 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.593 ' O ' HG22 ' A' ' 61' ' ' ILE . 96.3 mtp -61.63 -30.12 70.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.497 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HB2' ' HB1' ' A' ' 28' ' ' ALA . . . -71.02 -28.74 64.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.769 ' HB3' HG21 ' A' ' 87' ' ' VAL . 98.1 mt-10 -73.69 -45.2 53.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 58' ' ' MET . 16.1 tt -63.12 -32.03 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.875 . . . . 0.0 109.465 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.556 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -74.2 -34.52 63.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.329 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -56.24 -42.82 77.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.534 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.651 HG21 HG12 ' A' ' 87' ' ' VAL . 32.7 t -71.32 -45.5 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.51 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.524 ' HG2' ' CG1' ' A' ' 120' ' ' ILE . 97.8 mt-10 -55.76 -35.57 66.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.907 . . . . 0.0 109.56 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.524 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 8.8 t80 -62.11 -69.04 0.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.607 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 -13.95 51.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.492 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 41.4 t -66.08 -60.41 2.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.179 -0.951 . . . . 0.0 109.432 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -65.13 -40.12 93.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.463 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HE3' ' CE2' ' A' ' 66' ' ' PHE . 63.2 mttm -64.26 -34.96 79.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.416 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.414 ' O ' HG12 ' A' ' 74' ' ' ILE . . . -63.71 -65.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.468 HD21 ' SD ' ' A' ' 126' ' ' MET . 24.9 tp -51.23 -44.33 61.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.174 -0.953 . . . . 0.0 109.589 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' LEU . 83.5 tttt -43.55 -47.35 7.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.284 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.56 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 9.5 mm -48.51 142.72 8.24 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.14 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.2 Cg_endo -65.88 -5.02 11.09 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.49 2.127 . . . . 0.0 111.556 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.74 168.22 23.67 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 47.7 Cg_endo -68.85 137.35 37.96 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.583 2.188 . . . . 0.0 111.585 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 8' ' ' GLY . 21.7 t -123.82 159.1 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.46 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.582 ' HB2' HG22 ' A' ' 9' ' ' VAL . 6.5 mp -105.92 123.8 48.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.863 . . . . 0.0 109.59 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 40.2 t -103.6 121.62 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.453 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.875 HD12 ' CE2' ' A' ' 11' ' ' TYR . 13.8 mt -106.85 139.05 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.311 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.86 161.74 29.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.406 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 135' ' ' GLU . 68.1 m-20 -93.43 -2.5 54.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.304 -0.873 . . . . 0.0 109.464 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.458 ' HB3' HG23 ' A' ' 87' ' ' VAL . 71.1 m -108.5 120.75 43.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.575 ' HA ' ' CD2' ' A' ' 134' ' ' HIS . 61.2 t80 -71.31 -28.64 64.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.345 -0.847 . . . . 0.0 109.541 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -78.98 -46.33 18.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.316 -0.865 . . . . 0.0 109.745 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.769 HG21 ' HB3' ' A' ' 60' ' ' GLU . 30.9 t -57.68 -60.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 109.437 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.995 ' HB1' ' CG2' ' A' ' 132' ' ' ILE . . . -53.19 -51.75 61.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 0.0 109.408 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -52.31 -38.27 58.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.52 ' HB3' ' CH2' ' A' ' 117' ' ' TRP . 19.2 t -56.91 -48.2 78.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.901 . . . . 0.0 109.428 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.92 -0.91 45.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.355 -0.841 . . . . 0.0 109.765 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -92.68 -73.77 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.003 -1.06 . . . . 0.0 110.072 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 32.5 mmtp -127.52 -27.13 2.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.099 -1.0 . . . . 0.0 110.239 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 53.8 mt-10 -62.75 -20.54 65.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 110.176 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.937 HD21 ' HB2' ' A' ' 121' ' ' ALA . 25.4 tp -64.86 -58.33 13.32 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.965 -1.084 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.2 Cg_endo -66.14 -36.12 30.45 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.545 2.163 . . . . 0.0 111.442 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -65.79 -34.61 78.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 108.935 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.851 ' NE1' HD11 ' A' ' 111' ' ' LEU . 23.1 m0 -64.74 -50.41 67.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.4 -0.812 . . . . 0.0 109.123 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 98' ' ' TRP . 79.2 mttt -44.11 -31.31 0.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 109.609 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -29.06 62.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.194 -0.941 . . . . 0.0 109.587 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 98' ' ' TRP . 77.0 m-20 -99.31 23.11 9.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 109.606 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.66 ' O ' HG23 ' A' ' 104' ' ' VAL . . . 64.23 35.26 91.75 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.568 ' CG ' ' O ' ' A' ' 102' ' ' GLY . 9.4 p90 40.75 34.26 0.25 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.431 -1.04 . . . . 0.0 109.903 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 102' ' ' GLY . 21.5 t -99.81 114.04 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.969 . . . . 0.0 109.631 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.584 ' HA ' HD13 ' A' ' 111' ' ' LEU . 53.7 p30 -51.32 173.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.421 -0.8 . . . . 0.0 109.71 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -129.73 -111.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.324 -0.86 . . . . 0.0 109.024 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -64.37 -30.09 71.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.759 -1.213 . . . . 0.0 108.849 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.529 ' CB ' ' HD3' ' A' ' 110' ' ' PRO . 42.4 mttt -109.2 -160.99 0.74 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 108.927 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -133.96 43.18 0.94 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 0.0 109.837 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 109' ' ' LYS . 50.5 Cg_endo -73.1 -18.63 23.68 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.409 2.072 . . . . 0.0 111.99 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.851 HD11 ' NE1' ' A' ' 98' ' ' TRP . 7.7 mp -91.84 21.21 5.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 0.0 109.469 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.518 ' CD ' ' HB2' ' A' ' 109' ' ' LYS . 45.9 mttt -89.24 157.37 18.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 108.847 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 61.71 34.83 17.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.057 -1.027 . . . . 0.0 109.149 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.659 HD11 ' O ' ' A' ' 111' ' ' LEU . 45.6 mm -48.86 -41.64 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.327 -0.858 . . . . 0.0 109.08 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.8 t -47.39 -44.01 23.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 108.784 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 40.3 mttm -63.38 -46.08 88.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 108.952 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.52 ' CH2' ' HB3' ' A' ' 90' ' ' SER . 47.9 m95 -62.17 -42.39 99.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -0.867 . . . . 0.0 109.216 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -51.66 -48.15 63.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.255 -0.903 . . . . 0.0 109.34 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.2 m -49.54 -39.8 35.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.24 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.524 ' CG1' ' HG2' ' A' ' 65' ' ' GLU . 61.9 mt -73.27 -33.32 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.268 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.937 ' HB2' HD21 ' A' ' 95' ' ' LEU . . . -64.96 -36.82 85.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -54.25 -40.3 67.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 109.407 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.92 -50.61 12.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.41 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.49 -35.98 75.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 0.0 109.357 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.2 t -58.96 -35.14 72.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.887 . . . . 0.0 109.476 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.468 ' SD ' HD21 ' A' ' 72' ' ' LEU . 65.9 mtt -65.35 -34.78 79.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.0 OUTLIER 172.37 152.72 0.22 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.915 . . . . 0.0 109.557 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.7 Cg_endo -71.76 3.2 3.97 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.813 2.342 . . . . 0.0 112.059 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 128' ' ' PRO . 81.2 m-20 -42.36 -30.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 109.581 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 72' ' ' LEU . 38.1 mt -82.76 111.64 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.514 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 79' ' ' LEU . 32.9 m -97.72 151.16 20.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.391 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.995 ' CG2' ' HB1' ' A' ' 88' ' ' ALA . 63.7 mt -125.27 129.07 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.634 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.425 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.2 mt-30 -119.17 157.31 28.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.38 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.961 ' NE2' ' HB3' ' A' ' 88' ' ' ALA . 27.3 m170 -112.03 133.57 54.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.665 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.441 ' CD ' ' ND2' ' A' ' 150' ' ' ASN . 49.7 tp10 -90.64 146.08 24.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.873 . . . . 0.0 109.289 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -90.05 32.02 0.94 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -0.943 . . . . 0.0 109.523 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.27 -47.44 55.84 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -54.95 -44.23 74.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -1.17 . . . . 0.0 109.445 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -124.23 84.75 55.63 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.533 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.26 54.28 1.35 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.649 2.233 . . . . 0.0 111.822 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.1 m -60.98 -37.18 81.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.299 -0.876 . . . . 0.0 109.331 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -139.36 -179.53 5.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 0.0 109.396 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.5 p -127.8 158.16 38.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.527 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 79.2 p -145.78 162.19 38.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.3 tt -55.54 -31.38 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.857 . . . . 0.0 109.554 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -66.33 -31.77 72.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.435 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.2 m -51.95 -48.49 64.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.439 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -47.59 -51.37 21.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -52.39 -40.4 53.68 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.441 ' ND2' ' CD ' ' A' ' 135' ' ' GLU . 87.9 m-20 -64.96 -39.26 93.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -1.141 . . . . 0.0 109.465 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.79 -48.54 72.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.819 ' O ' HD12 ' A' ' 156' ' ' LEU . 6.6 mp -64.17 -41.13 97.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.441 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.733 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -64.9 -36.97 86.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.461 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.456 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 76.4 m-20 -61.18 -42.74 99.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -60.8 -45.45 94.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.27 -0.894 . . . . 0.0 109.527 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.819 HD12 ' O ' ' A' ' 152' ' ' LEU . 1.0 OUTLIER -63.89 -38.19 90.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.23 93.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 109.465 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.663 HG22 ' HE1' ' A' ' 162' ' ' TYR . 56.2 m -64.7 -41.65 95.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.5 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.49 -33.14 72.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.89 . . . . 0.0 109.624 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.79 -42.23 96.38 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.488 ' HB2' HD12 ' A' ' 17' ' ' ILE . 95.6 p -56.73 -28.68 61.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -1.171 . . . . 0.0 109.631 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.663 ' HE1' HG22 ' A' ' 158' ' ' THR . 87.9 m-85 -72.72 -25.11 61.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 109.524 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.77 HG21 ' HG3' ' A' ' 50' ' ' PRO . 77.1 t -64.17 -42.55 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.899 . . . . 0.0 109.411 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 161' ' ' SER . 41.0 t -122.43 158.63 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.413 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.441 ' N ' HG12 ' A' ' 164' ' ' VAL . 47.9 t-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.471 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.27 -25.85 68.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -1.155 . . . . 0.0 109.504 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.798 ' HE2' HD12 ' A' ' 79' ' ' LEU . 89.3 mtp -62.67 -35.86 81.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.147 -0.971 . . . . 0.0 109.498 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . -42.7 164.39 0.02 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 74.2 mt-30 66.36 39.84 3.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.121 . . . . 0.0 109.63 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 3' ' ' MET . 7.9 p90 -135.62 152.7 51.5 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.312 -0.868 . . . . 0.0 109.35 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.493 ' OE2' ' CD ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -88.5 -31.41 18.74 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -177.24 -177.08 45.87 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 79' ' ' LEU . 59.4 t -124.8 142.63 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -1.133 . . . . 0.0 109.25 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.813 ' CE1' HG21 ' A' ' 78' ' ' VAL . 5.4 m-85 -114.3 146.58 40.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.861 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.594 ' CE2' HG13 ' A' ' 81' ' ' ILE . 67.8 m-85 -119.64 129.1 54.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.394 -0.817 . . . . 0.0 109.104 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.804 HG22 HD12 ' A' ' 32' ' ' ILE . 16.0 p -118.02 147.46 43.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.64 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 58.8 t0 -144.34 150.65 38.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.548 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.475 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -134.96 120.99 2.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.7 m -133.13 150.68 52.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -1.137 . . . . 0.0 109.625 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -119.75 154.46 34.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.479 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 161' ' ' SER . 66.6 mt -122.55 134.17 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.162 -0.961 . . . . 0.0 109.629 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HG2' ' CG ' ' A' ' 26' ' ' ASN . 37.2 mttp -103.12 152.31 21.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.557 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -124.61 176.35 2.4 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.362 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 46.4 Cg_endo -68.78 128.62 17.22 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.497 2.131 . . . . 0.0 111.321 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 53.75 60.32 11.59 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 108.917 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 19' ' ' SER . 46.7 Cg_endo -67.75 69.5 0.79 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.938 2.425 . . . . 0.0 112.013 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 p -57.67 -16.94 12.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.858 . . . . 0.0 109.2 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -118.26 -174.97 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 m -70.37 151.64 44.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 7.8 m120 -60.43 -178.99 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.843 . . . . 0.0 109.431 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' ILE . 23.7 m120 -99.53 113.7 26.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.413 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . . . -93.17 150.35 20.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.9 143.03 9.81 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 63.4 mtm -115.39 162.86 16.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -1.152 . . . . 0.0 109.359 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' A' ' 156' ' ' LEU . . . -151.27 130.22 3.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.804 HD12 HG22 ' A' ' 12' ' ' THR . 23.4 mm -114.76 140.65 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -1.116 . . . . 0.0 109.382 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 11' ' ' TYR . 40.6 t -127.88 130.2 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.597 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.676 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 19.6 m170 -105.67 137.57 43.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.144 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.1 168.63 19.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.709 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -137.01 164.32 28.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.379 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.499 ' CE2' ' HE1' ' A' ' 3' ' ' MET . 59.4 m-85 -102.48 14.78 31.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 109.494 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.578 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -51.17 179.8 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 108.942 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.3 Cg_endo -66.1 -6.21 14.05 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.137 1.891 . . . . 0.0 111.447 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' CD ' ' NE2' ' A' ' 42' ' ' GLN . 79.7 tt0 -135.16 106.55 6.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.427 -0.795 . . . . 0.0 109.066 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -58.38 122.96 14.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.258 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.469 ' NE2' ' CD ' ' A' ' 40' ' ' GLU . 45.1 mt-30 -154.14 148.17 25.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.683 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 43' ' ' VAL . 8.6 p -82.96 123.78 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 54.4 mt -64.27 -34.18 77.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 44' ' ' LEU . 21.7 t-20 178.69 155.3 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.512 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.405 ' HB3' HD21 ' A' ' 156' ' ' LEU . 94.2 mt-30 -109.32 142.39 40.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.322 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.485 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 1.2 t-105 -126.52 136.4 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.591 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.1 t -127.29 132.49 50.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.361 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.921 HD11 ' CE2' ' A' ' 66' ' ' PHE . 3.3 mt -132.77 91.73 28.72 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.74 136.22 29.89 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.713 2.275 . . . . 0.0 111.728 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.57 ' CD1' ' HB2' ' A' ' 59' ' ' ALA . 44.0 mt -101.48 143.98 30.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.41 -68.41 1.13 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -109.87 64.09 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.19 . . . . 0.0 109.537 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 81.0 m80 -132.1 171.95 12.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.521 HG22 ' HG3' ' A' ' 58' ' ' MET . 11.7 t -121.0 174.22 6.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.83 -45.26 78.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' GLU . 90.1 mt-30 -60.35 -64.03 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.447 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.521 ' HG3' HG22 ' A' ' 55' ' ' THR . 97.1 mtp -44.35 -35.3 2.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 109.371 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.57 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . . . -80.39 -25.9 38.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 57' ' ' GLN . 78.0 tt0 -64.48 -40.56 95.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.404 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.651 HD11 ' CZ2' ' A' ' 117' ' ' TRP . 12.1 tt -84.1 -29.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.474 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -67.73 -25.84 65.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 109.465 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.27 -36.38 81.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.512 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.574 HG22 HG21 ' A' ' 82' ' ' THR . 96.7 t -79.29 -38.97 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.569 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -66.8 -39.37 87.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.078 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.921 ' CE2' HD11 ' A' ' 49' ' ' ILE . 27.6 t80 -59.72 -64.54 0.91 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.447 -0.783 . . . . 0.0 109.608 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.94 -32.2 70.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.839 . . . . 0.0 109.751 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 1.051 ' SG ' HG23 ' A' ' 120' ' ' ILE . 50.8 t -54.82 -54.18 45.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -62.87 -45.67 91.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.581 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 62.9 mttm -63.38 -38.0 89.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 109.669 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.641 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -56.75 -63.05 1.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.57 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.941 ' HB2' HD11 ' A' ' 130' ' ' ILE . 25.2 tp -53.48 -45.74 69.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.19 -0.944 . . . . 0.0 109.489 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 72' ' ' LEU . 20.8 tttp -43.06 -43.21 4.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.371 -0.831 . . . . 0.0 109.23 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 8.0 mt -48.25 142.44 7.92 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 108.877 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.8 Cg_endo -66.11 -4.3 10.06 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.447 2.098 . . . . 0.0 111.696 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.409 ' HA3' ' CD ' ' A' ' 7' ' ' GLU . . . -140.77 166.96 25.76 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.493 ' CD ' ' OE2' ' A' ' 7' ' ' GLU . 46.7 Cg_endo -67.64 127.17 15.88 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.418 2.079 . . . . 0.0 111.591 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.813 HG21 ' CE1' ' A' ' 10' ' ' PHE . 7.3 p -123.47 151.41 28.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.165 -0.959 . . . . 0.0 109.495 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.798 HD12 ' HE2' ' A' ' 3' ' ' MET . 15.5 mt -93.15 146.78 23.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.457 ' O ' HD13 ' A' ' 81' ' ' ILE . 65.1 t -118.09 135.84 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 109.396 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.594 HG13 ' CE2' ' A' ' 11' ' ' TYR . 26.1 mm -114.75 132.67 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.574 HG21 HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -129.77 161.62 30.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.953 . . . . 0.0 109.481 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 58.7 p30 -94.57 11.38 31.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.363 -0.835 . . . . 0.0 109.435 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.45 ' CB ' HG12 ' A' ' 87' ' ' VAL . 8.3 t -131.92 119.21 20.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.498 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.528 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 68.9 t80 -75.96 -34.3 59.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 109.339 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -57.95 -53.62 56.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.383 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 88' ' ' ALA . 13.7 p -61.06 -46.67 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.338 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.61 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -53.5 -51.72 61.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.204 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 84.4 tt0 -55.93 -36.5 67.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.623 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 67.8 m -54.87 -49.51 71.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.451 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.544 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -85.95 -1.0 56.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.719 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.459 ' OD1' ' HB ' ' A' ' 132' ' ' ILE . 81.3 m-20 -87.1 -73.32 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.072 -1.017 . . . . 0.0 109.722 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 67.6 mttm -127.08 -30.76 2.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -0.87 . . . . 0.0 109.835 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 69.4 mt-10 -58.09 -28.21 64.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.727 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 117' ' ' TRP . 0.4 OUTLIER -59.64 -61.23 8.29 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.0 109.458 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -66.3 -30.87 44.77 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.691 2.261 . . . . 0.0 111.572 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -67.55 -39.51 84.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.013 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.487 ' CZ2' ' HB3' ' A' ' 94' ' ' GLU . 27.9 m0 -63.46 -51.38 65.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 109.173 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 98' ' ' TRP . 15.3 tttp -45.0 -41.98 7.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 m -57.91 -41.55 82.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -86.09 10.82 13.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.465 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 75.99 39.79 31.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 85.9 m-85 62.42 43.56 7.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.214 -1.168 . . . . 0.0 109.48 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.81 135.11 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.551 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 109' ' ' LYS . 41.0 t-20 -67.57 141.51 56.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.45 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -51.66 -35.29 41.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -77.54 164.24 25.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -55.61 -31.34 62.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 105' ' ' ASN . 2.1 mptp? -61.43 141.82 94.25 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.516 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.11 154.69 66.11 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.732 2.288 . . . . 0.0 111.742 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.015 HD23 ' CD1' ' A' ' 114' ' ' ILE . 10.1 tp -81.92 134.2 35.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 12.8 mmtp -115.24 167.08 11.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.56 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 49.0 m80 65.61 34.56 7.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.517 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.015 ' CD1' HD23 ' A' ' 111' ' ' LEU . 35.8 mm -68.09 -42.73 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.399 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.444 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 23.2 m -55.96 -40.76 73.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.837 . . . . 0.0 109.346 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -65.37 -39.21 92.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.37 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.651 ' CZ2' HD11 ' A' ' 61' ' ' ILE . 22.6 m95 -71.64 -39.15 70.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.316 -0.865 . . . . 0.0 109.317 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 115' ' ' SER . 55.3 mtmt -57.38 -42.16 81.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 109.383 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.3 m -58.41 -42.42 87.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 1.051 HG23 ' SG ' ' A' ' 68' ' ' CYS . 83.4 mt -76.36 -34.06 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.473 ' HB2' HD13 ' A' ' 95' ' ' LEU . . . -63.62 -40.05 95.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.941 . . . . 0.0 109.432 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -57.46 -42.53 82.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.4 m -67.53 -49.68 62.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.583 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 91' ' ' ALA . 56.0 mt -62.71 -30.56 71.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.913 . . . . 0.0 109.571 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.0 m -56.04 -36.37 67.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.498 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.745 ' SD ' HD21 ' A' ' 72' ' ' LEU . 65.3 mtt -64.15 -34.85 79.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.985 . . . . 0.0 109.427 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 126' ' ' MET . 1.3 mttp 170.76 156.53 0.21 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.626 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 129' ' ' ASP . 53.4 Cg_endo -71.82 2.65 4.51 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.823 2.349 . . . . 0.0 111.897 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 128' ' ' PRO . 91.3 m-20 -41.73 -43.97 3.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.875 . . . . 0.0 109.685 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.941 HD11 ' HB2' ' A' ' 72' ' ' LEU . 50.3 mt -68.35 115.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.51 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.598 ' HB ' HD22 ' A' ' 79' ' ' LEU . 24.5 m -107.52 142.95 36.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 0.0 109.095 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.544 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 61.8 mt -124.96 137.99 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 109.781 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.501 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 94.8 mt-30 -133.03 161.19 35.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.354 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.528 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 20.0 t-80 -105.07 135.68 45.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 109.412 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.526 ' HG3' HG22 ' A' ' 81' ' ' ILE . 99.4 mt-10 -75.16 154.54 37.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.84 33.66 1.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.476 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 84.13 -164.17 40.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -118.93 132.87 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -1.131 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.439 ' HG2' ' HD2' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -143.3 138.46 15.59 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.168 -0.957 . . . . 0.0 109.526 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.439 ' HD2' ' HG2' ' A' ' 139' ' ' GLN . 49.6 Cg_endo -70.71 -24.51 25.25 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.733 2.288 . . . . 0.0 111.695 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.6 m -64.53 -35.46 81.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.454 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 56.63 49.33 14.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.6 p -70.44 -20.26 62.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.483 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.9 p -117.62 152.02 36.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.462 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.4 HD13 ' CE1' ' A' ' 37' ' ' TYR . 12.9 tt -67.01 -28.69 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.515 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -65.41 -34.38 78.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.902 . . . . 0.0 109.467 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 51.9 m -56.86 -49.17 76.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 109.444 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -52.03 -48.3 64.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.433 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.6 -37.35 82.52 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -60.08 -40.06 88.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -1.119 . . . . 0.0 109.491 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.06 -52.84 62.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.489 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.9 mt -57.31 -48.64 78.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.491 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.464 ' N ' HG21 ' A' ' 33' ' ' VAL . . . -54.43 -40.44 68.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.529 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.453 ' OD1' ' OD2' ' A' ' 13' ' ' ASP . 88.8 m-20 -59.25 -40.29 85.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -60.58 -42.64 97.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 156' ' ' LEU . 6.6 mp -66.28 -39.86 89.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.527 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.72 -53.2 58.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 39.0 m -59.12 -42.83 91.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.905 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.572 ' O ' HG23 ' A' ' 163' ' ' VAL . 49.1 tt0 -63.11 -40.05 96.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.516 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -61.73 -51.29 58.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.547 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 30.3 m -61.92 -33.39 74.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -1.133 . . . . 0.0 109.465 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -62.99 -35.86 81.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.892 . . . . 0.0 109.46 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 159' ' ' GLN . 40.4 t -64.96 -16.76 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 51' ' ' LEU . 40.2 t -109.34 134.76 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.472 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.32 79.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.448 ' O ' ' OH ' ' A' ' 6' ' ' TYR . 59.4 mtm -62.72 -33.01 74.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.88 177.26 19.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -103.73 116.14 31.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -1.149 . . . . 0.0 109.511 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 1.032 ' CD2' HD11 ' A' ' 79' ' ' LEU . 64.8 m-85 -119.47 168.65 10.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.352 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 76.6 mm-40 -63.0 -38.66 92.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.171 -0.956 . . . . 0.0 108.942 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.48 -170.71 41.64 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.98 HG21 ' OH ' ' A' ' 37' ' ' TYR . 73.8 t -133.26 139.1 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -1.082 . . . . 0.0 109.007 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.635 ' CD2' ' ND1' ' A' ' 34' ' ' HIS . 5.1 m-85 -113.8 138.6 50.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.905 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.873 ' CE1' HD12 ' A' ' 81' ' ' ILE . 75.2 m-85 -114.05 117.2 30.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.146 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 1.113 HG22 HG23 ' A' ' 32' ' ' ILE . 10.4 p -114.55 157.16 23.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.786 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 49.9 t0 -155.77 156.01 34.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.279 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.495 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -131.25 141.96 13.29 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.9 t -141.62 138.6 32.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -1.115 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.965 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . . . -118.97 143.62 46.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.521 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 63.9 mt -119.82 134.96 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.378 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -97.35 127.02 42.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.485 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 3.7 m -115.21 158.77 40.29 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.435 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.47 -28.33 21.99 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.747 2.298 . . . . 0.0 111.855 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.591 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -72.61 -66.44 0.6 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.528 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 50.0 Cg_endo -69.7 65.7 1.75 Allowed 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.671 2.247 . . . . 0.0 111.804 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.6 m -54.72 -43.14 72.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -97.88 33.43 2.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.44 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 22' ' ' PRO . 35.2 t -162.69 147.98 12.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -131.24 159.96 36.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.447 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.801 ' HB3' HG23 ' A' ' 164' ' ' VAL . 21.8 m120 -91.68 114.97 27.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.485 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . . . -99.26 143.08 29.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.93 151.44 20.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.833 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 72.4 mtm -128.68 160.45 32.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -1.145 . . . . 0.0 109.518 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -153.34 115.67 0.69 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.113 HG23 HG22 ' A' ' 12' ' ' THR . 4.3 mp -123.54 120.53 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -1.175 . . . . 0.0 109.431 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.601 HG22 HG13 ' A' ' 43' ' ' VAL . 11.6 p -120.82 148.0 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.635 ' ND1' ' CD2' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -109.24 145.52 35.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.03 173.11 11.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -133.22 157.03 46.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 109.664 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.98 ' OH ' HG21 ' A' ' 9' ' ' VAL . 16.7 m-30 -103.48 12.79 34.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.51 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.591 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -50.82 -179.62 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 108.941 179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.591 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.5 Cg_endo -65.11 -7.43 15.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.038 1.825 . . . . 0.0 111.288 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -128.11 106.25 8.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.429 -0.795 . . . . 0.0 108.965 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -61.82 127.37 31.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.149 -0.97 . . . . 0.0 109.237 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -161.42 154.24 20.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.925 . . . . 0.0 109.562 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.601 HG13 HG22 ' A' ' 33' ' ' VAL . 41.9 t -91.05 122.54 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 109.24 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 45.5 mt -62.46 -40.21 95.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 109.346 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 33' ' ' VAL . 64.2 t30 178.45 154.49 0.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.878 . . . . 0.0 109.684 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.722 ' OE1' HD21 ' A' ' 156' ' ' LEU . 56.2 mt-30 -107.58 143.06 36.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.054 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.2 t-105 -118.52 131.85 56.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 109.599 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.2 m -121.88 145.34 48.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.579 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 9.9 mt -149.56 96.88 3.57 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.554 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 50.0 Cg_endo -70.02 128.4 15.74 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.684 2.256 . . . . 0.0 111.661 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.669 ' HB2' ' HB3' ' A' ' 28' ' ' ALA . 49.0 mt -114.36 148.67 37.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 109.49 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.65 -46.89 0.2 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -87.47 11.11 15.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -1.156 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 51' ' ' LEU . 78.2 m80 -112.61 147.21 37.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.482 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.1 OUTLIER -89.58 168.47 12.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.9 . . . . 0.0 109.111 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.965 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . . . -49.38 -38.76 29.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.1 -1.0 . . . . 0.0 109.056 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' MET . 89.2 mt-30 -70.09 -58.77 3.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.332 -0.855 . . . . 0.0 109.311 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.539 ' O ' HG22 ' A' ' 61' ' ' ILE . 93.3 mtp -45.43 -30.59 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.158 -0.964 . . . . 0.0 109.199 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.648 ' HB2' ' HB1' ' A' ' 28' ' ' ALA . . . -75.28 -37.35 60.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 109.416 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.452 ' HB3' ' OG ' ' A' ' 84' ' ' SER . 96.3 mt-10 -62.74 -44.9 95.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.358 -0.839 . . . . 0.0 109.562 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.63 ' CD1' ' CZ2' ' A' ' 117' ' ' TRP . 8.2 tt -67.29 -35.09 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.238 -0.914 . . . . 0.0 109.4 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.833 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -65.89 -29.69 70.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.192 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.767 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -70.01 -44.79 68.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.44 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.779 HG21 HG13 ' A' ' 87' ' ' VAL . 68.6 t -63.13 -47.3 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.335 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' A' ' 120' ' ' ILE . 84.6 tt0 -64.83 -38.3 90.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 109.417 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 49' ' ' ILE . 16.3 t80 -53.66 -68.82 0.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.395 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -63.23 -15.94 58.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.369 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.69 ' SG ' HG23 ' A' ' 120' ' ' ILE . 39.8 t -70.79 -58.03 4.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.432 ' NZ ' ' OE2' ' A' ' 65' ' ' GLU . 25.5 mttt -59.76 -48.69 80.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.486 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 37.5 mttm -60.87 -38.48 85.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.227 -0.92 . . . . 0.0 109.505 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.794 ' HB1' ' CG1' ' A' ' 78' ' ' VAL . . . -55.74 -69.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.63 ' HB2' HD11 ' A' ' 130' ' ' ILE . 6.3 tp -44.89 -48.51 11.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 109.434 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 20.2 mttm -43.81 -44.36 6.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.281 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 9.7 mt -48.81 143.11 8.51 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.043 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 43.6 Cg_endo -66.29 -2.68 7.48 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.601 2.2 . . . . 0.0 111.921 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.516 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -141.64 166.4 26.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.3 Cg_endo -69.34 122.75 9.54 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 122.552 2.168 . . . . 0.0 111.714 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.794 ' CG1' ' HB1' ' A' ' 71' ' ' ALA . 2.8 p -112.77 156.44 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.032 HD11 ' CD2' ' A' ' 6' ' ' TYR . 19.3 mt -101.58 140.26 36.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.759 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 52.0 t -120.92 130.33 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.137 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.873 HD12 ' CE1' ' A' ' 11' ' ' TYR . 8.0 mt -118.71 136.23 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 109.742 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.8 t -140.97 143.26 34.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.237 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -66.69 -25.34 66.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.905 . . . . 0.0 109.57 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.58 ' CB ' ' CG1' ' A' ' 87' ' ' VAL . 3.6 m -64.69 110.93 2.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.194 -0.942 . . . . 0.0 109.286 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.659 ' CD2' ' CE1' ' A' ' 134' ' ' HIS . 49.2 t80 -78.05 -41.45 35.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.688 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -71.15 -35.98 71.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.319 -0.863 . . . . 0.0 109.908 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.779 HG13 HG21 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -67.36 -47.16 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.135 -0.978 . . . . 0.0 109.497 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.964 ' HB3' ' NE2' ' A' ' 134' ' ' HIS . . . -54.32 -51.4 64.8 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.229 -0.919 . . . . 0.0 108.964 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 72.6 tt0 -55.26 -33.39 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.332 -0.855 . . . . 0.0 108.967 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.637 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 16.6 m -57.3 -49.11 77.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.844 . . . . 0.0 109.352 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.798 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -85.71 -0.72 55.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.749 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.48 ' OD1' ' HB ' ' A' ' 132' ' ' ILE . 85.7 m-20 -88.48 -73.48 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 109.947 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 63.0 mttt -127.42 -30.07 2.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.017 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 37.5 mm-40 -57.04 -31.54 65.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.078 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.606 HD23 ' HB2' ' A' ' 121' ' ' ALA . 0.5 OUTLIER -58.32 -60.8 9.05 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 0.0 109.503 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -66.8 -26.33 45.12 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.642 2.228 . . . . 0.0 111.581 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.507 ' CE2' ' OD1' ' A' ' 101' ' ' ASN . 77.7 t80 -73.82 -36.83 65.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 108.977 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.1 m0 -65.33 -50.35 65.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.35 -0.844 . . . . 0.0 109.239 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -51.03 -40.09 57.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.382 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 82.7 p -63.46 -35.99 82.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.389 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.653 ' O ' HG23 ' A' ' 104' ' ' VAL . 24.5 m120 -85.73 8.37 20.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 77.41 37.16 32.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 87.3 m-85 63.25 48.8 3.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -1.173 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 109' ' ' LYS . 46.7 t -110.14 134.89 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.54 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 1.041 ' HB2' HD12 ' A' ' 111' ' ' LEU . 48.8 t30 -98.89 136.3 39.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.464 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -57.47 -38.78 75.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.4 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -67.66 -46.46 72.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.396 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 105' ' ' ASN . 33.7 mttm -132.86 145.22 50.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.9 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.657 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -44.71 -65.2 0.66 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 109.531 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 109' ' ' LYS . 49.3 Cg_endo -70.1 138.4 36.67 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.686 2.257 . . . . 0.0 111.873 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.041 HD12 ' HB2' ' A' ' 105' ' ' ASN . 11.3 tp -85.96 142.25 28.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.393 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.532 ' HD3' ' CE1' ' A' ' 113' ' ' HIS . 80.8 tttt -101.23 151.88 21.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.591 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.535 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 39.5 m80 65.31 28.55 11.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.569 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.585 HG12 HD23 ' A' ' 111' ' ' LEU . 80.0 mt -62.88 -45.48 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.167 -0.958 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -55.67 -46.08 77.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.53 -45.48 91.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.637 ' CH2' ' CB ' ' A' ' 90' ' ' SER . 54.3 m95 -66.42 -36.55 83.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.439 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -56.4 -46.17 80.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.484 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.6 m -59.96 -44.11 94.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.407 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.69 HG23 ' SG ' ' A' ' 68' ' ' CYS . 87.8 mt -68.79 -39.58 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.606 ' HB2' HD23 ' A' ' 95' ' ' LEU . . . -62.87 -36.24 82.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.472 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -56.2 -37.92 70.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 6.0 m -79.43 -51.34 9.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.387 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 124' ' ' LEU . 19.4 tp -58.56 -34.59 71.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.417 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.0 m -60.47 -31.88 70.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.549 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.78 -33.38 75.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.447 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.45 145.95 0.29 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 109.511 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.6 Cg_endo -72.35 2.72 4.76 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.741 2.294 . . . . 0.0 111.774 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 128' ' ' PRO . 79.5 m-20 -42.87 -46.16 5.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.504 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.63 HD11 ' HB2' ' A' ' 72' ' ' LEU . 52.8 mt -61.92 121.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.342 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.627 ' HB ' HD22 ' A' ' 79' ' ' LEU . 24.4 m -110.85 146.77 35.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.372 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.798 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 54.1 mt -125.12 128.13 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.462 ' HB2' HG12 ' A' ' 81' ' ' ILE . 79.9 mt-30 -127.24 154.9 44.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.964 ' NE2' ' HB3' ' A' ' 88' ' ' ALA . 34.1 m170 -90.67 141.01 29.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.791 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HG2' ' OD1' ' A' ' 150' ' ' ASN . 98.3 mt-10 -75.71 147.03 39.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 109.286 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -101.55 37.85 1.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.559 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -46.26 -33.96 5.94 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -91.32 135.2 33.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 0.0 109.428 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.479 ' O ' ' CG2' ' A' ' 143' ' ' THR . 2.2 tp60 67.11 73.02 0.39 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.506 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.533 ' HA ' HG21 ' A' ' 143' ' ' THR . 50.0 Cg_endo -70.63 -16.94 33.92 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.704 2.27 . . . . 0.0 111.719 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.6 m -76.3 139.89 41.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.496 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 60.74 44.51 11.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.448 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.533 HG21 ' HA ' ' A' ' 140' ' ' PRO . 27.1 p -119.31 159.05 24.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.463 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.3 m -70.99 174.52 6.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.535 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 24.3 pt -70.2 -10.04 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.893 . . . . 0.0 109.476 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.622 ' CD2' HD11 ' A' ' 81' ' ' ILE . 71.9 m80 -65.31 -27.09 68.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.1 m -51.35 -45.92 62.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.315 -0.866 . . . . 0.0 109.563 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -52.22 -49.81 63.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 109.506 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -57.43 -36.1 75.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.45 ' OD1' ' HG2' ' A' ' 135' ' ' GLU . 77.1 m-20 -60.42 -41.13 93.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -1.15 . . . . 0.0 109.575 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.24 -48.48 79.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.402 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 26.0 tp -65.28 -42.26 93.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.32 -40.73 98.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 0.0 109.509 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.457 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 56.2 t0 -58.26 -43.17 87.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.861 . . . . 0.0 109.559 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 78.6 tttt -62.19 -38.13 87.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.51 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.722 HD21 ' OE1' ' A' ' 46' ' ' GLN . 78.8 mt -64.29 -38.2 90.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.568 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.22 83.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.923 . . . . 0.0 109.463 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 36.3 m -61.59 -41.46 97.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.472 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.78 ' O ' HG23 ' A' ' 163' ' ' VAL . 95.2 mt-30 -62.4 -35.96 80.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 50' ' ' PRO . . . -62.54 -55.94 24.38 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 88.1 p -67.48 -28.69 68.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -1.146 . . . . 0.0 109.516 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -63.85 -36.14 82.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.551 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 159' ' ' GLN . 39.1 t -64.95 -11.79 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.514 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.801 HG23 ' HB3' ' A' ' 27' ' ' ASN . 22.3 m -126.98 155.55 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.455 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 164' ' ' VAL . 17.0 m120 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.539 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.5 146.22 49.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -1.157 . . . . 0.0 109.55 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 77.9 mtm -63.92 -40.27 96.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 68.5 -172.21 35.67 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 75.0 mm-40 82.55 -24.91 0.16 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.724 -0.868 . . . . 0.0 110.259 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.672 ' CB ' HD13 ' A' ' 79' ' ' LEU . 24.0 p90 -129.22 166.74 18.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.902 -1.124 . . . . 0.0 109.565 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.489 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -94.72 -33.86 12.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 108.924 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.587 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -165.74 175.42 41.4 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.819 HG22 ' HB2' ' A' ' 79' ' ' LEU . 91.8 t -124.95 138.02 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.196 -1.179 . . . . 0.0 109.357 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE2' ' CG ' ' A' ' 34' ' ' HIS . 5.3 m-85 -111.38 139.55 46.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.558 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.795 ' CE1' HD12 ' A' ' 81' ' ' ILE . 82.2 m-85 -113.93 127.34 55.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.908 . . . . 0.0 109.39 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.818 HG22 HG23 ' A' ' 32' ' ' ILE . 16.3 p -118.49 152.6 35.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.574 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 53.7 t0 -151.36 152.87 33.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -135.08 118.0 1.84 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.8 m -122.18 150.28 42.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -1.149 . . . . 0.0 109.536 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -123.44 145.89 48.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.493 ' CD1' ' OG ' ' A' ' 161' ' ' SER . 74.5 mt -117.73 141.48 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 109.461 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 pttm -104.62 136.43 44.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.587 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.486 ' OG ' ' HD2' ' A' ' 22' ' ' PRO . 4.0 t -120.04 155.1 55.81 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.479 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 46.4 Cg_endo -67.67 -18.51 48.11 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.621 2.214 . . . . 0.0 112.009 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.582 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -82.38 -66.4 0.22 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.223 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 21' ' ' ASP . 52.3 Cg_endo -71.91 68.4 3.11 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.592 2.195 . . . . 0.0 111.56 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.0 m -54.61 -43.64 72.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.374 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -98.41 36.06 1.68 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.312 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' A' ' 22' ' ' PRO . 16.2 t -161.5 138.12 8.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.371 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -126.36 159.13 34.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.559 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 78.1 m-20 -92.9 115.55 28.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.477 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -99.19 148.29 24.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.4 ' HA3' ' N ' ' A' ' 161' ' ' SER . . . -141.83 153.18 24.05 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.943 ' CE ' HD21 ' A' ' 51' ' ' LEU . 70.9 mtm -119.95 161.5 20.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.449 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 12' ' ' THR . . . -154.42 117.48 0.79 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.818 HG23 HG22 ' A' ' 12' ' ' THR . 4.8 mp -125.74 120.29 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -1.138 . . . . 0.0 109.256 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.584 HG22 HG13 ' A' ' 43' ' ' VAL . 9.6 p -119.59 145.89 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.735 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.688 ' CG ' ' CE2' ' A' ' 10' ' ' PHE . 0.6 OUTLIER -105.72 136.17 45.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.147 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.38 167.37 20.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.642 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.6 t -124.56 159.85 29.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.369 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.549 ' CG ' ' OH ' ' A' ' 6' ' ' TYR . 17.7 m-85 -106.71 16.9 23.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.71 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.589 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -51.28 -178.7 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.852 . . . . 0.0 108.711 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.589 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 41.5 Cg_endo -65.02 -6.37 12.73 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.964 1.776 . . . . 0.0 111.566 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -131.64 106.09 7.94 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.736 ' CE1' HG23 ' A' ' 145' ' ' ILE . 60.5 t80 -57.44 126.02 25.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.469 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -155.21 149.14 25.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -0.91 . . . . 0.0 109.534 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.584 HG13 HG22 ' A' ' 33' ' ' VAL . 51.4 t -91.49 121.06 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.92 . . . . 0.0 109.523 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 53.1 mt -63.93 -38.89 92.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.536 ' O ' HG23 ' A' ' 33' ' ' VAL . 39.9 t30 -179.99 156.29 0.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.579 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.528 ' HG2' ' CG2' ' A' ' 33' ' ' VAL . 93.5 mt-30 -110.46 147.82 33.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.426 -0.796 . . . . 0.0 109.025 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.519 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -126.07 132.89 51.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.124 -0.985 . . . . 0.0 109.716 -179.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.7 t -126.22 132.11 51.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.242 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.476 ' HB ' ' CE ' ' A' ' 30' ' ' MET . 3.0 mt -135.51 111.64 10.69 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.722 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.499 ' HB3' ' CG2' ' A' ' 163' ' ' VAL . 50.2 Cg_endo -70.87 134.92 26.65 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.729 2.286 . . . . 0.0 111.665 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.943 HD21 ' CE ' ' A' ' 30' ' ' MET . 49.9 mt -104.51 138.28 41.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.248 -0.907 . . . . 0.0 109.617 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' O ' ' ND1' ' A' ' 54' ' ' HIS . . . -113.81 127.63 7.91 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 18.4 m120 64.44 38.55 7.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -1.181 . . . . 0.0 109.469 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 52' ' ' GLY . 75.9 m80 -124.74 165.46 17.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.492 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.581 HG23 ' HG3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -110.56 171.42 7.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 109.179 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 60' ' ' GLU . . . -53.95 -39.72 66.19 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.094 -1.004 . . . . 0.0 109.231 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 60' ' ' GLU . 92.4 mt-30 -67.35 -53.66 27.48 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.871 . . . . 0.0 109.263 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.581 ' HG3' HG23 ' A' ' 55' ' ' THR . 69.7 mmm -44.73 -34.61 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.33 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.685 ' HB2' HD12 ' A' ' 51' ' ' LEU . . . -76.83 -32.49 57.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.399 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' GLN . 97.7 mt-10 -62.85 -40.61 97.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.58 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.571 HD11 ' CE2' ' A' ' 117' ' ' TRP . 17.7 tt -74.73 -35.12 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.549 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.606 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -71.02 -30.15 66.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.56 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.705 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -59.93 -39.29 84.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.555 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.685 HG21 HG12 ' A' ' 87' ' ' VAL . 44.3 t -77.14 -43.99 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.555 ' HG2' HD11 ' A' ' 120' ' ' ILE . 98.1 mt-10 -55.78 -36.83 67.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.548 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.586 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 10.8 t80 -59.87 -68.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.645 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 71' ' ' ALA . . . -60.77 -13.58 16.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 109.602 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.676 ' SG ' HG23 ' A' ' 120' ' ' ILE . 40.2 t -66.3 -60.77 2.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.485 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -65.65 -40.99 93.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.586 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 54.3 mttm -65.86 -27.42 68.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.566 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 67' ' ' ALA . . . -69.14 -57.13 5.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 72' ' ' LEU . 24.7 tp -61.52 -39.25 90.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.902 . . . . 0.0 109.469 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -47.07 -37.47 9.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.543 ' CG2' ' HD2' ' A' ' 75' ' ' PRO . 33.9 mm -61.66 142.8 94.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 108.958 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 41.5 Cg_endo -64.6 -5.94 11.19 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.575 2.183 . . . . 0.0 111.731 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.463 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -134.29 166.79 24.03 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.497 ' HG2' ' O ' ' A' ' 5' ' ' GLN . 47.5 Cg_endo -68.65 140.97 48.57 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.547 2.165 . . . . 0.0 111.679 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.628 HG11 ' CE1' ' A' ' 10' ' ' PHE . 21.8 t -126.32 159.31 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.537 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.819 ' HB2' HG22 ' A' ' 9' ' ' VAL . 1.9 mp -113.32 124.52 52.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.834 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 62.4 t -104.9 133.13 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.795 HD12 ' CE1' ' A' ' 11' ' ' TYR . 31.9 mt -119.97 135.71 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.935 . . . . 0.0 109.479 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.666 HG21 HG22 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -130.66 161.79 30.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 109.258 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 83' ' ' ASP . 53.9 p-10 -90.02 10.86 22.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.189 -0.945 . . . . 0.0 109.548 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.4 t -112.04 126.02 54.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.579 ' HB2' ' CE1' ' A' ' 134' ' ' HIS . 70.8 t80 -80.64 -40.23 25.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 90' ' ' SER . 96.0 m-85 -61.02 -49.56 76.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.685 HG12 HG21 ' A' ' 64' ' ' VAL . 48.4 t -61.7 -52.12 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.403 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.596 ' HA ' HG21 ' A' ' 132' ' ' ILE . . . -52.88 -61.04 2.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.895 . . . . 0.0 109.341 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 81.5 tt0 -57.82 -18.98 25.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.191 -0.943 . . . . 0.0 109.277 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.532 ' HA ' ' CG ' ' A' ' 94' ' ' GLU . 8.4 t -66.73 -65.09 0.72 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.557 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.883 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -69.82 -7.5 40.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.553 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 85.1 m-20 -86.58 -46.33 10.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.678 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 96' ' ' PRO . 62.6 mttp -126.46 -47.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 109.732 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.583 ' HB3' ' CE2' ' A' ' 98' ' ' TRP . 81.7 mt-10 -51.46 -44.22 62.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.694 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.883 HD23 ' HA ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -50.68 -63.45 1.87 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.912 . . . . 0.0 109.54 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.521 ' CD ' ' CB ' ' A' ' 95' ' ' LEU . 48.0 Cg_endo -68.69 -42.05 5.24 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.749 2.299 . . . . 0.0 112.035 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -63.31 -40.05 96.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.622 ' CE2' ' CD2' ' A' ' 111' ' ' LEU . 39.9 m0 -65.07 -43.71 91.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.59 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -50.18 -39.89 45.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 109.565 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.1 p -66.02 -29.95 70.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -90.31 8.57 32.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 109.511 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.68 33.24 71.23 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.97 ' C ' HD12 ' A' ' 111' ' ' LEU . 20.8 m-85 68.21 32.59 4.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -1.108 . . . . 0.0 109.457 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.24 127.26 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.406 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.503 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 18.7 t-20 -87.8 -73.64 0.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.538 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 105' ' ' ASN . 25.1 m120 -144.25 157.11 44.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.524 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -60.94 -32.52 72.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.464 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.94 -37.45 84.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.207 -0.933 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.86 127.24 3.96 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.467 ' HG2' ' HE2' ' A' ' 112' ' ' LYS . 50.4 Cg_endo -70.25 167.19 25.79 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.593 2.195 . . . . 0.0 111.739 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.97 HD12 ' C ' ' A' ' 103' ' ' PHE . 21.0 mt -59.51 -39.03 82.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.452 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.467 ' HE2' ' HG2' ' A' ' 110' ' ' PRO . 34.2 mttt 59.74 152.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 64.0 m80 60.23 27.05 16.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.444 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 80.5 mt -62.5 -38.33 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.361 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.9 t -56.27 -45.85 79.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.278 -0.889 . . . . 0.0 109.315 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.44 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 61.8 mttp -60.06 -54.06 50.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.346 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.571 ' CE2' HD11 ' A' ' 61' ' ' ILE . 91.9 m95 -65.21 -33.15 75.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 109.387 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -54.01 -45.95 71.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.378 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.9 m -53.29 -44.13 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.306 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.676 HG23 ' SG ' ' A' ' 68' ' ' CYS . 83.7 mt -72.01 -32.79 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.364 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.91 88.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.89 . . . . 0.0 109.358 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.91 -39.01 83.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.875 ' SG ' HD11 ' A' ' 130' ' ' ILE . 23.0 t -68.58 -44.09 75.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.563 HD23 HD12 ' A' ' 130' ' ' ILE . 55.1 mt -68.15 -34.15 75.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.5 t -59.64 -33.75 71.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.427 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.458 ' O ' ' HG3' ' A' ' 127' ' ' LYS . 92.0 mtp -67.91 -33.96 75.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 126' ' ' MET . 0.6 OUTLIER 177.35 136.58 0.22 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.512 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.9 Cg_endo -71.56 2.45 4.55 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.728 2.285 . . . . 0.0 112.078 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 31.6 p-10 -43.71 -39.04 3.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 109.662 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.875 HD11 ' SG ' ' A' ' 123' ' ' CYS . 52.6 mt -59.3 115.57 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.741 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.0 m -111.6 134.05 53.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.025 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.795 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 64.4 mt -116.44 135.9 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.081 -1.012 . . . . 0.0 109.887 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 81' ' ' ILE . 87.8 mt-30 -126.0 154.22 43.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.359 -0.838 . . . . 0.0 109.3 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.579 ' CE1' ' HB2' ' A' ' 85' ' ' PHE . 17.4 t-80 -108.34 127.0 53.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -70.48 145.8 50.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.727 ' CE ' HG23 ' A' ' 141' ' ' THR . 30.8 mttm -96.25 35.4 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.418 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.74 -154.27 41.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -56.28 -40.75 74.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -1.136 . . . . 0.0 109.511 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -64.94 125.83 89.9 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.46 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.72 ' HB3' HG23 ' A' ' 147' ' ' THR . 50.3 Cg_endo -70.43 136.74 31.94 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.641 2.227 . . . . 0.0 111.761 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.727 HG23 ' CE ' ' A' ' 136' ' ' LYS . 45.3 m -57.15 -44.27 83.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.404 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 141' ' ' THR . 96.5 m-20 -139.3 -43.17 0.46 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 140' ' ' PRO . 17.3 p -130.17 159.87 35.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 109.466 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 82.5 p -70.15 -14.16 62.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.498 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.736 HG23 ' CE1' ' A' ' 41' ' ' TYR . 88.4 mt -61.93 -35.38 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.583 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -69.15 -36.85 77.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.509 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.72 HG23 ' HB3' ' A' ' 140' ' ' PRO . 58.3 p -69.05 -40.24 78.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.478 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 144' ' ' SER . 97.3 mt-10 -54.07 -37.41 64.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.54 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -65.13 -34.54 89.98 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -65.73 -38.12 88.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -1.185 . . . . 0.0 109.458 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.91 -48.8 67.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.551 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 mt -65.7 -44.32 86.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.92 -37.7 83.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.427 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 57.4 t0 -62.59 -41.24 98.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 159' ' ' GLN . 69.0 mttm -63.4 -36.02 82.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.501 ' CD1' ' HB ' ' A' ' 33' ' ' VAL . 71.4 mt -69.31 -37.23 77.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.49 -43.94 68.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 31.7 m -60.14 -42.2 94.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.574 ' O ' HG13 ' A' ' 163' ' ' VAL . 95.1 mt-30 -65.23 -33.31 75.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.313 -0.867 . . . . 0.0 109.541 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.87 ' O ' HG22 ' A' ' 163' ' ' VAL . . . -61.84 -46.61 93.8 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.493 ' OG ' ' CD1' ' A' ' 17' ' ' ILE . 91.2 p -72.9 -26.19 61.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -1.136 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -68.36 -35.99 78.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 160' ' ' GLY . 18.1 m -70.87 -14.23 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.573 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.422 HG23 HG23 ' A' ' 163' ' ' VAL . 41.0 t -105.34 134.69 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.508 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 51.3 t30 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.472 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 5' ' ' GLN . . . -63.78 -31.2 72.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -1.185 . . . . 0.0 109.475 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.766 ' HE2' ' CZ ' ' A' ' 37' ' ' TYR . 92.7 mmm -62.6 -32.95 74.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.513 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.94 -18.15 32.08 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 97.3 mt-30 -52.12 -33.24 38.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -1.138 . . . . 0.0 109.525 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 1.032 ' CD2' HD11 ' A' ' 79' ' ' LEU . 43.9 m-85 -100.76 176.09 5.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.611 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -76.48 -36.3 57.91 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.256 -0.903 . . . . 0.0 109.19 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.47 -166.46 35.26 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.779 HG13 ' HB3' ' A' ' 35' ' ' ALA . 7.2 p -125.29 140.72 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.377 -1.072 . . . . 0.0 108.996 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.858 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.6 m-85 -117.69 135.89 53.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 109.85 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.84 ' CE1' HD12 ' A' ' 81' ' ' ILE . 95.0 m-85 -114.08 118.72 34.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.994 HG22 HG23 ' A' ' 32' ' ' ILE . 19.0 p -115.79 151.61 34.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 0.0 109.728 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 14' ' ' GLY . 53.1 t0 -147.51 156.15 42.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.351 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 13' ' ' ASP . . . -163.21 117.11 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.463 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 68.7 m -138.85 147.98 43.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -1.163 . . . . 0.0 109.74 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -107.81 140.52 40.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.465 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.796 HD12 ' HB3' ' A' ' 161' ' ' SER . 68.6 mt -107.58 137.52 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.905 . . . . 0.0 109.524 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 36.6 tttp -93.08 145.3 24.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.266 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.542 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -125.53 176.38 2.49 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.346 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 44.9 Cg_endo -68.27 -7.74 20.9 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.463 2.109 . . . . 0.0 111.284 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -134.81 70.63 70.89 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.455 -0.778 . . . . 0.0 109.091 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.78 7.22 0.6 Allowed 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.95 2.433 . . . . 0.0 112.773 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 m -57.61 -25.14 59.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.903 -1.123 . . . . 0.0 109.147 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 25' ' ' SER . 42.9 mttt -103.68 25.91 9.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.369 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 8.2 t 66.63 164.01 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.861 . . . . 0.0 109.651 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 18' ' ' LYS . 96.0 m-20 -77.31 149.56 35.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.464 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -93.65 129.2 40.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 108.987 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.643 ' CB ' ' CE1' ' A' ' 54' ' ' HIS . . . -119.46 164.47 15.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -0.99 . . . . 0.0 110.158 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.82 146.77 18.75 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.776 ' SD ' ' HB3' ' A' ' 62' ' ' ALA . 61.7 mtm -120.0 145.75 46.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.479 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.81 118.61 1.78 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.994 HG23 HG22 ' A' ' 12' ' ' THR . 4.6 mp -120.86 116.87 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -1.153 . . . . 0.0 109.255 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 45' ' ' ASN . 7.2 p -124.45 144.47 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.101 -1.0 . . . . 0.0 109.731 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.674 ' CG ' ' CE2' ' A' ' 10' ' ' PHE . 1.4 m-70 -101.59 141.72 34.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.852 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.779 ' HB3' HG13 ' A' ' 9' ' ' VAL . . . -129.81 165.81 21.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.44 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.1 t -126.16 165.25 19.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.766 ' CZ ' ' HE2' ' A' ' 3' ' ' MET . 82.8 m-85 -107.92 10.16 28.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.58 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -51.18 179.72 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.007 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.58 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 42.2 Cg_endo -65.45 -5.38 11.31 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.183 1.922 . . . . 0.0 111.658 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -129.25 106.02 8.54 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -64.83 129.93 41.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -167.66 154.12 7.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.479 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 43' ' ' VAL . 32.6 m -89.37 120.59 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.887 . . . . 0.0 109.461 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 34' ' ' HIS . 55.3 mt -57.78 -38.8 76.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.342 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.731 ' O ' HG23 ' A' ' 33' ' ' VAL . 60.9 t30 -169.6 155.43 6.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.918 . . . . 0.0 109.594 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.528 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 91.9 mt-30 -112.59 137.8 50.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.831 . . . . 0.0 109.103 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.52 ' N ' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -118.01 133.38 55.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.142 -0.974 . . . . 0.0 109.659 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.5 t -119.85 140.17 51.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 109.31 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.645 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 1.7 mt -145.5 92.32 5.57 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 109.693 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.671 ' HG3' HG11 ' A' ' 163' ' ' VAL . 49.8 Cg_endo -70.39 147.5 58.98 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.682 2.254 . . . . 0.0 111.598 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 50' ' ' PRO . 43.1 mt -123.88 129.44 51.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.698 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.689 ' HA2' HG11 ' A' ' 164' ' ' VAL . . . -92.78 -73.57 1.24 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -102.22 87.98 3.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.165 . . . . 0.0 109.154 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.643 ' CE1' ' CB ' ' A' ' 28' ' ' ALA . 6.7 p-80 -132.29 -163.82 1.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.976 . . . . 0.0 109.949 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.841 HG23 ' HE3' ' A' ' 58' ' ' MET . 0.2 OUTLIER -128.93 144.8 51.29 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 55' ' ' THR . . . -44.69 -33.91 2.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.084 -1.01 . . . . 0.0 109.13 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 61' ' ' ILE . 85.5 mt-30 -77.79 -47.78 18.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.841 ' HE3' HG23 ' A' ' 55' ' ' THR . 24.2 ttm -48.79 -35.07 13.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.987 . . . . 0.0 109.23 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' A' ' 54' ' ' HIS . . . -74.18 -45.86 45.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.382 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.91 -34.83 77.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.577 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.669 HD12 ' CZ2' ' A' ' 117' ' ' TRP . 18.7 tt -77.32 -37.28 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.557 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.776 ' HB3' ' SD ' ' A' ' 30' ' ' MET . . . -65.9 -29.78 70.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.15 92.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.654 HG21 HG12 ' A' ' 87' ' ' VAL . 46.5 t -77.82 -49.97 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.524 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 68' ' ' CYS . 87.2 tt0 -53.09 -39.79 63.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.632 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.645 ' CZ ' HD11 ' A' ' 49' ' ' ILE . 13.0 t80 -57.76 -69.11 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 109.57 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.528 ' HB3' HG11 ' A' ' 80' ' ' VAL . . . -62.34 -15.95 51.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 109.462 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 1.057 ' SG ' HG23 ' A' ' 120' ' ' ILE . 39.4 t -66.09 -63.07 1.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -60.99 -44.35 97.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.566 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 48.7 mttm -62.85 -36.52 83.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.856 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -59.28 -64.18 1.04 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.366 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.876 ' HB2' HD11 ' A' ' 130' ' ' ILE . 20.0 tp -51.98 -46.73 64.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.922 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 72' ' ' LEU . 19.4 tttm -42.58 -41.1 2.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.0 109.276 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.555 HG23 ' HD2' ' A' ' 75' ' ' PRO . 34.8 mm -52.29 143.44 25.98 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.823 . . . . 0.0 108.802 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.555 ' HD2' HG23 ' A' ' 74' ' ' ILE . 43.1 Cg_endo -65.09 -2.47 5.73 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.632 2.221 . . . . 0.0 112.203 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.484 ' H ' HG22 ' A' ' 74' ' ' ILE . . . -143.13 170.65 25.29 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 47.7 Cg_endo -69.46 119.86 6.77 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.445 2.097 . . . . 0.0 111.693 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.858 HG21 ' CE1' ' A' ' 10' ' ' PHE . 7.7 p -114.01 146.56 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.399 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.032 HD11 ' CD2' ' A' ' 6' ' ' TYR . 15.9 mt -93.05 143.28 26.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.737 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.528 HG11 ' HB3' ' A' ' 67' ' ' ALA . 49.6 t -124.13 126.33 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 109.183 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.84 HD12 ' CE1' ' A' ' 11' ' ' TYR . 33.6 mt -113.49 136.22 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.784 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.557 HG21 ' CG2' ' A' ' 64' ' ' VAL . 10.3 t -142.31 159.27 42.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.351 -0.843 . . . . 0.0 109.276 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.47 ' HB3' ' OE1' ' A' ' 135' ' ' GLU . 51.0 p-10 -92.69 20.22 6.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.152 -0.967 . . . . 0.0 109.466 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.49 ' CB ' ' HB ' ' A' ' 87' ' ' VAL . 41.9 m -105.57 104.48 14.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 109.347 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.567 ' CE2' ' OE2' ' A' ' 89' ' ' GLU . 74.8 t80 -69.37 -50.19 48.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 109.583 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -60.81 -40.57 93.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.609 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.654 HG12 HG21 ' A' ' 64' ' ' VAL . 92.5 t -62.84 -39.57 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.378 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.61 -60.66 3.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.567 ' OE2' ' CE2' ' A' ' 85' ' ' PHE . 94.0 mt-10 -50.93 -35.35 32.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.618 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 70.6 m -55.91 -47.24 77.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.612 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -88.6 -0.92 57.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.907 . . . . 0.0 109.805 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.454 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 84.2 m-20 -90.61 -73.61 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.122 -0.986 . . . . 0.0 109.953 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 96' ' ' PRO . 96.8 mttt -127.13 -31.66 2.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.0 109.842 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 57.0 mt-10 -52.18 -40.49 61.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.911 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.064 HD21 ' HB2' ' A' ' 121' ' ' ALA . 6.4 tp -62.93 -58.3 17.16 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.063 -1.023 . . . . 0.0 109.537 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 44.3 Cg_endo -65.89 -26.02 52.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.521 2.147 . . . . 0.0 111.261 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -75.56 -35.74 60.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.345 -0.847 . . . . 0.0 108.72 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.568 ' CD2' HD21 ' A' ' 111' ' ' LEU . 15.9 m0 -63.05 -48.31 79.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.291 -0.881 . . . . 0.0 108.979 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 98' ' ' TRP . 4.6 mtmt -43.57 -44.03 5.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 109.418 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.4 m -64.2 -42.17 96.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.4 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -68.72 -14.14 62.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.332 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 84.53 34.11 17.44 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 40.4 m-85 67.22 37.97 3.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -1.148 . . . . 0.0 109.375 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 109' ' ' LYS . 60.9 t -117.07 129.33 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.499 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 109' ' ' LYS . 40.0 t-20 -86.23 117.31 24.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.89 . . . . 0.0 109.446 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -58.57 -35.67 72.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.433 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -58.17 -37.19 74.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 109.463 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.476 ' O ' ' CG ' ' A' ' 109' ' ' LYS . 85.4 mttt -135.17 -82.57 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.418 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.591 ' CB ' ' CD ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -172.53 -67.44 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.168 -0.957 . . . . 0.0 109.529 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 109' ' ' LYS . 52.6 Cg_endo -71.85 141.35 36.96 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.598 2.199 . . . . 0.0 111.933 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.568 HD21 ' CD2' ' A' ' 98' ' ' TRP . 19.0 tp -93.65 133.98 36.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.239 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 20.6 mttt -97.61 149.14 22.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.667 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.568 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 48.1 m80 66.29 30.4 9.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.341 -0.849 . . . . 0.0 109.679 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 111' ' ' LEU . 91.1 mt -64.56 -50.35 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.133 -0.98 . . . . 0.0 109.308 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.2 m -60.08 -44.18 94.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.233 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -59.19 -50.17 75.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.308 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.669 ' CZ2' HD12 ' A' ' 61' ' ' ILE . 53.0 m95 -69.27 -35.77 76.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.907 . . . . 0.0 109.325 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -56.88 -45.93 82.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.341 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.9 m -55.43 -45.36 76.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.375 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 1.057 HG23 ' SG ' ' A' ' 68' ' ' CYS . 69.0 mt -66.82 -36.62 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.409 -0.807 . . . . 0.0 109.411 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 1.064 ' HB2' HD21 ' A' ' 95' ' ' LEU . . . -57.42 -43.4 83.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.461 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.21 -45.84 75.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.506 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 93.4 m -66.52 -46.56 75.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.23 -32.51 73.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.365 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.4 m -61.65 -35.17 77.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.55 ' SD ' HD21 ' A' ' 72' ' ' LEU . 66.1 mtt -64.6 -34.38 78.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.423 ' HG2' ' C ' ' A' ' 126' ' ' MET . 0.2 OUTLIER 174.57 145.39 0.21 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.242 -0.911 . . . . 0.0 109.559 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' A' ' 129' ' ' ASP . 52.6 Cg_endo -72.17 2.33 5.07 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.698 2.265 . . . . 0.0 111.763 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 128' ' ' PRO . 76.9 m-20 -42.39 -46.79 4.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.559 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 72' ' ' LEU . 60.5 mt -56.6 122.14 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.527 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.658 ' CB ' HD22 ' A' ' 79' ' ' LEU . 24.6 m -112.2 141.55 45.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.154 -0.966 . . . . 0.0 109.337 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.612 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 70.8 mt -125.25 134.61 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.935 . . . . 0.0 109.669 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.444 ' HB2' HG12 ' A' ' 81' ' ' ILE . 91.4 mt-30 -124.94 157.89 34.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.477 ' NE2' ' HB2' ' A' ' 85' ' ' PHE . 46.4 t-80 -113.48 127.75 56.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.499 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.47 ' OE1' ' HB3' ' A' ' 83' ' ' ASP . 95.3 mt-10 -58.05 151.68 18.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 140' ' ' PRO . 65.6 mttm -93.65 33.71 1.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.41 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.95 -164.21 29.81 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -78.11 -27.34 48.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.289 -1.124 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -116.39 76.19 6.9 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.885 . . . . 0.0 109.419 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.474 ' CG ' ' OG1' ' A' ' 147' ' ' THR . 49.1 Cg_endo -69.93 153.9 67.65 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.722 2.282 . . . . 0.0 111.738 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 37.8 m -120.15 142.82 48.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 109.362 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.794 ' O ' HG23 ' A' ' 143' ' ' THR . 81.4 m-20 55.85 48.03 18.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.416 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 142' ' ' ASN . 0.1 OUTLIER 176.6 35.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.448 ' O ' ' HB ' ' A' ' 147' ' ' THR . 86.8 p -64.67 -23.65 67.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.903 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 83.4 mt -58.36 -55.29 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -65.4 -21.46 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.474 ' OG1' ' CG ' ' A' ' 140' ' ' PRO . 97.7 m -61.24 -47.01 88.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 109.52 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.15 -46.23 53.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -61.66 -36.82 93.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.411 ' O ' ' CG ' ' A' ' 154' ' ' ASP . 82.1 m-20 -63.55 -37.25 86.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -1.191 . . . . 0.0 109.418 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.89 -51.6 66.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.426 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 57.1 mt -66.32 -43.64 85.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.59 87.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.542 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.46 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 94.8 m-20 -66.35 -41.25 89.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.88 . . . . 0.0 109.534 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -59.45 -39.79 84.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.54 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 46' ' ' GLN . 70.8 mt -65.57 -37.43 86.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.91 93.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.926 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.707 HG22 ' HE2' ' A' ' 162' ' ' TYR . 50.6 m -61.76 -41.66 97.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -0.943 . . . . 0.0 109.667 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.538 ' O ' HG23 ' A' ' 163' ' ' VAL . 62.1 tt0 -63.34 -34.34 77.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.603 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.24 -42.37 88.21 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.796 ' HB3' HD12 ' A' ' 17' ' ' ILE . 17.3 m -61.47 -37.21 82.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -1.161 . . . . 0.0 109.581 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.707 ' HE2' HG22 ' A' ' 158' ' ' THR . 89.6 m-85 -69.53 -21.09 63.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 0.0 109.509 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.671 HG11 ' HG3' ' A' ' 50' ' ' PRO . 39.3 t -66.0 -29.6 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.689 HG11 ' HA2' ' A' ' 52' ' ' GLY . 47.5 t -112.82 137.63 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.507 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.446 179.965 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.88 142.73 53.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -1.158 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.575 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 88.5 mtp -62.9 -37.17 85.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.487 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 106.86 -14.37 41.28 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 92.3 mt-30 62.99 44.85 5.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -1.101 . . . . 0.0 109.488 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 1.053 ' CD2' HD11 ' A' ' 79' ' ' LEU . 98.2 m-85 -50.4 -179.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.135 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.515 ' CG ' ' HA3' ' A' ' 76' ' ' GLY . 74.5 mm-40 -68.45 -37.01 79.82 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.079 -1.013 . . . . 0.0 109.04 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.62 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -179.35 -177.06 47.5 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 79' ' ' LEU . 95.1 t -133.29 132.23 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.346 -1.09 . . . . 0.0 108.943 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.664 ' CE1' HG21 ' A' ' 78' ' ' VAL . 6.9 m-85 -113.23 140.1 48.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 110.058 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 1.071 ' CE2' HD12 ' A' ' 81' ' ' ILE . 70.9 m-85 -112.15 133.71 54.13 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.364 -0.835 . . . . 0.0 109.095 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 1.047 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 7.1 p -121.05 152.51 38.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.645 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -152.86 152.6 31.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.347 -0.846 . . . . 0.0 109.388 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.17 128.67 5.68 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.553 ' OG ' ' HB3' ' A' ' 157' ' ' ALA . 50.6 m -122.17 148.88 44.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -1.146 . . . . 0.0 109.307 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 27' ' ' ASN . . . -133.82 145.03 49.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 78.3 mt -119.69 137.7 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.325 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HG3' ' OD1' ' A' ' 26' ' ' ASN . 20.8 tttt -99.97 158.17 16.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.506 ' CB ' ' CD ' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -126.55 -177.71 0.63 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.459 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 19' ' ' SER . 55.3 Cg_endo -85.95 104.8 0.77 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.798 2.332 . . . . 0.0 111.668 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.596 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER 58.89 41.36 0.61 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.149 -0.969 . . . . 0.0 110.151 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 21' ' ' ASP . 54.6 Cg_endo -74.03 91.1 0.94 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.061 1.841 . . . . 0.0 111.229 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.1 m -52.44 -20.23 2.72 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.621 -0.832 . . . . 0.0 108.93 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 25' ' ' SER . 14.5 ttpt -93.57 140.41 29.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 0.0 108.699 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 26' ' ' ASN . 26.4 t -41.61 147.79 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.102 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 25' ' ' SER . 96.7 m-20 -47.51 174.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.446 -0.784 . . . . 0.0 109.279 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 95.1 m-20 -96.12 129.12 43.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.406 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -112.2 156.35 22.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.736 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.25 160.48 26.82 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 1.0 ' SD ' HD21 ' A' ' 51' ' ' LEU . 76.2 mtp -121.15 150.89 40.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -1.189 . . . . 0.0 109.678 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.53 117.76 0.84 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 32' ' ' ILE . 5.4 mp -121.73 139.89 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 109.638 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' CG1' HG13 ' A' ' 43' ' ' VAL . 21.3 t -114.73 139.64 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.323 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.559 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 40.5 m170 -107.24 139.95 40.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.615 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.59 166.51 24.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.596 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.592 ' HB ' HD11 ' A' ' 44' ' ' LEU . 15.4 t -139.9 164.45 29.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.654 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.513 ' OH ' HG21 ' A' ' 9' ' ' VAL . 58.6 m-85 -97.69 14.17 27.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.645 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.574 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 2.2 mttt -50.88 178.57 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 108.776 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.574 ' HD2' ' CB ' ' A' ' 38' ' ' LYS . 43.5 Cg_endo -65.33 -6.46 13.4 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.179 1.92 . . . . 0.0 111.534 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.446 ' HG3' ' HG3' ' A' ' 42' ' ' GLN . 38.9 tp10 -137.75 106.43 5.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -0.846 . . . . 0.0 109.086 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.434 ' CZ ' ' CG2' ' A' ' 145' ' ' ILE . 51.7 t80 -63.3 118.09 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.908 . . . . 0.0 109.297 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.446 ' HG3' ' HG3' ' A' ' 40' ' ' GLU . 93.5 mt-30 -151.9 145.61 25.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.582 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.448 HG13 ' CG1' ' A' ' 33' ' ' VAL . 24.5 t -63.56 117.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.3 -0.875 . . . . 0.0 109.512 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.592 HD11 ' HB ' ' A' ' 36' ' ' THR . 43.0 mt -63.51 -37.55 87.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -177.59 158.99 1.43 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.667 HE21 HD21 ' A' ' 152' ' ' LEU . 90.1 mt-30 -106.94 138.81 42.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.329 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -126.45 131.4 51.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.776 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.4 m -129.92 136.45 49.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.244 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.578 HD11 ' CZ ' ' A' ' 66' ' ' PHE . 3.8 mt -134.95 112.12 11.28 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.53 138.06 34.57 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.744 2.296 . . . . 0.0 111.623 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.0 HD21 ' SD ' ' A' ' 30' ' ' MET . 61.6 mt -111.18 139.58 46.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.51 ' O ' ' ND1' ' A' ' 54' ' ' HIS . . . -115.17 132.03 10.11 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 52' ' ' GLY . 72.3 m-20 62.94 38.02 11.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.151 . . . . 0.0 109.502 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 52' ' ' GLY . 74.3 m80 -124.61 159.56 30.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.58 HG23 ' SD ' ' A' ' 58' ' ' MET . 0.1 OUTLIER -101.87 168.47 9.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 0.0 109.171 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.86 -33.57 66.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -0.981 . . . . 0.0 108.975 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.2 -50.89 24.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.319 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.58 ' SD ' HG23 ' A' ' 55' ' ' THR . 99.2 mtp -55.15 -28.84 55.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . . . -74.18 -40.42 62.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.493 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.17 -42.83 95.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.612 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.815 ' HA ' HG21 ' A' ' 87' ' ' VAL . 14.9 tt -69.62 -32.11 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.73 -27.7 67.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.0 109.327 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.047 ' HB1' ' HB ' ' A' ' 12' ' ' THR . . . -71.27 -38.07 71.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.483 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.746 HG22 HG21 ' A' ' 82' ' ' THR . 89.8 t -69.44 -40.52 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.587 ' HG2' HD11 ' A' ' 120' ' ' ILE . 99.2 mt-10 -64.74 -41.95 95.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.016 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.596 ' CZ ' ' HE2' ' A' ' 70' ' ' LYS . 27.8 t80 -59.73 -65.25 0.71 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.485 -0.759 . . . . 0.0 109.711 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.21 68.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 109.725 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.689 ' SG ' HG23 ' A' ' 120' ' ' ILE . 50.4 t -60.7 -53.49 56.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 0.0 109.485 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -59.12 -50.86 72.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.664 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.596 ' HE2' ' CZ ' ' A' ' 66' ' ' PHE . 62.9 mttm -61.15 -36.31 79.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.862 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.882 ' HA ' HG11 ' A' ' 78' ' ' VAL . . . -57.0 -69.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.718 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.846 ' HB2' HD11 ' A' ' 130' ' ' ILE . 22.1 tp -46.83 -46.32 20.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.591 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 72' ' ' LEU . 14.4 tptt -44.19 -45.13 8.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.206 -0.934 . . . . 0.0 109.269 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.671 HD12 ' HB ' ' A' ' 78' ' ' VAL . 7.3 mt -48.36 142.87 7.79 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.023 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 74' ' ' ILE . 42.8 Cg_endo -65.57 -4.77 10.25 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.573 2.182 . . . . 0.0 111.749 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.515 ' HA3' ' CG ' ' A' ' 7' ' ' GLU . . . -140.62 168.57 25.18 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 6' ' ' TYR . 48.1 Cg_endo -68.4 122.11 9.11 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.411 2.074 . . . . 0.0 111.77 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.882 HG11 ' HA ' ' A' ' 71' ' ' ALA . 4.6 p -113.71 155.25 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.419 -0.801 . . . . 0.0 109.262 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.053 HD11 ' CD2' ' A' ' 6' ' ' TYR . 22.6 mt -99.8 149.04 23.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 109.833 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 132' ' ' ILE . 76.0 t -130.35 135.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.38 -0.825 . . . . 0.0 109.066 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.071 HD12 ' CE2' ' A' ' 11' ' ' TYR . 20.4 mt -119.87 139.47 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.953 . . . . 0.0 109.649 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.746 HG21 HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -128.29 161.85 28.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -0.854 . . . . 0.0 109.364 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 135' ' ' GLU . 58.3 p30 -92.48 13.39 19.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.442 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 42.6 m -132.82 125.47 30.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.59 ' N ' ' CD2' ' A' ' 134' ' ' HIS . 67.5 t80 -77.59 -42.02 36.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -49.9 -57.25 7.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.381 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.815 HG21 ' HA ' ' A' ' 61' ' ' ILE . 14.9 p -61.05 -46.61 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.291 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.615 ' N ' HG13 ' A' ' 87' ' ' VAL . . . -55.52 -55.5 31.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.902 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 92' ' ' ASN . 79.6 tt0 -54.75 -31.56 58.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.944 . . . . 0.0 109.184 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.604 ' CB ' ' CH2' ' A' ' 117' ' ' TRP . 18.0 t -56.68 -56.27 23.51 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 132' ' ' ILE . . . -80.32 -0.83 38.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.729 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.462 ' HB2' ' HA ' ' A' ' 89' ' ' GLU . 89.8 m-20 -84.54 -73.35 0.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.094 -1.004 . . . . 0.0 110.038 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 74.5 mttt -127.34 -27.84 2.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.132 -0.98 . . . . 0.0 110.269 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 68.1 mm-40 -61.04 -30.87 70.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.095 -1.003 . . . . 0.0 109.89 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -61.41 -58.53 18.07 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.718 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 95' ' ' LEU . 43.9 Cg_endo -66.02 -25.47 51.64 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.552 2.168 . . . . 0.0 111.694 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -71.46 -38.17 71.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.173 -0.954 . . . . 0.0 109.044 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.456 ' CE3' HD21 ' A' ' 111' ' ' LEU . 39.1 m0 -67.01 -47.89 70.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.257 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -47.38 -42.67 22.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.856 . . . . 0.0 109.472 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.6 m -57.42 -39.2 75.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.22 -0.925 . . . . 0.0 109.373 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -90.28 10.45 24.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.436 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 103' ' ' PHE . . . 72.65 40.92 52.31 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.47 ' CD1' HG23 ' A' ' 114' ' ' ILE . 97.9 m-85 60.69 33.08 20.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -1.123 . . . . 0.0 109.444 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.57 133.99 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -77.44 148.2 35.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.939 . . . . 0.0 109.521 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -50.13 -32.26 15.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.365 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -77.02 158.26 30.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -56.22 -31.45 63.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -63.19 143.84 97.55 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.495 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.71 165.82 29.64 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.659 2.239 . . . . 0.0 111.811 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.834 HD23 HG12 ' A' ' 114' ' ' ILE . 10.4 tp -78.92 135.6 37.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.465 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 113' ' ' HIS . 18.9 mttp -98.81 152.45 19.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.569 ' O ' ' CD1' ' A' ' 117' ' ' TRP . 36.7 m80 67.48 31.07 6.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.834 HG12 HD23 ' A' ' 111' ' ' LEU . 78.5 mt -68.74 -39.0 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.366 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.6 m -62.07 -44.61 96.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.362 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.454 ' HB3' ' OE2' ' A' ' 65' ' ' GLU . 54.3 mttp -61.45 -41.36 97.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.624 ' HH2' HG23 ' A' ' 87' ' ' VAL . 40.2 m95 -76.75 -30.69 56.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.37 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -59.27 -39.25 82.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.8 m -62.54 -44.86 95.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.689 HG23 ' SG ' ' A' ' 68' ' ' CYS . 78.0 mt -72.58 -30.25 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.442 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.505 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -61.72 -41.62 97.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.416 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -59.04 -40.23 84.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 109.387 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 46.3 m -68.15 -47.11 68.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.2 tp -63.32 -32.4 73.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.34 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 m -61.59 -31.8 71.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.568 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.478 ' HB3' ' HE3' ' A' ' 127' ' ' LYS . 93.6 mmm -67.54 -34.17 76.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 126' ' ' MET . 0.0 OUTLIER 170.67 147.6 0.14 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 129' ' ' ASP . 51.0 Cg_endo -71.63 -0.04 7.69 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.73 2.286 . . . . 0.0 111.633 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 128' ' ' PRO . 93.4 m-20 -42.49 -47.24 5.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.428 -0.795 . . . . 0.0 109.632 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.846 HD11 ' HB2' ' A' ' 72' ' ' LEU . 56.8 mt -58.89 119.14 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.618 ' HB ' HD22 ' A' ' 79' ' ' LEU . 24.8 m -112.42 140.44 47.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.689 ' CD1' ' HB3' ' A' ' 91' ' ' ALA . 58.8 mt -122.54 137.46 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 109.696 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.429 ' HB2' HG12 ' A' ' 81' ' ' ILE . 84.6 mt-30 -122.73 163.07 20.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.218 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.59 ' CD2' ' N ' ' A' ' 85' ' ' PHE . 14.8 t-80 -118.58 131.39 56.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 109.62 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.795 ' CD ' HG21 ' A' ' 81' ' ' ILE . 96.5 mt-10 -129.22 138.45 51.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.403 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.438 ' CE ' ' HB3' ' A' ' 138' ' ' HIS . 20.8 tttp -118.29 125.68 50.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.78 -41.54 96.01 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.438 ' HB3' ' CE ' ' A' ' 136' ' ' LYS . 84.9 t60 -58.36 -44.26 88.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.12 . . . . 0.0 109.569 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -85.89 151.8 55.49 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 109.502 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.53 143.01 50.52 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.752 2.301 . . . . 0.0 111.818 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.608 HG21 ' HB2' ' A' ' 146' ' ' HIS . 40.5 m -74.99 139.8 43.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -51.74 -40.23 59.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.535 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.413 ' H ' HG22 ' A' ' 141' ' ' THR . 24.3 p -126.77 152.06 47.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.166 -0.959 . . . . 0.0 109.517 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.4 m -69.85 -26.49 64.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.66 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.434 ' CG2' ' CZ ' ' A' ' 41' ' ' TYR . 92.4 mt -60.9 -45.65 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 109.599 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.608 ' HB2' HG21 ' A' ' 141' ' ' THR . 13.1 m170 -68.77 -23.23 64.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.562 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.41 ' OG1' ' HB ' ' A' ' 141' ' ' THR . 45.0 m -67.34 -45.27 76.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.0 109.679 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.99 -36.46 70.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.48 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -70.41 -28.51 71.14 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -69.38 -36.0 76.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 109.592 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -72.89 -52.8 13.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.597 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.667 HD21 HE21 ' A' ' 46' ' ' GLN . 25.0 tp -61.64 -37.71 85.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.172 -0.955 . . . . 0.0 109.626 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.58 -35.76 82.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.936 . . . . 0.0 109.664 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -67.68 -36.37 80.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.67 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.417 ' HE2' ' NE2' ' A' ' 159' ' ' GLN . 78.4 tttt -70.99 -36.11 72.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.775 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 66.4 mt -68.23 -34.77 76.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 109.658 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.553 ' HB3' ' OG ' ' A' ' 15' ' ' SER . . . -70.15 -39.73 75.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.544 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 44.7 m -66.06 -38.76 89.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.49 ' O ' HG23 ' A' ' 163' ' ' VAL . 94.6 mt-30 -66.35 -34.0 76.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 0.0 109.558 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.22 91.57 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.7 m -63.87 -37.42 87.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.418 ' O ' ' OD1' ' A' ' 165' ' ' ASN . 62.3 t80 -62.85 -40.76 98.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.602 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 159' ' ' GLN . 95.4 t -53.79 -39.61 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.537 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 66.7 t -55.95 -44.62 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.937 . . . . 0.0 109.546 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 162' ' ' TYR . 93.0 m-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.417 179.985 . . . . . . . . 1 1 . 1 stop_ save_